Download Final Programme European Congress of Clinical

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Public health genomics wikipedia, lookup

Hygiene hypothesis wikipedia, lookup

Infection wikipedia, lookup

Marburg virus disease wikipedia, lookup

Multiple sclerosis research wikipedia, lookup

Transmission (medicine) wikipedia, lookup

Pandemic wikipedia, lookup

Infection control wikipedia, lookup

Syndemic wikipedia, lookup

Compartmental models in epidemiology wikipedia, lookup

Epidemiology wikipedia, lookup

Focal infection theory wikipedia, lookup

Antimicrobial resistance wikipedia, lookup

Transcript
European Congress of
Clinical Microbiology
and Infectious Diseases
24th
Barcelona, Spain
10 – 13 May 2014
ECCMID
Final Programme
www.eccmid.org
Join us today –
our commitment
is infectious!
– Become an
ESCMID member
– Then sign-up for
Study Groups
!
VISIT US WORLD
SCMID
IN THE E ID BARCELONA
AT ECCM
Good reasons for membership:
• Society’s journals: CMI, NMNI
• Registration discounts for events
• Participation in Study Groups
• ESCMID Newsletter and Yearbook
• Discounts to other journals
• Access to the Online Lecture Library
and Membership Directory
• Eligibility for ESCMID Awards,
Research Grants and Observerships
• Right to vote and participate in ESCMID
Apply for Membership
Visit our website and join us now!
www.escmid.org/membership
Address during the Congress
24th ECCMID
Centre Convencions Internacional Barcelona (CCIB)
Placa de Willy Brandt, 11-14
08019 Barcelona, Spain
www.ccib.es Important Addresses
01
Acknowledgements03
Welcome Address
05
Congress Venue Overview
06
Committees09
Administrative Secretariat
Kenes International
1-3 rue de Chantepoulet, PO Box 1726
1211 Geneva, Switzerland
Phone: +41 22 908 0488
Fax: +41 22 906 9140
Email: eccmid@kenes.com
18
23
24
25
Scientific Programme
Saturday, 10 May 2014
27
Sunday, 11 May 2014
39
Monday, 12 May 2014
51
Tuesday, 13 May 2014
63
ePoster Sessions
Sunday, 11 May 2014 Monday, 12 May 2014
ePosters Viewing
Saturday, 10 May 2014 – Tuesday, 13 May 2014
87
Poster Sessions
Saturday, 10 May 2014
Sunday, 11 May 2014
Monday, 12 May 2014
Tuesday, 13 May 2014
127
157
187
217
List of Chairpersons
List of Speakers & Authors
Instructions for Speakers & Authors
248
251
313
Integrated Symposia
314
Industrial Exhibition Overview
List of Exhibitors
Exhibitors’ Guide
327
328
331
Opening Ceremony and Networking Reception
General Information A – Z
Future Congresses
360
361
362
ePosters
77
81
Posters
Scientific Secretariat
24th ECCMID
c/o ESCMID Executive Office
P.O. Box 214
4010 Basel, Switzerland
Phone: +41 61 508 01 50
Email: eccmid@escmid.org
Scientific Programme Overview
CME Accreditation
Introduction to the Scientific Programme
ESCMID Study Groups and Business Meetings
Chairs, Speakers & Authors
ECCMID Deputy Programme Director
Prof Winfried V. Kern
Division of Infectious Diseases
Albert-Ludwigs-University
Hugstetter Strasse 55
79106 Freiburg, Germany
12
Exhibition
ECCMID Programme Director
Prof Dr Jordi Vila Estape
Head of the Department of Clinical Microbiology
Hospital Clinic
School of Medicine, University of Barcelona
Villarroel, 170
08036 Barcelona, Spain
Awards, Grants and Fellowships 2014
www.eccmid.org
24th ECCMID / Barcelona
Final Programme
01
General Information
ESCMID President
Prof Gunnar Kahlmeter
Dept. of Clinical Microbiology
Central Hospital
351 85 Växjö, Sweden
Awards
TABLE OF CONTENTS
Overview & Programme
IMPORTANT ADDRESSES
Introduction
Final Programme of the
24th ECCMID in Barcelona, Spain
10 – 13 May 2014
Forthcoming Events
Postgraduate Education Courses and Workshops
ESCMID Summer School
Receive state-of-the-art knowledge from expert
educators. Gather hands-on experience in your field
of interest. Discuss your work with senior and
peer colleagues.
An intense one-week course covering diverse topics
in the infection field. The high faculty-student ratio and
the high level of interactivity make it so popular.
30 Jun –
4 Jul 2014
Molecular Typing Methods for Pathogens
Lyon, France
ESCMID Postgraduate Education Course
4 – 6 Jul
2014
Bringing PK and PD in Fungal Infections
into the Clinic
Nijmegen, The Netherlands
ESCMID Postgraduate Education Course
16 – 19 Sep
2014
22 – 24 Sep
2014
Infectious Diseases in the Mediterranean
and the Middle East: Current Challenges
Izmir, Turkey
ESCMID Postgraduate Education Course
29 Sep –
1 Oct 2014
Anaerobic Bacteria: Next Generation
Technology Meets Anaerobic Diagnostics
Groningen, The Netherlands
ESCMID Postgraduate Technical Workshop
2 – 3 Oct
2014
Infection Management in the Elderly:
Room for Improvement
Annecy, France
ESCMID Postgraduate Education Course
6 – 8 Oct
2014
Advanced Antimicrobial Pharmacokinetic
and Pharmacodynamic Modelling and
Simulation
Liverpool, United Kingdom
ESCMID Postgraduate Technical Workshop
16 – 17 Oct
2014
02
3rd Workshop on Antimicrobial
Susceptibility Testing and Surveillance
Linz, Austria
ESCMID Postgraduate Technical Workshop
Mobility and Infection:
Diagnosis and Management
Dubrovnik, Croatia
ESCMID Postgraduate Education Course
20 – 23 Oct
2014
ESCMID-SHEA Training Course in Hospital
Epidemiology
Phuket, Thailand
29 – 31 Oct
2014
Acute Infectious Encephalitis: Challenges in Clinical and Biological Diagnosis
Grenoble, France
ESCMID Postgraduate Education Course
7 – 8 Nov
2014
How to Design and Perform your Clinical
Studies in Infectious Diseases and
Clinical Microbiology
Tübingen, Germany
ESCMID Postgraduate Education Course
24th ECCMID / Barcelona
Final Programme
5 – 12 Jul
2014
13th ESCMID Summer School
Sigtuna, Sweden
ESCMID Conferences
Get the latest news about your field of work
delivered from selected experts. Exchange ideas
with your colleagues on hot topics.
5 – 6 Jun
2014
3rd ESCMID Workshop on
Professional Affairs in
Clinical Microbiology and
Infectious Diseases
Ljubljana, Slovenia
19 – 20 Sep
2014
Infections and their Prevention
Beijing, China
22 – 24 Oct
2014
Reviving Old Antibiotics
Vienna, Austria
6 – 8 Mar
2015
Vaccines for Mutual Protection
Lisbon, Portugal
Future ECCMIDs
25 – 28 Apr
2015
25th ECCMID
Copenhagen, Denmark
9 – 12 Apr
2016
26th ECCMID
Istanbul, Turkey
22 – 25 Apr
2017
27th ECCMID
21 – 24 Apr
2018
28th ECCMID
n
d informatio
More detaile
ebsi te:
w
ID
M
the E S C
on
d
n
u
fo
e
b
can
.org
w w w.escmid
Acknowledgements
The ECCMID Programme Committee is proud to acknowledge the
scientific input from the following organisations in setting up
the scientific programme and/or organising joint workshops and
symposia:
Platinum Sponsors
ASM – American Society for Microbiology, Programme Committee of the
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Making sense of our relationships with mucosal commensals and
pathogens (page 49)
Gold Sponsors
Introduction
The Organising Committee expresses its thanks and
appreciation to all who have generously contributed to the
success of the 24th European Congress of Clinical Microbiology
and Infectious Diseases:
EAACI – European Academy of Allergy and Clinical Immunology ESCMID
guidelines for diagnosis and treatment of Aspergillus diseases (page 31)
EACS – European AIDS Clinical Society
Cryptococcal infections in HIV-infected patients:
what is new in 2014? (page 59)
Awards
EANM – European Association of Nuclear Medicine
Infections and devices: imaging & nuclear medicine meets infectious
diseases (page 50)
ECMM – European Confederation of Medical Mycology
ESCMID guidelines for diagnosis and treatment of Aspergillus diseases (page 31)
Overview & Programme
ECDC – European Centre for Disease Prevention and Control
Ins and outs of Legionnaires Disease (page 50)
Laboratory response to emerging viral diseases:
from pathogen discovery to disease monitoring (page 36)
ERS – European Respiratory Society
ESCMID guidelines for diagnosis and treatment of
Aspergillus diseases (page 31)
ePosters
EUCAST – European Committee on Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing with EUCAST breakpoints and methods
(page 29)
EUCAST questions and answers (page 51)
European Commission
Antimicrobial resistance research, supported by funding
from the EU and the US NIH/NIAID (page 63)
Posters
ICHS – International Immunocompromised Host Society
What is new in immunocompromised patients? (page 64)
Chairs, Speakers & Authors
IDSA – Infectious Diseases Society of America
Clinical Grand Round 2014 (page 64)
ISF – International Sepsis Forum
What’s new in sepsis in 2014 (page 32)
The MSG – Mycoses Study Group of the International Society
for Human and Animal Mycology
Predicting the future in fungal diagnosis and therapy (page 60)
UEMS – European Union of Medical Specialists (Infectious Disease and
Medical Microbiology Section) Training in infection in Europe – progress in
curricula and assessments (page 46)
US NIAID – United States National Institute of Allergy and Infectious Diseases
Antimicrobial resistance research, supported by funding from the EU and the
US NIH/NIAID (page 63)
24th ECCMID / Barcelona
Final Programme
03
Exhibition
SAM – Society for Anaerobic Microbiology
Two-faced companions: highlights in the world of anaerobes (page 74)
General Information
Silver Sponsors
ESCMID presents:
ECCMID Infection Control Highlights
Saturday, 10 May 2014
Monday, 12 May 2014
Educational Workshop: 08.45 – 10.45 h, Hall B
EW01: Infection prevention and management
in long-term care facilities
Chairpersons: Sheldon Stone (UK), Leonardo Pagani (CH)
Meet-the-Expert Session: 07.45 – 08.45 h, Hall J
Current challenges and emerging evidence of infection control
and prevention measures in long-term care facilities
Experts: Maria Luisa Moro (IT), Beatrice Jans (BE)
2-hour Oral Session: 13.30 – 15.30 h, Hall E
Lessons learned from Clostridium difficile
molecular epidemiology
Chairpersons: Mark H. Wilcox (UK), Ed J. Kuijper (NL)
2-hour Oral Session: 09.00 – 11.00 h, Hall H
Outbreaks of MDR Gram-negative bacteria:
what works and what does not work?
Chairpersons: Barry Cookson (UK), Anna-Pelagia Magiorakos (SE)
2-hour Symposium: 13.30 – 15.30 h, Hall I
Application of new methods in medical microbiology
and infection control
Chairpersons: Frederic Laurent (FR),
Francois Vandenesch (FR)
Keynote Lecture: 14.30 – 15.30 h, Hall J
On the cutting edge of infection control research:
what to do when evidence is missing?
Speaker: Leonard A. Mermel, USA
2-hour Symposium: 16.30 – 18.30, Hall J
Carbapenemases from prevention to treatment
Chairpersons: Luis Martinez-Martinez (ES),
Marek Gniadkowski (PL)
2-hour Symposium: 16.30 – 18.30, Hall A
Implementing international guidelines to reduce
the spread of MDR Gram-negatives at national level
Chairpersons: Uwe Frank (DE), Achilleas Gikas (GR)
2-hour Symposium: 16.00 – 18.00 h, Hall H
New approaches to prevent transmission
of Clostridium difficile infections
Chairpersons: Ed J. Kuijper (NL), Franz Allerberger (AT)
Sunday, 11 May 2014
Tuesday, 13 May 2014
Meet-the-Expert Session: 07.45 – 08.45 h, Hall D
Outbreak of P. aeruginosa in your hospital and
you think it could be water-related? Want to know
what to do next?
Experts: Michael Weinbren (UK),
Matthias Trautmann (DE)
Meet-the-Expert Session: 07.45 – 08.45 h, Hall C
Control of vancomycin-resistant enterococci: efforts justified?
Experts: Markus Dettenkofer (DE), Luisa M. V. Peixe (PT)
Meet-the-Expert Session: 07.45 – 08.45 h, Hall I
Screening for carbapenemase production,
molecular and phenotypic methods
Experts: Laurent Poirel (CH), Christian G. Giske (SE)
2-hour Symposium: 09.00 – 11.00 h, Hall A
What is new on surgical site infection prevention?
Chairpersons: Werner Zimmerli (CH),
Jean-Christophe Lucet (FR)
1-hour Symposium: 14.30 – 15.30 h, Hall A
The year in Infection Control
Chairperson: Jan A.J.W. Kluytmans (NL)
Speakers: Barry Cookson (UK),
Christina Vandenbroucke-Grauls (NL)
04
2-hour Oral Session: 16.00 – 18.00 h, Hall D
New transmission routes and genotypic diversity:
are we looking at a new MRSA?
Chairpersons: Stephan J. Harbarth (CH), Benito Almirante (ES)
24th ECCMID / Barcelona
Final Programme
2-hour Oral Session: 09.00 – 11.00 h, Hall F
Healthcare-associated infections – from analysis to interventions
Chairpersons: Susan S. Huang (USA), Khetam Hussein (IL)
1-hour Symposium: 11.30 – 12.30 h, Hall C
Surveillance of healthcare-associated infections:
infections or procedures?
Chairpersons: Hanan Balkhy (SA), Khetam Hussein (IL)
2-hour Symposium: 13.30 – 15.30 h, Hall C
Antimicrobial prophylaxis of surgical site infections: time to review?
Chairpersons: Joseph S. Solomkin (USA), Matthew Dryden (UK)
2-hour Symposium: 13.30 – 15.30 h, Hall A
Controlling transmission of multidrug-resistant pathogens
in the intensive care unit
Chairpersons: Francesco Menichetti (IT),
Jose Antonio Martinez Martinez (ES)
Welcome Address
Dear Colleagues and Friends,
Introduction
It is our great pleasure and privilege to be your hosts at the 24th European Congress of Clinical Microbiology and Infectious
Diseases in Barcelona, Spain. Over the past several years, ECCMID has rapidly grown to become the world´s largest congress
in the field of clinical microbiology and infectious diseases and in Barcelona we expect 10,000 delegates or more. In addition,
ECCMID also offers various activities in many related fields such as infection control and vaccines. The Programme Committee
has prepared a series of educational workshops, symposia, meet-the-expert sessions, poster- and oral sessions in many parallel
tracks to keep you very busy for 4 days. We encourage you to join one or more of our many Study Groups and to visit the exhibition
Awards
where companies present tomorrow´s equipment and therapeutics. ECCMID now hosts the most comprehensive exhibition of
new equipment and diagnostics in the field for large and small laboratories.
Barcelona’s International Convention Centre forms part of the new technological and business district known as “22@”, one of
Overview & Programme
the city’s best developed urban areas, which includes a selection of hotels and communications and transport network that
seamlessly connects it to the rest of the city. Modern installations, architectural beauty and seaside location makes Barcelona’s
International Convention Centre truly unique as one of the largest convention centres in Southern Europe. With a surface area of
100,000 sqm including the Convention Centre and the Forum Auditorium, the centre can welcome up to 15,000 delegates.
Exhibition
Prof Winfried V. Kern
ECCMID Deputy
Programme Director
24th ECCMID / Barcelona
Final Programme
05
General Information
Prof Jordi Vila Prof Gunnar Kahlmeter ECCMID Programme Director
ESCMID President
Chairs, Speakers & Authors
Posters
ePosters
We wish you a fruitful meeting and a wonderful stay in Barcelona.
H
I
J
Congress Venue Overview
LEVEL 0
n
To hall A
tra
En
nce
tra
En
nce
tra
N
ITIO
HIB
Po
st
er
s
EX
ID
CM
ES ORLD
W
gi
Re
n
atio
str
nce
tra
En
En
nce
C
h
Ex
tio
i
b
i
A
B
LEVEL
LEVEL 2
0
LEVEL 1
24th
ECCMID
LEVEL 1
European Congress of Clinical Microbiology
and Infectious Diseases
127
128
Barcelona, Spain, 10 - 13 May 2014
125
124
129
130
131
132
133
134
123
122
The Congress of
121
120
118
D
119
J
I
H
G
F
E
m
rs
ake y Roo
e
p
S ead
R
06
24th ECCMID / Barcelona
Final Programme
LEVEL 0
Congress Venue Overview
LEVEL 2
Overview & Programme
Po
st
er
s
Awards
C
Introduction
LEVEL 2
129
130
131
132
133
134
123
122
118
D
119
Chairs, Speakers & Authors
121
120
LEVEL 0
M218
M219, M220
M221
24th ECCMID / Barcelona
M211
M212
M217
Final Programme
Exhibition
M213
M214
Press Room M219, M220
I
H
G
F
E
m
rs
ake y Roo
e
p
S ead
R
07
General Information
125
124
Posters
127
128
ePosters
LEVEL 1
J
MEZZANINE LEVEL
ESCMID presents:
EUCAST at ECCMID Barcelona
Saturday, 10 May
08.45 – 12.45, Hall A
Educational Workshop
Antimicrobial susceptibility testing with
EUCAST breakpoints and methods.
Susceptibility testing of infrequently isolated fastidious
organisms. L. Martinez-Martinez, Spain
Update on EUCAST 2014. R. Canton Moreno, Spain
15.30 – 16.30, Poster Exhibition Hall
Poster session I
EUCAST Antimicrobial susceptibility testing
Update on EUCAST methods and breakpoints.
G. Kahlmeter, Sweden
Internal quality control. R. L. Skov, Denmark
External quality assessment.
D.F.J. Brown, United Kingdom
Moderated panel discussion on questions from the
audience (part 1). A. P. MacGowan, United Kingdom
Susceptibility testing systems – are some more
equal than others? J. D. Turnidge, Australia
Issues in testing susceptibility to beta-lactam /
beta-lactamase inhibitor combinations.
R. Howe, United Kingdom
Moderated panel discussion on questions from
the audience(part 2). A. P. MacGowan, United Kingdom
Monday, 12 May
07.45 – 08.45, Hall D
Meet the Experts
EUCAST questions and answers
D.F.J. Brown, United Kingdom, E. Matuschek, Sweden
12.45 – 14.15, Meeting Room 122/123
EUCAST General Committee Meeting
16.30 – 18.00, Meeting Room 122/123
EUCAST AFST General Committee Meeting
EUCAST is a standing committee jointly organised
by ESCMID, ECDC (European Centre for Disease
Prevention and Control) and European national breakpoint committees.
Visit EUCAST representatives at the EUCAST booth
in the ESCMID World at ECCMID Barcelona!
Sunday, 11 May: 12.30–13.30
Monday, 12 May: 12.30–13.30
Tuesday, 13 May: 12.30–13.30
Committees
Michel Drancourt, Marseille, France
(NMNI Editor-in-Chief)
Giuseppe Cornaglia, Verona, Italy
(Past President & Communications Officer)
William Hope, Liverpool, United Kingdom
(Medical Guidelines Director)
Cornelia Lass-Flörl, Innsbruck, Austria (Treasurer)
Didier Raoult, Marseille, France
(CMI Editor-in-Chief)
Mario Poljak, Ljubljana, Slovenia
(Professional Affairs Officer CM)
Jordi Vila Estape, Barcelona, Spain
(ECCMID Programme Director)
Awards
Murat Akova, Ankara, Turkey
(President-elect, Sec. General &
Scientific Affairs Officer)
Overview & Programme
Rafael Canton, Madrid, Spain
(EUCAST Chairman)
ePosters
Gunnar Kahlmeter, Växjö, Sweden
(President)
Introduction
ESCMID Ad-hoc Executive Committee Members
Chairs, Speakers & Authors
Posters
Jesús Rodríguez-Baño, Seville, Spain
(Education Officer)
Evelina Tacconelli, Tübingen, Germany
(Professional Affairs Officer ID)
Exhibition
New ESCMID Executive Committee
Annelies Zinkernagel, Zurich, Switzerland
24th ECCMID / Barcelona
Final Programme
09
General Information
ESCMID Executive Committee
Committees
ECCMID Programme Committee
Jordi Vila Estape, Barcelona, Spain (ECCMID Programme Director)
Winfried V. Kern, Freiburg, Germany (ECCMID Deputy Programme Director)
Murat Akova, Ankara, Turkey
Emmi Andersson, Stockholm, Sweden
Jordi Carratala, Barcelona, Spain
Elisa Cordero Matias, Seville, Spain
Giuseppe Cornaglia, Verona, Italy
Carmen-Michaela Cretu, Bucharest, Romania
Alexander W. Friedrich, Groningen, The Netherlands
Johan Giesecke, Stockholm, Sweden – ECDC
Gilbert Greub, Lausanne, Switzerland
Hans H. Hirsch, Basel, Switzerland
Po-Ren Hsueh, Taipei, Taiwan
Gunnar Kahlmeter, Växjö, Sweden
Cornelia Lass-Flörl, Innsbruck, Austria
Marc Lecuit, Paris, France
Rogelio Lopez-Velez, Madrid, Spain
Alasdair MacGowan, Bristol, UK
Surbhi Malhotra-Kumar, Antwerp, Belgium
Luis Martinez-Martinez, Santander, Spain
Patricia Munoz Garcia, Madrid, Spain
Alvaro Pascual Hernandez, Seville, Spain
Mical Paul, Petah-Tiqva, Israel
Nicola Petrosillo, Rome, Italy
Mario Poljak, Ljubljana, Slovenia
Didier Raoult, Marseille, France
Guénaël Rodier, Geneva, Switzerland – WHO Europe
Jesús Rodríguez-Baño, Seville, Spain
Alex Soriano, Barcelona, Spain
Evelina Tacconelli, Tübingen, Germany
Andrew J. Ullmann, Würzburg, Germany
Maria Virginia Villegas, Cali, Columbia
Annelies Zinkernagel, Zurich, Switzerland
ESCMID Education Subcommittee (ES)
Jesús Rodríguez-Baño, Seville, Spain (Chair)
Emmi Andersson, Stockholm, Sweden
Sibel Ascioglu, Ankara, Turkey
Kanita Dedic, Bihac, Bosnia and Herzegovina (Ad-hoc)
Alejandro Martin-Quiros, Madrid, Spain (Ad-hoc)
Dorothea Orth, Innsbruck, Austria
Tibor Pál, Al Ain, United Arab Emirates
Eskild Petersen, Aarhus, Denmark
Céline Pulcini, Nice, France
Bernd Salzberger, Regensburg, Germany
Maurizio Sanguinetti, Rome, Italy
Maria Souli, Athens, Greece
ESCMID Scientific Affairs Subcommittee (SAS)
Murat Akova, Ankara, Turkey (Chair)
Maiken Cavling Arendrup, Copenhagen, Denmark
Hanan Balkhy, Riyadh, Saudi Arabia
Rosemary Barnes, Cardiff, UK
German Bou Arevalo, La Coruña, Spain
Birgitta Evengård, Umeå, Sweden
Marek Gniadkowski, Warsaw, Poland
Hervé Pelloux, Grenoble, France
Hakan Leblebicioglu, Samsun, Turkey
Paul Savelkoul, Amsterdam, The Netherlands
10
24th ECCMID / Barcelona
Final Programme
ESCMID Professional Affairs Subcommittee (PAS)
Mario Poljak, Ljubljana, Slovenia (Chair, CM)
Evelina Tacconelli, Tübingen, Germany (Chair, ID)
Guido Antonelli, Rome, Italy
Petra Apfalter, Linz, Austria
Bridget Atkins, Oxford, UK
Nicholas John Beeching, Liverpool, UK
Maria Adriana Cataldo, Rome, Italy
Hilary Humphreys, Dublin, Ireland
Khetam Hussein, Haifa, Israel
Ulrik Stenz Justesen, Odense, Denmark
Piotr Kochan, Cracow, Poland
Truls Michael Leegaard, Lørenskog, Norway
Endre Ludwig, Budapest, Hungary
Mario Umberto Mondelli, Pavia, Italy
(UEMS ID Section Representative)
Leonardo Pagani, Bolzano, Italy
Pilar Retamar Gentil, Seville, Spain
Katja Seme, Ljubljana, Slovenia
Hilpi Rautelin, Uppsala, Sweden
Andrej Trampuz, Berlin, Germany
Andrew J. Ullmann, Würzburg, Germany
ESCMID Publication Subcommittee (PS)
Giuseppe Cornaglia, Verona, Italy (Chair)
Rupert Cousens, Chichester, UK
Michel Drancourt, Marseille, France
Didier Raoult, Marseille, France
Parity Commission (PC)
Evelina Tacconelli, Tübingen, Germany (Chair)
Mario Poljak, Ljubljana, Slovenia (Chair)
Nur Benzonana, Istanbul, Turkey
Titia M. Kortbeek, Bilthoven, The Netherlands
Dan Otelea, Bucharest, Romania
Trainee Association of ESCMID (TAE)
Polona Maver Vodicar, Ljubljana, Slovenia (Chair)
Joana Cortez, Coimbra, Portugal
Chrysanthi Skevaki, Athens, Greece
Davorka Dusek, Zagreb, Croatia
Kanita Dedic, Bihac, Bosnia and Herzegovina
Alejandro Martin-Quiros, Madrid, Spain
Committees
Clinical Parasitology (ESGCP)
www.escmid.org/esgcp
Titia M. Kortbeek, Bilthoven, The Netherlands
Titia.Kortbeek@rivm.nl
Clostridium difficile (ESGCD)
www.escmid.org/esgcd
Ed J. Kuijper, Leiden, The Netherlands
e.j.kuijper@lumc.nl
Critically Ill Patients (ESGCIP)
www.escmid.org/esgcip
Jordi Rello, Barcelona, Spain
jrello@crips.es
Elderly Infections (ESGIE)
www.escmid.org/esgie
Mical Paul, Haifa, Israel
paulm@post.tau.ac.il
Epidemiological Markers (ESGEM)
www.escmid.org/esgem
Alexander W. Friedrich, Groningen, The Netherlands
alex.friedrich@mmb.umcg.nl
Food/Water Infections (EFWISG)
www.escmid.org/efwisg
Kevin Kerr, Harrogate, UK
kevin.kerr@hdft.nhs.uk
Fungal Infection (EFISG)
www.escmid.org/efisg
Andrew J. Ullmann, Würzburg, Germany
ullmann_a@klinik.uni-wuerzburg.de
Helicobacter (EHSG)
www.escmid.org/ehsg
Giovani Gasbarrini, Rome, Italy
ggasbarinni@rm.unicatt.it
Immunocompromised Hosts (ESGICH)
www.escmid.org/esgich
José Maria Aguado, Madrid, Spain
jaguadog1@gmail.com
Introduction
Awards
Mycobacterial Infections (ESGMYC)
www.escmid.org/esgmyc
Emmanuelle Cambau, Paris, France
emmanuelle.cambau@lrb.aphp.fr
Overview & Programme
Brain Infections (ESGIB)
www.escmid.org/esgib
Stephen Leib, Berne, Switzerland
stephen.leib@babs.admin.ch
Molecular Diagnostics (ESGMD)
www.escmid.org/esgmd
Paul Savelkoul, Amsterdam, The Netherlands
p.savelkoul@mumc.nl
Mycoplasma Infections (ESGMI)
www.escmid.org/esgmi
Cecile Bebear, Bordeaux, France
cecile.bebear@u-bordeaux.fr
Nosocomial Infections (ESGNI)
www.escmid.org/esgni
Barry D. Cookson, London, UK
bsajcookson@btinternet.com
ePosters
Bloodstream Infections (ESGBIS)
www.escmid.org/esgbis
Jesús Rodríguez-Baño, Seville, Spain
jesusrb@us.es
Lyme Borreliosis (ESGBOR)
www.escmid.org/esgbor
Gerold Stanek, Vienna, Austria
gerold.stanek@meduniwien.ac.at
PK/PD of Anti-Infectives (EPASG)
www.escmid.org/epasg
Ursula Theuretzbacher, Vienna, Austria
utheuretzbacher@cefaia.com
Resistance Surveillance (ESGARS)
www.escmid.org/esgars
Patrice Nordmann, Fribourg, Switzerland
patrice.nordmann@unifr.ch
Posters
Biofilms (ESGB)
www.escmid.org/esgb
Thomas Bjarnsholt, Copenhagen, Denmark
tbjarnsholt@sund.ku.dk
Legionella Infections (ESGLI)
www.escmid.org/esgli
Jeroen den Boer, Haarlem, The Netherlands
j.denboer@streeklabhaarlem.nl
Staphylococci (ESGS)
www.escmid.org/esgs
Francois Vandenesch, Bron, France
francois.vandenesch@univ-lyon1.fr
Chairs, Speakers & Authors
Antibiotic Policies (ESGAP)
www.escmid.org/esgap
Dilip Nathwani, Dundee, UK
dilip.nathwani@nhs.net
Intracellular Bacteria (ESCAR)
www.escmid.org/escar
Amel Letaief, Sousse, Tunisia
amel.letaief@famso.rnu.tn
Travel and Migration (ESGITM)
www.escmid.org/esgitm
Hakan Leblebicioglu, Samsun, Turkey
hakan@omu.edu.tr
Vaccines (EVASG)
www.escmid.org/evasg
Susanna Esposito, Milan, Italy
susanna.esposito@unimi.it
Exhibition
Anaerobic Infections (ESGAI)
www.escmid.org/esgai
Elisabeth Nagy, Szeged, Hungary
nagy.erzsebet@med.u-szeged.hu
Implant Infections (ESGIAI)
www.escmid.org/esgiai
Andrej Trampuz, Berlin, Germany
andrej.trampuz@gmail.com
Viral Hepatitis (ESGVH)
www.escmid.org/esgvh
Joop Arends, Utrecht, The Netherlands
j.e.arends@umcutrecht.nl
24th ECCMID / Barcelona
Final Programme
11
General Information
ESCMID Study Groups
Awards and Grants 2014
ESCMID Award for Excellence
in Clinical Microbiology
and Infectious Diseases 2014
Ilaria Capua
Ilaria Capua is currently a Member of the Italian Parliament and Vice-President of the 7th Parliamentary Commission for Culture, Science and Education. Therefore,
she has taken a leave of absence from her position as
Director of the Division of Comarative Biomedical Sciences at the Istituto Zooprofilattico Sperimentale delle
Venezie, Legnaro (Padua), Italy; her division hosts the
Food and Agriculture Organization of the United Nations
(FAO), the World Organization for Animal Health (OIE)
Reference Laboratories for animal and avian influenzas
and Newcastle disease, rabies and the OIE Collaborating Centre for Diseases at the Human-Animal Interface.
She is also a visiting professor at the Centre for Virus
Research at the University of Glasgow. Her group in Legnaro of over 70 staff provides diagnostic expertise globally and conducts cutting-edge research on influenza
viruses and viral zoonoses.
She has extensive experience in coordinating international research projects funded by the European Commission, and has also worked closely with FAO, managing
Technical Cooperation Projects covering 40 countries,
and with OIE in international activities and twinning projects. She is author or co-author of over 200 publications
in peer-reviewed journals as well as editor of scientific
books and of books and articles for the general public. In 2006 she ignited an international debate on enhancing interdisciplinary collaboration to foster transparency of genetic data of influenza viruses, which has
promoted a review of international health policies on
data sharing to improve pandemic preparedness.
In 2007 she was among the winners of the Scientific
American 50 Award and, in 2008, was included among
Seed Magazine’s Revolutionary Minds for leadership in
science policy. She is the first female recipient of the
Penn Vet World Leadership in Animal Health Award, the
most prestigious award in veterinary medicine (2011).
In 2012 she became a Grande Ufficiale della Repubblica
Italiana, the Order of Merit of the Italian Republic awarded by the Italian President.
12
24th ECCMID / Barcelona
Final Programme
Research interests
Her areas of research include viral diseases of birds,
mammals and fish, with particular reference to zoonotic viral infections. Her group is actively involved
in the epidemiology, evolution and phylogeny of avian influenza viruses and in the development of novel
vaccines for influenza infections. In addition, studies
on interspecies transmission mechanisms and on the
metabolic consequences of influenza infection have
become core parts of her research activities. The group
also functions as an international reference laboratory
for rabies and lyssaviruses, which is involved in molecular evolution studies and the development of novel
control and prevention strategies. Other areas of interest include diagnosis and control of Newcastle disease
and coronavirus infections in poultry, pathogenesis and
vaccine development for viral diseases of fish and poultry and research on selected viral zoonotic agents, including astroviruses, West Nile virus and related flaviviruses. The application and integration of advanced tools
in molecular genetics and bioinformatics for research
focusing on infectious diseases at the animal-human
interface is also a key activity of her group.
Ilaria Capua will be presented with her award during
the ESCMID Excellence Award ceremony by Gunnar
Kahlmeter, ESCMID President, and Giuseppe Cornaglia,
ESCMID Past President, on Monday, 12 May 2014, 14.30
– 15.30 in Hall C. During this ceremony she will give her
recipient's lecture: ‘Close encounters of the third kind –
pathogens and globalisation’.
Michael Ramharter will be presented with his award
during the ESCMID Young Investigator Awards Session
on 13 May 2014 at 11.30 – 12.30 in Hall E. During the
session, he will present his work: ‘Development of antimalarial drugs in Lambaréné, Gabon’.
Joost Wiersinga will be presented with his award
during the ESCMID Young Investigator Awards Session
on 13 May 2014 at 11.30 – 12.30 in Hall E. During the
session, he will present his work: ‘Gut-lung axis: the intestinal microbiota in pneumonia’.
24th ECCMID / Barcelona
Final Programme
13
Overview & Programme
ePosters
Posters
Chairs, Speakers & Authors
Research Interests
He investigates innate immune responses in sepsis,
with a special interest in sepsis caused by Streptococcus pneumoniae, Klebsiella pneumoniae, Burkholderia
pseudomallei and Salmonella typhi. Recent interests
include the role of gut microbiota during severe bacterial infections and optimisation of antibiotic therapy
for – among others – cellulitis / erysipelas. He currently
steers the European Sepsis Academy grant initiative
and the European Melioidosis Network. His work has
been published in Nat Rev Microbiol, PLoS Pathog, PLoS
Medicine, N Engl J Med and other journals.
Exhibition
Research Interests
Starting from the preclinical evaluation of antimalarial drugs, he developed a strong interest in the
clinical development of antimalarial combination therapies. He has led a series of clinical trials investigating
novel drugs and drug combinations for the treatment
and prevention of malaria in children and pregnant
women – two of the most vulnerable patient populations in sub-Saharan Africa. Besides malaria, his main
research activities focus on the epidemiology and management of neglected tropical diseases including schistosomiasis and echinococcosis and other infectious
diseases occurring in the tropics.
Joost Wiersinga
He received his medical training at the University of
Amsterdam (The Netherlands) with additional courses
at the Mayo Clinic (Rochester, MN) and the National
Institutes of Health (NIH, Bethesda, MD). He achieved
his PhD on the topic ‘On Toll-like receptors and the innate immune response in sepsis caused by Burkholderia pseudomallei (melioidosis)’, cum laude under the
guidance of Professor Tom van der Poll (University of
Amsterdam) and Professor Sharon Peacock (University
of Oxford); during this period he worked in Thailand at
the Wellcome Trust South-East Asia Major Overseas Programme in Bangkok. Previous awards won by him are
the O'Callaghan PhD Award, the Andreas Bonn Medallion
and the GSK ICAAC Award. At the moment, he divides his
time between patient care at the Department of Medicine (sub-specialty Infectious Diseases), teaching and
research in the Center for Experimental Molecular Medicine (CEMM) and the Center for Infection and Immunity
(CINIMA), all at the Academic Medical Center, University
of Amsterdam, The Netherlands.
General Information
Michael Ramharter
He is Associate Professor at the Medical University of
Vienna, Austria, and leader of the Infectious Disease
Control Group – a scientific working group co-affiliated
to the Institut für Tropenmedizin, Universität Tübingen,
and the Centre de Recherches Médicales de Lambaréné
in the Central African country of Gabon. Early in his career he worked under the guidance of Walther H. Wernsdorfer on the preclinical development of anti-malarials
in the Thai-Myanmar border region – an experience
which sparked an ever-increasing interest in the clinical
investigation of infectious diseases in the tropics. He
shifted the focus of his work to Central Africa when he
joined Professor Peter G. Kremsner’s team at the Centre
de Recherches Médicales de Lambaréné, at the Albert
Schweitzer Hospital in Gabon. He has held postdoctoral
positions at the Institut für Tropenmedizin, Universität Tübingen, and the Institut Pasteur, Université de la
Méditerranée, Marseille, France. He currently works as
a specialist in Internal Medicine and consultant in Infectious Diseases and Tropical Medicine at the Division
of Infectious Diseases and Tropical Medicine headed by
Professor Wolfgang Graninger.
Awards
ESCMID Young Investigator Awards for Research in Clinical
Microbiology and Infectious Diseases 2014
ESCMID Research Grants 2014
The following ESCMID members have received a
Research Grant in 2014 for the indicated project.
Paula Espinal
Microbiology, Centre Esther
Koplowitz, Barcelona, Spain
Project: Relationship between
resistance mechanisms and
potential virulence in
Acinetobacter spp. strains using
the Caenorhabditis elegans
model
Anália Lourenço
University of Vigo,
Ourense, Spain
Project: Reconstruction of
polymicrobial interactions in
infections: the case of
Pseudomonas aeruginosa
and Candida albicans cross
talk in ventilator-associated
pneumonia
Sandra Sousa
Infection and Immunity,
Group of Molecular
Microbiology, IBMC,
Porto, Portugal
Project: Novel interfaces
during host responses to
pore forming toxins: crosstalk
between ER chaperones and
cytoskeletal proteins
14
24th ECCMID / Barcelona
Final Programme
Ana Sofia Ferreira
BSRG, Institute for Biotechnology
and Bioengineering (IBB)/Instituto
Superior Técnico (IST),
Lisbon, Portugal
Project: How do bacterial
phosphotyrosine phosphatase
proteins modulate host-pathogen
interactions?
Michael McConnell
Laboratory of Infectious Diseases,
Biomedical Institute of Seville,
Seville, Spain
Project: Identification of novel
antibiotic targets for Acinetobacter
baumannii through the characterization of metabolic genes required
for biofilm formation, virulence
and infection
Debby van Riel
Viroscience, Erasmus MC,
Rotterdam, The Netherlands
Project: Cell-to-cell transmission of influenza viruses
along the olfactory route
Mateja Jelen
Institute of Microbiology
and Immunology,
Ljubljana, Slovenia
Bostjan J. Kocjan
Institute of Microbiology
and Immunology,
Ljubljana, Slovenia
Project: Profile of the protein
response in the process to
tetracycline resistance by
Coxiella burnetii
Project: Genome sequencing
analysis of more than 2’000
vaccine-relevant, globally
circulating, human
papillomavirus HPV-6 and
HPV-11 isolates
Project: Determination of
molecular mechanisms of
low-risk HPV-mediated
carcinogenesis
Overview & Programme
Awards
Gabriela Flores-Ramirez
Department of Rickettsiology,
Institute of Virology,
Bratislava, Slovakia
ESCMID / FEMS Fellow 2014
Project: New 3D-infection models
based on tissue-engineering to
study pathogenicity of Helicobacter
pylori and Campylobacter jejuni
Isabel Soares Silva
Serviço de Nefrologia,
Hospital de S. João,
Porto, Portugal
Project: Establishment of an in vitro
model system for the study of
biofilm formation in haemodialysis
tunneled catheters
Posters
Project: PLGA nanoparticles as
specific carriers for nebulized drug
delivery of antibiotic combinations
against respiratory infections
caused by high-risk clones of
P. aeruginosa in the murine model
Cynthia Mira Sharma
Institute for Molecular Infection
Biology (IMIB)/ Research Center
for Infectious Diseases (ZINF),
University of Würzburg,
Würzburg, Germany
ePosters
Jana Basas Satorras
Infectious Diseases, Hospital
Universitari Vall d’Hebron,
Barcelona, Spain
Chairs, Speakers & Authors
ESCMID / FEMS Fellow 2014
Project: The ATP-binding
cassette transporters
Plasmodium falciparum
multidrug resistance proteins
(pfMRPs) and their relevance in
antimalarial drug resistance
24th ECCMID / Barcelona
Final Programme
15
General Information
Exhibition
M. Isabel Veiga
Life and Health Sciences
Research Institute (ICVS),
University of Minho,
Braga, Portugal
ESCMID TAE Awards for
Training Achievements 2014
Neven Papic
University Hospital for
Infectious Diseases,
Zagreb, Croatia
Liliana Praticò
Fondazione IRCCS
Policlinico San Matteo,
Pavia, Italy
Infectious Diseases
Infectious Diseases
Erlangga Yusuf
University Hospital Brussels,
Brussels, Belgium
Medical Microbiology
ISF Sepsis Award 2014
Jacqueline Lankelma will give a short presentation
about her project in the ISF session on Saturday,
10 May 2014 from 13.30 – 15.30 h in Hall K.
Jacqueline M. Lankelma
Academic Medical Center,
Amsterdam, The Netherlands
Project: Protective role of
the gut microbiota in pneumoniaderived sepsis
16
24th ECCMID / Barcelona
Final Programme
Awards, Grants and Fellowships 2014
Travel Grant Awardees
The ECCMID travel grant programme is sponsored by the European
Society of Clinical Microbiology and Infectious Diseases (ESCMID).
Grants were awarded to those with outstanding abstracts.
Exhibition
Chairs, Speakers & Authors
Posters
ePosters
Overview & Programme
Awards
Lankelma, Jacqueline (Amsterdam, The Netherlands)
Le Govic, Yohann (Lille, France)
Leon, Ricardo (Madrid, Spain)
Lopez-Cortes, Luis Eduardo (Seville, Spain)
Lozano García, Lorena (Murcia, Spain)
Lucas, Marjolein Jose (Amsterdam, The Netherlands)
Mason, Lauren Maxine Kate (Amsterdam, The Netherlands)
Mena Romo, Damián (Seville, Spain)
Micaelo, Maite (Paris, France)
Mika, Moana (Berne, Switzerland)
Mouro Pinto, Rita (Porto, Portugal)
Norihito, Kaku (Nagasaki City, Japan)
Ong, David (Utrecht, The Netherlands)
Ozog, Yves (Maastricht, The Netherlands)
Payne, Michael (Vancouver, Canada)
Pires, João (Porto, Portugal)
Pulido Toledano, Marina (Seville, Spain)
Radulescu, Mihaela Andreea (Bucharest, Romania)
Rajendran, Ranjith (Glasgow, UK)
Rascanu, Aida (Bucharest, Romania)
Ribeiro Gonçalves, Teresa (Porto, Portugal)
Sánchez – Valenzuela, Antonio (Madrid, Spain)
Schröder, Wiebke (Tübingen, Germany)
Seiffert, Salome (Berne, Switzerland)
Shaw, Timothy (Belfast, UK)
Simões Silva, Liliana (Porto, Portugal)
Siniuk, Kanstantsin (Minsk, Belarus)
Smith, Jordan (Royal Oak, MI, United States)
Stappers, Mark (Nijmegen, The Netherlands)
Svensson, Elin (Uppsala, Sweden)
Tkhilaishvili, Tamta (Tbilisi, Georgia)
van Dorp, Sofie Maria (Leiden, The Netherlands)
van Mourik, Maaike S.M. (Utrecht, The Netherlands)
van Vught, Lonneke Alette (Amsterdam, The Netherlands)
Varlamis, Sotirios, Thessaloniki (Kalamaria, Greece)
Viala, Céline (Paris, France)
Vidal García, Matxalen (Zaragoza, Spain)
Wagemakers, Alex (Amsterdam, The Netherlands)
Wright, Laura (London, UK)
Yan, Lin (Seattle, WA, United States)
24th ECCMID / Barcelona
Final Programme
17
General Information
Adamczuk, Marcin (Minsk Mazowiecki, Poland)
Ainoda, Yusuke (Tokyo, Japan)
Altinkanat Gelmez, Gulsen (Istanbul, Turkey)
Amado Cecílio, Pedro (Matosinhos, Portugal)
Amarsy-Guerle, Rishma (Paris, France)
Baietto, Lorena (Turin, Italy)
Barber, Katie (Detroit, United States)
Birgand, Gabriel (Paris, France)
Blanco Lobo, Pilar (Seville, Spain)
Bulnes Ramos, Ángel (Seville, Spain)
Candel Perez, Carmen (Murcia, Spain)
Chilton, Caroline (Leeds, UK)
Claeys, Kimberly (Detroit, United States)
D’Abramo, Alessandra (Rome, Italy)
de Jong, Hanna (Amsterdam, The Netherlands)
de Stoppelaar, Sacha (Amsterdam, The Netherlands)
Delaire, Caroline (Poitiers, France)
Di Nauta, Alessia (Turin, Italy)
Diolez, Jeremie (Pessac, France)
Dudikova, Daria (Kiev, Ukraine)
Dulama, Raluca Ioana (Bucharest, Romania)
Fernandez-Barat, Laia (Barcelona, Spain)
Foschi, Federico (Tübingen, Germany)
García Quintanilla, Meritxell (Seville, Spain)
Gawryszewska, Iwona (Warsaw, Poland)
Gits-Muselli, Maud, (Paris, France)
Gonzalez Sanz, Marta (London, UK)
Gostev, Vladimir (St. Petersburg, Russian Federation)
Grosso Ledo, Filipa (Porto, Portugal)
Gueret, Dorothee (Paris, France)
Heimann, Sebastian (Cologne, Germany)
Hertz, Frederik Boetius (Hvidovre, Denmark)
Holban, Alina Maria (Bucharest, Romania)
Holmes, Christopher William (Leicester, UK)
Huson, Michaela Aurelia Maria (Amsterdam, The Netherlands)
Istrate, Claudia (Bucharest, Romania)
Jacquier, Hervé (Paris, France)
Johansson, Åsa (Växjö, Sweden)
Kasanmoentalib, Erna Soemirien (Amsterdam, The Netherlands)
Khodaparast, Laleh (Leuven, Belgium)
Lakatos, Botond (Budapest, Hungary)
Scientific Programme Overview
Saturday, 10 May 2014
8:45
9:00
Hall A
Hall B
Hall C
Hall D
08:45 – 12:45
P. 29
EW10:
Antimicrobial susceptibility testing
with EUCAST breakpoints and
methods
08:45 – 10:45
P. 27
EW01:
Infection prevention and management in long-term care facilities
08:45 – 10:45
P. 27
EW02:
Basic concepts of pharmacokinetics
and pharmacodynamics
08:45 – 10:45
P. 27
EW03:
Tuberculosis and other mycobacterial
infections in low-income countries
Hall E
08:45 – 10:45
EW04:
Vaccination in the elderly:
perspectives
P. 27
10:00
11:00
11:00 – 13:00
EW11:
Recent research in critically ill
patients: hands-on evidence
P. 29 11:00 – 13:00
P. 30 11:00 – 13:00
P. 30
EW12:
EW13:
Bloodstream infections: opportunities Basics of infections in travellers
for outcome improvement
11:00 – 13:00
P. 30
EW14:
Elderly and chronic hepatitis C
– to treat or not to treat?
12:00
13:00
13:30 – 15:30
What’s new in sepsis in 2014
14:00
P. 32 13:30 – 15:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 316 for details
13:30 – 15:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 316 for details
13:30 – 15:30
Uncertainties in transplant
vaccination
16:30 – 18:30
P. 35
The Good, the Bad and the Ugly:
recently approved and developmental
anti-bacterials
16:30 – 18:30
P. 35
New insights in epidemiology,
resistance and pathogenesis to
improve HIV management
P. 32 13:30 – 15:30
P. 32
Lessons learned from Clostridium
difficile molecular epidemiology
15:00
16:00
17:00
16:30 – 18:30
P. 34
Implementing international
guidelines to reduce the spread of
MDR Gram-negatives at national level
16:30 – 18:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 317 for details
16:30 – 18:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 317 for details
18:00
19:00
19:00 – 22:00
Opening Ceremony
followed by Networking Reception
Sunday, 11 May 2014
Hall A
Hall B
7:45
8:00
07:45 – 08:45
Sepsis management beyond
antibiotics
9:00
09:00 – 11:00
P. 39 09:00 – 11:00
What is new on surgical site infection Integrated Symposium
prevention?
(not included in main event
CME/CPD credit)
Refer to page 319 for details
10:00
Hall C
Hall D
Hall E
07:45 – 08:45: Outbreak of P. 39
P. aeruginosa in your hospital and
you think it could be water-related?
Want to know what to do next?
P. 39
09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 319 for details
09:00 – 11:00
Monitoring antibiotic use
P. 40 09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 320 for details
11:00
12:00
13:00
11:30 – 12:30
P. 42 11:30 – 12:30
P. 43 11:30 – 12:30
P. 43 11:30 – 12:30
P. 43 11:30 – 12:30
P. 43
Deep insights in mycobacteria:
Genomic diagnostics: transforming
Macrolides are still safe and effective Great scientific success with scarce Emergence of Clostridium difficile
genomics and susceptibility
clinical and public health microbiology to be used in clinical practice. Pro /
resources. Is money issue a crucial
infections outside healthcare facilities
practice
Con debate
point?
13:00 – 14:00: EPOSTER & POSTER VIEWING
13:00 – 14:00
P. 77
ePoster Session:
Post-surgical and implant infections:
from head to knee
14:00
14:30 – 15:30
The year in Infection Control
15:00
16:00
17:00
P. 45 14:30 – 15:30
Hepatitis B treatment and
management
16:00 – 18:00
P. 48 16:00 – 18:00
Improving empirical antibiotic treat- Integrated Symposium
ment in hospital
(not included in main event
CME/CPD credit)
Refer to page 321 for details
18:00
18
24th ECCMID / Barcelona
Final Programme
P. 46 14:30 – 15:30
P. 46
Knowledge and social norms shaping
the discovery, use, and resistance
trends of antimicrobial agents
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 321 for details
14:30 – 15:30
P. 46 14:30 – 15:30
Training in infection in
Listeria and listeriosis
Europe – progress in curricula and
assessments
P. 46
16:00 – 18:00
P. 48 16:00 – 18:00
P. 49
Use of next generation sequencing in Making sense of our relationships
clinical practice
with mucosal commensals and
pathogens
Meet-the-Expert Sessions
2-hour Symposia
1-hour Symposia
Hall F
08:45 – 10:45
EW05:
Tick-borne diseases
prevalent in Europe
Keynote Lectures
Hall G
1-hour Oral Sessions
2-hour Oral Sessions
ePoster & Poster Sessions
Hall H
P. 28 08:45 – 10:45
P. 28 08:45 – 10:45
P. 28
EW06:
EW07:
Diagnosis and treatment of
Viral infections in pregnancy
Helicobacter pylori infection.
What is new in 2014?
Integrated Symposia
Saturday, 10 May 2014
Hall I
Hall J
08:45 – 10:45
P. 28
EW08:
Management of ocular parasitic
diseases
08:45 – 10:45
P. 29
EW09:
How to diagnose and treat
bacterial and fungal biofilm
infections
Registration, Exhibition,
Posters
Hall 132/133
Registration
07:00 – 18:30
Exhibition
12:00 – 18:45
Posters
15:30 – 16:30 Session I
P. 33 13:30 – 15:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 316 for details
16:30 – 18:30
P. 36 16:30 – 18:30
Epidemiology based on
Integrated Symposium
whole genome sequencing
(not included in main event
CME/CPD credit)
Refer to page 317 for details
16:30 – 18:30
P. 36
Laboratory response to
emerging viral diseases: from
pathogen discovery to disease
monitoring
11:00 – 13:00
P. 31
EW18:
Human parasites of the gut:
epidemiology and diagnostic
approaches in the molecular era
11:00 – 13:00
P. 31
EW19:
ESCMID guidelines for diagnosis
and treatment of Aspergillus
diseases
13:30 – 15:30
P. 34
Application of new methods
in medical microbiology and
infection control
13:30 – 15:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 316 for details
16:30 – 18:30
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 318 for details
16:30 – 18:30
Carbapenemases from
prevention to treatment
ePosters Viewing
Throughout congress hours
13:30 – 16:45
TAE Trainees Day
P. 34
P. 37
Overview & Programme
P. 33 13:30 – 15:30
Improving antibiotic
prescription quality
11:00 – 13:00
P. 31
EW17:
How to prevent the
consequences of EBV infection
in transplant recipients?
Sunday, 11 May 2014
Hall G
07:45 – 08:45
P. 39
Addressing the problem of MDR
Neisseria gonorrhoeae
11:30 – 12:30
Automation in diagnostic
bacteriology
13:00 – 14:00
ePoster Session:
PK/PD to imporve treatment of
critically ill patients
Registration, Exhibition,
Posters
Hall J
07:45 – 08:45
P. 39
Controversies in treatment of malaria
and crimean-congo haemorrhagic
fever
P. 44 11:30 – 12:30
MDR Acinetobacter baumannii
07:45 – 08:45
P. 39 07:45 – 08:45
P. 39 Registration
Screening for carbapenemase
New viruses: pathogens or innocent 07:00 – 18:00
production, molecular and phenotypic bystanders?
methods
Exhibition
09:00 – 17:30
09:00 – 11:00
P. 41 09:00 – 11:00
P. 41 09:00 – 11:00
P. 42
Posters
News in travel, tropical and parasitic MALDI-TOF mass spectrometry:
Basic science: pathogenesis and
12:30 – 13:30 Session II
infections
ongoing revolution in clinical
epidemiology of Gram-positive
13:30 – 14:30 Session III
microbiology
bacteria
Posters
P. 40 09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 320 for details
ePosters Viewing
Throughout congress hours
P. 44 11:30 – 12:30
P. 44 11:30 – 12:30
The great filter: parasitic infections
Emerging resistance in fungi
of the liver
P. 45 11:30 – 12:30
P. 45
Viral opportunists in the critically
ill patient
13:00 – 14:00: EPOSTER & POSTER VIEWING
P. 79 13:00 – 14:00
P. 77 13:00 – 14:00
P. 78 13:00 – 14:00
P. 79
ePoster Session:
ePoster Session:
ePoster Session:
Microbiome and resistance: what are STD and other genital infections
Antifungal drug susceptibility and
they telling us?
resistance
14:30 – 15:300
P. 46 14:30 – 15:30
Why are some carbapenemases
Microbiome and microbiota:
successful?
new “M”s in microbiology
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 322 for details
Hall I
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 322 for details
P. 47 14:30 – 15:30
An update on malaria
P. 47 14:30 – 15:30
P. 48 14:30 – 15:30
Different prevention strategies in
Hot topic: Ebola in Africa
immunocompromised patients
P. 48
Exhibition
09:00 – 11:00
Exploring and treating biofilms
Hall H
Chairs, Speakers & Authors
Hall F
ePosters
13:30 – 15:30
Ticks and tick-borne
pathogens
11:00 – 13:00
P. 31
EW16:
Update on anaerobes: new
methods bring new information
about the bugs and their
importance in health and
disease
16:00 – 18:000
P. 50 16:00 – 18:000
P. 50 16:00 – 18:000
P. 50
Ins and outs of Legionnaires disease Infections and devices: imaging &
Bacterial persistence and tolerance:
nuclear medicine meets infectious
from bench to bedside
diseases
24th ECCMID / Barcelona
Final Programme
19
General Information
11:00 – 13:00
P. 30
EW15:
When is a food-borne infection
not a food-borne infection?
Scientific Programme Overview
Monday, 12 May 2014
HALL A
HALL B
HALL C
7:45 07:45 – 08:45
P. 51
8:00 The management of HIV/HCV infection
in the era of direct active drugs
9:00 09:00 – 11:00
What is hot in HIV in 2014?
10:00
HALL D
HALL E
07:45 – 08:45
P. 51
EUCAST questions and answers
P. 51 09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 323 for details
09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 323 for details
09:00 – 11:00
Colistin: position in the era of
multi-resistance
P. 52 09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 324 for details
11:00
11:30 – 12:30
P. 53 11:30 – 12:30
P. 53 11:30 – 12:30
P. 54 11:30 – 12:30
Better to prevent than to cure: case
Molecular diagnosis: commercial or
Fighting against fungal infections:
Antivirulence drugs
of
HIV
home-made
tests
–
Pro
/
Con
debate
cells
on
the
front
lines
12:00
P. 54 11:30 – 12:30
Enterococcal resistance
P. 54
13:00 – 14:00: ePoster & Poster viewing
13:00
13:00 – 14:00
P. 81
ePoster Session:
Antibacterial drug activity and interactions in Gram-positive organisms
14:00
14:30 – 15:30
HIV – behaviour and beliefs
15:00
P. 56 14:30 – 15:30
P. 56 14:30 – 15:30
P. 57 14:30 – 15:30
P. 57 14:30 – 15:30
Going away from blood: why not to
Excellence Award Lecture: Close
New antibiotics in clinical trials
T-cells in invasive aspergillosis
test oral fluid and urine?
encounters of the third kind –
pathogens and globalisation
16:00 16:00 – 18:00
P. 59
Cryptococcal infections in HIVinfected patients: what is new in
2014?
17:00
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 325 for details
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 325 for details
16:00 – 18:00
P. 59 16:00 – 18:00
New transmission routes and
Predicting the future in fungal
genotypic diversity: are we looking at diagnosis and therapy
a new MRSA?
P. 57
P. 60
18:00
Tuesday, 13 May 2014
Hall A
Hall B
7:45
8:00
9:00
07:45 – 08:45
How to use next generation
sequencing in future virology
09:00 – 11:00
Clinical Grand Round 2014
Hall C
Hall D
Hall E
P. 63 07:45 – 08:45
P. 63 07:45 – 08:45
P. 63
Control of vancomycin-resistant
Management and troubleshooting of
enterococci: efforts justified?
in-house molecular diagnostics in the
microbiological lab
07:45 – 08:45
P. 63
Antimicrobial resistance research,
supported by funding from the EU and
the US NIH/NIAID
P. 64 09:00 – 11:00
P. 64 09:00 – 11:00
P. 64 09:00 – 11:00
P. 65 09:00 – 11:00
P. 65
The challenge of respiratory viruses What is new in immunocompromised Nebulised antibiotics: challenge
Combined antimicrobial therapy
patients?
for 2014
for multi-resistant Gram-negative
bacteria
10:00
11:00
12:00
11:30 – 12:30
P. 67 11:30 – 12:30
P. 67 11:30 – 12:30
P. 68 11:30 – 12:30
P. 68 11:30 – 12:30
P. 69
The year in Clinical Microbiology
Cross-neutralising antibodies for
Surveillance of healthcare-associated Advances in CMV infection in transYoung Investigator Award Lectures
respiratory virus therapy and vaccine infections: infections or procedures? plant recipients
design
ePoster & Poster Viewing
13:00
14:00
13:30 – 15:30
P. 70 13:30 – 15:30
Controlling transmission of multidrug- Hot topics in
resistant pathogens in the intensive vaccine-preventable diseases
care unit
15:00
15:15
15:30
20
24th ECCMID / Barcelona
Final Programme
P. 70 13:30 – 15:30
P. 70 13:30 – 15:30
Antimicrobial prophylaxis of surgical Emerging infectious diseases
site infections: time to review?
P. 71 13:30 – 15:30
Case-based decisions
in the era of XDR
Gram-negatives: towards
individualised therapy?
P. 71
Meet-the-Expert Sessions
2-hour Symposia
1-hour Symposia
HALL F
Keynote Lectures
HALL G
1-hour Oral Sessions
2-hour Oral Sessions
ePoster & Poster Sessions
HALL H
Integrated Symposia
Monday, 12 May 2014
HALL I
07:45 – 08:45
New nomenclature:
new species – any meaning
for clinical relevance?
P. 51
07:45 – 08:45
Altered drug disposition in
the elderly
09:00 – 11:00
Full laboratory automation
P. 52 09:00 – 11:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 324 for details
09:00 – 11:00
P. 52 09:00 – 11:00
Outbreaks of MDR Gram-negative
An update on leishmaniasis
bacteria: what works and what does
not work?
Registration, Exhibition,
Posters
HALL J
07:45 – 08:45: P. 51 Registration
Current challenges and emerging evidence 07:00 – 18:00
of infection control and prevention
Exhibition
measures in long-term care facilities
09:00 – 17:30
P. 53 09:00 – 11:00
P. 53
Posters
Staphylococcus aureus
12:30 – 13:30 Session IV
bacteraemia: controversial issues
13:30 – 14:30 Session V
P. 51 07:45 – 08:45
P. 51
Who should and who should not
receive drug treatment for Chagas
disease?
ePosters Viewing
Throughout congress hours
11:30 – 12:30
P. 55 11:30 – 12:30
P. 55 11:30 – 12:30
Molecular detection of resistance:
Community-acquired pneumonia –
Viral paediatric infections
dream or reality?
current challenges and future
directions
P. 55 11:30 – 12:30
P. 56 11:30 – 12:30
P. 56
Acute anaemia after treatment of
The year in Infectious Diseases
malaria with intravenous artesunate –
a new variant of “blackwater fever”?
13:00 – 14:00: ePoster & Poster viewing
13:00 – 14:00
P. 82 13:00 – 14:00
P. 83 13:00 – 14:00
P. 84 13:00 – 14:00
P. 85
ePoster Session:
ePoster Session:
ePoster Session:
ePoster Session:
Assessing and decreasing environCommunity-acquired pneumonia
Vaccine development
Highlights from molecular mycology
mental contamination
P. 58 14:30 – 15:30
P. 58 14:30 – 15:30
P. 58
Diagnostic tools in parasitology
On the cutting edge of infection
control research: what to do when
evidence is missing?
16:00 – 18:00
P. 60 16:00 – 18:00
P. 60
Forensic and post-mortem
New approaches to prevent
microbiology in the 21st century
transmission of Clostridium difficile
infections
16:00 – 18:00
P. 60
Non-molecular diagnosis of central
nervous system and bloodstream
infections
Overview & Programme
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 326 for details
P. 57 14:30 – 15:30
Viral diagnostics in the
immunocompromised
16:00 – 18:00
Integrated Symposium
(not included in main event
CME/CPD credit)
Refer to page 326 for details
Tuesday, 13 May 2014
Hall F
Hall G
Hall H
07:45 – 08:45
P. 63 07:45 – 08:45
P. 63
Strategies for malaria prevention, why Healthcare providers and influenza
do national guidelines differ?
vaccination
Hall I
Registration, Exhibition,
Posters
Hall J
07:45 – 08:45
P. 63
How to treat MDR tuberculosis?
ePosters
14:30 – 15:30
P. 57 14:30 – 15:30
The effects of antibiotic pollution on Detection of broad-spectrum
the environmental resistance gene
beta-lactamases
reservoir
Registration
07:00 – 15:30
Exhibition
09:00 – 15:30
Posters
P. 67 09:00 – 11:00
P. 67
Optimisation of empirical and targeted Posters
12:30 – 13:30 Session VI
antifungal therapy for invasive
aspergillosis
ePosters Viewing
Throughout congress hours
Chairs, Speakers & Authors
11:30 – 12:30
P. 69
Advances in molecular
mycology: notes from the bench
P. 66 09:00 – 11:00
P. 67 09:00 – 11:00
PK/PD – the merits of models and
The hidden Beijing
measurement
M. tuberculosis pandemic
11:30 – 12:30
P. 69 11:30 – 12:30
P. 69 11:30 – 12:30
P. 69
Can we treat Gram-negative
Mycobacteria in cutaneous infections HIV and hepatitis C co-infection:
bacteraemia with a short-course of
double trouble?
antibiotics? Pro / Con debate
ePoster & Poster Viewing
P. 72 13:30 – 15:30
New old antibiotics:
safety and efficacy
P. 73 13:30 – 15:30 Improving treatment
of severe infections
P. 74 13:30 – 15:30
P. 74 13:30 – 15:30
P. 75
Two-faced companions: highlights in
PCR and other molecular tests
the world of anaerobes
directly on blood: what is new?
Exhibition
13:30 – 15:30
Clinical mycology
update 2014
24th ECCMID / Barcelona
Final Programme
21
General Information
09:00 – 11:00
P. 65 09:00 – 11:00
Healthcare-associated infections –
Bacterial paediatric infections
from analysis to interventions
Sat, 10 May 2014
24th ECCMID 2014, Barcelona, Spain
Don’t miss the
4th TAE Trainees
Day session!
If you are currently training in Clinical Microbiology
or Infectious Diseases, this is an excellent
opportunity to receive valuable information and tips
from internationally renowned experts as well
as to network with trainees from all over Europe. This
year’s programme will cover STDs, bioterrorism
and outbreak detection, and sepsis in a CM and ID
perspective.
E!
VISIT TA WorlD
SCMID
In THE E ID BArCElonA
AT ECCM
Sat, 10 May 2014, 13:30 – 16:45, Room 133/134
Chairs: P. Maver Vodicar, Ljubljana, Sl
E. Vlieghe, Antwerp, BE
Welcome and TAE President’s address
P. Maver Vodicar, Ljubljana, Sl
STDs – are they still hot? Beyond the typical case
M. Vera Garcia, Madrid, ES
The silent threat of bioterrorism – be prepared
M. Barbeschi, Geneva, CH
The challenges of outbreak detection and response
K. Leitmeyer, Stockholm, SE
Sepsis: think globally, treat locally – CM perspective
S. Stefani, Catania, IT
Sepsis: think globally, treat locally – ID perspective
E. Vlieghe, Antwerp, BE
Also prepared in collaboration with TAE:
Sat 10 May 2014, 11:00 – 13.00, Hall G:
Update on anaerobes: new methods bring new information about
the bugs and their importance in health and disease
Sun 11 May 2014, 11:30 – 12:30, Hall D:
Great scientific success with scarce resources. Is money issue
a crucial point?
Sun 11 May 2014, 14:30 – 15:30, Hall D:
Training in infection in Europe – progress in curricula and
assessments
22
24th ECCMID / Barcelona
Final Programme
www.eccmid.org
www.escmid.org/tae
tae@escmid.org
www.facebook.com/ESCMID.TAE
TAE – Trainee Association of ESCMID
CME Accreditation
•
•
Target Audience
ECCMID 2014 is the global meeting place for microbiologists,
infectious disease specialists and related fields. Because of the
diverse, clinically focused educational offering, participants are
able to tailor the curriculum to meet the needs of international
clinicians of all levels of experience.
Accreditation Statement and Credit Designation
European Accreditation Council for Continuing Medical Education
(UEMS/EACCME)
The 24th European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID)
is accredited by the European Accreditation Council for Continuing
Medical Education (EACCME) to provide the following CME activity
for medical specialists.
The EACCME is an institution of the European Union of Medical
Specialists (UEMS): www.uems.net The 24th European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID)
is designated for a maximum of, or up to, 23 European external
CME credits. Each medical specialist should claim only those hours
of credit that he/she actually spent in the educational activity.
American Medical Association (AMA)
Through an agreement between the European Union of Medical
Specialists and the American Medical Association, physicians may
convert EACCME credits to an equivalent number of AMA PRA Category
1 Credits™. Information on the process to convert EACCME credit to
AMA credit can be found at www.ama-assn.org/go/internationalcme
Royal College of Physicians and Surgeons of Canada
Live educational activities, occurring outside of Canada,
recognised by the UEMS-EACCME for ECMEC credits are deemed
to be Accredited Group Learning Activities (Section 1) as
defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada. For more
information visit: www.royalcollege.ca
6
Sunday, 11 May 2014
6
Monday, 12 May 2014
6
Tuesday, 13 May 2014
5
Total Credits:
23
To Receive Your CME/CPD Certificate
Your CME/CPD certificate will be delivered electronically after
completing the educational evaluation and credit claiming
procedure. The process will take 5 minutes. We thank you for your
feedback as it is an important part of the CME/CPD accreditation
process and helps improve future educational offerings.
Before 10 June 2014:
1. Follow the link in the email notification sent at the end of
the event or visit the CME/CPD Accreditation page on the event
website. 2. Complete the anonymous online evaluation. 3. You will be automatically directed to the credit claim system.
4. Login with your unique User ID (included in your registration
package, on your badge or in the email sent after the event).
5. Indicate the number of hours you attended.
6. Your CME/CPD certificate will be available for download and
also emailed to the address provided.
7. Retain the certificate for your personal records.
Disclosure and Resolution of Personal Conflicts of Interest
In accordance with CME/CPD accreditation criteria and standards for
commercial support to ensure balance, independence, objectivity,
and scientific rigor, those in control of the educational content
must disclose potential or actual conflicts of interest. Disclosure
information is evaluated and conflicts of interest resolved.
Disclosure is made to participants prior to the activity. Participants
will be asked on the evaluation to assess the objectivity and
independence of the event.
Disclosure information can be viewed on the congress website
under the CME information pages.
Industry Support Disclosure
This event is supported, in part, by funding from industry.
All support is managed in strict accordance with CME/CPD
accreditation criteria and standards for commercial support.
Appropriate acknowledgement of all supporting organisations
is made in the programme guide, on the event website, and with
signage during the event.
•
•
A list of all industry supporters is available on page 3
Detailed programmes for all Industry Sessions are available
on pages 314–326
24th ECCMID / Barcelona
Final Programme
23
Overview & Programme
•
Saturday, 10 May 2014
ePosters
•
Maximum Credits
Posters
•
Day
Chairs, Speakers & Authors
•
Address individual needs in compliance with their Continuous
Professional Development (CPD) plan
Exchange ideas and knowledge in the field of microbiology
and infectious disease across continents, institutions and
individuals
Discuss the latest research outcomes in the field of
antimicrobials, molecular biology, virology and infection control
Discuss the latest research outcomes in the field of infectious
diseases, microbiology and research
Discuss outcomes of the latest studies in Europe in the field of
public health and vaccines
Summarise good and bad immune responses
Discuss diagnostics, therapeutics and prevention in the field
of infectious diseases
Exhibition
•
Credit Breakdown
Each participant should claim only those hours of credit that he/
she actually spent in the educational activity.
General Information
Educational Objectives After attending this event, participants should be able to: Introduction to the Scientific Programme
Educational Workshops
At the beginning of ECCMID, on Saturday morning, 10 May 2014,
from 08:45 – 13:00 a series of Educational Workshops will take
place. They are organised in cooperation with ESCMID Study
Groups and partnering organisations. Participation in Educational
Workshops is free of charge and corresponding educational
material is available online in the ESCMID Online Lecture Library
(www.escmid.org/oll).
ePoster Sessions
Selected ePosters have been scheduled for ePoster sessions on
Sunday, 11 May and Monday, 12 May between 13:00 – 14:00. In
additional to being displayed on the ePoster stations though the
4 congress days, these selected ePosters will be presented orally
in the designated session halls. Please refer to the scientific
programme for the detailed ePoster sessions (see page 313). The
presenting author is indicated by an asterisk (*).
Meet-the-Expert Sessions
Sunday through Tuesday, the day will start at 07:45 with Meetthe-Expert Sessions led by experts in their fields. These sessions
depend on active participation of the audience. After a short
presentation, the expert will open the session for discussion.
Coffee will be offered.
ePoster Viewing
ePosters have been divided in 38 thematical sessions, which will
be displayed all 4 congress days on 25 ePoster stations within the
CCIB, on the mobile website and application of the congress. The
new ePoster format will give participants the possibility to interact
with presenters and send the ePoster by email (see page 87). The
presenting author is indicated by an asterisk (*).
TAE Trainees Day
On Saturday, 10 May 2014, 13:30 – 16:45, the Trainee Association
of ESCMID (TAE) organises the European Trainees Day, a day of
teaching dedicated to the unique needs of trainees. During this
session various topics in CM and ID will be discussed in a highly
interactive way between trainees and experienced CM and ID
specialists. A second and equally important aim of the day is to
give trainees an opportunity to meet and network with each other.
Participation is free of charge to ECCMID attendees.
Keynote and Award Lectures
Sunday through Tuesday at 11:30 and 14:30, lectures of 60
minutes will be given by opinion leaders in their fields as well as by
the winner of the ESCMID Excellence Award 2014.
Symposia
From 09:00 – 12:30 and from 14:30 – 18:00 each day, parallel
symposia will convene renowned speakers from Europe and other
continents who will cover a wide range of recent developments in
their fields. On Tuesday, 13 May 2014, the last round of symposia
takes place from 13:30 – 15:30. A number of symposia are
arranged in cooperation with ESCMID Study Groups, while others
are jointly organised with partnering societies or organisations.
Symposia arranged by the industry are organised in close
cooperation with the ECCMID Programme Committee. They are an
integral part of the scientific programme (Integrated Symposia).
Oral Sessions
During the same time slots as the before mentioned symposia,
you will also find sessions composed of abstracts selected for oral
presentation, which are indicated by the prefix “O” in front of the
programme numbers. The presenting author is indicated with an
asterisk (*).
24
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Most of the accepted abstracts are scheduled for poster
presentation from Saturday through Tuesday. The selection is
based on a blind review by at least three experts in each field.
The posters are displayed in the Poster Area on the 2nd floor of
the CCIB. The poster area is open to all participants on Saturday
from 12:00 –18:30, on Sunday and Monday from 09:00 – 17:30
and on Tuesday from 09:00 – 15:00. Please note that posters are
exchanged on a daily basis. Poster authors must be present at their
posters for discussion during their poster session (see page 313
for details). The presenting author is indicated by an asterisk (*).
Publication Only
Due to a large response to the call for abstracts, the Programme
Committee has had to restrict the number of abstracts for
presentation during the meeting. Abstracts of this category are not
included in the Final Programme but are published in the ESCMID
Online Lecture Library (www.escmid.org/oll).
Online Meeting Planner during the 24th ECCMID
The final scientific programme including all accepted abstracts
is available on the congress website at www.eccmid.org. Go to
the “Scientific Programme” link to compose your personalised
programme of lectures. You can use the search function to find
keywords, speakers and chairpersons. In addition all functions
have been implemented in the mobile application and mobile
website onsite as well.
The following prefixes have been used throughout the
programme:
EW = Educational Workshop
O = Oral Session
KL = Keynote Lecture eP = ePoster Session
SY = Symposium P = Poster Session
ME = Meet-the-Expert Session
IS = Integrated Symposium
ESCMID Business Meetings
Saturday, 10 May 2014 13:00 – 14:00
17:00 – 18:45
Monday, 12 May 2014 CMI & NMNI Reception
Room 124/125
Reception for travel grantees, Young
Investigators and Excellence Awardee
Room 124/125
24th ECCMID / Barcelona
Final Programme
25
General Information
Exhibition
Chairs, Speakers & Authors
Posters
ePosters
Overview & Programme
09:00 – 12:00 CAESAR Meeting
Room 122/123
12:45 – 14:15 EUCAST General Committee Meeting Room 122/123
13:15 – 14:15 ESGAI Business Meeting
Room M211/M212
13:15 – 14:15 ESGAP Business Meeting
Sunday, 11 May 2014 Room 132
13:15 – 14:15 ESGB Business Meeting
13:15 – 14:15 ESGARS Business Meeting
Room 131
Room 132
13:15 – 14:15 ESGBIS Business Meeting 13:15 – 14:15 ESGCP Business Meeting
Room 125
Room 133/134
13:15 – 14:15 ESGBOR Business Meeting 13:15 – 14:15 ESGICH Business Meeting
Room 133/134
Room M213/M214
13:15 – 14:15 ESGCIP Business Meeting 13:15 – 14:15 ESGMD Business Meeting Room 130
Room 124
13:15 – 14:15 ESGEM Business Meeting 13:15 – 14:15 ESGNI Business Meeting
Room 129
Room 131
13:15 – 14:15 ESGIB Business Meeting
13:15 – 14:15 ESGVH Business Meeting
Room 127/128
Room 130
13:15 – 14:15 EVASG Business Meeting
18:15 – 19:15 EFISG Business Meeting
Room 124
Room 127/128
14:15 – 15:15 ESGAI: ENRIA Meeting
18:15 – 19:15 EFWISG Business Meeting
Room M211/M212
Room 132
16:30 – 18:00 EUCAST AFST General Committee Meeting
18:15 – 19:15 EPASG Business Meeting
Room 122/123
Room 131
18:00 – 18:30 European Council Meeting 18:15 – 19:15 ESCAR Business Meeting Room 124/125
Room 130
18:30 – 20:00 ESCMID General Assembly 18:15 – 19:45 ESGCD Business Meeting
Room 133/134
Room M211/M212
18:15 – 19:15 ESGIAI Business Meeting
Room 133/134
18:15 – 19:15 ESGIE Business Meeting
Room 129
18:15 – 19:15 ESGITM Business Meeting Room 125
18:15 – 19:15 ESGMI Business Meeting
Room 121
18:15 – 19:15 ESGMYC Business Meeting
Room 124
18:15 – 19:15 ESGS Business Meeting
Room 123
www.escmid.org/summerschool
Summer School
13th ESCMID
Summer School
Sigtuna, Sweden
5 – 12 July 2014
Postgraduate and continuing medical education in
clinical microbiology and infectious diseases
Including:
• State-of-the-art lectures
• Update lectures
• Small group tutorial sessions
• Pro and Contra sessions
• Career advice
Please register at www.escmid.org/summerschool.
Places are limited, apply by 9 May 2014!
Organised by the ESCMID Education Subcommittee
Hosted at «Sigtuna Folkhögskola» in Sigtuna, Sweden
Scientific Programme
Saturday, 10 May 2014
HALL B
EDUCATIONAL WORKSHOP 01:
Infection prevention and management
in long-term care facilities
8:45 – 10:45
EDUCATIONAL WORKSHOP 03:
Tuberculosis and other mycobacterial
infections in low-income countries
ESGAP,ESGIE,ESGNI
ESGMYC
Chairs: Sheldon Stone (United Kingdom)
Leonardo Pagani (Switzerland)
Chairs: Julian Gonzalez-Martin (Spain)
Miguel Viveiros (Portugal)
EW001 8:45 Antibiotic-resistant bacteria in elderly facilities:
EW009 8:45 How to diagnose mycobacterial infections
good news and pitfalls
Richard Aschbacher (Italy)
in low-income countries
Miguel Viveiros (Portugal)
EW011 9:45 Mycobacterial infections in HIV-positive patients
in low-income countries
Miguel Santin (Spain)
Mical Paul (Israel)
EW004 10:15 Challenges, strategies and research priorities of
antimicrobial stewardship programmes in LTCFs
for the elderly
Dilip Nathwani (United Kingdom)
arranged with the ESCMID Study Group for
Antibiotic Policies (ESGAP); the ESCMID Study
Group for Infections in the Elderly (ESGIE)
and the ESCMID Study Group for Nosocomial
Infections (ESGNI)
EW012 10:15 Leprosy and Buruli ulcer in Africa
Overview & Programme
EW003 9:45 Clostridium difficile infection in the elderly
in migrants
Jon S. Friedland (United Kingdom)
Emmanuelle Cambau (France)
arranged with the ESCMID Study Group for
Mycobacterial Infections (ESGMYC)
8:45 – 10:45
HALL E
EDUCATIONAL WORKSHOP 04:
Vaccination in the elderly: perspectives
ePosters
long-term care facilities: should infection control
limit daily activities?
M. Adriana Cataldo (Italy)
EW010 9:15 Strategy for TB treatment and management
ESGIE, EVASG
Chairs: Gaetan Gavazzi (France)
Susanna Esposito (Italy)
HALL C
EW013 8:45 Immune senescence: impact on vaccination
efficacy
Pierre O. Lang (Switzerland)
EPASG
Chairs: Johan W. Mouton (The Netherlands)
Ursula Theuretzbacher (Austria)
EW005 8:45 Basic concepts of PK/PD
Johan W. Mouton (The Netherlands)
EW014 9:15 New and old vaccines for the elderly
Albert D.M.E. Osterhaus (The Netherlands)
EW015 9:45 Vaccination in elderly: the need of a life-course
programme
Jean-Pierre Michel (Switzerland)
EW006 9:15 Translating PK/PD concepts into dosing
strategies
William A. Craig (United States)
EW016 10:15 Vaccine coverage in elderly population in Europe
Piotr Kramarz (Sweden)
EW007 9:45 Optimising therapy in obese and frail patients
Hartmut Derendorf (United States)
EW008 10:15 Optimising therapy to minimise emergence of
resistance
Ursula Theuretzbacher (Austria)
Posters
EDUCATIONAL WORKSHOP 02:
Basic concepts of pharmacokinetics
and pharmacodynamics
arranged with the ESCMID Study Group for
Infections in the Elderly (ESGIE) and with the
ESCMID Vaccine Study Group (EVASG)
Exhibition
8:45 – 10:45
arranged with the ESCMID PK/PD of AntiInfectives Study Group (EPASG)
24th ECCMID / Barcelona
Final Programme
Chairs, Speakers & Authors
EW002 9:15 Implications of MDR control in different types of
HALL D
27
General Information
8:45 – 10:45
Scientific Programme
Saturday, 10 May 2014
8:45 – 10:45
HALL F
EDUCATIONAL WORKSHOP 05:
Tick-borne diseases prevalent in Europe
8:45 – 10:45
EDUCATIONAL WORKSHOP 07:
Viral infections in pregnancy
ESCAR, ESGBOR
ESGVH
Chairs: Gerold Stanek (Austria)
Amel Letaief (Tunisia)
Chairs: Resat Ozaras (Turkey)
Dominique Salmon-Ceron (France)
EW017 8:45 Human granulocytic anaplasmosis in Europe
EW025 8:45 Hepatitis B in pregnancy
Tatjana Avsic Zupanc (Slovenia)
Resat Ozaras (Turkey)
EW018 9:15 Human babesiosis in Europe
EW026 9:15 Hepatitis C in pregnancy
Jeremy Gray (Ireland)
Philippe Sogni (France)
EW019 9:45 Tick-borne encephalitis: what doctors need to
know about this disease
Franc Strle (Slovenia)
within the sway of antibiotic maximalism
Wolfgang Kristoferitsch (Austria)
EW028 10:15 Hepatitis E in pregnancy
Sabela Lens (Spain)
arranged with the ESCMID Study Group for
Coxiella, Anaplasma, Rickettsia and Bartonella
(ESCAR) and with the ESCMID Study Group for
Lyme Borreliosis (ESGBOR)
8:45 – 10:45
EW027 9:45 Prevention of mother to child transmission of HIV
TBD
EW020 10:15 Treatment regimens for Lyme neuroborreliosis
HALL H
HALL G
EDUCATIONAL WORKSHOP 06:
Diagnosis and treatment of Helicobacter pylori infection.
What is new in 2014?
arranged with the ESCMID Study Group for Viral
Hepatitis (ESGVH)
8:45 – 10:45
HALL I
EDUCATIONAL WORKSHOP 08:
Management of ocular parasitic diseases
ESGCP
Chairs: Birgitta Evengard (Sweden)
Carmen-Michaela Cretu (Romania)
EW029 8:45 Ocular acanthamoebiasis
EHSG
Chairs: Leif P. Andersen (Denmark)
Emilie Bessede (France)
EW021 8:45 Real-time PCR for H. pylori diagnosis.
Better than culture?
Leif P. Andersen (Denmark)
EW022 9:15 MALDI-TOF mass spectrometry applied to
H. pylori diagnosis and typing
Emilie Bessede (France)
EW023 9:45 Lessons from the study of gastric microbiota
Lars Engstrand (Sweden)
EW024 10:15 Sequential therapy or pylera(R) to eradicate
H. pylori
Xavier Calvet (Spain)
28
arranged with the European Helicobacter Study
Group (EHSG)
24th ECCMID / Barcelona
Final Programme
Francisco Arnalich (Spain)
EW030 9:15 Ocular larva migrans, cysticercosis, dirofilariasis
Carmen-Michaela Cretu (Romania)
EW031 9:45 Ocular toxoplasmosis
Hélène Yera (France)
EW032 10:15 Diagnosis of ocular parasites
Peter Chiodini (United Kingdom)
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
Scientific Programme
Saturday, 10 May 2014
HALL J
EW043 11:15 Susceptibility testing systems – are some more
equal than others?
John D. Turnidge (Australia)
EDUCATIONAL WORKSHOP 09:
How to diagnose and treat bacterial and
fungal biofilm infections
EW044 11:35 Issues in testing susceptibility to beta-lactam /
beta-lactamase inhibitor combinations
Robin Howe (United Kingdom)
ESGB
Chairs: Cornelia Lass-Flörl (Austria)
Thomas Bjarnsholt (Denmark)
EW045 11:55 Susceptibility testing of infrequently isolated
EW033 8:45 Fungal biofilm diagnosis
fastidious organisms
Luis Martinez-Martinez (Spain)
Gordon Ramage (United Kingdom)
EW034 9:15 Fungal biofilm treatment
EW046 12:15 Moderated panel discussion on questions from
the audience (part 2)
Alasdair P. MacGowan (United Kingdom)
EW035 9:45 Bacterial biofilm diagnosis
Thomas Bjarnsholt (Denmark)
EW036 10:15 Bacterial biofilm treatment
Claus Moser (Denmark)
arranged with the European Committee on
Antimicrobial Susceptibility Testing (EUCAST)
11:00 – 13:00
arranged with the ESCMID Study Group for
Biofilms (ESGB)
HALL B
Overview & Programme
Mariana Henriques (Portugal)
EDUCATIONAL WORKSHOP 11:
Recent research in critically ill patients: hands-on evidence
ESGCIP
Chairs: Jordi Rello (Spain)
Garyfallia Poulakou (Greece)
HALL A
EW047 11:00 Advances in randomised control trials on
candidaemia
Matteo Bassetti (Italy)
EUCAST
Chairs: Rafael Canton Moreno (Spain)
Derek F.J. Brown (United Kingdom)
EW048 11:30 How molecular biology is changing the diagnosis
of respiratory infections in critically ill patients
Ricardo Serrano Garcia (Spain)
EW037 8:45 Introduction
Derek F.J. Brown (United Kingdom)
EW038 8:55 Update on EUCAST 2014
EW049 12:00 A critical review of new biomarkers in VAP/HAP/
SCAP
José M. Pereira (Portugal)
Rafael Canton Moreno (Spain)
EW039 9:15 Update on EUCAST methods and breakpoints
EW050 12:30 Time is changing: monitoring VAP, VAT or IVAC?
Gunnar Kahlmeter (Sweden)
EW040 9:35 Internal quality control
Robert L. Skov (Denmark)
Posters
EDUCATIONAL WORKSHOP 10:
Antimicrobial susceptibility testing with
EUCAST breakpoints and methods
Joaquim Serra (Spain)
Chairs, Speakers & Authors
8:45 – 12:45
ePosters
8:45 – 10:45
arranged with the ESCMID Study Group for
Critically Ill Patients (ESGCIP)
EW041 9:55 External quality assessment
Derek F.J. Brown (United Kingdom)
EW042 10:15 Moderated panel discussion on questions from
10:45 Coffee break
24th ECCMID / Barcelona
Final Programme
29
General Information
Exhibition
the audience (part 1)
Alasdair P. MacGowan (United Kingdom)
Scientific Programme
Saturday, 10 May 2014
11:00 – 13:00
HALL C
EDUCATIONAL WORKSHOP 12:
Bloodstream infections:
opportunities for outcome improvement
11:00 – 13:00
EDUCATIONAL WORKSHOP 14:
Elderly and chronic hepatitis C – to treat or not to treat?
Group of ESCMID ID members interested in viral hepatitis (lead persons: Adriana Vince, Zagreb, Croatia and Heiner Wedermeyer, Hannover, Germany)
Chairs: Mario U. Mondelli (Italy)
Adriana Vince (Croatia)
ESGBIS
Chairs: Esther Calbo (Spain)
Winfried V. Kern (Germany)
EW051 11:00 Rapid diagnostic tests and early reporting
EW059 11:00 What a difference the age makes? Clinical course
of chronic hepatitis C in the elderly
Jerzy Jaroszewicz (Poland)
Martin Sundqvist (Sweden)
EW052 11:30 Clinical evaluation and management
EW060 11:30 Treatment of chronic hepatitis C in the elderly –
are we missing opportunities?
Antonella Cingolani (Italy)
Pilar Retamar Gentil (Spain)
EW053 12:00 Optimising therapy
EW061 12:00 Management of chronic hepatitis C in the elderly
Sibel Ascioglu (Turkey)
not eligible for standard treatment
Karin Lindahl (Sweden)
EW054 12:30 Bacteraemia in difficult patients
Winfried V. Kern (Germany)
arranged with the ESCMID Study Group for
Bloodstream Infections and Sepsis (ESGBIS)
11:00 – 13:00
HALL D
EDUCATIONAL WORKSHOP 13:
Basics of infections in travellers
EW062 12:30 Elderly with chronic hepatitis C in real-life setting
Adriana Vince (Croatia)
11:00 – 13:00
EFWISG
Chairs: Kevin G. Kerr (United Kingdom)
Eskild Petersen (Denmark)
Chairs: Hakan Leblebicioglu (Turkey)
Jon S. Friedland (United Kingdom)
EW055 11:00 Infections with a long incubation period in
returning travellers
Francesco Castelli (Italy)
EW056 11:30 Imported malaria in Europe – migrants and
visiting-friends-and-relatives travellers as high
risk groups
Patricia Schlagenhauf (Switzerland)
EW057 12:00 Misinterpretation of symptoms and overlooked
illnesses in migrants – differentials to infections
(case discussion)
Christian Wejse (Denmark)
EW058 12:30 Fever in returning travellers (case discussion)
Nicholas J. Beeching (United Kingdom)
30
arranged with the ESCMID Study Group for
Infections in Travellers and Migrants (ESGITM)
24th ECCMID / Barcelona
Final Programme
HALL F
EDUCATIONAL WORKSHOP 15:
When is a food-borne infection not a food-borne infection?
ESGITM
HALL E
EW063 11:00 Risky reptiles and perilous pets: food-borne
pathogens acquired from companion animals
Malcolm Bennett (United Kingdom)
EW064 11:30 Norovirus: kitchen hygiene versus hand hygiene
Marion Koopmans (The Netherlands)
EW065 12:00 Tracking down toxoplasmosis
Eskild Petersen (Denmark)
EW066 12:30 Campylobacter: do not just blame the chickens
Philippe Lehours (France)
arranged with the ESCMID Food- and Water-borne
Infections Study Group (EFWISG)
Scientific Programme
Saturday, 10 May 2014
HALL G
EDUCATIONAL WORKSHOP 16:
Update on anaerobes: new methods bring new information
about the bugs and their importance in health and disease
11:00 – 13:00
EDUCATIONAL WORKSHOP 18:
Human parasites of the gut: epidemiology and
diagnostic approaches in the molecular era
ESGAI, TAE
ESGCP, ESGMD
Chairs: Elisabeth Nagy (Hungary)
Kanita Dedic (Bosnia and Herzegovina)
Chairs: Titia M. Kortbeek (The Netherlands)
Paul Savelkoul (The Netherlands)
EW067 11:00 What is hidden behind the name? Why taxonomic
changes are key to elucidating the role of
anaerobic pathogens
Haroun N. Shah (United Kingdom)
EW075 11:00 General introduction and epidemiology of
common parasites of the human gut
Marjan van Esbroeck (Belgium)
EW068 11:30 'User friendly' identification of anaerobes: the
role of MALDI-TOF
Elisabeth Nagy (Hungary)
EW069 12:00 Does antibiotic resistance exist in anaerobic
bacteria? Disk diffusion for antimicrobial
susceptibility testing and beyond
Ulrik S. Justesen (Denmark)
EW076 11:30 Classical diagnostic methods for detection of
parasites
Theo Mank (The Netherlands)
EW077 12:00 Detection of parasites with molecular methods
Spencer Polley (United Kingdom)
Simone Caccio (Italy)
anaerobes in a variety of conditions
Diane M. Citron (United States)
arranged with the ESCMID Study Group for
Anaerobic Infections (ESGAI) and the Trainee
Association of ESCMID (TAE)
11:00 – 13:00
HALL H
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP) and the ESCMID Study
Group for Molecular Diagnostics (ESGMD)
11:00 – 13:00
Overview & Programme
EW078 12:30 Molecular typing of parasites
EW070 12:30 Who would believe it? The unexpected role of
HALL I
HALL J
EDUCATIONAL WORKSHOP 19:
ESCMID guidelines for diagnosis and treatment
of Aspergillus diseases
ePosters
11:00 – 13:00
EFISG, ESGICH, ECMM, ERS and EACCI
EW071 11:00 Dynamics of EBV viraemia and its relationship
with the development of PTLD
Helen E. Heslop (United States)
Cornelia Lass-Flörl (Austria)
EW080 11:30 Invasive aspergillosis in children
Andreas H. Groll (Germany)
EW081 12:00 Invasive aspergillosis in haematology and
oncology
Andrew J. Ullmann (Germany)
EW072 11:30 Which population should be monitored?
Rafael San Juan Garrido (Spain)
EW073 12:00 Is there any role of antivirals and rituximab in the
pre-emptive management of PTLD?
Hans H. Hirsch (Switzerland)
EW074 12:30 Role of reduction of immunosuppression,
immune-adoptive therapy and other measures
Oriol Manuel (Switzerland)
arranged with the ESCMID Study Group for
Infections in Compromised Hosts (ESGICH)
Posters
EW079 11:00 Diagnostic procedures
Chairs, Speakers & Authors
Chairs: Oriol Manuel (Switzerland)
Stipan Jonjic (Croatia)
EW082 12:30 Non-invasive aspergillosis
David W. Denning (United Kingdom)
arranged with the ESCMID Fungal Infection Study
Group (EFISG); the ESCMID Study Group for
Infections in Compromised Hosts (ESGICH); the
European Confederation of Medical Mycology
(ECMM); the European Respiratory Society (ERS)
and the European Academy of Allergy and Clinical
Immunology (EAACI)
24th ECCMID / Barcelona
Final Programme
31
Exhibition
ESGICH
Chairs: Sevtap Arikan-Akdagli (Turkey)
Jose M. Aguado Garcia (Spain)
General Information
EDUCATIONAL WORKSHOP 17:
How to prevent the consequences of EBV infection in
transplant recipients?
Scientific Programme
Saturday, 10 May 2014
13:30 – 15:30
HALL A
SYMPOSIUM:
What’s new in sepsis in 2014
ISF
Chairs: Tom van der Poll (The Netherlands)
Thierry Calandra (Switzerland)
SY083
ISF Awardee Lecture: Protective role of the gut
microbiota in pneumonia-derived sepsis
Jacqueline Lankelma (The Netherlands)
13:30 – 15:30
ORAL SESSION:
Lessons learned from Clostridium difficile
molecular epidemiology
Chairs: Mark H. Wilcox (United Kingdom)
Ed J. Kuijper (The Netherlands)
O001
Thierry Calandra (Switzerland)
SY085 14:00 Prevention of sepsis in the ICU
O002
Mihai Gheorghe Netea (The Netherlands)
SY087 15:00 Combination antibiotic therapy for pneumococcal
O003
arranged with the International Sepsis Forum
(ISF)
13:30 – 15:30
HALL D
O004
O005
and solid organ transplant recipients
Catherine Cordonnier (France)
O006
and CMV. What is new in the transplant setting?
Oriol Manuel (Switzerland)
SY091 15:00 Influenza vaccination. How can we improve its
24th ECCMID / Barcelona
Final Programme
14:30 Dutch sentinel surveillance for Clostridium
difficile infections shows stable hospital
incidence since 2009, but a re-emergence of type
027
S.M. Van Dorp* (Leiden, The Netherlands),
D.W. Notermans, S. De Greeff, E.J. Kuijper 
SY090 14:30 Other vaccines beside pneumococcal, influenza,
32
14:18 The changing epidemiology of Clostridium difficile
ribotypes in Scotland between 2009-2013
C. Wiuff* (Glasgow, United Kingdom), A. Banks,
D.J. Brown, D. Henderson, J.E. Coia, T. Inkster
SY089 14:00 What can be expected from cytomegalovirus
effectiveness?
Pilar Perez-Romero (Spain)
14:06 Prevalence, proportions and diversity of
Clostridium difficile PCR ribotypes in London from
2007-2012
D. Ready* (London, United Kingdom), C. Ryan,
M. Cairns, H. Auburn, N. Murphy, C. Ling, N. Shetty,
R. Manuel
Chairs: Paolo A. Grossi (Italy)
Carlos Lumbreras (Spain)
vaccine?
Vincent Emery (United Kingdom)
13:54 Household transmission of Clostridium difficile
V.G. Loo, P. Brassard, M.A. Miller* (Montreal,
Canada)
SYMPOSIUM:
Uncertainties in transplant vaccination
SY088 13:30 Conjugated pneumococcal vaccine in stem cell
13:42 Increased diversity of C. difficile PCR-ribotypes
across European countries and disparity of 027
prevalence; results of a European prevalence
study of Clostridium difficile infection (EUCLID)
K. Davies* (Leeds, United Kingdom), H. Ashwin,
G.L. Davis, F. Lee, C.M. Longshaw, M.H. Wilcox
SY086 14:30 Fungal sepsis
sepsis: what is the evidence?
Antonio Torres (Spain)
13:30 Whole genome sequencing demonstrates
children are a potentially important reservoir for
Clostridium difficile infections in adults
D.W. Eyre* (Oxford, United Kingdom), N.E. Stoesser,
G. Pill, A. Vaughan, D.W. Crook, T.E.A. Peto,
A.S. Walker
SY084 13:30 Year in review in sepsis
Marc J.M. Bonten (The Netherlands)
HALL E
O007
14:42 Growth patterns of Clostridium difficile –
correlation with strain types, binary toxin
production and disease severity: results from a
prospective cohort study
S. Tschudin Sutter* (Basel, Switzerland),
O. Braissant, A. Stranden, G. Bonkat, R. Frei,
A.F. Widmer
Scientific Programme
Saturday, 10 May 2014
Chairs: Winfried V. Kern (Germany)
Nur Benzonana (Turkey)
O011
disease severity or recurrence
K.A. Bauer* (Columbus, United States),
J.E.W. Johnston, D.A. Goff, C.H. Cook,
J.M. Balada-Llasat, P. Pancholi, J.E. Mangino
stewardship – is there value in early reviewing at
48 hour post-antibiotic prescription?
Y.X. Liew, D.M.M. TAY, M.P. Chlebicki, W. Lee,
J. Teo, S.S.L. Tang, Y.P.J. Zhou, N.G.S. Chua,
A. Kwa* (Singapore, Singapore)
15:18 Analysis of actual Clostridium difficile
epidemiology in Germany based on a multi-centre
bi-annual point prevalence study in European
countries (EUCLID)
L. Von Müller* (Homburg/Saar, Germany), D. Zevallos,
A. Nimmesgern, M. Herrmann,  EUCLID study group
O012
management of prescribing for UTIs) study:
a complex cluster intervention
A. Vellinga* (Galway, Ireland), S. Duane, A. Callan,
S. Galvin, M. Cormican, A.W. Murphy
O013
13:30 – 15:30
SYMPOSIUM:
Ticks and tick-borne pathogens
Chairs: Gerold Stanek (Austria)
Tatjana Avsic Zupanc (Slovenia)
O014
Benoît Jaulhac (France)
SY093 14:00 Rickettsial infection
O015
TBD
SY095 15:00 Emerging tick-borne viral infections
14:18 Effect of antibiotic stewardship programmes on
Clostridium difficile incidence: a meta-analysis
L.M. Feazel, A. Malhotra, E.N. Perencevich, P. Kaboli,
D.J. Diekema, M.L. Schweizer* (Iowa City, IA, United
States)
SY094 14:30 Tick-borne encephalitis
Koray Ergunay (Turkey)
14:06 Do we need to review and escalate the
antimicrobial stewardship education in health
and veterinary undergraduate courses in the
United Kingdom? Results of a national survey
E. Castro Sanchez* (London, United Kingdom),
S. Farrell, L.D. Drumright, A.H. Holmes
SY092 13:30 Lyme disease: from bench to bedside
Pierre-Edouard Fournier (France)
13:54 Antibiotic prescribing in acute national health
service hospitals; still lacking focus
K. Hand, A.S. Walker, M.J. Llewelyn* 
(Brighton, United Kingdom)
HALL F
ESCAR, ESGBOR
13:42 The simple (supporting the improvement and
Overview & Programme
O010
13:30 Prospective review and feedback in antimicrobial
ePosters
15:06 Clostridium difficile NAP1 does not influence
ORAL SESSION:
Improving antibiotic prescription quality
O016
arranged with the ESCMID Study Group for
Coxiella, Anaplasma, Rickettsia and Bartonella
(ESCAR) and the ESCMID Study Group for Lyme
Borreliosis (ESGBOR)
14:30 A prospective interrupted time series cross over
study aimed at improving antibiotic quality at
seven non-ICU wards
S. Scheithauer* (Aachen, Germany), D. Manamayil,
H. Häfner, B. Karasimos, ABS working group,
S. Lemmen
O017
14:42 Post-prescription review improves the in-hospital
antibiotic use: a multi-centre randomised
controlled trial
P. Lesprit* (Suresnes, France), A. De Pontfarcy,
M. Esposito-Farese, H. Ferrand, J.L. Mainardi,
M. Lafaurie, F. Tubach, J.C. Lucet
24th ECCMID / Barcelona
Final Programme
33
Posters
O009
HALL G
Chairs, Speakers & Authors
outbreak caused by the epidemic BI/NAP1/027
strain of Clostridium difficile in a single centre in
Israel
Y. Wiener-Well* (Jerusalem, Israel), E. Ben-Chetrit,
M. Abed-Eldaim, M.V. Assous, T. Miller-Roll, A. Adler
13:30 – 15:30
Exhibition
14:54 Clinical and molecular characteristics of an
General Information
O008
Scientific Programme
Saturday, 10 May 2014
O018
14:54 No impact of electronic alerts on parenteral
prescribing of antimicrobials with good
bioavailability
B. Huttner* (Geneva, Switzerland), C. Lovis,
S. Harbarth
O019
TAE
Chairs: Polona Maver Vodicar (Slovenia)
Erika Vlieghe (Belgium)
15:06 Financial evaluation of a multidisciplinary
TD100 13:30 Welcome and TAE President's Address
Polona Maver Vodicar (Slovenia)
TD101
of prudent antibiotic prescribing teaching for
undergraduate students
C. Pulcini* (Nice, France), N. Frimodt-Møller,
W.V. Kern, D. Nathwani, J. Rodríguez Baño,
G.S. Simonsen, V. Vlahovic-Palcevski, I.C. Gyssens
HALL I
SYMPOSIUM:
Application of new methods in medical microbiology
and infection control
TD102 14:15 The silent threat of bioterrorism – be prepared
Maurizio Barbeschi (Switzerland)
TD103 14:45 The challenges of outbreak detection and
response
Katrin Leitmeyer (Sweden)
15:15 Networking time
TD104 15:45 Sepsis: think globally, treat locally –
CM perspective
Stefania Stefani (Italy)
TD105 16:15 Sepsis: think globally, treat locally –
ID perspective
Erika Vlieghe (Belgium)
ESGEM, ESGMD, ESGNI
Chairs: Frederic Laurent (France)
Francois Vandenesch (France)
SY096 13:30 Next-generation sequencing: a one-stop shop
for bacterial identification, antimicrobial
susceptibility testing, virulence and subtyping?
Dag Harmsen (Germany)
SY097 14:00 Infection control within healthcare communities:
using modern technology and network analysis
Alexander W. Friedrich (The Netherlands)
Rosanna Peeling (United Kingdom)
SY099 15:00 Detecting polymicrobial causes of infections
Chairs: Uwe Frank (Germany)
Achilleas Gikas (Greece)
SY106 16:30 Agreements and disagreements from
international guidance documents
Evelina Tacconelli (Germany)
SY107
17:00 Identifying and tackling the challenges in local
application
Anna-Pelagia Magiorakos (Sweden)
SY108 17:30 How to measure success of implementing
guidelines
Petra Gastmeier (Germany)
SY109 18:00 Limitations of extracting the evidence for
guidelines in infection control
Kristina Bryant (United States)
34
24th ECCMID / Barcelona
Final Programme
HALL A
SYMPOSIUM:
Implementing international guidelines to reduce the
spread of MDR Gram-negatives at national level
Bernard La Scola (France)
arranged with the ESCMID Study Group for
Epidemiological Markers (ESGEM); the ESCMID
Study Group for Molecular Diagnostics (ESGMD)
and the ESCMID Study Group for Nosocomial
Infections (ESGNI)
arranged with the Trainee Association of ESCMID
(TAE)
16:30 – 18:30
SY098 14:30 Modern diagnostics in the developing world
13:45 STDs – are they still hot? Beyond the typical case
Mar Vera Garcia (Spain)
15:18 Cross-sectional European survey on principles
13:30 – 15:30
Room 133/134
TAE TRAINEES DAY:
TAE Trainees Day – a time for trainees to share their
knowledge under the supervision of seniors
antimicrobial stewardship-team using an
automatic day-2 intervention
J.H. Dik* (Groningen, The Netherlands),
J.R. Lo-Ten-Foe, B. Sinha, K.R. Wilting,
Y.K. Kuychukova, P.N. Panday, R. Hendrix,
A.W. Friedrich
O020
13:30 – 16:45
Scientific Programme
Saturday, 10 May 2014
HALL C
O024
immunodeficiency virus type 1 envelope
glycoproteins isolated from homosexual individuals
homozygous for the CCR5 delta 32 allele
Q. Jin* (Nanjng, China), Q. Niu, G. Alkhatib 
SYMPOSIUM:
The Good, the Bad and the Ugly: recently approved and
developmental anti-bacterials
EPASG
O025
immune escape in HIV-2 infection
T. De Silva* (Sheffield, United Kingdom),
A. Leligdowicz, J. Carlson, M. Garcia-Knight,
S. Hue, N. Miller, L.M. Yindom, T. Dong, M. Cotten,
S. Rowland-Jones
Michael J. Rybak (United States)
O026
17:30 Fidaxomicin
patients treated with a raltegravir-containing
regimen
F. Falasca, C. Montagna, L. Mazzuti, G. D’Ettorre,
P. Maida, V. Vullo, G. Antonelli, O. Turriziani* (Rome,
Italy)
Martin Llewelyn (United Kingdom)
18:00 Tigecycline
Miguel Sanchez Garcia (Spain)
arranged with the ESCMID PK/PD of AntiInfectives Study Group (EPASG)
16:30 – 18:30
O027
decreases in bone mineral density among HIV
patients on CART
I. Koga* (Tokyo, Japan), K. Seo, Y. Wakabayashi,
S. Suzuki, Y. Yoshino, T. Kitazawa, I. Kurahashi,
Y. Ota
HALL D
ORAL SESSION:
New insights in epidemiology, resistance and
pathogenesis to improve HIV management
Chairs: Maria Rosaria Capobianchi (Italy)
Giuseppe Pantaleo (Switzerland)
O021
O022
16:54 Human immunodeficiency virus type 1
17:54 HIV-1 subtype distribution and mutations in
the region of southwestern Greece; subtype
A1 has surpassed subtype B and is the most
prevalent strain
N. Davanos, G. Panos, C. Gogos* (Patras, Greece),
A. Mouzaki
O029
18:06 X4 viruses prediction is significantly associated
with nadir CD4 T cell below 100 cells /mm3
M. Sechet, C. Roussel, J.-L. Schmit, C. Saroufim,
K. Ghomari, D. Merrien, F. Cordier, Y. Douadi, D. Liné,
S. Castelain* (Amiens, France)
16:42 HIV tangles with coagulation activation during
sepsis: results from a prospective observational
study in Gabon
M. Huson* (Amsterdam, The Netherlands),
R. Kalkman, A.S. Alabi, J.O. Beyeme, M.P. Grobusch,
J.C.M. Meijers, T. Van der Poll
O023
O028
16:30 Changes in patterns of expression of human
immunodeficiency virus type 1 spliced RNAs in
diverse peripheral blood mononuclear cell types
associated with disease progression
Y. Vega, E. Delgado, C. Carrera, A. Mariño, A. Ocampo,
C. Miralles, I. López-Miragaya, H. Álvarez, P. Ordóñez,
M. Thomson* (Madrid, Spain)
17:42 Increased urinary NTX predicts progressive
ePosters
SY113
17:30 Dynamics of integrated and total HIV1-DNA in
O030
18:18 The use of genotypic resistance in peripheral
blood mononuclear cells (PBMCs) for
modification of antiretroviral treatment in HIV
patients who controlled viral replication
E. Denes* (Limoges, France), P. Weinbreck,
S. Ranger-Rogez
Exhibition
SY112
transcripts using splice sites near the 3' end of
the viral genome are frequently expressed in vivo
and enhance viral replication
Y. Vega, E. Delgado, C. Carrera, A. Mariño, A. Ocampo,
C. Miralles, I. López-Miragaya, H. Álvarez, P. Ordóñez,
M. Thomson* (Madrid, Spain)
24th ECCMID / Barcelona
Final Programme
Overview & Programme
17:00 Ceftaroline
Posters
16:30 Developmental beta-lactamase inhibitors in
phase 2/3 clinical trials
Ursula Theuretzbacher (Austria)
SY111
17:18 Evidence for constrained CD8+ T-cell driven
Chairs, Speakers & Authors
Chairs: Fernando Baquero (Spain)
Federico Pea (Italy)
SY110
17:06 Broad coreceptor usage by human
35
General Information
16:30 – 18:30
Scientific Programme
Saturday, 10 May 2014
16:30 – 18:30
HALL F
O037
investigated by the use of whole genome
sequencing
M. Torpdahl* (Copenhagen, Denmark), S. Persson,
K. Kiil, E.M. Nielsen
ORAL SESSION:
Epidemiology based on whole genome sequencing
Chairs: Dag Harmsen (Germany)
Hajo Grundmann (The Netherlands)
O038
O031
16:30 Whole-genome molecular epidemiology
of isolates causing increase in Neisseria
meningitidis serogroup Y disease
B. Törös* (Örebro, Sweden), S. Thulin Hedberg,
M. Unemo, S. Jacobsson, D. Hill, H. Fredlund,
H. Bratcher, K. Jolley, M. Maiden, P. Mölling
O032
O033
O034
17:06 Better understanding of outbreaks of CA-MRSA
USA300 (ST8-spa t008) by using whole-genome
sequencing
A.J. Sabat* (Groningen, The Netherlands),
S. Hermelijn, V. Akkerboom, J.E. Degener,
A.W. Friedrich
O035
17:30 Combined analysis of whole genome MLST data
and whole genome mapping data for clinical
Campylobacter jejuni and C. coli isolates
K. De Bruyne* (Sint-Martens-Latem, Belgium),
R. Burggrave, A. Cody, M. Rijnsburger, H. Pouseele,
M. Maiden, B. Pot 
O040
24th ECCMID / Barcelona
Final Programme
18:18 An automated analysis pipeline for whole genome
MLST data using BioNumerics®
K. De Bruyne* (Sint-Martens-Latem, Belgium),
L. Hauben, H. Pouseele, K. Janssens
16:30 – 18:30
HALL H
SYMPOSIUM:
Laboratory response to emerging viral diseases:
from pathogen discovery to disease monitoring
ECDC
Chairs: Mikel J. Martinez (Spain)
Ilaria Capua (Italy)
SY114
16:30 Discovery and epizootic investigation of
Schmallenberg virus infections in livestock
Martin Beer (Germany)
SY115
17:00 Discovery of Middle-East respiratory syndrome
coronavirus and development of diagnostics
Marion Koopmans (The Netherlands)
SY116
17:30 Investigation of avian influenza A(H7N9)
emergence in China
George F. Gao (China)
SY117
18:00 Monitoring emerging infectious diseases:
role of public health laboratory networks
Marc J. Struelens (Sweden)
36
18:06 Whole genome sequencing of isogenic drug-
resistant Mycobacterium tuberculosis isolates
shows antibiotic selection ensures genomic
stability
I. Bergval* (Amsterdam, The Netherlands),
A. Schuitema, H. De Ronde, F. Coll, K. Mallard,
A. Pain, R. McNerney, T. Clark, R. Anthony
17:18 Whole genome sequencing of Listeria isolates
for surveillance and outbreak investigations
J.T. Larsson, K. Kiil, E.M. Nielsen* (Copenhagen,
Denmark)
O036
O039
16:54 Spread of Clostridium difficile between humans
and farm animals in The Netherlands revealed by
whole genome sequencing
W. Knetsch* (Leiden, The Netherlands), T. Connor,
A. Mutreja, I. Sanders, S. Van Dorp, L. Lipman,
L. Keessen, J. Corver, E. Kuijper, T. Lawley
17:54 Incorrectly annotated carbapenemase sequences
in GenBank matter now more than ever
M.J. Ellington* (Cambridge, United Kingdom),
K. Apagyi
16:42 Comparison of bioinformatics approaches
for whole genome sequencing analysis of
Legionnaires' disease clusters
D. Harmsen, K. Prior, E. Yakunin, L. Valinsky,
V. Agmon, I. Grotto, J. Moran-Gilad* (Beit Kama,
Israel)
17:42 A Danish Salmonella mikawasima outbreak
arranged with the European Centre for Disease
Prevention and Control (ECDC)
Scientific Programme
Saturday, 10 May 2014
16:30 – 18:30
HALL J
SYMPOSIUM:
Carbapenemases from prevention to treatment
ESGARS
Chairs: Luis Martinez-Martinez (Spain)
Marek Gniadkowski (Poland)
SY118
16:30 Carbapenemases from (not) detection to control
Yehuda Carmeli (Israel)
SY119
17:00 Update on OXA carbapenemases
Patrice Nordmann (Switzerland)
SY120
17:30 NDM dissemination
Timothy R. Walsh (United Kingdom)
SY121
18:00 KPC around the world
Maria Virginia Villegas (Colombia)
Exhibition
Chairs, Speakers & Authors
Posters
ePosters
Overview & Programme
arranged with the ESCMID Study Group for
Antimicrobial Resistance Surveillance (ESGARS)
24th ECCMID / Barcelona
Final Programme
37
General Information
ESCMID Online Lecture Library
IN TH VISIT
US !
EE
FOR ECCMIDSCMID WO
HAND
R
S-ON BARCELO LD AT
TRIAL NA
OF TH
E OLL
find lectures,
abstracts, posters
... online
Epidemiology of Candida bloodstream infections and antifungal
susceptibility profiles: 10-year experience with 381 candidemia
episodes in a tertiary care university centre
Take your ECCMID home!
Sehnaz ALP, Sevtap ARIKAN-AKDAGLI, Dolunay GULMEZ, Sibel ASCIOGLU, Omrum UZUN, Murat AKOVA
Hacettepe University Faculty of Medicine, Ankara, Turkey
C.albicans was always the dominant one [p-value for trend test between years 2001-2010
Introduction and Purpose
Candida spp. are the most common fungal pathogens responsible for invasive diseases
in humans. Among them, Candida albicans is in general responsible for more than half of
all Candida infections. However, recent studies showed a remarkable shift from C.albicans
to non-albicans Candida species (NAC) at least in a number of centres. Candida krusei is
known to be intrinsically resistant to fluconazole. Moreover, a decreased susceptibility to
fluconazole among other NAC, especially for Candida glabrata has been reported. The
changing epidemiology of candidemia and antifungal susceptibility data have an impact
on the preferred empirical antifungal regimen. This study was undertaken to (i) state
for C.albicans and non-albicans Candida species (NAC) was non-significant (p>0.05)].
There were 213 Candida strains with available AST results (123 C.albicans, 37 Candida
parapsilosis, 27 Candida tropicalis, 12 C. glabrata, 5 C. krusei, 3 Candida kefyr, 3 Candida
guilliermondii and one of each Candida dubliniensis, Candida lusitaniae, Candida rugosa).
Among them, there were 188 isolates tested against fluconazole, 145 isolates tested
against voriconazole, 151 isolates tested against itraconazole and 99 isolates tested
against caspofungin. Available AST results interpreted according to the currently approved
species-specific CLSI breakpoints are given in Table-2.
the ranking of Candida isolates among all positive blood cultures in our centre; ii) define
the species distribution of Candida strains responsible for bloodstream infections and
Table-2. The number of Candida isolates with available AST results interpreted according to
explore whether there is any potential increase in non-albicans Candida as compared to
currently approved CLSI breakpoints*
C. albicans; and to (iii) determine the influence of currently approved CLSI breakpoints
on interpretation of antifungal susceptibility test (AST) results.
Candida
Antifungal
drug
species
(n)
Methods
C.albicans
(122)
We retrospectively evaluated our database and records of Mycology Laboratory from
blood culture yielding Candida species were included in the study. In case of multiple
-
17
1
-
-
88
4
-
1
1
C.glabrata
(8)
C.krusei
(3)
Itraconazole
C.parapsilosis
(18)
C.tropicalis
(21)
Antifungal
drug
6
-
1
1
1
-
1
16
2
-
-
11
6
-
4
Candida
species
(n)
C.albicans
(92)
1
1
PT
-
Results
isolates among all positive blood cultures are shown in Table-1.
R
-
During the study period, there were 18.426 positive blood cultures of which 858 grew
infection. The distribution of species in 381 candidemia episodes and ranking of Candida
I
-
PT
2
(18)
Candida spp. For the current analysis 381 candidemia episodes were included. Candida
2
11
PT
20
C.albicans
(93)
ranked the fifth (ranged 4-7 during individual years) frequent cause of bloodstream
SDD
PT
C.tropicalis
currently approved CLSI breakpoints.
Currently approved
CLSI
S
C.krusei
(5)
Fluconazole
results obtained from the archive of Mycology Laboratory were interpreted according to
119
C.glabrata
(12)
C.parapsilosis
(22)
January 2001 to December 2010. Patients who were reported to have at least one positive
candidemia episodes during the same course, only the first episode was included. AST
C.glabrata
(10)
Voriconazole
C.krusei
(4)
C.parapsilosis
(17)
C.tropicalis
(15)
C.albicans
(45)
C.glabrata
(4)
Caspofungin
C.krusei
(3)
C.parapsilosis
(29)
C.tropicalis
(13)
Currently approved
CLSI
S
SDD
I
R
92
-
-
-
IE
IE
IE
IE
3
IE
1
-
17
-
-
-
15
-
-
-
45
-
-
-
2
-
2
-
2
-
1
-
28
-
1
-
13
-
-
-
*Per the absence of any specific recommended breakpoints, species other than C.albicans, C.glabrata, C.krusei, C.parapsilosis and C.tropicalis
Table-1. Distribution of candidemia episodes (n=381) according to isolated Candida species
were not included in the susceptibility profile analysis
CLSI: Clinical and Laboratory Standards Institute
S: Susceptible
2001
Species
C.albicans
n
(%)
13
(50.0)
2002
n
(%)
21
(61.8)
2003
2004
n
(%)
n
(%)
14
(66.7)
23
(65.7)
n
(%)
34
(58.6)
6
n
(%)
35
(62.5)
2007
n
(%)
31
(65.9)
2008
n
(%)
16
(42.1)
9
2009
n
(%)
16
(51.6)
2010
n
(%)
19
(54.3)
Total
n
(%)
222
(58.3)
58
3
8
6
9
4
8
(11.5)
(23.5)
(9.5)
(8.6)
(10.3)
(10.7)
(19.1)
(23.7)
(12.9)
(22.9)
(15.2)
C.tropicalis
3
(11.5)
2
(5.9)
5
(23.8)
4
(11.4)
11
(18.9)
11
(19.6)
4
(8.5)
6
(15.8)
4
(12.9)
1
(2.9)
51
(13.4)
3
(11.5)
1
(2.9)
-
3
(8.6)
2
(3.4)
3
(5.4)
1
(2.1)
5
(13.2)
4
(12.9)
4
(11.4)
26
(6.8)
-
-
-
-
1
(1.7)
1
(2.1)
2
(5.3)
-
1
(2.9)
5
(1.3)
C.krusei
3
2006
C.glabrata
C.parapsilosis
2
2005
C.kefyr
1
(3.8)
-
-
-
-
2
(6.5)
1
(2.9)
5
(1.3)
Other NAC*
3
(11.5)
2
(5.9)
-
2
(5.7)
4
(6.9)
1
(1.8)
-
-
1
(3.2)
1
(2.9)
14
(3.7)
26
34
21
35
58
56
47
38
31
35
381
6
4
7
7
4
4
6
6
4
6
5
-
-
1
(2.1)
SDD: Susceptible dose dependent
I: Intermediate
R: Resistant
PT: Poor target to be treated with the denoted drug
IE: Insufficient evidence
Conclusions
(1) Candida spp. play a prominent role among the common bloodstream isolates in our
centre.
(2) Among all Candida species, C. albicans has been the most common cause of
candidemia and this trend has not changed during the study period.
(3) Resistance to tested antifungal drugs is not common among our candidemia isolates
except for itraconazole.
(4) We observed decreased susceptibility to fluconazole for our C.glabrata strains. This
is possibly due to the intrinsic feature of this species for susceptibility to fluconazole
and the conclusive nonexistence of the category of “susceptible” in the currently revised
breakpoint scale.
References
1. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed., CLSI
Total
Ranking among
all positive
blood cultures
*Other non-albicans Candida species (NAC) included in this study were: 4 C.guilliermondii, 4 C.lusitaniae, 2 C.inconspicua/norvegensis, 2 C.rugosa,
1 C.dubliniensis, 1 C.colliculosa
document M27-A3. Clinical and Laboratory Standards Institute 2008, Wayne, PA.
P
2. Cuenca-Estrella M, Bernal-Martinez L, Buitrago MJ, et al. Update on the epidemiology and diagnosis of invasive fungal infection. Int J Antimicrob Agent
Agents
2008;32 Suppl 2:S143-7.
3. Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am
J Med 1996;100:617-23.
-Wild-type MIC distributions,
4. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff
ff
f A, Sheehan D; CLSI Subcommittee for Antifungal Susceptibility Testing.
T
epidemiological cutoff
ff
f values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth
microdilution methods. Drug Resist Updat 2010;13:180-95.
5. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus
neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff
f values to characterize resistance in the
ff
SENTRY
R Antimicrobial Surveillance Program (2009). Diagn Microbiol Infect Dis 2011;69:45-50.
RY
Over 3’500 abstracts,
Around 2’000 (e)posters,
More than 250 slide-sets
and recorded webcasts
Check it out online at
www.escmid.org/OLL
Scientific Programme
Sunday, 11 May 2014
7:45 – 8:45
HALL A
MEET-THE-EXPERT SESSION:
Sepsis management beyond antibiotics
ESGBIS
Experts:
W. Joost Wiersinga (The Netherlands)
Jean-Louis Vincent (Belgium)
arranged with the ESCMID Study Group for
Bloodstream Infections and Sepsis (ESGBIS)
7:45 – 8:45
HALL D
MEET-THE-EXPERT SESSION:
Outbreak of P. aeruginosa in your hospital and you think it
could be water-related? Want to know what to do next?
7:45 – 8:45
HALL I
MEET-THE-EXPERT SESSION:
Screening for carbapenemase production,
molecular and phenotypic methods
Experts:
Laurent Poirel (Switzerland)
Christian G. Giske (Sweden)
7:45 – 8:45
HALL J
MEET-THE-EXPERT SESSION:
New viruses: pathogens or innocent bystanders?
Experts:
Ulrike Wieland (Germany)
Albert D.M.E. Osterhaus (The Netherlands)
EFWISG
HALL F
MEET-THE-EXPERT SESSION:
Addressing the problem of MDR
Neisseria gonorrhoeae
SY128
7:45 – 8:45
ePosters
SY129
9:30 The CDC/HICPAC recommendations for SSI
prevention: what is new after 15 years?
Joseph S. Solomkin (United States)
HALL H
MEET-THE-EXPERT SESSION:
Controversies in treatment of malaria and
crimean-congo haemorrhagic fever
ESGITM
Experts:
Hakan Leblebicioglu (Turkey)
Eskild Petersen (Denmark)
9:00 The burden and prevention of SSI:
a global perspective from WHO
Benedetta Allegranzi (Switzerland)
Experts:
Michelle Cole (United Kingdom)
Magnus Unemo (Sweden)
Chairs: Werner Zimmerli (Switzerland)
Jean-Christophe Lucet (France)
SY130 10:00 Barriers to implementing good antibiotic
prophylaxis and how to overcome them
Petra Gastmeier (Germany)
SY131
Posters
7:45 – 8:45
SYMPOSIUM:
What is new on surgical site infection prevention?
Overview & Programme
arranged with the ESCMID Food- and Water-borne
Infections Study Group (EFWISG)
10:30 Controversial issues in the prevention of
surgical site infections
Jan A.J.W. Kluytmans (The Netherlands)
Chairs, Speakers & Authors
HALL A
arranged with the ESCMID Study Group for
Infections in Travellers and Migrants (ESGITM)
Exhibition
9:00 – 11:00
24th ECCMID / Barcelona
Final Programme
39
General Information
Experts:
Michael Weinbren (United Kingdom)
Matthias Trautmann (Germany)
Scientific Programme
Sunday, 11 May 2014
9:00 – 11:00
HALL D
O047
10:12 Outpatient parenteral antimicrobial therapy
(OPAT) for the management of cellulitis:
an eighteen-month review at a large general
hospital in the UK
P. Minagh, A. Hamda, M. Murdoch, T. Vaghela,
P. Seetulsingh* (Watford, United Kingdom)
ORAL SESSION:
Monitoring antibiotic use
Chairs: Céline Pulcini (France)
Inge C. Gyssens (The Netherlands)
O041
9:00 Systemic outpatient antibiotic use in urban
O048
10:24 Drivers’ identification and intervention study
and rural areas in Japan
Y. Gu* (Sendai, Japan), A. Versporten, S. Coenen,
N. Adriaenssens, H. Goossens, M. Kaku
O042
9:12 Antimicrobial consumption in Brazil:
impact of restricting over-the-counter sales
M.L.N. Moura* (São Paulo, Brazil), I. Boszczowski,
R. Lobo, N. Mortari, A.S. Levin
O043
antibiotic use and vaccination uptake amongst
15-18 year olds: an international project
M.K.D. Hawking* (Gloucester, United Kingdom),
D.M. Lecky, P. Touboul Lundgren, E.K. Aldigs,
H.A. Abdulmajed, D. Hadjichambi, E. Ioannidou,
C.A.M. McNulty
O050
9:00 – 11:00
Chairs: Kim Lewis (United States)
Thomas Bjarnsholt (Denmark)
SY132
24th ECCMID / Barcelona
Final Programme
9:00 Bacterial biofilms in VAP: implications for
diagnosis and treatment
Laia Fernandez-Barat (Spain)
10:00 Complications of outpatient parenteral
antimicrobial therapy – a four-year service
review
M.C. Cabeza Brasa* (London, United Kingdom),
M. Cotter, S. Mullen, A. Breathnach, M. Laundy,
P. Riley, T. Planche
HALL F
SYMPOSIUM:
Exploring and treating biofilms
SY133
40
10:48 Polymyxin B consumption and resistance in
Gram-negative bacteria
D.R. Falci* (Porto Alegre, Brazil), R.C.F. Da Silva,
L.S. Puga, D.M. Simas, C.P. Baldin, I.I. Limberger,
F.M. Pinto, A.P. Zavascki
9:48 Hospital antibiotic use in Europe:
are comparisons relevant?
C. Dumartin* (Bordeaux, France), K. De With,
P. Parneix, A.M. Rogues
O046
10:36 Using social marketing to improve appropriate
9:36 National parenteral glycopeptide consumption
figures poorly reflect the MRSA situation in the
hospital sector and EU/EAA countries between
2007 and 2011
K. Weist* (Stockholm, Sweden), O. Heuer,
L. Diaz-Högberg, C. Suetens, D.L. Monnet,
A. Muller,  Network Members 
of the ECDC Surveillance Networks EARS-Net 
ESAC-Net and HAI-Net
O045
O049
9:24 Healthcare-associated infections and
antimicrobial use in European long-term care
facilities (HALT): results of two point prevalence
surveys
K. Latour* (Brussels, Belgium), B. Jans, M.L. Moro,
F. Fitzpatrick, E. Ricchizzi, T. Dillane, B. Cookson,
J. Fabry, C. Suetens
O044
for containing an OXA-48 producing Klebsiella
pneumonia outbreak in a renal unit in London
M. Gharbi* (London, United Kingdom), M. Gilchrist,
L.S.P. Moore, E.T. Brannigan, K.B. Bamford,
A.H. Holmes
9:30 Dissecting the S. aureus biofilmome
Surbhi Malhotra-Kumar (Belgium)
SY134
10:00 Anti-biofilm agents: where are we?
Andrej Trampuz (Germany)
SY135
10:30 In vitro models for the study of antibiotic
PK/PD in biofilms
Francoise van Bambeke (Belgium)
Scientific Programme
Sunday, 11 May 2014
O058
10:24 Leishmaniasis in Turkey: in vitro and in vivo
assessments of emerging resistance to
meglumine antimonate among the Leishmania
tropica isolates from Anatolia
A. Ozbilgin, M. Harman, C. Gunduz, I. Cavus, O. Kurt*
(Istanbul, Turkey), Y. Ozbel
ORAL SESSION:
News in travel, tropical and parasitic infections
Chairs: Titia M. Kortbeek (The Netherlands)
Joaquim Gascon (Spain)
O059
10:36 Leishmaniasis in Turkey: comparison of
healthy controls than in gastroenteritis cases
by molecular detection in The Netherlands
M. Boer de* (Hengelo, The Netherlands),
A. Zanden vd, L. Bruijnesteijn, T. Schuurs, T. Mank,
G. Ruijs, B. Mulder
infection/AIDS in a population in Mozambique
R. Gálvez-López, D. Torrús-Tendero* (Alicante,
Spain), E. Cobos, E. Nacarapa, M.E. Verdú
O054
9:48 Results of a collaborative screening programme
of imported diseases in immigrant population
between a tropical medicine unit and Spanish
red cross
I. Piñero, D. Caravia, B. Pedrayes, M. Rodriguez,
J. Fernandez, E. Carus, C. Suarez,
A. Rodriguez-Guardado* (Oviedo, Spain)
O056
10:00 One-stop blood testing for TB, HIV, and
hepatitis B/C in new migrants
S. Hargreaves* (London, United Kingdom),
F. Seedat, J. Car, R. Escombe, S. Hasan, J. Eliahoo,
J. Friedland
O057
10:48 The carcinogenic human liver fluke, Opisthorchis
viverrini: disease in fish indicates patient
infection in rural community of Thailand
K. Natthawut* (Muang, Thailand), R. Rujirakul,
J.K. Soraya
9:36 Risk factors for ARDS development in severe
imported malaria: a retrospective study
N. Rocha Pereira* (Anta-Espinho, Portugal),
C. Figueiredo, L. Santos, A. Ferreira, C. Lima Alves,
P. Figueiredo Dias, A. Sarmento
O055
O060
10:12 Leishmaniasis in Turkey: establishment of
cutaneous leishmaniasis models on hamsters
(Mesocricetus auratus) using Leishmania
tropica, L. infantum and L. major isolates
obtained from Turkish patients
A. Ozbilgin, M. Harman, I. Cavus, O. Kurt* (Istanbul,
Turkey)
9:00 – 11:00
HALL I
Overview & Programme
9:24 Clinical course of malaria in patients with HIV
SYMPOSIUM:
MALDI-TOF mass spectrometry:
ongoing revolution in clinical microbiology
Chairs: Paul Savelkoul (The Netherlands)
Alexander W. Friedrich (The Netherlands)
ePosters
O053
isoenzyme, real-time PCR and MALDI-TOF
analyses for the identification of Leishmania
species in clinical samples
A. Ozbilgin, O. Kurt, I. Akyar* (Istanbul, Turkey),
G. Culha, F. Zeyrek, C. Gunduz, T. Oyur, F. Pratlong,
P. Bastien, Y. Ozbel
SY136 9:00 MALDI-TOF: Challenges and solutions in
identification of bacteria from isolated colonies
Robin Patel (United States)
SY137
Posters
9:00 Significantly more Dientamoeba fragilis in
9:30 Clinical impact of MALDI-TOF on blood cultures
Olivier Vandenberg (Belgium)
SY138 10:00 MALDI-TOF: usefulness for typing, taxonomy and
epidemiology
Jean-Marc Rolain (France)
Chairs, Speakers & Authors
O051
SY139 10:30 MALDI-TOF: a new tool to rapidly assess the
antibiotic susceptibility
Sören Schubert (Germany)
Exhibition
HALL H
24th ECCMID / Barcelona
Final Programme
41
General Information
9:00 – 11:00
Scientific Programme
Sunday, 11 May 2014
9:00 – 11:00
HALL J
O067
aureus infection: results from a population-based
case-control genome-wide association study
G. Delorenze, C. Nelson, W. Scott, A. Allen, G.T. Ray,
V. Fowler* (Durham, NC, United States)
ORAL SESSION:
Basic science: pathogenesis and epidemiology of
Gram-positive bacteria
Chairs: Anna Norrby-Teglund (Sweden)
Francois Vandenesch (France)
O061
O062
O064
9:36 Clindamycin and intravenous immunoglobulin
influence group A Streptococcus virulence factor
activity
A. Tarnutzer* (Zurich, Switzerland), C.M. Zuercher,
F. Andreoni, K. Schilcher, R.A. Schuepbach,
A.S. Zinkernagel
O065
O069
O070
11:30 – 12:30
dynamics modulate intracellular virulence in
Staphylococcus aureus
J.P. Rasigade* (Lyon, France), C. Dunyach-Remy,
A. Sapin, N. Messad, S. Trouillet-Assant, J.P. Lavigne,
F. Laurent
42
24th ECCMID / Barcelona
Final Programme
HALL A
ORAL SESSION:
Deep insights in mycobacteria: genomics and susceptibility
Chairs: Erik C. Böttger (Switzerland)
Dick van Soolingen (The Netherlands)
O086
11:30 Onsite genome screening to monitor multidrug-
resistance in Mycobacterium tuberculosis in
a region with considerable pathogen genetic
diversity and drug resistance
S. Sengstake* (Amsterdam, The Netherlands),
N. Bablishvili, N. Bzekalava, N. Tadumaze,
M. Akhalaia, N. Tukvadze, R. Aspindzelashvili,
R. Anthony, I. Bergval
9:48 Antimicrobial activity against intra-osteoblastic
10:00 From colonisation to invasion: phage
10:48 Selection of low-level mupirocin-resistance in
hospital but not community MRSA clones
J. Hughes* (London, United Kingdom),
R. Stabler, T. Karadag, N. Desai, A. Patel, J.A. Otter,
J.D. Edgeworth, O. Tosas Auguet
Staphylococcus aureus: a new therapeutic
concept for bone and joint infection?
F. Valour, N. Riffard, S. Trouillet-Assant,
J.P. Rasigade, C. Chidiac, F. Vandenesch, T. Ferry,
F. Laurent* (Lyon, France)
O066
10:36 Staphylococcus aureus spa-type t437:
a clone with emerging public health
importance encroaching upon Europe
C. Glasner* (Groningen, The Netherlands),
G.N. Pluister, J.P. Arends, M. Heck, H.T. Westh,
H. Grundmann, J.M. Van Dijl
9:24 Pathogenesis of necrotising soft tissue
infections: analyses at the local tissue site in
patient biopsies and in a novel 3D skin model
N. Siemens, L. Johansson, B. Chakrakodi,
INFECT Study Group, M. Svensson,
A. Norrby-Teglund* (Stockholm, Sweden)
10:24 How MRSA behaves inside the household: the
community-onset Staphylococcus aureus
household cohort (COSAHC) study, Australia
C. Bennett* (Burwood, Australia), G. Coombs,
G. Wood, E. Bogatyreva, B. Howden, P. Johnson
9:12 Complement factor H deficiency increases
mortality in experimental pneumococcal
meningitis through C3 depletion
E.S. Kasanmoentalib* (Amsterdam, The
Netherlands), M. Valls Seron, M.C. Brouwer,
D. Van de Beek
O063
O068
9:00 Genomic monitoring of within-host evolution
of Streptococcus pneumoniae indicates strong
selective pressure
M.R. Oggioni* (Leicester, United Kingdom), L. Furi,
S. Arioli, D. Mora, A. Gerlini
10:12 Human genetic susceptibility to Staphylococcus
O087
11:42 Non-steroid anti-inflammatory drugs to tackle
drug resistance of Mycobacterium tuberculosis
S. Bhakta* (London, United Kingdom)
Scientific Programme
Sunday, 11 May 2014
aminoglycoside- and macrolide-resistance in
clinical isolates of Mycobacterium abscessus
F. Mougari* (Paris, France), R. Amarsy, L. Raskine,
C. Bernard, F. Brossier, E. Cambau
Parity Commission, TAE
Chairs: Nur Benzonana (Turkey)
TBD
SY143 11:30 Scientific career in adverse economic and social
conditions
Stipan Jonjic (Croatia)
SY144 12:00 Research in extraordinary times of war
Mirsada Hukic (Bosnia and Herzegovina)
12:18 Analysis of the genomic variations observed
in persistent infection or reactivation by
Mycobacterium tuberculosis and evaluation of
their impact
L. Pérez-Lago, Y. Navarro, I. Comas, M. Herranz,
M.J. Ruiz Serrano, P. Montilla, E. Bouza,
D. Garcia de Viedma* (Madrid, Spain)
11:30 – 12:30
HALL B
KEYNOTE LECTURE:
Genomic diagnostics: transforming clinical and
public health microbiology practice
11:30 – 12:30
ESGCD
Chairs: Ed J. Kuijper (The Netherlands)
Emilio Bouza Santiago (Spain)
SY145 11:30 Clostridium difficile in food and in production
Dag Harmsen (Germany)
11:30 – 12:30
HALL E
SYMPOSIUM:
Emergence of Clostridium difficile infections
outside healthcare facilities
animals
Scott Weese (Canada)
Chair: Alexander W. Friedrich (The Netherlands)
KL140 arranged with the Parity Commission (PC)
and the Trainee Association of ESCMID (TAE)
ePosters
O090
SYMPOSIUM:
Great scientific success with scarce resources.
Is money issue a crucial point?
12:06 Increased tolerance to transient exposures to
rifampicin of M. tuberculosis strains of the
Beijing genotype compared to strains with the
EAI genotype
A.L. Den Hertog* (Amsterdam, The Netherlands),
S. Menting, D. Van Soolingen, R.M. Anthony
HALL D
SY146 12:00 Risk factors and a clinical prediction score for CDI
acquired in the community
Marjolein Hensgens (The Netherlands)
HALL C
SYMPOSIUM:
Macrolides are still safe and effective to be used in clinical
practice. Pro / Con debate
arranged with the ESCMID Study Group for
Clostridium difficile (ESGCD)
Posters
O089
11:30 – 12:30
Overview & Programme
11:54 Phenotypic and genetic characterisation of
Chairs, Speakers & Authors
Chairs: Jordi Carratala (Spain)
Murat Akova (Turkey)
SY141 11:30 Yes, we can use them unequivocally
Francesco B. Blasi (Italy)
SY142 12:00 Beware! Too many drug interactions and side
Exhibition
effects...
James Chalmers (United Kingdom)
24th ECCMID / Barcelona
Final Programme
43
General Information
O088
Scientific Programme
Sunday, 11 May 2014
11:30 – 12:30
HALL F
ORAL SESSION:
Automation in diagnostic bacteriology
11:30 – 12:30
ORAL SESSION:
MDR Acinetobacter baumannii
Chairs: Gerard Lina (France)
Johan Van Eldere (Belgium)
O071
11:30 Digital microscopic quantification of bacteria,
Chairs: Carmen Torres (Spain)
Luisa M. V. Peixe (Portugal)
O076
11:30 Identification of a new integron-borne blaIMP-10
leukocytes and epithelial cells coupled with
detection of leukocyte esterase and nitrites for
the screening of urine submitted for culture
A. Tessari* (Rovigo, Italy), N. Osti, A. Astolfi,
M. Boldrin, P. Gotto, C. Scolaro, M. Scarin
O072
11:42 Evaluation of manual versus automated
in carbapenem-resistant Acinetobacter
baumannii (ACB) clinical isolates in Brazil
R. Cayô* (São Paulo, Brazil), F. Rodrigues-Costa,
A.P. Matos, W. Martins, K.E. Da Silva, G. Braun,
L.C.C. Fehlberg, C.G. Carvalhaes, A.C. Gales
O077
11:42 The effect of closely related OXA-51 variants
inoculation
A. Croxatto* (Lausanne, Switzerland), K. Dijkstra,
G. Prod'hom, G. Greub
O073
O074
on carbapenem susceptibility in Acinetobacter
baumannii
E. Zander* (Cologne, Germany), H. Seifert,
P.G. Higgins
11:54 Comparison of ESwab™ collection and WASP®
automation with dacron swab and manual
plating for smear interpretation and detection of
pathogens associated with wound specimens
K. Chapin* (Providence, United States), L. McVeigh,
M. Andrade, A. Angelone, K. Beach
12:06 Evaluation of Copan SnotBuster™ for improved
O078
11:54 AbaGI-R, a genomic island in Acinetobacter
baumannii highly correlated with multidrug
resistance
Y. Jiang, Y. Feng* (Hangzhou, China), H. Zhou,
Z.H. Zhou, J.S. Ji, Y.F. Wang, Y. Chen, Y.S. Yu
O079
12:06 Genetic changes which maintain bacterial fitness
sputum culture results
B. Buchan, T. Mackey* (Oak Creek, United States),
E. Beck, J. Connolly, N. Ledeboer
O075
12:18 Validation of the smart incubator system
HALL G
and virulence after exposure to colistin
M.E. Wand* (Salisbury, United Kingdom), L.J. Bock,
L. Bonney, J.M. Sutton
O080
12:18 Synergistic interaction of AdeR and AdeS on the
(SIS) [bioMérieux] for prolonged incubation of
fastidious bacteria
C. Fulchiron, M. Guicherd, L. Munoz, D. Archeny,
S. Ghirardi, A. Van Belkum, G. Durand* (La Balmeles-Grottes, France)
expression of the RND-efflux pump AdeB confers
decreased susceptibility to a broad range of
antibiotics in Acinetobacter baumannii
J. Nowak* (Cologne, Germany), T. Schneiders,
H. Seifert, P.G. Higgins
11:30 – 12:30
HALL H
KEYNOTE LECTURE:
The great filter: parasitic infections of the liver
ESGCP
Chair: Miriam José Alvarez Martinez (Spain)
44
24th ECCMID / Barcelona
Final Programme
KL147 Peter Chiodini (United Kingdom)
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
Scientific Programme
Sunday, 11 May 2014
ORAL SESSION:
Emerging resistance in fungi
11:30 – 12:30
SYMPOSIUM:
Viral opportunists in the critically ill patient
Chairs: Sevtap Arikan-Akdagli (Turkey)
Jesus Guinea (Spain)
11:30 Intra-abdominal candidiasis is an important
reservoir for the emergence of FKS mutations
among Candida glabrata and Candida albicans
R.K. Shields, M.H. Nguyen, C.J. Clancy* (Pittsburgh,
United States)
O082
11:54 Post-treatment antifungal resistance among
colonising Candida isolates in candidaemia
patients: preliminary results from a systematic
multi-centre study
R.H. Jensen* (Copenhagen, Denmark),
H.K. Johansen, L.M. Søes, L.E. Lemming,
F.S. Rosenvinge, L. Nielsen, B.R.S. Olesen,
L. Kristensen, C. Leitz, M. Arendrup
O084
SY148 11:30 Basic aspects of cytomegalovirus subversion
and immune control
Ineke J. M. Ten Berge (The Netherlands)
SY149 12:00 Clinical science: when to ignore,
observe or treat?
Ajit P. Limaye (United States)
11:42 Functional and genomic correlates
of heteroresistance to fluconazole in
Candida glabrata
R. Ben-Ami* (Tel Aviv, Israel), O. Zimmerman,
T. Finn, A. Novikov, N. Blutraich, J. Berman
O083
Chairs: Jordi Rello (Spain)
Hans H. Hirsch (Switzerland)
14:30 – 15:30
HALL A
SYMPOSIUM:
The year in Infection Control
Chair: Jan A.J.W. Kluytmans (The Netherlands)
SY150 14:30 Part I
Barry Cookson (United Kingdom)
SY151
15:00 Part II
Christina Vandenbroucke-Grauls (The Netherlands)
12:06 Circulation of moulds between clinical and
12:18 Azole resistance mechanisms found among
Chairs, Speakers & Authors
fluconazole-resistant Candida albicans clinical
isolates: report from the sentry antifungal
resistance programme
L.M. Deshpande, M.A. Pfaller, L.N. Woosley,
R.N. Jones, M. Castanheira* (North Liberty, IA,
United States)
Exhibition
O085
Posters
environmental reservoirs in a COPD patient
population: emergence of Aspergillus fumigatus
azole-resistance in the north of France
C. Dauchy, A. Standaert-Vitse, O. Le Rouzic, S. Nseir,
E. Dei-Cas, E.M. Aliouat, S. Fry, E. Frealle* (Lille,
France)
24th ECCMID / Barcelona
Final Programme
45
General Information
O081
HALL J
Overview & Programme
HALL I
ePosters
11:30 – 12:30
Scientific Programme
Sunday, 11 May 2014
14:30 – 15:30
HALL B
ORAL SESSION:
Hepatitis B treatment and management
TAE, Professional Affairs Subcommittee, UEMS-ID, UEMS-MM
Chairs: Mario U. Mondelli (Italy)
Hilpi Rautelin (Sweden)
14:30 Different facilities and trends in the management
of chronic hepatitis B virus infection in Europe
R. Ozaras* (Istanbul, Turkey), G. Corti, S. Ruta,
K. Lacombe, M. Mondelli, W. Irving, M. Puoti,
D. Salmon, H. Leblebicioglu, J. Arends
O092
14:42 Efficacy and safety of tenofovir treatment at 240
weeks in patient with chronic HBV infection
A. Perrella* (Naples, Italy), A. Galeota Lanza,
C. Sbreglia, G. Di Costanzo, P. Bellopede, O. Perrella
SY153 14:30 Training in infectious diseases
Nicholas J. Beeching (United Kingdom)
SY154 14:45 Training in clinical microbiology
Truls Michael Leegaard (Norway)
SY155 15:00 Trainees viewpoints and survey results
Polona Maver Vodicar (Slovenia)
SY156 15:15 Discussion
O093
14:54 Hepatitis B virus in pregnancy: evaluation of
antiviral treatment efficacy and risk of perinatal
transmission
A. Batirel* (Istanbul, Turkey), I.I. Balkan, O. Karabay,
K.K. Yasar, F. Duygu, I.N. Hakyemez, R. Guner,
A. Ogutlu, A.D. Celik, M. Dogan
O094
15:06 Effectiveness of hepatitis B virus vaccination
programme in Egypt: seroprotection and HBV
infection
I. Salama, S. Samai, Z. Said* (Cairo, Egypt),
M. El-Sayed, S. Salama, T. Rabah, A. Abdel Mohsin,
S. Hemida, A. Hassanin, N. Abd Alhalim
O095
15:18 A clinical trial on atorvastatin treatment and
efficacy of hepatitis B vaccinations
N. Jonaidi Jafari* (Tehran, Iran), M. Izadi,
A. Saburi, S.M. Alavian, R. Ranjbar, M. Safiabadi,
A. Hosseinpour, M. Mohammad Jonaidi
14:30 – 15:30
HALL C
KEYNOTE LECTURE:
Knowledge and social norms shaping the discovery,
use, and resistance trends of antimicrobial agents
Chair: Nienke van de Sande-Bruinsma (Denmark)
KL152 Fernando Baquero (Spain)
arranged with the Trainee Association of ESCMID
(TAE); the Professional Affairs Subcommittee
(PAS); European Union of Medical Specialists
(Infectious Disease and Medical Microbiology
Section)
14:30 – 15:30
Chairs: Marc Lecuit (France)
Annelies Zinkernagel (Switzerland)
SY157
14:30 Listeria genomics
Sylvain Brisse (France)
SY158 15:00 Listeriosis: a prospective study of 800 cases
Caroline Charlier-Woerther (France)
14:30 – 15:30
Final Programme
HALL F
SYMPOSIUM:
Why are some carbapenemases successful?
Chairs: Ana Gales (Brazil)
Maria Virginia Villegas (Colombia)
SY159 14:30 Why are some carbapenemases more successful
than others?
Rafael Canton Moreno (Spain)
do we have the right ones?
Yehuda Carmeli (Israel)
24th ECCMID / Barcelona
HALL E
SYMPOSIUM:
Listeria and listeriosis
SY160 15:00 Beta-lactamase and breakpoints:
46
HALL D
SYMPOSIUM:
Training in infection in Europe – progress in curricula and
assessments
Chairs: Karin Lindahl (Sweden)
Resat Ozaras (Turkey)
O091
14:30 – 15:30
Scientific Programme
Sunday, 11 May 2014
ORAL SESSION:
An update on malaria
Chairs: Jose Luis Martinez (Spain)
Emmi Andersson (Sweden)
O101
children
A.E. Budding* (Amsterdam, The Netherlands),
T.G.J. De Meij, F.M. Jansen, E. De Groot,
A.A. Van Bodegraven, P.H.M. Savelkoul
predictors of malaria in patients with fever
returning from tropical countries
D. Torrús-Tendero* (Alicante, Spain), A. Zurita,
H. Pinargote, S. Reus, V. Boix, E. Merino, M. Andreu,
A. Gimeno, A. Tello, J. Portilla
14:42 Microbiome data reveals gut bacteria
characteristic of individuals with and without
Clostridium difficile infection
A.M. Schubert* (Ann Arbor, United States),
M.A.M. Rogers, C. Ring, J. Mogle, J.P. Petrosino,
V.B. Young, D.M. Aronoff, P.D. Schloss
O102
molecular diagnosis of malaria
M. Manser, D. Nolder, S. Polley, C. Sutherland,
P. Chiodini* (London, United Kingdom)
O103
O098
14:54 Dynamics of the nasopharyngeal microbiota
O104
15:06 Airway microbiota in cystic fibrosis patients with
O105
15:18 Altered proteobacteria composition in patients
with acute uncomplicated diverticulitis
A. Eck* (Amsterdam, The Netherlands), L. Daniels,
M.A. Boermeester, J.A. Bogaards, P.H.M. Savelkoul,
A.E. Budding
15:06 How did travellers use rapid diagnostic tests for
malaria provided by a travel-clinic during their
trip? A cohort study
D. Berthod* (Lausanne, Switzerland), J. Rochat,
R. Voumard, B. Genton, V. D'Acremont
a severe decline in lung function
E. Fiscarelli* (Rome, Italy), P. Paganin,
V. Tuccio, M. Chiancianesi, G. Taccetti, V. Lucidi,
A. De Alessandri, A. Mengoni, A. Bevivino
O100
14:54 Retrospective cohort study on the outcome
of acute respiratory distress syndrome due to
malaria
T. Chandra* (Manipal, India), A. Gupta,
A. Chakrapani, M. Varm
in healthy infants within the first year of life:
a prospective study
M. Mika* (Berne, Switzerland), I. Mack, U. Frey,
P. Latzin, M. Hilty
O099
14:42 External quality assessment scheme for the
Overview & Programme
O097
14:30 Epidemiological, clinical and laboratory
ePosters
14:30 Core gut microbiome and temporal stability in
Chairs: Michael Ramharter (Austria)
TBD
15:18 Preferred choice of travellers visiting low-risk
malaria area regarding antimalarial prevention:
a prospective study
R. Voumard* (St-Blaise, Switzerland), D. Berthod,
V. D'Acremont, B. Genton
Posters
O096
HALL H
Chairs, Speakers & Authors
ORAL SESSION:
Microbiome and microbiota: new M’s in microbiology
14:30 – 15:30
Exhibition
HALL G
24th ECCMID / Barcelona
Final Programme
47
General Information
14:30 – 15:30
Scientific Programme
Sunday, 11 May 2014
14:30 – 15:30
HALL I
ORAL SESSION:
Different prevention strategies in
immunocompromised patients
Chairs: Per Ljungman (Sweden)
Georg Maschmeyer (Germany)
O106
14:42 Efficacy and safety of influenza vaccination
during the first six months post-transplantation
Á. Bulnes Ramos* (Seville, Spain), E. Cordero,
T.A. Aydillo, B. Leon Jiménez, J. Torre Cisneros,
R. Lara, J. Gavaldà, M. Gentil, M. Gómez Bravo,
P. Pérez Romero
O108
14:54 Spleen off – a prospective multi-centre case-
control study on the epidemiology, microbiology
and outcome of severe sepsis/septic shock after
splenectomy
C. Theilacker* (Freiburg, Germany), K. Ludewig,
M. Bögelein, V. Bahr, A. Pohl, K. Kogelmann,
S. Frieseke, R. Bogdanski, F.M. Brunkhorst, W.V. Kern
O109
15:06 A computer simulation model of the cost-
effectiveness of routine Staphylococcus aureus
screening and decolonisation among lung and
heart-lung transplant recipients
C.J. Clancy* (Pittsburgh, United States), S. Bartsch,
R. Shields, D. Stuckey, B. Lee, M.H. Nguyen
O110
15:18 Safety and efficacy of caspofungin in prophylaxis
of invasive fungal infection (IFI) in liver
transplant recipients (LTR): a multi-centre study
J. Fortun Abete* (Madrid, Spain), O. Len,
J.M. Montejo, M. Bodro, J. Torre-Cisneros, A. Moreno,
M.C. Fariñas, P. Martin-Davila, J. Gavalda, A. Muriel
HALL J
SYMPOSIUM:
Hot topic: Ebola in Africa
Chairs: TBA
Laboratory response to Ebola virus infections:
from the field to suspected imported cases
TBC: Sylvain Baize (France)
14:30 Compliance with post-haematopoietic stem
cell transplantation vaccination consensus
guidelines
E. Ariza-Heredia* (Houston, United States),
A. Gulbis, P. Kebriaei, K. Stolar, K. McConn,
V. Mulanovich, G. Viola, R. Chemaly
O107
14:30 – 15:30
Clinical and epidemiological aspects with a focus
on the recent epidemic in West Africa
TBC: Stephane Hugonnet (Switzerland)
16:00 – 18:00
HALL A
SYMPOSIUM:
Improving empirical antibiotic treatment in hospital
Chairs: Jesús Rodríguez-Baño (Spain)
Gunnar Kahlmeter (Sweden)
SY162 16:00 The contribution of rapid diagnostic techniques to
current clinical practice
Michel Drancourt (France)
SY163
16:30 What are we trying to improve: long-term
outcomes of sepsis
Leonard Leibovici (Israel)
SY164 17:00 Does appropriate empirical antibiotic treatment
improve outcomes for infections caused by MDR
bacteria?
Evelina Tacconelli (Germany)
SY165 17:30 Ecological use of antibiotics. Is it possible?
David L. Paterson (Australia)
16:00 – 18:00
HALL D
ORAL SESSION:
Use of next generation sequencing in clinical practice
Chairs: Jordi Vila Estape (Spain)
Gilbert Greub (Switzerland)
O111
16:00 Investigation of vanA Enterococcus faecium
isolates associated with hospital outbreak in
Copenhagen using whole genome sequencing,
multi-locus sequence typing and pulsed-field gel
electrophoresis
M. Pinholt* (Hvidovre, Denmark),
H. Larner-Svensson, L. Jacobsen, S.S. Olsen,
J.B. Nielsen, P. Worning, H.T. Westh,
A.M. Hammerum, The Danish Enterococcus 
study group
48
24th ECCMID / Barcelona
Final Programme
Scientific Programme
Sunday, 11 May 2014
O119
resistant Staphylococcus aureus (VRSA) isolated
in Europe
J.A. Carrico* (Lisbon, Portugal), A. Friães, K. Prior,
D. Harmsen, M. Ramirez, J. Melo-Cristino
TB genomes across large data sets
C. Del Ojo Elias* (Oxford, United Kingdom),
J. Hedge, T. Walker, D. Wilson, D. Crook, T. Peto
O120
16:24 Draft genome sequence of methicillin-resistant
community-acquired methicillin-resistant
Staphylococcus aureus lineage, assessed by
whole genome sequencing of a time-based and
geographically diverse collection
M. Stegger* (Copenhagen, Denmark), T. Wirth,
P.S. Andersen, R.L. Skov,
A. De Grassi, P. Martins-Simoes, L.B. Price,
F. Vandenesch, A.R. Larsen, F. Laurent
Staphylococcus aureus (MRSA) representative of
predominant MRSA sequence type 8 circulating in
Moscow, Russia
O. Dmitrenko, V. Gostev* (St. Petersburg, Russia),
A. Kudryavtseva, M. Gracheva, S. Sidorenko
16:36 Whole genome sequenced based epidemiology
16:48 Phylogenetic analysis of Streptococcus mitis
and Streptococcus oralis causing infective
endocarditis based on house-keeping genes
sequences extracted from whole genome
sequencing
L.H. Rasmussen, R. Dargis, F. Rosenvinge, C. Moser,
U.S. Justesen, O. Skovgård, J.J. Christensen,
X.C. Nielsen* (Slagelse, Denmark)
O116
17:00 Blinded validation study of genotypic prediction
of antimicrobial resistance from Staphylococcus
aureus whole genome sequences
N.C. Gordon* (London, United Kingdom), J. Price,
K. Cole, A.M. Kearns, B. Pichon, T.E.A. Peto, D. Crook,
A.S. Walker, T. Golubchik
O117
O118
SYMPOSIUM:
Making sense of our relationships with mucosal
commensals and pathogens
ICAAC
Chairs: Marc Lecuit (France)
Robin Patel (United States)
SY166 16:00 Streptococcus pneumoniae colonisation of the
human host and transmission
Jeffrey N. Weiser (United States)
SY167
16:30 Shigella and the gut: an inflamed debate
Philippe Sansonetti (France)
SY168 17:00 The specificity of Salmonella enterica Typhi for
humans: uncovering cell and host restriction
factors
Jorge Galan (United States)
SY169 17:30 Understanding Neisseria meningitidis
pathogenesis to design and evaluate
meningococcal vaccines
Chris Tang (United Kingdom)
17:12 Evaluation of an accelerated workflow using an
amplicon-based commercial kit and automated
analysis of next generation sequencing results
for surveillance of ESBL-producing E. coli
J.W. Rossen* (Groningen, The Netherlands),
J. Veenemans, G.C. Raangs, P.C. Langereis,
J.A.J.W. Kluytmans, A.W. Friedrich, B. Sinha
HALL E
Overview & Programme
O115
16:00 – 18:00
ePosters
of vancomycin-resistant Enterococcus faecium
during an epidemic rise in Dutch hospitals
R. Willems* (Utrecht, The Netherlands), M. De Been,
J. Sinnige, E. Brouwer, W. Van Schaik, J. Corander,
M. Bonten
Posters
O114
17:48 Sub-Saharan origin of the European ST80
arranged with the ASM, American Society for
Microbiology, Programme Committee of the
Interscience Conference on Antimicrobial Agents
and Chemotherapy (ICAAC)
17:24 The importance of sample pre-treatment and DNA
extraction methods for successful whole genome
sequencing of MGIT culture for Mycobacterium
diagnosis
L.J. Pankhurst* (Oxford, United Kingdom),
A.A. Votintseva, T.M. Walker,
C. Del Ojo Elias,  MMM Consortium
Exhibition
O113
17:36 A real-time computational method for matching
Chairs, Speakers & Authors
16:12 Whole genome analysis of the first vancomycin-
24th ECCMID / Barcelona
Final Programme
49
General Information
O112
Scientific Programme
Sunday, 11 May 2014
16:00 – 18:00
HALL H
SYMPOSIUM:
Ins and outs of Legionnaires Disease
16:00 – 18:00
HALL J
SYMPOSIUM:
Bacterial persistence and tolerance: from bench to bedside
ESGLI, European Centre for Disease Control (ECDC)
Chairs: Annelies Zinkernagel (Switzerland)
Surbhi Malhotra-Kumar (Belgium)
Chairs: Birgitta de Jong (Sweden)
Ed P.F. Ijzerman (The Netherlands)
SY170 16:00 Diagnosis of Legionnaires Disease
SY178
tolerance
Jan Michiels (Belgium)
Christian Lück (Germany)
SY171
16:30 Treatment of Legionnaires Disease
SY179
Ed P.F. Ijzerman (The Netherlands)
SY172
SY180 17:00 Clinical relevance of bacterial persistence and
SY181
arranged with the ESCMID Study Group for
Legionella Infections (ESGLI) and the European
Centre for Disease Control (ECDC)
16:00 – 18:00
HALL I
SYMPOSIUM:
Infections and devices: imaging & nuclear medicine meets
infectious diseases
European Association of Nuclear Medicine (EANM)
Chairs: Werner Zimmerli (Switzerland)
Alberto Signore (Italy)
SY174
16:00 Bone and prosthetic joint infections: what the
infectious disease specialist needs
Andrej Trampuz (Germany)
SY175
16:30 Bone and prosthetic joint infections: the point of
view of the nuclear medicine specialist
Alberto Signore (Italy)
SY176 17:00 Endocarditis: what the infectious disease
specialist needs
Patricia Munoz (Spain)
SY177
17:30 Endocarditis: how imaging and nuclear medicine
can help
Francois Rouzet (France)
50
tolerance
Alex Soriano (Spain)
17:30 Prevention and control of Legionnaires Disease
Maria Luisa Ricci (Italy)
arranged with the European Association of
Nuclear Medicine (EANM)
24th ECCMID / Barcelona
Final Programme
16:30 Microbiological insights into heteroresistance
and persistence in Gram-negative bacteria
Spyros Pournaras (Greece)
17:00 Epidemiology of travel-associated
Legionnaires Disease
Birgitta de Jong (Sweden)
SY173
16:00 Molecular basis of bacterial persistence and
17:30 Novel strategies for eradication of persister cells
Kim Lewis (United States)
Scientific Programme
Monday, 12 May 2014
HALL A
MEET-THE-EXPERT SESSION:
The management of HIV/HCV infection in the era
of direct active drugs
7:45 – 8:45
MEET-THE-EXPERT SESSION:
Who should and who should not receive drug
treatment for Chagas disease?
ESGVH
ESGCP
Experts:
Dominique Salmon-Ceron (France)
David Back (United Kingdom)
arranged with the ESCMID Study Group for Viral
Hepatitis (ESGVH)
7:45 – 8:45
HALL D
MEET-THE-EXPERT SESSION:
EUCAST questions and answers
EUCAST
Experts:
Erika Matuschek (Sweden)
Derek F.J. Brown (United Kingdom)
arranged with the European Committee on
Antimicrobial Susceptibility Testing (EUCAST)
7:45 – 8:45
HALL F
MEET-THE-EXPERT SESSION:
New nomenclature: new species – any meaning for
clinical relevance?
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
7:45 – 8:45
HALL J
MEET-THE-EXPERT SESSION:
Current challenges and emerging evidence of infection
control and prevention measures in long-term care facilities
Experts:
Maria Luisa Moro (Italy)
Beatrice Jans (Belgium)
9:00 – 11:00
HALL A
SYMPOSIUM:
What is hot in HIV in 2014?
Chairs: Dan Otelea (Romania)
Guido Antonelli (Italy)
EFISG
arranged with the ESCMID Fungal Infection Study
Group (EFISG)
7:45 – 8:45
HALL H
MEET-THE-EXPERT SESSION:
Altered drug disposition in the elderly
Martin Tolstrup (Denmark)
SY189 9:30 Immunological control in HIV infection:
is it achievable?
Giuseppe Pantaleo (Switzerland)
Posters
SY188 9:00 Toward a functional HIV cure
SY190 10:00 When to start HIV treatment?
Anna Maria Geretti (United Kingdom)
SY191
10:30 HIV therapy: what is in the pipeline in 2014?
Chairs, Speakers & Authors
Experts:
Malcolm Richardson (United Kingdom)
Yvonne Gräser (Germany)
EPASG, ESGIE
Experts:
William Couet (France)
Leonardo Pagani (Switzerland)
Jose M. Gatell (Spain)
arranged with the ESCMID PK/PD of AntiInfectives Study Group (EPASG) and the ESCMID
Study Group for Infections in the Elderly (ESGIE)
Exhibition
Overview & Programme
Experts:
Rogelio López-Vélez (Spain)
Pere Albajar (Switzerland)
ePosters
HALL I
24th ECCMID / Barcelona
Final Programme
51
General Information
7:45 – 8:45
Scientific Programme
Monday, 12 May 2014
9:00 – 11:00
HALL D
SYMPOSIUM:
Colistin: position in the era of multi-resistance
9:00 – 11:00
ORAL SESSION:
Outbreaks of MDR Gram-negative bacteria:
what works and what does not work?
Chairs: Juan P. Horcajada (Spain)
Helen Giamarellou (Greece)
Chairs: Barry Cookson (United Kingdom)
Anna-Pelagia Magiorakos (Sweden)
SY192 9:00 PK/PDs and susceptibility testing: are we far from
the correct direction?
John D. Turnidge (Australia)
O121
Robert Hancock (Canada)
SY195 10:00 Efficacy issues: clinical evidence on
monotherapy and combination therapies
David L. Paterson (Australia)
O122
patients: the Prato Consensus
Roger L. Nation (Australia)
HALL F
SYMPOSIUM:
Full laboratory automation
O123
SY196 9:00 Advantages and limitations of the different full
O124
O125
SY198 10:00 Microbiology modernisation and rationalisation:
9:48 Main failings of interventions aimed at
minimising the hospital spread of multidrugresistant Gram-negative bacteria
M.A. Cataldo, F. Foschi* (Tübingen, Germany),
G. De Angelis, G. Restuccia, J. Rodriguez-Baňo,
B. Cookson, E. Tacconelli
a professional challenge
Hilary Humphreys (Ireland)
SY199 10:30 Information technology and automation:
ground floor view from London
Peter Wilson (United Kingdom)
9:36 Klebsiella pneumoniae in fibreoptic endoscope
causes ICU-outbreak
S. Jørgensen* (Lørenskog, Norway), M. Skogstad,
K. Helmersen, M. Weider, A.H. Schreiner
9:30 What to take into consideration when planning to
move towards full lab automation?
Johan Van Eldere (Belgium)
9:24 A ventilator-focused intervention to reduce the
rate of Acinetobacter baumannii infection among
ventilated patients
R. Cohen* (Netanya, Israel), Z. Shimoni, R. Ghara,
R. Ram, R. Ben-Ami
Chairs: Gerard Lina (France)
Margareta Ieven (Belgium)
lab automated systems for bacteriology
Antony Croxatto (Switzerland)
9:12 Successful control of a nosocomial outbreak
and endemicity of Acinetobacter baumannii
with the implementation of a multicomponent
intervention programme H.U. Virgen del Rocío
(UHVR ) 2012-2013
V. Gonzalez Galan* (Seville, Spain), R. Valencia,
A. Cazalla, J. Lepe, R. Alvarez, C. Martin, I. Alonso,
J. Dominguez, J. Aznar, J. Cisneros
SY194 10:30 Challenges of clinical trials in critically ill
SY197
9:00 Outbreak of colistin-resistant carbapenemase-
producing Klebsiella pneumoniae (KPC-Kp) in The
Netherlands, with inter-institutional spread
V. Weterings* (Breda, The Netherlands),
E. Weterings, E. Verkade, D. Van Stenis,
E. Thewessen, J.A.J.W. Kluytmans
SY193 9:30 The polymyxin resistome
9:00 – 11:00
HALL H
O126
10:00 Effects of a multimodal intervention programme
on compliance with standard precautions at a
German university hospital
S. Wehrle, D. Luft, W. Ebner, S. Barkhausen,
W.V. Kern, M. Dettenkofer* (Freiburg, Germany)
52
24th ECCMID / Barcelona
Final Programme
Scientific Programme
Monday, 12 May 2014
10:12 Incremental value of real-time feedback to
9:00 – 11:00
healthcare workers during direct hand hygiene
observations
K. Hussein* (Haifa, Israel), S. Warman, Y. Cohen,
G. Rabino, L. Froymovich, N. Kazman, M. Furer,
T. Zuckerman, M. Paul
10:24 Timing of the emergence of the Hawthorne effect
in hand hygiene surveillance: a multi-centre
prospective cohort study
J. Yin, H.S. Reisinger, M. Vander Weg, M.L. Schweizer,
A. Jesson, D.J. Morgan, G. Forrest, L. Pineles,
E.N. Perencevich* (Iowa City, IA, United States)
O129
10:36 Countries- expenditure on healthcare and
ESGBIS
Chairs: Harald Seifert (Germany)
Alvaro Pascual Hernandez (Spain)
SY204 9:00 Pathogenesis of complicated SAB:
pathogen, host, or both?
Vance G. Fowler (United States)
SY205 9:30 Complicated SAB: who we should be worried
about and how to evaluate
Achim Kaasch (Germany)
SY206 10:00 Combined therapy versus monotherapy.
hospitals- provision of alcohol-based handrub:
results of the pan-European PROHIBIT survey
S. Hansen* (Berlin, Germany), W. Zingg, F. Schwab,
M. Behnke, D. Pittet, P. Gastmeier
O130
SYMPOSIUM:
Staphylococcus aureus bacteraemia: controversial issues
Any news?
Guy Thwaites (United Kingdom)
SY207 10:30 Vancomycin MIC in MSSA and MRSA.
What does it mean and does it really matter?
Miquel Pujol (Spain)
10:48 Infection prevention in Dutch hospitals: rapid
improvement through enforcement by healthcare
inspectorate
M. Langelar* (Amsterdam, The Netherlands),
S. Hulsbosch, M. Bilkert-Mooiman, R. Westerhof
9:00 – 11:00
HALL I
SYMPOSIUM:
An update on leishmaniasis
Overview & Programme
O128
HALL J
arranged with the ESCMID Study Group for
Bloodstream Infections and Sepsis(ESGBIS)
11:30 – 12:30
HALL A
KEYNOTE LECTURE:
Better to prevent than to cure: case of HIV
ePosters
O127
Chair: Mario Poljak (Slovenia)
KL208 Quarraisha Abdool Karim (South Africa)
Where are the hot spots?
Jorge Alvar (Switzerland)
SYMPOSIUM:
Molecular diagnosis: commercial or home-made tests –
Pro / Con debate
Chairs: Jordi Vila Estape (Spain)
Marijke Raymaekers (Belgium)
SY201 9:30 Infection vs disease – asymptomatic carriers
and risk factors for reactivation and recurrence
Caryn Bern (United States)
SY202 10:00 Diagnosis: monitoring outcome
SY209 11:30 Molecular diagnosis should be done using
CE-marked commercial kits
Margareta Ieven (Belgium)
Thomas Dorlo (The Netherlands)
SY203 10:30 Treatment options: evidence-based
recommendations for different Leishmania spp
Rogelio López-Vélez (Spain)
SY210
12:00 Molecular diagnosis should be done using
home-made test
Gilbert Greub (Switzerland)
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
24th ECCMID / Barcelona
Final Programme
53
General Information
HALL B
Chairs, Speakers & Authors
SY200 9:00 Global epidemiology of leishmaniasis.
11:30 – 12:30
Exhibition
Chairs: Emmanuel Bottieau (Belgium)
Martin P. Grobusch (The Netherlands)
Posters
ESGCP
Scientific Programme
Monday, 12 May 2014
11:30 – 12:30
HALL C
KEYNOTE LECTURE:
Fighting against fungal infections: cells on the front lines
11:30 – 12:30
HALL E
ORAL SESSION:
Enterococcal resistance
EFISG
Chairs: Markus Dettenkofer (Germany)
Rob Willems (The Netherlands)
Chair: Giuliana Lo Cascio (Italy)
KL211
Emmanuel Roilides (Greece)
arranged with the ESCMID Fungal Infection Study
Group (EFISG)
11:30 – 12:30
O136
mechanism and clonal relatedness
I. Gawryszewska* (Warsaw, Poland), D. Zabicka,
W. Hryniewicz, E. Sadowy
HALL D
ORAL SESSION:
Antivirulence drugs
O137
11:30 Synergistic mechanisms of action for a novel
multifunctional antibody format against
Pseudomonas aeruginosa used alone or
adjunctively with antibiotics
A. DiGiandomenico, A.E. Keller, C. Gao, G.J. Rainey,
P. Warrener, M.M. Camara, J. Bonnell, J. Hilliard,
W. Zhao, K. Stover* (Gathersburg, MD, United States)
O132
11:42 Carbohydrate-mediated inhibition of Bordetella
O138
O139
O134
12:06 Protein aggregation as a novel antimicrobial
strategy against Gram-negative bacteria
L. Khodaparast* (Leuven, Belgium),
L. Khodaparast, M. Shahrooei, J. Van Eldere
O135
12:18 Anti-alpha toxin mAb LC10 protects from severe
disease and exhibits synergy in combination with
antibiotics in a murine S. aureus pneumonia model
C. Tkaczyk, L. Hua, Y. Shi, J. Hilliard, L. Cheng,
C.K. Stover, B.R. Sellman* (Gaithersburg, United
States)
54
24th ECCMID / Barcelona
Final Programme
12:06 Antibiotic resistance, copper and mercury
tolerance genes are carried by RepA-N pLG1-like
megaplasmids among Enterococcus from several
origins and clones
E. Silveira, M. Barros, A. Freitas, P. Antunes,
T.M. Coque, L. Peixe, C. Novais* (Matosinhos,
Portugal)
11:54 How to use FimH-antagonists in urinary tract
infection treatment – evaluation of a potent
FimH-antagonist
A. Sigl* (Basel, Switzerland), K. Mayer, N. Lüdin,
P. Frei, B. Ernst
11:54 A putative novel mechanism of resistance to
quinupristin-dalfopristin in clinical isolates of
Enterococcus faecium in Northern Ireland
T.D. Shaw* (Belfast, United Kingdom),
T. Schneiders, M. Pathiraja, R.L.R. Hill, J.S. Elborn,
R. McMullan
bronchiseptica adhesion to rabbit respiratory
epithelium
M. Patiño* (Bogotá, Colombia), C. Gallego,
N.M. Martínez, C.A. Iregui
O133
11:42 Increased frequency of linezolid resistance
among clinical Enterococcus faecium isolates
from German hospital patients
G. Werner* (Wernigerode, Germany), A. Thuermer,
A. Mischnik, N. Mutters, J. Bender, I. Klare
Chairs: Robert A. Bonomo (United States)
Fernando Baquero (Spain)
O131
11:30 Linezolid-resistant enterococci – resistance
O140
12:18 Mature biofilms of Enterococcus faecalis and
Enterococcus faecium are highly resistant to
antibiotics
A. Holmberg* (Lund, Sweden), M. Rasmussen
Scientific Programme
Monday, 12 May 2014
HALL F
ORAL SESSION:
Molecular detection of resistance: dream or reality?
11:30 – 12:30
ORAL SESSION:
Viral paediatric infections
Chairs: Stefania Stefani (Italy)
Truls Michael Leegaard (Norway)
Chairs: Ron Dagan (Israel)
Mark Muscat (Denmark)
O146
O147
species colonisation by KPC-producing
Enterobacteriaceae
E. Khabra* (Tel Aviv, Israel), A. Adler, S. Paikin,
Y. Carmeli
O143
O144
O148
O149
11:30 – 12:30
KEYNOTE LECTURE:
Community-acquired pneumonia –
current challenges and future directions
HALL G
12:06 Prevalence of human parechovirus central
nervous system infections in children from five
distinct geographical regions in the United States
in 2012
R. Selvarangan* (Kansas City, United States),
S. Juretschko, J. Dunn, M. Marcon, H. Salimnia,
K. Estes
12:18 Transforming national reference services for
S. aureus: added value of WGS for public health
surveillance
A. Kearns* (London, United Kingdom), M. Doumith,
A. Underwood, S. Platt, R. Tewodle, L. Harwin, R. Hill,
N. Woodford, R. Pike, B. Pichon
11:54 Congenital cytomegalovirus infection in
Finland – a prospective cohort study
L. Puhakka* (Helsinki, Finland), M. Lappalainen,
T. Lönnqvist, R. Niemensivu, P. Lindahl, T. Nieminen,
N. Chowdhury, S. Boppana, H. Saxen
12:06 One sixteen-minute multiplex assay for the
detection of AmpCs, ESBLs, MBLs and KPCs using
rapid PCR amplification
C. Geyer, S. Morrow, N. Hanson* (Nebraska, United
States)
O145
aetiology in respiratory disease
S. Rhedin, A. Lindstrand, M. Rotzén-Östlund,
T. Tolfvenstam, L. Ohrmalm, M. Ryd Rinder,
A. Ortqvist, B. Henriques-Normark, K. Broliden,
P. Naucler* (Stockholm, Sweden)
11:54 Application of real-time PCR for the detection of
macrolide resistance in Belgian M. pneumoniae
strains
K. Loens* (Antwerp, Belgium), S.C. Masha,
K. Lagrou, H. Goossens, M. Ieven
11:42 The importance of controls in studies of viral
O150
12:18 Upper respiratory tract bacteria and viruses in
children presenting to primary care with acute
cough and RTI: preliminary results from the
'TARGET' cohort study
H. Christensen, N. Redmond, A. Lovering,
B. Vipond, J. Leeming, P. Muir* (Bristol,
United Kingdom), S. Turnbull, T. Peters, A. Hay,
On behalf of the TARGET study team
Chair: Robert C. Read (United Kingdom)
KL212
Overview & Programme
11:42 The tale of two outbreaks: mono- vs. multi-
ePosters
O142
positivity of amplification of RNA-dependent
RNA polymerase gene in laboratory diagnosis of
norovirus infection
F. Lin* (Taoyuan, Taiwan), Y. Shen, K. Tsao,
Y. Huang, C. Chen
Posters
resistant Pseudomonas aeruginosa be identified
based on oprD sequence?
F. Paasch, C. Lammens, S. Malhotra, H. Goossens,
R. Painter, D. Wisniewski, Y. Park, J. Hermes,
K. Young* (Kenilworth, United States)
11:30 Incidence and factors associated with false-
Chairs, Speakers & Authors
11:30 Can a molecular diagnostic for imipenem-
Exhibition
O141
HALL H
Jordi Carratala (Spain)
24th ECCMID / Barcelona
Final Programme
55
General Information
11:30 – 12:30
Scientific Programme
Monday, 12 May 2014
11:30 – 12:30
HALL I
SYMPOSIUM:
Acute anaemia after treatment of malaria with intravenous
artesunate – a new variant of blackwater fever?
14:30 – 15:30
ORAL SESSION:
HIV – behaviour and beliefs
Chairs: José M. Miro (Spain)
Martin Tolstrup (Denmark)
ESGCP
Chairs: Blaise Genton (Switzerland)
Clara Menendez (Spain)
O166
SY213
11:30 Acute anaemia after treatment of malaria with
12:00 Haemolysis in USA patients treated with
intravenous artesunate
Patrick Kachur (United States)
O167
11:30 – 12:30
HALL J
O168
SYMPOSIUM:
The year in Infectious Diseases
11:30 Part I
Jean Paul Stahl (France)
SY216
14:54 Combined antiretroviral treatment shows
preventive effectiveness in unprotected anal or
vaginal sex in serodiscordant couples
J. Del Romero, I. Río, B. Baza, M. Vera, J. Castilla,
V. Paredes* (Madrid, Spain), C. Rodríguez
Chair: Nicola Petrosillo (Italy)
SY215
14:42 HIV transmission clusters among injecting drug
users from Romania
S. Ruta* (Bucharest, Romania), C. Oprea,
A. Temereanca, A. Rosca, C. Sultana, I. Ianache,
E. Ceausu, S. Mehta
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
14:30 HPV infection in HIV-infected men who have sex
with men (MSM)
S.G. Parisi* (Padua, Italy), R. Scaggiante, A. Barelli,
S. Andreis, C. Boldrin, F. Dal Bello, M. Cruciani,
C. Mengoli, M. Basso, G. Palù
intravenous artesunate
Michael Ramharter (Austria)
SY214
HALL A
O169
15:06 Transition to adult care: health status and
treatment factors in Swiss youths living with HIV
C. Kahlert, C. Rudin, J. Fehr, P. Vernazza, D. Nicca* 
(St. Gallen, Switzerland)
12:00 Part II
Pierluigi Viale (Italy)
O170
15:18 Investigating health beliefs about HIV in South
Africa and the impact of the HIV and AIDS,
counselling and testing (HCT) campaign
M. Liyawdeen* (Edgware, United Kingdom),
S. Puvaneswaran, H. Afzal, J. Anthonypillai,
M. Bahra
14:30 – 15:30
HALL B
SYMPOSIUM:
Going away from blood: why not to test oral fluid and urine?
Chairs: Mario Poljak (Slovenia)
Gilbert Greub (Switzerland)
SY217
14:30 Oral fluid testing in microbiology
Nitika Pant Pai (Canada)
SY218
15:00 Urine testing in microbiology
Katja Seme (Slovenia)
56
24th ECCMID / Barcelona
Final Programme
Scientific Programme
Monday, 12 May 2014
HALL C
KEYNOTE LECTURE:
Excellence Award Lecture: Close encounters of the third kind
– pathogens and globalisation
14:30 – 15:30
SYMPOSIUM:
T-cells in invasive aspergillosis
EFISG
Chairs: Anne Puel (France)
Maiken Cavling Arendrup (Denmark)
Chair: Giuseppe Cornaglia (Italy)
Ilaria Capua (Italy)
Chairs: Joseph S. Solomkin (United States)
Sibel Ascioglu (Turkey)
O151
14:30 Early clinical improvement and clinical cure
in a randomised controlled phase 3 study of
ceftobiprole versus ceftazidime/linezolid in
patients with hospital-acquired pneumonia
T. Scheeren* (Groningen, The Netherlands),
A. Rodriguez, X. Zhou, M. Saulay, M. Engelhardt
SY221 15:00 Therapy
Thomas Lehrnbecher (Germany)
arranged with the ESCMID Fungal Infection Study
Group (EFISG)
14:30 – 15:30
KEYNOTE LECTURE:
The effects of antibiotic pollution on the environmental
resistance gene reservoir
Chair: Peter M. Hawkey (United Kingdom)
KL222 O152
14:42 A single dose of oritavancin (ORI) compared to
7-10 days of vancomycin (VAN): clinical response
across different lesion types in the SOLO noninferiority studies
G.R. Corey* (Durham, United States), H. Jiang,
S. Good, G. Moeck, M. Wikler
O153
O154
O155
15:18 Ceftaroline fosamil 600mg every 12 hours is
superior to ceftriaxone 2g every 24 hours for
Asian patients hospitalised with communityacquired pneumonia (CAP): a randomised trial
N. Zhong, T. Sun, G. D'Souza, S.H. Lee,
H.L. Nguyen, C.-H. Chiang, D. Wilson, F. Sun,
D. Melnick* (Wilmington, United States)
HALL G
ORAL SESSION:
Detection of broad-spectrum beta-lactamases
Chairs: Laurent Poirel (Switzerland)
Christina Vandenbroucke-Grauls
(The Netherlands)
O156
14:30 Bloodstream infections caused by Pseudomonas
spp.; how to detect carbapenemase producers
rapidly?
L. Dortet, L. Poirel, P. Nordmann* (St. Gallen,
Switzerland)
15:06 Comparison of the microbiological efficacy of
tedizolid and linezolid in the Establish-1 and
Establish-2 phase 3 clinical trials
C. De Anda* (San Diego, United States), E. Fang,
A. Das, P. Prokocimer
Joakim Larsson (Sweden)
14:30 – 15:30
14:54 Telavancin for acute bacterial skin and skin
structure infections (ABSSSI) – a retrospective
analysis of the phase 3 ATLAS trials considering
the 2013 FDA guidance
S.L. Barriere* (San Francisco, United States),
W. Wang, M.E. Stryjewski, G.R. Corey
HALL F
Overview & Programme
ORAL SESSION:
New antibiotics in clinical trials
Bart Jan Kullberg (The Netherlands)
ePosters
HALL D
O157
14:42 Species-dependent performance of a selective
screening method for extended-spectrum betalactamase producing Enterobacteriaceae in
hospitalised patients
M. Kluytmans - van den Bergh* (Breda,
The Netherlands), C. Verhulst, C. Verduin,
C. Vandenbroucke-Grauls, M. Bonten,
J.A.J.W. Kluytmans, A.W. Friedrich, SoM study group
24th ECCMID / Barcelona
Final Programme
57
Posters
14:30 – 15:30
SY220 14:30 Pathogenicity
Chairs, Speakers & Authors
Exhibition
KL219
HALL E
General Information
14:30 – 15:30
Scientific Programme
Monday, 12 May 2014
O158
14:54 Comparison of several combination disk tests
O164
15:06 Clinical evaluation of a fully automated PCR
for the detection of metallo-beta-lactamaseproducing Pseudomonas aeruginosa
A. Heinrichs* (Brussels, Belgium), T.D. Huang,
C. Berhin, P. Bogaerts, Y. Glupczynski
O159
15:06 Development and analysis of assays
for the detection of carbapenemases in
Enterobacteriaceae
F.J. Hamilton* (Edinburgh, United Kingdom),
R. Crispin, D. Coyle, L. Mulhern, A.P. Gibb,
K.O. Helgason, E.C. Class, K.E. Templeton
O160
assay for the detection of CMV-DNA in plasma
of immunosuppressed patients receiving solid
organ and bone marrow transplantation
G. Gregori, M.G. Milia, T. Allice, A. Proietti, C. Costa*
(Turin, Italy), S. Mantovani, F. Sidoti, R. Cavallo,
V. Ghisetti
O165
15:18 Detection of herpes simplex virus 1 and 2, and
varicella zoster virus using the Quidel® molecular
HSV 1+2/VZV assay on three real time PCR
platforms
B.W. Buchan* (Milwaukee, United States),
J. Connolly, W.J. Olson, N.A. Ledeboer
15:18 Sensitivity of the modified Hodge test performed
with ertapenem and meropenem for detection of
carbapenemases in 942 samples of carbapenemresistant Enterobacteriaceae (CRE)
F. Tuon, L. Arend, M. Pilonetto, C. Siebra, P. Arruda*
(Ponta Grossa, Brazil)
14:30 – 15:30
HALL I
SYMPOSIUM:
Diagnostic tools in parasitology
ESGCP
14:30 – 15:30
HALL H
ORAL SESSION:
Viral diagnostics in the immunocompromised
Chairs: Laurent Kaiser (Switzerland)
Pilar Perez-Romero (Spain)
O161
14:42 Molecular diagnosis of central nervous system
infections using PCR coupled to electrosprayionization mass spectrometry analysis of CSF
samples
L. Andreoletti* (Reims, France), N. Leveque,
J. Legoff, C. Mengelle, Y. Nguyen, F. Renois, F. Simon,
J. Izopet
O163
14:54 Exhaustive monitoring of persistent viral
infections after allogeneic haematopoietic stem
cell transplantation using broad-range PCR
combined with electrospray-ionization mass
spectrometry
M. Salmona* (Paris, France), F. Sicre De Fontbrune,
S. Mercier-Delarue, R. Peffault De Latour, G. Socie,
F. Simon, J. Legoff
58
SY223 14:30 Advantages of mass spectrometry over
microscopy
Renaud Piarroux (France)
SY224 15:00 Benefits of PCR and microscopy, and its
combinations, in Diagnostic Parasitology
Tom van Gool (The Netherlands)
14:30 The use of PCR coupled with mass spectrometry
analysis for the diagnosis of viral infections in
plasma samples of immunosuppressed patients
C. Mengelle* (Toulouse, France), J. Le-Goff,
S. Mercier-Delarue, K. Sauné, J.-M. Mansuy,
F. Simon, J. Izopet
O162
Chairs: Titia M. Kortbeek (The Netherlands)
Martin P. Grobusch (The Netherlands)
24th ECCMID / Barcelona
Final Programme
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
14:30 – 15:30
HALL J
KEYNOTE LECTURE:
On the cutting edge of infection control research: what to do
when evidence is missing?
Chair: Evelina Tacconelli (Germany)
KL225 Leonard A. Mermel (United States)
Scientific Programme
Monday, 12 May 2014
HALL A
O174
Staphylococcus aureus and methicillin-resistant
S. aureus bacteraemia in southern latitudes
among 104 United States (US) hospitals:
retrospective cohort study
E. Perencevich* (Iowa City, IA, United States), J. Yin,
M. Goto, M. Ohl, M. Schweizer, M. Carrel
SYMPOSIUM:
Cryptococcal infections in HIV-infected patients:
what is new in 2014?
EFISG, EACS
Chairs: José M. Miro (Spain)
Anton Pozniak (United Kingdom)
O175
bacteraemia over 5 years in Italy
M. Monaco* (Rome, Italy), F. Mancini, M. Del Grosso,
R. Camilli, A. Sanchini, A. Pantosti
O176
air ventilation system-associated transmission
routes
P.J. Van Duijn* (Utrecht, The Netherlands), W. Bras,
L. De Graaf-Miltenburg, J. Dokter, A. Troelstra,
M.J.M. Bonten
SY228 17:00 Advances in antifungal therapy of cryptococcal
infections
Olivier Lortholary (France)
SY229 17:30 Antiretroviral therapy of patients with AIDSO177
only a minority of apparent acquisitions of
Staphylococcus aureus can be explained by
transmission from other patients, healthcare
workers or the environment
J.R. Price* (Brighton, United Kingdom),
T. Golubchik, K. Cole, A. Bexley, D.J. Wilson,
D.W. Crook, A.S. Walker, T.E.A. Peto, J. Paul,
M.J. Llewelyn
arranged with the ESCMID Fungal Infection Study
Group (EFISG) and the European AIDS Clinical
Society (EACS)
16:00 – 18:00
HALL D
ORAL SESSION:
New transmission routes and genotypic diversity: are we
looking at a new MRSA?
O178
16:00 Surveillance of Staphylococcus aureus
colonisation in a remote African pygmy
population from 2009 to 2013
F. Schaumburg* (Münster, Germany), A. Alabi,
M.P. Grobusch, R. Köck, A. Mellmann, P.G. Kremsner,
G. Peters, K. Becker
O172
16:12 Intercontinental travel and import of
Staphylococcus aureus into Europe: the
StaphTrav network
D. Nurjadi* (Heidelberg, Germany), P. Zanger
O173
16:24 MRSA in Portuguese-speaking African countries:
the missing data to fill the world map
T. Conceição, C. Coelho, I. Santos-Silva,
H. De Lencastre, M. Aires de Sousa* 
(Lisbon, Portugal)
17:24 Perioperative nasal mupirocin ointment and
chlorhexidine body wash prevent superficial
surgical site infections in cardiac surgery
P. Kohler* (Zurich, Switzerland),
S. Kuster, F. Schönrath, E. Ajdler-Schäffler,
A. Anagnostopoulos, S. Tschirky, V. Falk, H. Sax
Chairs: Stephan J. Harbarth (Switzerland)
Benito Almirante (Spain)
O171
17:12 Whole-genome sequencing shows that
ePosters
associated cryptococcosis: when to start and
what to start with
David R. Boulware (United States)
17:00 MRSA outbreak in a Dutch burn centre: role of
O179
Posters
and cryptococcal-IRIS
Robert L. Colebunders (Belgium)
17:36 Emergence of EMRSA-15 as a significant cause of
S. aureus bacteraemia in Israel
A. Rokney* (Jerusalem, Israel), E. Anuka,
O. Barzilay, J. Moran-Gilad, V. Agmon, L. Valinsky
O180
Overview & Programme
SY227 16:30 Clinical manifestations of cryptococcal disease
17:48 Genotypic diversity of methicillin-resistant
Staphylococcus aureus (MRSA) strains
colonising and infecting patients in a large
multinational prospective cohort study
P. Francois, G. De Angelis, W. Schroeder* (Tübingen,
Germany), G. Restuccia, E.J. Bonetti, J. Schrenzel,
E. Tacconelli
24th ECCMID / Barcelona
Final Programme
59
Chairs, Speakers & Authors
Cryptococcus spp. in HIV-infected patients
Manuel Cuenca-Estrella (Spain)
16:48 Changes in Staphylococcus aureus clones from
Exhibition
SY226 16:00 Epidemiology and microbiology of
16:36 Higher incidence of community-associated
General Information
16:00 – 18:00
Scientific Programme
Monday, 12 May 2014
16:00 – 18:00
HALL E
SYMPOSIUM:
Predicting the future in fungal diagnosis and therapy
Chairs: Peter G. Pappas (United States)
Andrew J. Ullmann (Germany)
ESGCD
Chairs: Ed J. Kuijper (The Netherlands)
Franz Allerberger (Austria)
SY230 16:00 Non-cultural methods for aspergillosis
SY238 16:00 What is the protective factor of the microbiota?
Kieren Marr (United States)
Trevor Lawley (United Kingdom)
16:30 Candidal diagnostic tests
SY239 16:30 Does antimicrobial stewardship and specific
Maurizio Sanguinetti (Italy)
Clostridium difficile antimicrobial prophylaxis
prevent CDI?
Oliver A. Cornely (Germany)
SY232 17:00 New cryptococcal and histoplasmosis tests
George R. Thompson III (United States)
SY233 17:30 Designing new diagnostic-driven therapy
SY240 17:00 What is the role of asymptomatic patients and
concepts
Johan Maertens (Belgium)
other reservoirs in acquisition of CDI?
Derrick Crook (United Kingdom)
arranged with the ESCMID Fungal Infection Study
Group (EFISG) and the Mycoses Study Group of
the International Society for Human and Animal
Mycology (MSG)
16:00 – 18:00
SY241
Future ESCMID study group on forensic microbiology (Amparo Fern·ndez-RodrÌguez, Veroniek Saegeman)
Chairs: Katja Seme (Slovenia)
Emmi Andersson (Sweden)
Chairs: Dianelys Quinones (Cuba)
Antony Croxatto (Switzerland)
O181
SY236 17:00 Sudden unexpected death in infancy and
O182
archival clinical samples
Mario Poljak (Slovenia)
24th ECCMID / Barcelona
Final Programme
16:12 Usefulness of a microbiological diagnostic
protocol in a cohort of adult patients with
meningoencephalitis – proposal for a stepwise
algorithm
C. López Sánchez* (Barcelona, Spain), E. Sulleiro,
C. Bocanegra, S. Romero, I. Sanz, M.T. Tórtola,
C. Pigrau, G. Codina, A. Pahissa, V. Falcó
SY237 17:30 Looking for microbes in paraffin blocks and other
60
16:00 Biomarker patterns in cerebrospinal fluid (CSF)
from patients evaluated for neuroborreliosis (NB)
D. Nyman* (Jomala Åland, Finland), S.A. Carlsson,
C. Nyberg, C. Jansson
transplantation: practical guidelines
Veroniek Saegeman (Belgium)
arranged with the future ESCMID study
group on forensic microbiology (Amparo
Fernández-Rodríguez, Veroniek Saegeman)
HALL I
ORAL SESSION:
Non-molecular diagnosis of central nervous system and
bloodstream infections
SY235 16:30 Microbiological testing of tissues and cells for
childhood: how frequent is infectious etiology?
Marta Cohen (United Kingdom)
arranged with the ESCMID Study Group for
Clostridium difficile (ESGCD)
16:00 – 18:00
SY234 16:00 Forensic and autopsy microbiology:
general overview and current challenges
Amparo Fernández-Rodríguez (Spain)
17:30 How to eradicate Clostridium difficile spores from
the environment?
Frédéric Barbut (France)
HALL G
SYMPOSIUM:
Forensic and post-mortem microbiology in the 21st century
HALL H
SYMPOSIUM:
New approaches to prevent transmission of Clostridium
difficile infections
EFISG, MSG
SY231
16:00 – 18:00
O183
16:24 Rapid detection of pathogenic microorganisms in
blood and fluids using the multiplex PCR ready-touse FilmArray® Blood Culture (FABC) assay
R. Amarsy-Guerle* (Paris, France), F. Mougari,
H. Jacquier, J. Riahi, L. Raskine, B. Berçot,
E. Cambau
Scientific Programme
Monday, 12 May 2014
O184
16:36 Comparison of the BACTEC™ blood culture system
with conventional culture of cerebrospinal fluid
samples
A. Calderaro* (Parma, Italy), M. Martinelli,
F. Motta, S. Montecchini, C. Gorrini, S. Larini,
M.C. Arcangeletti, F. De Conto, C. Chezzi, M.C. Medici
O185
16:48 Selection of blood culture media matters –
antibiotic prescribing and de-escalation are
influenced by recovery rate differences between
blood culture media
R. Zadroga* (Minneapolis, United States),
D.N. Williams, M. Kuskowski, G.T. Hansen
17:00 One-hour bacterial identification, resistance
O187
Overview & Programme
and virulence profiling by electrospray mass
spectrometry from cultured isolates and blood
culture samples
O. Dauwalder* (Bron, France), Y. Charretier,
C. Franceschi, E. Degout-Charmette, G. Zambardi,
T. Cecchini, M. Bes, G. Durand, F. Vandenesch,
J.P. Charrier
17:12 Identification of microorganisms with FilmArray®
O188
ePosters
directly from blood culture bottles prior to
positivity
M. Almuhayawi, O. Altun, K. Strålin, V. Ozenci*
(Stockholm, Sweden)
17:24 Highly accurate MALDI-TOF identification using
O189
Posters
the VITEK® MS plus system when challenged with
intentional mixtures prepared from bacteria and
yeast colonies
B.M. Willey* (Toronto, Canada), E. Ramoutar, P. Lo,
S.M. Poutanen
17:36 Neonatal percutaneously inserted silicone
17:48 The performance of four different anaerobic blood
culture bottles in detection of anaerobic bacteria
and direct identification by MALDI-TOF MS
M. Almuhayawi, A. Abdulmajeed, O. Altun,
E. Tideholm, M. Ullberg, V. Ozenci* (Stockholm,
Sweden)
Exhibition
O190
Chairs, Speakers & Authors
catheters must be sectioned to detect its
colonisation
P. Martin-Rabadan* (Madrid, Spain), F. Perez-Garcia,
H.S. Nisa, M. Guembe, E. Bouza
24th ECCMID / Barcelona
Final Programme
61
General Information
O186
ESCMID Conference on
Reviving Old Antibiotics
Vienna, Austria
22 – 24 October 2014
Organising Committee
Rafael Canton, Madrid, ES
Christian Giske, Stockholm, SE
Gunnar Kahlmeter, Växjö, SE
Alasdair MacGowan, Bristol, UK
Johan Mouton, Nijmegen, NL
Roger Nation, Melbourne, AU
Mical Paul, Tel Aviv, IL
Ursula Theuretzbacher, Vienna, AT
John Turnidge, Adelaide, AU
Françoise Van Bambeke, Brussels, BE
Contact: vienna2014@escmid.org
Find more information and registration information on our website
www.escmid.org/vienna2014
Including:
• Optimisation of therapy – General principles
• Optimisation of therapy in Gram-negative infections
• Individualisation of therapy
• Extending the life of old antibiotics
• Clinical trials
• Breakpoints and susceptibility testing
• Communicating new knowledge to where it is needed
• Solved and unsolved problems with old antibiotics, identify need for action
Scientific Programme
Tuesday, 13 May 2014
7:45 – 8:45
HALL B
MEET-THE-EXPERT SESSION:
How to use next generation sequencing in future virology
Experts:
Marc Eloit (France)
Maria Rosaria Capobianchi (Italy)
7:45 – 8:45
HALL C
MEET-THE-EXPERT SESSION:
Control of vancomycin-resistant enterococci:
efforts justified?
7:45 – 8:45
HALL F
MEET-THE-EXPERT SESSION:
Strategies for malaria prevention,
why do national guidelines differ?
ESGCP
Experts:
Peter Chiodini (United Kingdom)
Blaise Genton (Switzerland)
arranged with the ESCMID Study Group for Clinical
Parasitology (ESGCP)
7:45 – 8:45
HALL G
ESGNI
Experts:
Markus Dettenkofer (Germany)
Luisa M. V. Peixe (Portugal)
MEET-THE-EXPERT SESSION:
Healthcare providers and influenza vaccination
EVASG
arranged with the ESCMID Study Group for
Nosocomial Infections (ESGNI)
7:45 – 8:45
MEET-THE-EXPERT SESSION:
Management and troubleshooting of in-house molecular
diagnostics in the microbiological lab
ESGMYC
Experts:
Erik C. Böttger (Switzerland)
Christoph Lange (Germany)
arranged with the ESCMID Study Group for
Molecular Diagnostics (ESGMD)
7:45 – 8:45
HALL I
MEET-THE-EXPERT SESSION:
How to treat MDR tuberculosis?
ESGMD
arranged with the ESCMID Vaccine Study Group
(EVASG)
7:45 – 8:45
Experts:
Jacob Moran-Gilad (Israel)
Marijke Raymaekers (Belgium)
HALL D
Overview & Programme
HALL E
ePosters
Experts:
Susanna Esposito (Italy)
Timo Vesikari (Finland)
arranged with the ESCMID Study Group for
Mycobacterial Infections (ESGMYC)
Posters
MEET-THE-EXPERT SESSION:
Antimicrobial resistance research, supported by
funding from the EU and the US NIH/NIAID
European Commission, United States National Institute of Allergy and Infectious Diseases (US NIAID)
arranged with the European Commission, United
States National Institute of Allergy and Infectious
Diseases (US NIAID)
Exhibition
24th ECCMID / Barcelona
Final Programme
63
General Information
Chairs, Speakers & Authors
Experts:
Arjon Van Hengel (Belgium)
Dennis M. Dixon (United States)
Scientific Programme
Tuesday, 13 May 2014
9:00 – 11:00
HALL A
CLINICAL GRAND ROUND:
Clinical Grand Round 2014
9:00 – 11:00
HALL B
SYMPOSIUM:
The challenge of respiratory viruses
IDSA
Chairs: Emmi Andersson (Sweden)
TBD
Chairs: Robert C. Read (United Kingdom)
Jeronimo Pachon-Diaz (Spain)
Experts:
Nicholas J. Beeching (United Kingdom)
Ajit P. Limaye (United States)
Mario U. Mondelli (Italy)
David L. Paterson (Australia)
Adriana Vince (Croatia)
SY256 9:00 Diagnostic challenges:
speed, loads and multiplex
Fausto Baldanti (Italy)
SY257 9:30 Emerging respiratory viruses
Ron A.M. Fouchier (The Netherlands)
SY258 10:00 Vaccination and treatment
Seven cases will be presented to experienced
professors of infectious disease, who will then
discuss the differential diagnosis and management
plan. All cases have been carefully selected for
their instructive qualities and topicality, and will be
presented by fellows from major infectious disease
centres in Europe and beyond.
Case presenters:
Alex Cochrane (United Kingdom)
Julia Fischer (Germany)
Angela Martinez (Spain)
Nélia Neves (Portugal)
Zaira Palacios Baena (Spain)
Anat Stern (Israel)
Sara Tedeschi (Italy)
arranged with the Infectious Diseases Society
of America (IDSA)
Alexander C. Schmidt (Belgium)
SY259 10:30 Infection control of respiratory viruses:
global and local
Andreas F. Widmer (Switzerland)
9:00 – 11:00
HALL C
SYMPOSIUM:
What is new in immunocompromised patients?
ICHS
Chairs: Georg Maschmeyer (Germany)
Jose M. Aguado Garcia (Spain)
SY260 9:00 Innate immunity and infections in transplant
patients – new insights
Jose M. Aguado Garcia (Spain)
SY261
9:30 CMV infections: new options for clinical
management
Per Ljungman (Sweden)
SY262 10:00 Clinical relevance of respiratory viruses in
immunocompromised patients
Hans H. Hirsch (Switzerland)
SY263 10:30 Emerging bacterial resistance and its impact on
therapy in cancer patients
Claudio Viscoli (Italy)
64
24th ECCMID / Barcelona
Final Programme
arranged with the International
Immunocompromised Host Society (ICHS)
Scientific Programme
Tuesday, 13 May 2014
HALL D
SYMPOSIUM:
Nebulised antibiotics: challenge for 2014
9:00 – 11:00
ORAL SESSION:
Healthcare-associated infections –
from analysis to interventions
ESGCIP
Chairs: Joan Gavaldà (Spain)
William Couet (France)
Chairs: Susan S. Huang (United States)
Khetam Hussein (Israel)
SY264 9:00 Nebulisers and technique of administration
O191
cohort study of bacteraemia due to ESBL and
carbapenemase-producing Enterobacteriaceae:
the Increment project
B. Gutierrez* (Seville, Spain), S. Pérez-Cortés,
E. Salamanca, R.A. Bonomo, Y. Carmeli, D. Paterson,
A. Pascual, J. Rodríguez-Baño
nebulised antimicrobials
Alasdair P. MacGowan (United Kingdom)
SY266 10:00 Nebulised antibiotics for mechanically-
O192
SY267 10:30 Nebulised antibiotics in cystic fibrosis and
multiresistant bacteria in European hospitals: a
multi-centre retrospective cohort study
A. Stewardson* (Geneva, Switzerland), A. Allignol,
S. Harbarth, On behalf of the TIMBER study group 
brochiectasis
Tobias Welte (Germany)
arranged with the ESCMID Study Group for
Critically Ill Patients (ESGCIP)
9:00 – 11:00
9:12 The burden of bloodstream infections caused by
O193
9:24 Multi-drug resistance is an important risk factor
for inappropriate empiric therapy among ICU
patients with Gram-negative sepsis: a cohort
study
M. Zilberberg* (Goshen, MA, United States),
A.F. Shorr, S.T. Micek, M. Kollef
HALL E
SYMPOSIUM:
Combined antimicrobial therapy for multi-resistant
Gram-negative bacteria
ESGARS
O194
multi-resistant Gram-negative bacteria
Mical Paul (Israel)
SY269 9:30 Combined therapy for carbapenemase-producing
O195
O196
arranged with the ESCMID Study Group for
Antimicrobial Resistance Surveillance (ESGARS)
10:00 A multi-centre surveillance of ventilator-
associated events in China
Z. Zong* (Chengdu, China), S. Zhu
Acinetobacter baumannii
Po-Ren Hsueh (Taiwan)
Chairs, Speakers & Authors
Pseudomonas aeruginosa
Robert A. Bonomo (United States)
10:30 Combined therapy for carbapenemase-producing
9:48 Effect of standardised surveillance of intensive
care unit-acquired infections on ventilatorassociated pneumonia incidence
T. Bénet* (Lyon, France), R. Ecochard, N. Voirin,
A. Machut, A. Lepape, A. Savey, P. Vanhems
SY270 10:00 Combined therapy for carbapenemase-producing
SY271
Posters
surveillance of hospital-acquired infections
yielding serial weekly point-prevalence scores
R. Streefkerk, G. Borsboom, C. Van der Hoeven,
R. Verkooijen* (Rotterdam, The Netherlands),
H. Verbrugh
SY268 9:00 Aminoglycosides used in combined treatment for
Klebsiella pneumoniae
Mario Tumbarello (Italy)
9:36 Evaluation of an algorithm for electronic
O197
Exhibition
Chairs: Achilleas Gikas (Greece)
Leonard Leibovici (Israel)
Overview & Programme
SY265 9:30 Pharmacokinetics and pharmacodynamics of
ventilated patients
Jean-Jacques Rouby (France)
9:00 Design and analysis feasibility of an international
ePosters
Jean Chastre (France)
HALL F
10:12 Implementation of national guidelines for the
prevention of healthcare-associated infections:
results of the pan-European PROHIBIT survey
S. Hansen* (Berlin, Germany), W. Zingg, F. Schwab,
M. Behnke, D. Pittet, P. Gastmeier
24th ECCMID / Barcelona
Final Programme
65
General Information
9:00 – 11:00
Scientific Programme
Tuesday, 13 May 2014
O198
10:24 The PROHIBIT (preventing hospital-acquired
infections by intervention and training)
intervention trial – results of a clusterrandomised European multi-centre study on the
reduction of central line-related bloodstream
infections
T. Van Der Kooi* (Bilthoven,
The Netherlands), M. Wolkewitz,
B. Van Benthem, S. De Greeff, H. Grundmann,
W. Zingg on behalf of the PROHIBIT study 
group
O199
O204
blood culture bottles using automated multiplex
real-time PCR panel
X. Zheng* (Chicago, United States), W. Polanco,
D. Carter, S. Shulman
O205
O206
10:48 The effects of decontamination of the oropharynx
O208
HALL G
Chairs: James Wai-Kuo Shih (China)
Carlos Rodrigo (Spain)
9:00 Benefits of a costly and work intensive
O209
microbiological surveillance in a cohort of very
low birth weight infants (VLBWI, <1500g)
W. Lindner* (Ulm, Germany), A. Essig, H. Hummler,
H. Von Baum
O202
O203
9:24 Microbiota profiling in children with functional
constipation
T.G.J. De Meij* (Amsterdam, The Netherlands),
E.F.J. De Groot, M.A. Benninga, A.E. Budding,
P.H.M. Savelkoul
66
24th ECCMID / Barcelona
Final Programme
10:36 Carbapenem-resistant Klebsiella pneumoniae
in European children: experience from EARS-Net
2011/2012
J. Bielicki* (London, United Kingdom),
L. Diaz Högberg, O. Heuer, M. Sharland,
EARS-Net Participants
9:12 Postoperative mediastinitis: experience of a
single paediatric centre of cardiac surgery
F.I. Calò Carducci* (Rome, Italy), L. Gramatica,
E. Ferretti, P. Bernaschi, M. Carletti,
M.L. Ciofi Degli Atti, R. Netto, A. Carotti,
G. Pongiglione, P. D'Argenio
10:24 Impact of infectious diseases consultation on
the management of S. aureus bacteraemia in
children
R.B. Saunderson, T. Gouliouris* (Cambridge,
United Kingdom), E.J. Cartwright, E.J. Nickerson,
S.H. Aliyu, D.R. O’Donnell, W. Kelsall, S.J. Peacock,
M.E. Torok
ORAL SESSION:
Bacterial paediatric infections
O201
10:12 Staphylococcus capitis in nosocomial
bacteraemia in intensive care neonates:
worldwide distribution of an endemic
methicillin-resistant clone (NRCS-A)
P. Martins Simões, M. Butin, S. Lemriss, J.-C. Picaud,
A. Kearns, O. Denis, R. Goering, F. Vandenesch,
J.-P. Rasigade, F. Laurent* (Lyon, France)
and intestinal tract on antibiotic resistance in
ICUs: a cluster-randomised cross-over trial
E.A.N. Oostdijk* (Utrecht, The Netherlands),
J. Kesecioglu, A. De Smet, M.J.M. Bonten,
N.A. On behalf of the SDD-SOD study group
9:00 – 11:00
10:00 Noninvasive pneumococcal serotypes in
hospitalised children in Moscow (Russia)
N. Mayanskiy* (Moscow, Russia), N. Alyabieva,
A. Lazareva, O. Ponomarenko, L. Katosova,
A. Ivanenko, M. Lazareva, T. Kulichenko,
L. Namazova-Baranova
O207
O200
9:48 Serotyping of S. pneumoniae strains isolated
from blood cultures of paediatric population over
the last decade
G. Chronopoulou* (Athens, Greece), G. Kavarnou,
E. Katzilierakis, V. Syriopoulou, K. Agrafioti
10:36 Prior digestive colonisation with extended-
spectrum beta-lactamase producing
Enterobacteriaceae in intensive care unit:
significance in patients with ventilatorassociated pneumonia
R. Bruyere, C. Vigneron, A. Pechinot, J. Bador,
J.P. Quenot, S. Prin, S. Aho, P.E. Charles* (Dijon,
France)
9:36 Rapid pathogen identification from paediatric
O210
10:48 Measurement of sCD14 – presepsin is a good
alternative to monitor children after external
ventricular drainage (EVD) in case of suspected
bacterial ventriculitis/meningitis
M. Skvarc* (Ljubljana, Slovenia), D. Stubljar,
M. Groselj Grenc, A. Kopitar
Scientific Programme
Tuesday, 13 May 2014
HALL H
SYMPOSIUM:
PK/PD – the merits of models and measurement
9:00 – 11:00
SYMPOSIUM:
Optimisation of empirical and targeted antifungal
therapy for invasive aspergillosis
EPASG
Chairs: William A. Craig (United States)
Paul M. Tulkens (Belgium)
Chairs: Kieren Marr (United States)
Catherine Cordonnier (France)
SY272 9:00 Pre-clinical in vitro models
SY280 9:00 Persistent febrile neutropenia: diagnostic-
Karen E. Bowker (United Kingdom)
driven antifungal therapy vs. empirical
antifungal therapy
Manuela Aguilar-Guisado (Spain)
SY273 9:30 Pre-clinical in vivo models
Niels Frimodt-Moller (Denmark)
10:00 Measurement of beta-lactams in serum
SY281 9:30 Therapeutic monitoring of drug levels for invasive
aspergillosis
Susan J. Howard (United Kingdom)
Federico Pea (Italy)
10:30 Value of the measurement of antibiotic
SY282 10:00 First-line therapy with combined antifungal for
concentration in tissues
Johan W. Mouton (The Netherlands)
SY283 10:30 Salvage therapy of invasive aspergillosis
refractory to primary therapy with voriconazole
Johan Maertens (Belgium)
HALL I
SYMPOSIUM:
The hidden Beijing M. tuberculosis pandemic
Chairs: Julian Gonzalez-Martin (Spain)
Christoph Lange (Germany)
11:30 – 12:30
SYMPOSIUM:
The year in Clinical Microbiology
Chair: Robert L. Skov (Denmark)
SY276 9:30 Rapid detection and infective and clonal
behaviours in the Beijing lineage
Dario Garcia de Viedma (Spain)
SY277 9:00 Resistance of Beijing tuberculosis
Sonia Borrell (Switzerland)
SY284 11:30 Part I
Emmanuelle Cambau (France)
SY285 12:00 Part II
Miquel Bart Ekkelenkamp (The Netherlands)
SY278 10:00 Treatment and hospital management of
contagious multiresistant Beijing tuberculosis
pulmonary infection
Keertan Dheda (South Africa)
SY279 10:30 Selective advantages of the Beijing genotype of
Mycobacterium tuberculosis
Dick van Soolingen (The Netherlands)
HALL A
ePosters
9:00 – 11:00
Overview & Programme
arranged with the ESCMID PK/PD of AntiInfectives Study Group (EPASG)
Posters
aspergillosis
Raoul Herbrecht (France)
11:30 – 12:30
HALL B
KEYNOTE LECTURE:
Cross-neutralising antibodies for respiratory virus therapy
and vaccine design
Chair: Joan Gavaldà (Spain)
KL286 Chairs, Speakers & Authors
SY275
Davide Corti (Switzerland)
Exhibition
SY274
HALL J
24th ECCMID / Barcelona
Final Programme
67
General Information
9:00 – 11:00
Scientific Programme
Tuesday, 13 May 2014
11:30 – 12:30
HALL C
SYMPOSIUM:
Surveillance of healthcare-associated infections:
infections or procedures?
11:30 – 12:30
HALL D
ORAL SESSION:
Advances in CMV infection in transplant recipients
Chairs: Claudio Viscoli (Italy)
Per Ljungman (Sweden)
Chairs: Hanan Balkhy (Saudi Arabia)
Khetam Hussein (Israel)
O211
SY287 11:30 Infections
11:30 Cytomegalovirus specific T-cell immune response
as a risk factor of infection in solid organ
transplant recipients at low risk for CMV infection
D. Mena Romo* (Seville, Spain), P. Pérez-Romero,
C. Martín-Gandul, P. Blanco-Lobo, M. Sánchez,
M. Gentil, M. Gómez, E. Lage, E. Cordero
Petra Gastmeier (Germany)
SY288 12:00 Procedures
Jesús Rodríguez-Baño (Spain)
O212
11:42 Reconstitution of CMV-specific immunity post
heart transplantation may guide customisation of
immunosuppressive and antiviral strategies:
a prospective randomised study
T. Lazzarotto* (Bologna, Italy), A. Chiereghin,
G. Bianchi, G. Piccirilli, B. Perciaccante, L. Borgese,
G. Magnani, F. Grigioni, M.P. Landini, L. Potena
O213
11:54 CMV- and EBV-specific immune recovery in lung
transplant recipients is not associated with
protection from infection
A. Saldan, D. Tinto, F. Franceschi, M. Loy, F. Rea,
C. Mengoli, D. Sgarabotto, G. Palu, D. Abate* (Padua,
Italy)
O214
12:06 Effectiveness of early-onset vs delayed-onset
universal cytomegalovirus (CMV) prophylaxis in
D+/R- solid organ transplant (SOT) recipients:
importance of cytomegalovirus (CMV)-specific
T-cell response
R. San Juan Garrido* (Madrid, Spain), D. Navarro,
A. Garcia-Reyne, M. Montejo, P. Muñoz, J. Carratala,
O. Len, J. Fortun, B. Muñoz-Cobo, J. Aguado
O215
12:18 Delayed-onset cytomegalovirus coded during
hospital readmission in a retrospective cohort of
liver transplant recipients in the United States
C.A.Q. Santos* (St. Louis, United States),
D.C. Brennan, W.C. Chapman, V.J. Fraser, M.A. Olsen
68
24th ECCMID / Barcelona
Final Programme
Scientific Programme
Tuesday, 13 May 2014
11:30 – 12:30
HALL E
O220
12:18 Genotyping supports the clinical significance of
isolation of Aspergillus fumigatus from sputum
and bronchial secretion samples for the diagnosis
of invasive pulmonary aspergillosis
P. Escribano, T. Peláez, P. Muñoz, B. Padilla, E. Bouza,
J. Guinea Ortega* (Madrid, Spain)
SYMPOSIUM:
Young Investigator Award Lectures
Chair: Murat Akova (Turkey)
SY289 11:30 Gut-lung axis: the intestinal microbiota in
pneumonia
W. Joost Wiersinga (The Netherlands)
11:30 – 12:30
SY290 12:00 Development of antimalarial drugs in
HALL H
SYMPOSIUM:
Can we treat Gram-negative bacteraemia with a short-course
of antibiotics? Pro / Con debate
Lambaréné, Gabon
Michael Ramharter (Austria)
Chairs: Jean Chastre (France)
Harald Seifert (Germany)
Aspergillus fumigatus and its resistance pattern
by real-time PCR
G. Gaajetaan, G. Dingemans, W. Van de Sande,
B. Rijnders* (Rotterdam, The Netherlands),
M.P. Hayette, R. Waber, D. Van Tegelen, G. Simons
O217
11:42 Development and evaluation of a novel multiplex
assay using RenDx® surface enhanced resonance
Raman scattering (SERRS) technology to aid in
the diagnosis of invasive fungal disease
L. White* (Cardiff, United Kingdom), J. Green,
M. Perry, G. McNay, R. Stevenson, R. Barnes
O218
11:54 Microsatellite-based molecular typing method for
Pneumocystis jirovecii
M. Gits-Muselli, J. Menotti, N. Guigue, S. Bretagne,
A. Alanio* (Paris, Franc)
O219
12:06 Characterisation of a PCR/ESI-MS assay for
detection and identification of diverse fungi in
bronchoalveolar lavage specimens
R. Lovari* (Carlsbad, United States), D. Metzgar,
D. Toleno, H. Carolan, L. Blyn, S. Peterson, K. Carroll,
S. Zhang, F. D'Alessio, R. Rothman
Juan P. Horcajada (Spain)
11:30 – 12:30
HALL I
Overview & Programme
11:30 A new diagnostic assay for the detection of
SY292 12:00 Con
SYMPOSIUM:
Mycobacteria in cutaneous infections
ESGMYC
Chairs: Dick van Soolingen (The Netherlands)
Miguel Viveiros (Portugal)
ePosters
O216
Helen Giamarellou (Greece)
SY293 11:30 Buruli ulcer due to M. ulcerans
Francoise Portaels (Belgium)
SY294 12:00 Leprosy: the old and new leprosy bacilli
Stewart T. Cole (Switzerland)
Posters
Chairs: Giuliana Lo Cascio (Italy)
Emmanuel Roilides (Greece)
SY291 11:30 Pro
arranged with the ESCMID Study Group for
Mycobacterial Infections (ESGMYC)
11:30 – 12:30
HALL J
SYMPOSIUM:
HIV and hepatitis C co-infection: double trouble?
Chairs: Linos Vandekerckhove (Belgium)
Massimo Puoti (Italy)
SY295 11:30 HIV-HCV co-infection: wait or treat?
Chairs, Speakers & Authors
ORAL SESSION:
Advances in molecular mycology: notes from the bench
Exhibition
HALL F
Jürgen Rockstroh (Germany)
SY296 12:00 Interferon-free treatment for chronic
hepatitis C – how and when?
Jean-Michel Pawlotsky (France)
24th ECCMID / Barcelona
Final Programme
69
General Information
11:30 – 12:30
Scientific Programme
Tuesday, 13 May 2014
13:30 – 15:30
HALL A
SYMPOSIUM:
Controlling transmission of multidrug-resistant pathogens in
the intensive care unit
Chairs: Francesco Menichetti (Italy)
Jose Antonio Martinez Martinez (Spain)
SY297 13:30 Decolonisation options for MRSA, VRE, ESBL and
CPE: efficacy and safety
Christian Brun-Buisson (France)
SY299 14:30 MDRO screening and targeted decolonisation
strategy
Marc J.M. Bonten (The Netherlands)
SY300 15:00 Universal decolonisation strategy
HALL B
EVASG
Chairs: Pier Luigi Lopalco (Sweden)
Mark Muscat (Denmark)
SY301 13:30 Measles and rubella eradication
Mark Muscat (Denmark)
SY302 14:00 Vaccine pipeline in China: current achievements
and bright future
James Wai-Kuo Shih (China)
SY303 14:30 Reducing the burden of pneumococcal disease
with pneumococcal conjugate vaccines
Ron Dagan (Israel)
SY304 15:00 Use of conjugate vaccines for prevention of
meningococcal disease
Susanna Esposito (Italy)
arranged with the ESCMID Vaccine Study Group
(EVASG)
Final Programme
SY305 13:30 Etiology and consequences of surgical site
Andreas F. Widmer (Switzerland)
SY307 14:30 Surgical antimicrobial prophylaxis in solid organ
transplantation (SOT): which antibiotic for which
microorganism?
Nicola Petrosillo (Italy)
surgery with foreign body implantation?
Alex Soriano (Spain)
SYMPOSIUM:
Hot topics in vaccine-preventable diseases
24th ECCMID / Barcelona
Chairs: Joseph S. Solomkin (United States)
Matthew Dryden (United Kingdom)
SY308 15:00 Is it necessary to modify the prophylaxis in
Susan S. Huang (United States)
70
SYMPOSIUM:
Antimicrobial prophylaxis of surgical site infections:
time to review?
SY306 14:00 When do you need to administer the prophylaxis?
epidemiological and clinical determinants
Stephan J. Harbarth (Switzerland)
HALL C
infections
Werner Zimmerli (Switzerland)
SY298 14:00 Effectiveness of MDRO decolonisation:
13:30 – 15:30
13:30 – 15:30
Scientific Programme
Tuesday, 13 May 2014
O227
Nile virus strains in northern Italy
L. Barzon* (Padua, Italy), M. Pacenti, E. Franchin,
E. Lavezzo, L. Squarzon, G. Masi, S. Pagni, M. Cattai,
R. Cusinato, G. Palù
ORAL SESSION:
Emerging infectious diseases
Chairs: Albert D.M.E. Osterhaus (The Netherlands)
Eskild Petersen (Denmark)
O228
13:30 Long-term epidemiological pattern and disease
consumption. The last two decades:
a systematic review
M. Bellou* (Patras, Greece), A. Birmpa, P. Kokkinos,
A. Vantarakis
burden of dengue in Venezuela
L. Echezuria, M. Fernandez, J. Torres* (Caracas,
Venezuela), A. Rizquez, P. Romero
O223
O224
14:06 Acceptance of vaccinations in pandemic
outbreaks: a discrete choice experiment in
The Netherlands
D. Determann* (Rotterdam, The Netherlands),
I.J. Korfage, M.S. Lambooij, M.C.J. Bliemer,
J.H. Richardus, E.W. Steyerberg,
E.W. De Bekker-Grob
O225
mikurensis in Ixodes ricinus and natural
vertebrate hosts in southern Sweden
M. Andersson* (Lund, Sweden), K. Scherman,
L. Råberg
O230
13:30 – 15:30
Chairs: Yehuda Carmeli (Israel)
José Garnacho-Montero (Spain)
SY309 13:30 Empirical therapy for MDR and XDR
Gram-negatives
Mical Paul (Israel)
SY310
14:30 West Nile virus excreted in urine during acute
infection is infectious
M. Pacenti, R. Cusinato, E. Franchin, L. Squarzon,
G. Marcati, M. Cattai, G. Palù, L. Barzon* (Padua,
Italy)
14:00 Definitive therapy for ESBL-producers:
life beyond carbapenems?
Jesús Rodríguez-Baño (Spain)
SY311
O226
HALL E
SYMPOSIUM:
Case-based decisions in the era of XDR Gram-negatives:
towards individualised therapy?
14:18 Outbreak of phlebovirus infection in Lombardia,
a northen Italy region in summer 2013
E. Percivalle, A. Sarasini, G. Campanini, B. Mariani,
A. Pan, F. Moschiano, E. Marchioni, M. Gramegna,
M. Fabbi, F. Baldanti* (Pavia, Italy)
15:18 Accuracy of clinical diagnosis of dengue fever in
southern Sri Lanka, 2012- 2013
C.K. Bodinayake* (Galle, Sri Lanka),
L.G. Tillekeratne, A. Nagahawatte,
W. Kodikara Arachchi, V. Devasiri, D. Vidanagama,
T. Ostbye, D.J. Gubler, C.W. Woods, M.E. Reller
13:54 Significant changes in the epidemiology of
bloodstream infections (BSI): results of a
prospective, longitudinal, region-wide survey
conducted between 2007 and 2013
C. Danet, H. Gbaguidi-Haore, S. Borges Dos Santos,
N. Girard, R. Quentin, N. Van der Mee-Marquet*
(Tours, France), BSI Study Group
15:06 The tick-borne pathogen Candidatus Neoehrlichia
14:30 Definitive therapy for carbapenemase-producing
Enterobacteriaceae: MIC matters?
Mario Tumbarello (Italy)
SY312
15:00 XDR-Pseudomonas aeruginosa and Acinetobacter
Gokhan Metan (Turkey)
24th ECCMID / Barcelona
Final Programme
Overview & Programme
genomic clades and epigenetic barriers
restricting widespread recombination and
horizontal gene transfer
T. Nandi* (Singapore, Singapore), M.T.G. Holden,
J.A. Boddey, I. Beacham, S.L. Chen, R. Titball,
J. Parkhill, P. Tan
O229
ePosters
13:42 Burkholderia pseudomallei sequencing identifies
Posters
O222
14:54 Viral outbreaks linked to fresh produce
71
Chairs, Speakers & Authors
O221
14:42 Multiple introductions and local evolution of West
Exhibition
HALL D
General Information
13:30 – 15:30
Scientific Programme
Tuesday, 13 May 2014
13:30 – 15:42
HALL F
O235
invasive aspergillosis
C. Garcia Vidal* (Barcelona, Spain), M. Peghin,
C. Cervera, C. Gudiol, I. Ruiz-Camps, A. Moreno,
C. Royo-Cebrecos, J. Ayats, J. Carratalà
ORAL SESSION:
Clinical mycology update 2014
Chairs: Andreas H. Groll (Germany)
Susan J. Howard (United Kingdom)
O236
O230a 13:30 A phase 3 randomised, double-blind trial
evaluating isavuconazole vs. voriconazole for
the primary treatment of invasive fungal disease
caused by Aspergillus spp. or other filamentous
fungi (secure)
J. Maertens* (Leuven, Belgium), T. Patterson,
G. Rahav, D. Kontoyiannis, K. Marr, R. Maher, M. Lee,
B. Zeiher, A. Ullmann
O231
O232
O233
14:06 Decreased invasive fungal disease but no impact
on overall survival by posaconazole compared to
fluconazole prophylaxis; a retrospective cohort
study in AML and MDS patients
T. Dahlén* (Stockholm, Sweden), K. Cederlund,
M. Kalin, A. Nordlander, M. Björkholm, P. Ljungman,
O. Blennow
O234
14:18 Accuracy of bis(methylthio)gliotoxin in
diagnosis of invasive pulmonary aspergillosis:
a comparative study with galactomannan
M. Vidal García* (Zaragoza, Spain), M.P. Domingo,
P. Soria, C. Lapresta, P. Delgado, M.J. Revillo,
J. Pardo, E.M. Gálvez, A. Rezusta
72
O237
24th ECCMID / Barcelona
Final Programme
14:54 The strategies for treating persistent
candidaemia: do echinocandins do better?
K.Y. Lin* (Taipei City, Taiwan), P.Y. Chen, H.Y. Sun,
C.C. Lai, Y.C. Chuang, W.H. Sheng, Y.C. Chen,
S.C. Chang
O238
15:06 Antifungal stewardship at a London teaching
hospital achieves sustained cost reduction over 3
years without compromising microbiological and
clinical outcomes
L. Whitney* (London, United Kingdom),
H. Al-Ghusein, M. Koh, M. Klammer, T. Bicanic
13:54 Impact of early antifungal treatment on invasive-
candidiasis-free survival in ICU patients
ventilated for more than 4 days. A pseudorandomised trial based on marginal structural
models
S. Bailly, R. Hamidfar-Roy, M. Garrouste-Orgeas,
M. Darmon, M. Cornet, S. Ruckly, S. Chemam,
C. Adrie, M. Rabilloud, J.F. Timsit* (Grenoble, France)
14:42 Multi-country estimate of different
manifestations of aspergillosis in adult
cystic fibrosis patients
J. Armstead* (Cheshire, United Kingdom),
D.W. Denning
13:42 Worrisome trends in incidence and mortality of
candidaemia in intensive care units
(Paris area, 2002-2010)
O. Lortholary* (Paris, France), C. Renaudat,
K. Sitbon, L. Denoeud-Ndam, M. Wolff, A. Fontanet,
S. Bretagne, F. Dromer, F.M.S.G. French Mycoses
Study Group
14:30 Current causes of death for patients with
O239
15:18 Reversed halo sign; the clinical meanings and the
formation processes during neutropenia, a cohort
study
K. Kyo* (Hiroshima, Japan), K. Toishigawa, T. Ochi,
T. Okatani, R. Imanaka, M. Itagaki, Y. Katayama,
K. Iwato, H. Asaoku, T. Kyo
O240
15:30 IL17A and IL22 in patients with candidaemia,
Candida-colonised ICU patients and healthy
controls
R. Krause* (Graz, Austria), I. Zollner-Schwetz,
T. Valentin, R. Raggam, B. Rinner, F. Quehenberger,
M. Hönigl
Scientific Programme
Tuesday, 13 May 2014
O248
antimicrobial therapy outcomes in acute
care – a prospective cross-sectional study
E. Charani* (London, United Kingdom), M. Gharbi,
G. Frost, A.H. Holmes
ORAL SESSION:
New old antibiotics: safety and efficacy
Chairs: Roger L. Nation (Australia)
Benito Almirante (Spain)
O249
O241
13:30 Colistin-associated nephrotoxicity in critically
ill patients and simulated colistimethate sodium
and colistin levels
T.P. Gauthier* (Fort Lauderdale, United States),
W.R. Wolowich, E. Cano, J. Altamirano, P. Laowansiri,
A. Reddy, J. Wasko, E. Lantz, L. Smith, L. Abbo
O242
13:42 Risk factors for acute kidney injury in patients
treated with polymyxin B according to RIFLE and
AKIN scores: a prospective cohort study
M.H. Rigatto* (Porto Alegre, Brazil), L.C. Antochevis,
L.W.L. Costa, D.R. Falci, T. Freitas, N.T. Lopes,
F.R. Vieira, A.P. Zavascki
O243
14:54 Adult weight and its impact on infection and
15:06 Is the efficacy of ertapenem reduced in the
presence of severe hypoalbuminaemia?
L. Farbman* (Tel Aviv, Israel), O. Zusman, Z. Tredler,
V. Daitch, A. Lador, L. Leibovici, M. Paul
O250
15:18 Outcome of patients with bacteraemia due to
Enterobacteriaceae treated with fluoroquinolones
accruing to MIC (REIPI bacteraemia-MIC study)
E. Torres* (Seville, Spain), C. Peñas,
M. Delgado-Valverde, A.M. Planes, C. Peña Miralles,
N. Borrell, J. Corzo Delgado, A. Valiente Mendez,
A. Pascual, J. Rodriguez-Baño
Overview & Programme
HALL G
13:54 The potential role of phosphomycin in combating
O244
ePosters
ESBL-producing organisms causing urinary tract
infections in district general hospital in the UK
A. Ghazy* (Southall Middlessex, United Kingdom),
S.A. Aali, P. Khanna, K. Cheema, W. Lynn
14:06 Colistin-associated nephrotoxicity:
the impact of definition
J.M. Pogue* (Detroit, United States), D. Marchaim,
K. Hayakawa, H. Pulluru, K.S. Kaye
14:18 Safety of daptomycin at different doses: results
Posters
O245
O246
Chairs, Speakers & Authors
from EU-CORE(SM) and from post-marketing
surveillance
K. Malizos* (Basel, Switzerland), R. Utili,
P. Gargalianos-Kakolyris, G. Dalekos, R.A. Seaton,
P. Dohmen, S. Titaevski, K. Bouylout, A. Trylesinski
14:30 Fluoroquinolones and the risk of severe arrythmia
– a nationwide cohort study
M. Inghammar* (Lund, Sweden), B. Pasternak,
H. Swanström, A. Hviid, M. Melby
14:42 Fluoroquinolones and QT prolongation in the
Exhibition
O247
clinical setting: study of their impact in the
heavily predisposed hospitalised population
M. Zorzou* (Chios, Greece), A. Kosti, M. Stoupaki,
A. Kallergi, S. Skoulikidi, E. Papadopoulou,
A. Pitsikouli, M. Psallas, P. Pramangioulis,
G. Dounias
24th ECCMID / Barcelona
Final Programme
73
General Information
13:30 – 15:30
Scientific Programme
Tuesday, 13 May 2014
13:30 – 15:30
HALL H
O258
A. Dinh* (Paris, France), I. Ghout, D. Mulleman,
B. Marchou, B. Issartel, V. Zeller, N. Belmatoug,
M. Dupon, L. Bernard
ORAL SESSION:
Improving treatment of severe infections
Chairs: Jose Miguel Cisneros Herreros (Spain)
M. Adriana Cataldo (Italy)
O251
O259
13:42 Antistaphylococcal beta-lactams vs vancomycin
O260
in the treatment of infective endocarditis due
to methicillin-susceptible coagulase-negative
staphylococci – a prospective cohort study from
the international collaboration on endocarditis
M. Carugati* (Milan, Italy), C. Arnold, J. Miro',
Z. Kanafani, A. Bayer, V. Chu
O253
13:54 Effect of days of therapy on detection of
pathogens from sterile clinical specimens
submitted for culture following initiation of
antibiotic treatment
J.J. Farrell* (Peoria, United States), H. Wang,
R. Sampath, R.A. Bonomo
13:30 – 15:30
ESGAI, Society for Anaerobic Microbiology
Chairs: Dorothea Orth (Austria)
Elisabeth Nagy (Hungary)
SY314
O256
14:30 Cost-effectiveness of fidaxomicin as first-line
treatment for Clostridium difficile infection
J. Nesnas, L. Whitney, A. Ahmad, T. Planche*
(London, United Kingdom)
O257
14:42 Appropriate empiric antibiotic treatment does not
reduce 30-day mortality among inpatients with
catheter-associated urosepsis: observational
cohort study
T. Babich* (Petah Tikva, Israel), T. Avni, M. Paul,
L. Leibovici
74
24th ECCMID / Barcelona
Final Programme
14:00 Escape from the biofilm – disseminated oral
anaerobic infections
Riina Richardson (United Kingdom)
14:18 Tailoring the empirical antimicrobial therapy
in VAP patients by means of an E-test based
direct testing
F. M'Zali* (Bordeaux, France), J. Goret, E. Chalus,
D. Anquetil, C. Bouchiat, B. Clouzeau, H.N. Bui,
M. Kann, D. Gruson, A. Boyer
13:30 More than a nasty smell – burden of emerging
anaerobes in the era of molecular detection
Bernard La Scola (France)
SY315
O255
HALL I
SYMPOSIUM:
Two-faced companions: highlights in the world of anaerobes
14:06 In vivo development of fluoroquinolone
and macrolide resistance in Streptococcus
pneumoniae
M. Alonso, J.M. Marimon Ortiz de Zarate* (San
Sebastian, Spain), I. De la Caba, M. Ercibengoa,
E. Pérez-Trallero
15:18 Colistin and tobramycin resistance during
long-term use of selective decontamination
strategies in Dutch ICUs
B.H.J. Wittekamp* (Utrecht, The Netherlands),
E.A.N. Oostdijk, M.J.M. Bonten
SY313
O254
15:06 Long-term benefit from clarithromycin treatment
in patients with sepsis and ventilator-associated
pneumonia (VAP): impact on the hospitalisation cost
T. Tsaganos* (Haidari, Greece), M. Raftogiannis,
M. Pratikaki, S. Christodoulou, A. Kotanidou,
E. Papadomichelakis, C. Routsi,
E.J. Giamarellos-Bourboulis
13:30 Cross-sectional study: an international survey
on controversial antibiotic options in infective
endocarditis
G. Béraud* (Poitiers, France), C. Pulcini,
J.R. Paño-Pardo, B. Hoen, B. Beovic, D. Nathwani
O252
14:54 Antibiotic treatment of vertebral osteomyelitis
14:30 Anaerobes in medical device infections –
a failed diagnosis?
Sheila Patrick (United Kingdom)
SY316
15:00 Anaerobes in sinusitis and chronic respiratory
tract infections
Kenneth Bruce (United Kingdom)
arranged with the ESCMID Study Group for
Anaerobic Infections (ESGAI) and with the Society
for Anaerobic Microbiology (SAM)
Scientific Programme
Tuesday, 13 May 2014
HALL J
O268
detection of pathogens in patients with
suspected sepsis
A. Onnberg* (Örebro, Sweden), I. Ziegler, B. Törös,
K. Strålin, P. Mölling
ORAL SESSION:
PCR and other molecular tests directly on blood: what is new?
Chairs: Jean-Luc Mainardi (France)
Paul Savelkoul (The Netherlands)
O269
O261
13:30 Bench to bedside: rapid identification and
13:42 Development and initial characterisation of a
PCR/ESI-MS assay capable of detecting and
identifying diverse bacteria and Candida in
normally sterile body fluids and tissues
M. Frinder, D. Metzgar* (Carlsbad, United States),
M. Rounds, H. Carolan, D. Toleno, R. Sampath,
L. Blyn
O263
15:06 Matrix-assisted laser desorption/ionization-time
of flight mass-spectrometry (MALDI-TOF MS)
directly from positive blood culture flasks allows
rapid detection and identification of bloodstream
infection (BSI)
A. Egli* (Basel, Switzerland), M. Osthoff,
D. Goldenberger, M. Weisser, R. Frei
susceptibility testing of Staphylococcus aureus
from blood culture isolates
M. Menon* (Newcastle, Australia), C. Pedersen,
A. Foster, P. Kalukottege, J. Davis, S. Graves
O262
14:54 Magicplex™ sepsis real-time PCR for rapid
O270
15:18 Molecular epidemiology and characterisation of
S. aureus bacteraemic isolates during four
decades in Sweden
G. Rasmussen* (Örebro, Sweden), S. Monecke,
R. Ehricht, B. Söderquist
Overview & Programme
13:30 – 15:30
13:54 Evaluation of the FilmArray® blood culture
O264
ePosters
identification panel in identification of
polymicrobial blood culture bottles
A. Giaquinto, F. Arena, T. D'Inzeo, B. Fiori,
G. De Angelis* (Rome, Italy), G. Menchinelli,
L. Piccioni, M. Sanguinetti, G.M. Rossolini, T. Spanu
14:06 Accuracy and potential clinical utility of two
14:18 Rapid detection of Gram-negative bacteria and
O266
Chairs, Speakers & Authors
resistance determinants directly from positive
blood cultures using the microarray-based
sample-to-result Verigene® BC-GN assay
N.A. Ledeboer* (Milwaukee, United States),
T.A. Mackey, B.W. Buchan
14:30 Impact of the Verigene® Gram-positive blood
O267
Exhibition
culture assay in a tertiary care paediatric
hospital
S. Felsenstein* (Los Angeles, CA, United States),
C. Taketomo, P. Sandha, J. Dien Bard
14:42 Field evaluation of the new QuickFISH™ assays for
the rapid diagnosis of sepsis
A. Calderaro* (Parma, Italy), M. Martinelli, F. Motta,
S. Montecchini, C. Gorrini, M.C. Arcangeletti,
F. De Conto, C. Chezzi, M.C. Medici
24th ECCMID / Barcelona
Final Programme
75
General Information
O265
Posters
rapid molecular panels for detection of
bloodstream infection
C. Ward* (London, United Kingdom), K. Stocker,
J. Begum, P. Wade, U. Ebrahimsa, S. Goldenberg
3rd ESCMID Conference on Vaccines
Vaccines for Mutual Protection
Lisbon, Portugal
6 – 8 March 2015
Organising Committee
Ron Dagan, Beer Sheva, IL
Susanna Esposito, Milan, IT
Mario Poljak, Ljubljana, SI
Contact: lisbon2015@escmid.org
Find more information and registration information on our website
www.escmid.org/lisbon2015
Including:
• Mutual protection – the key for disease prevention
• Influenza – how best to prevent transmission
• Recent threats of poliovirus – did we open the Pandora box?
• Safety issues in vaccines – potential risk for mutual protection
• Pertussis protection throughout life – how can we achieve this?
• New insight into prevention of gastrointestinal infections in all ages
• Can we achieve meningococcal control in Europe?
• How can we achieve HPV control in Europe?
ePoster Sessions
Sunday, 11 May 2014
eP042 13:06 Risk factors for surgical site infection after
microvascular reconstruction for head and neck
cancer
J.L. Wagner* (Detroit, United States), R.M. Kenney,
T.A. Ghanem, J.A. Vazquez, S.L. Davis
eP044 13:12 Sternal plate fixation for chest wall
reconstruction post coronary artery bypass
surgery appears to increase the risk of surgical
site infection
M. Charles* (Edmonton, Canada), L. Saxinger,
S. Smith
eP041 13:18 Infection of spinal cord stimulation devices:
remove or retain?
G. Béraud* (Poitiers, France), M. Roulaud,
O. Monlezun, F. Guetarni, B. Bataille, P. Rigoard
eP053 13:24 Impact of multidrug-resistant Gram-negative
bacilli on organ/space infections associated
to elective colorectal surgery – a prospective
analysis in a university hospital in Spain
E. Shaw* (Barcelona, Spain), R. Escofet, G. Cuervo,
D. Garcia, O. Arch, A. Hornero, T. Vidal, C. Peña,
J. Ariza, M. Pujol
eP055 13:30 Post-arthroscopic septic arthritis of the knee
analysis of the outcome after treatment in a
series of cases
T. Ascione* (Naples, Italy), G. Balato, P. Pagliano,
R. Rotondo, G. De Stefano, M. Conte, M. Mariconda
eP056 13:36 Management and clinical outcomes of
Staphylococcus aureus prosthetic joint
infections: a retrospective review
S. Parsaei* (Saint Louis, MO, United States),
N. Ganeshraj, A. Gu, P. Bodavula, J. Marschall,
D. Warren, M. Lane
eP058 13:42 SSI after hip or knee arthroplasty:
a French cohort study using hospital
discharge database, 2008-2012
L. Grammatico-Guillon* (Tours, France), S. Baron,
C. Gaborit, E. Rusch, P. Astagneau
eP060 13:54 Standards of infection control to prevent surgical
site infections in Switzerland: a cross-sectional
survey in 82 hospitals
D. Vuichard Gysin* (Basel, Switzerland), N. Troillet,
M.C. Eisenring, M. Dangel, G. Zanetti, A.F. Widmer
13:00 – 14:00
HALL F
EPOSTER SESSION:
PK/PD to improve treatment of critically ill patients
eP002 13:00 Impact of beta-lactam pharmacokinetics/
pharmacodynamics on clinical outcome of
bloodstream infections in critically ill patients
M. Nunez-Nunez* (Seville, Spain), G. Wong,
S.C. Wallis, B. McWhinney, J.P.G. Ungerer, J. Mayer,
J. Lipman, J.A. Roberts
ePosters
related to craniotomy in a tertiary care university
hospital – a prospective surveillance programme
A. Soriano* (Barcelona, Spain), E. Shaw, O. Arch,
A. Gabarros, D. Garcia, C. Cabellos, I. Pelegrin,
C. Peña, J. Ariza, M. Pujol
eP008 13:06 Population pharmacokinetics of ceftazidime
and cefepime in septic shock patients during
continuous renal replacement therapy
M. Carlier* (Ghent, Belgium), F. Taccone, L. Seyler,
F. Jacobs, M. Beumier, J.L. Vincent, J. Lipman,
J. Roberts
Posters
eP039 13:00 Risk factors and surgical site infection rates
duration of antibiotic prophylaxis for prevention
of neurosurgical infections
A. Ulu-Kilic* (Kayseri, Turkey), E. Alp Mese,
F. Cevahir, H. Demiraslan, B. Tucer, A. Selcuklu,
M. Doganay
eP004 13:12 Pharmacokinetic/pharmacodynamic evaluation
of the efficacy and cost-effectiveness of various
carbapenem dosing regimens for the treatment of
Gram-negative bacterial bloodstream infections
T.P. Lim, Y. Cai, J. Teo, Z.W. Wang, W. Lee, T.Y. Tan,
T.T. Tan, L.Y. Hsu, T.H. Koh, A. Kwa* (Singapore,
Singapore)
eP005 13:18 The effect of extracorporeal membrane
oxygenation in critically ill patients on meropenem
pharmacokinetics: a matched cohort study
J. Roberts* (Brisbane, Australia), K. Shekar,
J. Fraser, D. Mullany, S. Wallis, J. Lipman
24th ECCMID / Barcelona
Final Programme
77
Chairs, Speakers & Authors
EPOSTER SESSION:
Post-surgical and implant infections: from head to knee
eP040 13:48 Cost-effectiveness analysis of appropriate
Exhibition
HALL D
General Information
13:00 – 14:00
ePoster Sessions
Sunday, 11 May 2014
eP006 13:24 Comparative evaluation of the accuracy and
precision of pharmacokinetic equations to predict
free meropenem concentrations in critically ill
patients
A. Farkas, G. Wong, G. Daroczi, J. Lipman,
J. Roberts* (Queensland, Australia)
eP007 13:30 Microdialysis tissue pharmacokinetics and
pharmacokinetic-pharmacodynamic modelling
of ertapenem after 1g/12h administrations to
critically ill patients
N. Gregoire* (Poitiers, France), N. Hamitouche,
L. Laksiri, T. Loupec, S. Marchand, O. Mimoz,
W. Couet
eP009 13:36 Explaining variability in gentamicin peak
concentrations to optimise gentamicin dosing in
critically ill patients
R.M. Van Hest* (Amsterdam, The Netherlands),
C.S.C. Bouman, C.E. Visser, N.P. Juffermans,
C.J. Hodiamont, R.A. Mathot
eP010
13:42 Amikacin peak loading in obese patients:
application of adjusted body weight formula with
modern posologies. Are 30 mg/kg enough?
C. Lu, M. Meddour, N. Van Grunderbeeck* (Lens,
France), M. Nyunga, M. Boyer-Besseyre, J. Gois,
E. Parmentier-Decrucq, J. Mallat, D. Thevenin,
N. Lemaire
eP001 13:48 Population probability of target attainment
of colistin at different levels of renal function
against Pseudomonas aeruginosa and
Acinetobacter baumannii in Europe
A. Farkas, K. Hoffman, C. Levy,
J. Roberts* (Queensland, Australia)
13:00 – 14:00
HALL G
EPOSTER SESSION:
Microbiome and resistance: what are they telling us?
eP492 13:00 Gut microbiota continues to evolve during the
first five years of life
A. Eck* (Amsterdam, The Netherlands),
N.B.M.M. Rutten, I. Besseling-van der Vaart,
G.T. Rijkers, A.M. De Vlieger, P.H.M. Savelkoul,
A.E. Budding
78
24th ECCMID / Barcelona
Final Programme
eP490 13:06 Profile similarities of gut microbiota in allergic
and non-allergic children at 5 and 10 years of age
T. Drell* (Tartu, Estonia), A. Larionova, J. Simm,
K. Heilman, T. Voor, E. Sepp
eP493 13:12 Effects of selective digestive decontamination
(SDD) on the gut resistome
E. Bülow* (Utrecht, The Netherlands),
T. Bello Gonzalez, D. Versluis, L. Ogilvie,
M.M. D’Andrea, H. Smidt, B.V. Jones, R.J.L. Willems,
M. Bonten, W. Van Schaik
eP496 13:18 Use of the mucosal F. prausnitzii/E.coli index as a
marker of microbiota improvement in ulcerativecolitis dysbiosis after treatment with mesalazineMMX (Mezavant™)
J. Miquel Cusachs* (Girona, Spain),
D. Busquets Casals, M. Serra-Pagès, J. Garcia Gil,
X. Aldeguer Manté
eP502 13:24 Searching for peritonitis-causing agents in the
normal microbiota of peritoneal dialysis patients:
analysis of possible routes of infection
L. Simões Silva* (Porto, Portugal), S. Ferreira,
S. Silva, R. Araujo, M.J. Sousa, C. Santos-Araújo,
M. Pestana, I. Soares-Silva, B. Sampaio-Maia
eP498 13:30 The oral resistome: from metagenomics to
antimicrobial resistance of the microbiota
in the mouth
B.B. Wintermans* (Amsterdam, The Netherlands),
C.M.J.E. Vandenbroucke-Grauls, A.E. Budding
eP500 13:36 Molecular identification of bacterial communities
associated with caries by denaturing gradient gel
electrophoresis fingerprinting approach
E. Alia, B. Romero-Hernández* (Madrid, Spain),
A.M. Sánchez-Díaz, J.D. Caballero,
M. Hernández-García, G. Chinchón,
D. Parra-Pecharomán, J. López-Palafox, L. Gil,
R. Del Campo
eP488 13:42 The vaginal microbiome as a predictor for
acquiring Chlamydia trachomatis, a case
control study
R. Van Houdt* (Amsterdam, The Netherlands),
B. Ma, J. Van der Helm, S. Bruisten, H. De vries,
J. Ravel
ePoster Sessions
Sunday, 11 May 2014
eP572 13:36 High rates of sexually transmitted infections in
eP555 13:00 Optimisation of the diagnostic strategy for
detecting C. trachomatis as a cause of female
infectious infertility
K. Gillmann, M.K. Bohlmann, R. Speer, H. Mark,
S. Graspeuntner, A. Schultze- Mosgau, R. Lettau,
G. Griesinger, I. König, J. Rupp* (Lübeck, Germany)
eP561 13:06 Genital Chlamydia trachomatis testing and care
in general practice in UK, France, Sweden and
Estonia
A. Uusküla, E. Ricketts, R. Kalda, A. Tisler-Sala*
(Tartu, Estonia), H. Fredlund, J. Hedlund, B. Dunais,
B. Touboul, C. McNulty
eP564 13:12 Prevalence and predictors of lymphogranuloma
venereum in a high-risk population in Italy
A. Marangoni* (Bologna, Italy), C. Foschi,
A. D’Antuono, M. Compri, P. Nardini, S. Bellavista,
N. Banzola, A. Filippini, R. Cevenini
eP578 13:18 Infection with Chlamydia trachomatis in infertile
women in Poland
I. Chudzicka-Strugala* (Poznan, Poland),
T.M. Karpinski, A. Zeidler, B. Banaszewska,
L. Pawelczyk, A. Szkaradkiewicz
eP566 13:24 Prevalence and risk factors associated with
Mycoplasma genitalium infection in a South
African women cohort
J.-H. Dubbink, B. Hay, S. Ouburg, C. Le Roy,
S. Pereyre, S.A. Morré, C. Bebear* (Bordeaux,
France), R.H. Peters
eP570 13:30 High prevalence of HIV infection in homo/bisexual
men with other sexually transmitted diseases
R. Del Romero* (Madrid, Spain), B. Menéndez,
T. Puerta, J. Balllesteros, P. Clavo, M. Vera,
M. Raposo, V. Paredes, C. Rodríguez, I. Río
age groups of symptomatic patients
S. Baka, I. Tsirmpa* (Athens, Greece), E. Saltaoura,
A. Chasiakou, S. Hassiakou, V. Gennimata,
E. Kouskouni
eP576 13:48 Global prevalence of recurrent vulvovaginal
candidiasis
D.W. Denning, M. Kneale, R. Rautemaa-Richardson*
(Manchester, United Kingdom), J.D. Sobel
13:00 – 14:00
HALL I
EPOSTER SESSION:
Antifungal drug susceptibility and resistance
eP232 13:00 Echinocandin MICs against Candida species at
hospitals that routinely perform susceptibility
testing of bloodstream isolates
G. Eschenauer, M.H. Nguyen, S. Shoham,
J. Vazquez, A. Morris, C. Kubin, P. Carver, K. Hanson,
S. Chen, C.J. Clancy* (Pittsburgh, United States)
ePosters
EPOSTER SESSION:
STD and other genital infections
13:42 Prevalence of aerobic vaginitis among different
eP235 13:06 Species distribution and antifungal
susceptibilities of bloodstream Candida sp. from
the Asia-Pacific region
T.Y. Tan* (Singapore, Singapore), L.Y. Hsu,
M.M. Alejandria, T. Chinniah, P. Kiratisin, J.H. Shin,
T.T.N. Tran, A.L. Tan, L.S.Y. Ng
Posters
HALL H
eP575
eP242 13:12 Echinocandin failure case due to a yet unreported
FKS mutation in Candida krusei
R. Jensen* (Copenhagen, Denmark), U. Justesen,
A. Rewes, D. Perlin, M. Arendrup
eP243 13:18 Twofold point mutations in Candida albicans FKS1
gene leading to echinocandin resistance after
long-term treatment
K. Heidrich, R. Krause* (Graz, Austria), M. Hoenigl,
C. Lass-Floerl, W. Buzina
Chairs, Speakers & Authors
13:00 – 14:00
HIV-infected individuals attending an STD clinic in
the US
J. Castro* (Miami, United States), M. Alcaide
Exhibition
of healthy pregnant women of four ethnic
backgrounds, and of Caucasian pregnant women
in health and disease
G.L. Mendz* (Darlinghurst, NSW, Australia),
S.J. Lord, N.O. Kaakoush, J.A. Quinlivan
eP238 13:24 Is micafungin uniformly active against Candida
albicans biofilms showing different degrees of
metabolic activity?
L.J. Marcos-Zambrano, P. Escribano, E. Bouza,
J. Guinea Ortega* (Madrid, Spain)
24th ECCMID / Barcelona
Final Programme
79
General Information
eP489 13:48 Comparisons of the vaginal microbiomes
ePoster Sessions
Sunday, 11 May 2014
eP246 13:30 Aspergillus fumigatus with prior azole exposure
decreases amphotericin B sensitivity in vitro
R. Rajendran* (Glasgow, United Kingdom),
C. Williams, B. Jones, G. Ramage
eP247 13:36 Investigation of primary clinical samples and
azole-resistant isolates of immunocompromised
patients for cyp51A mutations in Aspergillus
fumigatus using established and a novel TR46
PCR assays
B. Spiess* (Mannheim, Germany), P. Postina,
A. Hamprecht, J. Vehreschild, C. Lass-Flörl,
M. Hönigl, P.-M. Rath, T. Miethke,
W.-K. Hofmann, D. Buchheidt
eP252 13:42 First Danish report of TR34/L98H A. fumigatus
in three non-cystic fibrosis patients despite
apparent lack of resistant isolates in recent soil
samples
K.M.T. Astvad* (Valby, Denmark), R.H. Jensen,
T.M. Hassan, E.G. Mathiasen, G.M. Thomsen,
U.G. Pedersen, M. Christensen, M.C. Arendrup
eP249 13:48 Simple, low-cost molecular detection of TR34/
L98H mutations in cyp51A gene for rapid
detection of triazole-resistant Aspergillus
fumigatus isolates
S. Ahmad* (Safat, Kuwait), Z. Khan, L. Joseph,
F. Hagen, J. Meis, J. Meis
eP259 13:54 Optimising antifungal combination therapy
of voriconazole+amphotericin B against
Aspergillus fumigatus using a pharmacokineticpharmacodynamic (PK-PD) model
M. Siopi* (Athens, Greece), N. Siafakas, L. Zerva,
J. Meletiadis
80
24th ECCMID / Barcelona
Final Programme
ePoster Sessions
Monday, 12 May 2014
HALL D
eP171
tested against vancomycin-resistant/susceptible
enterococcal clinical isolates recovered from
European medical centres (2009-2013)
R.E. Mendes* (North Liberty, United States),
D.J. Farrell, J.M. Streit, R.N. Jones
EPOSTER SESSION:
Antibacterial drug activity and interactions in Gram-positive
organisms
eP193 13:00 Activity of ceftaroline against clinically relevant
strains of penicillin non-susceptible
S. pneumoniae
I. Burckhardt* (Heidelberg, Germany), J. Panitz,
P. Jaehn, S. Zimmermann
eP189 13:42 In vitro and in vivo susceptibility of Streptococcus
pyogenes to trimethoprim-sulphamethoxazole in
northern Australia
A.C. Bowen* (Casuarina, Australia), S.Y.C. Tong,
M.I. McDonald, J.R. Carapetis
eP180 13:06 Allosteric site missense mutations in PBP2a
affecting ceftaroline susceptibility detected in
epidemic HA-MRSA clonotypes ST228 (south
German) and ST247 (Iberian) in western
Switzerland
W.L. Kelley, A. Jousselin, C. Barras, E. Lelong,
A. Renzoni* (Geneva, Switzerland)
eP183
13:12 In vitro activity of ceftaroline against
EP15T mecC-positive methicillin-resistant
Staphylococcus aureus from humans and
livestock
E. Cercenado* (Madrid, Spain), F. García-Garrote,
M. Marín, A. Vindel, A. Méndez, E. Bouza
13:36 Current analysis of oritavancin potency when
eP191
13:48 Antimicrobial activity of solithromycin tested
against serotyped macrolide-resistant
Streptococcus pneumoniae collected from
medical centres across the USA (2012)
D.J. Farrell* (North Liberty, IA, United States),
R.E. Mendes, R.N. Jones
eP192 13:54 Comparison of commercial methods with broth
microdilution for determining beta-lactam
susceptibilities of Streptococcus pneumoniae
isolates
M. Charles* (Edmonton, Canada), B. Berenger,
L. Turnbull, R. Rennie, J. Fuller
ePosters
eP176 13:18 Mutant prevention concentration (MPC) values
Posters
of tedizolid (TDZ) against clinical strains of
methicillin-resistant Staphylococcus aureus
(MRSA) shows a low propensity for resistance
selection
A. Alsaeed, S. Shebelski, J. Blondeau* (Saskatoon,
SK, Canada)
eP185 13:24 Activity of the peptide deformylase inhibitor
Chairs, Speakers & Authors
GSK1322322 against intracellular forms of
susceptible and resistant S. aureus: comparison
with azithromycin, clindamycin, linezolid,
vancomycin, daptomycin, and moxifloxacin
F. Peyrusson, P.M. Tulkens* (Brussels, Belgium),
F. Van Bambeke
eP184 13:30 The use of natural alkaloids and flavonoids in
Exhibition
combination with antibiotics to prevent and
control Staphylococcus aureus biofilms
A.C. Abreu* (Porto, Portugal), I. Gomes, J. Malheiro,
M. Simões
24th ECCMID / Barcelona
Final Programme
81
General Information
13:00 – 14:00
ePoster Sessions
Monday, 12 May 2014
13:00 – 14:00
HALL F
EPOSTER SESSION:
Assessing and decreasing environmental contamination
eP270 13:00 Effects of a syphon disinfection device on
colonisation with multiresistant Pseudomonas
aeruginosa in sinks on a tertiary care centre ICU
E.H.R. Van Essen* (Leiden, The Netherlands),
M.G.J. De Boer, R.B.P. De Wilde, H.C.M. DogteromBallering, K.E. Veldkamp, E. De Jonge
eP271
13:06 Bath basins in healthcare settings from Europe
and North America as common reservoirs for
multi-drug resistant organisms
B. Ackerman, K.S. Kaye, D. Marchaim* (Zerifin,
Israel)
eP263 13:12 Antimicrobial resistant Gram-negative bacilli in
the ICU: examining the interplay between patient
colonisation and environmental contamination
H. McDermott* (Dublin, Ireland), M. Scally,
H. Humphreys, D. Fitzgerald-Hughes
eP280 13:18 Can toy wash and disinfection reduce bacteria
load and sickness in day care centres?
T. Ibfelt* (Copenhagen, Denmark), L. Andersen
eP281 13:24 Pneumatic transport systems (PTS) are prone to
contamination with multiresistant organisms –
lessons learned from an Acinetobacter spp. (GIM1) pseudooutbreak at a large university hospital
M. Herrmann* (Homburg/Saar, Germany),
S. Jungmann, A. Dawson, A. Halfmann, M. Kaase,
S. Gatermann, L. Von Müller, B. Gärtner
eP275 13:30 A novel approach for in vitro evaluation of the
potential risk of patient contamination during
endovaginal ultrasound examinations
F. MZali* (Bordeaux, France), S. Leroy, M. Kann,
C. Quentin-Noury
82
24th ECCMID / Barcelona
Final Programme
eP276 13:36 Risk of HIV and hepatitis C infection related to
endocavitary ultrasound probe exposure
T. Bénet* (Lyon, France), J. Ritter, P. Vanhems
eP267 13:42 Assessing the efficacy of two commonly used
disinfecting agents in hospital isolation rooms
M. Smith* (Kilmarnock, United Kingdom),
W.G. Mackay, K. Smith, C. Woodall, C.L. Williams,
R.G. Masterton
eP264 13:48 Decontamination of hospital surfaces using an air
plasma multi-jet
T. Claro* (Dublin, Ireland), O. Cahill, N. O’Connor,
S. Daniels, H. Humphreys
eP269 13:54 Using electrolysed water to clean near-patient
sites: is disinfectant better than detergent?
M. Stewart* (Glasgow, United Kingdom),
S.J. Dancer, A. Bogusz, J. Hunter, I. Devanny, B. Yip,
D. Reid, C. Robertson
ePoster Sessions
Monday, 12 May 2014
eP072 13:00 Qualitative and quantitative analysis of the
microbiota in lower respiratory tract infections
reveals a high proportion of polymicrobial
infections
G. Platt* (London, United Kingdom), S. Schwenk,
Y. Personne, K. Thomas, V. Gant, V.I. Enne, A.I. Zumla
eP061 13:06 Microbiological investigation of patients
with community-acquired pneumonia using
quantitative multiplex real-time bacterial PCR
C.D. Russell* (Edinburgh, United Kingdom),
N.J. Gadsby, H. Mark, D. Guerendiain,
A. Conway Morris, I.F. Laurenson, A.T. Hill,
K.E. Templeton
eP071
13:12 The value of procalcitonin to determine the need
for hospital admission in adults with communityacquired pneumonia
A.F. Simonetti* (Barcelona, Spain), D. Viasus,
C. Garcia-Vidal, J. Dorca, F. Morandeira-Rego,
J. Carratala
eP062 13:18 Predictors of bacteraemia in patients hospitalised
with suspected community-acquired pneumonia:
a cohort study
C.H. Van Werkhoven* (Utrecht, The Netherlands),
S.M. Huijts, D.F. Postma, J.J. Oosterheert,
M.J.M. Bonten
among patients with community-acquired
pneumonia (CAP): a propensity score-matched
analysis of ceftaroline fosamil (CPT-F)-treated
vs ceftriaxone-treated patients
Y. Golan* (Boston, MA, United States), R. Ruthazer,
M. Ding, Q. Zhao, X. Huang
eP064 13:42 Beta-lactam monotherapy versus beta-lactam-
macrolide combination treatment in moderately
severe community-acquired pneumonia:
a randomised non-inferiority trial
N. Garin* (Geneva, Switzerland), D. Genné,
S. Carballo, C. Chuard, G. Eich, O. Hugli, P. Petignat,
O. Rutschmann, S. Harbarth, A. Perrier
eP065 13:48 In-hospital modifications of antibacterial therapy
initiated in the emergency department for
community-acquired pneumonia
N. Goffinet, M. Cousin, E. Montassier, C. Peron,
N. Lecadet, G. Potel, E. Batard* (Nantes, France)
eP066 13:54 Antibiotic treatment patterns and outcomes
among patients hospitalised in ICU with
community-acquired bacterial pneumonia:
a US cohort study
S. Eapen* (Boston, United States), E. Tuttle, C. Llop,
M. Barrett
ePosters
EPOSTER SESSION:
Community-acquired pneumonia
eP068 13:36 Mortality and hospital length of stay (HLOS)
Posters
HALL G
eP063 13:24 Factors associated with prolonged time to clinical
Chairs, Speakers & Authors
stability in hospitalised adults with communityacquired pneumonia
A.F. Simonetti, D. Viasus* (Barranquilla, Colombia),
C. Garcia-Vidal, J. Carratala
eP067 13:30 Impact of initial antibiotic failure on duration of
Exhibition
hospitalisation (DOH) for community-acquired
pneumonia (CAP): results of a randomised
clinical trial of ceftaroline fosamil versus
ceftriaxone
N. Zhong, T. Sun, G. D’Souza, S.H. Lee, H.L. Nguyen,
C.-H. Chiang, D. Wilson, F. Sun, D. Melnick*
(Wilmington, United States)
24th ECCMID / Barcelona
Final Programme
83
General Information
13:00 – 14:00
ePoster Sessions
Monday, 12 May 2014
13:00 – 14:00
HALL H
eP140 13:30 Development of a novel six-valent recombinant
protein vaccine against toxoplasmosis using
antigens discovered by high-throughput protein
microarray analysis of patient and infected
murine model sera
M. Doskaya* (Izmir, Turkey), E. Atalay, L. Liang,
A. Caner, H. Can, S. Gulce Iz, D.H. Davies,
A. Degirmenci Doskaya, P.L. Felgner, Y. Guruz
EPOSTER SESSION:
Vaccine development
eP134
13:00 Safety, tolerability, and immunogenicity of
a novel 4-antigen Staphylococcus aureus
vaccine (SA4Ag) in healthy adults: results of a
randomised, placebo-controlled first-in-human
phase 1/2 study
R. Frenck* (Cincinnati, United States),
C. Buddy Creech, E. Sheldon, D.J. Seiden,
M. Kankam, J. Baber, E. Zito, R. Hubler, J. Eiden,
J.M. Severs, S. Sebastian, J. Nanra, K.U. Jansen,
A.S. Anderson, D. Girgenti
eP144 13:36 Knowledge and risk perception of measles and
factors associated with vaccination decisions in
subjects consulting university affiliated public
hospitals after measles infection: a retrospective
epidemiological study
M. Saadatian-Elahi* (Lyon, France), A. Toure,
D. Floret, B. Lina, J.S. Casalegno, P. Vanhems
eP146 13:06 Advancing the development of an effective
Staphylococcus aureus vaccine by targeting
multiple bacterial virulence factors
A.S. Anderson, I.L. Scully, P.A. Liberator, D. Cooper*
(Pearl River, United States), J. Baber, D.Q. Girgenti,
E. Zito, J. Eiden, W. Gruber, E. Emini, K.U. Jansen
eP135
13:12 Development and evaluation of Staphylococcus
epidermidis DNA, mRNA and protein vaccines
L. Yan* (Seattle, United States), J. Bryers
eP132
13:18 A phase II study of the safety and
immunogenicity of different formulations of a
candidate Clostridium difficile toxoid vaccine:
dose and formulation selection for phase III
G. De Bruyn* (Swiftwater, United States), G. Foglia,
J. Saleh, D. Workman, R. Pollak, R. Gesser
eP139 13:24 Vaccination with a lipopolysaccharide-deficient
inactivated whole cell vaccine provides
protection against experimental Acinetobacter
baumannii infection
M. García Quintanilla* (Seville, Spain),
J. Pachón Díaz, M.J. McConnell
84
24th ECCMID / Barcelona
Final Programme
eP145 13:42 FMD vaccine (Ronavac®) potency, stability,
safety and efficacy test
P. Zare, J. Shalmashi, O. Fakhri* (Tabriz, Iran),
F. Ghaderi, Y. Farshi, S. Shadi
eP131
13:48 The cost-effectiveness of vaccination against
seasonal influenza in England
M. Baguelin* (London, United Kingdom),
A. Camacho, S. Flasche, J.W. Edmunds
eP147 13:54 Development of an oral vaccine against
candidiasis using molecular display technology
S. Shibasaki* (Kobe, Japan), M. Ueda
ePoster Sessions
Monday, 12 May 2014
HALL I
EPOSTER SESSION:
Highlights from molecular mycology
eP381 13:00 Use of PCR for diagnosis of invasive aspergillosis;
a 3-year prospective cohort study
H.C. Kung* (Taipei, Taiwan), Y.C. Chen, U.I. Wu,
B.S. Ko, S.C. Chang
eP384 13:06 Comparison of qPCR with bronchoalveolar lavage
fluid and serum for the diagnosis of invasive
pulmonary aspergillosis
J. Yu* (Beijing, China), S. Zhang, R. Li
eP385 13:12 Can genotyping discriminate between invasive
and colonising Aspergillus fumigatus isolates?
P. Escribano, T. Peláez, E. Bouza, J. Guinea Ortega*
(Madrid, Spain)
eP378 13:18 Is the frequency of Candida albicans epidemics
and hyper-epidemic genotypes causing similar
candidaemia in various European hospitals?
L. Marcos-Zambrano, P. Escribano, M. Sanguinetti,
E. Gomez G. de la Pedrosa, E. De Carolis, R. Cantón,
E. Bouza, J. Guinea Ortega* (Madrid, Spain)
eP394 13:36 Biofilm phenotypic and genotypic heterogeneity
amongst Candida albicans bloodstream isolates
differentially affects amphotericin B tolerance
L. Sherry* (Glasgow, United Kingdom),
R. Rajendran, B. Jones, C. Williams, C. Nile,
G. Ramage
eP390 13:42 Development of a new commercial qPCR assay to
detect and differentiate dermatophyte infections
of the skin, nails and hair
G. Dingemans* (Maastricht, The Netherlands),
M. Van den Bosch, M.P. Hayette, S. Goethel, V. Rusu,
R. Sacheli, J. Meis, G. Gaajetaan, G. Simons
eP392 13:48 Search strategy of new antifungal targets based
on analysis of the protein domain and domain
architecture content of fungal proteomes
A. Barrera, A. Alastruey-Izquierdo* (Madrid, Spain),
M. Martin, J.A. Vizcaino, I. Cuesta
eP396 13:54 Measuring C. albicans and host gene expression
during intra-abdominal candidiasis of humans
and mice with RNA-Seq
C.J. Clancy* (Pittsburgh, United States), S. Cheng,
L. Losada, S. Mounaud, W. Nierman, N. Solis,
S. Filler, W. Xu, A. Mitchell, M.H. Nguyen
eP393 13:24 Multi-locus sequence typing of invasive and
ePosters
13:00 – 14:00
Posters
colonising Candida albicans isolates
K. Heidrich, W. Buzina* (Graz, Austria), M. Hönigl,
R. Krause
eP397 13:30 The discordance between epidemiologically
24th ECCMID / Barcelona
Final Programme
85
General Information
Exhibition
Chairs, Speakers & Authors
related invasive and fluconazole resistant
Candida tropicalis isolates highlight the
necessity to further optimise C. tropicalis multilocus sequence typing
X. Fan* (Beijing, China), M. Xiao, T.J. Gray, F.R. Kong,
H. Wang, L. Zhang, Y.C. Xu
IM
PA
CT
CONTENTS
THEME SECTION
845
Reviews
The usefulness of whole genome sequencing in the
management of Staphylococcus aureus infections
J. Price, N. Claire Gordon, D. Crook, M. Llewelyn and J. Paul
Advantages and limitations of genomics in prokaryotic
taxonomy
E. Sentausa and P.-E. Fournier
Contact investigations for outbreaks of Mycobacterium
tuberculosis: advances through whole genome sequencing
T. M. Walker, P. Monk, E. Grace Smith and T. E. A. Peto
Rapid bacterial genome sequencing: methods and
applications in clinical microbiology
C. Bertelli and G. Greub
784
790
796
803
INFECTIOUS DISEASES
822
829
E377
E386
831
E395
859
E398
BACTERIOLOGY
860
869
875
881
E405
882
E409
E412
E416
EPIDEMIOLOGY
Original Articles
Outbreak of Burkholderia cepacia bloodstream infections
traced to the use of Ringer lactate solution as multiple-dose
vial for catheter flushing, Phnom Penh, Cambodia
B. De Smet, C. Veng, L. Kruy, C. Kham, J. van Griensven,
C. Peeters, S. Ieng, T. Phe, E. Vlieghe, P. Vandamme and
J. Jacobs
Impact of a multimodal intervention to reduce bloodstream
infections related to vascular catheters in non-ICU wards: a
multicentre study
N. Freixas, F. Bella, E. Limón, M. Pujol, B. Almirante and
F. Gudiol
832
838
Evolution and aetiological shift of catheter-related
bloodstream infection in a whole institution: the
microbiology department may act as a watchtower
M. Rodríguez-Créixems, P. Muñoz, P. Martín-Rabadán,
E. Cercenado, M. Guembe and E. Bouza
A multicentre analysis of epidemiology of the
nosocomial bloodstream infections in Japanese
university hospitals
M. Nagao
Abstract of Online-Only Original Article
Molecular epidemiology of Staphylococcus aureus strains
isolated from inpatients with infected diabetic foot ulcers
in an Algerian University Hospital
N. Djahmi, N. Messad, S. Nedjai, A. Moussaoui, D. Mazouz,
J.–L. Richard, A. Sotto and J.–P. Lavigne
E421
E424
Original Articles
The changing epidemiology of bacteraemias in Europe:
trends from the European Antimicrobial Resistance
Surveillance System
M. E. A. de Kraker, V. Jarlier, J. C. M. Monen, O. E. Heuer,
N. van de Sande and H. Grundmann
Fast determination of antibiotics in whole blood
Q. Chen, A. Andersson, M. Mecklenburg and B. Xie
Distribution of edin in Staphylococcus aureus isolated from
diabetic foot ulcers
N. Messad, L. Landraud, B. Canivet, G. Lina, J.-L. Richard,
A. Sotto, J.-P. Lavigne, E. Lemichez and the French Study
Group on the Diabetic Foot
Abstract of Online-Only Original Article
Sequences of multiple bacterial genomes and a Chlamydia
trachomatis genotype from direct sequencing of DNA
derived from a vaginal swab diagnostic specimen
P. Andersson, M. Klein, R. A. Lilliebridge and P. M. Giffard
Abstracts of Online-Only Research Notes
Klebsiella pneumoniae harbouring OXA-48 carbapenemase
in a Libyan refugee in Italy
E. Kocsis, C. Savio, M. Piccoli, G. Cornaglia and
A. Mazzariol
Combined disc methods for the detection of KPC- and/or
VIM-positive Klebsiella pneumoniae: improving reliability
for the double carbapenemase producers
V. Miriagou, E. Tzelepi, S. D. Kotsakis, G. L. Daikos, J. Bou
Casals and L. S. Tzouvelekis
Prevalence and spread of extended-spectrum
β -lactamase-producing Enterobacteriaceae in
Ngaoundere, Cameroon
C. Lonchel Magoué, P. Melin, J. Gangoué-Piéboji,
M.-C. Okomo Assoumou, R. Boreux and P. De Mol
Emergence of Klebsiella pneumoniae co-producing
NDM-type and OXA-181 carbapenemases
M. N. D. Balm, M.-V. La, P. Krishnan, R. Jureen, R. T. P. Lin
and J. W. P. Teo
First detection in Europe of the metallo-β -lactamase
IMP-15 in clinical strains of Pseudomonas putida and
Pseudomonas aeruginosa
R. Gilarranz, C. Juan, J. Castillo-Vera, F. J. Chamizo,
F. Artiles, I. Álamo and A. Oliver
E454
889
902
908
917
Editorial
The return of the big three killers
P. Parola
936
943
E428
E435
945
E443
E447
E451
948
955
961
E458
9
September 2013
IM
Original Articles
Modulation of potential respiratory pathogens by pH1N1
viral infection
R. K.-K. Leung, J.-W. Zhou, W. Guan, S.-K. Li, Z.-F. Yang and
S. K.-W. Tsui
Factors associated with virological success with
raltegravir-containing regimens and prevalence of
raltegravir-resistance-associated mutations at failure in
the ARCA database
S. Rusconi, P. Vitiello, F. Adorni, B. Bruzzone, A. De Luca,
V. Micheli, P. Meraviglia, R. Maserati, M. Di Pietro, G. Colao,
G. Penco, A. Di Biagio, G. Punzi, L. Monno and M. Zazzi
on behalf of the Antiretroviral Resistance Cohort Analysis
Collaborative Group
Abstracts of Online-Only Original Articles
Accurate human papillomavirus genotyping by 454
pyrosequencing
V. Militello, E. Lavezzo, G. Costanzi, E. Franchin,
B. Di Camillo, S. Toppo, G. Palù and L. Barzon
The significance of rhinovirus detection in hospitalized
children: clinical, epidemiological and virological features
J. C. Rahamat-Langendoen, A. Riezebos-Brilman, E. Hak,
E. H. Schölvinck and H. G. M. Niesters
Abstracts of Online-Only Research Notes
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and
predictors of resistance to ETR in a large Italian resistance
database (ARCA)
S. Rusconi, F. Adorni, B. Bruzzone, A. Di Biagio, G. Meini,
A. Callegaro, G. Punzi, E. Boeri, M. Pecorari, L. Monno,
N. Gianotti, L. Butini, L. Galli, E. Polilli and M. Galli on behalf
of the ARCA Collaborative Group
Prognostic value of human papillomavirus types 16 and 18
DNA physical status in cervical intraepithelial neoplasia
A. Gradíssimo Oliveira, C. Delgado, N. Verdasca and Â. Pista
Detection of specific antibodies against West Nile and
Usutu viruses in healthy blood donors in northern Italy,
2010–2011
A. Pierro, P. Gaibani, C. Spadafora, D. Ruggeri, V. Randi,
S. Parenti, A. C. Finarelli, G. Rossini, M. P. Landini and V. Sambri
FA techniques and their application in clinical
CT
OR
microbiology
:4
.57
8
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
the feasibility and usefulness of rapid dirty genomics in clinical microbiology. Right panel: Comparisons of
three raw genomes sequences with corresponding whole genome sequences (missing DNA segments are
shown in white). The green genome is that of Vibrio cholerae O1 strain 2010EL-1786 isolated during the Haiti
Original Articles
Predictive scoring model of mortalitycholera
in Gram-negative
outbreak. The brown genome is that of the Escherichia coli O104:H4 strain LB226692 isolated during
bloodstream infection
the German EHEC outbreak. The blue genome is that of the Parachlamydia acanthamoebae strain Hall coccus
M. N. Al-Hasan, B. D. Lahr, J. E. Eckel-Passow
andfrom
L. M.the
Baddour
isolated
water of an humidifier during the investigation of an outbreak of fever in a print shop in USA.
Long-term mortality following bloodstream
infection
These three
examples demonstrate that the dirty genome approach provides a significant proportion of all
P. J. Lillie, J. Allen, C. Hall, C. Walsh, K.genomic
Adams, sequence and supports the use of such rapid sequencing without gap closure for biomedical
H. Thaker, P. Moss and G. D. Barlow applications. (images from C. Bertelli and G. Greub).
Volume 19
Abstract of Online-Only Original Article
Simultaneous detection of gastrointestinal pathogens with
a multiplex Luminex-based molecular assay in stool
samples from diarrhoeic patients
C. Mengelle, J. M. Mansuy, M. F. Prere, E. Grouteau,
I. Claudet, N. Kamar, A. Huynh, G. Plat, M. Benard,
N. Marty, A. Valentin, A. Berry and J. Izopet
EPIDEMIOLOGY
962
969
E466
Original Articles
Healthcare-associated, community-acquired and
hospital-acquired bacteraemic urinary tract infections in
hospitalized patients: a prospective multicentre cohort
study in the era of antimicrobial resistance
J. P. Horcajada, E. Shaw, B. Padilla, V. Pintado, E. Calbo,
N. Benito, R. Gamallo, M. Gozalo, J. Rodríguez-Baño,
and other members of the ITUBRAS group, on behalf of Grupo
de Estudio de Infección Hospitalaria (GEIH) and Sociedad
Española de Enfermedades Infecciosas y Microbiología
Clínica (SEIMC)
Abstract of Online-Only Original Article
The use of dried cerebrospinal fluid filter paper spots as a
substrate for PCR diagnosis of the aetiology of bacterial
meningitis in the Lao PDR
I. Elliott, S. Dittrich, D. Paris, A. Sengduanphachanh,
P. Phoumin and P. N. Newton
BACTERIOLOGY
970
975
980
988
E473
Original Articles
Cohort study of the seasonal effect on nasal carriage and
the presence of Mycobacterium leprae in an endemic area
in the general population
M. Lavania, R. P. Turankar, S. Karri, V. S. Chaitanya,
U. Sengupta and R. S. Jadhav
High prevalence of azithromycin resistance to Treponema
pallidum in geographically different areas in China
X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang, R.-R. Peng,
H.-P. Zheng, J.-P. Zhang, B.-Y. Zhu, Q.-Z. Liu and S.-J. Huang
Microbiological changes and diversity in autochthonous
non-toxigenic Corynebacterium diphtheriae isolated in France
E. Farfour, E. Badell, S. Dinu, S. Guillot and N. Guiso
Abstract of Online-Only Original Article
Extrapulmonary infections caused by a dominant strain of
Mycobacterium massiliense (Mycobacterium abscessus
subspecies bolletii)
A. Cheng, Y.-C. Liu, M.-L. Chen, C.-C. Hung, Y.-T. Tsai, W.-H. Sheng,
C.-H. Liao, P.-R. Hsueh, Y.-C. Chen and S.-C. Chang
THE OFFICIAL PUBLICATION OF THE
EUROPEAN SOCIETY OF CLINICAL
MICROBIOLOGY AND INFECTIOUS DISEASES
Number
10
October 2013
1063
E483
THEME SECTION
Editorial
Foreseeing the future in infectious diseases: can we?
Top Centre: Chest CT Scan of a 24-year old woman with XDR destructive pulmonary
M. Paul tuberculosis
E490
Top right: A mosquito vector of malaria, Anopheles dirus during a blood meal. Source: http://cdanofel.fr with
Reviews
permission
993 Modelling in infectious diseases: between haphazard and
Bottom right: Images from a thin blood smear showing rings of Plasmodium falciparum (May-Grünwald
hazard
Giemsa; X1000). Source: http://cdanofel.fr with permission
A. Neuberger, M. Paul, A. Nizar and D. Raoult
Top and bottom left: 2 Schematic representations of HIV (Acknowledgments:
Prof. Philippe
Colson)and prediction in infectious
999 Mathematical
modelling
clm_v19_i10_oc.indd 1
1014
disease epidemiology
A. Huppert and G. Katriel
An overview of Internet biosurveillance
D. M. Hartley, N. P. Nelson, R. R. Arthur, P. Barboza,
N. Collier, N. Lightfoot, J. P. Linge, E. van der Goot,
A. Mawudeku, L. C. Madoff, L. Vaillant, R. Walters,
R. Yangarber, J. Mantero, C. D. Corley and J. S. Brownstein
Modelling during an emergency: the 2009 H1N1 influenza
pandemic
B. Y. Lee, L. A. Haidari and M. S. Lee
1065
E499
1029
PARASITOLOGY
1035
1042
Original Articles
Massive Plasmodium falciparum visceral sequestration: a
cause of maternal death in Africa
P. Castillo, C. Menéndez, A. Mayor, C. Carrilho, M. R. Ismail,
C. Lorenzoni, F. Machungo, N. Osman, L. Quintó,
C. Romagosa, C. Dobaño, P. L. Alonso and J. Ordi
Rapid and sensitive diagnosis of Acanthamoeba keratitis
by loop-mediated isothermal amplification
Z. Ge, Y. Qing, S. Zicheng and S. Shiying
EPIDEMIOLOGY
1049
Latest Impact Factor: 4.578
1058
IM
Original Articles
Predictive factors for mortality in patients with
methicillin-resistant Staphylococcus aureus bloodstream
infection: impact on outcome of host, microorganism and
therapy
O. Gasch, M. Camoez, M. A. Dominguez, B. Padilla,
V. Pintado, B. Almirante, J. Molina, F. Lopez-Medrano,
E. Ruiz, J. A. Martinez, E. Bereciartua, F. Rodriguez-Lopez,
C. Fernandez-Mazarrasa, M. A. Goenaga, N. Benito,
J. Rodriguez-Baño, E. Espejo, M. Pujol and on behalf of
REIPI/GEIH Study Groups
Single nucleotide polymorphisms typing of Mycobacterium
leprae reveals focal transmission of leprosy in high
endemic regions of India
M. Lavania, R. S. Jadhav, R. P. Turankar, V. S. Chaitanya,
M. Singh and U. Sengupta
1072
1078
1082
1089
E502
E509
1091
E516
E519
Original Articles
Discrimination between Streptococcus pneumoniae and
Streptococcus mitis based on sorting of their MALDI mass
spectra
L. N. Ikryannikova, A. V. Filimonova, M. V. Malakhova,
T. Savinova, O. Filimonova, E. N. Ilina, V. A. Dubovickaya,
S. V. Sidorenko and V. M. Govorun
Human-associated Staphylococcus aureus strains within
great ape populations in Central Africa (Gabon)
PA
CT
FA
CT
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
Volume
19
Number
11
OR
:4
.57
8
November 2013
9/6/2013 2:41:49 PM
CMI CLINICAL MICROBIOLOGY AND INFECTION
Editor-in-Chief: Didier Raoult
Original Articles
Chromoblastomycosis caused by Fonsecaea:
clinicopathology, susceptibility and molecular
identification of seven consecutive cases in southern
China
Y.-P. Yang, W. Li, W.-M. Huang, Y. Zhou and Y.-M. Fan
Incidence of invasive fungal disease after unmanipulated
haploidentical stem cell transplantation was significantly
higher than that after HLA-matched sibling transplantation
Y. Sun, L. Xu, D. Liu, X. Zhang, W. Han, Y. Wang, H. Chen,
Y. Chen, F. Wang, J. Wang, Y. Ji, F. Tang, K. Liu and X.-J. Huang
THE OFFICIAL PUBLICATION OF THE
EUROPEAN SOCIETY OF CLINICAL
MICROBIOLOGY AND INFECTIOUS DISEASES
BACTERIOLOGY
1066
MYCOLOGY
1023
Abstracts of Online-Only Original Articles
Season is associated with Pseudomonas aeruginosa
acquisition in young children with cystic fibrosis
K. J. Psoter, A. J. De Roos, J. Wakefield, J. Mayer and
M. Rosenfeld
Wastewater drainage system as an occult reservoir in
a protracted clonal outbreak due to metallo-βlactamase-producing Klebsiella oxytoca
S. Vergara-López, M. C. Domínguez, M. C. Conejo,
Á. Pascual and J. Rodríguez-Baño
Abstract of Online-Only Research Note
Tuberculosis patients hospitalized in the Albert Schweitzer
Hospital, Lambaréné, Gabon—a retrospective
observational study
S. M. Stolp, M. A. M. Huson, S. Janssen, J. O. Beyeme and
M. P. Grobusch
Volume 19 / Number 11 / November 2013
Editorial—Hot Topic
Impact factors of scientific journals: the new season
D. Raoult
991
1006
8/1/2013 1:28:47 PM
Theme Section Editor: P. Parola: The Return of the Big Three Killers
CONTENTS
989
M. Nagel, J. Dischinger, M. Türck, D. Verrier, M. Oedenkoven,
B. Ngoubangoye, G. Le Flohic, J. F. Drexler, G. Bierbaum and
J.-P. Gonzalez
Interferon-γ release assays in the diagnosis of active
tuberculosis disease in a low-incident setting: a 5-year
review of data
T. W. Lavender, A. Barrett, J. Magee and E. L. C. Ong
Diversity in Acinetobacter baumannii isolates from
paediatric cancer patients in Egypt
L. Al-Hassan, H. El Mehallawy and S. G. B. Amyes
Abstracts of Online-Only Original Articles
Comparative performance of Thin Layer Agar and
Löwenstein–Jensen culture for diagnosis of
tuberculosis
T. Battaglioli, N. Rintiswati, A. Martin, K. R. Palupi,
G. Bernaerts, B. Dwihardiani, R. A. Ahmad, F. Matthys,
Y. Mahendradhata and P. Van der Stuyft
A nosocomial outbreak of KPC-2-producing Klebsiella
pneumoniae in a Chinese hospital: dissemination of ST11
and emergence of ST37, ST392 and ST395
J. Yang, L. Ye, L. Guo, Q. Zhao, R. Chen, Y. Luo, Y. Chen,
S. Tian, J. Zhao, D. Shen and L. Han
Abstracts of Online-Only Research Notes
Large IncHI2-plasmids encode extended-spectrum
β-lactamases (ESBLs) in Enterobacter spp. bloodstream
isolates, and support ESBL-transfer to Escherichia coli
E. Nilsen, B. C. Haldorsen, A. Sundsfjord, G. S. Simonsen,
A. Ingebretsen, U. Naseer, Ø. Samuelsen and the Norwegian
Study Group on Invasive Enterobacter
Chromosomal integration of the novel plasmid pUR3912
from methicillin-susceptible Staphylococcus aureus ST398
of human origin
E. Gómez-Sanz, M. Zarazaga, K. Kadlec, S. Schwarz and
C. Torres
Theme Section Editor: M. Paul: Predictions on Infectious Diseases
IM
CONTENTS
1115
Reviews
National Advisory Groups and their role in immunization
policy-making processes in European countries
H. Nohynek, O. Wichmann, F. D’Ancona and VENICE National
Gatekeepers
Guidelines for the treatment of pneumonia and urinary
tract infections: evaluation of methodological quality using
the Appraisal of Guidelines, Research and Evaluation II
instrument
O. Henig, D. Yahav, L. Leibovici and M. Paul
Management and diagnostic guidelines for fungal diseases
in infectious diseases and clinical microbiology: critical
appraisal
S. Leroux and A. J. Ullmann
Abstracts of Online-Only Original Articles
Roman carving
Necrotizing soft tissue infections caused
by Streptococcus
Bottom
left: Chicken voodoo. Source : http://www.thelocal.es/page/view/home/2013-03-19
pyogenes and Streptococcus dysgalactiae
subsp.
Bottom
right : Example of mathematical modeling
equisimilis of groups C and G in western Norway
T. Bruun, B. R. Kittang, B. J. de Hoog, S. Aardal,
H. K. Flaatten, N. Langeland, H. Mylvaganam, H. A. Vindenes
and S. Skrede
Serum antibody responses to pneumococcal colonization
in the first 2 years of life: results from an SE Asian
longitudinal cohort study
P. Turner, C. Turner, N. Green, L. Ashton, E. Lwe, A. Jankhot,
clm_v19_i11_oc.indd
1
N. P. Day, N. J. White,
F. Nosten and D. Goldblatt
E559 Oral bacterial community dynamics in paediatric patients
with malignancies in relation to chemotherapy-related oral
mucositis: a prospective study
Y. Ye, G. Carlsson, M. Barr Agholme, J. A. L. Wilson, A. Roos,
Volume
B. Henriques-Normark, L. Engstrand, T. Modéer and
K. Pütsep
E551
BACTERIOLOGY
VIROLOGY
1122
Original Articles
Heparin-binding protein (HBP) in critically ill patients with
influenza A (H1N1) infection
K.-M. Kaukonen, R. Linko, H. Herwald, L. Lindbom,
E. Ruokonen, T. Ala-Kokko and V. Pettilä
Abstracts of Online-Only Original Articles
Transmitted drug-resistance in human immunodeficiency
virus-infected adult population in El Salvador, Central America
Á. Holguín, G. Yebra, L. Martín, A. T. de Pineda,
L. E. Ruiz, A. Y. Quezada, A. I. Nieto and G. Escobar
Combining rapid diagnostic tests and dried blood spot
assays for point-of-care testing of human immunodeficiency
virus, hepatitis B and hepatitis C infections in Burkina Faso,
West Africa
D. Kania, A. M. Bekalé, N. Nagot, A.-M. Mondain, L. Ottomani,
N. Meda, M. Traoré, J. B. Ouédraogo, J. Ducos, P. Van de
Perre and E. Tuaillon
Abstract of Online-Only Research Note
Virological rebound in human immunodeficiency
virus-infected patients with or without residual viraemia:
results from an extended follow-up
N. Gianotti, L. Galli, S. Salpietro, M. Cernuschi, S. Bossolasco,
M. Maillard, V. Spagnuolo, F. Canducci, M. Clementi,
A. Lazzarin and A. Castagna
Clinical Microbiology and Infection
is delighted to present these
Special Issues:
E533
1131
E542
1158
1163
1169
1173
E568
INFECTIOUS DISEASES
1132
1140
1148
Original Articles
Epidemiology, risk factors and impact on long-term
pancreatic function of infection following pancreas-kidney
transplantation
J. M. Herrero-Martínez, C. Lumbreras, A. Manrique,
R. San-Juan, A. García-Reyne, F. López-Medrano,
M. Lizasoain, B. de Dios, A. Andrés, C. Jiménez, E. Gutiérrez,
E. Moreno and J. M. Aguado
Enterococcal endocarditis in the beginning of the 21st
century: analysis from the International Collaboration on
Endocarditis-Prospective Cohort Study
C. Chirouze, E. Athan, F. Alla, V. H. Chu, G. Ralph Corey,
C. Selton-Suty, M.-L. Erpelding, J. M. Miro, L. Olaison,
B. Hoen and on behalf of the International Collaboration on
Endocarditis Study Group
Invasive pneumococcal disease in patients with an
underlying pulmonary disorder
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg,
C.-G. Löfdahl and A. Egesten
Original Articles
Evidence of transmission of a Panton–Valentine
leukocidin-positive community-acquired methicillinresistant Staphylococcus aureus clone: a family affair
P. Cocchi, G. Taccetti, C. Montagnani, S. Campana, L. Galli,
C. Braggion and M. de Martino
Vancomycin minimum inhibitory concentration, host
comorbidities and mortality in Staphylococcus aureus
bacteraemia
N. E. Holmes, J. D. Turnidge, W. J. Munckhof, J. O. Robinson,
T. M. Korman, M. V. N. O’Sullivan, T. L. Anderson,
S. A. Roberts, S. J. C. Warren, W. Gao, P. D. R. Johnson and
B. P. Howden
Daptomycin non-susceptible Staphylococcus aureus at a
US medical centre
A. Velazquez, C. A. DeRyke, R. Goering, V. Hoover and
M. R. Wallace
Abstract of Online-Only Original Article
Impact of rapid microbial identification directly from
positive blood cultures using matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry on
patient management
D. Martiny, F. Debaugnies, D. Gateff, M. Gérard, M. Aoun,
C. Martin, D. Konopnicki, A. Loizidou, A. Georgala,
M. Hainaut, M. Chantrenne, A. Dediste, O. Vandenberg and
S. Van Praet
FA
CT
19
OR
THE OFFICIAL PUBLICATION OF THE
EUROPEAN SOCIETY OF CLINICAL
MICROBIOLOGY AND INFECTIOUS DISEASES
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
Number
12
:4
.57
8
10/3/2013 4:16:23 PM
December 2013
CMI CLINICAL MICROBIOLOGY AND INFECTION
1129
E523
CT
Top left : Tarot of Marseille. Source : http://lestarotsdejulia.e-monsite.com/pages/les-differents-tarots.html
Top right: Achilles consulting Pythia, the priestess presiding over the Oracle of Apollo at Delphi.
1155
E545
EPIDEMIOLOGY
1174
1181
1188
E582
Original Articles
An evaluation of clinical stability criteria to predict hospital
course in community-acquired pneumonia
A. R. Akram, J. D. Chalmers, J. K. Taylor, J. Rutherford,
A. Singanayagam and A. T. Hill
Small Indian mongooses and masked palm civets serve as
new reservoirs of Bartonella henselae and potential
sources of infection for humans
S. Sato, H. Kabeya, Y. Shigematsu, H. Sentsui,
Y. Une, M. Minami, K. Murata, G. Ogura and
S. Maruyama
Abstract of Online-Only Original Article
Cost–benefit of infection control interventions targeting
methicillin-resistant Staphylococcus aureus in hospitals:
systematic review
L. Farbman, T. Avni, B. Rubinovitch, L. Leibovici and
M. Paul
Theme Section Editor: M. Paul: Guidelines, consensus, expert opinions, analysis, meta-analysis:
Who are the experts? How reliable are they?
IM
PA
CT
CONTENTS
Cover images:
CMI editorial report 2014
M. Leffad, R. Cousens and D. Raoult
THEME SECTION
Editorial
8
clm_v19_i12_oc.indd 1
Reviews
10
17
22
29
Measuring contact patterns with wearable sensors: methods,
data characteristics and applications to data-driven
simulations of infectious diseases
A. Barrat, C. Cattuto, A. E. Tozzi, P. Vanhems and N. Voirin
Web-based participatory surveillance of infectious diseases: the
Influenzanet participatory surveillance experience
D. Paolotti, A. Carnahan, V. Colizza, K. Eames, J. Edmunds,
G. Gomes, C. Koppeschaar, M. Rehn, R. Smallenburg,
C. Turbelin, S. Van Noort and A. Vespignani
MediHandTrace®: a tool for measuring and understanding hand
hygiene adherence
S. Boudjema, J. C. Dufour, A. S. Aladro, I. Desquerres and
P. Brouqui
New technologies to monitor healthcare worker hand hygiene
A. R. Marra and M. B. Edmond
Reviews
101
114
123
51
O2
Dissemination of bla VIM in Greece at the peak of the epidemic of
2005–2006: clonal expansion of Klebsiella pneumoniae clonal
complex 147
C. M. Hasan, A. Turlej-Rogacka, A. C. Vatopoulos,
P. Giakkoupi, M. Maâtallah and C. G. Giske
Knowledge, attitudes, beliefs and practices of general
practitioners towards measles and MMR vaccination in
southeastern France in 2012
C. Pulcini, S. Massin, O. Launay and P. Verger
Epidemiological investigation of a nosocomial outbreak of
multidrug-resistant Corynebacterium striatum at one Belgian
university hospital
A. Verroken, C. Bauraing, A. Deplano, P. Bogaerts, D. Huang,
G. Wauters and Y. Glupczynski
Abstract of Online-Only Research Note
Clostridium difficile PCR ribotype 046 is common among
neonatal pigs and humans in Sweden
T. Norén, K. Johansson and M. Unemo
BACTERIOLOGY
136
152
075
Risk factors for superficial wound complications in hip and
knee arthroplasty
K. Carroll, M. Dowsey, P. Choong and T. Peel
Does a rapid diagnosis of Clostridium difficile infection
impact on quality of patient management?
F. Barbut, L. Surgers, C. Eckert, B. Visseaux, M. Cuingnet,
C. Mesquita, N. Pradier, A. Thiriez, N. Ait-Ammar, A. Aifaoui,
E. Grandsire and V. Lalande
Incidence, clinical characteristics and 30-day mortality of
enterococcal bacteraemia in Denmark 2006–2009:
a population-based cohort study
M. Pinholt, C. Østergaard, M. Arpi, N. E. Bruun,
H. C. Schønheyder, K. O. Gradel, M. Søgaard and
J. D. Knudsen for the Danish Collaborative Bacteraemia
Network (DACOBAN)
Abstract of Online-Only Original Article
Update on treatment options for spinal brucellosis
A. Ulu-Kilic, A. Karakas, H. Erdem, T. Turker, A. S. Inal,
O. Ak, H. Turan, E. Kazak, A. Inan, F. Duygu, H. Demiraslan,
C. Kader, A. Sener, S. Dayan, O. Deveci, R. Tekin, N. Saltoglu,
M. Aydın, E. S. Horasan, H. C. Gul, B. Ceylan, A. Kadanalı,
O. Karabay, G. Karagoz, U. Kayabas, V. Turhan, D. Engin,
S. Gulsun, N. Elaldı and S. Alabay
153
159
O83
Evaluation of two matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF
MS) systems for the identification of Candida species
C. Lacroix, A. Gicquel, B. Sendid, J. Meyer, I. Accoceberry,
N. François, F. Morio, G. Desoubeaux, J. Chandenier,
C. Kauffmann-Lacroix, C. Hennequin, J. Guitard, X. Nassif
and M.-E. Bougnoux
Abstract of Online-Only Original Article
Epidemiological study of a large cluster of fungaemia cases
due to Kodamaea ohmeri in an Indian tertiary care centre
A. Chakrabarti, S. M. Rudramurthy, P. Kale, P. Hariprasath,
M. Dhaliwal, S. Singhi and K. L. N. Rao
VIROLOGY
Original Articles
160
Risk factors of Ganciclovir-related neutropenia after
allogeneic stem cell transplantation: a retrospective
monocentre study on 547 patients
G. Venton, R. Crocchiolo, S. Fürst, A. Granata, C. Oudin,
C. Faucher, D. Coso, R. Bouabdallah, P. Berger, N. Vey,
P. Ladaique, C. Chabannon, M. le Merlin, D. Blaise and
J. El-Cheikh
O39
VIROLOGY
91
O47
59
65
70
79
Serotypes, genotypes and antimicrobial resistance patterns of
human diarrhoeagenic Escherichia coli isolates circulating in
southeastern China
Y. Chen, X. Chen, S. Zheng, F. Yu, H. Kong, Q. Yang, D. Cui,
N. Chen, B. Lou, X. Li, L. Tian, X. Yang, G. Xie, Y. Dong, Z. Qin,
D. Han, Y. Wang, W. Zhang, Y.-W. Tang and L. Li
Mycobacterium leprae is identified in the oral mucosa from
paucibacillary and multibacillary leprosy patients
M. A. M. Morgado de Abreu, A. M. Roselino, M. Enokihara,
S. Nonogaki, L. E. Prestes-Carneiro, L. L. M. Weckx and
M. M. A. Alchorne
Comparison of testing approaches for Clostridium difficile
infection at a large community hospital
J. D. Grein, M. Ochner, H. Hoang, A. Jin, M. A. Morgan and
A. R. Murthy
Patient nostril microbial flora: individual-dependency and
diversity precluding prediction of Staphylococcus aureus
acquisition
A. S. Alvarez, L. Remy, C. Allix-Béguec, C. Ligier, C. Dupont,
O. Leminor, C. Lawrence, P. Supply, D. Guillemot,
J. L. Gaillard, J. Salomon and J.-L. Herrmann
Abstracts of Online-Only Original Articles
174
Impact of carbapenem resistance on clinical and economic
outcomes among patients with Acinetobacter baumannii
infection in Colombia
E. V. Lemos, F. P. de la Hoz, N. Alvis, T. R. Einarson,
E. Quevedo, C. Castañeda, Y. Leon, C. Amado, O. Cañon and
K. Kawai
Abstracts of Online-Only Original Articles
Prevalence and characterization of extended-spectrum
β-lactamase-producing clinical Salmonella enterica
isolates in Dakar, Senegal, from 1999 to 2009
D. Harrois, S. Breurec, A. Seck, A. Delauné, S. Le Hello,
M. Pardos de la Gándara, L. Sontag, J.-D. Perrier-Gros-Claude,
J.-M. Sire, B. Garin and F.-X. Weill
Infections caused by carbapenem-resistant Klebsiella
pneumoniae among patients in intensive care units in
Greece: a multi-centre study on clinical outcome and
therapeutic options
F. Kontopidou, H. Giamarellou, P. Katerelos, A. Maragos,
I. Kioumis, E. Trikka-Graphakos, C. Valakis and
H. C. Maltezou on behalf of the Group for the Study of
KPC-producing Klebsiella pneumoniae infections in
intensive care units
Genome-wide single nucleotide polymorphism-based
assay for high-resolution epidemiological analysis of the
methicillin-resistant Staphylococcus aureus hospital clone
EMRSA-15
A. Holmes, G. McAllister, P. R. McAdam, S. Hsien Choi,
K. Girvan, A. Robb, G. Edwards, K. Templeton and J. R. Fitzgerald
Abstract of Online-Only Research Note
KPC-2 and OXA-48 carbapenemase-harbouring
Enterobacteriaceae detected in an Austrian wastewater
treatment plant
H. Galler, G. Feierl, C. Petternel, F. F. Reinthaler, D. Haas,
A. J. Grisold, J. Luxner and G. Zarfel
BACTERIOLOGY
Original Articles
181
O109
O117
184
O132
Volume
20
Number
Abstracts of Online-Only Research Note
Changing aetiology of hand, foot and mouth disease in Linyi,
China, 2009–2011
J. Du, X. Wang, Y. Hu, Z. Li, Y. Li, S. Sun, F. Yang and Q. Jin
058
OR
:4
.57
8
1
January 2014
Abstracts of Online-Only Original Articles
A prospective, cohort, multicentre study of candidaemia in
hospitalized adult patients with haematological malignancies
M. N. Gamaletsou, T. J. Walsh, T. Zaoutis, M. Pagoni,
M. Kotsopoulou, M. Voulgarelis, P. Panayiotidis, T. Vassilakopoulos,
M. K. Angelopoulou, M. Marangos, A. Spyridonidis,
D. Kofteridis, A. Pouli, D. Sotiropoulos, P. Matsouka,
A. Argyropoulou, S. Perloretzou, K. Leckerman, A. Manaka,
P. Oikonomopoulos, G. Daikos, G. Petrikkos and N. V. Sipsas
Survival of influenza virus on human fingers
Y. Thomas, P. Boquete-Suter, D. Koch, D. Pittet and L. Kaiser
PARASITOLOGY
94
O65
95
O72
96
Abstracts of Online-Only Original Article
Detection of Cryptosporidium and Giardia in clinical laboratories
in Europe—a comparative study
M. Manser, M. Granlund, H. Edwards, A. Saez, E. Petersen,
B. Evengard and P. Chiodini on behalf of the European Society of
Clinical Microbiology and Infectious Diseases Study Group on
Clinical Parasitology
Abstracts of Online-Only Research Note
Saliva as a source of anti-Toxoplasma gondii IgG for enzyme
immunoassay in human samples
B. F. C. Sampaio, M. S. Macre, L. R. Meireles and H. F. Andrade Jr
Corrigendum
Theme Section Editor: P. Brouqui: Emerging technology in tracking contagion
IM
PA
Cover images:
Molecular characterization of methicillin-resistant
Staphylococcus aureus isolated over a 2-year period in a
Qatari hospital from multinational patients
T. S. El-Mahdy, M. El-Ahmady and R. V. Goering
CT
11/5/2013 2:10:12 PM
CT
Top Left: Contact pattern network; source: Alain Barrat
Centre: Medihand equipped room; source: Philippe Brouqui
EPIDEMIOLOGY
Original Article
FA
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
MYCOLOGY
92
O50
Original Articles
52
169
O124
MYCOLOGY
Original Articles
89
O33
Global impact of an educational antimicrobial stewardship
programme on prescribing practice in a tertiary hospital centre
J. M. Cisneros, O. Neth, M. V. Gil-Navarro, J. A. Lepe,
F. Jiménez-Parrilla, E. Cordero, M. J. Rodríguez-Hernández,
R. Amaya-Villar, J. Cano, A. Gutiérrez-Pizarraya,
E. García-Cabrera and J. Molina, PRIOAM team
Abstracts of Online-Only Original Articles
Streptococcal vertebral osteomyelitis: multiple faces of the
same disease
O. Murillo, A. Roset, B. Sobrino, J. Lora-Tamayo, R. Verdaguer,
E. Jiménez-Mejias, J. M. Nolla, J. de. D. Colmenero and J. Ariza
Enhanced antimicrobial activity of peptide-cocktails against
common bacterial contaminants of ex vivo stored platelets
K. V. K. Mohan, S. Sainath Rao, Y. Gao and C. D. Atreya
Top Right: Wearable sensor, source: Alain Barrat
Abstract of Online-Only Original Article
Bottom
HCW pathway; source: Philippe Brouqui
A comparison of efficacy and safety of
2-yearLeft:
telbivudine
Bottom
Right:
Nurse backscreen information Medihand; source: Philippe Brouqui
and entecavir treatment in patients with
chronic
hepatitis
B: a match–control study
M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu,
J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen and
T.-H. Hu
168 Abstracts of Online-Only Research Notes
O101 First detection of Toscana virus in Corsica, France
L. Bichaud, A. Izri, X. de Lamballerie, G. Moureau and
R. N. Charrel 1
clm_v20_i1_oc.indd
O105 Predictors of H1N1 influenza in the emergency
department: proposition for a modified H1N1 case
definition
H. Flick, M. Drescher, J. Prattes, K. Tovilo, H. H. Kessler,
K. Vander, K. Seeber, M. Palfner, R. B. Raggam, A. Avian,
R. Krause and M. Hoenigl
INFECTIOUS DISEASES
Original Articles
130
145
INFECTIOUS DISEASES
Original Articles
82
Original Articles
44
THE OFFICIAL PUBLICATION OF THE
EUROPEAN SOCIETY OF CLINICAL
MICROBIOLOGY AND INFECTIOUS DISEASES
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
Volume
20
Number
2
FA
CT
OR
:4
.57
8
12/10/2013 12:09:44 PM
February 2014
CMI CLINICAL MICROBIOLOGY AND INFECTION
• ESCMID Update of the Treatment
Guidance Document for Clostridium
difficile Infection
105
Systematic reviews and meta-analyses in infectious
diseases: topics that merit special attention
L. Leibovici, D. Yahav and M. Paul
Systematic reviews and meta-analyses of diagnostic test
accuracy
M. M. G. Leeflang
Antiretroviral therapy for initial human immunodeficiency
virus/AIDS treatment: critical appraisal of the evidence
from over 100 randomized trials and 400 systematic
reviews and meta-analyses
S. Kanters, E. J. Mills, K. Thorlund, H. C. Bucher and
J. P. A. Ioannidis
The effects of clinical and statistical heterogeneity on the
predictive values of results from meta-analyses
W. G. Melsen, M. C. J. Bootsma, M. M. Rovers and
M. J. M. Bonten
O30
EPIDEMIOLOGY
34
38
167
O90
Systematic review or meta-analysis? Their place in the
evidence hierarchy
M. Paul and L. Leibovici
81
O27
An 8-year survey of strains identified in blood cultures
in a clinical haematology unit
A. Bousquet, J.-V. Malfuson, N. Sanmartin, J. Konopacki,
C. MacNab, B. Souleau, T. de Revel, M. Elouennass,
T. Samson, C. Soler, V. Foissaud and C. Martinaud
Dual infections with different Legionella strains
G. Wewalka, D. Schmid, T. G. Harrison, S. A. Uldum and C. Lück on
behalf of the European Society of Clinical Microbiology Infectious
Diseases Study Group for Legionella Infections (ESGLI)
Four-year epidemiological study of extended-spectrum
β-lactamase-producing Enterobacteriaceae in a French
teaching hospital
L. Gibold, F. Robin, R.-N. Tan, J. Delmas and R. Bonnet
Abstracts of Online-Only Research Notes
Emergence of VIM-4 metallo-β-lactamase-producing Klebsiella
pneumoniae ST15 clone in the Clinical Centre University of
Pécs, Hungary
S. Melegh, K. Kovács, T. Gám, A. Nyul, B. Patkó, Á. Tóth,
I. Damjanova and G. Mestyán
Acremonium sclerotigenum-Acremonium egyptiacum: a
multi-resistant fungal pathogen complicating the course of
aplastic anaemia
J. Guitard, A. Degulys, G. Buot, A. Aline-Fardin, E. Dannaoui,
B. Rio, J. P. Marie, S. Lapusan and C. Hennequin
Volume 20 / Number 2 / February 2014
THEME SECTION
Editorial
O20
New technologies to trace infection
P. Brouqui
CONTENTS
97
O13
CMI CLINICAL MICROBIOLOGY AND INFECTION
• ESCMID Guidelines for the Management
of the Infection Control Measures to
Reduce Transmission of Multidrugresistant Gram-negative Bacteria in
Hospitalized Patients
O7
Editorial
1
Volume 20 / Number 1 / January 2014
INFECTION HOT TOPIC
Top Left: Alice’s Adventures in Wonderland: A Mad Tea Party. (Source: Wikicommons)
Bottom Left: The Moneylender and his Wife. Quentin Matsys, 1514.O1 From the Hajj: it’s the flu, idiot
R. Charrel, P. Gautret and P. Parola
Right: Plato’s Academy mosaic — from the Villa of T. Siminius Stephanus D.
inRaoult,
Pompeii.
PARASITOLOGY
185
O135
O139
Theme Section Editor: M. Paul: Systematic reviews and meta-anaylses in infectious diseases
Abstracts of Online-Only Research Notes
A family cluster of giardiasis with variable treatment
responses: refractory giardiasis in a family after a trip to
India
A. Requena-Méndez, P. Goñi, S. Lóbez, I. Oliveira,
E. Aldasoro, M.-E. Valls, A. Clavel, J. Gascón and
J. Muñoz
Molecular survey of knockdown resistance to pyrethroids
in human scabies mites
V. Andriantsoanirina, A. Izri, F. Botterel, F. Foulet,
O. Chosidow and R. Durand
IM
PA
Cover images:
J. McConnell and D. Raoult
THEMED SECTION
Editorial
189 Microbe discovery: lessons from the past
M. Drancourt
Reviews
clm_v20_i2_oc.indd 1
EPIDEMIOLOGY
Original Articles
219 Clinical and epidemiological characterization of a
lymphogranuloma venereum outbreak in Madrid, Spain:
co-circulation of two variants
M. Rodríguez-Domínguez, T. Puerta, B. Menéndez,
J. M. González-Alba, C. Rodríguez, T. Hellín, M. Vera,
F. J. González-Sainz, P. Clavo, M. Villa, R. Cantón,
J. Del Romero and J. C. Galán
226 Abstract of Online-Only Original Article
O142 Single nucleotide polymorphism-based molecular
typing of M. leprae from multicase families of leprosy
patients and their surroundings to understand the
transmission of leprosy
R. P. Turankar, M. Lavania, V. S. Chaitanya, U. Sengupta,
J. Darlong, F. Darlong, K. S. R. Siva Sai and
R. S. Jadhav
VIROLOGY
Original Articles
227 The relationship between tumour necrosis factor-α
gene polymorphism and susceptibility and clearance of
the persistent hepatitis B virus infection in a Chinese
population: a meta-analysis
T.-C. Zhang, Y.-Q. Zhao, G.-L. Hu, X.-Q. Liu and
X.-K. Huang
235 Viral load and humoral immune response in association
with disease severity in Puumala hantavirus-infected
patients—implications for treatment
L. Pettersson, T. Thunberg, J. Rocklöv, J. Klingström,
M. Evander and C. Ahlm
242 Abstracts of Online-Only Original Articles
O150 Molecular epidemiology of enterovirus 71,
coxsackievirus A16 and A6 associated with hand,
foot and mouth disease in Spain
M. Cabrerizo, D. Tarragó, C. Muñoz-Almagro, E. del Amo,
M. Domínguez-Gil, J. Mª Eiros, I. López-Miragaya,
C. Pérez, J. Reina, A. Otero, I. González, J. E. Echevarría
and G. Trallero
INFECTIOUS DISEASE
Original Articles
246 Inadequate management of pregnancy-associated
listeriosis: lessons from four case reports
C. Charlier, F. Goffinet, E. Azria, A. Leclercq and M. Lecuit
250 Abstract of Online-Only Original Article
O182 Added value of multiplex Luminex Gastrointestinal
Pathogen Panel (xTAG® GPP) testing in the diagnosis of
infectious gastroenteritis
E. Wessels, L. G. Rusman, M. J. A. W. M. van Bussel and
E. C. J. Claas
BACTERIOLOGY
Original Articles
251 Extended-spectrum β-lactamase producing Klebsiella
spp. in chicken meat and humans: a comparison of
typing methods
I. T. M. A. Overdevest, M. Heck, K. van der Zwaluw,
X. Huijsdens, M. van Santen, M. Rijnsburger, A. Eustace,
L. Xu, P. Hawkey, P. Savelkoul, C. VandenbrouckeGrauls, I. Willemsen, J. van der Ven, C. Verhulst and
J. A. J. W. Kluytmans
256 Mycobacterium avium genotype is associated with the
therapeutic response to lung infection
T. Kikuchi, Y. Kobashi, T. Hirano, N. Tode, A. Santoso,
T. Tamada, S. Fujimura, Y. Mitsuhashi, Y. Honda,
T. Nukiwa, M. Kaku, A. Watanabe and M. Ichinose
263 Mycobacterium tuberculosis bacteraemia: experience
from a non-endemic urban centre
H. M. El Sahly, L. D. Teeter, J. M. Musser and E. A. Graviss
269 Abstracts of Online-Only Original Articles
O188 Exposure to ertapenem is possibly associated with
Pseudomonas aeruginosa antibiotic resistance
M. J. Cohen, C. S. Block, A. E. Moses and R. Nir-Paz
O197 Mediastinitis due to Gram-negative bacteria is
associated with increased mortality
H. Charbonneau, J. M. Maillet, M. Faron, O. Mangin,
E. Puymirat, P. Le Besnerais, L. Du Puy-Montbrun,
P. Achouh, J. L. Diehl, J.-Y. Fagon, J.-L. Mainardi and
E. Guerot
271 Abstract of Online-Only Research Note
0203 Mobile genetic elements of Pseudomonas aeruginosa
isolates from hydrotherapy facility and respiratory
infections
S. G. Pereira and O. Cardoso
272 Erratum
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
FA
CT
OR
:4
.57
8
1/9/2014 6:21:53 PM
Volume
20
Number
3
March 2014
CMI CLINICAL MICROBIOLOGY AND INFECTION
191 The greatest steps towards the discovery of Vibrio
cholerae
D. Lippi and E. Gotuzzo
196 Steps towards the discovery of Mycobacterium
tuberculosis by Robert Koch, 1882
E. Cambau and M. Drancourt
202 Plague history: Yersin’s discovery of the causative
bacterium in 1894 enabled, in the subsequent
century, scientific progress in understanding the
disease and the development of treatments and
vaccines
T. Butler
210 The rediscovery of smallpox
C. Thèves, P. Biagini and E. Crubézy
CT
O157 Quasispecies tropism and compartmentalization in gut
and peripheral blood during early and chronic phases of
HIV-1 infection: possible correlation with immune
activation markers
G. Rozera, I. Abbate, C. Vlassi, E. Giombini, R. Lionetti,
M. Selleri, P. Zaccaro, B. Bartolini, A. Corpolongo,
G. D’Offizi, A. Baiocchini, F. Del Nonno, G. Ippolito and
M. R. Capobianchi
O167 Clinical significance of intra-host variability of
Dengue-1 virus in venous and capillary blood
E. Descloux, C. La Fuentez, Y. Roca and X. De Lamballerie
245 Abstract of Online-Only Research Note
0176 Increased incidence of acute parvovirus B19 infections
in Marseille, France, in 2012 compared with the
2002–2011 period
S. Aherfi, L. Ninove, C. Zandotti, P. Crepey, H. Richet,
A. Nougairede, X. de Lamballerie and R. N. Charrel
Volume 20 / Number 3 / March 2014
C OWikimedia
N T E N Tcommons,
S
Top: Weighing the heart, From Thebes, Egypt 19th Dynasty, around 1275 BC, source:
public domain.
Bottom Left: Clinical malaria among children receiving iron +/- folic acid versus placebo or no treatment in randomized
controlled trials. Analysis sub-grouped by settings with or without malaria surveillance and treatment services, showing
divergence of results. Re-generated from data in Okebe et al. Oral iron supplements
for childrenHot
in malaria-endemic
areas.
Infection
Topic
Cochrane Database Syst Rev. 2011 Oct 5;( 10):CD006589.
187 Emerging respiratory viruses: is it ‘much ado about
Bottom Right: The pyramid of evidence-based medicine. Source: M. Paul.
nothing’? (Shakespeare)
Theme Section Editor: M. Drancourt: Microbe discovery: lessons from the past
14-64530
1106
Editorial
Guidelines in infectious diseases: how reliable are they?
M. Paul, E. Roilides and P. T. Tassios
Volume 19 / Number 12 / December 2013
1096
PA
Cover images:
THEMED SECTION
1093
•Pneumococcal Conjugate Vaccines
.54
0
clm_v19_i9_oc.indd 1
Cover images:
2012 ISI Journal Citation Reports®
Number
:4
CMI CLINICAL MICROBIOLOGY AND INFECTION
Reviews
The re-emergence of tuberculosis: what have we learnt
from molecular epidemiology?
M. W. Borgdorff and D. van Soolingen
The changes in mosquito vector behaviour and the
emerging resistance to insecticides will challenge the
decline of malaria
C. Sokhna, M. O. Ndiath and C. Rogier
Fighting drug-resistant Plasmodium falciparum: the
challenge of artemisinin resistance
C. Wongsrichanalai and C. H. Sibley
The emerging and re-emerging human immunodeficiency
virus epidemics in Europe
I. Bozicevic, S. Handanagic, S. Z. Lepej and
J. Begovac
INFECTIOUS DISEASES
VIROLOGY
930
19
Co-infections with hepatitis B and C viruses in human
immunodeficiency virus-infected patients in
Morocco
Cover images:
K. Rebbani, A. Ouladlahsen, A. Bensghir,
A. Akil, H. Lamdini,
Genomics
of medical importance. Left panel: Increasing number of genomes sequenced from 1995 to 2012;
H. Issouf, I. Brahim, B. Kitab, F. Z. Fakhir,
L. Wakrim,
please
note that genomics progressively shifted from complete genomes to draft genomes allowing reduced
K. Marhoum El Filali, H. Himmich, S. Ezzikouri
S. Benjelloun
time toand
results;
the genome of the EHEC strain isolated from the German outbreak of May 2011 demonstrated
Volume 19 / Number 10 / October 2013
Yellow fever revaccination guidelines change – a decision
too feverish?
M. P. Grobusch, A. Goorhuis, R. W. Wieten, J. D. M. Verberk,
E. F. F. Jonker, P. J. J. van Genderen and L. G. Visser
THEME SECTION
887
Volume
OR
P
INFECTION HOT TOPIC
The authoritative source of information across the
fields of microbiology and infectious disease
CT
AC
Theme Section Editors: G.Greub & P. E. Fournier:
T Genomics in routine diagnostic labs - new
CONTENTS
885
FA
CMI
CLINICAL MICROBIOLOGY
AND INFECTION
CMI CLINICAL MICROBIOLOGY AND INFECTION
Original Articles
Mapping ongoing European research activities examining
the infectious aetiology of chronic conditions
J. C. Semenza, I. Svederud, E. Medin, S. Orrskog and
S. Tsolova
Prospective survey of acute osteoarticular infections in a
French paediatric orthopedic surgery unit
A. Ferroni, H. Al Khoury, C. Dana, G. Quesne, P. Berche,
C. Glorion and Z. Péjin
Abstracts of Online-Only Original Articles
Current management of patients hospitalized with
complicated skin and soft tissue infections across Europe
(2010–2011): assessment of clinical practice patterns
and real-life effectiveness of antibiotics from the REACH
study
J. Garau, H. Ostermann, J. Medina, M. Ávila, K. McBride and
F. Blasi, on behalf of the REACH study group
The cultivable human oral gluten-degrading microbiome
and its potential implications in coeliac disease and gluten
sensitivity
M. Fernandez-Feo, G. Wei, G. Blumenkranz, F. E. Dewhirst,
D. Schuppan, F. G. Oppenheim and E. J. Helmerhorst
Abstract of Online-Only Research Note
Asymptomatic brucellosis infection in humans:
implications for diagnosis and prevention
Q. Zhen, Y. Lu, X. Yuan, Y. Qiu, J. Xu, W. Li, Y. Ke, Y. Yu,
L. Huang, Y. Wang and Z. Chen
814
852
Volume 19 / Number 9 / September 2013
Editorial
Genomics of medical importance
G. Greub
781
Cover images:
Clockwise from bottom right
Figure 1: Jean Antoine Villemin; source: Wikipedia
Figure 2: J. A. Villemin thesis; source: Bibliotheque Numérique Medica
(http://www2.biusante.parisdescartes.fr/livanc/index.las?cote=34844&p=4&do=page)
Figure 3: Robert Koch; source: Wikipedia
Figure 4: R. Koch’s tuberculosis paper; source: Google
Figure 5: First M. Tuberculosis isolate; source: Hunterian Museum, Royal College of Surgeons, London
Figure 6: Mycobacterium tuberculosis; source: Michel Drancourt.
clm_v20_i3_oc.indd 1
www.cmijournal.com
2/7/2014 12:08:54 PM
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP008
Population pharmacokinetics of ceftazidime
and cefepime in septic shock patients during
continuous renal replacement therapy
M. Carlier* (Ghent, Belgium), F. Taccone, L. Seyler,
F. Jacobs, M. Beumier, J.L. Vincent, J. Lipman,
J. Roberts
eP009
Explaining variability in gentamicin peak
concentrations to optimise gentamicin dosing in
critically ill patients
R.M. Van Hest* (Amsterdam, The Netherlands),
C.S.C. Bouman, C.E. Visser, N.P. Juffermans,
C.J. Hodiamont, R.A. Mathot
eP010
Amikacin peak loading in obese patients:
application of adjusted body weight formula with
modern posologies. Are 30 mg/kg enough?
C. Lu, M. Meddour, N. Van Grunderbeeck* (Lens,
France), M. Nyunga, M. Boyer-Besseyre, J. Gois,
E. Parmentier-Decrucq, J. Mallat, D. Thevenin,
N. Lemaire
EPOSTER VIEWING:
PK/PD to improve treatment of critically ill patients
eP004
How do changes in settings of renal replacement
therapies in critically ill patients change the
pharmacokinetics of piperacillin, meropenem and
vancomycin?
J.A. Jamal* (Brisbane, Australia), A.A. Udy,
J. Lipman, J.A. Roberts
Pharmacokinetic/pharmacodynamic evaluation
of the efficacy and cost-effectiveness of various
carbapenem dosing regimens for the treatment of
Gram-negative bacterial bloodstream infections
T.P. Lim, Y. Cai, J. Teo, Z.W. Wang, W. Lee, T.Y. Tan,
T.T. Tan, L.Y. Hsu, T.H. Koh, A. Kwa* (Singapore,
Singapore)
eP005
The effect of extracorporeal membrane
oxygenation in critically ill patients on
meropenem pharmacokinetics: a matched
cohort study
J. Roberts* (Brisbane, Australia), K. Shekar,
J. Fraser, D. Mullany, S. Wallis, J. Lipman
eP006
Comparative evaluation of the accuracy and
precision of pharmacokinetic equations to predict
free meropenem concentrations in critically ill
patients
A. Farkas, G. Wong, G. Daroczi, J. Lipman,
J. Roberts* (Queensland, Australia)
eP007
Microdialysis tissue pharmacokinetics and
pharmacokinetic-pharmacodynamic modelling
of ertapenem after 1g/12h administrations to
critically ill patients
N. Gregoire* (Poitiers, France), N. Hamitouche,
L. Laksiri, T. Loupec, S. Marchand, O. Mimoz,
W. Couet
Viewing Stations
EPOSTER VIEWING:
Carbapenem and quinolone resistance in Enterobacteriaceae
eP011
Prevalence of carbapenem-resistant organisms
in German ICUs: first results from the national
nosocomial infection surveillance system (KISS)
F. Maechler* (Berlin, Germany), L. Pena Diaz,
C. Geffers, M. Behnke, P. Gastmeier
eP012
Epidemiology and predictors of IMP-type metallobeta-lactamase-producing Enterobacter cloacae
isolation in a tertiary medical centre: a casecontrol study
K. Hayakawa* (Tokyo, Japan), T. Miyoshi-Akiyama,
S. Kubota, E. Kuroda, Y. Sugiki, M. Nagamatsu,
N. Takeshita, S. Kutsuna, T. Kirikae, N. Ohmagari
eP013
An outbreak caused by carbapenem-resistant
Serratia marcescens (SME) clinical isolates coproducing KPC-2 and IMP-10 in a tertiary teaching
hospital in Brazil
K.E. Silva, C. Carvalhaes, R. Cayô* (São Paulo,
Brazil), F. Rodrigues-Costa, F. Patussi, J.H.R. Croda,
F.J. Negrão, A.C. Gales, S. Simionatto
24th ECCMID / Barcelona
Final Programme
87
ePosters
eP003
Impact of beta-lactam pharmacokinetics/
pharmacodynamics on clinical outcome of
bloodstream infections in critically ill patients
M. Nunez-Nunez* (Seville, Spain), G. Wong,
S.C. Wallis, B. McWhinney, J.P.G. Ungerer, J. Mayer,
J. Lipman, J.A. Roberts
Posters
eP002
Population probability of target attainment
of colistin at different levels of renal function
against Pseudomonas aeruginosa and
Acinetobacter baumannii in Europe
A. Farkas, K. Hoffman, C. Levy, J. Roberts*
(Queensland, Australia)
Chairs, Speakers & Authors
eP001
Exhibition
Viewing Stations
General Information
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP014
The host bacterial-plasmid network: observations
of Klebsiella pneumoniae-carbapenemase (KPC)
gene mobility in a K. pneumoniae cohort using
whole genome sequencing
A.J. Mathers* (Charlottesville, United States),
N. Stoesser, A.E. Sheppard, A. Geiss, X. Didelot,
C.D. Sifri, D.W. Crook
eP023
Sequence types of Staphylococcus epidermidis
associated with prosthetic joint infections are not
present in the laminar air flow during prosthetic
joint surgery
E. Månsson* (Västerås, Sweden), B. Hellmark,
M. Sundqvist, B. Söderquist
eP015
Characterisation of carbapenem-resistant
Enterobacteriaceae isolated in four countries of
the Arabian peninsula
T. Pal* (Al Ain, United Arab Emirates), A. Sonnevend,
A. Ghazawi, D. Darwish, R. Hashmey, W. Jamal,
V. Rotimi, A. Al-Jardani, S. Al-Abri, A. Shibl
eP024
Computer-enhanced surveillance of surgical site
infections: early assessment of a generalisable
method for French hospitals
B. Leclère, C. Lasserre, C. Bourigault, M.E. Juvin,
M.P. Chaillet, M. Hanf, J. Caillon, D. Lepelletier*
(Nantes, France)
eP016
Prevalence and characterisation of quinolone
resistance mechanisms in indicator Escherichia coli
D. Wasyl* (Pulawy, Poland), A. Hoszowski, M. Zajac
eP025
Cardiac tamponade with bacterial pericarditis
following open heart surgery: successful
management with subxiphoid drainage and
antibiotics
H. Osada* (Kyoto, Japan), H. Nakajima, K. Meshii,
M. Ohnaka, M. Nagao
eP017
Quinolone resistance in Salmonella Newport
D. Wasyl* (Pulawy, Poland), M. Zajac, A. Hoszowski
eP018
Prevalence of qnr genes in 1032 invasive isolates
of Escherichia coli in Croatia
M. Jelic* (Zagreb, Croatia), Gužvinec, I. Butic,
S. Bukovski, A. Tambic-Andraževic
eP026
Perioperative infection prevention in
cardiothoracic surgery
T. Götting* (Freiburg, Germany), J. Rauch,
M. Willhauck, W. Ebner, G. Trummer, F. Beyersdorf,
M. Dettenkofer
eP019
Emergence of ciprofloxacin-resistant Salmonella
enterica serovar Typhi in Italy
A. Garcia-Fernandez, S. Owczarek, A.M. Dionisi,
I. Benedetti, I. Luzzi* (Rome, Italy)
eP027
Prevalence and mechanism of fluoroquinoloneresistance in clinical isolates of Proteus mirabilis
in Japan
R. Nakano* (Tokyo, Japan), A. Nakano, R. Okamoto,
A. Michiko, N. Nagano, M. Asahara, Y. Ono
Surgical site infection in cardiothoracic surgery
– a single intervention surveillance study from
Lancashire Cardiac Centre comparing chlorhexidineisopropyl alcohol to iodine-IPA skin prep
A. Guleri* (Blackpool, United Kingdom), R. Sharma,
N. Waddington
eP020
eP028
Successful sterilisation of femoral head allograft
using high hydrostatic pressure
M.A.J. Van de Sande, I.M. Sanders, M. Van Wijk,
E.J. Kuijper* (Leiden, The Netherlands)
Viewing Stations
eP029
Breast-MF: identification of breast flora in
patients undergoing aesthetic and oncologic
breast surgery
O. Streinu-Cercel, A. Streinu-Cercel, D.M. Jianu,
I. Berciu, A. Blidaru, M. Filipescu, I.P. Florescu,
O. Cobani, S.A. Jianu, A. Streinu-Cercel* (Bucharest,
Romania)
EPOSTER VIEWING:
Successful reduction of surgical site infections
eP021
Adherence to principles of hygiene in operating
theatres: development of a monitoring system
R. Fulchini* (St. Gallen, Switzerland), M. Hoffmann,
B. Schoebi, K. De Martin, U. Schaefer, M. Schlegel
eP022
Hospital discharge database for SSI surveillance
after hip or knee arthroplasty
L. Grammatico-Guillon* (Tours, France), S. Barons,
C. Gaborit, E. Rusch, P. Astagneau
88
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP031
Quantifying the association of antibiotic
consumption to carbapenem-resistance in
Acinetobacter baumannii: a mathematical
modelling analysis
M.W. Tan* (Singapore, Singapore), D. Lye, T.M. Ng,
C.B. Teng, M. Nikolaou, V.H. Tam
eP032
eP033
Bloodstream infection within 48 hours of
admission: the effect of healthcare-associated
risk factors on antibiotic resistance – a crosssectional study
J. Greig* (Plymouth, United Kingdom)
MRSA/SA and C. difficile real-time PCR tests –
evaluation with 2013 QCMD EQA panels
G. Stefanuto, S. Chiaramello, M. Enrietto,
A. Estampes* (Puteaux, France), C. Olivo
eP034
Chloramphenicol use and susceptibility patterns
in Israel: a national cross-sectional survey
O. Nitzan* (Afula, Israel), Y. Kennes, R. Colodner,
H. Edelstein, R. Raz, B. Chazan
eP035
Development of within-host antibiotic-resistant
Gram-negative bacteria during SDD and SOD in
intensive care unit patients
Y. Noteboom* (Utrecht, The Netherlands),
D.S.Y. Ong, E.A. Oostdijk, M.J.M. Bonten
eP036
Determining the clinical and economic impact
of a formal intervention programme against
carbapenem-resistant Klebsiella pneumoniae
infections
C.J. Clancy, O. Marroquin, K. Lynch, G. Eschenauer,
R.K. Shields, B. Potoski, B. Hao, M.H. Nguyen*
(Pittsburgh, United States)
eP037
Safety and efficacy of outpatient parenteral
antimicrobial therapy (OPAT) for spinal
infections
S. O’Connell* (Dublin, Ireland), C. O’Connor, D. Hare,
S.J. Yeung, K. Synnott, J. Lambert, G. Sheehan,
A. Poynton, M. Timlin, P. Mallon
eP038
First confirmed case of spondylodiscitis and
epidural abscess due to Parvimonas micra: review
of Parvimonas micra infection
S. Endo* (Sendai, Japan), T. Nemoto, H. Yano,
H. Kanamori, T. Aoyagi, M. Hatta, Y. Gu, K. Tokuda,
M. Kitagawa, M. Kaku
eP039
Risk factors and surgical site infection rates
related to craniotomy in a tertiary care university
hospital. A prospective surveillance programme
A. Soriano* (Barcelona, Spain), E. Shaw, O. Arch,
A. Gabarros, D. Garcia, C. Cabellos, I. Pelegrin,
C. Peña, J. Ariza, M. Pujol
eP040
Cost-effectiveness analysis of appropriate
duration of antibiotic prophylaxis for prevention
of neurosurgical infections
A. Ulu-Kilic* (Kayseri, Turkey), E. Alp Mese,
F. Cevahir, H. Demiraslan, B. Tucer, A. Selcuklu,
M. Doganay
eP041
Infection of spinal cord stimulation devices:
remove or retain?
G. Béraud* (Poitiers, France), M. Roulaud,
O. Monlezun, F. Guetarni, B. Bataille, P. Rigoard
eP042
Risk factors for surgical site infection after
microvascular reconstruction for head and neck
cancer
J.L. Wagner* (Detroit, United States), R.M. Kenney,
T.A. Ghanem, J.A. Vazquez, S.L. Davis
eP043
Significant decrease of S. aureus mediastinitis
post cardiac surgery as a result of molecular
nasal carrier screening and decontamination
C. Plouzeau* (Poitiers, France), S. Thevenot,
A.S. Cognee, M. Albouy-Llaty, A. Michaud,
S. Peguilhan, P. Corbi, C. Jayle, C. Burucoa
eP044
Sternal plate fixation for chest wall
reconstruction post coronary artery bypass
surgery appears to increase the risk of surgical
site infection
M. Charles* (Edmonton, Canada), L. Saxinger,
S. Smith
24th ECCMID / Barcelona
Final Programme
ePosters
Effects of an antibiotic stewardship programme
on carbapenem-resistant Gram-negative
epidemiology
A. Stern* (Haifa, Israel), S. Haddad, M. Paul,
Y. Barlavie, K. Hussein
EPOSTER VIEWING:
Post-surgical and implant infections: from head to knee
Posters
eP030
Viewing Stations
Chairs, Speakers & Authors
EPOSTER VIEWING:
Antibiotic consumption-resistance associations
Exhibition
Viewing Stations
89
General Information
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP045
Gram-negative rod bacteraemia following
cardiovascular surgery: characteristics and
clinical outcomes
S. Asahata* (Shinjuku Kwadacho, Japan),
Y. Ainoda, T. Fujita, Y. Hirai, A. Goto, K. Totsuka
eP046
Epidemiology and risk factors for surgical site
infections following thoracic surgery
S. Ceken* (Ankara, Turkey), S. Simsek Yavuz,
A. Sensoy, O. Imamoglu
eP047
eP048
eP049
eP050
eP051
Healthcare-associated haematogenous pyogenic
vertebral osteomyelitis: a severe and potentially
preventable infectious disease
C. Pigrau* (Barcelona, Spain), D. Rodriguez-Pardo,
B. Almirante, L. Moretó, N. Fernandez-Hidalgo,
N. Larrosa, M. Puig-Asensio, F. Pellisé, A. Pahissa
Outcome of attempted implant retention in early
and late-onset spinal implant infections
M.S. Lee* (Seoul, Korea), K. Park, M. Jung, S. Moon,
J.S. Son, K. Suk, J.H. Lee, J.S. Park, K.N. Rye
Is there a difference in phylotype of
Propionibacterium acnes strains in terms of
origin: spinal material, prosthetic devices and
environment?
S. Delliere, P. Bemer, G.G. Aubin, C. Plouzeau,
D. Tande, S. Corvec* (Nantes, France)
Economic burden of surgical site infections
after gynaecological operations in a middleincome country
E. Alp Mese* (Kayseri, Turkey), F. Cevahir,
A. Ulu-Kilic
Length of time to antibiotic administration and
surgical site infection in patients with open
appendectomy
J.A. Cortes* (Bogota, Colombia), V. Robayo,
D.C. Bermudez, M. Ibañez
eP052
Surgical site infection in appendectomy –
is the risk different for adults and children?
A. Breier* (Berlin, Germany), C. Schröder,
R. Leistner, P. Gastmeier
eP053
Impact of multidrug-resistant Gram-negative
bacilli on organ/space infections associated
to elective colorectal surgery – a prospective
analysis in a university hospital in Spain
E. Shaw* (Barcelona, Spain), R. Escofet, G. Cuervo,
D. Garcia, O. Arch, A. Hornero, T. Vidal, C. Peña,
J. Ariza, M. Pujol
90
24th ECCMID / Barcelona
Final Programme
eP054
Use of outpatient antimicrobial therapy (OPAT)
in patients with intra-abdominal abscess after
abdominal surgery
A. Vivero Larraza* (Barcelona, Spain),
N. Sopena Galindo, M. Piñol Pascual, M. Bonet Farell,
G. Bonet papell, E. Blanco Hernandez,
A. Cuxart Melich
eP055
Post-arthroscopic septic arthritis of the knee
analysis of the outcome after treatment in a
series of cases
T. Ascione* (Naples, Italy), G. Balato, P. Pagliano,
R. Rotondo, G. De Stefano, M. Conte, M. Mariconda
eP056
Management and clinical outcomes of
Staphylococcus aureus prosthetic joint
infections: a retrospective review
S. Parsaei* (Saint Louis, MO, United States),
N. Ganeshraj, A. Gu, P. Bodavula, J. Marschall,
D. Warren, M. Lane
eP057
Economic burden of prosthetic joint infections in
a middle-income country
E. Alp Mese* (Kayseri, Turkey), F. Cevahir, S. Ersoy,
A. Guney
eP058
SSI after hip or knee arthroplasty:
a French cohort study using hospital discharge
database, 2008-2012
L. Grammatico-Guillon* (Tours, France), S. Baron,
C. Gaborit, E. Rusch, P. Astagneau
eP059
Healthcare-associated infection after red blood
cell transfusion: a systematic review and metaanalysis of randomised trials
M.A.M. Rogers* (Ann Arbor, United States),
J.M. Rohde, D.E. Dimcheff, N. Blumberg, S. Saint,
K.M. Langa, L. Kuhn, A. Hickner
eP060
Standards of infection control to prevent surgical
site infections in Switzerland: a cross-sectional
survey in 82 hospitals
D. Vuichard Gysin* (Basel, Switzerland), N. Troillet,
M.C. Eisenring, M. Dangel, G. Zanetti, A.F. Widmer
ePoster Viewing
Direct costs of hospital admission for
pneumococcal and non-pneumococcal
pneumonia
S.M. Huijts* (Utrecht, The Netherlands),
M.J.J. Mangen, D.F. Postma, C.H. Van Werkhoven,
M.J.M. Bonten
eP062
eP070
Factors associated with prolonged time to clinical
stability in hospitalised adults with communityacquired pneumonia
A.F. Simonetti, D. Viasus* (Barranquilla, Colombia),
C. Garcia-Vidal, J. Carratala
Hospitalisation due to respiratory syncytial virus
(RSV) infection in adult patients: a retrospective
cohort study
C. Volling* (Toronto, Canada), K. Hassan, T. Mazzulli,
K. Green, A. Al-Den, P. Hunter, R. Mangat, J. Ng,
A. McGeer
eP063
eP071
Beta-lactam monotherapy versus beta-lactammacrolide combination treatment in moderately
severe community-acquired pneumonia: a
randomised non-inferiority trial
N. Garin* (Geneva, Switzerland), D. Genné,
S. Carballo, C. Chuard, G. Eich, O. Hugli, P. Petignat,
O. Rutschmann, S. Harbarth, A. Perrier
The value of procalcitonin to determine the need
for hospital admission in adults with communityacquired pneumonia
A.F. Simonetti* (Barcelona, Spain), D. Viasus,
C. Garcia-Vidal, J. Dorca, F. Morandeira-Rego,
J. Carratala
eP064
eP072
In-hospital modifications of antibacterial therapy
initiated in the emergency department for
community-acquired pneumonia
N. Goffinet, M. Cousin, E. Montassier, C. Peron,
N. Lecadet, G. Potel, E. Batard* (Nantes, France)
Qualitative and quantitative analysis of the
microbiota in lower respiratory tract infections
reveals a high proportion of polymicrobial
infections
G. Platt* (London, United Kingdom), S. Schwenk,
Y. Personne, K. Thomas, V. Gant, V.I. Enne, A.I. Zumla
eP065
eP073
Community-acquired pneumonia caused by
Staphylococcus aureus in France: interim results
of a prospective cohort study
M. Saadatian-Elahi* (Lyon, France), A. Tristan,
Y. Gillet, M. Bes, C. Bouchiat, O. Dumitrescu,
C. Picard, L. Argaud, F. Vandenesch
Microbiological investigation of patients
with community-acquired pneumonia using
quantitative multiplex real-time bacterial PCR
C.D. Russell* (Edinburgh, United Kingdom),
N.J. Gadsby, H. Mark, D. Guerendiain,
A. Conway Morris, I.F. Laurenson, A.T. Hill,
K.E. Templeton
Predictors of bacteraemia in patients hospitalised
with suspected community-acquired pneumonia:
a cohort study
C.H. Van Werkhoven* (Utrecht, The Netherlands),
S.M. Huijts, D.F. Postma, J.J. Oosterheert,
M.J.M. Bonten
eP066
Antibiotic treatment patterns and outcomes
among patients hospitalised in ICU with
community-acquired bacterial pneumonia:
a US cohort study
S. Eapen* (Boston, United States), E. Tuttle, C. Llop,
M. Barrett
eP067
Impact of initial antibiotic failure on duration of
hospitalisation (DOH) for community-acquired
pneumonia (CAP): results of a randomised
clinical trial of ceftaroline fosamil versus
ceftriaxone
N. Zhong, T. Sun, G. D’Souza, S.H. Lee, H.L. Nguyen,
C.-H. Chiang, D. Wilson, F. Sun, D. Melnick*
(Wilmington, United States)
24th ECCMID / Barcelona
Final Programme
91
General Information
eP061
Posters
eP069
EPOSTER VIEWING:
Community-acquired pneumonia
Chairs, Speakers & Authors
Mortality and hospital length of stay (HLOS)
among patients with community-acquired
pneumonia (CAP): a propensity score-matched
analysis of ceftaroline fosamil (CPT-F)-treated vs
ceftriaxone-treated patients
Y. Golan* (Boston, MA, United States), R. Ruthazer,
M. Ding, Q. Zhao, X. Huang
Viewing Stations
Exhibition
eP068
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
Viewing Stations
eP081
Reduction in the number of patients with
neuroborreliosis, following a significant reduction
in roe deer abundance on the island of Fuen,
Denmark
N.S. Andersen* (Odense, Denmark), P.M. Jensen,
S. Skarphédinsson, C.R. Olesen, T.G. Jensen,
H.J. Kolmos
eP082
A 5-year observational study of the epidemiology
of Lyme borreliosis in Scotland
S. Mavin* (Inverness, United Kingdom), R. Evans
eP083
Identification of complex species of Borrelia
burgdorferi using MALDI-TOF mass spectrometry,
it’s possible!
S.J. De Martino* (Strasbourg, France), F. Schramm,
P. Riegel, L. Zilliox, B. Jaulhac
eP084
Presence of Lyme disease agents in the
Portuguese ixodofauna: development of realtime PCR assays for the identification of Borrelia
burgdorferi genospecies
M. Nunes* (Lisbon, Portugal), N. Lopes, C. Maia,
T. Carreira, J. Inácio, M.L. Vieira
eP085
Usefulness of quantitative IgG assays Borrelia
VlsE liaison and the new VIDAS® Lyme for
serological follow-up of patients with Lyme
borreliosis
O. Péter* (Sion, Switzerland), R. Vonlanthen,
A. Bonnet-Pierroz, A. Schaller, C. Béguelin, D. Genné,
R. Lienhard
EPOSTER VIEWING:
Lyme borreliosis
eP074
Intrathecal Th17 response in Lyme
neuroborreliosis and the relation to clinical
disease course
P. Gyllemark, A. Matussek, P. Forsberg, J. Ernerudh,
A.J. Henningsson* (Jönköping, Sweden)
eP075
CXCL13 concentrations in cerebrospinal
fluid of Lyme neuroborreliosis and other
neuroinflammatory patients
J. Hytönen* (Turku, Finland), E. Kortela, J. Salo,
M. Waris, J. Oksi
eP076
Comparison of a cell-based SpiroFind assay with
classical serology for the diagnosis of acute
Lyme borreliosis
M. Lupse* (Cluj, Romania), M. Oosting, M. Flonta,
O. Daraban, J.W.M. Van der Meer, M.G. Netea,
L.A.B. Joosten, B.J. Kullberg
eP077
Epidemiology and costs of Lyme borreliosis
hospital care in Germany: lessons from a health
care utilisation database analysis
B. Lohr* (Frankfurt, Germany), I. Müller,
O. Schöffski, K.-P. Hunfeld
eP078
Erythema migrans and re-infection with Borrelia
burgdorferi species – analysis of patients with
early form of Lyme disease in north-eastern
Poland
A. Moniuszko* (Bialystok, Poland), S. Pancewicz,
K. Guziejko, J. Dunaj, R. Swierzbinska, M. Kondrusik,
S. Grygorczuk, P. Czupryna, P. Aleksiejczuk,
J. Zajkowska
Viewing Stations
EPOSTER VIEWING:
Molecular diagnosis of bacterial gastrointestinal infections
eP079
Clinical and microbiological characteristics of
Slovenian patients with Bannwarth’s syndrome
K. Ogrinc* (Domzale, Slovenia), S. Lotric-Furlan,
D. Stupica, V. Maraspin, P. Bogovic, T. Rojko,
T. Cerar Kisek, E. Ruzic-Sabljic, F. Strle
eP086
Evaluation of a multiplex PCR for the detection of
bacterial and parasitic pathogens in clinical stool
samples compared with conventional methods
I. Cooper* (Brisbane, Australia), R. Vohra,
P. O’loughlin, J. Sergent, T. Bruce
eP080
Course and outcome of solitary erythema
migrans in patients treated for breast cancer
V. Maraspin* (Ljubljana, Slovenia), J. Cimperman,
E. Ruzic-Sabljic, F. Strle
eP087
Multiplex PCRs for the diagnosis of
gastrointestinal pathogens are unreliable for the
detection of Salmonella enterica
L.R. Macfarlane-Smith* (Leeds, United Kingdom),
K.A. Davies, H.M. Ashwin, L.J. Pankhurst,
L.W. Anson, A.S. Walker, D.W. Crook, M.H. Wilcox
92
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP093
eP094
eP095
A diagnostic screening algorithm to optimise
detection of Shigella spp. and entero-invasive
Escherichia coli
R.F. De Boer* (Groningen, The Netherlands),
A. Ott, W. De Boer, M.C. Scholts, K. Van Huisstede,
A.M.D. Kooistra-Smid
Prevalence and molecular characterisation of
shiga-toxin-producing E. coli of patients in the
northern and western region of The Netherlands
M. Ferdous* (Groningen, The Netherlands),
A.M.D. Kooistra-Smid, R.F. De Boer, H. Fijan,
P. Van Barneveld, A.W. Friedrich, J.W.A. Rossen
Case-control study gastroenteritis: value of
molecular diagnostics
A.G.M. Zanden van der* (Hengelo,
The Netherlands), T.A. Schuurs, J.F.L. Weel,
G.J.H.M. Ruijs, W.A. Reijden van der, L. Mulder,
L.E.S. Bruijnesteijn van Coppenraet 
External quality assessment of laboratories
using molecular diagnostic tests for Clostridium
difficile
E. Mcculloch* (Glasgow, United Kingdom),
P.S. Wallace, J. Coia, C. Williams, W.G. Mackay
eP096
Hospital characteristics associated with higher
Staphylococcus aureus bacteraemia mortality in
Veterans Affairs Healthcare System:
a retrospective cohort study
M. Goto* (Iowa City, IA, United States),
M.L. Schweizer, E.N. Perencevich, M.E. Ohl
eP097
Influence of methicillin-resistance on mortality
in a large cohort of patients with Staphylococcus
aureus bloodstream infection
C. Feijoó* (Barcelona, Spain), O. Gasch,
M.L. Machado, N. Muñoz, M. Espasa, M. Navarro,
L. Falgueras, B. Font, D. Fontanals, F. Segura
eP098
Predictors of persistent S. aureus bacteraemia
and impact on related mortality
L. Morata* (Barcelona, Spain), I. Alejo, I. Fernández,
N. Cobos-Trigueros, C. De la Calle, M. Almela,
F. Marco, J.A. Martínez, A. Soriano, J. Mensa
eP099
Clinical analysis of prognostic factors in
methicillin-resistant Staphylococcus aureus
bloodstream infection: association with 30-day
mortality
M. Maeda* (Tokyo, Japan), H. Shoji, K. Fukuchi,
T. Shirakura, T. Takuma, K. Tanaka, K. Ishino, Y. Niki
eP100
Factors associated with case-fatality in
Staphylococcus aureus bacteraemia,
a large observational study
P. Braquet* (Montpellier, France), L. Minary,
C. Cornu, L. Piroth,
E. Curlier, M. Revest, C. Lechiche, V. Le Moing
eP101
Lack of correlation between clinical parameters
of sepsis and molecular strain typing in
Staphylococcus aureus
J. Zhang, K. Wu, J. McClure, K. Zhang, J. Conly*
(Calgary, Canada)
eP102
Characteristics and prognosis of patients
with staphylococcal prosthetic vascular graft
infection (PVGI): a prospective cohort of 92
patients
A. Pasquet* (Tourcoing, France), M. Valette,
L. Legout, P. Choisy, P. D’elia, B. Saraz-Bournet,
O. Leroy, E. Senneville
24th ECCMID / Barcelona
Final Programme
ePosters
eP092
Molecular detection of Shigella spp. impacts on
apparent epidemiology and reference laboratory
workload
N. De Lappe, J. O Connor, D. Morris* (Galway,
Ireland)
EPOSTER VIEWING:
Sepsis, bloodstream and graft infections:
Staphylococcus aureus and others
Posters
eP091
Detection of verocytotoxin-producing
E. coli (VTEC) needs a change in culture
G.L. Vanstone* (London, United Kingdom),
C. Jenkins, R. Smith
Viewing Stations
Chairs, Speakers & Authors
eP090
Rapid microbial diagnosis of acute
gastroenteritis: comparison of three multiplexed
molecular tests on 194 paediatric stool samples.
Are culture methods obsolete?
A. Beucher, N. Vernet, G. Maccio, P.O. Verhoeven,
J.M. Roque, A. Epercieux, Y. Mekki, F. Vandenesch,
A.M. Freydiere, O. Dauwalder* (Bron, France)
Exhibition
eP089
Evaluation of the fully automated real-time BD
MAX™ enteric bacterial panel assay
M.D. Perry* (Cardiff, United Kingdom)
93
General Information
eP088
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP103
Risk factors, prognostic factors and outcome in
patients with bloodstream infection caused by
Klebsiella pneumoniae versus Escherichia coli
M. Vading* (Stockholm, Sweden), P. Nauclér,
M. Kalin, C.G. Giske
eP104
Outcome in patients with community-onset
bacteraemia and septic shock: pathogen species
and infection sites are associated with mortality
C. Hernandez* (Barcelona, Spain), C. Fehér,
N. Cobos, L. Morata, C. DeLaCalle, M. Almela,
A. DelRio, J. Mensa, A. Soriano, J.A. Martínez
eP105
Are incidence and epidemiology of anaerobic
bloodstream infections really changing?
A ten-year retrospective study
A. Vena* (Madrid, Spain), M. Rodriguez-Creixéms,
C. Sanchez, L. Alcalà, P. Muñoz, E. Bouza
Viewing Stations
EPOSTER VIEWING:
Multifaceted approaches to reduce MDR Gram-negative
infections
eP106
Are contact precautions for extended-spectrum
beta-lacatase-producing Gram-negative rods
warranted in areas of high endemicity?
S. Mahmood* (Karachi, Pakistan), R. Khowaja,
S. Musani, N. Nosheen, R. Roshan
eP107
Stenotrophomonas maltophilia infections and
controls in intensive care unit
K. Suer, M. Guvenir* (Lefkosa, Cyprus), N. Cakir
eP108
First outbreak of carbapenemase-producing
Klebsiella pneumoniae strain (ST512) in a Finnish
long-term acute care hospital, June 2013
M. Kanerva* (Helsinki, Finland), K. Skogberg,
A. Pahkamäki, K. Ryynänen, J. Jalava, E. Tarkka,
O. Lyytikäinen
eP109
First documented outbreak of KPC-2 producing
K. pneumoniae in Switzerland: infection control
measures and clinical management
E. Lemmenmeier* (St.Gallen, Switzerland),
P. Kohler, T. Bruderer, D. Goldenberger, J.R. Kleger,
M. Schlegel
eP110
First outbreak of OXA-232-producing Klebsiella
pneumoniae in a Korean secondary care hospital
J. Chae* (Seoul, Korea), W. Choe, M. Kim
eP111
Evaluation of knowledge of hairdressers on
blood-borne diseases
S. Ozcimen* (Konya, Turkey), L.S. Demir, N. Demir
94
24th ECCMID / Barcelona
Final Programme
eP112
Management and investigation of a large
outbreak of Enterobacteriaceae-producing
OXA-48 carbapenemase in a French university
hospital
B. Semin-Pelletier, C. Bourigault, M.E. Juvin,
S. Pineau, D. Boutoille, C. Agard, M. Hourmant,
S. Corvec, J. Caillon, D. Lepelletier* (Nantes, France)
eP113
Nosocomial spread of metallo-beta-lactamase
producing Pseudomonas aeruginosa in a
university hospital with possible link to
contaminated sink drains – an outbreak report
A. Stjarne Aspelund* (Lund, Sweden),
B. Olsson Liljequist, E. Melander
eP114
Metallo-beta-lactamase producing Pseudomonas
aeruginosa outbreak in the children’s ICU
B. Kotnik Kevorkijan* (Maribor, Slovenia), G. Novak,
A. Golle, S. Lorencic Robnik, S. Janežic, M. Rupnik
eP115
Campylobacter concisus pseudo-outbreak
caused by improved culture conditions
C. Casanova* (Berne, Switzerland), A. Schweiger,
N. Von Steiger, S. Droz, J. Marschall
eP116
Nosocomial outbreak of Acinetobacter baumannii
producing a plasmid-encoded OXA-23 betalactamase associated with the insertion
sequence ISAba4 in Spain
I. Guerrero-Lozano, F. Fernandez-Cuenca,
F. Galan-Sanchez, P. Egea, M.A. Rodríguez-Iglesias*
(Cadiz, Spain), A. Pascual
eP117
Evolution of MIC values of colistin in
MDR-Acinetobacter baumannii after the
implementation of a multicomponent intervention
programme to control MDRAB University Hospital
Virgen del Rocío
V. Gonzalez Galan* (Seville, Spain), J.A. Lepe,
M.J. Artacho, R. Valencia, A. Cazalla, R. Alvarez,
J.M. Cisneros, J. Aznar
eP118
First description of a long-term, low frequency
outbreak of a GIM-1-producing Enterobacter
cloacae ST-89 in a tertiary care hospital in
Germany
A.F. Wendel* (Düsseldorf, Germany),
S. Kolbe-Busch, S. Ressina, R. Deenen, K. Köhrer,
S. Wohlfromm, K. Pfeffer, C.R. MacKenzie
eP119
Lessons from an outbreak of a KPC-2 producing
Klebsiella pneumoniae strain
A. Rodloff* (Leipzig, Germany), N. Lippmann,
S. Faucheux, C. Lübbert, T. Kaiser, U. Kaisers
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP127
Value of PET/CT for the diagnosis and
management of infective endocarditis
N. Fernández-Hidalgo* (Barcelona, Spain),
G. Oristrell, M.N. Pizzi, A. Roque,
M.T. Gonzàlez-Alujas, M. Galiñanes, S. Aguadé,
P. Tornos, B. Almirante
eP128
Mortality determinants in 4340 infective
endocarditis cases in France
S. Sunder* (Tours, France), L. Guillon, C. Gaborit,
L. Pericart, E. Rusch, L. Fauchier, S. Baron,
L. Bernard
EPOSTER VIEWING:
Infective endocarditis and cardiovascular device infections
Characteristics of infective endocarditis in
French West Indies: a 13-year observational
study
E. Fernandes* (Pointe A Pitre, Guadeloupe), C. Olive,
J. Inamo, R. Theodose, F. Roques, D. Courcier,
A. Cabie, B. Hoen, P. Hochedez
eP122
Bartonella infective endocarditis: a 20-year
experience in a Tunisian tertiary care centre
S. Ben Kahla, L. Abid, M. Koubaa, A. Znazen, D. Abid,
A. Hammami, M. Ben Jemaa* (Sfax, Tunisia),
S. Kammoun
eP123
Length of treatment and outcome of enterococcal
endocarditis treated with ampicillin plus
ceftriaxone. A comparison with standard
ampicillin plus gentamicin regimen
J. Pericas* (Barcelona, Spain), C. Cervera,
A. Moreno, C. Garcia-de-la-Mària, C. Falces,
M. Almela, Y. Armero, J.M. Gatell, C.A. Mestres,
J.M. Miro
eP124
eP125
eP126
Viewing Stations
EPOSTER VIEWING:
Vaccine development
Prokaryotic chimera protein consisting of
multiple M2e of influenza A virus and Leishmania
major HSP70 induced specific immune responses
in mice
F. Fotouhi* (Tehran, Iran), N. Taheri,
H. Soleimanjahi, B. Farahmand, M.T. Kheiri, A. Torabi,
Z. Kianmehr
eP130
Chimeric influenza virosome
M. Tavassoti Kheiri* (Tehran, Iran), A. Abdoli,
H. Soleimanjahi, A. Jamali
eP131
Characteristics and outcome of polymicrobial
infections of cardiovascular implantable
electronic devices
S. Carbonara* (Bari, Italy), G. Luzzi, C. Fabrizio,
A. Mosca, Z. Palamà, R. Trotta, F. Napoli, S. Favale,
G. Miragliotta, G. Angarano
The cost-effectiveness of vaccination against
seasonal influenza in England
M. Baguelin* (London, United Kingdom),
A. Camacho, S. Flasche, J.W. Edmunds
eP132
Cardiovascular implantable electronic device
infections: correlation between microbiology and
clinical presentation
E. Carrara* (Pavia, Italy), E. Seminari, L. Scudeller,
R. Rordorf, A. Vicentini, M. Brandolini, P. Marone,
L. Minoli, A. Di Matteo
A phase II study of the safety and
immunogenicity of different formulations of a
candidate Clostridium difficile toxoid vaccine:
dose and formulation selection for phase III
G. De Bruyn* (Swiftwater, United States), G. Foglia,
J. Saleh, D. Workman, R. Pollak, R. Gesser
eP133
A phase II study of the safety and
immunogenicity of different vaccination
schedules of a candidate Clostridium difficile
toxoid vaccine: vaccination schedule selection
for phase II
G. De Bruyn* (Swiftwater, United States), G. Foglia,
J. Saleh, D. Workman, R. Pollak, R. Gesser
Evaluation of ventricular assist device-related
infections
C. Buke* (Izmir, Turkey), T. Yagdi, C. Engin,
F. Cilli Hall, A.L.P. Aslan, M. Ozbaran
24th ECCMID / Barcelona
Final Programme
ePosters
eP129
95
Posters
eP121
Prevalence and risk factors for infective
endocarditis in patients with Staphylococcus
aureus bacteraemia
B. Varatharaj Palraj* (La Crosse, United States),
L.M. Baddour, J.M. Steckelberg, W.R. Walter,
M.R. Sohail
Chairs, Speakers & Authors
eP120
Exhibition
Viewing Stations
General Information
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP134
eP135
eP136
eP137
eP138
Safety, tolerability, and immunogenicity of
a novel 4-antigen Staphylococcus aureus
vaccine (sa4ag) in healthy adults: results of a
randomized, placebo-controlled first-in-human
phase 1/2 study
R. Frenck* (Cincinnati, United States),
C. Buddy Creech, E. Sheldon, D.J. Seiden,
M. Kankam, J. Baber, E. Zito, R. Hubler, J. Eiden,
J.M. Severs, S. Sebastian, J. Nanra, K.U. Jansen,
A.S. Anderson, D. Girgenti
eP141
Inter-lineage cross-protection induced by a
West Nile virus lineage 1 recombinant
domain III vaccine
W. Widagdo (Rotterdam, The Netherlands), S. Lim,
B. Martina
eP142
Reducing the risk of tick-borne diseases –
identification of vaccine candidates against
Ixodes ricinus
W. Jochum* (Luxembourg, Luxembourg), A.L. Reye,
O. Hunewald, C.P. Muller
Development and evaluation of Staphylococcus
epidermidis DNA, mRNA and protein vaccines
L. Yan* (Seattle, United States), J. Bryers
eP143
Analysis of the proteome of a modified vaccinia
virus Ankara-based vaccine provides insight into
the effects of transgenic modification on virus
physiology
A.S. Okoli* (Tromsoe, Norway), M.I. Okeke,
C. Tummler, U. Moens, O. Nilssen, M. Tryland,
J. Ansgar-Bruun, T. Bøhn, T. Traavik
Use of a Staphylococcus aureus small colony
variant as an attenuated live vaccine for the
prevention of intramammary infections
J. Côté-Gravel* (Sherbrooke, Canada), E. Brouillette,
N. Obradovic, M. Allard, B. Talbot, C. Ster, F. Malouin
eP144
Knowledge and risk perception of measles and
factors associated with vaccination decisions in
subjects consulting university affiliated public
hospitals after measles infection: a retrospective
epidemiological study
M. Saadatian-Elahi* (Lyon, France), A. Toure,
D. Floret, B. Lina, J.S. Casalegno, P. Vanhems
eP145
FMD vaccine (Ronavac®) potency, stability,
safety and efficacy test
P. Zare, J. Shalmashi, O. Fakhri* (Tabriz, Iran),
F. Ghaderi, Y. Farshi, S. Shadi
eP146
Advancing the development of an effective
Staphylococcus aureus vaccine by targeting
multiple bacterial virulence factors
A.S. Anderson, I.L. Scully, P.A. Liberator, D. Cooper*
(Pearl River, United States), J. Baber, D.Q. Girgenti,
E. Zito, J. Eiden, W. Gruber, E. Emini, K.U. Jansen
eP147
Development of an oral vaccine against
candidiasis using molecular display technology
S. Shibasaki* (Kobe, Japan), M. Ueda
T-helper cell cytokine pattern induced by
synthetic manno-and gluco-oligosaccharide
conjugates
E. Paulovicova, R. Pilisiova* (Bratislava, Slovakia),
L. Paulovicova, D.V. Yashunsky, A.A. Karelin,
Y.E. Tsvetkov, N.E. Nifantiev
Immunisation with enolase of Trypanosoma cruzi
confers protective immunity against acute phase
of Chagas disease in mice
A. Carabarin-Lima, G. Cortés-Cortés* (Puebla,
Mexico), M.C. González-Vázquez,
O. Rodríguez-Morales, P.A. Reyes, M. Arce-Fonseca,
J.L. Rosales-Encina
eP139
Vaccination with a lipopolysaccharide-deficient
inactivated whole cell vaccine provides
protection against experimental Acinetobacter
baumannii infection
M. García Quintanilla* (Seville, Spain),
J. Pachón Díaz, M.J. McConnell
eP140
Development of a novel six-valent recombinant
protein vaccine against toxoplasmosis using
antigens discovered by high-throughput protein
microarray analysis of patient and infected
murine model sera
M. Doskaya* (Izmir, Turkey), E. Atalay, L. Liang,
A. Caner, H. Can, S. Gulce Iz, D.H. Davies,
A. Degirmenci Doskaya, P.L. Felgner, Y. Guruz
96
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
Retrospective database analysis of the impact of
pneumococcal conjugate vaccines on otitis media
and pneumonia among children in Germany
A. Busse, M. Laurenz, R. Sprenger, C. Von Eiff*
(Berlin, Germany)
eP157
A Streptococcus pneumoniae serotype 19F wzy
variant in Venezuela and pneumococcal vaccine
cross-protection
M.C. Sisco* (Caracas, Venezuela),
I.A. Rivera-Olivero, E. Simonetti, C. De Jong,
J. Hinds, P.W. Hermans, J.H. De Waard
eP158
Pherotype diversity is not affected by conjugate
vaccine-induced serotype changes
J. Diamantino-Miranda, S.I. Aguiar, J. Melo-Cristino,
M. Ramirez* (Lisbon, Portugal)
eP159
Feasibility of a single priming dose of the
meningococcal group C conjugate vaccine
NeisVac-C in infants
E.M. Poellabauer, B.G. Pavlova, S. Fritsch, J. Singer,
C. Neubauer, R. Petermann* (Vienna, Austria),
J. Doralt, B. Valenta-Singer, G. Aichinger
eP160
Plasmablasts and antibody response to
Haemophilus influenzae type B vaccine in
patients with chronic lymphocytic leukemia
E. Grywalska* (Lublin, Poland), A. Surdacka,
I. Korona-Glowniak, A. Malm, J. Rolinski
Recombinant vaccine for prevention of
Streptococcus pneumoniae infection
A. Suvorov* (St. Petersburg, Russia),
G. Leontieva, A. Orlov, N. Kramskaya, I. Koroleva,
I.L.I.A. Dukhovlinov
eP149
Distribution of serotypes causing invasive
pneumococcal disease in adults in 2010-2013 in
Spain (Odin study group)
A. Fenoll* (Madrid, Spain), E. Cercenado,
C. Ardanuy, F. Marco, A. Fleites,
J.L. Lopez-Hontangas, M.C. Zuñiga, B. Palop,
J. Liñares, I. Cifuentes
eP150
Per-serotype clinical presentations of invasive
pneumococcal disease in adults in Spain
(2010-2013). The Odin study group
A. Torres* (Madrid, Spain), A. Burillo, R. Pallares,
L. Molinos, M. Salavert, D. Sousa, J.L. De la Cruz,
I. Alfageme, A. Fenoll, I. Cifuentes
eP151
Serotype distribution and burden of
pneumococcal disease in adults in Germany –
reaching the limit of herd protection?
M. Van der Linden* (Aachen, Germany), M. Imöhl
eP152
Impact of pneumococcal conjugate vaccine on
invasive pneumococcal diseases in children less
than 5 years of age in Morocco
I. Diawara* (Casablanca, Morocco), K. Zerouali,
K. Katfy, H. Belabbes, N. Elmdaghri
eP153
In vitro fitness analysis of pneumococcal strains
before and after introduction of the conjugate
vaccine (PCV7) – what are the most accurate
parameters?
J.P. Fobiwe* (Jena, Germany), O. Makarewicz,
U. Schumacher, M. Lucas, M. Van der Linden, M. Pletz
eP154
Invasive pneumococcal disease in children and
adolescents: incidence of infection and serotype
coverage of conjugate vaccines in Portugal
S.I. Aguiar, M.J. Brito, A. Horácio, J.P. Lopes,
M. Ramirez* (Lisbon, Portugal), J. Melo-Cristino
eP155
Distribution of serotypes causing invasive
pneumococcal disease in adults in Galicia
(Spain) during 2011 and 2012: associated risk
factors, mortality and antibiotic susceptibility
S. Mendez Lage, J.A. Agulla Budiño* (Ferrol, Spain),
I. Losada Castillo, A. Malvar Pintos, X. Hervada Vidal,
P.G.G. Pneumococcal Group from Galicia
Viewing Stations
EPOSTER VIEWING:
Molecular typing of staphylococci
eP161
One-year epidemiological and molecular
analysis of community- and hospital-associated
methicillin-resistant Staphylococcus aureus in
a tertiary hospital in Japan using phage openreading frame typing
S. Inomata* (Sendai-City, Japan), K. Tokuda,
H. Yano, C. Ishizawa, S. Endo, H. Kanamori,
T. Aoyagi, M. Hatta, Y. Gu, M. Kaku
eP163
Relationship between the evolution of
methicillin-resistant Staphylococcus aureus and
the internal structure of variable-number tandem
repeat regions
Y. Skryabin* (Obolensk, Russia), I. Abaev, I. Dyatlov,
D.M. Donovan
24th ECCMID / Barcelona
Final Programme
97
Posters
eP148
Chairs, Speakers & Authors
EPOSTER VIEWING:
Vaccines for pneumococci, Haemophilus and meningococci
ePosters
eP156
Exhibition
Viewing Stations
General Information
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP164
eP165
High-resolution melting analysis for methicillinresistant Staphylococcus aureus spa typing
W. Mazi* (Stockholm, Sweden), V. Sangal, A. Saeed,
G. Sandstorm, J. Yu
Molecular characterisation of methicillinresistant Staphylococcus aureus surveillance
isolates in South Africa
A. Singh-Moodley* (Sandringham, South Africa),
O. Perovic
Viewing Stations
EPOSTER VIEWING:
Antibacterial drug activity and interactions in Gram-positive
organisms
eP170
Vancomycin MIC creep: a fact or an artifact?
M. Souli* (Athens, Greece), H. Giamarellou
On behalf  of The Hellenic Study Group on
Staphylococcal Infections 
eP166
Population dynamics of Staphylococcus aureus
recovered from the airways of cystic fibrosis
patients during a longitudinal prospective
observational multi-centre study
N. Braun, T. Janssen, C. Vogel, S. Deiwick, K. Becker,
G. Peters, B. Kahl* (Münster, Germany)
eP171
Current analysis of oritavancin potency when
tested against vancomycin-resistant/susceptible
enterococcal clinical isolates recovered from
European medical centres (2009-2013)
R.E. Mendes* (North Liberty, United States),
D.J. Farrell, J.M. Streit, R.N. Jones
eP167
Is EMBP a marker of invasiveness of
Staphylococcus epidermidis (SE) strains in
prosthetic joint infection?
M. Titecat* (Lille, France), C. Loiez, B. Grandbastien,
E. Senneville, H. Migaud, R. Courcol, F. Wallet
eP172
eP168
Molecular typing of toxic shock syndrome toxin-1
and enterotoxin A-producing methicillin-sensitive
Staphylococcus aureus isolates from a neonatal
intensive care unit
F. Layer* (Wernigerode, Germany), A. Sanchini,
B. Strommenger, C. Bührer, K. Schenkel,
J. Bätzing-Feigenbaum, U. Nübel, P. Gastmeier,
T. Eckmanns, G. Werner
Activity of oritavancin and comparator agents
against multidrug-resistant staphylococcal
and streptococcal isolates responsible for
documented infections in European hospitals
(2011-2013)
R.E. Mendes* (North Liberty, United States),
D.J. Farrell, R.K. Flamm, H.S. Sader, R.N. Jones
eP173
Longitudinal study of the activity of oritavancin
(ORI) against Staphylococcus aureus (SA) from
Europe (EU) between 2011 and 2013
D.F. Sahm* (Saint Laurent, QC, United States),
D.C. Draghi, G. Moeck, F.F. Arhin
eP174
Oritavancin does not antagonise the activity of
common antibacterial agents for Gram-positive
and Gram-negative infections
A. Belley* (Saint Laurent, QC, United States),
F.F. Arhin, G. Moeck
eP175
Susceptibility of clinical Staphylococcus and
Enterococcus isolates to glycopeptides, linezolid
and daptomycin in oncohaematological patients
in northwestern Greece, during a two-year period
E. Priavali, C. Gartzonika, P. Karagianni, E. Nita,
E. Gesouli, S. Levidiotou* (Ioannina, Greece)
eP176
Mutant prevention concentration (MPC) values
of tedizolid (TDZ) against clinical strains of
methicillin-resistant Staphylococcus aureus
(MRSA) shows a low propensity for resistance
selection
A. Alsaeed, S. Shebelski, J. Blondeau*
(Saskatchewan, Canada)
eP169
98
Clonal relationship of environmental
Staphylococcus epidermidis in hospital and
non-hospital environments
M. Heydorn, L. Radtke, J. Knobloch* (Lübeck,
Germany)
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
eP179
eP180
eP181
eP182
In vitro activity of ceftaroline against
Staphylococcus aureus using concentrations
achieved in humans determined by time-kill
methodology
M. Kresken* (Rheinbach, Germany),
B. Körber-Irrgang
Allosteric site missense mutations in PBP2a
affecting ceftaroline susceptibility detected in
epidemic HA-MRSA clonotypes ST228 (south
German) and ST247 (Iberian) in western
Switzerland
W.L. Kelley, A. Jousselin, C. Barras, E. Lelong,
A. Renzoni* (Geneva, Switzerland)
Comparative in vitro efficacy of ceftaroline and other
anti-staphylococcal antibiotics against a nationwide
collection of nosocomial Staphylococcus aureus
clinical isolates from Greece
M. Souli* (Athens, Greece), H. Giamarellou
On behalf of The Hellenic Study Group on
Staphylococcal Infections
In vitro antimicrobial activity of ceftaroline
against S. aureus strains isolated in Spain
A. Tenorio-Abreu* (Hueva, Spain), J. Gil Tomás,
E. Rodríguez-Molins, R. Ortiz de Lejarazu Leonardo,
M. Borrás Máñez, J. Colomina Rodríguez,
J.M. Saavedra Martín, A. Márquez Sanabria,
A. Domínguez Castaño, M. De La Iglesia Salgado
eP186
In vitro activities of telavancin, vancomycin
and linezolid against Gram-positive organisms
isolated from cancer patients
K. Rolston* (Houston, TX, United States), W. Wang,
L. Nesher, E. Coyle, S. Shelburne, R. Prince
eP187
Antimicrobial activity of ceftobiprole tested
against staphylococci and streptococci from
European countries and Israel (2013)
R.K. Flamm* (North Liberty, IA, United States),
D.J. Farrell, J.M. Streit, H.S. Sader, R.N. Jones
eP188
Ceftobiprole activity tested against bacterial
isolates from hospitalised patients with pneumonia
in European hospitals and Israel (2013)
R.K. Flamm* (North Liberty, IA, United States),
D.J. Farrell, J.M. Streit, H.S. Sader, R.N. Jones
eP189
In vitro and in vivo susceptibility of Streptococcus
pyogenes to trimethoprim-sulphamethoxazole in
northern Australia
A.C. Bowen* (Casuarina, Australia), S.Y.C. Tong,
M.I. McDonald, J.R. Carapetis
eP190
Comparison of solithromycin MIC against
respiratory streptococci determined by EUCAST
and CLSI broth microdilution methodology
I. Morrissey* (Epalinges, Switzerland),
P. Fernandes, B. Lemos, S. Hawser
eP191
Antimicrobial activity of solithromycin tested
against serotyped macrolide-resistant
Streptococcus pneumoniae collected from
medical centres across the USA (2012)
D.J. Farrell* (North Liberty, IA, United States),
R.E. Mendes, R.N. Jones
eP183
In vitro activity of ceftaroline against
EP15T mecC-positive methicillin-resistant
Staphylococcus aureus from humans and
livestock
E. Cercenado* (Madrid, Spain), F. García-Garrote,
M. Marín, A. Vindel, A. Méndez, E. Bouza
eP192
Comparison of commercial methods with broth
microdilution for determining beta-lactam
susceptibilities of Streptococcus pneumoniae
isolates
M. Charles* (Edmonton, Canada), B. Berenger,
L. Turnbull, R. Rennie, J. Fuller
eP184
The use of natural alkaloids and flavonoids in
combination with antibiotics to prevent and
control Staphylococcus aureus biofilms
A.C. Abreu* (Porto, Portugal), I. Gomes, J. Malheiro,
M. Simões
eP193
Activity of ceftaroline against clinically
relevant strains of penicillin non-susceptible S.
pneumoniae
I. Burckhardt* (Heidelberg, Germany), J. Panitz,
P. Jaehn, S. Zimmermann
24th ECCMID / Barcelona
Final Programme
Posters
Pharmacodynamic profile of commonly utilised
parenteral therapies against methicillinsusceptible/resistant Staphylococcus aureus
from US hospitals
S.T. Housman, C.A. Sutherland, D.P. Nicolau*
(Hartford, United States)
Activity of the peptide deformylase inhibitor
GSK1322322 against intracellular forms of
susceptible and resistant S. aureus: comparison
with azithromycin, clindamycin, linezolid,
vancomycin, daptomycin, and moxifloxacin
F. Peyrusson, P.M. Tulkens* (Brussels, Belgium),
F. Van Bambeke
Chairs, Speakers & Authors
eP178
eP185
Exhibition
Beta-lactam combinations with daptomycin
provide synergy against methicillin-resistant
Staphylococcus aureus and vancomycinresistant enterococci
J. Smith* (Royal Oak, United States), K. Barber,
M. Rybak
99
General Information
eP177
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP194
A novel approach using biofilm-time-kill-curves
to assess bactericidal activity of daptomycin
combinations against biofilm-producing
Enterococcus faecium (EFM) and Enterococcus
faecalis (EFC)
K. Barber* (Royal Oak, United States), J. Smith,
A. Raut, M. Rybak
eP201
Telavancin activity against uncommonly isolated
Gram-positive pathogens responsible for
documented infections in hospitals worldwide
(2011-2013) when using a revised susceptibility
testing method
R.E. Mendes* (North Liberty, United States),
H.S. Sader, R.K. Flamm, R.N. Jones
eP195
In vitro activity of cloxacilin against haemolytic
streptococci, pneumococci and Enterococcus
faecalis
K. Ghathian* (Hvidovre, Denmark),
N. Frimodt-Møller, C. Andersen
eP202
Epidemiology and antimicrobial susceptibility of
bacteria isolated from adults with complicated
skin and soft tissue infections in Belgium: results
from a premium ceftaroline study
J. Verhaegen, K. Magerman, H. De Beenhouwer,
G. Claeys* (Ghent, Belgium), D. Pierard, M. Ieven,
A. Vankeirsbilck
eP203
Effect of inoculum size, incubation temperature,
pH, atmosphere, serum, and combination/
synergy testing on the in vitro antibacterial
activity of AZD0914
M.D. Huband, R.A. Giacobbe, S. Patey* (Waltham,
United States)
eP204
Cycloserine as an alternative urinary tract
infection therapy; susceptibilities of 500 urinary
pathogens to standard and alternative therapy
antimicrobials
R. Kugathasan* (London, United Kingdom),
M. Wootton, R. Howe
eP205
Phage sensitivity of multiresistant strains of
microorganisms
A. Melkumyan* (Moscow, Russia), A. Mitichkin,
B. Berezhanskiy, O. Varnavin, A. Alekseev
Viewing Stations
EPOSTER VIEWING:
Antibacterial activity and drug interactions –
miscellaneous organisms and agents
eP196
eP197
eP198
Determination of minimum inhibitory
extracellular concentrations (MIECs) against
intracellular Francisella tularensis subsp.
Holarctica using a dye uptake assay
V. Sutera* (Grenoble, France), Y. Caspar, S. Boisset,
M. Maurin
In vitro susceptibility of Chlamydia trachomatis
strains isolated from Croatian patients
S. Ljubin-Sternak, T. Mestrovic* (Samobor, Croatia),
T. Vilibic-Cavlek, M. Sviben, G. Mlinaric-Galinovic,
A. Markotic, V. Skerk, J. Vranes
Evaluation of direct etest and disk diffusion
methods on blood cultures versus CLSI broth
microdilution reference method for ceftaroline
E. Cercenado* (Madrid, Spain), C. Sánchez-Carrillo,
B. Gama, M. Rodriguez-Creixems, A. Burillo, E. Bouza
eP199
Use of different disinfectants, phytochemicals
and antibiotics to inactivate resistant S. aureus
strains adhered to different materials
I. Gomes* (Porto, Portugal), J. Malheiro, A. Abreu,
F. Mergulhão, M. Simões
eP200
Virulence profiles, antimicrobial resistance and
genetic diversity of Escherichia coli strains of
urosepsis and soft tissue infections from India
and septicaemia isolates from Germany
A. Ranjan* (Hyderabad, India), A. Hussain,
N. Ahmed
100 24th ECCMID / Barcelona
Final Programme
Viewing Stations
EPOSTER VIEWING:
Polymyxins and carbapenem-resistant bacteria
eP206
High-dose intravenous colistin methanesulfonate
therapy is associated with high rates of
nephrotoxicity; a prospective cohort study from
Saudi Arabia
W.A. Alfahad* (Riyadh, Saudi Arabia), A.M. Baadani,
S.K. Aldalbhi, M.M. Shoukri, A.A. Almitwazi,
A.M. Albaraak, A.S. Omrani
eP207
Intravenous colistin for the treatment of
carbapenem-resistant Acinetobacter infections
(CRA): a retrospective review of 86 patients in a
regional hospital in Hong Kong
T.S. Kwong* (Hong Kong, China), T.C. Wu, W. Lam,
M.Y. Chu, H.C. Tang, S.Y. Chan, W.M. Ting
ePoster Viewing
eP217
Combined therapy with in vitro synergy
for the treatment of colistin-resistant
Enterobacteriaceae-KPC infections
S. De Gregorio, M. Nastro, N. Pozzi, C. Rodriguez,
C. Vay, A. Famiglietti, D. Stecher* (Buenos Aires,
Argentina), M. Foccoli
Concordance of empiric antibiotic therapy with
cultures from percutaneous cholecystostomy and
outcomes of patients with acute cholecystitis:
a cohort study
Y. Brodsky, O. Nitzan* (Afula, Israel), D. Hershko,
H. Edelstein, B. Chazan
eP218
No association between colistin daily dose and
clinical outcomes with low colistin dosing
L. Farbman* (Tel Aviv, Israel), E. Goldberg, D. Yahav,
J. Bishara, L. Leibovici, M. Paul
Does timely antimicrobial administration improve
mortality in septic patients admitted to ICU?
R. Pai* (London, United Kingdom), D. Tyl,
A. Gonzalez-Ruiz, M. Sange
eP219
Prudent prescribing versus prompt sepsis
treatment: using resistance surveillance to strike
the balance
A. Boulos, H. Brennan, C. Mallon, G. Ong* (Belfast,
United Kingdom)
eP220
Effects of inappropriate empirical antimicrobial
treatment on patients with coagulase-negative
staphylococcal bacteraemia
S. Park* (Goyang-si, Korea), J.-W. Chung, H. Huh,
S. Chae
eP221
Predictors of hospital mortality among ICU
patients with Gram-negative sepsis:
a cohort study
M. Zilberberg* (Goshen, MA, United States),
A.F. Shorr, S.T. Micek, M. Kollef
eP211
Intravenous polymyxin B: a retrospective
cross-sectional study to evaluate its use and
clinical outcomes
W.H.W. Ng* (Singapore, Singapore), Y. Yao, J.X.H. Li
eP212
Effect of a probiotic preparation (VSL#3) on
Klebsiella KPC enteric colonisation
A. Perrella* (Naples, Italy), C. Sbreglia, P. Bellopede,
G. Amato, M. Conte, O. Perrella
Viewing Stations
EPOSTER VIEWING:
Empirical antibiotic treatment
eP213
eP214
eP215
Optimisation of the length of empirical
antimicrobial therapy in patients with cancer and
febrile neutropenia
A. Martin-Pena* (Seville, Spain), M. Aguilar-Guisado,
J. Falantes, M.L. Martino, R. Parody, I. Montero,
J. Gónzalez-Campos, I. Espigado, J.M. Cisneros
Developing a score to shorten the time to
initiation of appropriate therapy for extensively
drug-resistant Gram-negative bacilli and avoid
unnecessary use of polymyxins
I. Vitkon-Barkay, M. Yekutiel, E.M. Martin,
K.N.F. De Almeida, D. Nestor, G. Geva, J. Volfson,
T. Azouri, K.S. Kaye, D. Marchaim* (Zerifin, Israel)
Delay in diagnosis of infective endocarditis
in Japan
T. Fukuchi* (Kobe, Japan), K. Iwata, G. Ohji
Viewing Stations
EPOSTER VIEWING:
The evolution of colistin resistance
eP222
The evolution of high colistin resistance in
Pseudomonas aeruginosa
N. Jochumsen, R.L. Marvig, S. Damkiær,
R.L. Jensen, L. Jelsbak, S. Molin,
A. Folkesson* (Fredriksberg, Denmark)
eP223
The mgrB gene as a key target for acquired
resistance to colistin in Klebsiella pneumoniae
L. Poirel* (Fribourg, Switzerland), A. Jayol,
M.V. Villegas, S. Turkoglü, P. Nordmann
24th ECCMID / Barcelona
Final Programme
Posters
Appropriateness of antimicrobial therapy in
patients with healthcare-associated bacteraemia
E. Van Hauwermeiren, P. Lanza, A. Zoncada,
S. Lorenzotti, F. Zacchi, C. Fornabaio, L. Galli,
M. Fornaciari, A. Pan* (Cremona, Italy)
Chairs, Speakers & Authors
eP210
eP216
101
Exhibition
eP209
Effectiveness of double-carbapenem regimen
in carbapenem and colistin-resistant Klebsiella
pneumoniae bloodstream infections: correlation
with in vitro analysis
A. D’Abramo* (Rome, Italy), A. Oliva, M.T. Mascellino,
C. D’Agostino, M. Iannetta, C. Gallinelli,
C.M. Mastroianni, V. Vullo
General Information
eP208
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP224
eP225
eP226
Resistance to colistin associated with an
identical mutation in protein PmrB among
clonally-unrelated Klebsiella pneumoniae
isolates
L. Poirel* (Fribourg, Switzerland), A. Jayol,
M.V. Villegas, M. Ozdamar, A. Brink, P. Nordmann
The role of outer membrane protein loss in
colistin-resistant Klebsiella pneumoniae ST258
and Enterobacter asburiae clinical isolates
B. Kocsis* (Budapest, Hungary), B. Kádár, A. Fullár,
P. Felso, B. Kocsis, K. Böddi, K. Kristóf, Á. Tóth,
K. Nagy, D. Szabó
Phenotypic and molecular characterisation of
colistin-resistant A. baumannii clinical isolates
from Greek hospitals
K. Dafopoulou, I. Kristo, O. Zarkotou, A. Poulou,
V. Gogou, C. Hadjichristodoulou, A. Tsakris,
S. Pournaras* (Athens, Greece)
eP227
A comparison of the diagnostic value of MRI and
FDG-PET/CT in suspected spondylodiscitis
C. Smids, I.J.E. Kouijzer, F.J. Vos, T. Sprong,
A.J.F. Hosman, J.W.J. De Rooy, W.J.G. Oyen,
C.P. Bleeker-Rovers* (Nijmegen, The Netherlands)
eP228
Is preoperative joint fluid aspiration useful for the
diagnosis of periprosthetic joint infection?
A. Bicart See, E. Bonnet* (Toulouse, France),
J. Lourtet, T. Pollon, J. Remi, C. Livideanu, P. Marlin,
L. Gautie, M. Felice, G. Giordano
eP229
Evaluation of BacT/Alert FAN blood culture bottles
inoculated with sonication fluid for the diagnosis
of implant-associated infection
A. Siverio* (Barcelona, Spain), M. Salvadó,
C. Heredia, D. Pérez, A. Alier, L. Sorli, J.P. Horcajada,
L. Puig, J. Gómez, M. Portillo Bordonabe
eP230
eP231
Matrix-assisted laser desorption ionization time
of flight mass spectrometry and prosthetic joint
infection
T. Peel* (Melbourne, Australia), N.C. Cole, B.L. Dylla,
R. Patel
Use of molecular techniques in the microbial
diagnosis of infectious spondylodiscitis
H. Jacquier* (Paris, France), V. Fihman, F. Meunier,
V. Delcey, R. Kaci, J. Laredo, F. Lioté, F. Zadegan,
E. Cambau, B. Berçot
24th ECCMID / Barcelona
Final Programme
Viewing Stations
EPOSTER VIEWING:
Antifungal drug susceptibility and resistance
eP232
Echinocandin MICS against Candida species at
hospitals that routinely perform susceptibility
testing of bloodstream isolates
G. Eschenauer, M.H. Nguyen, S. Shoham,
J. Vazquez, A. Morris, C. Kubin, P. Carver, K. Hanson,
S. Chen, C.J. Clancy* (Pittsburgh, United States)
eP233
A 7-year review of Candida isolates and antifungal susceptibility from clinical specimens in
Alberta, Canada
J. Kanji* (Edmonton, Canada), A. Bull, S. Shokoples,
J. Fuller
eP234
Low rate of cryptic species and antifungal
resistance in Candida isolates causing
candidaemia in Madrid
L.J. Marcos-Zambrano, P. Escribano, P. Muñoz,
E. Bouza, J. Guinea Ortega* (Madrid, Spain)
eP235
Species distribution and antifungal
susceptibilities of bloodstream Candida sp. from
the Asia-Pacific region
T.Y. Tan* (Singapore, Singapore), L.Y. Hsu,
M.M. Alejandria, T. Chinniah, P. Kiratisin, J.H. Shin,
T.T.N. Tran, A.L. Tan, L.S.Y. Ng
eP236
Comparative evaluation of a new commercial
colorimetric microdilution assay (SensiQuattro
Candida EU) with E-test and EUCAST broth
microdilution for susceptibility testing of
invasive Candida isolates
H.L. Köhling* (Essen, Germany), B. Willinger,
J. Buer, P.-M. Rath, J. Steinmann
eP237
CAS5 influences the activity of fluconazole
against Candida albicans
E.M. Vasicek, E.L. Berkow* (Memphis, TN, United
States), S.A. Flowers, K.S. Barker, P.D. Rogers
eP238
Is micafungin uniformly active against Candida
albicans biofilms showing different degrees of
metabolic activity?
L.J. Marcos-Zambrano, P. Escribano, E. Bouza,
J. Guinea Ortega* (Madrid, Spain)
eP239
Candidaemia in Bulgaria: an open follow-up
multicentre survey
A. Kouzmanov* (Sofia, Bulgaria), Z. Ivanova,
I. Philipova, T. Velinov, T. Kantardjiev
Viewing Stations
EPOSTER VIEWING:
Diagnosis of osteoarticular infection
102
ePoster Viewing
eP242
Echinocandin failure case due to a yet unreported
FKS mutation in Candida krusei
R. Jensen* (Copenhagen, Denmark), U. Justesen,
A. Rewes, D. Perlin, M. Arendrup
eP243
Twofold point mutations in Candida albicans FKS1
gene leading to echinocandin resistance after
long-term treatment
K. Heidrich, R. Krause* (Graz, Austria), M. Hoenigl,
C. Lass-Floerl, W. Buzina
eP244
eP245
eP246
eP247
eP248
Identification of novel transcription factors
associated with azole resistance in Aspergillus
fumigatus
E. Davies* (Manchester, United Kingdom),
M. Fraczek, P. Bowyer, R. Collins, M. Bromley
Surveillance of azole resistance among
environmental isolates of Aspergillus fumigatus
species complex in a general hospital in Madrid
T. Pelaez Garcia* (Madrid, Spain), S. Álvarez-Pérez,
M.E. García, J.L. Blanco, B. Gama, E. Mellado,
E. Bouza
Aspergillus fumigatus with prior azole exposure
decreases amphotericin B sensitivity in vitro
R. Rajendran* (Glasgow, United Kingdom),
C. Williams, B. Jones, G. Ramage
Investigation of primary clinical samples and
azole-resistant isolates of immunocompromised
patients for cyp51A mutations in Aspergillus
fumigatus using established and a novel TR46
PCR assays
B. Spiess* (Mannheim, Germany), P. Postina,
A. Hamprecht, J. Vehreschild, C. Lass-Flörl,
M. Hönigl, P.-M. Rath, T. Miethke,
W.-K. Hofmann, D. Buchheidt
Occurrence and molecular characterisation
of triazole-resistant Aspergillus fumigatus in
outdoor and hospital environment in Kuwait
Z. Khan* (Safat, Kuwait), S. Ahmad, L. Joseph,
A. Theyyathel, F. Hagen, J.F. Meis, J.F. Meis
eP250
Molecular identification and antifungal
susceptibility of Aspergillus clinical isolates from
11 hospitals in Korea
J.H. Shin* (Gwangju, Korea), S.H. Kim, M.J. Choi,
Y.J. Park, H.S. Lee, S.J. Jang
eP251
Antifungal susceptibility and outcome of
invasive fungal infection: a 10-year retrospective
electronic chart review
T. Wrba, B. Willinger, W. Graninger,
M. Diab-Elschahawi, E. Presterl* (Vienna, Austria)
eP252
First Danish report of TR34/L98H A. fumigatus
in three non-cystic fibrosis patients despite
apparent lack of resistant isolates in recent soil
samples
K.M.T. Astvad* (Valby, Denmark), R.H. Jensen,
T.M. Hassan, E.G. Mathiasen, G.M. Thomsen,
U.G. Pedersen, M. Christensen, M.C. Arendrup
eP253
Candida parapsilosis antifungal resistance:
a Portuguese surveillance survey
J. Branco, A. Silva-Dias, C. Martins-Cruz, N. Gomes,
A. Pinto-Silva, R. Silva, T. Gonçalves, C. Pina-Vaz,
A.G. Rodrigues, I.M. Miranda* (Porto, Portugal)
eP254
Performance in EQA for antifungal susceptibility
from 2007 to 2013 by United Kingdom national
external quality assessment service
S. Seaton* (London, United Kingdom), E. Johnson,
E. Fagan, C. Walton
eP255
In vitro antifungal synergy testing against spores
and hyphae of Mucorales and Fusarium species
A. Bakossi, M. Siopi, J. Meletiadis, G.L. Petrikkos*
(Athens, Greece), M. Drogari-Apiranthitou
eP256
Correlation of early trough levels (day 4)
with steady-state posaconazole plasma
concentrations – a cohort study
M. Hoenigl* (Graz, Austria), W. Duettmann,
B. Huber-Krassnitzer, J. Wagner, J. Prattes,
K. Troppan, K. Seeber, R.B. Raggam, A. Wölfler,
R. Krause
eP257
Determination of susceptibility breakpoints for
posaconazole and Aspergillus fumigatus using a
pharmacokinetic-pharmacodynamic model
A. Elefanti* (Athens, Greece), E. Mavridou,
J. Mouton, P.E. Verweij, J. Meletiadis
24th ECCMID / Barcelona
Final Programme
Posters
Antifungal susceptibility profiles of pathogens of
invasive candidiasis in Russia
E. Raush* (St. Petersburg, Russia), N. Vasilyeva,
E. Shagdileeva, N. Klimko
Simple, low-cost molecular detection of TR34/
L98H mutations in cyp51A gene for rapid
detection of triazole-resistant Aspergillus
fumigatus isolates
S. Ahmad* (Safat, Kuwait), Z. Khan, L. Joseph,
F. Hagen, J. Meis, J. Meis
Chairs, Speakers & Authors
eP241
eP249
Exhibition
Impact of the exposure of clinically relevant
yeasts to agricultural azoles in terms of
antifungal resistance
I. Faria-Ramos* (Porto, Portugal),
P. Ribeiro-Tavares, J. Neves-Maia, E. Ricardo,
I.M. Miranda, L.M. Estevinho, C. Pina-Vaz,
A.G. Rodrigues
103
General Information
eP240
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP258
In vitro evaluation of the efficacy of voriconazoleanidulafungin combination against azolesusceptible and -resistant Aspergillus
fumigatus strains with a novel pharmacokineticpharmacodynamic (PK-PD) model
M. Siopi* (Athens, Greece), N. Siafakas, L. Zerva,
J. Meletiadis
eP266
Impact of a hydrogen peroxide vapour-based
decontamination method on the infectivity and
detectability of feline caliciviruses as surrogates
for human noroviruses
S. Fister* (Vienna, Austria), F. Allerberger,
M. Wagner, P. Rossmanith
eP259
Optimising antifungal combination therapy
of voriconazole+amphotericin B against
Aspergillus fumigatus using a pharmacokineticpharmacodynamic (PK-PD) model
M. Siopi* (Athens, Greece), N. Siafakas, L. Zerva,
J. Meletiadis
eP267
Assessing the efficacy of two commonly used
disinfecting agents in hospital isolation rooms
M. Smith* (Kilmarnock, United Kingdom),
W.G. Mackay, K. Smith, C. Woodall, C.L. Williams,
R.G. Masterton
eP268
HyperDRYMist® system of 99T: major impact
in reducing surface bacterial and fungal
contamination
C. Dalla Valle, V. Monzillo, D. Scevola* (Pavia, Italy),
P. Marone
eP269
Using electrolysed water to clean near-patient
sites: is disinfectant better than detergent?
M. Stewart* (Glasgow, United Kingdom),
S.J. Dancer, A. Bogusz, J. Hunter, I. Devanny, B. Yip,
D. Reid, C. Robertson
eP270
Environmental sampling of air and surfaces on
hospital wards. What does it tell us?
T. Claro* (Dublin, Ireland), M. O’Reilly, H. Humphreys
Effects of a syphon disinfection device on
colonisation with multiresistant Pseudomonas
aeruginosa in sinks on a tertiary care centre ICU
E.H.R. Van Essen* (Leiden, The Netherlands),
M.G.J. De Boer, R.B.P. De Wilde,
H.C.M. Dogterom-Ballering, K.E. Veldkamp,
E. De Jonge
eP271
Antimicrobial resistant Gram-negative bacilli in
the ICU: examining the interplay between patient
colonisation and environmental contamination
H. McDermott* (Dublin, Ireland), M. Scally,
H. Humphreys, D. Fitzgerald-Hughes
Bath basins in healthcare settings from Europe
and North America as common reservoirs for
multi-drug resistant organisms
B. Ackerman, K.S. Kaye, D. Marchaim* (Zerifin,
Israel)
eP272
Stethoscope bacterial contamination and
cleaning practices among healthcare workers in a
district general hospital
N. Virgincar* (Reading, United Kingdom),
H. Aubrey-Jones, J. Hayward, J. Pritchard, L. Hosie
eP273
Endoscopy rinse water testing: 5 years’
experience
A. Marek* (Glasgow, United Kingdom), M. Peat,
A. Connell, I. Gillespie, A. Hamilton, D. Shaw,
A. Stewart, K. Hamilton, I. Smith, A. Smith
eP274
Persistence of microbial contamination on
transvaginal ultrasound probes despite low-level
disinfection procedure
F. MZali* (Bordeaux, France), S. Leroy, Y. Mekki,
C. Quentin-Noury, M. Kann
eP260
Reported cardiovascular events during
echinocandin pharmacotherapy
J. Cleary* (Brandon, United States), S.T. King,
K.R. Stover
eP261
In vivo evaluation of cardiac effects of
caspofungin
K.R. Stover* (Jackson MS, United States),
J.D. Cleary
Viewing Stations
EPOSTER VIEWING:
Assessing and decreasing environmental contamination
eP262
eP263
eP264
eP265
Decontamination of hospital surfaces using an air
plasma multi-jet
T. Claro* (Dublin, Ireland), O. Cahill, N. O’Connor,
S. Daniels, H. Humphreys
Efficacy of HyperDRYMist® micro-nebulised
hydrogen peroxide in reducing hospital-acquired
infections
M. Ferrari* (Lodi , Italy), A. Bocconi, A. Anesi,
C. Garzoni
104 24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
Do we really need to coat the novel silicone
intranasal splints with antibiotics? Dividing fact
from fiction
Z. Ciftci, M. Aydin* (Tekirdag, Turkey), A.D. Kaya,
G. Varol Saracoglu, M. Deniz, E. Gultekin
eP278
eP279
Copper-coated textiles with potent antimicrobial
activity against methicillin-resistant
Staphylococcus aureus
I. Galani, G. Priniotakis, K. Orlandou, I. Chronis,
A. Tzerachoglou, G. Petrikkos* (Athens, Greece),
M. Souli
Antimicrobial activity of copper-nickel-coated
door handles: a blind randomised controlled trial
in clinical setting
E.A. Idelevich* (Münster, Germany), I. Sielemann,
G. Peters, C. Gebert, K. Becker
eP280
Can toy wash and disinfection reduce bacteria
load and sickness in day care centres?
T. Ibfelt* (Copenhagen, Denmark), L. Andersen
eP281
Pneumatic transport systems (PTS) are prone to
contamination with multiresistant organisms –
lessons learned from an Acinetobacter spp.
(GIM-1) pseudooutbreak at a large university
hospital
M. Herrmann* (Homburg/Saar, Germany),
S. Jungmann, A. Dawson, A. Halfmann, M. Kaase,
S. Gatermann, L. Von Müller, B. Gärtner
eP282
eP283
Correlation of the safety climate in the internal
medicine departments and intensive care units
(ICUs) of a general hospital with the rate of
healthcare-associated infections
A. Karaiskou, A. Arvaniti, E. Trikka-Graphakos,
S. Sympardi* (Corfu, Greece), A. Kyratsa,
F. Klouva-Molyvdas
Prevalence of E. coli and coliform bacteria in
children’s playground sand in Austria
A. Badura* (Graz, Austria), G. Feierl, E. Leitner,
J. Luxner, L. Masoud-Landgraf, H. Galler, R. Riedl,
A.J. Grisold
Street-vending foods: an underestimated vehicle
of bacteria carrying virulence factors and
antibiotic resistance genes
J. Campos* (Porto, Portugal), J. Gil, J. Mourão,
L. Peixe, P. Antunes
eP286
Water quality of swimming pools:
a growing public health concern
M.J. Neuparth, A. Gomes, S. Alves, C. Diniz,
N. Ferreiro, J. Proença, S. Quinteira*
(Vila Nova Famalicao, Portugal)
eP287
External quality assessment for laboratory
testing of hospital tap water – findings from an
international pilot scheme
N. Patel* (London, United Kingdom)
Viewing Stations
EPOSTER VIEWING:
Basic science: biofilm pathophysiology
eP288
Setting up a NADH oxidase (NOX)-based assay
to quantify antibiotic activity in pneumococcal
planktonic cultures and biofilms
N.M. Vandevelde* (Brussels, Belgium),
Y. Dias Iglesias, P.M. Tulkens, F. Van Bambeke
eP289
Anti-biofilm activity secreted by Staphylococcus
aureus against Staphylococcus epidermidis
M. Tilotta* (Rome, Italy), R. Papa, A. Cellini, L. Selan,
M. Artini
eP290
Evidence for the involvement of Staphylococcus
epidermidis LPXTG surface protein SesC in biofilm
formation and catheter-related infections
L. Khodaparast* (Leuven, Belgium),
L. Khodaparast, M. Shahrooei, J. Van Eldere
eP291
Alpha-toxin production by clinical wound isolates
of Staphylococcus aureus correlates with
mucosal biofilm formation
M. Anderson* (Minneapolis, United States),
E. Schaaf, H. Wang, J. Johnson, M. Peterson
eP292
Serologic responses against biofilm-associated
Staphylococcus epidermidis cell surface
structures during prosthetic joint infections
H. Ocal* (Hamburg, Germany), G. Franke,
H. Büttner, M. Kohns, J.U.M.I. Klettke, T. Lange,
D. Mack, H. Rohde
24th ECCMID / Barcelona
Final Programme 105
ePosters
eP277
eP285
Posters
Risk of HIV and hepatitis C infection related to
endocavitary ultrasound probe exposure
T. Bénet* (Lyon, France), J. Ritter, P. Vanhems
High presence of Enterobacteriaceae and other
microorganisms isolated from meat products
L. Ruiz* (Barcelona, Spain), M.J. Pons, C. Gomes,
S. Martinez Puchol, N. Palma, T.J. Ochoa, J. Ruiz
Chairs, Speakers & Authors
eP276
eP284
Exhibition
A novel approach for in vitro evaluation of the
potential risk of patient contamination during
endovaginal ultrasound examinations
F. MZali* (Bordeaux, France), S. Leroy, M. Kann,
C. Quentin-Noury
General Information
eP275
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP293
eP294
eP295
eP296
Identification of a core microbiome of
endotracheal tubes associated with
Pseudomonas aeruginosa and/or Staphylococcus
epidermidis
A. Hotterbeekx* (Wilrijk, Belgium), B.B. Xavier,
P. Moons, C. Lammens, M. Ieven, P. Jorens,
E. Vandenbroeck, S. Kumar-Singh, H. Goossens,
S. Malhotra-Kumar
eP302
Use of a microfluidic system to study biofilm
formation in pathogenic Escherichia coli
Y.D.N. Tremblay, P. Vogeleer, J. Harel,
M. Jacques* (St-Hyacinthe, Canada)
eP303
Investigation of biofilm formation recovered from
endotracheal tubes among intensive care unit
paediatric patients
M.J.C. Salles* (São Paulo, Brazil),
G.F. Da Costa Leite, R.Y. Koto, T.O. Ferreira,
M.J. Mimica, C.B. Silva, A.P.I. Fonseca Souza,
S. Nigro, M.H. Yano
Investigation of the effect of different
temperature and acidic conditions on biofilm
structure of Salmonella enterica serotype
Virchow by FTIR spectroscopy
M.N. Badali* (Ankara, Turkey), N. Igci, M. Diani,
M. Akçelik, N. Akçelik
eP304
Polymicrobial biofilms by diabetic foot clinical
isolates
C. Mottola* (Lisbon, Portugal), J.J. Mendes,
J. Melo-Cristino, P. Cavaco-Silva, L. Tavares,
M. Oliveira
Effect of supernatants from selected
periopathogen cultures on ATP levels in human
gingival fibroblasts
A.K. Szkaradkiewicz, T.M. Karpinski,
I. Chudzicka-Strugala* (Poznan, Poland),
O. Goslinska-Kuzniarek
eP305
Biofilm production, adherence capacity, cellular
surface hydrophobicity and secreted aspartyl
protease activity of different species of the
genus Candida isolated from haemocultures
M.T. Blanco-Blanco* (Badajoz, Spain), M.A. Galán,
M.T. Blanco, L. Lucio, C. Pérez-Giraldo, A.C. GómezGarcía
BCR1 independent biofilm formation of outbreak
related Candida parapsilosis isolates from
nosocomial bloodstream infections
S. Pannanusorn* (Stockholm, Sweden), T. Schön,
J. Morschhäuser, U. Römling
Viewing Stations
EPOSTER VIEWING:
Biomarkers
eP297
Assessing composition and micromorphology of
biofilm in urinary catheters
I. Caola, F. Tessarolo* (Mattarello, Italy),
M. Leonardi, T. Cai, F. Piccoli, G. Nollo, G. Malossini,
R. Bartoletti, P. Caciagli
eP306
Diagnostic and prognostic value of serum
presepsin in cirrhotic patients with spontaneous
bacterial peritonitis
H. Okasha* (Alexandria, Egypt), A. Elgohary,
A. Abd El Moety, A. Elbadawy
eP298
Molecular investigation of bacterial
communities on intravascular catheters: not just
Staphylococcus anymore
L. Zhang* (Brisbane, Australia), G. John,
M. Morrison, L. Krause, C. Rickard
eP307
The superiority of procalcitonin versus C-reactive
protein in sepsis diagnosis
E. Puca* (Tirane, Albania), P. Pipero, A. Pilaca,
G. Stroni, E. Qyra, T. Kalo, E. Puca, G. Huti, K. Allajbeu,
D. Kraja
eP299
Regulatory systems of Streptococcus mutans in
biofilm formation on injured heart valves
S.C. Jung, J.S. Chia* (Taipei, Taiwan)
eP308
eP300
Development of a novel in vitro device that
simulates the real life of the biofilm formation
on catheters under both static and dynamic
systems
M. El-Azizi* (Cairo, Egypt)
Comparison of molecular and glutamate
dehydrogenase tests in a multistep diagnostic
algorithm in the laboratory diagnosis of
Clostridium difficile
E. Ho* (Antwerp, Belgium), W. Van Nijnatten,
I. Mermans, M. Ieven
eP309
Immunological predictors of nosocomial infection
in intensive care
O. Dzupova* (Prague, Czech Republic), A. Davidova,
O. Beran, J. Benes, M. Holub
eP301
Characterisation of a quroum sensing system in
Acinetobacter baumannii that enhances the pili
assembly and biofilms proficiency
L.M. Luo, L.J. Wu, Y.L. Xiao, D. Zhao, Y.C. Huang,
M. Kang, Q. Zhang, Y. Xie* (Chengdu, China)
106 24th ECCMID / Barcelona
Final Programme
ePoster Viewing
eP312
eP313
eP314
eP315
Screening of potential serological markers for
diagnosis of Pneumocystis pneumonia (PCP)
F. Esteves* (Lisbon, Portugal), S. Calé, B. De Sousa,
J. Gaspar, R. Badura, F. Antunes, M. Olga
Metabolic biomarkers for treatment outcome of
sepsis and injury-related SIRS
O. Rzhepishevska* (Umea, Sweden), S. Gouveia,
R. Pinto, M. Nording, J. Sunden-Cullberg,
Å. Johansson
Host biomarkers of inflammation and endothelial
activation as an alternative to chest x-ray among
Tanzanian children with clinical pneumonia:
a cohort study
V. D’Acremont, K.T. Hayford, L.K. Erdman,
M. Kilowoko, E. Kyungu, S. Philippina, L. Alamo,
W. Sangu, B. Genton* (Lausanne, Switzerland),
K. Kain
Clinical usefulness of infection biomarkers in
neutropenic SIRS patients in standard care wards
F. Ratzinger* (Vienna, Austria), I. Tsirkinidou,
M. Schuardt, K. Eichbichler, H. Haslacher,
T. Perkmann, H. Burgmann
Use of avibactam to detect ambler
class A carbapenemases and OXA-48 in
Enterobacteriaceae
N. Porres-Osante, C. De Champs, H. Dupont,
C. Torres, H. Mammeri* (Amiens, France)
eP319
Quantitative modified Hodge test (Q-MHT)
interpretation for the detection of Klebsiella
pneumoniae carbapenemase (KPC) in
Enterobacteriaceae. Is that possible?
A.P. Cury, J. Nobrega de Almeida Júnior, M. Maffucci,
H. Hehl Caiaffa Filho, F. Rossi* (São Paulo, Brazil)
eP320
Combined use of the modified Hodge test and
Carba NP test for the detection of carbapenemase
production in Gram-negative bacteria
W. Song* (Seoul, Korea), S.H. Jeong, S.G. Hong,
J.S. Kim, H.S. Kim
eP321
Pilot evaluation of the BLACTA test for predicting
3rd generation cephalosporin resistance (3GCR)
in Escherichia coli, Klebsiella pneumoniae,
Klebsiella oxytoca and Proteus mirabilis from
blood
B.M. Willey* (Toronto, Canada), X. Trimi, P. Lo,
S.M. Poutanen
eP322
Evaluation of ChromID®CARBA and
ChromID®OXA-48 media for the detection of
carbapenemase-producing Acinetobacter spp
P. Higgins* (Cologne, Germany), L. Devigne,
H. Seifert
eP323
Evaluation of the new strip E-test KPC MP/MPB
for K. pneumoniae carbapenemases detection in
comparison with Liofilchem® KPC strips on a large
Enterobacteriaceae collection
D. Halimi, R. Noblecourt, M. Pompilio, V. Sauvonnet,
G. Durand, G. Zambardi, R. Martelin* (La BalmeLes Grottes, France)
eP324
Accuracy of susceptibility test methods for the
detection of meropenem resistance in Gramnegative bacilli
F. Hurren* (Melbourne, Australia), J. Montgomery,
J. Wang, J. Ellem
Viewing Stations
EPOSTER VIEWING:
Diagnostics: detection of ESBLs and carbapenemases
eP316
eP318
Improving screening for carbapenemaseproducing organisms: evaluation of two
chromogenic media and confirmatory disc
diffusion assays
G.L. Vanstone* (London, United Kingdom),
A. Lyons, A. Morkowska, A. Williams, R. Smith,
I. Balakrishnan
24th ECCMID / Barcelona
Final Programme
Posters
Role of CD64 on monocytes and HLA-DR on
neutrophils in the diagnosis of sepsis and
outcome of critically ill patients
M. Papadimitriou Olivgeris* (Patras, Greece),
K. Lekka, K. Zisimopoulos, I. Spiliopoulou,
K. Filos, E. Anastassiou, F. Fligou, M. Karakantza,
M. Marangos
Phenotypic markers to suspect OXA-163
carbapenemase producers (OXA-163 PE) in
species of Enterobacteriaceae: a OXA-48 related
carbapenemase with low-level temocillin
resistance
F. Pasteran* (Buenos Aires, Argentina), O. Veliz,
E. Albornoz, C. Lucero, S. Gomez, G. Romero Thomas,
OXA-Arg Group, A. Corso
107
Chairs, Speakers & Authors
eP311
eP317
Exhibition
Procalcitonin in patients with cancer: role of
biomarker-assisted diagnosis for bacterial
infections, SIRS and sepsis syndrome
J. Torres Isasiga, J. Teperman, Y. Dubrovskaya,
R. Press, A. Safdar* (New York, United States)
General Information
eP310
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP325
Use of temocillin for identification of class D
carbapenemases
M. Cordovana* (Bologna, Italy), M.V. Tamburini,
G. Roncarati, A. Berlingeri, S. Ambretti, C. Foschi,
P. Gaibani, M.P. Landini
eP326
Phenotypic screening of carbapenemase
production in carbapenem-resistant Klebsiella
pneumoniae and Pseudomonas aeruginosa
strains
E. Protonotariou, P. Dimitriadis, O. Vasilaki,
D. Papadopoulou, S. Koufos, S. Varlamis*
(Thessaloniki, Greece), P. Tsiavi, S. Metallidis,
E. Diza, L. Skoura
eP333
A retrospective evaluation of the rapid biorad BLACTA test to detect 3rd generation
cephalosporin resistance (3GCR) in
Enterobacteriaceae (ENT)
B.M. Willey* (Toronto, Canada), D.A. Boyd, X. Trimi,
A. Tsang, O. Oleung, S. Kim, I. Manji, P. Lo, M. Mulvey,
S.M. Poutanen
eP334
Evaluation of methods for detection of VIM-1carbapenemase-producing Enterobacteriaceae in
bovine minced meat
M. San José, H. Hasman, J. Fischer, Y. Agerso,
S. Schmoger, S. Jahn, K. Thomas, E. Guiral,
R. Helmuth, B. Guerra Roman* (Berlin, Germany)
eP327
Further validation of Blue-CARBA, a recently
described quick and reliable method for
carbapenemase detection
J. Pires* (Porto, Portugal), Â. Novais, L. Silva,
J. Campos, J. Botelho, I. Czobor, I. Gheorghe, L. Peixe
eP335
Evaluation of the Rapid CARB Screen Diatab test
for the detection of carbapenemase production in
Gram-negative bacteria
B. Bharathan* (London, United Kingdom),
O. Oikonomou, D. Wareham, L. Phee
eP328
Characterisation of carbapenemase-producing
Enterobacteriaceae in colonised patients:
correlation between phenotypic and molecular
methods
C. Casares Peinado* (Madrid, Spain), B. Plata,
I. Sanchez-Romero, J. Oteo, V. Bautista, N. Lara,
F. Portero
eP336
Evaluation of chromid OXA-48 for the recovery of
carbapenemase-producing Enterobacteriaceae
from rectal swabs from hospitalised patients in
Ankara, Turkey
P. Zarakolu, K. Day, C. Lanyon, S. Cummings,
M. Akova, J. Perry* (Newcastle-upon-Tyne,
United Kingdom)
eP329
Screening of carbapenemase- and ESBLproducing bacteria with the Carba NP and ESBL
NDP tests, and correlation with molecular tests
A. Mazzariol* (Verona, Italy), G. Petrosino,
A.R. Centonze, M. Parisato, C. Castagna,
M. Bragantini, G. Cornaglia
eP337
Modified procedure for Carba NP detection of
carbapenemase-producing bacteria directly from
blood cultures
A. Mazzariol* (Verona, Italy), C. Castagna,
A.R. Centonze, M. Parisato, G. Petrosino,
M. Bragantini, L. Maccacaro, G. Cornaglia
eP330
Phenotypic detection of carbapenemaseproducing Gram-negative bacilli.
Which method is better?
J. Montgomery* (Melbourne, Australia), F. Hurren,
J. Wang
eP338
eP331
Comparative evaluation of Carba NP test and of
Rosco Rapid CARB screen kit for the detection of
carbapenemase in Pseudomonas aeruginosa
T.D. Huang* (Yvoir, Belgium), C. Berhin, P. Bogaerts,
Y. Glupczynski
Detection of beta-lactamase, aminoglycosidemodifying enzyme and carbapenemase
resistance biomarkers directly using MALDI-TOF
Tandem MS
E. Wey* (London, United Kingdom), I. Balakrishnan,
T. McHugh, O. Belgacem, P. Hart
eP339
The rapid CARB screen as a standardised
alternative for the Carba NP test in detecting
carbapenemase producing strains
S. Degandt* (Kortrijk, Belgium), J. Colaert,
A. Ryssaert, M. Boudewijns
eP340
Discrimination of antibiotic resistant Klebsiella
pneumoniae clones by Fourier Transform Infrared
Spectroscopy (FTIR)
C. Rodrigues* (Porto, Portugal), Â. Novais, C. Sousa,
V. De Scheerder, J. Lopes, E. Machado, T. Coque,
R. Cantón, L. Peixe
eP332
Evaluation of rapid colorimetric tests for
detection of Gram-negative rods resistant to
broad-spectrum beta-lactams on primary cultures
and on blood culture samples
M. Dodemont* (Brussels, Belgium), A. Lambert,
R. De Mendonca, S. Roisin, O. Denis, C. Nonhoff
108 24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Evaluation of the BD MAX™ CRE assay for the
detection of blaKPC, blaNDM and blaOXA-48
carbapenemase genes in multidrug-resistant
Gram-negative clinical isolates
D. Meunier* (London, United Kingdom), K. Hopkins,
S. Paule, G. Babini, N. Woodford
eP350
Budget impact of a ‘de-escalation’ strategy using
micafungin for the treatment of systemic Candida
infections in Spain and Italy
M. Casamayor, A. Van Engen, P. Musingarimi,
I.A.O. Odeyemi, O. Odufowora-Sita, M. Watt*
(Chertsey, United Kingdom)
eP351
Medical management of prosthetic valve
endocarditis caused by Candida parapsilosis
D. Mukherjee* (Kolkata, India)
Early appropriate antifungal therapy improves
outcomes of patients with candidaemia in
intensive care unit
P.Y. Chen* (Taipei, Taiwan), H.Y. Sun, Y.C. Chuang,
W.H. Sheng, Y.C. Chen, S.C. Chang
eP352
Retrospective cohort study comparing the
clinical efficacy and safety of micafungin versus
caspofungin for treatment of candidaemia and
invasive fungal disease
H. Habayeb* (Chertsey, United Kingdom),
C. Grundy, M. Barker, S. Van De Velde
Impact of initial antifungal therapy on the
outcome of Candida glabrata bloodstream
infections
M. Puig-Asensio* (Barcelona, Spain), P. Merino,
P. Martín-Dávila, M. Fernández-Ruiz, J.M. Aguado,
M. Cuenca-Estrella, B. Almirante
eP353
Echinocandins in unselected critically ill patients
with either proven or suspected invasive
candidiasis: a single-centre prospective cohort
4-year study
R. Bruyere, C. Vigneron, F. Dalle, S. Prin, J.P. Quenot,
C. Leon, P. Charles* (Dijon, France)
High-dose micafungin therapy for Candida
endophthalmitis
K. Furukawa* (Tokyo, Japan), Y. Natori, K. Ohkoshi
eP354
Is Clostridium difficile infection (CDI) correlated
to candidaemia?
R. Murri* (Rome, Italy), M. Fantoni, G. Scoppettuolo,
G. Ventura, M. Fabbiani, R. Cauda
Skin, eye and heart involvement in candidaemic
patients
M. Dizbay* (Ankara, Turkey), O. Karasahin,
I.I. Balkan, G.R. Yilmaz, T. Guven, F. Yilmaz Karadag,
S. Kose, M. Yemisen, M. Turken, S. Ozger
eP355
Clinical features of candidaemia in the AsiaPacific region: a preliminary analysis
M. Chayakulkeeree* (Bangkok, Thailand), T.Y. Tan,
L.Y. Hsu, R. Chaiwarith, Y.H. Chen, M. Mendoza,
T.X. Phan, K. Supparatpinyo, N. Syahidah
eP356
Candida tropicalis bloodstream infection: incidence,
risk factors and determinants of mortality in a
population-based surveillance in Spain
M. Fernández-Ruiz* (Madrid, Spain), J.M. Aguado,
B. Padilla, M. Puig-Asensio, M. Almela,
A. Díaz-Martín, J. Rodríguez-Baño,
M. Cuenca-Estrella
Viewing Stations
EPOSTER VIEWING:
Evolving therapeutic strategies for fungal infections
eP343
eP344
eP345
eP346
eP347
eP348
Poor outcomes of Candida ocular infection in
candidaemia patients: analysis of 845 cases over
a 15-year period
H.A. Kim* (Daegu, Korea), S.Y. Ryu
Intra-abdominal candidiasis is associated
with high mortality, repeated surgery and
echinocandin resistance, and often not initially
treated with antifungal agents
C.J. Clancy, R.K. Shields, M.H. Nguyen* (Pittsburgh,
United States)
24th ECCMID / Barcelona
Final Programme 109
Posters
Impact of an antimicrobial care bundle
application on management of candidaemia in a
hospital of northern Italy
E. Chiari* (Brescia, Italy), L. Signorini, S. Torri,
G. Moioli, E. Van Hauwermeiren, G. Paraninfo,
R. Stellini, F. Castelli
Chairs, Speakers & Authors
eP342
eP349
Exhibition
Imipenem heteroresistance: high prevalence
among Enterobacteriaceae KPC producers
C.S. Nodari, V.B. Ribeiro, A. Barth* (Porto Alegre,
Brazil)
General Information
eP341
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP357
KPC-producing Klebsiella pneumoniae
colonisation and infection predispose to
Candida spp. isolation and selection of
non-albicans species
M. Papadimitriou-Olivgeris* (Patras, Greece),
A. Spiliopoulou, F. Fligou, P. Manolopoulou,
I. Spiliopoulou, V. Dodou, K. Filos, E. Anastassiou,
M. Marangos, M. Christofidou
eP358
Is timely and appropriate antifungal drug
treatment enough for survival of adult cases with
candidaemia?
T. Yildirmak, H. Gedik* (Istanbul, Turkey), S. Funda,
E. Fatma Nur, G. Aysegul
eP359
Risk factors for the mortality in candidaemia
cases
O. Guzel Tunccan* (Ankara, Turkey), M. Dizbay,
K. Hizel, E. Senol, D. Arman, F. Ulutan, F. Aktas
eP360
Voriconazole in primary treatment of invasive
Aspergillosis – an observational study;
correlation of efficacy with C-reactive protein and
procalcitonin levels
L. Drgona* (Bratislava, Slovakia), J. Mikula,
E. Bojtarova, D. Horvathova, J. Chudej, T. Guman,
N. Stecova, D. Kapusta, P. Kukol, K. Sobonova
eP362
Safety of micafungin as antifungal prophylaxis in
high-risk liver transplantation patients: results from
a randomised, open-label, multi-centre study
L. Fischer* (Hamburg, Germany), A. Pascher,
O. Cointault, P.F. Laterre, J. De Waele, U. Cillo,
C. Cervera, L. Tweddle, A. Karas, F. Saliba
eP363
French real life cohort on the use of micafungin
as prophylactic or curative treatment for invasive
fungal infections: the Myriade study
J.F. Timsit* (Paris, France), N. Milpied, G. Leverger,
B. Gachot
eP364
Use of antifungal drugs in real conditions of
medical practice in haematology: a French multicentre prospective study (AFHEM study)
J.P. Gangneux* (Rennes, France), J. El Cheikh,
D. Caillot, I. Yakoub-Agha, M. Michallet
eP365
110
Posaconazole plasma concentration under
0.3µg/ml is associated with an increased risk of
breakthrough invasive fungal infection when on
posaconazole primary prophylaxis: a four-year
retrospective study
N. Lerolle* (Paris, France), R. Porcher, S. Touratier,
E. Raffoux, P. Ribaud, S. Bretagne, A. Bergeron,
E. Azoulay, J.-M. Molina, M. Lafaurie
24th ECCMID / Barcelona
Final Programme
eP366
Introduction of an antifungal stewardship
programme targeting liposomal amphotericin B,
voriconazole, caspofungin and micafungin at a
large tertiary hospital in Cambridge, England
C. Micallef* (Cambridge, United Kingdom),
R. Santos, S.H. Aliyu, D.A. Enoch
eP367
Antifungal prescribing and invasive fungal
infections in haematological malignancies other
than acute myeloid leukemia
J.C. Teng* (Fitzroy, Australia), M. Slavin,
S. Lingaratnam, M. Ananda-Rajah, B.W. Teh,
L. Worth, J. Seymour, K. Thursky
eP368
Anti-mould prophylaxis in patients with
superficial fusariosis on admission does not
prevent invasive fusariosis
A.G. Varon, M. Garnica, T. Akiti, G. Barreiros,
B.M. Trope, S.A. Nouer, M. Nucci* (Rio de Janeiro,
Brazil)
eP369
A high percentage of patients have off-target
trough voriconazole serum levels
J. Guinea* (Madrid, Spain), P. Escribano,
L.J. Marcos-Zambrano, M. Kestler, P. Muñoz,
F. López-Fabal, M. Valerio, C. Rodríguez-González,
E. Bouza
eP370
Comparison of monomicrobial invasive fungal
infections and mixed fungal-bacterial infections:
risk factors and outcomes in 211 patients
N. Kulková* (Bratislava, Slovakia), L. Micháliková,
J. Brnová, V. Krcméry
eP371
Invasive pulmonary aspergillosis in
immunocompetent patients with severe exposure
to Aspergillus spp. spores
N. Klimko* (St. Petersburg, Russia), E. Desyatik,
S. Khostelidi, O. Shadrivova, Y. Borzova,
R. Chernopyatova, S. Ignatyeva, T. Bogomolova,
A. Volkova, N. Vasileva
eP372
Large invasive aspergillosis (IA) pseudooutbreak
due to an intravenous (IV) formulation of
acetaminophen
M.T. Martin Gomez* (Barcelona, Spain),
P. Barba Sunol, D. Campany Herrero, I. Ruiz Camps
eP373
Multiple brain abscesses caused by Aspergillus
fumigatus in a four-year old child with chronic
granulomatous disease (CGD): a case report of
successful antifungal treatment
S. Bakheshwain* (Riyadh, Saudi Arabia),
N. AlKhizzi, T. Sulaiman, N. Alkhuraish, S. Aljubran,
P. Sarwat
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
Species identification of Aspergillus isolates by
DNA sequencing
A. Polischouk* (St. Petersburg, Russia),
Y. Mikhaylova, D. Lavnikevich, M. Rudneva,
G. Chilina, T. Bogomolova
eP383
Comparison of two Aspergillus real-time
PCR assays with galactomannan testing of
bronchoalveolar lavage fluid for the diagnosis of
invasive pulmonary aspergillosis
M. Hoogewerf* (Heiloo, The Netherlands),
Y.J. Debets-Ossenkopp, A. Koek, A. Pettersson
eP384
Comparison of qPCR with bronchoalveolar lavage
fluid and serum for the diagnosis of invasive
pulmonary aspergillosis
J. Yu* (Beijing, China), S. Zhang, R. Li
eP385
Can genotyping discriminate between invasive
and colonising Aspergillus fumigatus isolates?
P. Escribano, T. Peláez, E. Bouza,
J. Guinea Ortega* (Madrid, Spain)
eP386
A new multiplex real-time PCR for detection and
identification of zygomycetes and Aspergillus
spp. in human biosamples
A. Polischouk* (St. Petersburg, Russia),
Y. Mikhaylova, E. Belotcerkovskaya, T. Bogomolova
eP387
Moulds and cystic fibrosis: what can we learn
from studying lung mycobiota?
L. Delhaes* (Lille, France), L. Nguyen
eP388
Species identification of Fusarium by matrixassisted laser desorption ionization time-of-flight
mass spectrometry
L.R. Bissoli* (Rio de Janeiro, Brazil), M.Z. Aquino,
M. Tomaz, A. Doi, J. Sampaio, A.S. Levin, S.F. Costa
eP389
Comparison of T. rubrum specific PCR and pandermatophyte PCR with conventional methods in
patients with suspected onychomycosis
E. Dubljanin, I. Vujcic* (Belgrade, Serbia),
I. Colovic Calovski, M.C. Arendrup, R.F. Petersen,
R.H. Jensen
eP390
Development of a new commercial qPCR assay to
detect and differentiate dermatophyte infections
of the skin, nails and hair
G. Dingemans* (Maastricht, The Netherlands),
M. Van den Bosch, M.P. Hayette, S. Goethel, V. Rusu,
R. Sacheli, J. Meis, G. Gaajetaan, G. Simons
Evaluation of a novel RIDA®GENE Pneumocystis
jirovecii real-time PCR assay for the diagnosis of
Pneumocystis jirovecii pneumonia
A. Hiergeist, D. Martens* (Darmstadt, Germany),
L. Kastl, A. Pickel, S. Gatermann
eP375
Interest of adding Pneumocystis jirovecii DNA
detection in nasopharyngeal aspirates for febrile
pneumonia in adult patients
N. Guigue* (Paris, France), J. Menotti, A. Alanio,
N. De Castro, O. Peyrony, J. Le Goff, S. Bretagne
eP376
Chart review of patients with low positive
Histoplasma capsulatum urinary antigen results
P. Ramanan, E.S. Theel, M. Abidi* (Milwaukee,
United States)
eP377
Evaluation of PCR electro-spray ionization-mass
spectrometry (PCR/ESI-MS) fungal spectrum
assay
R. O’Hara, R. Barton, D. Gascoyne-Binzi* (Leeds,
United Kingdom), M. Wilcox
eP378
Is the frequency of Candida albicans epidemics
and hyper-epidemic genotypes causing similar
candidaemia in various European hospitals?
L. Marcos-Zambrano, P. Escribano, M. Sanguinetti,
E. Gomez G. de la Pedrosa, E. De Carolis, R. Cantón,
E. Bouza, J. Guinea Ortega* (Madrid, Spain)
eP379
eP380
eP381
Assessment of a QCMD proficiency programme
for molecular diagnosis of systemic Candida
infection
E. Mcculloch* (Glasgow, United Kingdom),
P.S. Wallace, C. Williams, G. Ramage, K. Lagrou,
W.G. Mackay
High resolution melting analysis for rapid
identification of twenty-five Candida species
from culture
E. Nemcova* (Brno, Czech Republic),
M. Cernochova, F. Ruzicka, B. Malisova,
M. Vanerkova, H. Suranska, P. Nemec, T. Freiberger
Use of PCR for diagnosis of invasive aspergillosis;
a 3-year prospective cohort study
H.C. Kung* (Taipei, Taiwan), Y.C. Chen, U.I. Wu,
B.S. Ko, S.C. Chang
24th ECCMID / Barcelona
Final Programme
111
Posters
eP374
Chairs, Speakers & Authors
EPOSTER VIEWING:
Highlights from molecular mycology
ePosters
eP382
Exhibition
Viewing Stations
General Information
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP391
Comparative evaluation of dermatophyte-PCR kit,
with conventional methods for rapid detection of
dermatophytes and identification of Trichophyton
rubrum in nail specimens
N. Karabicak* (Ankara, Turkey), D. Güldemir,
S. Topal, N. Alem, O. Danismaz, G. Elcin, R. Durmaz
eP392
Search strategy of new antifungal targets based
on analysis of the protein domain and domain
architecture content of fungal proteomes
A. Barrera, A. Alastruey-Izquierdo* (Madrid, Spain),
M. Martin, J.A. Vizcaino, I. Cuesta
eP393
Multi-locus sequence typing of invasive and
colonising Candida albicans isolates
K. Heidrich, W. Buzina* (Graz, Austria), M. Hönigl,
R. Krause
eP394
Biofilm phenotypic and genotypic heterogeneity
amongst Candida albicans bloodstream isolates
differentially affects amphotericin B tolerance
L. Sherry* (Glasgow, United Kingdom),
R. Rajendran, B. Jones, C. Williams, C. Nile,
G. Ramage
eP395
eP396
eP397
112
Relation between biofilm formation and mtl genes
in Candida tropicalis isolated from hospitalised
patients
M.A. Galán* (Badajoz, Spain), A. Beteta,
M.T. Blanco-Blanco, A.C. Gómez-García,
C. Pérez-Giraldo, M.T. Blanco
Measuring C. albicans and host gene expression
during intra-abdominal candidiasis of humans
and mice with RNA-Seq
C.J. Clancy* (Pittsburgh, United States), S. Cheng,
L. Losada, S. Mounaud, W. Nierman, N. Solis,
S. Filler, W. Xu, A. Mitchell, M.H. Nguyen
The discordance between epidemiologically
related invasive and fluconazole resistant
Candida tropicalis isolates highlight the
necessity to further optimise C. tropicalis
multi-locus sequence typing
X. Fan* (Beijing, China), M. Xiao, T.J. Gray, F.R. Kong,
H. Wang, L. Zhang, Y.C. Xu
24th ECCMID / Barcelona
Final Programme
Viewing Stations
EPOSTER VIEWING:
Influenza, from bench to bedside
eP398
2012-2013 winter hospitalisations at a university
hospital: high morbidity associated with influenza
and other acute respiratory viral infections in
adults
M. Bourgeois, V. Gérard, N. Ausselet, X. Muschart,
I. Michaux, T.-D. Huang, P. Bogaerts, Y. Glupczynski,
I. Thomas, B. Delaere* (Yvoir, Belgium)
eP399
Pandemic and epidemic influenza: many
similarities and few differences
O. Dzupova* (Prague, Czech Republic),
K. Herrmannova, M. Trojanek, Z. Blechova,
M. Havlickova, H. Jirincova, A. Nagy
eP400
Subtyping of influenza viruses in paediatric
patients hospitalised at Bambino Gesù children’s
hospital in the 2012-2013 season
M. Onori* (Rome, Italy), L. Mancinelli, C. Concato,
S. Chiavelli, L. Coltella, D. Menichella, C. Russo
eP401
Simultaneous detection of influenza A virus
subtypes using multiplex PCR
C. Cicek* (Izmir, Turkey), N. Bayram, M. Anil,
F. Gulen, H. Pullukcu, E.U. Saz, G. Cok
eP402
Serological study for A/H2N3 avian influenza
infection in Georgia
A. Machablishvili* (Tbilisi, Georgia), L. Urushadze,
M. Dgebuadze, M. Chubinidze, D. Tsereteli,
I. Karseladze, P. Imnadze
eP403
Viral aetiology of adult respiratory tract
infections during the influenza season in
southern Taiwan determined with PCR/ESI-MS
C. Wu* (Tainan, Taiwan), H. Shih, H. Wang, C. Chou,
H. Hsu, J. Wang, M. Hsieh, H. Sun, I. Su
eP404
Comparative analysis of human and chicken
influenza virus A(H7N9)-induced inflammatory
response and virus replication kinetics
K. To* (Hong Kong, China), C. Lau, J. Chan, C. Chan,
H. Chen, K. Yuen
eP405
Prevalence and identification of oseltamivirresistant influenza A viruses during 2009-2011 at
Siriraj Hospital, Thailand
N. Athipanyasilp* (Bangkok, Thailand),
N. Horthongkham, B. Kaewnapan, S. Siritantikorn,
W. Kantakamalakul, R. Sutthent
eP407
The vaccination coverage required to establish
herd immunity against influenza viruses
P. Plans* (Barcelona, Spain)
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP415
Treatment of acute bacterial skin and skin
structure infection (ABSSSI) with dalbavancin in
an outpatient setting
M. Dunne* (Branford, CT, United States),
S. Puttagunta, M. Wilcox, H. Boucher, G. Talbot
A single-dose of oritavancin compared to 7-10
days of vancomycin: clinical response and safety
in the MRSA subgroup treated in the ambulatory
setting (solo trials)
K. LaPensee* (Parsippany, NJ, United States),
W. Fan, S. Good, H. Jiang, T. Lodise
eP416
Clinical outcomes by pathogen in phase 3 studies
of single dose oritavancin versus 7 to 10 days of
vancomycin to treat CSSTI
G. Moeck* (Saint Laurent, Canada), F.F. Arhin,
H. Jiang, C. Fiset, D.C. Draghi, D.F. Sahm
eP417
The PVL gene does not impact clinical response to
treatment with single dose oritavancin or 7 to 10
days of vancomycin in patients with CSSTI
F.F. Arhin* (Saint Laurent, Canada), G. Moeck,
H. Jiang, C. Fiset, D.C. Draghi, D.F. Sahm
eP418
Concordance between early (48-72 hours) and
late (7-14 days post therapy) clinical response:
an analysis from the solo non-inferiority clinical
studies
G.R. Corey* (Durham, NC, United States), S. Good,
H. Jiang, G. Moeck, M. Wikler
eP419
A review of the health economics and resource
utilisation literature for the use of tigecycline
treatment of complicated intra-abdominal
infections
B. Wang, Y. Chen* (Beijing, China), W. Furnback,
A. Shelbaya
eP420
Superinfection rates following infections’
treatment with tigecycline
M. Katsiari* (Athens, Greece), Z. Roussou,
E.D. Platsouka, A. Maguina
eP421
Hypofibrinogenaemia associated with the
administration of tigecycline
I. Karaiskos* (Athens, Greece), E. Barmpouti,
K. Ioannidis, L. Galani, F. Baziaka, C. Paskalis,
H. Giamarellou
eP422
Retrospective multi-centre experience of the
effectiveness and safety with ceftaroline fosamil
(CPT) therapy in patients with acute bacterial
skin and skin structure infections (ABSSSI)
A. Casapao* (Detroit, United States), S. Davis,
V. Barr, D. Goff, K. Kaye, J. Pogue, M. Rybak
eP423
Ceftaroline fosamil for treatment of CSSTI due to
Staphylococcus aureus with vancomycin MICs of
1.5 to 2 mg/l: capture study experience
G.E. Stein, S. Wallace, A. Jandourek* (Oakland,
United States), H.D. Friedland
eP410
Daptomycin in the treatment of bone and
joint infections: clinical and microbiological
experience at Nantes University Hospital
S. Corvec* (Nantes, France), P. Bemer, L. Happi,
S. Touchais, N. Asseray, M. Lefebvre, D. Navas,
F. Gouin, C. Bourigault, D. Boutoille
eP411
Daptomycin for cardiac infections: documented
cardiac implantable electronic devices (CIED) /
cardiac circulatory devices (CCD) infections and
operated infective endocarditis (EI). A 43-case
series
P. Molmy, K. Moussa, N. Van Grunderbeeck* (Lens,
France), G. Leroy, S. Barrailler, Y. Lefetz, M. Boulo,
L. Guesnier, G. Fayad, O. Leroy
eP412
Daptomycin for the treatment of infections
in overweight/obese patients: results from
the European Cubicin® outcome registry and
experience
A. Timerman* (Frimley, Switzerland),
A. Gonzalez-Ruiz, R.A. Seaton, M. Bitzani,
P. Gargalianos-Kakolyris, G. Dalekos, M. Allen,
M. Bindschedler, A. Trylesinski
eP413
Daptomycin treatment for Gram-positive
infections in Europe: results of > 6 years’ clinical
experience from EU-CORE (SM)
A. Gonzalez-Ruiz* (Basel, Switzerland), K. Malizos,
P. Gargalianos-Kakolyris, A. Cogo, A. Timerman,
R. Utili, K. Bouylout, R. Pathan, A. Trylesinski
eP414
Treatment of Gram-positive extra-pulmonary
infections with daptomycin or vancomycin for ICU
patients: a retrospective analysis of efficacy and
nephrotoxicity
P. Gaudard* (Montpellier, France), M. Elhaj,
M. Villiet, P. Colson
24th ECCMID / Barcelona
Final Programme
Posters
Dalbavancin for the treatment of complicated
skin and soft tissue infections in patients with
and without diabetes mellitus in the DISCOVER
studies
S. Puttagunta* (Branford, CT, United States),
M. Dunne
113
Chairs, Speakers & Authors
eP409
Exhibition
eP408
General Information
EPOSTER VIEWING:
New and not so new antibiotics
ePosters
Viewing Stations
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP424
Ceftaroline as salvage therapy for MRSA
osteoarticular infections
S. Parsaei* (Saint Louis, MO, United States),
C. Johnson, S. Liang, J. Marschall
eP425
The effectiveness and safety with ceftaroline fosamil
(CPT) therapy for lower respiratory tract infections
(LRTI) in a retrospective multi-centre study
A. Casapao* (Detroit, United States), S. Davis,
V. Barr, K. Klinker, D. Goff, K. Barber, R. Mynatt,
K. Kaye, J. Pogue, M. Rybak
eP426
eP427
eP428
eP429
Ceftaroline fosamil for treatment of communityacquired pneumonia as first versus second-line
therapy: capture study experience
D. Guervil, K. Kaye, A. Hassoun, P. Cole* (Oakland,
United States), X. Huang, H.D. Friedland
eP434
Concordance between early and late response
in ESTABLISH-1 and ESTABLISH-2: pooled results
from two phase 3 trials in acute bacterial skin and
skin structure infections
E. Fang* (San Diego, United States), C. De Anda,
A. Das, P. Prokocimer
Viewing Stations
EPOSTER VIEWING:
New and old beta-lactamase inhibitors
eP435
Ceftaroline fosamil (CPT-F) in bacteraemia
associated with community-acquired pneumonia
(CAP) or acute bacterial skin and skin structure
infections (ABSSSI)
Y. Golan* (Boston, MA, United States), M. Ding,
Q. Zhao, A. Jandourek, X. Huang
Ceftazidime-avibactam activity tested against
select Gram-negative organisms from a global
surveillance programme (2011) in relation to the
ceftazidime epidemiologic cut-off value
R.K. Flamm* (North Liberty, IA, United States),
D.J. Farrell, H.S. Sader, R.N. Jones
eP436
In vitro activity of ceftazidime-avibactam
(CAZ-AVI) and comparators against Gramnegative pathogens isolated from patients in
Canadian hospitals in 2009-2012: CANWARD
surveillance study
P. Lagacé-Wiens* (Winnipeg, Canada), H. Adam,
A. Denisuik, J. Karlowsky, A. Walkty, D. Hoban,
G.G. Zhanel
eP437
Activity of ceftazidime-avibactam and
comparators against colistin non-susceptible
Enterobacteriaceae and Pseudomonas
aeruginosa isolated in 2012: the international
network for optimal resistance monitoring
(INFORM) study
M. Hackel* (Schaumburg, United States),
S. Bouchillon, R. Badal, D. Biedenbach, W.W. Nichols
eP438
Evaluation of the activity of ceftazidimeavibactam (CAZ-AVI) against fluoroquinolone
(FQ)-resistant Enterobacteriaceae and
Pseudomonas aeruginosa
C. Pitart* (Barcelona, Spain), F. Marco, T.A. Keating,
W.W. Nichols, J. Vila
Comparison of clinical outcomes with ceftaroline
fosamil (CPT-F) in the treatment of methicillinresistant Staphylococcus aureus bacteraemia
(MRSAB)
S. Arshad* (Detroit, United States), P. Hartman,
D. Moreno, M. Perri, M. Zervos
Staphylococcus aureus bacteraemia secondary
to CSSTI or CAP: capture study experience
J. Vazquez, C. Maggiore, D. Guervil, P. Cole*
(Oakland, United States), A. Smith, H.D. Friedland
eP431
Early clinical response in a randomised
controlled phase 3 study of ceftobiprole versus
ceftriaxone with or without linezolid in patients
with community-acquired pneumonia requiring
hospitalisation
T. Welte* (Hanover, Germany), G. Herrera,
Y.-C. Chuang, A. Demange, M. Engelhardt
114
Estimating the cost-effectiveness of linezolid
for the treatment of methicillin-resistant
Staphylococcus aureus (MRSA) nosocomial
pneumonia in Taiwan
B. Wang* (New York, United States), C.H. Fang,
W. Furnback, R. Kim, Y.W. Yang
Ceftaroline fosamil for treatment of communityacquired pneumonia in the intensive care unit:
capture study experience
C. Maggiore, J. Vazquez, D. Guervil, K. Kaye,
C. Cannon, A. Jandourek* (Oakland, United States),
A. Smith, H.D. Friedland
eP430
eP432
eP433
Linezolid use in a tertiary care centre:
indications, appropriateness of prescriptions,
predictive factors for adverse events
R. Buzelé* (Tours, France), F. Bastides, X. Pourrat,
B. Sautenet, P. Rosset, F. Lagarrigue, L. Bernard
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
eP443
eP444
eP445
eP447
Comparative in vitro activity of ceftolozane/
tazobactam against clinical isolates of
Enterobacteriaceae: results of the CENIT multicentre study
M. García-Castillo* (Madrid, Spain), M. Tato, G. Bou,
J. Calvo, E. Cercenado, P. Egea, M.I. Morosini,
R. Cantón
eP448
Comparative in vitro activity of ceftolozane/
tazobactam against clinical isolates of
Pseudomonas aeruginosa: results of the CENIT
multi-centre study
M. Tato* (Madrid, Spain), M. García-Castillo,
A. Moreno-Bofarull, F. Galán-Sánchez,
I. García-García, E. Ruiz de Gopegui, F. Marco,
R. Medina, R. Cantón
eP449
Ceftolozane/tazobactam activity when tested
against Gram-negative bacterial isolates
from hospitalised patients with pneumonia in
European hospitals (2011-2012)
D.J. Farrell* (North Liberty, IA, United States),
H.S. Sader, R.K. Flamm, R.N. Jones
Efficacy and safety of ceftolozane/tazobactam
versus levofloxacin in the treatment of
complicated urinary tract infections (CUTI)/
pyelonephritis in hospitalised adults: results
from the phase 3 aspect-CUTI trial
F. Wagenlehner* (Giessen, Germany),
O. Umeh, J. Huntington, D. Cloutier, I. Friedland,
J. Steenbergen, G. Yuan, M. Yoon, R. Darouiche
eP450
Antimicrobial activity of ceftolozane/tazobactam
and comparator agents tested against
Pseudomonas aeruginosa isolates from 15
European countries and Israel (2011-2012)
D.J. Farrell* (North Liberty, IA, United States),
H.S. Sader, M. Castanheira, R.N. Jones
Evaluation of the potential for drug-drug
interactions between ceftolozane/tazobactam
and drugs metabolised by CYP1A2 or CYP3A4 or
transported by OAT1 and OAT3
M. Wooley, P. Bernardo, B. Miller, E. Hershberger,
G. Krishna* (Lexington, United States)
eP451
Characterisation of beta-lactamase inhibition by
AAI101, an extended-spectrum beta-lactamase
inhibitor
P. Nordmann* (Fribourg, Switzerland), D. Girlich,
R. Pypstra, S. Shapiro
eP452
In vitro activity of AAI 101, a new beta-lactamase
inhibitor, combined with beta-lactam antibiotics
against a challenge panel of beta-lactamresistant Gram-negative clinical isolates
S. Mushtaq* (London, United Kingdom),
A. Chaudhry, R. Adkin, N. Woodford, R. Pypstra,
S. Shapiro
Aztreonam-avibactam (ATM-AVI) – inoculum
effect against Gram-negative isolates harbouring
ESBLs and/or MBLs
R. Singh* (Waltham, MA, United States), S. Patey,
R. Giacobbe, M. Tanudra, J. Harris, J. O’Donnell,
M. Huband
Antimicrobial activity of ceftolozane/tazobactam
and comparator agents tested against
Enterobacteriaceae isolates from 14 European
countries and Israel (2012)
D.J. Farrell* (North Liberty, IA, United States),
H.S. Sader, M. Castanheira, R.N. Jones
Ceftolozane/tazobactam activity against Gramnegative bacteria causing urinary tract infections
in European hospitals (2011-2012): a report
from an international antimicrobial surveillance
programme
S. McCurdy* (Lexingtong, MA, United States),
P.J. Petersen, J. Steenbergen, D.J. Farrell,
M. Bassetti
24th ECCMID / Barcelona
Final Programme
115
Posters
Comparative in vitro activity of ceftazidime
(CAZ) and ceftazidime-avibactam (CAZ-AVI) in a
European collection of Pseudomonas aeruginosa
from cystic fibrosis (CF) patients
H. Chalhoub* (Brussels, Belgium), M. Tunney,
S. Elborn, A. Vergison, O. Denis, P. Plésiat, B.C. Kahl,
F. Van Bambeke, P.M. Tulkens
eP442
Ceftolozane/tazobactam activity against Gramnegative bacteria causing intra-abdominal
infections in European hospitals (2011-2012):
a report from an international antimicrobial
surveillance programme
S. McCurdy* (Lexingtong, MA, United States),
P.J. Petersen, J. Steenbergen, D.J. Farrell,
M. Bassetti
Chairs, Speakers & Authors
eP440
eP441
eP446
Exhibition
In vitro activity of ceftazidime-avibactam and
comparators against Gram-negative pathogens
in Europe – the international network for optimal
resistance monitoring (INFORM) 2012
S. Bouchillon* (Schaumburg, United States),
R. Badal, I. Morrissey, D. Hoban, M. Hackel,
D. Biedenbach, G. Stone
General Information
eP439
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP453
Efficacy of extended-spectrum beta-lactamase
inhibitor AAI 101 combined with beta-lactams
in murine models of systemic Gram-negative
infection
M. Paul-Satyaseela, K. Koppolu, U.P. Senthilkumar,
R. Pypstra, S. Shapiro* (St-Louis, France)
eP461
A rapid latex agglutination test to distinguish
Shigella from Escherichia coli: patching the
MALDI-TOF “achilles’ heel”
B.M. Willey* (Toronto, Canada), G. Ricci,
C. Vermeiren, C. Watt, P. Lo, A.E. Simor,
S.M. Poutanen
eP454
A phase 1 study of the safety, tolerability, and
pharmacokinetics of the beta-lactamase inhibitor
RPX7009 in healthy adult subjects
D.C. Griffith* (San Diego, CA, United States),
J.S. Loutit, E.E. Morgan, S. Durso, M.N. Dudley
eP462
Mass spectrometry: a fast and efficient method in
respiratory bacterial pathogen identification
F. Lopez Fabal* (Madrid, Spain), M. Regodón,
J.L. Gómez-Garcés
eP463
Mitis-group streptococci id by MALDI-TOF MS
using a weighted nearest-neighbour approach
T. Maier* (Bremen, Germany), C. Lange,
M. Kostrzewa
eP464
Evaluation of the rapid detection of ST17 and ST-1
group B streptococci using a microflex MALDI-TOF
MS (Bruker)
C. Meex* (Liège, Belgium), R. Sacheli, R. Naim,
J. Descy, M.P. Hayette, P. Huynen, P. Melin
eP465
Usefulness of MALDI-TOF technology for
identification of microorganisms belonging to the
Staphylococcus intermedius group
E. Carretto* (Reggio Emilia, Italy), D. Barbarini,
F. Brovarone, C. Zuelli, C. Farina, S. Andreoni,
V. Savini
eP466
MALDI-TOF mass spectrometry based
intraspecies differentiation of Yersinia pestis
M. Afanasev* (Irkutsk, Russia), A. Ostyak,
G. Vdovichenko, E. Tokmakova, S. Balakhonov
eP467
Comparison of a direct colony method versus
an extraction method for identification of
Rhodococcus spp. and Dietzia spp. with the
VITEK® MS MALDI-TOF
C. Ruiz de Alegria Puig* (Santander, Spain),
L. Pilares, J. Navas, L. Martinez-Martinez
eP468
Comparison of MALDI-TOF, NAATS and monoclonal
kits to detect Neisseria gonorrhoeae
L. Gray, M. Wootton* (Cardiff, United Kingdom),
L. Davies, M. Perry, P. Brookes, R.A. Howe
eP469
MALDI-TOF MS and FTIR-ATR: different
biomolecules and distinct outputs in
Acinetobacter baumannii typing
C. Santana Sousa, J. Botelho, L. Silva* (Porto,
Portugal), F. Grosso, J. Lopes, L. Peixe
Viewing Stations
EPOSTER VIEWING:
MALDI-TOF
eP455
eP456
eP457
eP458
eP459
eP460
116
Utility of PCR and electrospray ionization mass
spectrometry with different types of clinical
specimens
D. Gascoyne-Binzi* (Leeds, United Kingdom),
J. Sandoe, R. O’Hara, R. Barton, M. Wilcox
Comparison of matrix-assisted laser desorption
ionization time-of-flight mass spectrometry
with pulsed-field gel electrophoresis for cluster
analysis
J.H. Rim* (Seoul, Korea), Y.S. Lee, Y.J. Park,
M.S. Kim, E.S. Park, E.J. Ha, D.E. Yong, S.H. Jeong,
K.W. Lee, Y.S. Chong
Evaluation of success rate, turnaround time,
cost analysis and biohazard waste for bacterial
identification by using MALDI-TOF MS
M. Ge* (Taoyuan, Taiwan), K. Liu, S. Chang, J. Chia,
P. Chang, J. Lu
Comparison of two commercially available MALDITOF systems for bacterial and yeast identification
in a clinical diagnostic laboratory
R. Murphy* (London, United Kingdom), M. Wilks
Use of the MALDI-TOF MS analyser in a routine
diagnostic microbiology laboratory in a
developing country
A. Bulane, A.A. Hoosen* (Bloemfontein,
South Africa)
Mass spectrometry with VITEK® MS: impact of
culture media on identification results
N. Desserrières, M. Arsac, N. Fanjat,
P.J. Cotte-Pattat, C. Arthaud, B. Cellière, V. Girard*
(La Balme-les Grottes, France), G. Durand,
A. Van Belkum, S. Ghirardi
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
eP472
eP473
eP474
eP475
eP476
eP477
Comparison of the Bruker biotyper and VITEK® MS
MALDI-TOF systems for identification of glucose
nonfermenting Gram-negative bacilli
P. Schreckenberger* (Maywood, United States),
K. McKinley, J. Tjhio, K. White, A. Rosenfeld,
M. Zilliox, X. Gai, A. Wolfe
Comparison of MALDI-TOF MS and AFLP for strain
typing of ESBL-producing Escherichia coli
isolates collected during an outbreak in a Dutch
nursing home
J. Veenemans* (Tilburg, The Netherlands),
M. Welker, A. Van Belkum, A. Pettersson, C. Verhulst,
M. Kluytmans- van den Bergh, J.A.J.W. Kluytmans
Suitability of MALDI-TOF MS for the identification
of Staphylococcus aureus, and members of
the Staphylococcus intermedius group (SIG)
complex
L. Alcalá* (Zaragoza, Spain), M. Simón,
A.I. Lopez-Calleja, C. Ortega, C. Torres, N. Viguera,
E. Gómez-Sanz, M.J. Revillo, A. Rezusta
Detection of extended-spectrum beta-lactamaseproducing Escherichia coli ST131 and ST405
clonal groups by matrix-assisted laser desorption
ionization-time of flight mass spectrometry
Y. Matsumura* (Kyoto, Japan), M. Tanaka,
Y. Yamamoto, M. Nagao, Y. Ito, S. Takakura,
S. Ichiyama
Impact of matrix-assisted laser desorption/
ionization-time of flight mass spectrometry on
antibiotic optimisation in critically ill patients
with Gram-negative pneumonia
C.V. Murphy* (Columbus, OH, United States),
S.M. Adriance, K.A. Bauer
Adenovirus serotype discrimination by matrixassisted laser desorption/ionization time-offlight (MALDI-TOF) mass spectrometry analysis
A. Calderaro* (Parma, Italy), M.C. Arcangeletti,
I. Rodighiero, M.C. Medici, F. De Conto, C. Chezzi
eP479
Evaluation of matrix-assisted laser
desorption ionization-time of flight mass
spectrometry (MALDI-TOF MS) for accurate
and fast identification of yeasts isolated from
bloodstream infections
N. Karabicak* (Ankara, Turkey), O. Karatuna,
I. Akyar
eP480
MALDI-TOF mass spectrometry analysis for
the differentiation of the pathogenic intestinal
amoeba Entamoeba histolytica from the nonpathogenic Entamoeba dispar isolated from
biological samples
A. Calderaro* (Parma, Italy), M. Piergianni,
C. Gorrini, G. Piccolo, M. Buttrini, S. Montecchini,
M.C. Medici, M.C. Arcangeletti, C. Chezzi, F. De Conto 
eP481
Differentiation of vanA-positive E. faecium from
vanA-negative E. faecium by matrix-assisted
laser desorption ionization-time of flight mass
spectrometry
S. Nakano* (Kyoto, Japan), Y. Matsumura,
T. Noguchi, M. Yamamoto, M. Nagao, Y. Ito,
S. Ichiyama
eP482
MALDI-TOF MS in Streptococcus agalactiae
screening of pregnant women
M. Pappné Ábrók* (Szeged, Hungary), Á. Arcson,
A. Lázár, E. Urbán, J. Deák
eP483
Direct identification of urinary tract pathogens
from urine samples using VITEK® MS matrixassisted laser desorption ionization time-of-flight
mass spectrometry system
K.G. Park* (Seoul, Korea), Y.J. Park, S.H. Shin,
J.Y. Chang, Y.S. Kim, K.W. Lee, H.J. Ryu
eP484
Rapid identification of Acinetobacter baumannii
via matrix-assisted laser desorption ionization
time-of-flight and antimicrobial stewardship
intervention in patients with pneumonia and/or
bacteraemia
E. Wenzler* (Hilliard, United States), D.A. Goff,
J.E.W. Johnston, K.A. Bauer
24th ECCMID / Barcelona
Final Programme
117
Posters
MALDI-TOF: a reliable method for the identification
of Aeromonas from clinical samples
F. Latif-Eugenín* (Reus, Spain), S. Solis del Baño,
D. Tena, N.M. Martínez, M. Álvarez, F. García,
A. Rezusta, R. Beaz-Hidaldo, M.J. Figueras
Characterisation and identification of poliovirus
type 1 proteins by matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF)
mass spectrometry
A. Calderaro* (Parma, Italy), M.C. Arcangeletti,
I. Rodighiero, M.C. Medici, F. De Conto, C. Chezzi
Chairs, Speakers & Authors
eP471
eP478
Exhibition
MALDI-TOF for the identification of Burkholderia
cepacia complex from patients with cystic fibrosis
C. Lucas, S. Srivastava, W. Mackay, I.M. Gould,
G. Ramage, C.L. Williams* (Kilmarnock, United
Kingdom)
General Information
eP470
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP485
To MALDI or not to MALDI: specificity of
chromogenic agars for identifying Escherichia
coli from urine cultures
B.M. Willey* (Toronto, Canada), O. Oleung, I. Manji,
S. Kim, A. Tsang, E. Ramoutar, S. Tharmaradinam,
P. Lo, S.M. Poutanen
eP493
Effects of selective digestive decontamination
(SDD) on the gut resistome
E. Bülow* (Utrecht, The Netherlands),
T. Bello Gonzalez, D. Versluis, L. Ogilvie,
M.M. D’Andrea, H. Smidt, B.V. Jones, R.J.L. Willems,
M. Bonten, W. Van Schaik
eP486
Comparison of two commercially available
chromogenic agars for the detection of MRSA in a
large panel of specimens
R. Walker* (Birmingham, United Kingdom),
J. Ashby, R. Anderson, P. Patel, H. Kilgariff
eP494
Respiratory microbiota of paediatric cystic
fibrosis patients using 16S-targeted deep
sequencing
C. Holmes* (Leicester, United Kingdom), D. Rivett,
D. Modha, K. Bruce, E. Gaillard
eP495
Study of the digestive flora of 20 Lebanese
patients in remission from Crohn’s disease and
comparison to healthy subjects
G. Rizkallah, R. Sayegh, A. Hajj* (Beyrouth,
Lebanon), P.H. Seksik, G. Trugnan, D. Karam Sarkis
eP496
Use of the mucosal F. prausnitzii/E.coli index as a
marker of microbiota improvement in ulcerativecolitis dysbiosis after treatment with mesalazineMMX (Mezavant™)
J. Miquel Cusachs* (Girona, Spain),
D. Busquets Casals, M. Serra-Pagès, J. Garcia Gil,
X. Aldeguer Manté
eP497
Comparisons of the vaginal microbiomes
of healthy pregnant women of four ethnic
backgrounds, and of Caucasian pregnant women
in health and disease
G.L. Mendz* (Darlinghurst, Australia), S.J. Lord,
N.O. Kaakoush, J.A. Quinlivan
Preliminary results on the impact of empirical
treatment using colistin-levofloxacin vs. meropenemlevofloxacin in the intestinal microbiome of VAP
patients: a randomised clinical trial
L. Muñoz* (Barcelona, Spain), I. Roca, J. Nowak,
E. Zander, J.M. Cisneros, P. Higgins, H. Seifert, J. Vila
eP498
Profile similarities of gut microbiota in allergic
and non-allergic children at 5 and 10 years of age
T. Drell* (Tartu, Estonia), A. Larionova, J. Simm,
K. Heilman, T. Voor, E. Sepp
The oral resistome: from metagenomics
to antimicrobial resistance of the microbiota
in the mouth
B.B. Wintermans* (Amsterdam, The Netherlands),
C.M.J.E. Vandenbroucke-Grauls, A.E. Budding
eP499
Dental root canal microbiota in chronic apical
periodontitis patients (data from Illumina
sequencing)
R. Mändar* (Tartu, Estonia), V. Vengerfeldt, K. Pilka,
M. Saag, H. Nõlvak, J.-K. Preem, K. Oopkaup, J. Truu
eP500
Molecular identification of bacterial communities
associated with caries by denaturing gradient gel
electrophoresis fingerprinting approach
E. Alia, B. Romero-Hernández* (Madrid, Spain),
A.M. Sánchez-Díaz, J.D. Caballero,
M. Hernández-García, G. Chinchón,
D. Parra-Pecharomán,
J. López-Palafox, L. Gil, R. Del Campo
Viewing Stations
EPOSTER VIEWING:
Microbiome and resistance: what are they telling us?
eP487
Analysis of vaginal microbiome of women with
vaginitis symptoms and comparison with BD
Affirm VPIII® identification test
K.H. Hong* (Seoul, Korea), S.K. Hong, S.I. Cho,
M. Seong, S.S. Park
eP488
The vaginal microbiome as a predictor for acquiring
Chlamydia trachomatis, a case control study
R. Van Houdt* (Amsterdam, The Netherlands),
B. Ma, J. Van der Helm, S. Bruisten, H. De vries,
J. Ravel
eP489
eP490
eP491
eP492
118
Gut microbiota in Mexican obese youth
N. Castro* (Chilpancingo, Mexico),
R.B. Radilla-Vázquez, B. Illades-Aguiar,
E. Flores-Alfaro, I. Parra-Rojas
Gut microbiota continues to evolve during the
first five years of life
A. Eck* (Amsterdam, The Netherlands),
N.B.M.M. Rutten, I. Besseling-van der Vaart,
G.T. Rijkers, A.M. De Vlieger, P.H.M. Savelkoul,
A.E. Budding
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
Viewing Stations
EPOSTER VIEWING:
MDR Acinetobacter baumannii
eP510
Fitness cost of fluoroquinolone resistance in
Acinetobacter baumannii mediated through a
combination of gyrA/parC mutations and efflux
J. Nowak* (Cologne, Germany), H. Seifert,
P.G. Higgins
Viewing Stations
EPOSTER VIEWING:
Antibiotic stewardship programmes
Large dissemination of blaOXA-58 and blaOXA-23
carbapenemase genes of Acinetobacter baumannii
in a Tunisian neonatal intensive care unit
A. Mabrouk, W. Achour* (Tunis, Tunisia),
S. Ennigrou, R. Baaboura, A. Ben Hassen
eP511
Relevance of microbiological aspects in the
results of the first year of a multidisciplinary
sepsis unit in a teaching hospital
J. Camarena* (Valencia, Spain), R. Gonzalez,
B. Bonet, S. Sancho, R. Zaragoza, J.M. Nogueira
eP504
Carbapenem resistance molecular determinants
in nosocomial isolates of multidrug-resistant
Acinetobacter baumannii in Tehran Hospital, Iran
A. Karmostaji* (Bandar-Abbas, Iran),
S. Najar Peerayeh, P. Davoodian, S. Javadpour
eP512
International antimicrobial stewardship
pharmacist mentoring programme: united we
stand, divided we fall
D.A. Goff* (Columbus, United States), K. Bauer,
D. Van den Bergh, A. Brink, J. Taljaard, M. Mendelson
eP505
First report of ISAba825 upstream of blaOXA-143
gene in carbapenem-resistant Acinetobacter
baumannii (ACB) clinical isolates
R. Cayô* (São Paulo, Brazil), A.P. Matos,
F. Rodrigues-Costa, R. Girardello, C.G. Carvalhaes,
A.C. Gales
eP513
Results of a stewardship programme for the
management of S. aureus bacteraemia
J. Boelens* (Ghent, Belgium),
I. Leroux-Roels, S. Callens, F. Buyle, D. Vogelaers,
On behalf of the Multidisciplinary Infection Team
eP514
eP506
OXA-253, a variant of the carbapenemhydrolysing class D beta-lactamase OXA-143 in
Acinetobacter baumannii
D. Girlich* (Le Kremlin Bicêtre, France),
Q. Damaceno, A.C. Oliveira, P. Nordmann
eP507
Effect of the acquisition of reduced susceptibility
to biocides on the expression of genes encoding
porins and efflux pumps in Acinetobacter
baumannii
F. Fernández-Cuenca* (Seville, Spain), P. Egea,
M. Tomás-Carmona, G. Bou, L. Martínez-Martínez,
J. Vila, J. Pachón, J.M. Cisneros, J. Rodríguez-Baño,
A. Pascual
Promoting the appropriateness of antibiotic
prescribing and decreasing the parenteral
antibiotic prescribing amount by an effective
multidimensional antibiotic stewardship
programme
W. Wang* (Taichung, Taiwan), C. Huang, S. Chou,
Y. Huang, S. Chan
eP515
Outcome of implementation of antimicrobial
review notice stickers and care bundle in a large
district general hospital in the east of England
T. Vaghela* (Watford, United Kingdom), A. Flatt,
S. Parida, R. Wiggins, P. Seetulsingh
eP516
Evaluation of active interventions for
bloodstream infections in a Japanese university
hospital
M. Nagao* (Kyoto, Japan), G. Hotta, K. Kato,
S. Nakano, T. Yunoki, M. Yamamoto, Y. Matsumura,
Y. Ito, S. Takakura, S. Ichiyama
eP508
Verification of the amino acid substitutions in
adeRS for increasing tigecycline resistance in
clinical isolates of the extensively drug resistant
Acinetobacter baumannii
J.R. Sun* (Taipei, Taiwan), T.S. Chiueh
24th ECCMID / Barcelona
Final Programme
Posters
eP503
ePosters
Searching for peritonitis-causing agents in the
normal microbiota of peritoneal dialysis patients:
analysis of possible routes of infection
L. Simões Silva* (Porto, Portugal), S. Ferreira,
S. Silva, R. Araujo, M.J. Sousa, C. Santos-Araújo,
M. Pestana, I. Soares-Silva, B. Sampaio-Maia
AdeR protein regulates AdeABC expression
by binding to a direct-repeat motif in the
intercistronic spacer
T.S. Chiueh* (Taipei, Taiwan), B.J. Huang, T.Y. Chang,
J.R. Sun, C.L. Perng
119
Chairs, Speakers & Authors
eP502
eP509
Exhibition
Human microbiota biobank (HUMB) at University
of Tartu, Estonia
T. Rööp* (Tartu, Estonia), H. Mändar, M. Mikelsaar,
R. Mändar
General Information
eP501
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP517
The implementation of a national OPAT
programme in Ireland
S. Clarke* (Dublin, Ireland), N. Curtin,
OPAT Working Group
eP518
Prospective cross-sectional audit of antibiotic
prescriptions in a sample of French general
practitioners
C. Etienne, C. Pulcini* (Nice, France)
eP519
eP520
Antimicrobial stewardship ward-focused
approach – the Pennine model
Z. Fang* (Oldham, United Kingdom), E. Hughes,
S. Shah, A. Stone, I. Cartmill, E. Trautt, H. Panigrahi
Antibiotic stewardship programme reduces the
usage and costs of systemic antibiotics and
lowers in-hospital mortality
D.S. Medvedev* (Cherepovets, Russia),
N.V. Zakharova
eP527
A multi-level antibiotic stewardship intervention
leading to huge changes in antibiotic class,
however overall antibiotic use remains the same
N. Fawcett* (Oxford, United Kingdom), N. Jones,
T. Clarke
eP528
Physicians’ perception of the factors which
impact on successful changes to antibiotic
prescribing made at a tertiary centre
N. Fawcett* (Oxford, United Kingdom), N. Jones
eP529
Reflection over prescribing patterns reduced
prescribing rates for antibiotics against
respiratory tract infections in western Sweden
C. Ahren* (Gothenburg, Sweden), D. Björk,
A. Edholm, M. Hess, G. Jacobsson, P.D. Sundvall,
P. Ulleryd
eP530
Run for the appropriateness: impact of an
antimicrobial stewardship programme in a large
general teaching hospital
M. Giannella* (Bologna, Italy), M. Bartoletti,
S. Tedeschi, F. Cristini, M. Morotti, C. Sacripanti,
F. Tumietto, F.F. Trapani, C. Puggioli, P. Viale
eP531
Escherichia coli isolated from urinary tract
infections of Lebanese patients between
2005 and 2012: epidemiology and profiles of
resistance
Z. Daoud, M.A. Abu Jaoudeh* (Beirut, Lebanon),
S. Samad, K. Masry
eP521
Attitudes towards antimicrobial stewardship:
a challenge for private hospitals in Australia?
M. Cotta* (Melbourne, Australia), M. Robertson,
M. Tacey, C. Marshall, K. Thursky, D. Liew, K. Buising
eP522
Improving in-hospital antimicrobial prescribing by
participating with prescribers to develop tailormade intervention bundles
J.J. Sikkens* (Amsterdam, The Netherlands),
M.H.H. Kramer, E.J.G. Peters, M.A. Van Agtmael
eP523
Impact of antimicrobial stewardship programme
implementation in medical wards, Saudi Arabian
experience
A. Malhani* (Riyadh, Saudi Arabia), N. Alghamdi,
M. Enani
eP532
The analyses of systemic fluoroquinolone use in
children under 18 years of age before and after
drug utilisation review
E. Kim* (Seoul, Korea), J. Shin, W. Kang, S. Hyeon,
D. Kim, S. Choi, K.I.M. Yae-Jean
eP524
Physicians’ knowledge, perception and
attitudes towards antimicrobial prescribing;
a cross-sectional study from Saudi Arabia
A.M. Albaadani* (Riyadh, Saudi Arabia),
W.A. Alfahadl, K. Baig, A.S. Omrani
eP533
eP525
Monthly prescriber-led antimicrobial stewardship
audits in a 900-bed tertiary and quaternary care
teaching hospital – an intervention to improve
compliance with good prescribing practice
A. Fife* (London, United Kingdom), N. Desai,
M. Talpaert, P. Donohoe
Increasing the knowledge and awareness of
antibiotics in Stockholm county by introducing
internet-based education tools for prescribers
and the public
A. Hahlin* (Stockholm, Sweden), S. Hellman,
E. Titelman, M. Vading, C. Falk, A. Lundevall
eP534
Can a mass media campaign affect antibiotic
use in a region with both a low rate of antibiotic
prescribing and low rate of antibiotic resistance?
G. Jacobsson* (Gothenburg, Sweden), D. Björk,
A. Edholm, M. Hess, P.-D. Sundvall, P. Ulleryd,
C. Ahrén, E. Lampi, F. Carlsson
eP526
120
An antimicrobial stewardship programme
improves clinical outcomes in surgical wards
R. Güerri Fernandez* (Barcelona, Spain),
J. Villar-García, M.L. Sorli Redo, J. Fernandez Morato,
A. Domínguez Gonzalez, M. Trenchs, A. Diez Perez,
S. Grau Cerrato, J.P. Horcajada Gallego
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP538
Mobile device applications for antimicrobial
stewardship – is there a role in primary care?
Preliminary findings from a survey of general
practitioners in the United Kingdom
M. Mcleod, E. Charani* (London, United Kingdom),
E. Castro-sanchez, L.S.P. Moore, M. Gharbi,
M. Gilchrist, A. Holmes
eP539
Usage statistics of individually designed
optimum dosing strategies, a multi-model-based
online application to individualise antibiotic
dosing in critically ill patients
A. Farkas, G. Daroczi, J. Roberts* (Queensland,
Australia)
eP540
Antifungal drug interactions database and apps
for iPhone and Android
G.T. Atherton* (Manchester, United Kingdom),
S. Banfield, J. Bartholomew, D.W. Denning
eP541
Determinants of the successful adoption of
a computerised antimicrobial stewardship
programme at a university teaching hospital
S. Zaidi* (Hobart, Australia)
eP542
Development of national antimicrobial
prescribing and stewardship competences
D.A. Ashiru-Oredope* (London, United Kingdom),
B. Cookson, C. Fry
eP543
Antimicrobial stewardship: does it really work?
Yes it does!
D. Nayar* (Durham, United Kingdom), S. Brown,
D. Allison, C. Aldridge, L. Lim, J. Sloss, C. Grey,
M. Wright, P. Gordon, A. Foden
eP544
Serotype distribution and antimicrobial
susceptibility of Streptococcus pneumoniae
causing peritonitis
M. Alonso, J.M. Marimon Ortiz de Zarate* (San
Sebastian, Spain), C. Zugazaga, M. Ercibengoa,
E. Pérez-Trallero
eP545
Study of clinical presentation, serotype
distribution, vaccination history and outcome of
pneumococcal bacteraemia in Milton Keynes, UK
A. Jarzynska* (Milton Keynes, United Kingdom),
L. Brako, M. Healy, R. Randhawa, M.M. Raza
eP546
Invasive pneumococcal disease in Poland,
2011-2012
A. Skoczynska* (Warsaw, Poland), A. Kuch,
I. Wasko, M. Markowska, P. Ronkiewicz, B. Matynia,
W. Hryniewicz
eP547
Characteristics of invasive pneumococcal
disease in immunocompromised adults
after PCV7 implementation, Toronto, Canada,
2005-2011
A. Shigayeva* (Toronto, Canada), A. McGeer,
W. Rudnick, K. Green, A. Plevneshi, S. Pong-Porter,
D.E. Low
eP548
Risk factors for adverse outcome in adult
patients with invasive pneumococcal disease
M. Trojanek* (Prague, Czech Republic),
K. Herrmannova, O. Dzupova, Z. Blechova,
S. Arientova, A. Gabrielova, J. Kozakova, J. Motlova,
H. Zemlickova, V. Maresova
eP549
The burden of pneumococcal pneumonia among
older adults in southern Catalonia, Spain
X. Raga* (Tarragona, Spain), X. Clivillé, S. Noguer,
Á. Vila, O. Ochoa, R. Reig, C. De Diego, M. Mas,
S. Hernández
eP550
Current epidemiology and burden of
pneumococcal diseases in elderly population in
the republic of Korea: a prospective, multi-centre,
observational study
M.J. Kim* (Seoul, Korea), S.Y. Kee, S.H. Paik,
Y.H. Choi, I. Bae, S.Y. Kim, Y.K. Kim, J.A. Hur, Y.M. Jo,
J.Y. Song
24th ECCMID / Barcelona
Final Programme
121
ePosters
Global online internet antimicrobial stewardship
training programmes
D. Goff* (Columbus, United States), J. Bosso,
M. Rybak
EPOSTER VIEWING:
Streptococcus pneumoniae
Posters
eP537
Viewing Stations
Chairs, Speakers & Authors
Taking antimicrobial stewardship initiatives to the
next level: development of a serious prescribing
game for acute care
E. Castro Sanchez* (London, United Kingdom),
E. Charani, L.S.P. Moore, M. Gharbi, A.H. Holmes
Exhibition
eP536
Establishing a futuristic model of communitybased outpatient parenteral antibiotic therapy
service with a balance of commissioning
elements: an acute-commissioner-primary care
transformational project in north-west England
A. Guleri* (Blackpool, United Kingdom), R. Sharma,
S. Rourke
General Information
eP535
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP551
eP552
eP553
Low prevalence of Streptococcus pneumoniae
respiratory infection among Malaysian Hajj
pilgrims in 2013
H. Hasan, N. Ismail* (Kelantan, Malaysia),
Z. Abdul Rahman, Z. Mohamed, S. Md Noor,
R. Abd. Rahman, N. Naing, A. Abd. Aziz,
N. Zainuddin, A. Harun
Bacteraemic pneumococcal pneumonia in chronic
obstructive pulmonary disease patients in the
13-valent conjugate vaccine era
A. Sangil* (Barcelona, Spain), M. Andrés, E. Espejo,
M. Riera, M. Xercavins, J. Pérez,
M. Rodríguez-Carballeira, J. Garau, E. Calbo
Epidemiology of invasive pneumococcal disease
in immunosupressed adults in a setting with a
slow progression in children conjugate vaccine
uptake. A. Sangil* (Barcelona, Spain), M. Andrés, E. Espejo,
M. Xercavins, M. Riera, M. Rodríguez-Carballeira,
J. Pérez, J. Garau, E. Calbo
Viewing Stations
eP559
Prevalence of Chlamydia trachomatis in
asymptomatic women in Algiers centre, Algeria
H. Ziane* (Algiers, Algeria), S. Gourari, H. Djaballah,
M. Boufekkane, S. Arib, I. Boubekri, M. Souici, Z. Sadi,
M. Tazir
eP560
Prevalence study of Chlamydia trachomatis in a
tertiary hospital (2009-2013). Potential role in
reactive arthritis
R. Bretones-Miguélez, B. Pino-Calm, C. Grillo Grillo*
(Santa Cruz de Tenerife, Spain), J. Alcoba-Flórez
eP561
Genital Chlamydia trachomatis testing and care
in general practice in UK, France, Sweden and
Estonia
A. Uusküla, E. Ricketts, R. Kalda, A. Tisler-Sala*
(Tartu, Estonia), H. Fredlund, J. Hedlund, B. Dunais,
B. Touboul, C. McNulty
eP562
Demonstration of earlier detection of Salmonella
species from stool samples by using chromogenic
media
E. Marrs, A. Jones, S. Cummings, J. Perry*
(Newcastle-upon-Tyne, United Kingdom)
eP563
Prevalence of Chlamydia trachomatis in
symptomatic patients: results from 2001 to 2013
of Ege university hospital
C. Cicek, H. Kalfaoglu* (Izmir, Turkey), M. Yalaz,
O. Nazli, G. Gundem
eP564
Prevalence and predictors of lymphogranuloma
venereum in a high-risk population in Italy
A. Marangoni* (Bologna, Italy), C. Foschi,
A. D’Antuono, M. Compri, P. Nardini, S. Bellavista,
N. Banzola, A. Filippini, R. Cevenini
eP565
Lymphogranuloma venereum in Switzerland,
2008-2013
D. Goldenberger* (Basel, Switzerland), R. Frei,
F. Dutly
eP566
Prevalence and risk factors associated with
Mycoplasma genitalium infection in a South
African women cohort
J.-H. Dubbink, B. Hay, S. Ouburg, C. Le Roy,
S. Pereyre, S.A. Morré, C. Bebear* (Bordeaux,
France), R.H. Peters
eP567
Y chromosome DNA presence in cervicovaginal
self-collected samples: implications for
epitheliotropic sexually transmitted infections
prevalence
J. Silva* (Porto, Portugal), F. Cerqueira, R. Medeiros
EPOSTER VIEWING:
STD and other genital infections
eP554
eP555
eP557
eP558
122
Self-collected vaginal lavage for detection of
human papillomavirus, bacterial vaginosis,
Chlamydia trachomatis, and other vaginal
pathogens in young women in Germany
Y. Deleré* (Berlin, Germany), M. Fesenfeld,
C. Remschmidt, A.M. Kaufmann, J. Leuschner,
O. Wichmann, M. Pawlita, M. Schmitt
Optimisation of the diagnostic strategy for
detecting C. trachomatis as a cause of female
infectious infertility
K. Gillmann, M.K. Bohlmann, R. Speer, H. Mark,
S. Graspeuntner, A. Schultze- Mosgau, R. Lettau,
G. Griesinger, I. König, J. Rupp* (Lübeck, Germany)
Diagnosis of extra-genital Chlamydia and/or
Neisseria gonorrhoeae infections by VERSANT®
CT/GC DNA 1.0 assay
A. Marangoni* (Bologna, Italy), C. Foschi, P. Nardini,
A. D’Antuono, M. Compri, F. Macca, A. Kintrili,
N. Banzola, A. Filippini, R. Cevenini
Prevalence of Chlamydia trachomatis infection in
the general population of women in Qatar
A. Athani* (Doha, Qatar), L. Abu-Raddad,
H. Abdul-Rahim
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP568
Prevalence of sexually transmitted diseases
among Italian prison inmates in 2012: the
experience of ‘Casa Circondariale di Modena’
A. Bedini* (Modena, Italy), E. Garlassi, C. Stentarelli,
G. Federzoni, S. Petrella, G. Filiberti, V. Hagbe,
S. Lucanto, A.M. Pezzi, C. Mussini
eP577
Ureaplasma species and antimicrobial
susceptibility in asymptomatic women in
northern Greece
T.Z. Kotrotsiou, M. Exindari, E. Diza, G. Gioula,
A. Melidou, K. Kaplanis, N. Malisiovas* (Malisiovas,
Greece)
eP569
Prevalence of high-risk HPV infection in female
sex workers in Spain
X. Camino Ortiz de Barron* (San Sebastian,
Spain), M.A. Von Wichmann de Miguel,
H. Azkune Galparsoro, M.J. Bustinduy,
I. Sanz Bereciartu, G. Cilla
eP578
Infection with Chlamydia trachomatis in infertile
women in Poland
I. Chudzicka-Strugala* (Poznan, Poland),
T.M. Karpinski, A. Zeidler, B. Banaszewska,
L. Pawelczyk, A. Szkaradkiewicz
eP570
High prevalence of HIV infection in homo/bisexual
men with other sexually transmitted diseases
R. Del Romero* (Madrid, Spain), B. Menéndez,
T. Puerta, J. Balllesteros, P. Clavo, M. Vera,
M. Raposo, V. Paredes, C. Rodríguez, I. Río
A new real-time multiplex polymerase chain
reaction for the detection of Treponema pallidum,
herpes simplex-1/2 and Haemophilus ducreyi in
genital, anal and oropharyngeal ulcers
M. Glatz, N. Juricevic, M. Altwegg, S. Bruisten,
P. Komericki, S. Lautenschlager, R. Weber,
P. Bosshard* (Zurich, Switzerland)
eP574
eP575
eP576
Epidemiology of genital herpes virus type 1 and 2
infections
F. Sidoti* (Turin, Italy), C. Balloco, A. Curtoni,
M. Rittà, E. Piasentin, G. Bianco, C. Costa, R. Cavallo
Prevalence of aerobic vaginitis among different
age groups of symptomatic patients
S. Baka, I. Tsirmpa* (Athens, Greece), E. Saltaoura,
A. Chasiakou, S. Hassiakou, V. Gennimata,
E. Kouskouni
Global prevalence of recurrent vulvovaginal
candidiasis
D.W. Denning, M. Kneale, R. Rautemaa-Richardson*
(Manchester, United Kingdom), J.D. Sobel
eP580
Malaria in Istanbul: the epidemiological,
laboratory, clinical and therapeutic features of 63
cases
A. Inan* (Istanbul, Turkey), S.C. Ozyurek,
S. Bolukcu, S.S. Akcay, C. Kuyumcu Akalan,
E. Karagul
eP581
Successful treatment of Plasmodium falciparum
malaria recrudescence with the same drug
despite previous treatment failure
S. Senbayrak Akcay, S. Ozyurek, A. Inan* (Istanbul,
Turkey), C. Akalan Kuyumcu, O. Barkay, S. Erol
eP582
Delayed haemolysis after parenteral artesunate
therapy for severe malaria in a returning
Canadian traveller
M. Charles* (Edmonton, Canada), L. Asadi,
J. Pattterson, S. Houston
eP583
False-positive patterns of malaria rapid
diagnostic tests in patients with rheumatoid
factor
J. Lee, J. Jang, C. Cho, C. Lim* (Seoul, Korea)
eP584
Malaria in travellers. Diagnostic approach in a
European health unit
M. Pessanha* (Lisbon, Portugal), T. BaptistaFernandes, T. Morais, J. Viana, R. Rodrigues,
T. Marques
24th ECCMID / Barcelona
Final Programme
ePosters
eP573
Staining property of roselle plant (Hibiscus
sabdariffa) on Plasmodium species and on blood
cells in malaria endemic country
M. Alo* (Abakaliki, Nigeria), U. Ugah
Posters
High rates of sexually transmitted infections in
HIV-infected individuals attending an STD clinic in
the US
J. Castro* (Miami, United States), M. Alcaide
eP579
Chairs, Speakers & Authors
eP572
EPOSTER VIEWING:
Malaria
Exhibition
Incidence of other sexually transmitted
infections in patients diagnosed with HIV
infection
M. Chamón, R. Pérez, M. Vera, I. Río, V. Paredes,
I. Calzas, M. Grau, M. Villa, C. Rodríguez,
J. Del Romero* (Madrid, Spain)
Viewing Stations
123
General Information
eP571
ePoster Viewing
Saturday, 10 May 2014 - Tuesday, 13 May 2014
eP585
An eleven-year epidemiological study report of
malaria in Adana, Turkey
F. Kuscu* (Adana, Turkey), D.B. Ozturk, S. Gul,
M.L. Babayigit
eP586
Antibody responses of Greeks and immigrants
residing in areas of local malaria transmission
in Greece
M. Mavrouli* (Athens, Greece), E.T. Piperaki,
C. Hadjichristidoulou, A. Tsakris
eP588
eP589
eP590
Performance of real-time PCR in the diagnosis of
imported malaria: comparison with microscopy
and RDT, and impact on submicroscopic malaria
P. Trevisi* (Madrid, Spain), M. Subirats, N. Iglesias,
B. López-Quintana, G. Ramírez, S. Puente, C. Toro
Evaluation of malaria species in Haiti: detection
of sub-clinical infection
T.M. Zervos* (Detroit, United States), T. Prentiss,
S. Arshad, K. Prentiss, J.M. Zervos, K. Wilt, S. Bruni,
J. Sime, M.A.B. Lucien, M.J. Zervos
Characterisation of the commercially available
fluorescent chloroquine-BODIPY conjugate,
LynxTag-CQ™ green, as a marker for chloroquine
resistance and uptake
C.C.Y. Loh, R. Suwanarusk, K.W.K. Chan, Y.Q. Lee*
(Singapore, Singapore), L. Rénia, B.M. Russell,
L.M.-C. Chow, M.J. Lear, F.H. Nosten, K.S.W. Tan
Treatment and risk factors for infections due to
polymyxin-resistant Enterobacteriaceae in a
university hospital in Londrina, PR, Brazil
C.M.D.M. Carrilho* (Londrina, Brazil), C.M.C. Grion,
M. Pelisson, M.R.E. Perugini, J.C. Pascual-Garcia,
J.S. Perozin, L. Oliveira, J. Gaudereto, M.R. Urbano,
S.F. Costa
eP595
Carbapenemase-producing bacteria in travellers
constitute a potential threat for current hospital
infection control programmes
R.H.T. Nijhuis* (Velp, The Netherlands),
P.H.M. Savelkoul, A.A. Van Zwet
eP596
Medical tourism as a source for multidrugresistant pathogens – a cohort analysis
M.J. Cohen, R. Nir-Paz, C. Schwartz, I. Gross,
N. Minster, A.E. Moses, S. Benenson* (Jerusalem,
Israel)
eP597
A single-day, point-prevalence study of
carbapenemase-producing Enterobacteriaceae
(CPE) faecal carriers in long-term care hospitals
in Madrid (Spain) depicts a complex clonal and
polyclonal dissemination of CPE
L. Beatobe, P. Ruiz-Garbajosa* (Madrid, Spain),
M. Tato, I. Méndez, M. Gil, L. Aranzábal, S. Alonso,
L. García-Picazo, M.A. Lópaz, R. Cantón
eP598
Efflux pump genes and chlorhexidine resistance;
a clue for Klebsiella pneumoniae infections in
intensive care units, Ismailia, Egypt
R. Kishk* (Ismailia, Egypt), M. Mandour,
W. Hessam, N. Nemr
eP599
CTX-M group 1-ESBL producing Klebsiella
pneumoniae intra- and extra-hospital clonal
dissemination in the north of Portugal
D. Gonçalves* (Porto, Portugal), P. Cecílio,
C. Iglésias, A. Faustino, A. Estrada, H. Ferreira
eP600
Duration of colonisation with ST131 versus other
extended-spectrum beta-lactamase (ESBL)producing Escherichia coli: outbreak in a longterm care facility (LTCF)
I. Overdevest* (Tilburg, The Netherlands),
J. Veenemans, Y. Hendriks, A. Mulders, W. Couprie,
J. Johnson, J. Kluytmans
eP601
Matrix-assisted laser desorption/ionization timeof-flight mass-spectrometry (MALDI-TOF MS)
based typing of ESBL Escherichia coli during a
hospital outbreak
A. Egli* (Basel, Switzerland), S. Tschudin-Sutter,
D. Goldenberger, A. Widmer, R. Frei
Viewing Stations
EPOSTER VIEWING:
MDR Enterobacteriaceae – a major threat
eP592
Carbapenemase-producing Enterobacteriaceae in
Austria 2010 to 2013
R. Hartl* (Linz, Austria), S. Widhalm, H. Kerschner,
P. Apfalter
eP593
Carbapenemase-producing Enterobacteriaceae
in Spain: results from a national multi-centre
study, 2013
J. Oteo, C. Conejo, M. Fernández-Martínez,
J. González-López, L. Martínez-García, M. Merino,
E. Miró* (Barcelona, Spain), G. Ruíz, L. Zamorano,
Spanish collaborating group for the study 
of carbapenemase-producing Enterobacteriaceae
124
eP594
24th ECCMID / Barcelona
Final Programme
ePoster Viewing
eP604
eP605
Persistence of related blaIMP-4 metallo-betalactamase-producing Enterobacteriaceae from
clinical and environmental specimens within a
burns unit in Australia – a six-year retrospective
study
G.H.Y. Leung* (Concord, Australia), T.J. Gray,
E.Y.L. Cheong, P. Haertsch, T. Gottlieb
Risk factors for acquisition and effect on
mortality of carbapenem-resistant K. pneumonia:
a case-control study
C. Bulut* (Ankara, Turkey), C. Ataman Hatipoglu,
K. Arslan, G. Tuncer Ertem, A. Adiloglu, A.P. Demiröz
eP606
The epidemiology of carbapenem-resistant
Klebsiella pneumoniae stratified by multi-locus
sequence typing
S. Dhar, E.M. Martin, J.P. McRoberts, K. Hayakawa,
T. Lazarovitch, R. Zaidenstein, F. Perez, R.A. Bonomo,
K.S. Kaye, D. Marchaim* (Zerifin, Israel)
eP607
KPC-producing Klebsiella pneumoniae resistant
to tigecycline: epidemiology and risk factors for
colonisation during intensive care unit stay
M. Papadimitriou Olivgeris* (Patras,
Greece), C. Bartzavali, F. Fligou, C. Sklavou,
S. Vamvakopoulou, M. Christofidou, K. Filos,
M. Marangos, E. Anastassiou
eP608
Which patients develop bloodstream infection
due to KPC-producing Klebsiella pneumoniae
within two days of rectal colonisation?
M. Papadimitriou Olivgeris* (Patras, Greece),
C. Bartzavali, F. Fligou, S. Vamvakopoulou,
C. Sklavou, E. Anastassiou, K. Filos, M. Christofidou,
M. Marangos
eP610
KPC-producing Enterobacter aerogenes infection
F. Tuon, C. Scharf, J. Rocha, J. Cieslinsk, G. Becker,
L. Arend, P. Arruda* (Ponta Grossa, Brazil)
eP611
Surveillance and molecular epidemiology of KPCproducing Klebsiella pneumoniae strains from an
intensive care unit
P. Marone* (Pavia, Italy), M. Corbella, A. Piralla,
R. Migliavacca, M. Brandolini, M. Spalla, D. Barbarini,
G. Ottonello, A. Piazza, L. Pagani
eP612
Copper-resistance in Enterobacteriaceae and
other proteobacteria from childrens’ intestines
A. Sánchez-Valenzuela* (Madrid, Spain), E. Morales,
M. Rodríguez, M.J. López-Espinosa, M.T. Coque,
J. Sunyer, F. Baquero
eP613
A bundle of interventions to reduce colonisation
and infection with extensively drug-resistant
microorganisms (XDR): focus on carbapenemresistant Klebsiella pneumoniae (CRKP)
L. Galani, K. Ioannidis, I. Karaiskos* (Athens,
Greece), F. Dasiras, M. Pitsoli, G. Plakias, C. Safiolea,
I. Apostolakis, H. Paskalis, H. Giamarellou
Posters
Microbiological surveillance in a hospitalwide outbreak of OXA-48 producing
Enterobacteriaceae. Where should the net be
thrown?
J.R. Pano-Pardo* (Zaragoza, Spain),
J. García-Rodríguez, J. Mingorance,
A. Sánchez-Purificación, J. Astray, R. Herruzo,
P. Elola, V. Pérez-Blanco, G. Ruiz-Carrascoso
Carbapenem-resistant Klebsiella pneumoniae
bloodstream infections in intensive care unit –
mortality and related predictors in a teaching
hospital in Italy
D.R. Giacobbe, V. Del Bono* (Varazze, Italy),
S. Scabini, C. Saffioti, A. Parisini, A. Molin,
G. Buscaglia, A. Gratarola, P. Pelosi, C. Viscoli
Chairs, Speakers & Authors
eP603
eP609
Exhibition
How long to screen for carbapenemase producing
Enterobacteriaceae? Time from exposure to
detection during a Vim-4 outbreak
D. Harvey* (Merseyside, United Kingdom),
A. Ledgerton
24th ECCMID / Barcelona
Final Programme
125
General Information
eP602
ePosters
Saturday, 10 May 2014 - Tuesday, 13 May 2014
ISSN: 2052-2975
NMNI
New MIcrobes aNd
New INfectIoNs
New Microbes aNd
New iNfectioNs
Editor-in-Chief: Michel Drancourt
ISSN: 2052-2975
NMNI is an Open Access journal with a focus on new
genomes, new microbes, and new technology applied to
the diagnosis of infectious and tropical diseases.
Submit your article at http://mc.manuscriptcentral.com/nmni
Reasons to publish with New Microbes and New Infections:
•
•
•
High standard, rigorous peer review
Rapid publication
Open Access – published articles are
licensed under Creative Commons and
authors are the copyright holder
•
•
•
Compliant with open access mandates
Highly competitive publication charges
Submissions accepted in English and
selected foreign languages
Register for emailed New Microbes and New Infections table of contents alerts
– the fastest and easiest way to stay informed on new research!
E-alert registration is free and completely risk-free. You can opt out at any time.
Setting up e-alerts on Wiley Online Library is as easy as 1, 2, 3...
1
2
3
Login or register on
Wiley Online Library
Go to New Microbes and
New Infections homepage
Select ‘Get New Content
Alert’ in the top left under
JOURNAL TOOLS
The New Microbes and New
Infections alert will then be
added to your profile.
Follow us on twitter:
@WB_InfDisease
14-64783
For full details, see www.newmicrobes.com
Poster Sessions
Antifungal activity of myriocin, a sphingolipid
metabolism inhibitor, on fungal biofilms:
a preliminary study
D. Cirasola, F. Perdoni, M. Biggiogera, P. Signorelli,
G. Morace, E. Borghi* (Milan, Italy)
P0008
Direct effects of tacrolimus and cyclosporine on
Candida albicans
M. Erdogan, A. Kalkanci, A. Fouad, E. Senol*
(Ankara, Turkey), G. Sucak Turkoz, S. Kustimur
P0009
Anti-candidal activity of 18-beta glycyrrhetinic
acid and hyaluronic acid
M. Stevan* (Vicenza, Italy), E. Fusato, D. Armanini,
G. Bertoloni, M. Rassu
P0010
In vivo efficacy of a JAK1/2 inhibitor in a murine
model of haematogenously disseminated
candidiasis
J. Meletiadis* (Athens, Greece), A. Elefanti,
N. Siafakas, L. Zerva, G. Dimitriadis, P. Tsirigotis
P0011
Central nervous system fungal infections and
CARD9 deficiency
F. Lanternier* (Paris, France), D. Mansouri,
A.-S. Bruneel, A. Angoulevant, M.E. Bougnoux,
H. Chaussade, O. Lortholary, J.L. Casanova,
C. Picard, A. Puel
P0012
Production of biofilm by Candida and non-Candida
spp. isolates causing fungaemia: comparison of
biomass production and metabolic activity and
development of a cut-off
L. Marcos-Zambrano, P. Escribano, E. Bouza,
J. Guinea Ortega* (Madrid, Spain)
P0013
Comparative stability analysis of two commercial
amphotericin B formulations: liposomal
(AmBisome) and lipid complex (abelcet)
M.A. Parra* (Madrid, Spain), J.R. Azanza, B. Sádaba
P0014
The influence of thymol on C. albicans isolates
adhesion – the key stage in biofilm formation
J. Szymanska* (Lublin, Poland), A. Kaminska,
A. Malm
P0015
The role of Candida albicans antigen in atopic
dermatitis
E. Kasumagic-Halilovic* (Sarajevo, Bosnia and
Herzegovina), N. Ovcina-Kurtovic, S. Samardic,
S. Omic
P0016
Identification and extracellular enzyme activity of
opportunistic human pathogenic bipolaris species
K. Krizsan* (Szeged, Hungary), A. Lengyel,
M. Czikora, C.S. Vágvölgyi, T. Papp
POSTER SESSION I:
Diagnosis of fungal infections
P0001
P0002
P0003
P0004
P0005
Ten-year retrospective case series of patients
with galactomannan antigenaemia: implications
on the use of serum galactomannan antigen
in the diagnosis of invasive and non-invasive
aspergillosis
J.F.W. Chan* (Hong Kong, China), S.K.P. Lau,
S.C.Y. Wong, K.K.W. To, V.C.C. Cheng, K.Y. Yuen,
P.C.Y. Woo
The value of different mycological methods in the
diagnosis of invasive pulmonary aspergillosis
A. Gracheva* (Moscow, Russia), V. Okhmat,
I. Frolova, G. Klyasova
Mupirocin disk diffusion technique for
presumptive identification of Pythium
insidiosum
J. Tondolo* (Santa Maria, Brazil), S. Itaqui, E. Loreto,
S. Alves, J. Santurio
MALDI-TOF MS as a rapid screening method for
azole-resistance in Aspergillus fumigatus
E. Vermeulen* (Leuven, Belgium), J. Maertens,
K. Lagrou
Cost and cost-effectiveness analysis of mass
spectrometry (MALDI-TOF MS) identification of
Candida spp. from candidaemia at species level
E. Gomez G. de la Pedrosa* (Madrid, Spain),
R. Canton
15:30 – 16:30
Poster Area
POSTER SESSION I:
News from the fungal frontier
P0005a
P0006
Incidence of mixed invasive aspergillosis in a
general hospital in Madrid: an underestimated
entity?
T. Pelaez Garcia* (Madrid, Spain), B. Gama,
V. García-Gil, L. Alcazar-Fuoli, P. Escribano, J. Guinea,
P. Muñoz, E. Mellado, E. Bouza
Combined effect of ozonous oleic acid and
terbinafine on Candida albicans
S. Gramatiuk* (Kharkov, Ukraine), E. Kochneva,
V. Minukhin, O. Jafarli
24th ECCMID / Barcelona
Final Programme
Chairs, Speakers & Authors
P0007
Exhibition
Poster Area
127
General Information
15:30 – 16:30
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0017
Phenotypic, genotypic and antifungal
susceptibility characterisation of clinical isolates
of Exophiala spp. from the stock culture collection
of Laboratório Especial de Micologia (LEMI),
EPM/UNIFESP
W. Colalto, S. Goncalves, D.W.C.L. Santos,
A.L. Colombo, A.S.A. Melo* (São Paulo, Brazil)
P0018
Characterisation and pathogenicity of Exophiala
dermatitidis strains from various sources
M. Olsowski* (Essen, Germany), P. Vidigal, J. Buer,
P.-M. Rath, J. Steinmann
P0019
Eumycetoma and plant-based pharmacotherapy
candidates
H.E. Hassan* (Medani, Sudan), E.M. Ahmed,
H.A. Fahal, W. Sande, A.H. Mohamedani
P0020
Role of RTA3 in fluconazole resistance in Candida
albicans
S.G. Whaley* (Memphis, United States), S. Tsao,
K. Barker, M. Raymond, P.D. Rogers
P0021
Mutant prevention concentration (MPC) and
mutant selection window (MSW) of fluconazole
and amphotericin B in Candida albicans and
Candida glabrata candidaemia
M.A. Bordallo Cardona* (Madrid, Spain),
E. Gómez G. de la Pedrosa, R. Cantón Moreno
P0022
17-beta-estradiol increases rhodamine 6G efflux
in Candida albicans detected by flow cytometric
analysis
H.C. Xu, X.P. Liu* (Shenzhen, China), S.R. Fan,
L.P. Nie
P0023
Synergistic effects of diphenyl diselenide and
amphotericin B in Trichosporon asahii isolates
D. Alves Nunes Mario* (Rio Grande do Sul, Brazil),
T. Felli Kubiça, P. Orlandi Barth, E. Silva de Loreto,
C. Nogueira, L. Bedin Denardi, S. Hartz Alves
P0024
P0025
128
Ultra deep pyrosequencing of Pneumocystis
jirovecii reveals higher diversity than previously
stated
A. Alanio* (Paris, France), J. Menotti,
S. Mercier-Delarue, S. Bretagne
Inhibition of adhesion of Paracoccidioides spp.
by 4 selected peptides identified using phage
display technology
H.C. Oliveira* (Araraquara, Brazil), J. Michaloski,
J.F. Da Silva, L. Scorzoni, A.C.A. De Paula e Silva,
D.S. Yamazaki, A.M. Fusco-Almeida, R.J. Giordano,
M.J.S. Mendes-Giannini
24th ECCMID / Barcelona
Final Programme
P0026
Acidosis promotes Rhizopus oryzae-induced
endothelial cell injury in vitro via overexpression
of host GRP78 receptor and fungal CotH3
T. Gebremariam, J. Edwards Jr., S.G. Filler,
A.S. Ibrahim* (Torrance, CA, United States)
P0027
14-3-3 gene silencing of Paracoccidioides
brasiliensis using antisense RNA
C.M. Marcos, J.F. Da Silva, H.C. Oliveira, P.A. Assato,
O. Hernández, J.G. McEwen, M.J.S. Mendes-Giannini,
A.M. Fusco-Almeida* (Araraquara, Brazil)
P0028
Impedance and toxin release studies of bacterial
biofilms developed in continuous flow conditions
O. Estrada-Leypón* (Barcelona, Spain), V. Ramos,
S. Borrós, A.T. Jenkins, A. Moya, G. Gabriel, J. Aguiló,
R. Villa
15:30 – 16:30
Poster Area
POSTER SESSION I:
How to improve fungal diagnosis
P0029
Introduction and evaluation of the ‘Candida score’
for adult critical care patients: a prospective,
observational pilot cohort study
R. Patel* (Dartford, United Kingdom), M. Gilchrist,
A. Gonzalez-Ruiz P0030
Characterisation of patients on anidulafungin
and evaluation of ‘Candida score’ in critically
ill patients on an intensive care unit in a large
district general hospital
T. Vaghela* (Watford, United Kingdom), A. Flatt,
P. Seetulsingh, V. Page, T. Stambach, S. Parida
P0031
Does the use of predictive scores really guide the
early initiation of antifungal therapy in patients
admitted to the ICU for peritonitis?
T. Geffriaud* (Lyon, France), A. Gregoire, J. Prothet,
B. Devigne, C. Ber, J. Crozon-Clauzel, B. Allaouchiche,
T. Rimmelé
P0032
An audit of ophthalmological examination of
patients with candidaemia; is fundoscopy
performed at the correct time?
S. Venturelli* (London, United Kingdom), P.A. Riley
P0033
Candida colonisation of the lower respiratory
tract investigated by conventional culture and
fungal microbiome analysis
R. Krause* (Graz, Austria), B. Halwachs, I. Klymiuk,
G. Gorkiewicz, I. Zollner-Schwetz, T. Valentin,
M. Hönigl, G. Thallinger
Poster Sessions
Saturday, 10 May 2014
P0036
P0037
P0038
P0039
P0040
P0041
P0042
Candida bloodstream infections caused
by a novel species Candida quercitrusa:
epidemiologically linked infection suggestive of
an outbreak with mycological characteristics
M. Xiao* (Peking, China), H. Wang, J. Lu, S. Chen,
F. Kong, X. Ma, Y. Xu
Contribution of 1,3-beta-D-glucan (BDG) to the
diagnosis of invasive candidiasis after liver
transplantation
S. El Anbassi, E. Levesque, E. Sitterle, F. Foulet,
J.C. Merle, F. Botterel* (Le Perreux sur Marne,
France)
Beta-D-glucan for guidance of antifungal therapy
at the ICU: a retrospective evaluation in a real life
setting: a cohort study
J. Wagner, J. Prattes, R.B. Raggam,
I. Zollner-Schwetz, T. Valentin, K. Seeber, F. Prueller,
S. Fruhwald, R. Krause, M. Hoenigl* (Graz, Austria)
Initial (1,3)-beta-D-glucan as a prognostic
marker of mortality in Candida spp. bloodstream
infections in a teaching hospital in Italy
D.R. Giacobbe, V. Del Bono* (Varazze, Italy),
A. Mesini, S. Grignolo, P. Tatarelli, F. Artom, A. Parisini,
E. Furfaro, F. Miletich, C. Viscoli
IL17A, IL22 and kynurenins in patients with
candidaemia and healthy controls
R. Krause* (Graz, Austria), M. Hönigl, T. Valentin,
J. Prattes, J. Wagner, B. Rinner, F. Quehenberger,
R. Raggam, A. Meinitzer, I. Zollner-Schwetz
Predictors of candidaemia caused by Candida
isolates with decreased susceptibility to
fluconazole (MIC >= 4 mg/l)
M. Puig-Asensio* (Barcelona, Spain), M. Salavert,
F. González-Romo, J. Guinea, O. Zaragoza,
B. Almirante
Should we perform lumbar punctures in every
patient with cryptococcosis?
S.H. Huang* (Taipei, Taiwan), H.Y. Sun, C.C. Hung,
Y.C. Chen, S.C. Chang
P0044
Real-time PCR for pneumocystosis diagnosis in
non-HIV patients
A.L. Bienvenu* (Lyon, France), M. Bouchrik,
C. Bossard, M. Wallon, S. Picot
P0045
High prevalence of Pneumocystis jirovecii in
bronchoalveolar lavage (BAL) samples using a
multiplex-nested PCR
L. Martinez-Lamas* (Pontevedra, Spain),
M. Álvarez-Fernández, M.P. Figueroa, M.E. Bouza,
M.I. Álvarez-Álvarez
P0046
A combined screening strategy for invasive
fungal infections in high-risk haematology
patients: early computed thoracic tomograpy and
serum 1,3-beta-D-glucan
G. Metan* (Kayseri, Turkey), M. Keklik, G. Dinc,
C. Pala, A. Yildirim, B. Saraymen, Y. Koker, B. Eser,
M. Cetin
P0047
Elderly versus non-elderly patients with
aspergillosis in the ICU
G. Dimopoulos* (Chaidari, Greece),
T. Christodoulopoulou, D. Matthaiou, D. Vogelaers,
S. Blot
P0048
Imaging findings of invasive pulmonary
aspergillosis in immunocompromised children
A. Volkova* (St. Petersburg, Russia), M. Popova,
E. Lyapina, O. Shadrivova, T. Bogomolova,
S. Ignatyeva, L. Zubarovskaya, B. Afanasyev,
N. Klimko
P0049
Utility of volumetric analysis of computed
tomography scans for prediction of treatment
success and survival in invasive pulmonary
aspergillosis
J.J. Vehreschild, C.P. Heussel, G. Würthwein,
M.J.G.T. Vehreschild, G. Silling, A.H. Groll, M. Brecht,
O.A. Cornely* (Cologne, Germany)
P0050
Prospective study of the performance of
the serum galactomannan assay as part of
a diagnostic-driven strategy for high-risk
haematology patients on posaconazole primary
prophylaxis
I. Sánchez-Ortega* (Barcelona, Spain), I. Cuesta,
B. Patiño, M. Arnan, A. Fernández de Sevilla,
C. Gudiol, J. Ayats, M. Cuenca-Estrella, R.F. Duarte
24th ECCMID / Barcelona
Final Programme
Posters
New strategies in the diagnosis of invasive
candidiasis in neonatal intensive care
L. Trovato* (Catania, Italy), P. Betta, V. Petrolito,
D. Sciortino, S. Oliveri
Diagnosis of Pneumocystis jirovecii pneumonia
in onco-haematological patients: efficiency of
combined detection of (1-3)-beta-D-glucan in
the serum and Pneumocystis jirovecii DNA in
respiratory samples
C. Angebault* (Paris, France), E. Chachaty,
J.-R. Zahar, A. Stoclin, B. Gachot, M.-E. Bougnoux,
M. Merad
129
Chairs, Speakers & Authors
P0035
P0043
Exhibition
Identification of Candida parapsilosis complex
species by RAPD, RFLP and VITEK® MS
L. Bonato de Souza, J. Nobrega De Almeida Junior*
(São Paulo, Brazil), A. Lopes Motta, F. Rossi,
G. Benard, G.M. Bárbaro Del Negro
General Information
P0034
Poster Sessions
Saturday, 10 May 2014
P0051
P0052
P0053
Bronchoalveolar lavage lateral-flow device test
for diagnosing invasive pulmonary aspergillosis
in patients with haematologic malignancies: a
multicentre study
M. Hoenigl* (Graz, Austria), D. Buchheidt,
B. Willinger, J. Prattes, M. Lackner, W. Duettmann,
V. Posch, B. Spiess, R. Krause, C. Lass-Flörl
Performance of serum and bronchoalveolar
lavage galactomannan and 1,3 beta-glucan
enzyme assays with computer tomography
scans in the diagnosis of invasive aspergillosis in
immunocompromised hosts
M. Batista* (São Paulo, Brazil), C. Lima Diogo,
C. Abreu Fonseca, S. Figueiredo Costa,
C. Melo Gamba, S. Vidal Campos,
I. Leonardo Silva França, F. Luiz Dulley, M.L. Moretti,
M.A. Shikanai-Yasuda
Performance of galactomannan, Aspergillus
lateral flow device test, beta-D-glucan,
conventional culture and PCR for diagnosis
of invasive pulmonary aspergillosis in
bronchoalveolar lavage: a cohort study
M. Hoenigl* (Graz, Austria), J. Prattes, B. Spiess,
J. Wagner, V. Posch, W. Buzina, C. Koidl, R. Raggam,
R. Krause, D. Buchheidt
P0054
Invasive aspergillosis in HIV-infected patients in
France: incidence, diagnosis, and outcome over
20 years
B. Denis* (Paris, France), M. Guiguet, F. Mechaï,
M. Revest, G. Melica-Gregoire, N. De Castro,
A. Mahamat, D. Costagliola, O. Lortholary
P0055
Evaluation of the in vitro potency of itraconazole,
voriconazole, and posaconazole and against rare
Aspergillus species
N. Wiederhold* (San Antonio, TX, United States),
A. Fothergill, D. McCarthy, C. Sanders, D. Sutton
15:30 – 16:30
P0057
Candida parapsilosis candidaemia: analysis of a
decade at a tertiary hospital
G. Fresco* (Madrid, Spain), J. Fortun Abete,
P. Martín-Dávila, E. Gomez-Garcia de la Pedrosa,
V. Pintado, J. Cobo, S. Moreno
P0058
Epidemiology, species distribution and outcome
of nosocomial Candida bloodstream infection in
Shanghai
Y.A.N.G. Zhi-Tao* (Shanghai, China), X.-Y. Liu,
E.-Z. Chen, O. Lortholary
P0059
Candida bloodstream infections: species
distribution and antifungal resistance in
intensive care unit (ICU) and in non-ICU wards at
an university hospital in Rome
M.T. Mascellino* (Rome, Italy), M.C. Ghezzi, A. Oliva,
G. Raponi
P0060
Candidaemia at two major teaching hospital
networks in New York
A. Safdar* (New York, United States), R. Press
P0061
A seven-year survey of Candida bloodstream
infections at a large Italian university hospital
G. De Angelis* (Rome, Italy), T. D’Inzeo, B. Fiori,
V. Prete, E. Liberto, E. De Carolis, R. Torelli,
B. Posteraro, T. Spanu, M. Sanguinetti
P0062
Nosocomial candidaemia in a paediatric unit of
a university hospital: analysis of 144 episodes
over a 3-year period
E. Kocabas* (Adana, Turkey), U. Cay,
G. Timurtas Dayar, G. Seydaoglu, F. Kibar
P0063
The incidence of Candida yeasts on the tongue
and in the intestinal tract in patients with
psoriasis
N. Ovcina-Kurtovic* (Sarajevo, Bosnia and
Herzegovina), E. Kasumagic-Halilovic, S. Samardzic
P0064
Candidaemia in the Coimbra Burns Unit in
Portugal: predictive factors for infection and
mortality
C. Chaves* (Coimbra, Portugal), L.V. Saraiva,
M. Caetano, N. Silva, L. Cabral
P0065
Candidaemia at a referral hospital in Sub-Saharan
Africa: emergence of Candida auris as a major
pathogen
N. Okinda, E. Kagotho, M. Castanheira, A. Njuguna,
G. Omuse, P. Makau, M. Pfaller, G. Revathi, R. Adam*
(Nairobi, Kenya)
Poster Area
POSTER SESSION I:
Confronting fungal infections
P0056
Candidaemia in patients with haematological
malignancies: epidemiology and outcome
G. Klyasova* (Moscow, Russia), E. Blokhina,
A. Gracheva, S. Kravchenko, E. Parovichnikova,
G. Galstyan, V. Okhmat
130 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Evaluation of twenty-eight cases of
mucormycosis
E. Kursun* (Adana, Turkey), T. Turunc,
Y. Ziya Demiroglu, H. Arslan
P0068
P0069
P0070
P0071
P0072
P0073
P0074
P0075
Post-traumatic mucormycosis: nationwide study
in France and review
L. Lelievre* (Paris, France), H. Abdoul,
D. Garcia-Hermoso, A.C. Mamez, M. Hivelin,
L. Lantieri, O. Lortholary, F. Lanternier
Mucormycosis: ten-year experience at a tertiarycare centre in Turkey
S. Kömür, A.S. Inal* (Adana, Turkey), B. Kurtaran,
U. Ulu Candevir, A. Uguz, Y. Tasova, H.S.Z. Aksu
Rhinocerebral and gastrointestinal
mucormycosis: a case report
C. Meddings, S. Raghuvanshi, T. Shimizu, R. Patel*
(Dartford Kent, United Kingdom), L. Cotter
Apophysomyces: an emerging Mucormycetes
species causing necrotizing fasciitis, a primary
cutaneous disease among humans – report of 17
cases from single institution of North India
J. Chander* (Chandigarh, India), N. Singla, M. Kaur,
K. Bala, R. Kaushik, U. Dalal, U. Handa, R.P.S. Punia,
J. Guarro
Fungiscope – global emerging fungal infection
registry
K. Wahlers* (Cologne, Germany),
M.J.G.T. Vehreschild, A. Hamprecht, S. De Hoog,
H. Wisplinghoff, J.J. Vehreschild, O. Cornely
Burden of serious fungal infections in Denmark
M.C. Arendrup* (Copenhagen, Denmark),
T. Benfield, D.W. Denning
Evaluation of knowledge and awareness of
invasive fungal infections amongst doctors in the
residency programme in Nigeria
R.O. Oladele* (Lagos, Nigeria), A.T. Olayinka,
A.A. Otu, H.A. Ekundayo, O.B. Makanjuola,
E. Ochang, E. Asuquo, O.A. Atoyebi, D. Denning
The burden of invasive and serious fungal
disease in the UK
D.W. Denning* (Manchester, United Kingdom),
M. Pegorie, W. Welfare
P0077
The burden of serious fungal infections in
Ukraine
A. Osmanov* (Simferopol, Ukraine), D.W. Denning
P0078
The burden of serious fungal infections in the
Czech Republic
A. Chrdle* (Ceske Budejovice, Czech Republic),
N. Mallatova, D.W. Denning P0079
The burden of serious fungal infections in
Germany
M. Ruhnke* (Berlin, Germany), A. Groll, P. Mayser,
M. Schaller, W. Mendling, A. Ullmann, D.W. Denning
P0080
Changing pattern of fungaemia in haematological
patients; a six-year surveillance study
A. Ulu-Kilic* (Kayseri, Turkey), A. Atalay,
H. Demiraslan, C. Pala, G. Metan, E. Alp Mese
P0081
Trichosporon asahii urinary tract infections in a
tertiary hospital
E. Belesiotou* (Athens, Greece), E. Perivolioti,
M. Nepka, Z. Psaroudaki, A. Argyropoulou,
T. Pittaras, A. Skoutelis
P0082
Invasive pulmonary infection caused by
Chrysosporium articulatum: the first case report
C. Suankratay* (Bangkok, Thailand),
O. Dhissayakamol, N. Uaprasert, N. Worasilchai,
A. Chindamporn
P0083
Agents of tinea capitis and their distribution
according to age groups in the Aegean region of
Turkey, 1974-2011
E. Tumbay, R. Inci, S. Hilmioglu-Polat* (Izmir,
Turkey), G. Kitapcioglu
P0084
Skin infection on both legs caused by
Acremonium strictum: case report
S. Polat-Hilmioglu, D.Y. Metin, M. Tasbakan* (Izmir,
Turkey), H. Pullukcu, T. Akalin, E. Tümbay
P0085
Epidemiology of fungal organisms isolated from
5923 otorrhea samples, a case control study: are
Candida species infective organisms?
Y. Hirai* (Tokyo, Japan), S. Asahata, Y. Ainoda,
T. Fujita, A. Goto, K. Totsuka
Estimating the burden of fungal diseases in
Vietnam
J. Beardsley* (Ho Chi Minh City, Vietnam),
D.W. Denning, N.V. Chau, J.A. Crump, J.N. Day
24th ECCMID / Barcelona
Final Programme
131
Chairs, Speakers & Authors
P0067
P0076
Exhibition
A decade of invasive aspergillosis in patients with
kidney transplantation
A. Desbois* (Paris, France), S. Poirée,
R. Sberro-Soussan, E. Catherinot, M.E. Bougnoux,
F. Lanternier, C. Legrendre, O. Lortholary, A. Scemla
General Information
P0066
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0086
An 8-year survey on the epidemiology and
management of tinea capitis and tinea faciei in
the Zurich area, Switzerland
S. Kieliger, A. Cozzio, P. Bosshard* (Zurich,
Switzerland)
P0087
Impact of prior voriconazole exposure on
frequency of mixed fungal infections in patients
with invasive mucormycosis
M. Abidi* (Milwaukee, United States), M. Sohail,
N. Cummins, M. Wilhelm, N. Wengenack, M. Litzow,
L. Letendre, B. Lahr, E. Poeschla, R. Walker
15:30 – 16:30
P0093
Lithium protects neurons from apoptosis in
experimental pneumococcal meningitis
F.D. Liechti* (Berne, Switzerland), N. Stüdle,
D. Grandgirard, W. Thormann, S.L. Leib
P0094
In experimental pneumococcal meningitis
the effects of adjuvant daptomycin and
dexamethasone differ and are influenced by
disease severity
P. Agyeman, D. Grandgirard* (Berne, Switzerland),
S.L. Leib
P0095
Experimental study of the efficacy of
moxifloxacin in the therapy of Listeria
monocytogenes meningitis
M. Vivas Roca* (Barcelona, Spain), E. Force,
C. El Haj, D. Garcia-Somoza, I. Pelegrín, J. Ariza,
C. Cabellos
P0096
Pituitary adenylate cyclase-activating
polypeptide (PACAP) treatment ameliorates
Toxoplasma gondii induced encephalitis in mice
M.M. Heimesaat* (Berlin, Germany), A. Parlog,
K. Wein, A. Tamas, G. Toth, D. Reglodi, I.R. Dunay
P0097
Efficacy of solithromycin (CEM-101) for
experimental otitis media (EPM) due to
nontypable Haemophilus influenzae (NTHI) and
Streptococcus pneumoniae (SP)
M. Figueira* (Boston, United States), S. Pelton
P0098
Activity of fluconazole, amphotericin B,
caspofungin and anidulafungin against Candida
albicans in an experimental foreign-body
infection model
E. Maiolo* (Lausanne, Switzerland),
U. Furustrand Tafin, O. Borens, A. Trampuz
P0099
In vivo and in vitro efficacy of preventive use
of azithromycin in pneumonia caused by
Pseudomonas aeruginosa
N. Kaku* (Nagasaki City, Japan), K. Yanagihara,
Y. Harada, Y. Morinaga, N. Uno, H. Hasegawa,
K. Izumikawa, S. Kohno
P0100
Assessment of the activity of an antibiofilm
molecule against Pseudomonas aeruginosa (PA)
in a mice model of pneumonia
S. Pineau* (Nantes, France), M. Simon, D. Boutoille,
C. Jacqueline, K. Asehnoune, A. Dufour, J. Caillon
P0101
Granzymes A and B contribute to the pulmonary
inflammatory response during Klebsiella
pneumoniae pneumonia
M.I. Garcia-Laorden* (Amsterdam, The Netherlands),
A.F. De Vos, D.C. Blok, S. Florquin, T. Van Der Poll
Poster Area
POSTER SESSION I:
Animal models: treatment
P0088
P0089
Combination of daptomycin plus fosfomycin
has synergistic, potent, and rapid bactericidal
activity against methicillin-resistant
Staphylococcus aureus (MRSA) in a rabbit model
of experimental endocarditis (EE)
J.M. Miro* (Barcelona, Spain), C. Garcia-de-la-Maria,
J.M. Pericas, Y. Armero, D. Soy, C. Cervera, C.A. Mestres,
C. Falces, F. Marco, A. Moreno
Daptomycin is more bactericidal than
vancomycin and vancomycin/rifampin
combination in a murine model of methicillinresistant Staphylococcus aureus vascular
prosthesis infection
M. Revest* (Rennes, France), C. Jacqueline,
J. Caillon, P. Tattevin, G. Potel, C. Michelet,
D. Boutoille
P0090
Daptomycin plus fosfomycin: a highly synergistic
combination in an experimental implantassociated MRSA-osteomyelitis in rats
T. Lingscheid* (Berlin, Germany), W. Poeppl,
D. Bernitzky, R. Plasenzotti, H. Burgmann
P0091
Minimal Biofilm Eradication Concentration
(MBEC) measurement predicts treatment failure
in murine biofilm infection model of implantassociated osteomyelitis
N. Jørgensen* (Aarhus, Denmark), R. Meyer,
F. Dagnæs-Hansen, K. Fuursted, E. Petersen
P0092
132
Bioactive titanium alloy prevents Staphylococcus
aureus prosthesis adherence: in vitro and in vivo
studies
A. Saleh-Mghir* (Garches, France), I. Ben Aissa,
L. Gatin, G. Hélary, V. Migonney, A.C. Crémieux
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Saturday, 10 May 2014
Murine model of invasive pulmonary
aspergillosis
N.V. Vasilyeva* (St. Petersburg, Russia), I.A. Bosak,
T.S. Bogomolova, I.V. Vybornova, O.N. Pinegina,
L.V. Filippova, S.M. Ignatyeva, A.A. Stepanova,
Y.L. Avdeenko, N.V. Eremina
P0106
In vivo efficacy of isavuconazole and
amphotericin B of in a non-neutropenic murine
model of disseminated Absidia corymbifera
P. Warn* (Manchester, United Kingdom), A. Sharp
P0107
In vivo activity of novel benzothiazinones BTZ169
and BTZ043 against Nocardia brasiliensis
L. Vera-Cabrera* (Monterrey, Mexico),
N.A. Gonzalez-Martinez, H.G. Lozano-Garza,
J. Villarreal-Martinez, N. Cavazos-Rocha,
J. Ocampo-Candiani, R.M. Hinojosa-Robles,
M. Makarov, S.T. Cole
P0108
P0109
Vaccine strategies to block T. cruzi infections
(the causative agent of Chagas disease in the
Americas) in a rodent model
J.G. Estrada Franco* (Tapachula, Mexico),
B.C. Perez Gutierrez, J.C. Vazquez Chagoyan,
A. Barbabosa Pliego, S. Gupta, N. Garg
Eravacycline protects in a Bacillus anthracisinfected New Zealand white rabbit treatment model
J. Sutcliffe* (Watertown, United States), J. Selden,
M. Gooldy, D. Pawlowski, A. Radcliff, K. Edwards,
K. Gillum
P0111
TP-271, a novel fluorocycline, is efficacious in
a treatment model of aerosolised Francisella
tularensis infection in BALB/c mice
T. Grossman* (Watertown, MA, United States),
W. Lin, K. Siefkas-Patterson, J. Sutcliffe
P0112
Ileal dosing of a nisin and miconazole
combination is efficacious in the hamster
Clostridium difficile associated disease model
M. Pulse* (Fort Worth, TX, United States), T. Murphy,
P. Nguyen, K. Peterson, J. Pierce, J. Simecka,
D. Valtierra, W. Weiss, S. Self
P0113
Effect of probiotic Lactobacillus strains with
antioxidant activity on inflammation and gut flora
in a mouse model of colitis
A. Tomusiak* (Krakow, Poland), A. Machul,
D. Mikolajczyk, G. Wiecek, E. Golinska, P.B. Heczko,
M. Strus
P0114
Chemically synthesised treatment-andprophylactic substance against monkeypox virus
and other orthopoxviruses
L. Shishkina* (Koltsovo, Russia), A. Kabanov,
A.L. Sergeev, L. Bulychev, M. Skarnovich, N. Bormotov,
A.R. Sergeev, O. Mazurkov, A. Agafonov, A. Sergeev
15:30 – 16:30
Poster Area
Posters
P0105
Gliotoxin neutralising antibodies enhance
angiogenesis and neutrophil trafficking in
invasive pulmonary aspergillosis
R. Ben-Ami* (Tel Aviv, Israel), S. Amit, V. Dergachev,
Y. Shadkchan, N. Osherov, I. Benhar
Efficacy of the investigational fluoroquinolone
finafloxacin in a murine inhalational model of
melioidosis
S. Harding, K. Barnes* (Porton Down, United
Kingdom), A. Simpson, A. Vente
POSTER SESSION I:
Animal models: pathophysiology
P0115
Role for coagulation factor XI during Klebsiella
pneumonia independent of factor XII
I. Stroo* (Amsterdam, The Netherlands),
C. Van ‘t Veer, J.J.T.H. Roelofs, J.C.M. Meijers,
F.J. Castellino, S. Zeerleder, T. Van der Poll
P0116
Platelet MyD88 signalling is not involved in
host defence during Gram-negative pneumoniaderived sepsis
S.F. De Stoppelaar* (Amsterdam, The Netherlands),
M.P.B. Jansen, J.J.T.H. Roelofs, C. Van ‘t Veer,
T. Van der Poll
P0117
Platelets contribute to host defence and local
haemostasis in Gram-negative pneumoniaderived sepsis
S.F. De Stoppelaar* (Amsterdam, The Netherlands),
J.J.T.H. Roelofs, C. Hau, C. Van ‘t Veer, T. Van der Poll 24th ECCMID / Barcelona
Final Programme
133
Chairs, Speakers & Authors
P0104
Comparison of the efficacy of colistin and
rifampicin in a mouse model of pneumonia
caused by carbapenem-resistant Acinetobacter
baumannii
V. Cassisa, M. Eveillard, H. Pailhoriès* (Anger,
France), M.-L. Joly-Guillou
P0110
Exhibition
P0103
Prevention of endotracheal tube biofilm
development through a novel closed suctioning
catheter in a pig model of Pseudomonas
aeruginosa severe pneumonia
L. Fernandez-Barat* (Barcelona, Spain),
G. Li Bassi, E. Aguilera, J.D. Martí, D. Wyncoll,
G. Ntoumenopoulos, M. Rigol, T. Comaru, F. De Rosa,
A. Torres
General Information
P0102
Poster Sessions
Saturday, 10 May 2014
P0118
Protective role of the gut microbiota in
pneumonia-derived sepsis
J.M. Lankelma* (Amsterdam, The Netherlands),
T.J. Schuijt, B.P. Scicluna, C. Belzer, A.F. De Vos,
W.M. De Vos, W.J. Wiersinga
P0119
The distinct roles of mmp-2 and mmp-9 in
mediating murine Campylobacter jejuni induced
enterocolitis
M. Alutis, U. Grundmann, A. Fischer, A.A. Kühl,
U.B. Göbel, S. Bereswill, M.M. Heimesaat* (Berlin, Germany)
P0120
P0121
P0122
P0123
P0124
Metalloproteinases gene expression in a model
of genital Chlamydia infection in female BALB/c
mice
A. Marangoni* (Bologna, Italy), C. Cavallini,
R. Tassinari, R. Aldini, P. Nardini, C. Foschi,
A. D’Errico, R. Cevenini
Comparison of in vivo and in vitro models for the
evaluation of the virulence of Salmonella enterica
serovar Typhimurium
H.Y. Tsen* (Taichung City, Taiwan), M.H. Chen,
P.H. Chen, H.Y. Hsih, C.W. Lin
A mouse model of Candida glabrata intraabdominal candidiasis highlights persistence
within abscesses and immune evasion as key
aspects of pathogenesis
C.J. Clancy* (Pittsburgh, United States), S. Cheng,
N. Solis, S. Filler, M.H. Nguyen
Hypoxia in Leishmania major-skin lesions impairs
the NO-dependent leishmanicidal activity of
macrophages
A. Mahnke, R.J. Meier, V. Schatz, J. Hofmann,
K. Castiglione, U. Schleicher, O.S. Wolfbeis,
C. Bogdan, J. Jantsch* (Erlangen, Germany)
The correlation between intensity of Opisthorchis
felineus infection with the eggs per gram of
faeces in hamster models
E. Perina* (Tomsk, Russia), E. Klikich,
N. Englevskiy, A. Bogdanov, I. Saltykova,
A. Sazonov, L. Ogorodova P0125
Latent Epstein-Barr virus infection via
nasopharynx in adult humanised mice
Q.Z. Ruan* (Milton Keynes, United Kingdom),
R.S. Ruan, C.P. Ye
P0126
Activity of a f8-like lytic bacteriophage against
metallo-beta-lactamase-producing Pseudomonas
aeruginosa in an invertebrate infection model
P.R. Neves* (São Paulo, Brazil), L.T. Cerdeira,
T.G.M. Oliveira, M. Mitne-Neto, J. Sampaio,
E.M. Mamizuka, C.E. Levy, N. Lincopan
134
24th ECCMID / Barcelona
Final Programme
P0127
Preliminary analysis of Paracoccidioides lutzii
infection in Galleria mellonella by flow cytometry
and cell analysis approaches
A.C.A. De Paula e Silva* (São Paulo, Brazil),
L. Scorzoni, F. Sangalli-Leite, H.C. Oliveira,
J.L. Singulani, A.M. Fusco-Almeida,
M.J.S. Mendes-Giannini
P0128
Virulence of the dimorphic fungus
Paracoccidioides spp in Galleria mellonella
model
L. Scorzoni* (Araraquara, Brazil), F. Sangalli-Leite,
A.C.A. De Paula e Silva, J.D. Singulani,
A.M. Fusco-Almeida, M.J.S. Giannini
P0129
Effect of cytolysin A of Escherichia coli in the wax
moth Galleria mellonella model
A. Márquez-López* (Santander, Spain),
A. Ocampo-Sosa, J.M. Andersen,
L. Martínez-Martínez, K. Fuursted
P0130
Whole genome expression profiles of Drosophila
melanogaster consecutive to Pseudomonas
aeruginosa infection allow selection of new
model genes implicated in host-parasite
relationship
A. Ecovoiu, A. Ratiu* (Bucharest, Romania),
I. Czobor, M.C. Chifiriuc
15:30 – 16:30
Poster Area
POSTER SESSION I:
Basic science: pathogenesis
P0131
Role of single nucleotide polymorhisms (SNPs)
of genes implicated in autophagy for the natural
course of sepsis by ventilator-associated
pneumonia (VAP)
A. Savva, T.H.E.O. Plantinga, A. Kotanidou,
M. Farcas, F. Baziaka, M. Raftogiannis, S. Orfanos,
G. Dimopoulos, M. Netea,
E. Giamarellos-Bourboulis* (Athens, Greece)
P0132
Paraoxonase-1 and monocyte chemoattractant
protein-1 alterations in patients with central
venous catheters
S. Iftimie* (Reus Tarragona, Spain),
A. García-Heredia, A. Cordoba, I. Pujol, F. Ballester,
A. Castro, J. Camps
P0133
Role of PMNs in the control of microbial infections
in multiple sclerosis patients
V. Allizond, S. Scutera, S. Rossi, T. Musso, C. Crocillà,
P. Cavalla, A.M. Cuffini, N. Mandras, V. Tullio,
G. Banche* (Turin, Italy)
Poster Sessions
Investigation of cytokines and intracellular
bacteria in relation to the administration of
lactoferrin in women with infertility
C. Contini* (Ferrara, Italy), S. Seraceni, N. Valente,
M. Maritati, M. Comar, R. Marci, E. Giugliano, F. Vesce
P0136
Evaluation of the influence of iron ions on the
expression and activation of catalases produced
by Escherichia coli strains, isolated from patients
with ulcerative colitis
M. Pilarczyk-Zurek* (Cracow, Poland), M. Strus,
P. Heczko, M. Bulanda
P0137
Immunomodulatory effects of extracts of
Origanum vulgare (oregano) against
Helicobacter pylori
A. Salinas Ibáñez, F. Canale, A. Arismendi Sosa,
M. Mattar, T. Alarcón* (Madrid, Spain), A. Vega
P0138
Production of corticotropin-releasing factor and
urocortin from human monocyte-derived dendritic
cells is stimulated by commensal bacteria
T. Ohkusa* (Kashiwa Chiba, Japan), S. Koido,
K. Uchiyama, H. Arakawa, M. Kajihara, S. Kan, M. Ito,
S. Homma
P0139
Gut microbiota depletion by broad-spectrum
antibiotics influences systemic innate immune
responses in human volunteers
J.M. Lankelma* (Amsterdam, The Netherlands),
A.F. De Vos, A.J. Hoogendijk, W.M. De Vos,
T. Van der Poll, W.J. Wiersinga
P0140
Faecal microbiota and bacterial translocation in
adult patients with liver cirrhosis
F. Santangelo* (Rome, Italy), V. Iebba, V. Totino,
A. Gagliardi, V. Giannelli, V. Di Gregorio, M. Merli,
S. Schippa
P0141
Susceptibility of Campylobacter concisus to the
bactericidal activity of healthy human serum
K. Kirk* (Aalborg, Denmark), H.L. Nielsen,
H. Nielsen
P0142
Serum-soluble CD14 as potential marker of
refractory ascites in liver cirrhosis
J. Pogorzelska* (Bialystok, Poland),
M. Rozkres-Bobrowska, J. Jaroszewicz, R. Flisiak
Supernatants of P. aeruginosa incubated with
azithromycin sub-MIC concentrations fail to
induce cytokine production in A549 and THP-1
cell lines
M. Banjanac* (Zagreb, Croatia), G. Ergovic,
M. Bosnar, V. Erakovic Haber
P0144
Outer membrane protein A (OmpA) epitopes
interacting with eukaryotic target cell are also
recognised by colicins: anti-OmpA directed
antimicrobials
J. Bosák* (Brno, Czech Republic), D. Zmajs
P0145
Lung macrophage GP96 is essential for host
defence during Gram-negative pneumonia
A.A. Anas* (Amsterdam, The Netherlands),
M.H.P. Van Lieshout, L. Zihai, C. Van ‘t Veer,
A.F. De Vos, T. Van der Poll
P0146
Expression and role of S100A8/A9 complexes in
clinical and experimental Gram-negative sepsis
H.K. De Jong* (Amsterdam, The Netherlands),
A. Achouiti, T.A.F. Weehuizen, G.C.K.W. Koh,
C.M. Parry, S. Baker, J. Roth, T. Vogl, T. Van der Poll,
W.J. Wiersinga
P0147
Inhibition of innate immune activation by
bacterial RNA modifications
K. Rimbach, A. Dalpke, T. Eigenbrod* (Heidelberg,
Germany)
P0148
Structure function of the death domain of human
IRAK-M
J. Du, G.A. Nicolaes, D. Kruijswijk, T. Van der Poll,
M. Versloot, C. Van ‘t Veer* (Amsterdam,
The Netherlands)
P0149
Toxinotype analysis on Clostridium perfringens
isolated in Japan and possibility of control by
probiotics
K. Wada* (Tokyo, Japan), M. Takahashi, K. Oka,
T. Osaki, M. Francesch, E. McCartney, H. Kunishima,
M. Kaku, S. Kamiya
P0150
Real causative anaerobes for intra-abdominal
infections and pelvic inflammatory diseases
based on culture method
H. Mikamo* (Tokyo, Japan), M. Matsumizu,
M. Nagashima P0151
Is hypokalaemia paradoxical metabolic acidosis
in meningococcal disease result of increased
urinary potassium excretion?
K.R. Kolbe* (São Paulo, Brazil), J. Sztajnbok,
L. Andrade
24th ECCMID / Barcelona
Final Programme
135
Chairs, Speakers & Authors
P0135
P0143
Exhibition
Vitamin D deficiency reduces the immune response
and the phagocytosis rate of microglial cells
M. Djukic* (Göttingen, Germany), M.L. Onken,
S. Schuetze, S. Redlich, T. Bertsch, C. Bollheimer,
C. Sieber, R. Nau
General Information
P0134
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0152
Description of pulmonary bacterial floras
associated with the presence of two pathogens,
Pseudomonas aeruginosa and Staphylococcus
aureus, in patients with cystic fibrosis
L. Pages* (Lyon, France), C. Commun, C. Bardel,
M. De Mont Clos, P. Reix, I. Durieux, F. Vandenesch,
J. Freney, B. Cournoyer, A. Doleans-Jordheim
P0153
Differential proteomic characterisation of patientrelated and environmental isolates of Legionella
pneumophila
S. Quero* (Badalona, Spain), M. García-Núñez,
N. Párraga-Niño, M.L. Pedro-Botet, L. Mateu,
M. Sabrià
P0154
P0155
Functional and phenotypical characterisation of
M. tuberculosis-specific T-cells in HIV-infected
patients with active tuberculosis or latent
infection naïve to antiretroviral treatment
T. Chiacchio, E. Petruccioli, V. Vanini, G. Cuzzi,
C. Pinnetti, A. Sampaolesi, D. Goletti* (Rome, Italy)
Mycobacterium tuberculosis PE_PGRS33
promotes entry into macrophages through TLR2
I. Palucci, S. Camassa, A. Cascioferro, M. Sali,
M. Minerva, R. Iantomasi, F. Ria, M. De Spirito,
R. Manganelli, G. Delogu* (Rome, Italy)
P0156
Mutation frequency in susceptible clinical
isolates of Mycobacterium tuberculosis under
anaerobic conditions
L. Joseph, A.W. Sturm* (Durban, South Africa)
P0157
The evaluation of the mechanical properties of
spirochetes surface Borrelia burgdorferi s.s. by
atomic force microscope (AFM)
M. Tokarska-Rodak, M. Koziol-Montewka* (Lublin,
Poland), K. Skrzypiec, E. Mendyk, T. Chmielewski,
S. Tylewska-Wierzbanowska, P. Dobosz
P0158
Synthesis of Th17 cytokines by peripheral blood
mononuclear cells stimulated with Borrelia
burgdorferi sensu lato
S. Grygorczuk* (Bialystok, Poland), J. Osada,
R. Swierzbinska, A. Moniuszko, J. Zajkowska,
M. Kondrusik, P. Czupryna, J. Dunaj, M. Dabrowska,
S.A. Pancewicz
P0159
136
Borrelia induces TLR-2-mediated migration of
dendritic cells in a novel human ex vivo skin
model of Lyme borreliosis
L.M.K. Mason* (Amsterdam, The Netherlands),
C. Van ‘t Veer, T. Van der Poll, T.B.H. Geijtenbeek,
J.W.R. Hovius
24th ECCMID / Barcelona
Final Programme
P0160
Characterisation of the role of type I and III
interferon response during West Nile virus and
Usutu virus infection
G. Cacciotti* (Rome, Italy), C. Selvaggi, G. Ribelli,
K. Monteleone, C. Lorenzi, M. Curtosi, A. Papa,
A. Pierangeli, G. Antonelli, C. Scagnolari
P0161
Genome-wide identification of pathogenicity
factors of the free-living amoeba Naegleria
fowleri
D. Zysset-Burri, N. Müller, M. Heller, N. Schürch,
M. Wittwer* (Spiez, Switzerland)
P0162
Riboproteomic applied to the study of posttranscriptional regulation in Leishmania
braziliensis
C. Ramirez, J.M. Requena, C.J. Puerta* (Bogota,
Colombia)
15:30 – 16:30
Poster Area
POSTER SESSION I:
Basic science: pathogenesis of Gram-negative bacteria
P0163
Experiments on the effect of probiotics on
extended-spectrum beta-lactamase producing
Escherichia coli by using growth, beta-lactamase
activity and conjugation assays
N. Ishibashi* (Sendai Miyagi, Japan), K. Wada,
H. Kunishima, K. Oka, M. Takahashi, K. Aoki,
A. Yoshizumi, T. Aoyagi, M. Kitagawa, M. Kaku
P0164
Differences in recombination events and
mutation frequencies among pathogenic and
commensal and environmental Escherichia coli
strains
M.C. Turrientes, J.M. González-Alba, A. Ripoll,
M.R. Baquero, R. Cantón, F. Baquero, J.C. Galán*
(Madrid, Spain)
P0165
The flagellar protein FliD of an atypical
enteropathogenic Escherichia coli strain acts as
an adhesin during interaction with enterocytes’
microvilli in vitro
S.C.F. Sampaio* (São Paulo, Brazil), B.G. Garcia,
W.B. LUIZ, R.C.C. Ferreira, J.L.M. Sampaio, S.G. Rita,
L.C.S. Ferreira, T.A.T. Gomes
P0166
Relationship between phylogenetic groups,
antibiotic resistance and patient characteristics
in terms of adhesin genes in cystitis and
pyelonephritis isolates of Escherichia coli
D.K. Er* (Kocaeli, Turkey), D. Dundar, H. Uzuner,
A. Osmani, L. Ozdemir
Poster Sessions
Comparative genomics reveals that O-antigen is
essential for virulence of ST127 UPEC in Galleria
mellonella larvae
M. Alghoribi* (Plymouth, United Kingdom),
S. Beatson, M. Upton
P0169
P0170
P0171
P0172
P0173
P0174
Therapeutic concentrations of cefotaxime
increase the conjugation frequency of a
widespread IncI-1 plasmid encoding CMY-2 betalactamase in Escherichia coli
M. Minoia, V. Bortolaia, L. Villa, A. Carattoli,
L. Guardabassi* (Frederiksberg, Denmark)
Modulation of the expression of adhesion and
inflammatory response in endothelial cells by
Pseudomonas aeruginosa quorum-sensing
molecules
F. Iordache* (Bucharest, Romania), F. Iordache,
A.M. Holban, C. Curutiu, V. Lazar, L.M. Ditu,
L. Marutescu, C.M. Chifiriuc
Emergence of mucoid and small colony variants
of P. aeruginosa in early infection development in
cystic fibrosis
A.M. Sousa* (Braga, Portugal), M.O. Pereira
A novel virulence strategy for Pseudomonas
aeruginosa mediated by an autotransporter with
arginine-specific aminopeptidase activity
E. Paredes-Osses* (Nottingham, United Kingdom),
J. Luckett, O. Darch, C. Watters, M. AbuOun,
V. Wright, S. Heeb, K. Rumbaugh, M. Camara,
K. Hardie
Phenotypical and gene expression study of the
impact of Pseudomonas aeruginosa culture
fractions on the human mesenchymal stem cells
viability and cytokine profile
A. Holban* (Bucharest, Romania), C. Bleotu,
M. Chifiriuc, L. Ditu, L. Marutescu, C. Curutiu,
V. Lazar
Cytotoxicity is correlated with type three
secretion system expression and inflammasome
activation but not with motility in clinical
isolates of Pseudomonas aeruginosa from acute
infections
A. Anantharajah* (Brussels, Belgium), J.M. Buyck,
Y. Glupczynski, M.P. Mingeot-Leclercq, P.M. Tulkens,
F. Van Bambeke
Pathogenic Klebsiella pneumoniae bacteria
evade recognition by the C-type lectin
receptors DC-SIGN and SIGNR1
A.F. De Vos* (Amsterdam, The Netherlands), L. Kors,
S. Terpstra, R. De Beer, L. Boon, S. Brisse, S. Alberti,
T. Van der Poll, T. Geijtenbeek
P0176
Microbial cooperation in cystic fibrosis:
Stenotrophomonas maltophilia significantly
modulates Pseudomonas aeruginosa virulence
V. Crocetta* (Chieti, Italy), A. Pompilio,
S. De Nicola, F. Verginelli, S. Guarnieri, E. Fiscarelli,
G. Di Bonaventura
P0177
Clinical impact of several virulence factors of
Acinetobacter baumannii
R. Alvarez Marin* (Seville, Spain), R. López Rojas,
F. Fernández Cuenca, M.J. McConnell,
J. Domínguez Herrera, M.J. Gómez Gómez,
J. Garnacho Montero, J.A. Márquez Vácaro,
J. Pachón
P0178
Genomic evolution of Acinetobacter baumannii
parental isolates in a decade
M. Lopez* (La Coruña, Spain), A. Rueda,
F. Fernandez-Cuenca, L. Martinez-Martinez, J. Vila,
J.M. Cisneros, J. Rodriguez-Baño, A. Pascual, G. Bou,
M. Tomas Carmona
P0179
Unraveling bacteria-host cell interactions in
Acinetobacter clinical isolates
S. Remuzgo Martínez* (Santander, Spain),
J.M. Icardo, L. Martínez-Martínez, J. Ramos-Vivas
P0180
Relationship between resistance mechanisms
and virulence in a NDM-1 producing-Acinetobacter
pittii-like strain using the Caenorhabditis elegans
model
P. Espinal* (Barcelona, Spain), D. Rolo, M. Telli,
N. Mosqueda, I. Roca, J. Vila
15:30 – 16:30
Poster Area
POSTER SESSION I:
Basic science: pathogenesis of streptococci,
enterococci, Listeria and Propionibacterium
P0181
Intracellular multiplication of group A
Streptococcus in endothelial cell
J.J. Wu* (Tainan City, Taiwan), H.W. Chen
24th ECCMID / Barcelona
Final Programme
Chairs, Speakers & Authors
P0168
P0175
Exhibition
MMRS-related genes in hypermutable Escherichia
coli strains
C. Lefebvre Garcia* (Sherbrooke, Canada),
R.J.R. Vaillancourt, P.-E. Jacques, S. Rodrigue,
M.S. Diarra, F. Malouin
137
General Information
P0167
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0182
Isolation and proteomic analysis of extracellular
membrane vesicles of Streptococcus
pneumoniae
E.C. Park* (Dajeon, Korea), C.W. Choi, S.H. Yun,
Y.G. Lee, S.Y. Lee, G.H. Kim, S.I. Kim
P0191
Human nasal microbiota and Staphylococcus
aureus carriage: a study based on culture and
mass spectrometry
A.G. Ranc* (Bron, France), F. Laurent, M. Bes,
A.M. Freydiere, G. Lina, F. Vandenesch, A. Tristan
P0184
Toxin-antitoxin system as a sensitive target in
pathogenic Enterococcus
N. Sadeghifard* (Ilam, Iran), S. Soheili,
S. Ghafourian, R.A. Hamat, Z. Sekawi
P0192
P0185
The SOS regulon of Enterococcus faecalis is not
involved in virulence traits
L. Carrilero* (Madrid, Spain), S. Matrat,
D. Thomas-Lopez, B. Gutiérrez, A. Santos-López,
C.M. Ovejero, L. Hidalgo, N. Montero-Serra, I.F. Nes,
B. Gonzalez-Zorn
Community-associated Staphylococcus aureus
isolates display distinct phenotypic profiles: link
to agr type and alpha-toxin levels
S. Mairpady Shambat, A. Haggar, F. Vandenesch,
G. Lina, W. Van Wamel, G. Arakere, M. Svensson,
A. Norrby-Teglund* (Stockholm, Sweden)
P0193
Are Staphylococcus aureus PVL toxin-positive
isolates causing acute bacterial skin and skin
structure infections (ABSSSI) associated with
more severe presentation or worse outcome?
S. Puttagunta* (Branford, CT, United States),
H. Boucher, M. Wilcox, G. Talbot, M. Dunne
P0194
Community-associated MRSA strains are not
more virulent than healthcare-associated MRSA
strains in a range of laboratory assays
E. Boakes, H. Marbach, S. Lynham, M. Ward,
J.D. Edgeworth, J.A. Otter* (London,
United Kingdom)
P0195
Differential induction of innate defence
antimicrobial peptides by bacterial culture
supernatants of invasive vs non-invasive
staphylococci in human keratinocyte and nasal
epithelial cell lines
C. Burgey* (Freiburg, Germany), W.V. Kern,
W. Römer, S. Rieg
P0196
Comparison of transcriptomics technologies
for assessment of Staphylococcus aureus gene
expression
D. Hernandez, C. Le Priol, D. Baud* (Geneva,
Switzerland), A. Fischer, F. Reynier, G. Gervasi,
S. Chatellier, J. Veyrieras, P. François, J. Schrenzel
P0197
Detection of pathogenicity factors of
Staphylococcus epidermidis by whole genome
sequencing
M. Kornienko* (Moscow, Russia), V. Kopyltsov,
I. Karpova, A. Larin, E. Kostryukova, E. Ilina,
L. Lubasovskaya, T. Priputnevich, G. Sukhikh,
V. Govorun
P0198
Dual role of live intracellular Staphylococcus
aureus on osteoclast lineage leading to increased
bone resorption
S. Trouillet-Assant* (Lyon, France), M. Gallet,
P. Nauroy, J.P. Rasigade, S. Flammier, P. Parroche,
J. Marvel, F. Vandenesch, P. Jurdic, F. Laurent
P0186
P0187
P0188
Listeria monocytogenes induces host DNA
damage and delays the host cell cycle to
promote infection
E. Leitão, A.C. Costa, C. Brito, R. Pombinho,
D. Cabanes, S. Sousa* (Porto, Portugal)
Microglia response to Listeria monocytogenes
infection
E. Frande Cabanes* (Santander, Spain),
R. Calderón González, C. Álvarez Domínguez,
M. López Fanarraga
Differences in immunostimulatory and cell
motility activity between Propionibacterium
acnes type I and II on prostate epithelial cells
S. Davidsson* (Örebro, Sweden), B. Söderquist,
O. Andrén, P. Mölling, J. Carlsson
15:30 – 16:30
Poster Area
POSTER SESSION I:
Basic science:
pathogenesis of staphylococci
P0189
Polyclonal colonisation with Staphylococcus
aureus
S. Mernelius* (Jonkoping, Sweden), K. Jansson,
S. Löfgren, P.-E. Lindgren, A. Matussek
P0190
Prospective study of the Staphylococcus aureus
nasal and rectal colonisation in intensive care
unit patients: prevalence, bacterial load and
genotyping of isolates
P.O. Verhoeven* (Saint-Etienne, France),
J. Gagnaire, C.H. Haddar, E. Botelho-Nevers,
C. Auboyer, M. Darmon, C. Mariat, F. Grattard,
B. Pozzetto, P. Berhelot
138
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Saturday, 10 May 2014
P0199
Phagosomal escape of hypervirulent
Staphylococcus aureus is not dependent on betatoxin expression
C. Dupieux* (Lyon, France), A. Sapin,
S. Trouillet-Assant, G. Lina, J. Etienne,
F. Vandenesch, F. Laurent, J.p. Rasigade
P0208
Clonal dissemination and virulence factors
among Staphylococcus lugdunensis from two
Greek hospitals during a six-year period
N. Giormezis* (Patras, Greece), F. Kolonitsiou,
A. Makri, A. Vogiatzi, E.D. Anastassiou,
I. Spiliopoulou
P0200
Expression of virulence gene and cytotoxicity
from Staphylococcus aureus ST clones
J.I. Yoo* (Seoul, Korea), H.K. Kim, J.W. Kim,
K.S. Kang, H.S. Kim, J.S. Yoo, J.Y. Yu, Y.S. Lee
P0209
P0201
Staphylococcus aureus small colony variants are
induced by low pH
N. Leimer* (Zurich, Switzerland), A. Furrer,
M. Schwarz, A.S. Bahlmann, F. Andreoni, U. Matt,
K. Seidl, R.A. Schüpbach, A.S. Zinkernagel
Staphylococcus pseudintermedius virulence
gene content from Swedish and Spanish canine
and human isolates: a comparative analysis
E. Gomez-Sanz, S. Börjesson, K. Ekström,
U. Andersson, C. Torres* (Logroño, Spain)
P0206
P0207
ST2249-MRSA-III: a second major Staphylococcus
aureus recombinant causing healthcare infection
in the 1970s
G.R. Nimmo* (Brisbane, Australia), J. Steen,
S. Monecke, R. Ehricht, P. Slickers, J.C. Thomas,
S.M. Grimmond, D.A. Robinson, G.W. Coombs
Correlation of staphylococcal cassette
chromosome MEC (SCCmec) types, accessory
gene regulator (agr) groups and panton-valentine
leukocidin (PVL) occurrence among MRSA
isolates in Mumbai, India
A. Subramanian* (Mumbai, India), R. Meharunkar,
S.P. Vaidya, R. Warke, R.A. Deshmukh, A. Chowdhary
Genetic variation of virulence and resistance
genes in Staphylococcus epidermidis circulating
in neonatal intensive care units
H. Soeorg* (Tartu, Estonia), K. Huik, U. Parm,
M.-L. Ilmoja, T. Metsvaht, I. Lutsar
Evaluation of synergistic activity of various
antibiotic combinations against multidrugresistant Acinetobacter baumannii
G. Aydin* (Ankara, Turkey), Z. Bayindir, A. Yalci,
I. Balik
P0211
In vitro synergy of minocycline combinations
against pan-drug-resistant Acinetobacter
baumannii
J.M. Balada-Llasat* (Columbus, United States),
K. Thomas, D. Smith, P. Pancholi
P0212
Exploring colistin-mediated potentiation
of daptomycin against A. baumannii using
molecular imaging and flow cytometry
C. Malmberg* (Uppsala, Sweden), C. Annerstedt,
P. Lagerbäck, O. Cars, P. Komp-Lindgren
P0213
Colistin resistance in Acinetobacter baumannii
is associated with a biological fitness cost and
increased susceptibility to multiple drugs
P. Komp Lindgren* (Uppsala, Sweden), P. Jonsson,
C. Annerstedt, O. Cars
P0214
In vitro effects of tigecycline and colistin in
combinations with various antibiotics against
MDR Acinetobacter baumannii isolates
A. Büyük, F.F. Yilmaz, S. Gül-Yurtsever,
M. Hosgor-Limoncu* (Izmir, Turkey)
P0215
In vitro effects of antibacterial combinations
against colistin resistance development of
A. baumannii strains
D. Gazel* (Canakkale, Turkey), M. Otkun
24th ECCMID / Barcelona
Final Programme
Posters
P0205
Mutations in the fabI promoter often associate
with alternative mechanisms of triclosan
resistance in Staphylococcus aureus
D. Grandgirard* (Berne, Switzerland), L. Furi,
M.L. Cuisa, L. Baldassarri, D. Knight, I. Morrissey,
C.R. Largiadèr, S.L. Leib, M. Oggioni
P0210
Chairs, Speakers & Authors
P0204
Prevalence of enterotoxin genes in
Staphylococcus aureus isolated from stool
samples in patients with diarrhoea
M. Pirs* (Ljubljana, Slovenia), N. Svent Kucina,
R. Kofol, M. Furlan, S. Ladinek, K. Seme
POSTER SESSION I:
Antibacterial drug activity and interactions in Gram-negative
bacteria
Exhibition
P0203
Role of SCCmec in Staphylococcus aureus
induced endothelial cell cytotoxicity
K. Seidl, M. Leemann, Y. Achermann,
A.S. Zinkernagel* (Zurich, Switzerland)
Poster Area
139
General Information
P0202
15:30 – 16:30
Poster Sessions
Saturday, 10 May 2014
P0216
In vitro interactions of various antibacterial
combinations against XDR and PDR A. baumannii
isolated from ICU patients
S. Vourli* (Athens, Greece), F. Frantzeskaki,
K. Paraskevi, M. Tsala, A. Armaganidis, L. Zerva,
G. Dimopoulos
P0217
Fosfomycin synergy activity against multidrugresistant Acinetobacter baumannii strains
G.C. Leite, C.K. Rocha, C. Rizek, A. Levin, S. Costa*
(Rio de Janeiro, Brazil)
P0218
Genotyping and in vitro activity of colistintigecycline and colistin-imipenem combinations
against carbapenem-resistant Acinetobacter
baumannii blood isolates
B. Dinc, A. Tezer Tekce* (Ankara, Turkey), O. Unaldi,
S.U.H.A. Sen, R.I.Z.A. Durmaz
P0219
The ability of biofilm formation in clinical isolates
of Acinetobacter baumannii and their colistin
susceptibility in biofilm
H.A. Kim* (Daegu, Korea), S.Y. Ryu, I.C. Seo, S.I. Suh,
M.H. Suh, W.K. Baek
P0220
In vitro activity of colistin, sulbactam,
tigecycline, rifampicin and imipenem in
combination against extensively resistant OXA23 Acinetobacter baumannii
A. Inan* (Istanbul, Turkey), S. Senbayrak Akcay,
S. Cevan, F. Kolayli, S.C. Ozyurek, S. Aksaray,
H. Vahaboglu
P0221
P0222
P0223
140
Ceftazidime-avibactam disk mass studies
for EUCAST disk diffusion method against
Enterobacteriaceae and P. aeruginosa
L. Koeth* (Westlake, United States), G. Stone,
E. Matuschek, G. Kahlmeter
In vitro synergy studies of antimicrobial
combinations against MDR/XDR high-risk clones
of Pseudomonas aeruginosa
Y. Meije, J. Basas, A. Oliver, N. Larrosa, X. Gomis,
J. Rello, T. Pumarola, R. Cantón, A. Pahissa,
J. Gavaldà* (Barcelona, Spain)
In vitro performance by time-kill assays
of fosfomycin-tobramycin combination in
Pseudomonas aeruginosa clinical isolates with
different tobramycin susceptibility
M. Diez Aguilar* (Madrid, Spain), M. Morosini,
Z. Aktas, C. Kayacan, R. Cantón
24th ECCMID / Barcelona
Final Programme
P0224
Comparison of broth microdilution and VITEK® 2
methods for susceptibility testing of minocycline
against carbapenem-resistant Klebsiella
pneumoniae and Acinetobacter baumannii
clinical isolates
P. Dimitriadis, S. Varlamis* (Thessaloniki, Greece),
E. Protonotariou, O. Vasilaki, P. Tsiavi, E. Diza,
S. Pournaras, L. Skoura
P0225
High occurrence of colistin-heteroresistant
subpopulations displaying stable resistance
in carbapenemase-producing Klebsiella
pneumoniae
I. Pena* (Madrid, Spain), I. Rodriguez-Avial,
C. Rodriguez-Avial, J.J. Picazo
P0226
Tigecycline-colistin is active against ST258,
KPC-producing Klebsiella pneumoniae with major
OmpK36 porin mutations, which do not respond
to doripenem-colistin
R.K. Shields, M.H. Nguyen, B. Hao, L. Chen,
B. Kreiswirth, C.J. Clancy* (Pittsburgh, United
States)
P0227
Time kill-assay of antibiotic combinations for
multiresistant clinical isolates of Klebsiella
pneumoniae harbouring OXA-48 carbapenemase
Z. Aktas* (Istanbul, Turkey), C. Kayacan, A. Abulaila,
M. Morosini, R. Cantón, M. Diez-Aguilar
P0228
Co-resistance between biocides and
antimicrobial agents among ESBL-producing
Klebsiella pneumoniae
F. Fernández-Cuenca* (Seville, Spain), M. Lossa,
F.J. Caballero-Moyano, P. Egea,
J.R. Hernández-Bello, J. Rodríguez-Baño, A. Pascual
P0229
Susceptibility of carbapenemase-producing
Enterobacteriaceae to non-beta-lactam
antibiotics
M. Kaase* (Bochum, Germany), A. Kaminski,
N. Pfennigwerth, S.G. Gatermann
P0230
Antibiotic susceptibility in urosepsis: molecular
response of uropathogenic E. coli to ciprofloxacin
in bloodstream infection models
S. Gandi* (Edinburgh, United Kingdom),
J. Brennecke, A. Tian, M. Petruskeviciute, S. Amyes,
K. Templeton, T. Bachmann
P0231
Consequences of the revised 2013 CLSI vs
EUCAST guidelines for antibiotic susceptibility
reporting for urinary Enterobacteriaceae
Y. Keness* (Afula, Israel), A. Adler
Poster Sessions
Saturday, 10 May 2014
P0236
P0237
P0238
P0239
P0241
In vitro evaluation of the novel fluoroquinolone
finafloxacin against Yersinia pestis
K. Barnes* (Salisbury, United Kingdom),
S.V. Harding, M. Richards, A. Vente
P0243
Rapid assessment of the effect of quinolones
on the chromosomal DNA fragmentation of an
isogenic collection of Escherichia coli
J. Rodriguez Martinez* (Seville, Spain), R. Santiso,
J. Machuca, G. Bou, A. Pascual, J. Fernández
In vitro activity of nitroxoline against
uropathogens other than Escherichia coli and
impact of pH
M. Kresken* (Rheinbach, Germany),
B. Körber-Irrgang
P0244
Efficacy of fosmidomycin alone and in
combination with colistin, tigecycline and
rifampicin against multidrug-resistant and
extensively drug-resistant Enterobacteriaceae
J. Tyrrell* (Cardiff, United Kingdom), T. Walsh
Clinical and microbiological efficacy of colistin
alone and different combinations with colistin in
ventilator-associated pneumonia
G.R. Yilmaz* (Ankara, Turkey), T. Guven, R. Guner,
Z. Kocak Tufan, F. Civelek Eser, M.A. Tasyaran
P0245
Evaluation of antibacterial activity against
extracellular and intracellular Legionella spp.
M.A. Casares, G. Reina-Gonzalez,
M. Fernández-Alonso* (Pamplona, Spain),
C.A. Alonso, A. Ramos, J. Leiva
Effects of external pH and bicarbonate on the
bacterial growth and MIC of erythromycin
K. Laub* (Budapest, Hungary), O. Dobay,
J. Gili-Kovács, A. Tóthpál, S. Kardos, C. Bognár,
K. Nagy, Á. Zsembery
P0246
In vitro testing for synergism of antibiotic
triple combination against multi-resistant
Gram-negative pathogens
C. Stein* (Jena, Germany), O. Makarewicz,
M.W. Pletz
Antibacterial susceptibility of Porphyromonas
gingivalis and Prevotella species in patients with
chronic periodontitis
F. Gamboa* (Bogota, Colombia), D.A. García,
A. Acosta, F. Aristizabal, M. Abba
Antimicrobial resistance of Faecalibacterium
prausnitzii
A. Rintala* (Turku, Finland), E. Munukka, E. Eerola,
P. Huovinen
Antibiotic susceptibility and proposed ECOFF
values for Burkholderia multivorans strains
obtained from non-cystic fibrosis patients
V. Hanulik* (Olomouc, Czech Republic),
M.A. Webber, M. Wootton, M. Roderova, O. Holy,
M. Kolar
15:30 – 16:30
Posters
Incidence and antimicrobial susceptibility of
Escherichia coli and Klebsiella pneumoniae
with extended-spectrum beta-lactamases in
community- and hospital-associated intraabdominal infections in China: SMART 2012
L. Zhang* (Beijing, China), Q.W. Yang, R.E. Badal,
Y.C. Xu
P0235
Antimicrobial susceptibility testing for
Burkholderia cepacia complex (BCC) clinical
isolates: comparison of broth microdilution,
agar dilution, Etest (TM) and disk diffusion
methodologies
L.C.C. Fehlberg* (São Paulo, Brazil), A.C.R. Silva,
F. Rodrigues-Costa, A. Nicoletti, A.P. Matos, R. Cayô,
E.A. Marques, A.C. Gales
Poster Area
Chairs, Speakers & Authors
P0233
P0234
P0240
POSTER SESSION I:
Antibiotic choices: clinical studies
P0247
Long-term alteration of intestinal microbiota
in patients with ulcerative colitis by antibiotic
combination therapy
T. Ohkusa* (Kashiwa, Japan), S. Koido,
K. Uchiyama, M. Kajihara, H. Arakawa, T. Kajiura,
J. Shinozaki, M. Suzuki
P0248
DAV132, developed to prevent side effects of
antibiotics in the gut flora: results of a pilot crossover study in healthy volunteers
A. Ducher* (Paris, France), C. Modess,
W. Weitschies, W. Siegmund, J. Dressman,
V. Augustin, C. Feger, A. Andremont, J. De Gunzburg
24th ECCMID / Barcelona
Final Programme
141
Exhibition
In vitro susceptibility of Escherichia coli isolated
from patients with intra-abdominal infections
in China: data from the study for monitoring
antimicrobial resistance trends (SMART)
2002-2012
Y. Wang* (Chongqing, China), Q.W. Yang, R.E. Badal,
Y.C. Xu, S. SMART Study Group in China
General Information
P0232
Poster Sessions
Saturday, 10 May 2014
P0249
Retrospective cohort service evaluation
regarding the use of temocillin in patients at high
risk of Clostridium difficile infection
E. Oscar* (Sheffield, United Kingdom), C. Winnard,
R. Townsend
P0250
Characterisation of antimicrobial use in patients
with a history of Clostridium difficile infection (CDI)
J.L. Wagner* (Detroit, United States), H. Alawy,
C. Tschannen, S. Bockelman, C. Hirsch, S.L. Davis
P0251
European Society of Clinical Microbiology and
Infectious Diseases (ESCMID): update of the
treatment guidance document for Clostridium
difficile infection (CDI)
S.B. Debast* (Amersfoort, The Netherlands,
M.P. Bauer, E.J. Kuijper)
P0252
Epidemiology of VAP and VAC
N. Layios* (Liège, Belgium), P. Damas
P0253
A randomised controlled trial of sitafloxacin and
ertapenem treatment for acute pyelonephritis
caused by extended-spectrum beta-lactamaseproducing Escherichia coli
C. Malaisri, A. Wibulpolprasert, P. Santanirand,
S. Kiertiburanakul* (Bangkok, Thailand)
P0254
P0255
Extended-spectrum beta-lactamase-producing
Enterobacteriaceae (ESBLPE) infection: is
alternative to carbapenems achievable in
practice?
B. Pilmis, M. Groh, T. Delory, E. Weiss, J.R. Zahar*
(Angers, France), P. Lesprit
Outcomes of patients with bloodstream
infection (BSI) of non-urinary source caused by
extended-spectrum beta-lactamase-producing
Enterobacteriaceae (ESBL): a multicentre
analysis comparing carbapenems to piperacillintazobactam (PTZ)
H. Ofer-Friedman, S. Sharma, C. Shefler, A. Tirosh,
D. Kandipalli, S. Sharma, P. Bathina, T. Lazarovitch,
K.S. Kaye, D. Marchaim* (Zerifin, Israel)
P0256
Coordination and management of a randomised
controlled trial funded by European Commission’s
7th framework programme 2010: MagicBullet
project, a multidisciplinary experience
C. Rosso Fernández, F. Pérez Martinez, S. Monteau,
M. Perales de los Santos, J. Garnacho Montero,
J.M. Cisneros Herreros* (Seville, Spain)
P0257
Elderly exclusion from randomised clinical trials
on the treatment of antimicrobial resistant
infections
G. De Angelis* (Rome, Italy), C. Palazzolo,
E. Di Meco, C. Donato, M. Paul, E. Tacconelli
142 24th ECCMID / Barcelona
Final Programme
P0258
Moxifloxacin monotherapy can be useful and safe
in patients with ARDS
J. Karlik* (Bochum, Germany), S. Martini,
L. Bergmann, M. Adamzik
P0259
Features of septic diseases in patients with
neoplasms of the central nervous system
A. Kolesnikov* (Makee, Ukraine), V. Cherniy,
K. Kardash, T. Mustafin, V. Stasiuk, I. Koktishev
P0260
Definition and significance of salvage treatment
for Gram-negative infections in critically ill
patients: preliminary results of an ESGCIP survey
G. Poulakou* (Athens, Greece), D.K. Matthaiou,
M. Bassetti, H. Erdem, G. Dimopoulos, J. Carlet,
J. Lipman, J.F. Timsit, H. Giamarellou, J. Rello
P0261
Clinical characteristics and outcomes of patients
with bacteraemia by multidrug-resistant (MDR)
microorganisms
X. Kortajarena Urkola, L. Martín* (Donostia, Spain),
A. Campins, J. Murillas, M. Riera, E. Delgado,
A. Oliver, J.L. Pérez, L. Periañez, O. Delgado
P0262
A randomised clinical trial on the effect of
probiotics on surgical site infections after
colorectal cancer surgery
F. Yousefi* (Ahvaz, Iran), N. Honarvar,
S. Salmanzadeh
P0263
Perioperative antibiotic prophylaxis: a
multicentre, prospective, cross-sectional study
(Baltic antibiotic collaborative network project)
A. Vilde* (Riga, Latvia), U. Dumpis, P. Mitt, P. Märtin,
B. Lytsy, Z. Dambrauskas, G. Gailiene
P0264
Preoperative antimicrobial prophylaxis for
appendectomy in children
N.A. Grishina* (Vologda, Russia)
P0265
Management of prosthetic joint infections:
a survey of UK practice
C. Cordina* (Glasgow, United Kingdom), A. Marek,
N. Khanna
P0266
Influence of daily dosage and frequency of
administration of rifampicin levofloxacin
combination therapy on tolerance and efficacy in
154 patients treated for prosthetic joint infection
E.M. Senneville* (Tourcoing, France), S. Nguyen,
H. Dezeque, C. Loiez, E. Beltrand, H. Migaud
Poster Sessions
Saturday, 10 May 2014
P0267
Evaluation of drug interactions in hospitalised
patients and antimicrobials’ role assessment
M. Jamshidi Makiani* (Tehran, Iran),
A.Z. Mahboobi Hajiaqa, M. Shafea, N. Mohebbi,
M. Zangeneh
P0268
Antibiotic use in psychiatric hospitals: pattern of
antibiotic prescribing and potential of interaction
between antibiotics and psychotropic drugs
M. Stuhec, B. Beovic* (Ljubljana, Slovenia),
B. Kores Plesnicar, M. Potocan, A. Zmitek, V. Winkler,
S. Celan Stropnik, J. Topolovec, M. Prasnicki
Poster Area
POSTER SESSION I:
EUCAST antimicrobial susceptibility testing
P0279
EUCAST disk diffusion with pefloxacin 5 µg
as screen for fluoroquinolone resistance in
Salmonella spp. – variation between media, disks
and testing sites
E. Matuschek* (Växjö, Sweden), R. Skov, J. Åhman,
M. Karlsson, A. Petersen, M. Torpdahl, G. Kahlmeter
P0280
MIC and zone diameter correlations for
Corynebacterium spp. using EUCAST methods and
breakpoints
E. Matuschek* (Växjö, Sweden), J. Åhman,
G. Kahlmeter
Recording of weight in patients being
administered antibiotics with a narrow
therapeutic index – a prospective cross-sectional
study from acute care
E. Charani* (London, United Kingdom), M. Gharbi,
G. Frost, A.H. Holmes
P0281
Evaluation of retapamulin E-test: validation
against broth microdilution and inter-laboratory
variation using EUCAST media
J. Åhman, K. Bowker, A. Mazzariol, C. Müllner,
A. Petersen, M. Tato Diez, E. Matuschek* (Växjö,
Sweden)
P0271
Worldwide availability and pricing of
antifungal drugs
E. Davies, M. Kneale, J.S. Bartholomew,
D.W. Denning* (Manchester, Switzerland)
P0282
P0275
Pharmaceutical quality and integrity of eight
generics of ceftriaxone preparation for injection
in eastern Asia
I. Arnet* (Basel, Switzerland), M. Altermatt,
Y. Roggo, G. Schnetzler
EUCAST fluoroquinolone breakpoints in
enterococci in urinary tract infections –
determination of disk diffusion criteria for
susceptibility testing
O. Ekelund* (Växjö, Sweden), E. Matuschek,
J. Åhman, G. Kahlmeter
P0283
Evaluation of EUCAST zone diameter breakpoints
for Pseudomonas spp.
J. Åhman* (Växjö, Sweden), E. Matuschek,
P.R. Rhomberg, R.N. Jones, G. Kahlmeter
P0284
Evaluation of the EUCAST disk diffusion method
for antimicrobial susceptibility testing of the
Bacteroides fragilis group isolates
Z. Eitel, E. Urbán, U. Justesen, E. Nagy* (Szeged,
Hungary)
P0285
Evaluation of different fluoroquinolone (FQ)
antibiotics for detection of FQ resistance in
Salmonella species by disk diffusion (DD)
R. Skov* (Copenhagen, Denmark), E. Matuschek,
J. Åhman, A. Petersen, M. Torpdahl, G. Kahlmeter
P0286
Comparison of EUCAST and CLSI cephalosporin
discs to detect ESBL phenotype in Escherichia
coli and Klebsiella spp.
L. Naumiuk* (Gdansk, Poland), A. Piorkowska,
R. Torunska, M. Bronk
P0276
P0277
P0278
Stability of different brands of meropenem
reconstituted in isotonic saline
M. Carlier* (Ghent, Belgium), V. Stove, A. Verstraete,
J. De Waele
Lack of stability of amoxicillin, ceftazidime and
imipenem in peritoneal dialysis solutions
G. Deslandes* (Nantes, France), E. Allain-Launay,
D. Navas, R. Bouquié, E. Dailly, A. Lemarec, P. Jolliet,
G. Roussey
Subcutaneously administered antibiotics:
a national survey of current practice from the
French infectious diseases (SPILF) and geriatric
medicine (SFGG) societies’ network
E. Forestier, C. Roubaud-Baudron, T. Fraisse,
M. Paccalin, L. Pagani, J. Gaillat* (Pringy, France),
G. Gavazzi
24th ECCMID / Barcelona
Final Programme
Exhibition
P0269
Posters
POSTER SESSION I:
Antibiotic interactions, formulations and administration
15:30 – 16:30
Chairs, Speakers & Authors
Poster Area
143
General Information
15:30 – 16:30
Poster Sessions
Saturday, 10 May 2014
P0287
Comparative evaluation of VITEK® 2 antimicrobial
susceptibility test system results for
Enterobacteriaceae according to CLSI, EUCAST
and VITEK® 2 Advanced Expert System (AES)
interpretive criteria
O. Karatuna* (Istanbul, Turkey), A. Karatas, I. Akyar
P0295
Challenges and solutions for development of
new antibacterials: results of the Combacte
opinion survey among pharmaceutical industry
professionals
E. Bettiol, J.D. Wetherington, N. Schmitt,
S. Harbarth* (Geneva, Switzerland)
P0288
Comparison of a custom made Trek panel
with EUCAST disc diffusion for antimicrobial
susceptibility testing of Staphylococcus aureus
A. Larsen* (Copenhagen, Denmark), A. Petersen,
R. Skov
P0296
P0289
Utility of a newly developed Muller-Hinton E agar
for the detection of MRSA carrying the novel mecA
homologue mecC
A. Larsen* (Copenhagen, Denmark), A. Petersen,
M. Holmes, A. Kearns, G. Edwards, C. Teale, R. Skov
Activity of BAL30072 alone and in combination
with carbapenems against Gram-negative
bacteria
I. Morrissey* (Epalinges, Switzerland),
C. Siegmund, E. Genet, M. Neri, S. Hawser, M. Jones,
M. Page, A. Santerre Henriksen P0297
Determination of the effect of blaNDM-1 gene
copy number on the activity of BAL30072 alone
and in combination with meropenem against
clinical NDM-1 positive bacteria
L. Jones* (Cardiff, United Kingdom), M.G.P. Page,
M.E. Jones, T. Walsh
P0298
In vivo activity of Fab001, a novel FabI inhibitor,
in a mouse model of Acinetobacter baumannii
pneumonia
C. Mouze-Soulama* (Paris, France), T. Sleger
P0299
In vitro potency of novel, fully synthetic
tetracyclines against MDR Gram-negative
pathogens, including carbapenem-resistant
Enterobacteriaceae
X. Xiao* (Watertown, United States), C. Sun,
D. Hunt, R. Clark, C. Fyfe, K. Kerstein, T. Grossman,
J. Sutcliffe
P0300
In vivo efficacy of novel, fully synthetic
tetracyclines in a murine lung infection model
challenged with KPC-producing Klebsiella
pneumoniae
T. Grossman, C. Fyfe, K. Kerstein, C. Sun, D. Hunt,
R. Clark, X. Xiao* (Watertown, United States),
J. Sutcliffe
P0301
Eravacycline does not prolong corrected QT
intervals in a thorough QT study conducted in
healthy subjects
P.T. Horn* (Watertown, United States), S. Redican,
X. Wei, R. Zhou, J. Liang, T.G. Todaro
P0302
POL7080 is highly efficacious in the murine
pneumonia model
C. Vingsbo Lundberg, F. Bernardini, K. Dembowsky,
G. Dale* (Allschwil, Switzerland)
P0303
The impact of creatinine clearance on the dosing
of POL7080, a new macrocyclic antibiotic
A.E. Muller* (Tilburg, The Netherlands), G. Dale,
J.W. Mouton
P0290
Evaluation of the EUCAST recommendations for
antimicrobial susceptibility of campylobacters
on the 3 main Campylobacter species isolated in
humans in France
P. Lehours* (Bordeaux, France), E. Siffre,
S. Ben Amor, H. Chardon, F. Megraud
P0291
Development of an agar dilution susceptibility
testing method for Fusobacterium necrophorum
M. Wootton* (Cardiff, United Kingdom), V. Hall,
T. Morris, R.A. Howe
P0292
Validation of MIC evaluator strips for testing
antimicrobial susceptibilities of fastidious
organisms according to EUCAST guidelines
M. Oleksiuk* (Basingstoke, United Kingdom),
C. Hopper, E. Scopes
15:30 – 16:30
Poster Area
POSTER SESSION I:
New therapeutic alternatives
P0293
Do you have the next antibiotic? The Worldwide
Antibiotic Discovery Initiative
M. Cooper* (St Lucia, Australia), J. Zuegg,
A.G. Elliott, M.A. Blaskovich, T.A. Bradford
P0294
Design and re-iterative data mining of a
pathways-based, highly diverse chemical library
used for antibacterial activity screenings
G. Chiriano* (Geneva, Switzerland),
A. Kranjc Petrucci, L. Slepikas, O. Patthey Vuadens,
P. Cosson, T. Soldati, H. Hilbi, J. McKinney,
L. Scapozza
144 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Population pharmacokinetics and target
attainment of the new antipseudomonal
macrocyclic antibiotic POL7080
A.E. Muller* (Tilburg, The Netherlands), G. Dale,
J.W. Mouton
P0313
Antibacterial action of nanosized metal-modified
TiO2 composites
M. Sredkova* (Pleven, Bulgaria), H. Hitkova,
A. Stoyanova, V. Popova, N. Ivanova,
A. Bachvarova-Nedelcheva, R. Iordanova
P0305
Anticlostridial activity and mode of action of
sucrose monolaurate in vitro
E. Skrivanova* (Prague, Czech Republic),
M. Marounek, P. Hovorkova
P0314
Antibacterial efficacy of gallium-doped bioactive
glass
S. Begum* (Birmingham, United Kingdom),
T. Worthington, W.E. Johnson, R.A. Martin
P0306
Antimicrobial efficiency of plant-derived
isothiocyanates against uropathogenic
Escherichia coli – a promising approach for
treatment of UTIs?
A. Mampel, N.T. Mutters* (Heidelberg, Germany),
K. Biehler, U. Frank
P0315
Potentiation of rifampicin and fusidic acid
through encapsulation with nanocine™
N.F. Kamaruzzaman* (London, United Kingdom),
L. Good
P0316
Antibacterial efficiency of hydroxyapatite
biomaterials with biodegradable polylactic acid
polymer, saturated with gentamicin
I. Skadins* (Riga, Latvia), J. Kroica, I. Salma,
A. Reinis, M. Sokolova, N. Berza
P0317
In vitro photodynamic effect of rose bengal on
Streptococcus spp and Candida spp
P. Soria Lozano* (Zaragoza, Spain), C. Alejandre,
M. Vidal García, M.J. Revillo, Y. Gilaberte, A. Rezusta
P0318
Comparative in vitro study on photodynamic
inactivation of some important
periodontopathogens (clinical and reference
strains) with Zn-phthalocyanines
M. Belcheva* (Sofia, Bulgaria), V. Kussovski,
V. Mantareva, I. Angelov, M. Durmus, H. Harmsen
P0319
In vitro activity of epigallocatechin gallate
(EGCG)-silver nanoparticle combinations versus
bacteria associated with skin and medical device
infections
J.W. Betts* (London, United Kingdom),
D.W. Wareham
P0320
Antibacterial and anti-biofilm activity of PEIbased nanoparticles against bacterial species
J. Barros* (Porto, Portugal), M.M. Azevedo,
A. Silva-Dias, A.P. Silva, I. Pina-Vaz, C. Pina-Vaz,
A.G. Rodrigues
P0321
Novel biopolymeric composites with antimicrobial
and anti-biofilm properties based on
polycaprolactone, chitosan and essential oils
P. Stoica* (Galbinasi, Romania), M.c. Chifiriuc,
M. Rapa, C. Bleotu, V. Lazar
P0309
P0310
Synthesis and antimicrobial evaluation of novel
substituted naphthoquinones
R. Nadjib Mohammed* (Tlemcen, Algeria), B. Zahia,
B. Mohammed, C. Noureddine
Antibacterial evaluation of synthetic bis(indolyl)
and pyrrolic derivatives
Y. Caspar* (Grenoble, France), E. Le Pihive,
L. Maigre, J. Blu, M. Jeanty, D. Schneider,
F. Minassian, N. Pelloux-Léon, M. Maurin, J.-N. Denis
Novel synthetic bis(indolyl) derivatives active
against Francisella tularensis subspecies
holarctica
Y. Caspar* (Grenoble, France), V. Sutera, J.-N. Denis,
M. Maurin
P0311
Uptake of the antibiotic negamycin into bacterial
cells
C. Schumacher* (Düsseldorf, Germany),
A. Berscheid, I. Zerfaß, K.-H. Glüsenkamp, H. BrötzOesterhelt
P0312
Potential synergy activity of the novel ceragenin,
CSA-13, against clinical isolates Acinetobacter
baumannii, including multidrug-resistant
A. baumannii
C. Bozkurt-Guzel* (Istanbul, Turkey), P. B.Savage,
B. Ozbek-Celik
24th ECCMID / Barcelona
Final Programme
145
Exhibition
P0308
Antimicrobial activity of the new derivative of
5-nitrothiazole – N-(5-nitrothiazole-2-il)-n’-(4(R)-benzole sulphonylamino) alkanediol diamide
by anaerobic microorganisms isolated from
patients
T. Sakalova* (Grodno, Belarus), M. Haretskaya
General Information
P0307
Chairs, Speakers & Authors
P0304
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0322
MazEF toxin-antitoxin system is a widespread
and sensitive antimicrobial target in antibioticresistant Staphylococcus aureus
S. Ghafourian* (Putra, Malaysia), Z. Sekawi,
L. Good, N. Sadeghifard
P0323
Antimicrobial activity and proteome analyses
of methicillin-resistant Staphylococcus aureus
treated with violacein
B. Araujo Lima* (Campinas, Brazil), M. Brocchi
P0324
Orthosiphon stamineus protects Caenorhabditis
elegans against Staphylococcus aureus infection
through immunomodulation
C. Kong, M.-W. Tan, S. Nathan* (Selangor, Malaysia)
P0325
The antimicrobial effects of Artocarpus communis
extracts against Propionibacterium acnes
Y.C. Lin* (Kaohsiung, Taiwan), F.L. Yen, H. Hsia,
D. Hung
P0326
P0327
P0328
Novel derivatives of isonicotinic acid are active
against Mycobacterium bovis and Mycobacterium
tuberculosis
O. Rzhepishevska, O. Zinchenko* (Odessa,
Ukraine), N. Shmatkova, T. Philippova, I. Seifullina,
C. Larsson
Isolation of new species and screening for new
antimicrobial compounds in Gram-positive
bacteria isolated from hypersaline environments
in north-eastern Algeria
E.S.M.A. Bendjama, L. Loucif, D. Gacemi-Kirane,
J.M. Rolain* (Marseille, France)
Isolation of producing NRP S and type-I PKS
Streptomyces strains with potential antimicrobial
activity from lacustrine sediments of the El Kala
lakes in northeastern Algeria
L. Loucif, E.S.M.A. Bendjama, D. Gacemi-Kirane,
J.M. Rolain* (Marseille, France)
P0329
Prevention of disease and lesions caused by P.
multocida in rabbits by using carbohydrates
C. Gallego* (Bogotá, Colombia), P. Patiño,
N. Martinez, C. Iregui
P0330
Identification of gene cluster responsible for
production of antibacterial agents in Pragia
fontium
K. Olejnickova* (Brno, Czech Republic),
E. Chaloupkova, D. Smajs
P0331
Studies on antibiotic acyldepsipeptide (ADEP)
producer Streptomyces hawaiiensis NNRL 15010
and its self-protection mechanism
D. Thomy* (Düsseldorf, Germany), P. Sass, Y. Cheng,
H. Brötz-Oesterhelt
146 24th ECCMID / Barcelona
Final Programme
15:30 – 16:30
Poster Area
POSTER SESSION I:
Rapid antimicrobial susceptibility testing
P0332
Next generation automated phenotypic antibiotic
susceptibility testing utilising automated
microscopy analysis of bacterial cells
A. Shamsheyeva, S. Metzger* (Tucson, United
States), C.S. Price, B. Turng, D. Howson
P0333
Direct susceptibility testing from positive
blood cultures with early reading and EUCAST
breakpoints
E. Jonasson* (Växjö, Sweden), Å. Johansson,
G. Kahlmeter, M. Sundqvist
P0334
Antibiotic susceptibility in Streptococcus
pneumoniae can be predicted after 8h incubation
E. Jonasson, A. Åkerlund, G. Cederbrant,
G. Kahlmeter, M. Sundqvist* (Växjö, Sweden)
P0335
5-hour antibiotic susceptibility testing
of Enterococcus faecium, E. faecalis and
Acinetobacter baumannii directly from positive
blood cultures using automated microscopy
A. Shamsheyeva, D. Gamage, S. Metzger, B. Turng,
D. Howson, C.S. Price* (Denver, United States)
P0336
Rapid method for susceptibility testing of
bacteria directly from positive blood cultures
C. Vismara, M.C. Sironi, A. Bielli* (Milan, Italy),
M. Coppola, G. Lombardi
P0337
A new technology for rapid antimicrobial
susceptibility testing from blood cultures
M. Crow* (Reading, United Kingdom), H. Bennett,
N. Woodford
P0338
Direct identification of cephalosporin-resistant
and carbapenem-resistant E. coli or K.
pneumoniae from positive blood cultures using
matrix-assisted laser desorption/ionization timeof-flight (MALDI-TOF) mass spectrometry
E. De Carolis* (Rome, Italy), S. Paoletti, D. Nagel,
A. Vella, I. Palucci, G. De Angelis, B. Posteraro,
T. D’Inzeo, T. Spanu, M. Sanguinetti
P0339
Rapid identification by mass spectrometry and
direct disk diffusion from positive blood cultures:
a comprehensive approach to improve clinical
outcome
C. Mauri, S. Bracco, D. Bernasconi, E. Meroni,
L. Principe, P. Bonfanti, F. Luzzaro* (Lecco, Italy)
Poster Sessions
Saturday, 10 May 2014
P0342
P0343
P0344
Quantitative MALDI-TOF MS applied for rapid
detection of bacterial resistance
K. Sparbier, C. Lange, B. Wegemann, M. Kostrzewa*
(Bremen, Germany)
Carbapenemase production: application of MALDITOF mass spectrometry for their detection in
strains of Enterobacteriaceae and Pseudomonas
species
J.J. Christensen* (Slagelse, Denmark),
M.B. Nielsen, S. Rasmussen, R. Dargis
Categorical agreements and discrepancies of
direct susceptibility tests in Pseudomonas
aeruginosa from clinical respiratory tract
samples
L. Perez* (Porto Alegre, Brazil), A.L.P. Freitas,
C.G. Dias
P0345
Rapid assessment of resistance to ciprofloxacin
and meropenem in Pseudomonas aeruginosa
F. Otero, M. Tamayo, R. Santiso, G. Bou, J.A. Lepe,
M. McConnell, J.M. Cisneros, J. Gosalvez,
J.L. Fernandez* (La Coruña, Spain)
P0346
Campylobacter spp. susceptibility testing: early
accurate reports?
C. Muñoz Paraíso, M.T. Perez Pomata* (Madrid,
Spain), N. Sanz Rodríguez, M.T. Llorente Rodríguez,
J.L. Gómez Garcés
P0347
P0348
The rapid identification and confirmation of
carbepenemase-resistant Enterobacteriaceae
(CRE) using Brilliance™ CRE agar and Sensititre™
Gram-negative plates (GN4F)
C. Hopper, A. Butler, K. Powell, M. Oleksiuk*
(Basingstoke, United Kingdom)
Direct determination of antimicrobial
susceptibility of Gram-negative bacilli from
respiratory samples on chromogenic agar plates
with gradient antibiotic strips
C. D’Humieres, M. Belhiba, F. Brocco, A. Andremont,
N. Grall* (Paris, France)
15:30 – 16:30
Poster Area
POSTER SESSION I:
Susceptibility testing of multiresistant bacteria
P0350
Detection of mecC-positive, methicillin-resistant
Staphylococcus aureus (MRSA) isolates
A. Kriegeskorte* (Münster, Germany), E.A. Idelevich,
F. Layer, B. Strommenger, O. Denis, G.K. Paterson,
M.A. Holmes, G. Peters, G. Werner, K. Becker
P0351
Evaluation of betaLACTA™ test directly on urine
samples
C. Viala* (Paris, France), L. Surgers, S. Gallah,
H. Cordel, S. Henquet, J.l. Meynard, P.M. Girard,
D. Decre, G. Arlet
P0352
Comparison of four methods for the
determination of tigecycline susceptibility in
multi-resistant E. coli and K. pneumoniae
A. Hamprecht* (Cologne, Germany), E. Zander,
T. Oestreicher, T. Seifert, P. Higgins
P0353
Evaluation of usefulness of the Carba NP
test for the carbapenemase detection in
Enterobacteriaceae, Pseudomonas spp. and
Acinetobacter spp. for routine laboratory
diagnostics
E. Literacka* (Warsaw, Poland), K. Malinowska,
A. Baraniak, K. Bojarska, M. Herda, W. Hryniewicz,
D. Zabicka, M. Gniadkowski
P0354
Evaluation of a new phenotypic method
to reveal AmpC presence and porin loss in
Enterobacteriaceae with decreased susceptibility
to carbapenems
E. Carretto* (Reggio Emilia, Italy), D. Barbarini,
M. Bardaro, F. Brovarone, G. Russello, F. Vailati,
C. Farina
P0355
Meropenem-colistin synergy testing of multidrugresistant Acinetobacter baumannii in routine
microbiology by two-dimensional E-tests
D. Halimi, E.-J. Bonetti, G. Renzi, A. Cherkaoui,
V. Sauvonnet, R. Martelin, A. Van Belkum, G. Durand,
S. Chatellier, J. Schrenzel* (Geneva, Switzerland)
24th ECCMID / Barcelona
Final Programme
147
Posters
Direct susceptibility testing of positive blood
cultures in 30 minutes
M.T. Pereira, M.A.C. Broeren, E. Retera, N.L.A. Arents*
(Veldhoven, The Netherlands)
A novel, direct diagnostic approach for rapid
susceptibility testing and identification of
pathogenic microorganisms in clinical specimens
by mean of Liofilchem® pathogenic system AST
F. MZali* (Bordeaux, France), L. Stecken, X. Berard,
A. Boyer, J. Goret, A. Quinart, D. Gruson, S. Pereyre
Chairs, Speakers & Authors
P0341
P0349
Exhibition
Bacterial counts by flow cytometry predict the
susceptibility of bacteria to antibiotics directly
from positive blood culture bottles
G. March Rosselló* (Valladolid, Spain),
M.C. García-Loygorri, M. Simarro, M.P. Gutiérrez,
A. Orduña, M.A. Bratos
General Information
P0340
Poster Sessions
Saturday, 10 May 2014
P0356
P0357
P0358
P0359
Comparison of VITEK® 2 antimicrobial
susceptibility results against vanA/vanB gene
PCR for detection of vancomycin-resistant
enterococci (VRE)
N. Sherry* (Heidelberg, Australia), P. Kelley,
A. Jaksic
An assessment of the reproducibility of
teicoplanin, vancomycin, daptomycin and
linezolid resistance determination using the
VITEK® 2 for staphylococci in a routine diagnostic
laboratory
Y. Protaschik, B. Edwards* (Aberdeen, United
Kingdom), P. Kalima, A. Gibb
Interlaboratory validation for antimicrobial
susceptibility testing of highly pathogenic
bacteria and identification of pitfalls in the CLSI
microdilution method
S. Schmoldt, P. Bolton, T. Boskani, G. Ezpeleta,
R. Grunow, P. Jureen, J. Papaparaskevas, O. Telleria,
B.R. Thoma, A. Tsakris, T. Wahab* (Solna, Sweden),
D. Jacob
Drug susceptibility testing of Mycobacterium
tuberculosis strains detected with rpoB
mutations: comparison between solid and
quantitative liquid culture-based methods
L. Guglielmetti* (Paris, France), L. Raskine,
N. Veziris, C. Bernard, E. Cambau, Group of the
French NRC for Mycobacteria: Aubry A. – Brossier F. – Mougari F. – Renvoisé A. –
Robert J. - Sougakoff W. – Jarlier V.
15:30 – 16:30
Poster Area
POSTER SESSION I:
Antibiotic consumption data
P0363
Restrictive interventions in ambulatory care in
Slovenia
M. Cizman* (Ig, Slovenia), T. Plankar Srovin,
T. Bajec, S. Pecar-Cad
P0364
Surveillance of antimicrobial use in Belgian acute
hospitals: 5-year trends
A. Ingenbleek* (Brussels, Belgium), M. Goossens,
B. Catry
P0365
Evaluation of antibiotics usage at provincial level
and provincial socio-economic development
index in Turkey in 2011
A. Sahin* (Ankara, Turkey), A. Alkan, H. Gursoz,
H. Celik, F. Isli, E. Sakalli, F. Savur, B. Melik, F. Efe,
E. Yilmaz
P0366
Antibiotic use in different regions of Turkey in
2011 (NUTS)
H.d. Celik, H. Gursoz, A. Alkan, B. Melik, A. Sahin,
F. Savur, M. Aksoy* (Ankara, Turkey), C. Seckin,
F. Isli, S. Unal
P0367
Evaluation of injectable antibiotic prescribing in
Turkey in 2011
F. Isli* (Ankara, Turkey), A. Alkan, E. Sakalli,
H. Gursoz, A. Sahin, M. Aksoy, P. Gobel, C. Seckin,
D. Celik, B. Melik
P0360
Evaluation of the GENSPEED® MRSA test kit and
its ability to detect the novel mecA homologue
mecC
A. Petersen* (Copenhagen, Denmark), A.J. Medina,
A.R. Larsen
P0368
Antimicrobial use in Turkey: first results of the
WHO/Europe-ESAC Project
H. Demet Celik, A. Versporten* (Antwerp, Belgium),
H. Gursoz, A. Alkan, B. Melik, F. Savur, M. Aksoy,
G. Bolokhovets, H. Bak Pedersen, H. Goossens
P0361
GSK2140944 MIC quality control ranges using a
multi-laboratory study design
J.E. Ross, R.K. Flamm, R.N. Jones* (North Liberty,
IA, United States)
P0369
P0362
Multicentre evaluation of tigecycline MIC results
for staphylococci using a MicroScan® Dried
Overnight performance evaluation device panel
M. Lewinski, C. Polage, S. Riedel, L. Mann,
D. Roe-Carpenter* (West Sacramento, United
States)
Antimicrobial use in Kyrgyzstan: first results of
the WHO/Europe-ESAC Project
B. Kambaralieva* (Ishlek, Kyrgyz Republic),
A. Versporten, A. Mamasheva, G. Bolokhovets,
N. Sautenkova, H. Goossens
P0370
Prescribing of systemic antimicrobials for
respiratory infections in children in primary care
in Russia
S. Rachina* (Smolensk, Russia), R. Kozlov,
L. Jarkova, Y. Belkova, V. Tatochenko,
E. PATRIOT study group: Dudnikova, I. Sakulina,
S. Maltsev, T. Spichak, V. Seroklinov, O. Chirikova,
N. Klimova, T. Shumatova, G. Batischeva,
S. Khokhlova, L. Kryukova, F. Manerov, T. Kaganova,
E. Pavlinova, E. Kondyurina, N. Chornaya,
I. Kosenko
148
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Saturday, 10 May 2014
Antimicrobial use in Armenia: first results of the
WHO/Europe-ESAC Project
L. Ghazaryan* (Yerevan, Armenia), A. Versporten,
H. Martyrosian, G. Bolokhovets, N. Sautenkova,
H. Goossens
P0373
Quinolone use in eastern Europe: first results of
the WHO/Europe-ESAC Project
A. Versporten* (Antwerp, Belgium), G. Bolokhovets,
N. Sautenkova, H. Bak Pedersen, H. Goossens,
And the WHO/Europe-ESAC Project Group
Point prevalence survey of healthcare-associated
infections (HAI) in Tuscany 2012: antibiotic use
characteristics and antimicrobial prevalence rates
M. Macchiarulo* (Pisa, Italy), A.D. Porretta,
M.T. Petrolo, F. Casalini, F. Uccelli, E. Lucaccini,
G. Privitera
15:30 – 16:30
Poster Area
POSTER SESSION I:
Basic science: biofilm treatment
P0381
Effect of aztreonam exposure in Pseudomonas
aeruginosa biofilms
E. Rojo Molinero* (Palma de Mallorca, Spain),
B. Moyà, M.D. Macià, J.L. Pérez, R. Cantón, A. Oliver
Antimicrobial use in Bosnia and Herzegovina:
first results of the WHO/Europe-ESAC Project
T. Spasojevic* (Banja Luka, Bosnia and
Herzegovina), A. Versporten, N. Grubisa,
G. Bolkhovets, H. Bak Pedersen, H. Goossens
P0382
Biofilm formation by Clostridium difficile strains
in the presence of sub-inhibitory concentrations
of metronidazole
C. Vuotto* (Rome, Italy), I. Moura, F. Barbanti,
P. Mastrantonio, G. Donelli, P. Spigaglia
P0375
Comparison of outpatient systemic antibiotic
use in 2010 between the United States and
19 European countries: different outcome
measurements, different results
N. Adriaenssens* (Antwerp, Belgium), S. Coenen,
H. Goossens
P0383
Anti-bacterial effect of the plasma discharge
against biofilm-producing Pseudomonas
aeruginosa
Y. Nakano* (Sendai, Japan), S. Fujimura, T. Sato,
D. Yoshino, A. Watanabe
P0384
P0376
Antifungal use in France: first multi-centre survey
in haematology, intensive care units and at
hospital level in 2012
C. Dumartin* (Bordeaux, France), X. Bertrand,
F. L’Hériteau, M. Péfau, M. Giard, S. Boussat,
S. Alfandari, B. Schlemmer, S. Vaux, A.M. Rogues
Arthroscopic débridement with graft retention
and early oral levofloxacin plus rifampicin as first
choice for the treatment of acute infections of
anterior cruciate ligament reconstruction
D. Perez Prieto* (Barcelona, Spain), A. Trampuz,
E. Portillo, A. Alier, M. Sorli, L. Puig-Verdié,
J. Horcajada
P0377
Cephalosporin use in eastern Europe: first results
of the WHO/Europe-ESAC Project
A. Versporten* (Antwerp, Belgium), G. Bolokhovets,
N. Sautenkova, H. Bak Pedersen, H. Goossens, And the WHO/Europe-ESAC Project Group
P0385
Hypericin photodynamic activity in combination
with antimicrobial agents against Staphylococcus
aureus biofilms
S. Ballesta* (Seville, Spain), I. García-Luque,
Y. Gilaberte, A. Rezusta, A. Pascual
P0378
Widespread increase of carbapenem consumption
in acute care hospitals in Catalonia, Spain
E. Fondevilla* (Barcelona, Spain), S. Grau,
S. Mojal, M. Palomar, L. Matas, F. Gudiol,
G. VINCat Antimicrobial Program Group
P0386
The efficiency of antimicrobial photodynamic
therapy using visual light and water infiltrated
infrared A on initial and mature oral biofilm
A. Al-Ahmad* (Freiburg, Germany), L. Karygianni,
S. Ruf, M. Bucher, E. Hellwig
P0379
Using periodic point-prevalence surveys
to assess appropriateness of antimicrobial
prescribing in Australian private hospitals
M. Cotta* (Melbourne, Australia), M. Robertson,
L. Upjohn, C. Marshall, D. Liew, K. Buising
P0387
Elimination and prevention of Acinetobacter
baumannii biofilms on surfaces using a
Myoviridae bacteriophage
A. Coffey* (Cork, Ireland), M. Elbreki
24th ECCMID / Barcelona
Final Programme
Exhibition
P0374
Posters
P0372
P0380
Chairs, Speakers & Authors
Antimicrobial use in Kosovo: first results of the
WHO/Europe-ESAC Project
L. Raka* (Pristina, Kosovo), A. Versporten,
A. Jakupi, V. Uka, S. Hajdari, B. Sejdiu,
G. Bolokhovets, H. Bak Pedersen, H. Goossens
149
General Information
P0371
Poster Sessions
Saturday, 10 May 2014
P0388
LED effects on E. coli’s ability to form biofilms
and on phagocytic activity of neutrophils with
NETs production in experimental localised
pyoinflammatory processes
M. Mishina* (Kharkiv, Ukraine), V. Myasoedov,
V. Davydenko, A. Korobov, E. Dubovik, Y. Mozgova,
Y. Mishin
P0395
Q fever as a cause of acute hepatic inflammation
in patients with community-acquired atypical
pneumonia
I. Hadji Petrusheva Meloska* (Skopje, Macedonia),
K. Konstantin Icev, B. Branko Jaglikovski,
B. Biljana Curcic-Trajkovska,
A. Anica Hadji-Petrusheva Jankijevikj P0389
Assessment of the anti-adherence and antibiofilm activity of novel biocompatible PE and PVC
polymers
L.M. Ditu, M.C. Chifiriuc, C. Bleotu, A.M. Holban,
C. Curutiu, L. Marutescu* (Bucharest, Romania),
A. Netoiu, A. Ficai, G. Mihaescu
P0396
Geographical repartition of Coxiella burnetii
genotypes
S. Edouard* (Marseille, France), D. Raoult
P0397
Animal reservoirs of Q fever: unveiling Coxiella
burnetii population structure in Portugal
A. Cumbassá, M.J. Barahona, A.S. Santos,
A. Botelho* (Lisbon, Portugal)
P0398
Reservoirs of the emerging pathogens Bartonella
spp. and Yersinia pestis in Peru
A. Martin-Alonso, M. Soto, P. Foronda* (La Laguna,
Spain), E. Aguilar, G. Bonnet, R. Pacheco,
B. Valladares, E. Abreu-Yanes, M.A. Quispe-Ricalde P0399
Bartonella pathogens in small mammals
(rodentia and insectivora) and their fleas
(Siphonaptera) and ticks (Ixodidae) in Lithuania
I. Lipatova* (Kaunas, Lithuania), A. Paulauskas,
J. Radzijevskaja, V. Gedminas
P0400
Data analysis on the incidence of Leptospira
infection in autonomous province of Vojvodina
A. Rosic* (Novi Sad, Serbia)
P0401
Leptospires and leptospirosis in Angola and
Guinea-Bissau: the involvement of a European
laboratory for research and diagnosis
T. Carreira* (Lisbon, Portugal), E. Estanislau, B. Ca,
E. Fortes-Gabriel, J. Garcia, M. Nunes, M.L. Vieira
P0402
Polymorphisms of TLR4 Asp299Gly gene and TNFalpha -308G>A gene of leptospirosis patients
N. Farhanah* (Semarang, Indonesia), M.H. Gasem,
S.M.H. Faradz
P0403
Prevalence of Borrelia miyamotoi in Ixodes ticks
in Europe and the United States
M. Eshoo* (Carlsbad, CA, United States), C. Crowder,
H. Carolan, M. Rounds, V. Honig, B. Mothes, H. Haag,
O. Nolte, B. Luft, L. Grubhoffer
P0404
Epidemiology and treatment response of
tularemia: an observational study from central
Anatolia
G. Iskender, M.C. Ogan, S. Ceken* (Ankara, Turkey),
H. Gedik, S. Kilic, G. Yapar Toros, E. Turk Aribas,
M. Ertek
P0390
P0391
P0392
Antiseptic effect of hyper-pure chlorine-dioxide
on bacteria and biofilm
A. Ghidan* (Budapest, Hungary), A. Herczegh,
M. Gyurkovics, H. Agababyan, Z. Lohinai
Effect of the use of clorhexidine dressings
(CHG Tegaderm™) on the formation of biofilm on
endoluminal and exoluminal surfaces of central
venous catheters
M. Gordon Sahuquillo* (Valencia, Spain),
M.T. Gisbert Garcia, A. Cortes Herrera,
E. Villarreal Tello, J. Mazarrota Palomares,
J.C. Mateo Pardo, S. Messeguer Cuenca,
E. Gonzalez Barbera, J. Bonastre Mora,
P. Ramirez Galleymore Susceptibility of biofilm-associated Clostridium
difficile to antimicrobial agents
A.D.A.M. Jones, R. Manuel, D. Ready* (London,
United Kingdom)
15:30 – 16:30
Poster Area
POSTER SESSION I:
Emerging infectious diseases
P0393
P0394
150
Q fever as a cause of prolonged fever –
a neglected zoonosis in Romania
C. Popescu, R. Dulama* (Bucharest, Romania),
G. Popescu, M. Radulescu, R. Mihailescu,
R. Nastase, R. Moroti, V. Molagic, A. Lobodan,
V. Arama
Neurological involvement of acute Coxiella
burnetii infection in the Balearic islands over a
time span of 10 years (2003-2013)
A. Ramirez Mena* (Bunyola, Spain), M. Raya Cruz,
M. Riera Jaume, A. Payeras Cifre
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Saturday, 10 May 2014
P0408
Genitourinary brucellosis: results of the GONCA
study
H. Erdem, N. Elaldi, O. Ak, Y. Cag* (Brucellosis Study
Group, Istanbul, Turkey)
P0409
Administration of a triple vs standard double
antibiotic regimen to brucellosis patients
efficiently eliminates bacterial DNA load
G. Vrioni* (Athens, Greece), A. Bourdakis, G. Pappas,
V. Pitiriga, V. Kapsimali, S. Pournaras, A. Tsakris
P0410
Elisa-IgG and -IgM assays are highly practical
in clinical laboratories’ diagnosis of human
brucellosis in a highly endemic region
A.A. Chentoufi* (Riyadh, Saudi Arabia),
M. Paz Rafael, S. Al Aidy, S. Usman, H. Albarghy,
A. AlMazrou, A. Hoosen, G. Elghazali
P0411
Actinomyces neuii: a case series and review of a
rarely encountered pathogen
N. Zelyas* (Edmonton, Canada), S. Gee, R. Rennie,
B. Nillson, T. Bennett
P0412
Investing in emerging infectious diseases:
a systematic analysis of UK research
J.R. Fitchett, M.G. Head* (London, United Kingdom),
D.L. Heymann, R. Atun
P0413
Janibacter terrae bacteraemia: two faces of the
same organism
I. Fernández-Natal* (León, Spain), J.A. Sáez-Nieto,
S. Valdezate-Ramos, J.M. Guerra-Laso,
R.H. Rodríguez-Pollán, I. Bresme-Trigo, F. Soriano
P0414
P0415
Is the Raoultella genus an emerging threat of
pathogens in elderly people?
K. Türker* (Istanbul, Turkey), P. Bulut, B. Tas,
M. Iktaç, C. Ozdalgiçoglu, B. Ozdemir
Non-toxigenic tox-bearing Corynebacterium
ulcerans infection in 13 game animals from
Germany
T. Eisenberg, P. Kutzer, M. Peters, A. Sing*
(Oberschleissheim, Germany), M. Contzen, J. Rau
P0417
The French Infectious Disease Society’s (FIDS)
preparation and response to an emerging
infectious disease
H. Coignard-Biehler* (Paris, France), B. Hoen,
S. Alfandari, P. Berthelot, M.C. Chopin, C. Rapp,
B. Guery, P. Brouqui, O. Lortholary, C. Leport
P0418
Brucellosis in endemic area: fifteen years’
experience
S. Bolukcu* (Istanbul, Turkey), A. Inan,
S.C. Ozyürek, S. Senbayrak Akcay, O. Barkay,
E. Karagül
15:30 – 16:30
Poster Area
POSTER SESSION I:
Tick borne infections
P0419
Prevalence of antibodies to Rickettsia conorii in
human beings and dogs from the Terrassa area
(Catalonia): a twenty-year perspective
E. Espejo* (Terrassa, Spain), M. Andrés, J. Pérez, J. Prat,
C. Guerrero, M.T. Muñoz, M.D. Alegre, J. Lite, F. Bella
P0420
Rickettsial diseases in Tunisia: report of 220
cases
A. Berriche, R. Abdelmalek, L. Ammari, F. Kanoun,
S. Aissa, A. Ghoubontini, B. Kilani* (Tunis, Tunisia),
H. Tiouiri Benaissa
P0421
Tick-borne infectious disease in the Republic of
Kazakhstan
R. Egemberdieva* (Almaty, Kazakhstan),
A. Dmitrovskiy, L. Eraliyeva, N. Turebekov,
K. Abdiyeva, A. Oradova, Z.H. Shapiyeva,
S. Tastanova, L. Ziyadina, T. Krasnova
P0422
Molecular analysis of Rickettsia species detected
in rickettsiosis cases and in arthropod vectors in
Tunisia
F. Khrouf* (Tunis, Tunisia), Y. M’Ghirbi, A. Znazen,
L. Ameri, J. Souissi, A. Letaief, A. Bouattour
P0423
Increased concentration of interferon beta and
interferon lambda 3 in the cerebrospinal fluid of
patients with tick-borne encephalitis
S. Grygorczuk* (Bialystok, Poland), A. Moniuszko,
R. Swierzbinska, J. Zajkowska, M. Kodrusik,
P. Czupryna, J. Dunaj, S.A. Pancewicz
24th ECCMID / Barcelona
Final Programme
151
Posters
Investigation of Brucella seroprevalence in
human and livestock in Igdir, Turkey
G. Arvas, Y. Akkoyunlu* (Istanbul, Turkey),
M. Berkoz, G. Acikgoz, A. Bora, F. Altindag
Four-year serological follow-up of a Dutch acute Q
fever cohort
C.C.H. Wielders* (’s-Hertogenbosch,
The Netherlands), G. Morroy, J.A.F. Van Loenhout,
A. Rietveld, D.W. Notermans, A.C.A.P. Leenders,
W. Van der Hoek, P.M. Schneeberger
Chairs, Speakers & Authors
P0407
P0416
Exhibition
Is the fourfold increase of the tularemia incidence
in Switzerland related to ticks?
C.M. Beuret* (Spiez, Switzerland)
General Information
P0405
Poster Sessions
Saturday, 10 May 2014
P0424
P0425
P0426
P0427
P0428
P0429
Epidemiology of the tick-borne relapsing fever in
the area of La Campiña, southeast of Seville from
1994 to 2013
M.C. Domínguez Jiménez* (Seville, Spain),
S. Vergara López, M.C. Gómez Sánchez,
M.E. Roldán Fontana
Endemicity of Anaplasma phagocytophilum
(previously Ehrlichia spp.) and Babesia microti
in Wisconsin, USA: benchmark results following
introduction of molecular diagnostic methods for
routine patient management (2012-2013)
T.R. Fritsche* (Marshfield, United States), T.N. Marti,
A.M. Schotthoefer, T.S. Uphoff
REVIVE, a surveillance programme for ticks and
tick-borne diseases: molecular detection of B.
burgdorferi s.l. and Rickettsia spp.
I. Lopes de Carvalho* (Lisbon, Portugal),
A.S. Santos, M.M. Santos-Silva, R. De Sousa,
M.S. Núncio, REVIVE Workgroup
Study on ticks’ distribution and species
identification infesting the bovine population
of the district Muzaffarabad of Azad Jammu and
Kashmir, Pakistan
A.S.I.M. Shamim* (Rawalakot Ajk, Pakistan),
A.M.I.R. Iqbal, R. Siddique
A homologue of tick salivary lectin pathway
inhibitor (TSLPI) in Ixodes ricinus protects
Borrelia burgdorferi sensu lato from killing by
human complement
A. Wagemakers* (Amsterdam, The Netherlands),
J. Coumou, G.A. Oei, A. Nijhof, T.J. Schuijt, E.A. Herkes,
S. Narasimhan, E. Fikrig, A.D. Bins, J.W. Hovius
Candidatus Neoehrlichia mikurensis – the
emerging tick-borne pathogen in patients
with autoimmune diseases and haematologic
malignancies
C. Wennerås* (Gothenburg, Sweden), P.O. Andersson,
K. Vaht, M. Sender, E. Trysberg, L. Höper, E. Sakiniene,
M. Stenson, M. Mattsson, A. Grankvist
P0430
Persistence of immunologic response of scrub
typhus patients at tertiary-care hospital,
northestern Thailand
W. Thipmontree* (Nakhon Ratchasima,
Thailand), W. Tantibhedhyangkul, E. Wongsawat,
S. Silpasakorn, D. Waywa, Y. Suputtamongkol
P0431
Anaplasmatacea in ticks in Tunisia
Y. Mghirbi* (Tunis, Tunisia), A. Bouattour
152
24th ECCMID / Barcelona
Final Programme
15:30 – 16:30
Poster Area
POSTER SESSION I:
Emerging viruses / viral infections
P0432
Toscana virus: emerging or undervalued virus?
N.M. Scalisi, T. Romano, M. Di Franco, C.I. Palermo,
C. Franchina, M.C. Laudani, C.M. Costanzo, R. Russo,
G. Scalia* (Catania, Italy)
P0433
Occurrence of chikungunya fever in Thailand and
active surveillance in vector mosquitoes
U. Thavara* (Muang Nonthaburi, Thailand),
A. Tawatsin, P. Siriyasatien, A. Phumee,
J. Chompoosri, P. Bhakdeenuan, S. Sangkitporn
P0434
A serologic survey of West Nile virus and Usutu
virus in Croatia
T. Vilibic-Cavlek, V. Stevanovic* (Zagreb, Croatia),
I. Pem-Novosel, I. Gjenero-Margan, B. Kaic,
L.J. Barbic, S. Ljubin-Sternak, E. Listes,
G. Mlinaric-Galinovic, G. Savini
P0435
West Nile virus seroprevalence and behavioural
risks in HIV-1 infected individuals, northern
Greece, 2011
D. Pilalas* (Thessaloniki, Greece), S. Metallidis,
L. Skoura, A. Kourelis, O. Tsachouridou,
T. Chrysanthidis, P. Kollaras, D. Valagkouti,
N. Malisiovas, A. Papa
P0437
Epidemiology of imported dengue virus in Iran
S. Chinikar* (Tehran, Iran), N. Shah-Hosseini,
T. Jalali, S. Khakifirouz
P0438
Ultrastructural studies on two ecotypes of dengue
virus infection in human monocytic U937 cells
C.-Y. Fish-Low, S. AbuBakar, F. Othman, H.-Y. Chee*
(Selangor, Malaysia)
P0439
Severe fever with thrombocytopenia syndrome on
Jeju Island, Korea
H. Sang Taek* (Jeju-si, Korea), L. Keun Hwa
P0440
Double filtration plasmapheresis as a supportive
therapy in patients with Crimean-Congo
haemorrhagic fever who developed hepatic
failure
Z. Ozkurt* (Erzurum, Turkey), S. Erol, H. Kursad,
A. Albayrak, E. Parlak, K.A. Güler, M. Keles,
H. Dursun
P0441
Evaluation of the Crimean-Congo haemorrhagic
fever cases followed and treated in our clinic
between 2009-2013
I. Celik* (Kayseri, Turkey), I. Yilbat Kiliç,
F. Kürklü Bozkir, F. Bahadir, S. Gürbüz,
Z. Bestepe Dursun
Poster Sessions
West Nile virus outbreak in Modena and Reggio
Emilia: a descriptive study
M. Vecchia* (Modena, Italy), M. Menozzi,
G. Guaraldi, G. Magnani, F. Prati, C. Mussini
P0444
P0445
P0446
P0447
P0448
P0449
Haemorrhagic fever with renal syndrome: an
analysis of the outbreak in Croatia in 2012
N. Papic* (Zagreb, Croatia), R. Civljak, I. Kuzman,
A. Topic, M. Vargovic, O. Dakovic Rode, A. Tadin,
L. Cvetko Krajinovic, P. Svoboda, A. Markotic
Raw date palm sap consumption practices
and people’s perception of Nipah virus in two
outbreak-affected districts in Bangladesh
N. Nahar* (Basel, Switzerland), R.C. Paul,
R. Sultana, F. Garcia, E.S. Gurley, J. Abedin,
M. Asaduzzaman, N. Ali Rimi, M. Rahman, S. Zimicki,
S.P. Luby
Field study of faecal excretion as a decision
support tool in response to silent reintroduction
of wild-type poliovirus 1 into Israel
J. Moran-Gilad* (Beit Kama, Israel), E. Mendelson,
C.C. Burns, R. Bassal, M. Gdalevich, D. Sofer,
S. Oberste, M. Hindiyeh, E. Kaliner, I. Grotto
Novel astrovirus associated with encephalopathy
in an immunocompromised patient, identified by
deep sequencing of brain tissue
J.R. Lockwood* (London, United Kingdom),
S. Morfopoulou, W. Emmet, W. Ip, D. Shah,
S.M.L. Paine, W. Tong, D. Clark, V. Plagnol, T. Jacques,
W. Qasim, M. Hubank, J. Breuer
Monitoring of supplementary immunisation
effect on wild poliovirus circulation using
complementary environmental and stool
surveillance approaches following reintroduction
of wild poliovirus type 1 into Israel
E. Mendelson* (Beit Kama, Israel), J. Moran-Gilad,
Y. Manor, R. Bassal, M. Hindiyeh, E. Kaliner, D. Sofer,
M. Weil, M. Gdalevich, I. Grotto
Serosurveillance of WNV in horses – useful tool
for public health
L. Barbic, V. Stevanovic* (Zagreb, Croatia),
T. Vilibic-Cavlek, S. Kovac, I. Pem-Novosel, B. Kaic,
E. Listes, L. Maltar, I. Lohman-Jankovic, V. Staresina
Molecular detection of Salehabad / Adria virus in
sandflies and West Nile virus in mosquitoes from
eastern Thrace, Turkey
K. Ergunay, K. Oter, S. Orsten* (Ankara, Turkey),
O. Erisoz Kasap, F. Gunay, A.Z. Akkutay, A. Ozkul,
B. Alten
P0451
Pneumomediastinum and subcutaneous
emphysema as initial presentation of furious
rabies
P. Davoodian* (Bandarabbas, Iran), H. Dadvand,
M. Farsad, K. Seddighi, F. Naghshvar,
M. Rezaei Nodoushan, A. Javadi
P0452
Deriving dengue infection incidence using
sequential serological data and routine disease
notifications: a Bayesian evidence synthesis
study
M. Baguelin* (London, United Kingdom), C.F. Yung,
L.C. Ng, J. Tay, Y.S. Leo
P0453
The course of Crimean-Congo haemorrhagic fever
cases in Georgia
T. Tkhilaishvili* (Tbilisi, Georgia), M. Javakhadze,
D. Kikabidze, M. Mamulashvili
P0454
Feasibility of a new clinical severity scoring
index to identify the patients with CrimeanCongo haemorrhagic fever who will benefit from
ribavirin
G. Kalin, G. Metan* (Kayseri, Turkey),
H. Demiraslan, M. Doganay
P0455
2 case reports of a rare complication in dengue
infection of travellers at Bangkok Samui hospital,
Thailand
T. Narkwiboonwong* (Bangkok, Thailand)
P0456
Detection of IgM antibodies, NS1 antigen and viral
RNA in the diagnosis of acute dengue fever
M. Trojanek* (Prague, Czech Republic), J. Maixner,
N. Sojkova, D. Tomickova, H. Rohacova, V. Maresova,
F. Stejskal
P0457
The first cases of laboratory-confirmed dengue
virus infection in Mimika, Papua Province,
Indonesia
R. Herman* (Jakarta, Indonesia), A. Agustiningsih,
H.D. Ikawati, A.A. Nugraha, V. Setiawaty
P0458
A phase 1, multiple ascending dose study of AVI7288, a PMOplus™ compound with activity against
Marburg virus
A. Heald* (Bothell, United States), M. O’Connor,
J.B. Saoud, E. Kaye, M. Al-Ibrahim
24th ECCMID / Barcelona
Final Programme
153
Chairs, Speakers & Authors
P0443
P0450
Exhibition
The impact of dynamic clay system on infectious
viruses
M. Bellou* (Patras, Greece), V. Syngouna,
S. Paparrodopoulos, A. Vantarakis,
C. Chrysikopoulos
General Information
P0442
Posters
Saturday, 10 May 2014
Poster Sessions
Saturday, 10 May 2014
P0459
Evaluation of serum cytokines and adhesion
molecules as prognostic factors in patients with
Crimean-Congo haemorrhagic fever
G. Canpolat, C. Ataman Hatipoglu* (Ankara, Turkey),
C. Bulut, H. Uludag Altun, S. Kinikli, A. Demiröz
15:30 – 16:30
Poster Area
POSTER SESSION I:
Other viral infections
P0465
Respiratory viral infections during 2013 in
Evaggelismos General Hospital, GR: incidence
and patterns of multiple virus co-infections
E. Grispou* (Athens, Greece), E. Douka,
V. Papastamopoulos, F. Veini, S. Kostourou,
D. Tsimpouki, P. Karageorgou, K. Fountoulis,
S. Zakynthinos, A. Skoutelis
Hantavirus antibody seroprevalence in patients
with chronic renal disease in Turkey
D. Akduman, R. Sariismailoglu, I.O. Tekin, E. Hur,
F. Kokturk, N. Piskin* (Zonguldak, Turkey),
H. Aydemir, G. Celebi
P0466
Respiratory viruses in hospitalised children with
lower respiratory tract infections in Riyadh
L. Skakni* (Riyadh, Saudi Arabia), R. Hasan,
N. Al Ragi, H. Al Qudairy, J. Al Mutairy, E. Al Kafari,
D.A. Al Shahrani, M. Al Shehri
P0462
West Nile virus outbreak in Lombardia region,
northern Italy, in summer 2013
F. Rovida* (Pavia, Italy), A. Sarasini, G. Campanini,
E. Percivalle, A. Pan, S. Possenti, L. Manzini,
F. Castelli, M. Gramegna, F. Baldanti
P0467
The viral aetiology of acute lower respiratory tract
infections in hospitalised children younger than 2
years at a university hospital in Istanbul, Turkey
K. Midilli* (Istanbul, Turkey), M. Kuskucu, S. Ergin,
A. Abdelkareem, Y. Camcioglu
P0463
Simultaneous outbreak of dengue and
chikungunya fever in Al Hodayda, Yemen
G. Rezza* (Rome, Italy), G. El-Sawaf, G. Faggioni,
F. Vescio, R. Al Ameri, G. Helaly, A. Pomponi, H. Qadi,
M. Ciccozzi, F.R. Lista
P0468
Clinical severity of rhinovirus/enterovirus
compared to other respiratory viruses in children
S. Asner* (Toronto, Canada), A. Petrich, J.S. Hamid,
D. Mertz, S.E. Richardson, M. Smieja
P0464
The rapid response for Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) detection in
Indonesia
V. Setiawaty* (Jakarta, Indonesia), H.A. Pawestri,
N.K. Susilarini, E. Samoedro, B.R. Hapsari, G. Tallis,
E.W. Wulandari, M. Sudomo, P. Multihartina,
T.Y. Aditama
P0469
Human rhinovirus molecular detection in
respiratory tract infections: a retrospective study
of 43 adults
A. Brebion* (Clermont-Ferrand, France),
C. Archimbaud, M. Chambon, A. Mirand,
C. Regagnon, H. Peigue-Lafeuille, C. Henquell
P0470
Cytomegalovirus (CMV) infection in nonimmunocompromised critically ill patients
T. Al Musawi* (Al Khobar, Saudi Arabia),
A. Khawaldeh, A. Ghoneim, M. Sabry, M. Aldarweesh
P0471
Cytomegalovirus seroprevalence as a risk factor
in acute respiratory distress syndrome
D.S.Y. Ong* (Utrecht, The Netherlands),
P.M.C. Klein Klouwenberg, F.M. Verduyn-Lunel,
C. Spitoni, J.F. Frencken, B. Dekker, M.J. Schultz,
M.J.M. Bonten, O.L. Cremer
P0472
HSV-1 reactivation in mechanically ventilated
patients shows standard kinetics regardless of
worsening respiratory function
S. Scheithauer* (Aachen, Germany), M. Kleines,
L. Schmidt-Redemann, H. Schulze-Steinen,
S. Lemmen, G. Marx, T. Schürholz
P0460
Antibody responses and viral load in patients
with with Crimean-Congo haemorhagic fever: a
comprehensive analysis during the early stages
of the infection
Z. Kocak Tufan, K. Ergunay, C. Bulut* (Ankara,
Turkey), A. Ozkul, S. Kinikli, A.P. Demiroz
P0461
154
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Saturday, 10 May 2014
P0475
Usefulness of MRI in patients with remote history
of a severe course of tick-borne encephalitis
A. Moniuszko* (Bialystok, Poland), E. Tarasow,
P. Czupryna, S. Pancewicz, S. Grygorczuk,
M. Kondrusik, J. Zajkowska
P0476
Can IL28B genotype predict herpes labialis’
recurrence among immunocompetent
population?
M. Spaziante* (Rome, Italy), E. Biliotti, C. Franchi,
D. Palazzo, R. Esvan, C. Furlan, G. Iaiani, C. Marsiglia,
L. Fontanelli-Sulekova, G. Taliani
P0477
Herpes zoster in a tertiary-care teaching hospital
in Turkey
S. Alp Cavus, O. Eren Kutsoylu* (Izmir, Turkey),
M. Celik, N. Yapar, V. Avkan-Oguz
P0478
Phylodynamic characterisation of coxsackievirus B2
Y.Y. Shi* (Kaohsiung, Taiwan), Y.C. Huang, P.Y. Chu
P0479
Detection of common viral genomes and
immunohistological inflammatory markers
in endomyocardial biopsies of patients with
unexplained dilated cardiomyopathy
F. Renois, Y. Nguyen, C. Boulagnon, F. Lesaffre,
P. Fornes, D. Metz, L. Andreoletti* (Reims, France)
P0480
Presence of human herpes virus-6 genomic
sequence in DNA samples of patients with thyroid
gland diseases
S. Gravelsina* (Riga, Latvia), M. Cistjakovs,
A. Sultanova, S. Chapenko, A. Roce, E. Cunskis,
S. Roga, M. Murovska, Z. Nora-Krukle
P0481
Cytokine gene polymorphisms and relationship
with congenital cytomegalovirus (CMV)
infection in newborns and mother-to-foetus CMV
transmission
B. Kasztelewicz* (Warsaw, Poland),
J. Czech-Kowalska, M. Kornacka,
K. Dzierzanowska-Fangrat
P0483
Epstein-Barr virus reactivation as a prognostic
factor in elderly immunocompetent bacteraemic
patients
I.G. Bae* (Jinju, Korea), D.Y. Chang, O.H. Cho,
S.J. Kim
Posters
Detection of virus in aqueous humour samples
from Hospital de la Princesa (Madrid, Spain)
J. Martiáñez* (Madrid, Spain), E. Lomas, E. Gallego,
P. Sánchez, A. Guiu, A. Correa, L. Cardeñoso
Comparison of HHV-6 specific T-cell immunity
in individuals with and without chromosomally
integrated HHV-6 (CIHHV-6)
V. Strenger* (Graz, Austria), S. Kayser, D. Lassner,
M. Seidel, W. Schwinger, S.W. Aberle, G. Jahn,
S. Jürgens, C. Urban, T. Feuchtinger
Chairs, Speakers & Authors
P0474
P0482
Exhibition
Risk factors and outcome of virus-related ARDS in
249 patients from 28 ICUs in the period 2009-2013
B. Mariani, F. Rovida* (Pavia, Italy), A. Piralla,
A. Muzzi, G.A. Iotti, A. Braschi, F. Baldanti
24th ECCMID / Barcelona
Final Programme
155
General Information
P0473
ESCMID WHO Observership in 2014
Visit the WHO Regional
Office for Europe
and learn about their
programmes!
A group of 10 observers (ESCMID members) are offered
a 3 day programme at the WHO Regional Office for
Europe, Division of Communicable Diseases, Health Security
and Environment (DCE) in Copenhagen, Denmark.
Date of Observership: 30 September –2 October 2014
Applications accepted from: 15 May 2014, 10:00 CET
Selection: ‘First come, first served’, ensuring CM, ID,
gender and country balance.
To apply, visit the ESCMID website.
Deadline for applications: 30 May 2014, 16:00 CET
www.escmid.org/WHO_Observer
www.euro.who.int
RZ_Ins_WHO_02.04.2014.indd 1
02.04.14 11:33
ESCMID ECDC Observerships in 2014
Visit ECDC and
learn about
the organisation!
A group of 10 observers (ESCMID members) are offered
a 5 day programme at the European Centre for
Disease Prevention and Control (ECDC) in Stockholm, Sweden.
Date of Observership: 01–05 September 2014
Applications accepted from: 15 May 2014, 10:00 CET
Selection: ‘first come, first served’ but ensuring CM, ID,
gender and country balance.
To apply, visit the ESCMID website.
Deadline for applications: 30 May 2014, 16:00 CET
www.escmid.org/ECDC_Observer
www.ecdc.europa.eu
RZ_Ins_ECDC_14.04.2014.indd 1
16.04.14 10:18
Poster Sessions
Sunday, 11 May 2014
P0492
Evaluation of a new method for the rapid
exclusion of suspected bacteraemia and
fungaemia
M. Crow* (Reading, United Kingdom), H. Bennett,
M. Grover, M. Dryden
P0493
Rapid screening of positive blood cultures and
instant verification of B. fragilis carbapenemase
activity using matrix-assisted laser desorption
ionization-time of flight mass spectrometry
(MALDI-TOF MS)
Å. Johansson* (Växjö, Sweden), J. Soki, E. Nagy
P0494
Direct identification of bacteria in positive blood
cultures using MALDI-TOF MS
C. Ostergaard* (Vejle, Denmark)
POSTER SESSION II:
Infective endocarditis, bacteraemia and sepsis
P0484
Unique blood culture for diagnosis of bloodstream
infections: a prospective multicentre study
S. Dargere* (Caen, France), J.J. Parienti, P.E. Gancel,
N. Smaiti, C. Loiez, L.M. Joly, L. Lemée, R. Verdon,
R. Leclercq, V. Cattoir
P0485
Impact of monitoring of blood volume in BD
BACTEC™ FX blood culture system: virtual volume
vs actual volume
J. Chang* (Seoul, Korea), J. Park, S. Park, B. Choi,
N. Yoon, H. Sung, M. Kim
Validation of the module for blood volume
monitoring on the BD EpiCenter™ system as a
continuous quality improvement measure
L. Coorevits* (Wevelgem, Belgium),
A.M. Van den Abeele
P0495
Rapid pathogen identification in blood cultures
by means of short-incubation MALDI-TOF
(SI-MALDI-TOF)
A. Kalanti* (Helsinki, Finland), A. Oksaharju,
K. Rantakokko-Jalava, P. Kuusela
P0487
How to distinguish between contamination and
true bloodstream infection? A prospective cohort
study of over six thousand blood cultures
V. Fihman* (Creteil, France), G. Barnaud,
F. Magdoud, T. Billard-Pomares, V. Manceron,
B. Mesples, J.D. Ricard, C. Branger
P0496
Automatic identification of bacterial species
in a polymicrobial sample by MALDI-TOF mass
spectrometry
P. Mahé* (Marcy-l’Étoile, France), M. Arsac,
S. Chatellier, V. Monnin, N. Perrot, S. Mailler, V. Girard,
B. Lacroix, A. Van Belkum, J.B. Veyrieras
P0488
Value of direct examination of peripheral and
catheter-drawn blood samples for the diagnosis
of catheter-related bloodstream infection in
intensive-care neonates
M. Deleers* (Brussels, Belgium), M. Dodemont,
B. Van Overmeire, Y. Hennequin, D. Vermeylen,
S. Roisin, O. Denis
P0497
Microbiological diagnosis in cardiac device
infections: the role of sonication
A. Oliva* (Rome, Italy), B.L. Nguyen,
M.T. Mascellino, G. Riitano, A. Cipolla, A. D’Abramo,
M. Iannetta, C.M. Mastroianni, V. Vullo
P0498
Concordance between isolates from blood
cultures, intraoperative tissue specimens and
graft cultures (sonicates) in vascular graft
infections
T. Lejko-Zupanc* (Ljubljana, Slovenia),
B. Kokozar - Ulcar, M. Logar, N. Lakic, S. Jeverica
P0499
Increased length of stay and mortality attributed
to hospital-acquired infections in a tertiary
hospital; a 12-year prospective observational
study
A. Koch* (Bergen, Norway), R. Nilsen, R. Cox,
S. Harthug
P0500
Determinants of recourse to surgery in 998
infective endocarditis cases in France
S. Sunder* (Tours, France), L. Guillon, C. Gaborit,
E. Rusch, S. Baron, L. Bernard
Rapid test for the detection of bloodstream
infections
R. Verma* (La Canada, United States), K. Zangwill,
H. Lee, C. Yu, A. Ibrahim
P0490
Assessing the turnaround time for organism
identification in bloodstream infections by
conventional microbiological method
K.Y. Ng* (Hong Kong, China), P.Y. Law, M.K. Yan,
V.C. Cheng, P.L. Ho
P0491
Rapid and convenient direct identification of
bacteria and yeast in positive blood culture by
use of the VITEK® MS MALDI-TOF MS system
S. Kawakami* (Tokyo, Japan), M. Asahara,
Y. Atukawa, T. Hurukawa, N. Matsunaga, Y. Ono
24th ECCMID / Barcelona
Final Programme
Exhibition
P0489
Posters
P0486
Chairs, Speakers & Authors
Poster Area
157
General Information
12:30 – 13:30
Poster Sessions
Sunday, 11 May 2014
P0501
Infective endocarditis caused by toxigenic
Corynebacterium diphtheriae
M. Saule* (Riga, Latvia), A.O. Balode, T. Obidenova,
P. Aldins, I. Jansone
P0502
Preoperative assessment of factors associated
with mortality after cardiac surgery for infective
endocarditis
S. Patrat-Delon* (Rennes, France), A. Rouxel,
A. Gacouin, E. Flecher, O. Fouquet, Y. Le Tulzo,
N. Lerolle, P. Tattevin, J.M. Tadie
P0503
P0504
Infective endocarditis in Turkey: causative
microorganisms, clinical features and analysis of
risk factors for mortality in 325 cases
S. Simsek Yavuz* (Istanbul, Turkey), A. Sensoy,
H. Kasikçioglu, S. Ceken, D. Deniz, A. Yavuz,
F. Koçak, K. Midilli, M. Eren, I. Yekeler
Endocarditis by Enterococcus spp. diagnosed
in the University Hospital Miguel Servet in
Saragossa during the years 2011, 2012 and 2013
S. Ruiz Aliende* (Zaragoza, Spain), E. Lain Miranda,
M.C. Villuendas Usón, M. Vidal García,
M.J. Revillo Pinilla
P0505
Analysis of Escherichia coli (EC) bloodstream
infection (BSI) during a four-year period in a
French general hospital
S. Nguyen* (Tourcoing, France), S. Dekeyser,
E. Beclin, F. Dufossez, E. Senneville, D. Descamps
P0506
Predictors of third-generation cephalosporinresistant Enterobacteriaceae in the elderly with
community-onset bloodstream infections
C. Fehér* (Barcelona, Spain), C. Hernandez,
N. Cobos, C. DeLaCalle, L. Morata, F. Marco,
M. Almela, J. Mensa, A. Soriano, J.A. Martínez
P0507
Predictors of Pseudomonas aeruginosa in the
elderly with community-onset bloodstream
infections
C. Fehér* (Barcelona, Spain), C. Hernandez,
N. Cobos, C. DeLaCalle, L. Morata, F. Marco,
M. Ortega, J. Mensa, A. Soriano, J.A. Martínez
P0508
P0509
158
Functional status and quality of life after
community-acquired bacteraemia: a matched
cohort study
M. Dalager-Pedersen* (Aalborg, Denmark),
R.W. Thomsen, H.C. Schønheyder, H. Nielsen
The microbiology of severe sepsis
M.L. Heginbothom* (Cardiff, United Kingdom),
R.A. Howe, R. McArtney, M. Smithies, J. Parry-Jones,
T. Szakmany
24th ECCMID / Barcelona
Final Programme
P0510
Mortality attributed to bacteraemia in an
Andalusian secondary hospital. Study of
prognostic factors
A. Del Arco* (Marbella, Spain), A. Blázquez,
J. De la Torre, N. Montiel-Quezel, J. Olalla,
J.L. Prada, F. Rivas, M.V. Uribe, J. García Alegría,
F. Fernández Sánchez
P0511
Urosepsis in hospitalised urological patients:
increasing rates in the multinational, multi-centre
global prevalence of infections in urology (GPIU)
study (2003 to 2011)
Z. Tandogdu, M. Cek, M. Grabe, B. Wullt, P. Tenke,
K. Naber, R. Pickard, R. Bartoletti, F. Wagenlehner*
(Giessen, Germany), T. Bjerklund Johansen
P0512
Multidrug-resistant bacteria and bacterial
bloodstream infection among spinal cord injury &
disorder (SCID) patients, severity and outcome:
15 years’ experience
A. Dinh* (Paris, France), M. Saliba, I. Pierre,
P. Denys, E. Ronco, C. Lawrence, B. Clair, C. Perronne,
L. Bernard
P0513
Results of an early intervention programme in
patients with bacteraemia in a secondary hospital
– epidemiological and evolutive characteristics
A. Blazquez* (Marbella, Spain), A. Del Arco,
J. De la Torre, J. Olalla, F. Fernández Sánchez,
J.L. Prada, F. Rivas, M.V. Uribe, J. García Alegría,
N. Montiel Quezel
P0514
Bloodstream infections caused by anaerobes
– aetiology and antibiotic susceptibility profile
during a 3-year period at University Hospital for
Infectious Diseases, Zagreb, Croatia
S. Bukovski-Simonoski* (Zagreb, Croatia), T. Tot
P0515
Eggerthella lenta bacteraemia: a retrospective
case series
B.J. Gardiner, A. Tai* (Melbourne, Australia),
D. Kotsanas, S.A. Roberts, R. Junckerstorff,
T.M. Korman
P0516
Predictive value of biomarkers for death in sepsis
A. Cioara* (Cluj-Napoca, Romania), J. Ten Oever,
T. Crisan, I. Filipescu, M. Flonta, M. Netea, M. Lupse
P0517
Procalcitonin fails to rule out bloodstream
infection in patients with SIRS: a case-control
study
M. Hoenigl* (Graz, Austria), R.B. Raggam,
J. Wagner, F. Prueller, J. Prattes, K. Seeber, E. Leitner,
I. Zollner-Schwetz, A.J. Grisold, R. Krause
Poster Sessions
Sunday, 11 May 2014
P0520
P0521
P0522
P0523
P0524
Poster Area
POSTER SESSION II:
Molecular diagnosis of bloodstream infections
P0526
Diagnosing bloodstream infection with broad
range bacterial 16S rRNA PCR from whole blood:
a new protocol using a CD64-guided diagnostic
algorithm
D. Stubljar, M. Skvarc* (Ljubljana, Slovenia),
P. Rogina, T. Lejko, A. Kaasch
P0527
Nationwide study on the use of endovascular
catheters in internal medicine departments
M. Guembe* (Madrid, Spain), M.J. Pérez Granda,
J. Capdevila, J. Barberán, B. Pinilla,
P. Martín-Rabadán, E. Bouza
Multi-centre evaluation of Verigene® BC-GN test
for rapid detection of Gram-negative bacteria
from positive blood cultures from paediatric
inpatients
J. Mortensen* (Cincinnati, United States),
B. DeBurger, N. Turner, S. Roundtree, C. Ventrola,
D. BLecker-Shelly, K. Sullivan
P0528
Pathogenesis and clinical outcome of peripheral
line-associated bloodstream infections in Japan
H. Kurai* (Shizuoka, Japan), I. Kawamura,
N. Hosokawa, M. Abe, M. Kimura, Y. Ainoda, T. Fujita,
N. Sekiya, N. Takeshita, N. Ohmagari
Evaluation of FilmArray® blood culture system in
bloodstream infections in a tertiary hospital
L. Goterris Bonet* (Barcelona, Spain), M. Lung,
Z. Moure, M.T. Martín, A. Rando, C. Gulín, T. Pumarola,
A.M. Planes
P0529
Outcome of subcutaneous injection port
(SIP) infections in a cohort study: proposal of
additional criteria for prompt removal
M. Vidal* (Clermont Ferrand, France), N. Mrozek,
J. Genillon, E. Forestier, S. Trouillier, B. Pereira,
O. Lesens
FilmArray® blood culture identification system
(BCID); an integrated, fully automated sample
processing/multiplex PCR for rapid identification
of pathogens from positive blood culture bottles
H. Salimnia* (Detroit, United States), P. Lephart,
T. Painter, R. Mitchell, T. Burger, K. Kanack, M. Fairfax
P0530
Efficacy of antibiotic-lock therapy in the
treatment of infections related to long-term
catheters in cancer patients
K.Y. Ibrahim, T. Ferretti, M. Freire, A.E. Zerati,
J.M. Leal Filho, P.H.X. Nabuco, P.M. Hoff,
L.C. Pierrotti* (São Paulo, Brazil), E. Abdala
Rapid identification of microorganisms in blood
cultures applying the FilmArray® blood culture
identification panel
E. Leitner* (Graz, Austria), S. Klingsbigel,
B. Neuhold, M. Hoenigl, R. Krause, G. Feierl,
A. Grisold
P0531
Comparison of the efficacy of SeptiFast (Roche)
and FISH methods in detecting bacteria in whole
blood of patients with sepsis
T. Gosiewski* (Crakow, Poland), A. Flis, R. Drwila,
A. Sroka, A. Kedzierska, A. Pietrzyk, M. Bulanda
POSTER SESSION II:
News on catheter-related bloodstream infections
P0519
12:30 – 13:30
Unusual distribution of pathogens in a European
multi-centre study about central venous
catheter-related bloodstream infections
T. Van Der Kooi* (Bilthoven, The Netherlands),
M. Wolkewitz, B. Van Benthem, S. De Greeff,
H. Grundmann, W. Zingg on behalf of the
PROHIBIT study group
Evaluation of catheter-related bloodstream
infections in elderly patients undergoing
haemodialysis
S. Kose* (Izmir, Turkey), G. Ersan, B. Tatar, Y. Ulu,
P. Adar
24th ECCMID / Barcelona
Final Programme
159
Posters
Poster Area
Clinical characteristics, treatment and outcomes
of methicillin-resistant Staphylococcus aureus
(MRSA) catheter-related bacteraemia in
haemodialysis patients
G. Cuervo* (Barcelona, Spain), E. Shaw, O. Gasch,
M. Camoez, M. Dominguez, B. Padilla, V. Pintado,
J. Rodriguez-Baño, N. Benito, M. Pujol
Chairs, Speakers & Authors
12:30 – 13:30
P0525
Exhibition
Major impact over mortality of a sepsis code
based on an early detection electronic algorithm,
a standardised order set and a sepsis team
approach
P. Martin Rico* (Denia, Spain), A. Valdivia Perez,
M.D. Marco Lattur, J. Chorda Ribelles,
J.M. Lacalle Martinez, O. Esparcia Rodriguez,
J. Cardona Pereto, A. Navarro Juanes,
V. Moncho Mas, R. Sala Lopez
General Information
P0518
Poster Sessions
Sunday, 11 May 2014
P0532
Multiplex RT-PCR for rapid diagnosis
of bacteraemia in neutropenic febrile
haematological patients
J. Gomez* (El Prat De Llobregat, Spain), S. Diaz,
A. Viu, E. Gimeno, L. Sorli, J.P. Horcajada, M. Salvado
P0533
The Tm mapping method: a novel method
that enables rapid identification of unknown
pathogenic bacteria in sepsis within three hours
of whole blood collection
H. Niimi* (Toyama, Japan), T. Ueno, M. Mori,
H. Tabata, H. Minami, M. Goto, S. Saito, I. Kitajima
P0534
P0535
P0536
Development of a rapid molecular test for
bacteria and Candida detection using large
volume blood samples
A. Bacconi* (Carlsbad, United States), G. Richmond,
L. Blyn, R. Sampath, D.J. Ecker
Establishing the potential for whole genome
sequencing of Escherichia coli directly from
positive blood culture media
L.W. Anson* (Oxford, United Kingdom),
L.J. Pankhurst, A. Votintseva, N. Stoesser, D. Crook
Use of peptide nucleic acid fluorescence insitu hybridisation on blood cultures without
antimicrobial stewardship (AS) intervention does
not improve time to appropriate therapy
E. Avdic* (Baltimore, United States), T. Wakefield,
M. Gherna, E. Hadhazy, K. Carroll, S. Cosgrove
P0537
Association between lower PaCO2 levels and
true-positive blood cultures
Y. Natori* (Tokyo, Japan), A. Mikami,
G.A. Deshpande
P0538
Quicker identification of Gram-positive cocci in
clusters in patients with suspected sepsis
C. Retz, S. Andersson, H. Enroth, L. Ljungström,
D. Karlsson, A.K. Pernestig* (Skövde, Sweden)
P0539
Pathogen identification from positive
blood cultures using automated sample
preparation and automated fluorescent in
situ hybridisation (FISH)
K. Hance, C. Michel, E. Allers, M. Mensack, E. Tuttle,
S. Metzger* (Tucson, United States), C.S. Price,
D. Howson
160 24th ECCMID / Barcelona
Final Programme
P0540
Multiplex detection of Gram-positive bacteria
from blood culture with GenMark’s developmental
sample-to-answer platform
H. Liang, A. Marchese, S. Yousif, A. Maer, Y. Chen,
L. Freeman-Cook, J. Hawkins* (San Diego, CA,
United States)
P0541
Potential impact of a microarray-based nucleic
acid assay for the rapid detection of Gramnegative bacteria and resistance markers in
positive blood cultures
L. Infurnari* (Milan, Italy), N. Mancini, N. Ghidoli,
A. Valzano, N. Clementi, R. Burioni, M. Clementi
P0542
Rapid detection of extended-spectrum
beta-lactamases, plasmid-mediated
cephalosporinases (AmpC) and carbapenemases
directly from blood cultures by use of a nucleic
acid DNA microarray
P. Pancholi* (Columbus, United States), R. Faubel,
K. Thomas, D. Smith, J.M. Balada-Llasat
P0543
Development and characterisation of a PCR/ESIMS assay capable of detecting and identifying
diverse bacteria and Candida in whole blood
M. Frinder* (Carlsbad, United States), D. Metzgar,
H. Carolan, D. Toleno, R. Sampath, L. Blyn, D. Ecker,
R. Rothman, S. Peterson, K. Carroll
P0544
Routine microbiological screening of central
venous catheters in haemato-oncological
patients
J. Wagner* (Graz, Austria), W. Duettmann, G. Theiler,
P. Neumeister, I. Zollner-Schwetz, M. Hoenigl,
T. Valentin, R. Krause
P0545
Metabolites in blood for predicting bacteraemia
in patients admitted to an infectious diseases
clinic, a pilot study
A. Kauppi, A. Edin, I. Ziegler, A. Gylfe, A. Sjöstedt,
P. Mölling, K. Strålin, Å. Johansson* (Umea,
Sweden)
P0546
Comparison of PCR/ESI-MS with 16s rDNA PCR
for the detection of microbial pathogens in heart
valve samples
D. Gascoyne-Binzi, M. Wilcox, J. Sandoe* (Skipton,
United Kingdom)
Poster Sessions
P0547
Emerging superbugs: impact of active vs passive
surveillance in detection of carbapenemresistant organisms – a single centre experience
C. Akhoon* (London, United Kingdom), N. Desai,
M. Graver, J. Philpott-Howard, A. Verma
Epidemiology of carbapenemase-producing
Klebsiella pneumoniae in a north-west Italian
region: report from the regional surveillance
system
A. Rocchetti, C.M. Zotti, P.A. Argentero, R. Raso,
A. Biglino, S. Livigni, S. Romagnoli, S. Corcione*
(Turin, Italy), F.G. De Rosa, V. Ghisetti
P0548
P0557
Performance and cost effectiveness of IDMsurveillance®, a software tool for automated
detection of hospital-acquired infections
I.A.M. Ten Seldam, H.R.A. Streefkerk,
C. Van der Hoeven, R. Kamphuis, H.A. Verbrugh,
A.W. Friedrich, J.L.V. Eriksson, N. Al Naiemi*
(Hengelo, The Netherlands)
The impact of carbapenemase-producing
Enterobacteriaceae on overall intensive care unit
mortality
A.N. Wekesa* (Hilversum, The Netherlands),
A. Antoniadou, M.J.D. Bonten, C. Brun-Buisson,
M.J.D. Dautzenberg, L.P.G. Derde, H. Giamarellou,
M. Gniadkowski, G.L. Petrikkos, O.B.O. MOSAR
P0549
P0558
Lessons learned from a clonal OXA-48 outbreak:
proactive rather than reactive surveillance better
suits healthcare facilities where carbapenemresistant Enterobacteriaceae are endemic
K. Marimuthu* (Singapore, Singapore), P. Krishnan,
D. Lye, A. Chow, B. Ang
P0550
P0559
Infection control policies and ICU-acquired
ESBL-cases in Germany: a cross-sectional
questionnaire survey of 224 ICUs
F. Maechler* (Berlin, Germany), F. Schwab,
C. Geffers, A. Gropmann, P. Gastmeier
Surveillance of healthcare-associated outbreaks
in Germany; comparison of outbreaks on nonpaediatric ICUs and neonatal and paediatric ICUs,
2012/2013
S. Haller* (Berlin, Germany), T. Eckmanns,
M. Abu Sin
P0551
P0560
Characterisation of carbapenem-resistant
Enterobacteriaceae in China: a nationwide,
retrospective, 9-year surveillance study
Q. Yang* (Beijing, China), H. Duan, H. Zhang,
H. Wang, M. Xiao, Y. Xu, M. Chen
Seven-year surveillance of ESKAPE pathogens in
culture-positive pneumonia – a hospital-based
study
A. Slavcovici* (Cluj-Napoca, Romania),
A. Radulescu, N. Hagau
P0552
P0561
Active surveillance for carbapenemase-producing
Enterobacteriaceae (CRE) from 6/2011 to 6/2013
C. Wessels, D. Peter* (Cologne, Germany),
S. Messler, F. Mattner
P0553
P0562
Carbapenem-resistant Klebsiella pneumoniae:
the role of rectal swab specimens in surveillance
E. Sala* (San Fermo della Battaglia, Italy), R. Mauri,
A. Genasetti, S. Armitano, S. Tettamanti, S. Campa,
D. Santoro, G. Giana
P0554
Healthcare-associated infections and
antimicrobial use: results of the European point
prevalence survey in Sicily, Italy
A. Agodi, M. Barchitta* (Catania, Italy), R. Cunsolo,
G. Murolo, V. Torregrossa, M.L. Moro
Determining transmissibility of Klebsiella
pneumoniae and Escherichia coli in European
intensive care units using Raman spectroscopy
M.J.D. Dautzenberg* (Utrecht, The Netherlands),
L.P.G. Derde, C. Brun-Buisson, M. Gniadkowski,
M.J.M. Bonten, On behalf the MOSAR WP3 study group
Prediction of carriage with ESBL-producing bacteria
at hospital admission; a cross-sectional study
T. Platteel* (Utrecht, The Netherlands),
J. Cohen Stuart, M. Leverstein-van Hall, S. Thijsen,
E. Mascini, B. Van Hees, A. Fluit, M. Bonten
Prevalence of ESBL-producing
Enterobacteriaceae mother colonisation and
mother-to-neonate transmission
L. Lopez Cerero* (Seville, Spain), C. Jiménez,
S. Luna, C. Vera, J. Rodríguez-Baño, A. Pascual
24th ECCMID / Barcelona
Final Programme
161
Chairs, Speakers & Authors
P0556
POSTER SESSION II:
Surveillance of healthcare-associated infections
Exhibition
Emergence of NDM-1 enzyme in A. soli in Cuba:
report from national surveillance programme
(2010-2012) of Acinetobacter spp.
D. Quiñones, I. Carvajal, Y. Pérez, M. Hart, J. Pérez,
S. García, D. Salazar, R. Del Campo* (Madrid, Spain),
S. Ghosh, N. Kobayashi
Poster Area
General Information
P0555
12:30 – 13:30
Posters
Sunday, 11 May 2014
Poster Sessions
Sunday, 11 May 2014
P0563
Surveillance of ESBL-producing isolates in urine
in the elderly during a period of 3 years (20112013) in Aveiro, Portugal
S. Magalhaes, C. Brandao, S. Soares, E. Ramalheira,
S. Ferreira* (Aveiro, Portugal)
P0564
Cohort study on the prevalence and risk factors
for ESBL/AmpCs at Dutch day care centres
M. Koningstein* (Bilthoven, The Netherlands),
M. Leenen, R. Zuidema, R. Ensering, K. Veldman,
D. Mevius, W. Van Pelt
P0566
Active surveillance and feedback in a renal
dialysis network reduces infection rates
S. Collier* (London, United Kingdom), H. Kandil,
V. Pang, J. Cross, S. Hopkins
P0567
A prospective community intervention trial to
assess scabies and pyoderma prevalence in a
highly endemic population
L. Romani* (Sydney, Australia), J. Kaldor,
H. Whitfeld, H. Wand, A. Steer
12:30 – 13:30
Poster Area
P0572
Impact of comprehensive implementation
strategy of practice guideline for central lineassociated bloodstream infection prevention: 12
months’ intervention results in 15 hospitals in
Korea
P.G. Choe, M.J. Shin, H.Y. Jin, Y.H. Choi, O.J. Choi,
N.J. Park, K.H. Kim, S.H. Han, E.J. Choo, H.B. Kim*
(Seongnam, Korea)
P0573
Effectiveness of a bundle-intervention for
reducing catheter-associated bacteriuria in two
medical and surgical wards
M. Gimenez* (Badalona, Spain), R. Raya, M. Ribas,
M. Corral, N. Sopena, I. Casas, M. Barbera, L. Mateu,
J. Areal, M. Caraballo
P0574
Lower catheter failure and longer dwell time using
a closed peripheral venous catheter system
(CPVCS) without scheduled replacement: a quasiexperimental study
A. Hornero* (Barcelona, Spain), R. Escofet,
G. Cuervo, E. Shaw, E. Castillo, A. Baque, A. Palau,
R. Solà, A. Fabregas, M. Pujol
P0575
A strategy to reduce central line-associated
bloodstream infections: external inspection of
compliance with standards
S. Cherifi* (Brussels, Belgium), S. Arias,
J. Devriendt, D. De Bels, P. Gottignies, B. Byl
P0576
Catheter-related bacteraemia prevention:
the Spanish experience
M. Palomar* (Lleida, Spain), F. Alvarez Lerma,
Y. Yagra, P. Olaechea
P0577
Individual prognostic impact of the components
of a bundle related to Staphylococcus aureus
bacteraemia clinical management
L.E. Lopez-Cortes* (Seville, Spain), M.D. Del Toro,
J. Gálvez-Acebal, E. Bereciartua-Bastarrica,
M.C. Fariñas, M. Saenz-Franco, C. Natera, J.E. Corzo,
A. Pascual, J. Rodríguez-Baño
POSTER SESSION II:
Targeting zero S. aureus and CVC-BSI
P0568
Effect of contact precaution and cefazolinbased antimicrobial prophylaxis stewardship for
preventing methicillin-resistant Staphylococcus
aureus (MRSA) surgical site infections (SSI) in
clean orthopaedic surgeries
H. Kawamura* (Kagoshima, Japan), A. Shigemi,
K. Matsumoto, T. Koriyama, M. Orita, S. Nagano,
K. Setsuro, K. Tokuda, J. Nishi
P0569
Decolonisation of Staphylococcus aureus carriers
in arthroplasty surgery. Results of intervention
study in Príncipe de Asturias Hospital
J. Barbero* (Alcala de Henares, Spain), E. Montero,
R. Agudo, M. García, A. Rebollar, A. Culebras,
L. Pérez, L. Gete, J. López
P0570
Strict infection control (IC) leads to low incidence
of methicillin-resistant Staphylococcus aureus
(MRSA) bloodstream infections over 20 years
B. Lakatos* (Budapest, Hungary), R. Frei,
A. Widmer, U.H.B.S. Infection Control Team
P0571
Methicillin-sensitive Staphylococcus aureus
(MSSA) bacteraemia in haemodialysis patients –
using root cause analysis to define interventions
I. Gupta* (Birmingham, United Kingdom),
M. Holland, S. Powers, V. Suresh
162
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Sunday, 11 May 2014
P0586
POSTER SESSION II:
Automation of diagnostics
Multicenter Evaluation of the Rolling-bead
Automated Inoculation Technology (bd Kiestra
Inoqula Bt™) for Isolation of Bacterial Cultures
A. Brivio, F. Arena, G. Babini* (Mascalucia, Italy),
E. Cesari, L. Ferrari, G. Giuliani, G.M. Rossolini,
B.D. Participants to the Italian BD Kiestra Workshop
Tour
P0580
Initial evaluation of an image analysis device for
the screening of cultures from clinical specimens
J. Glasson* (Adelaide, Australia), R. Hill,
M. Summerford
P0581
Combination of urine flow-cytometry (UF) and
matrix-assisted laser desorption/ionizationtime of flight mass-spectrometry (MALDI-TOF
MS) directly from urine specimens allows rapid
identification of bacterial pathogens
A. Egli* (Basel, Switzerland), G. Müller,
D. Goldenberger, A. Regeniter, R. Frei, G. Bonkat
P0582
Comparative evaluation of inoculation of urine
samples with WASP and InoqulA™ utilising a 10
microlitre inoculum for each instrument
J. Iversen, G. Stendal, C.M. Gerdes, C.H. Meyer,
C.O. Andersen, N. Frimodt-Moller* (Hvidovre,
Denmark)
P0583
Evaluation and optimisation of the Sysmex
UF1000i system for the screening of urinary tract
infection in primary healthcare elderly patients
G. Martín Gutiérrez* (Seville, Spain),
A. Porras González, C. Martín-Pérez,
J.A. Lepe Jiménez, J. Aznar Martín
P0584
Automated quantitative screening for
antibiotic-resistant bacteria
S. Edberg* (Sarasota, FL, United States)
P0585
IgG avidity test for diagnosis of toxoplasmosis:
performance of a new fully automated system
(Liaison® XL)
V. Meroni* (Pavia, Italy), P. Lanzarini, A. Vola,
M. Chiaretto, F. Genco
12:30 – 13:30
Poster Area
POSTER SESSION II:
Molecular diagnostic methods in bacteriology –
miscellaneous
P0587
Contribution of molecular methods to diagnostics
of native joint infections
T. Freiberger* (Brno, Czech Republic), B. Malisova,
E. Nemcova, M. Cernochova, J. Novak, M. Filipovic,
J. Jurankova
P0588
Utility of the FilmArray® blood culture
identification (BCID) panel for molecular
diagnosis of infectious diseases from samples
other than blood cultures
M. Micó García* (Barcelona, Spain), F. Navarro,
Y. González, A. Brell, C. López, D. De Miniac,
F. Sánchez, B. Mirelis, P. Coll
P0589
Spectrum of pathogens in surgically treated
infective endocarditis patients with focus on
fastidious and non-cultivable bacteria
M. Cernochova* (Brno, Czech Republic),
E. Nemcova, M. Vanerkova, H. Suranska, J. Pol,
P. Nemec, T. Freiberger
P0590
Underestimation of the number of different
bacterial species in pleural infections’ cultures
M. Kemp* (Odense, Denmark), K.H. Jensen,
C.N. Meyer, T.R. Thomsen, O. Kommedal, R. Dargis,
J.J. Christensen
P0591
Intrapartum GBS screening in a delivery room
with an on demand PCR: a feasibility study
E. Van Elzakker* (The Hague, The Netherlands),
S. Thijssen, S. Schoondermark-Stolk, C. Visser,
A. Sprij, P. Ottervanger
P0592
Group B streptococcal infections among adults in
Iceland: 1978-2012 surveillance
E.S. Björnsdóttir* (Reykjavik, Iceland),
E.R. Ferreira Martins, H. Erlendsdóttir,
G. Haraldsson, J. Melo-Cristino, M. Ramirez,
K.G. Kristinsson
P0593
Comparison between phenotypic and
genotypic methods for the identification of the
Streptococcus anginosus group
R. Arinto-Garcia* (Lisbon, Portugal), M.D. Pinho,
M. Ramirez, J. Melo-Cristino
24th ECCMID / Barcelona
Final Programme
163
Posters
P0579
Validation of optimal sample volume/loop/
streaking/pattern and flexibility to customise
solutions for Walk-Away Specimen Processor
(WASP) users
R. Botrugno* (Brescia, Italy), G. Catalano, L. Conter,
P. Valzelli, S. Castriciano
Chairs, Speakers & Authors
P0578
Mining clinically relevant signatures from colony
morphology images
A.M. Sousa* (Braga, Portugal), M.O. Pereira,
A. Lourenço
Exhibition
Poster Area
General Information
12:30 – 13:30
Poster Sessions
Sunday, 11 May 2014
P0594
Development of a real-time LAMP assay for the
detection of group B Streptococcus in pregnant
women
L. O’Connor* (Galway, Ireland), C. Mullin, E. Keady,
S. Lahiff, B. Glynn, T.J. Smith
P0595
The epidemiology of group B Streptococcus
bloodstream infection: a multi-national
population-based assessment of its incidence in
neonates and adults
M. Ballard* (Calgary, Canada), H. Schønheyder,
J. Knudsen, O. Lyytikäinen, M. Dryden, K. Karina,
L. Valiquette, M. Pinholt, K. Laupland
P0596
P0597
P0598
Comparison between culture and a helicasedependent amplification method for the detection
of group B Streptococcus
T. Marti* (Marshfield, United States), K. Flavin,
B. Olson, T. Novicki, T. Uphoff
Detection of vancomycin-resistant enterococci
(VRE) by loop-mediated isothermal amplification
(LAMP): a rapid, simple and cost-effective
alternative to PCR
P. Jayaratne* (Hamilton, Canada), L. Monkman
Improving the routine identification of Aeromonas
species by a novel multiplex PCR
K.E.P. Olsen* (Copenhagen, Denmark), S. Persson,
J.N. Jensen
P0599
DNA-based assay for detailed pathogen
characterisation
I. Barisic* (Vienna, Austria), J. Petzka,
S. Schoenthaler, H. Wiesinger-Mayr
P0600
Evaluation of the RIDA®GENE Bordetella realtime PCR assay for the laboratory diagnosis of
Bordetella infections
L. Kastl* (Darmstadt, Germany), A. Simons,
A. Veldenzer, U. Eigner, M. Holfelder
P0601
P0602
164
Are PCR and single IgG measurement in
convalescent serum complementary for the
diagnosis of an acute B. pertussis infection?
K. Loens* (Antwerp, Belgium), K. Huygen,
T. Verheij, J. Teepe, C. Lammens, H. Goossens,
M. Ieven
Identification by 16S rRNA gene sequencing
defines new species and clarifies pathogenicity
of Haemophilus spp. recovered from the
genitourinary tract of adult males
J. Clarridge* (Seattle, United States)
24th ECCMID / Barcelona
Final Programme
P0603
Clinical spectrum and molecular characteristics
of Klebsiella pneumoniae causing invasive
infections
M. Basma* (Sfax, Tunisia), A. Hammami
P0604
Detection and distribution of virulence genes in
clinical isolates of Aeromonas spp.
M. Marzouk, H. Bargui, A. Ferjani, N. Hannachi,
M. Haj ali, J. Boukadida* (Sousse, Tunisia)
P0605
Development of multiplex real-time PCR assay
for detection of Acinetobacter baumannii,
Pseudomonas aeruginosa, Klebsiella
pneumoniae and Escherichia coli
J.A. Savochkina* (Moscow, Russia),
I.A. Alexandrova, A.E. Guschin, G.A. Shipulin
P0606
Long-term storage of clinical samples in CyMol®
medium for fluorescence in situ hybridisation
(FISH) and culturing from the ESwab™ system
L. Larsen, Y. Xu, M. Pedersen, H. Schønheyder*
(Aalborg, Denmark), T. Thomsen
P0607
Detection of Streptococcus tigurinus in the
human oral microbial flora by a specific 16S
rRNA gene real-time PCR
A. Zbinden* (Zurich, Switzerland), F. Aras,
G.V. Bloemberg, P. Schmidlin, N. Bostanci
P0608
Prevalence of Streptococcus gallolyticus in
tumours and matched normal mucosa in an
unselected cohort of CRC patients
A. Galiana* (Elche, Spain), M. Andrés,
V. Sánchez-Hellín, P. López-García, M. Ruiz-García,
M.I. Castillejo, A. Castillejo, V.M. Barberá, J.L. Soto,
G. Royo
P0609
Identification of Nocardia species by RFLP with
sodA gene
K. Sánchez-Herrera, H. Sandoval Trujillo,
A. Couble, D. Mouniée, N. Ramírez-Durán,
M. Uzcategui de Morillo, J.A. Serrano, E. Bergeron,
P. Boiron, V. Rodriguez Nava* (Lyon, France)
P0610
Molecular identification and susceptibilities of
Nocardia clinical strains
F. Kontos, A. Argiropoulou, G.S. Christodoulatos,
E. Trikka-Graphakos, V. Liakou, V. Baca, S. Lyroni,
K. Tsiveriotis, K. Paraskevi, L. Zerva* (Athens,
Greece)
P0611
The mystery of a presumably saprophytic strain
of Leptospira sp. Bairam-Ali
M.S. Kunda* (Moscow, Russia, O.L. Voronina,
E.I. Aksenova, A.N. Semenov, E.M. Petrov, V.G. Lunin,
Y.U.V. Ananyina, A.L. Gintsburg)
Poster Sessions
Sunday, 11 May 2014
P0614
Molecular approaches to the diagnosis of ocular
infectious diseases
K. Ohkusu* (Gifu, Japan), K. Mochizuki, T. Ezaki
P0615
A rapid and innovative molecular detection
platform for the identification of pathogens in
severe infections
J. Gutierrez* (Carlsbad, United States), J. Fillman,
S. Thorson, G. Liaw, R. Warren, J. Drader, J. McCoy
P0616
Importance of in silico control of primers and
probes in clinical molecular diagnosis
A. Wicky* (Lausanne, Switzerland), R. Brouillet,
R. Sahli, P. Meylan, P.M. Hauser, A. Telenti, G. Greub,
K. Jaton
P0617
Review of 16S and its direct sequencing results
for clinical specimens submitted to a reference
laboratory
M. Payne* (Vancouver, Canada), L. Hoang
P0618
An approach towards a standardised
microbiological sampling protocol in forensic
pathology
A. Fernández-Rodríguez* (Madrid, Spain),
V. Saegeman, J. Lucena, W. Van De Voorde,
A. Angelini, N. Ziyade, N. Elgörmüs, G. Yagmur,
P.M. Garamendi, M.C. Cohen
POSTER SESSION II:
Point-of-care tests
P0620
Evaluating the accuracy of a point-of-care
immunoassay to identify viral and/or bacterial
immune response in patients with acute febrile
respiratory infection
R. Sambursky* (Sarasota, FL, United States),
N. Shapiro, M. Machin, W. Hooker, T. Phillips,
P. Condon
P0621
Evaluation of the SD Bioline test for the detection
of Legionella serogroup 1 antigen in urine
samples
E. Heylen, E. De Witte, K. Loens, C. Lammens,
J. Almirall, H. Goossens, G. Ieven* (Antwerp,
Belgium)
P0622
Evaluation of the Sofia Legionella FIA in
comparison with the BinaxNOW® Legionella
Urinary Antigen Card in two national reference
centres
A. Freydiere* (Bron, France), K. Gervasoni,
G. Descours, V. Gaia, G. Lina, F. Vandenesch,
S. Jarraud
P0623
Repositioning of rapid antigen detection tests
(RADT) for the diagnosis of invasive group A
streptococcal infections
V. Gazzano* (Bron, France), A. Berger, Y. Benito,
A.M. Freydière, A. Tristan, S. Boisset, A. Carricajo,
C. Poyart, F. Vandenesch, G. Descours
P0624
Detection of Streptococcus pneumoniae
in patients with bacteraemia using a new
pneumococcal urinary antigen test (Uni-Gold™
S. pneumoniae) and other pneumococcal rapid
tests
H.B. Eriksen, M. Schei Haugan, S. Otte,
N. Frimodt-Møller, J. Dahl Knudsen* (Hvidovre,
Denmark)
P0625
Fast measurement of staphylococcal cell wall
proteins and exotoxins from culture material
using antibody microarrays and fluorescence
staining
R. Ehricht, E. Müller, B. Stieber, V. Baier,
D. Weicherding, J. Buechler, S. Monecke* (Dresden,
Germany)
P0626
The Unyvero™ implant and tissue infection
cartridge – a rapid test to detect challenging
pathogens
H. Motejadded* (Holzgerlingen, Germany), S. Barth,
M. Klein, K. Schwarzer, G.H. Luedke
24th ECCMID / Barcelona
Final Programme
Posters
Massive diversification and mutants’ emergence
in E. coli colonies living in an open environment
C. Saint-Ruf* (Paris, France), P. Francino, G. D’Auria,
I. Matic
Poster Area
165
Chairs, Speakers & Authors
P0613
12:30 – 13:30
Exhibition
Molecular investigation of an hospital outbreak
caused by multidrug-resistant Klebsiella
pneumoniae
A. Colombo* (Varese, Italy), R. Onori, G. Cassani,
P. Grossi, A. Tebini, G. Minoja, D. Sassera, C. Bandi,
T. Giani, A. Toniolo
General Information
P0612
Poster Sessions
Sunday, 11 May 2014
P0635
Gnathostomiasis: a 10-year experience at King
Chulalongkorn Memorial Hospital, Thailand
O. Dhissayakamol* (Bangkok, Thailand),
P. Siriyasatien, C. Suankratay
The role of recombinant antigens in the
serodiagnosis of human cystic echinococcosis
A. Hernández-González, M. Mariconti,
V. Meroni, L. Piccoli, E. Brunetti, J.M. Delgado,
J. Rojas González, M. Stojkovic, T. Junghanss,
M. Siles-Lucas* (Salamanca, Spain)
P0636
Investigation of Toxocara canis IgG seropositivity
and risk factors in patients with chronic urticaria
B. Selek, O. Baylan* (Istanbul, Turkey), A. Kutlu,
N. Ozaydin, M. Ozyurt
The Italian registry of cystic echinococcosis
F. Tamarozzi, P. Rossi, F. Galati, M. Mariconti,
F. Rinaldi* (Pavia, Italy), G.J. Nicoletti, E. Pozio,
E. Brunetti
P0637
Seroprevalence of Echinococcus granulosus
infection in Croatian patients with cystic liver
disease
M. Sviben, S. Ljubin-Sternak, T. Vilibic-Cavlek,
T. Mestrovic* (Samobor, Croatia),
G. Mlinaric-Galinovic
P0638
Giant pulmonary hydatid cysts in a child
E. Tasci, S. Dogan Kaya, S. Menekse Yilmaz*
(Istanbul, Turkey)
P0639
Multiple lung hydatidosis with pulmonary artery
localisations
S. Menekse Yilmaz* (Istanbul, Turkey), S. Deniz,
S. Sahin, S. Dogan Kaya, E. Tasci
12:30 – 13:30
Poster Area
POSTER SESSION II:
Helminths
P0627
P0628
P0629
P0630
Has dracunculiasis been completely eradicated
in Australia? A recent surgical experience with the
waterborne disease in Melbourne
M. Pereira E Cotta* (Fitzroy, Australia), H. Sheorey,
W. Morrison, J. Darby
Seroprevalence and geographical distribution
of chronic strongyloidiasis in an immigrant
population in Spain
A. Morilla, J.A. Boga, P. Martinez, M. Rodriguez,
J. Fernandez, S. Rojo, F. Vazquez,
A. Rodriguez-Guardado* (Oviedo, Spain)
P0631
Strongyloidiasis and viral co-infection in
immigrants in a Portuguese hospital
R. Tavares* (Ereira, Portugal), J. Torres,
P. Rodrigues, H. Oliveira, L. Glória, V. Rodrigues,
I. Galvão, A. Messias, M. Cravo
P0640
Improved serodiagnosis of human fascioliasis
using recombinant saposin-like protein 2 from
Fasciola hepatica
B. Gottstein* (Berne, Switzerland), G. Boubaker,
B. Merkle, M. Spiliotis, N. Müller, M. Doherr
P0632
Retinitis and eosinophilic meningitis due to
Angiostrogylus cantonensis treated with pan
retinal photocoagulation and steroid
E. Thiansukhon* (Udon Thani, Thailand),
R. Pongsamart, N. Smitasin
P0641
Detection of IL-4 after specific whole blood
stimulation to diagnose and monitor cystic
echinococcosis disease
L. Petrone, V. Vanini, E. Petruccioli, G.M. Ettorre,
E. Busi-Rizzi, V. Schininà, M.A. Gomez Morales,
E. Pozio, A. Teggi, D. Goletti* (Rome, Italy)
P0633
Ocular larva migrans – an underestimated
disease
P. Mihailescu* (Bucharest, Romania), L. Voinea,
I. Ceaus, C. Istrate, C.-M. Cretu
P0642
P0634
Dirofilaria repens in humans – an emerging
anthropozoonosis in a Central European country
(Romania): case-series
A. Rascanu* (Bucharest, Romania), C. Chiotan,
R.M. Hrisca, V. Gheorghita, C. Constantin,
B. Bacescu, R. Moroti
In vitro and in vivo investigations to develop
functional imaging by positron emission
tomography (PET) for murine and human alveolar
echinococcosis
B. Gottstein* (Berne, Switzerland), J. Wang,
C. Porot, J. Knapp, O. Blagosklonov, D. Vuitton,
S. Germain, Y. Seimbille, D. Camporese, C. Bordier
166
24th ECCMID / Barcelona
Final Programme
Poster Sessions
P0651
Giardia intestinalis and faecal microbiota of
patients from Ivory Coast
V. Totino* (Rome, Italy), V. Iebba, F. Santangelo,
D. Di Cave, F. Berrilli, R. D’Alfonso, S. Schippa
P0652
Giardia lamblia triggers NF-kappaB cleavage
and suppresses LPS-induced pro-inflammatory
response in macrophages
C.P. Faria, A. Silva, J.D. Martins, M.T. Cruz, S. Pereira,
G.M. Zanini, M. Sousa* (Coimbra, Portugal)
P0653
Intestinal parasites and anaemia in Piaroa
Amerindians of the Venezuelan Amazonia
C. Rivas Nuñez* (Caracas, Venezuela),
C. Navarro Ocando, D. Santander, G. Navas,
G. Coronado, A. Rodriguez, G. Gottberg, Z. Cordero,
M. Uribe, L. Pocaterra
P0654
Genetic characterisation of cryptosporidia in
patients with haematological malignancies and
human immunodeficiency virus infection
P. Ranjan* (Lucknow, India), U. Ghoshal, A. Dey,
V. Agarwal, S. Nityanand, U.C. Ghoshal
P0655
Five-year review – intestinal parasite detection
in patients treated at the University Hospital for
Infectious Diseases, Zagreb, Croatia from 2008
to 2012
S. Bukovski* (Zagreb, Croatia), J. Lozic, D. Lukas,
J. Granic
Detection and genetic characterisation of
Cryptosporidium in renal transplant recipients by
real-time PCR and melting curve analysis
A. Dey* (Lucknow, India), U. Ghoshal, P. Ranjan,
U.C. Ghoshal, R.K. Sharma
P0656
Bacterial and protozoal intestinal associations of
patients with Blastocystis invasion
A. Sigidaev* (St. Petersburg, Russia), E. Tarasova,
M. Suvorova, V. Turitsin, S. Kozlov, K. Zhdanov,
S. Zakharenko
To compare the efficacy of percutaneous needle
aspiration with percutaneous catheter drainage
in the treatment of amoebiac liver abscess
K. Singh* (New Delhi, India), A. Gogia, A. Gupta,
S.P. Byotra
P0657
High prevalence of Blastocystis in irritable bowel
syndrome patients is associated with changes in
gut microbiota composition; a case-control study
C. Nourrisson, J. Scanzi, C. Nkoud Mongo,
I. Wawrzyniak, B. Pereira, E. Viscogliosi,
F. Delbac, V. Livrelli, M. Dapoigny, P. Poirier*
(Clermont Ferrand, France)
P0658
Intestinal parasites and anaemia in Jivi
Amerindians of the Venezuelan Amazonia
C. Navarro, C. Rivas Nuñez* (Caracas, Venezuela),
G. Gottberg, A. Coronado, G. Navas, A. Rodriguez,
Z. Cordero, M. Uribe, D. Santander, L. Pocaterra
POSTER SESSION II:
Intestinal parasites
P0643
P0644
P0645
P0646
P0647
P0648
P0649
Two years of seasonal increase of
Cryptosporidium in the The Netherlands but
different subtypes: the importance of molecular
typing
J.H. Roelfsema* (Bilthoven, The Netherlands),
H. Sprong, B. Schimmer, J.A. Sane, S.M. Cacciò,
W. Van Pelt, J.W.B. Van der Giessen, L.M. Kortbeek
Peridomestic rodents from Cape Verde as
reservoirs of zoonotic genotypes of Giardia
duodenalis
A. Fernandez Alvarez* (San Cristóbal De La Laguna,
Spain), I. Guillama, M. Barbosa,
H. Spencer da Costa Lima, M. Djata, C. Feliu,
B. Valladares, P. Foronda
Enteric parasites in high-prevalence settings –
a challenge for the diagnostic routine?
H. Frickmann, N.G. Schwarz, J.N. Heriniaina,
N. Randriamampionona, T. Razafindrabe,
J.P. Rakotondrainiarivelo, R. Rakotozandrindrainy,
J. May, R.M. Hagen* (Hamburg, Germany)
A survey of intestinal parasites and commensals,
and associated risk factors in humans, animals,
water, and soil in Panama
N.R. Sandoval, N. Rios, A. Mena, R. Fernández,
M. Perea, R. Manzano-Román,
J. Ruiz Santa-Quiteria, A. Hernández-Gonzalez,
M. Siles-Lucas* (Salamanca, Spain)
24th ECCMID / Barcelona
Final Programme
167
Chairs, Speakers & Authors
Public health significance of Giardia duodenalis
in livestock in the Ismailia Canal zone of Egypt:
epidemiology and molecular analysis
Y.A. Helmy* (Berlin, Germany), C. Klotz, J. Krücken,
K. Nöckler, G. Von Samson-Himmelstjerna,
K.-H. Zessin, T. Aebischer
First report of Crypstosporidium in rodents from
Santiago (Cape Verde) and the possible role in
the transmission of zoonotic genotypes
A. Fernandez Alvarez* (San Cristóbal De La Laguna,
Spain), I. Guillama, M. Barbosa,
H. Spencer da Costa Lima, M. Djata, C. Feliu,
B. Valladares, P. Foronda
Exhibition
P0650
General Information
Poster Area
12:30 – 13:30
Posters
Sunday, 11 May 2014
Poster Sessions
Sunday, 11 May 2014
P0659
History of antimicrobial use and the risk of
Dientamoeba fragilis carriage
D. Röser* (Copenhagen, Denmark), J. Simonsen,
H.V. Nielsen, C.R. Stensvold, K. Mølbak
P0660
The role of colonic antimicrobial peptides in
human Blastocystis infections
J.A. Yason* (Singapore, Singapore), K.S.W. Tan
P0661
Amoebic liver abscess: a 10-year experience at
King Chulalongkorn Memorial Hospital, Thailand
P. Mahaparn* (Bangkok, Thailand), P. Siriyasatien,
C. Suankratay
P0662
Isolation and molecular identification of free
living amoeba from diverse environmental
resources of Pakistan
A. Matin* (Haripur, Pakistan), T. Tanveer,
A. Hameed, A. Akbar, A. Gul
P0663
Protozoan-associated diarrhoeal infections in
Portuguese patients
M. Oleastro* (Lisbon, Portugal), A. Santos, I. Costa,
S. Ferreira, A. Rodrigues, C. Júlio
P0664
T. vaginalis in dry vaginal swabs: TMB TV assay
run in the open channel of the Roche Z480
versus the GMT Presto plus assay in the Roche
LightCycler® 480 II
S.A. Morré* (Amsterdam, The Netherlands),
D.J. De Waaij, J.H. Dubbink, H. Struthers,
J.A. McIntyre, S. Ouburg, R.P.H. Peters
12:30 – 13:30
Poster Area
P0667
Immunosuppression as a risk factor for the
development of visceral leishmaniasis: a
changing cohort at the Hospital for Tropical
Diseases, London
K. Fletcher, R. Issa* (London, United Kingdom),
D. Lockwood
P0668
Leishmaniasis in Turkey : cases of visceral
leishmaniasis caused by Leishmania tropica
M.E. Limoncu* (Manisa, Turkey), A. Ozbilgin
P0669
MALDI-TOF mass spectrometry for the research
of specific biomarkers of Leishmania infection
by analysing strains isolated from biological
samples
A. Calderaro* (Parma, Italy), M. Piergianni,
C. Gorrini, G. Piccolo, M. Buttrini, S. Montecchini,
M.C. Medici, M.C. Arcangeletti, C. Chezzi, F. De Conto
P0670
Congenital visceral leishmaniasis: a case report
M. Gonzalez Sanz* (London, United Kingdom),
S. Gomes, A. Kumar Dsa, K. Ritmeijer
P0671
Demonstration of Leishmania spp. by nested PCR
in stray cats of Izmir located in western Turkey
H. Can* (Izmir, Turkey), M. Doskaya, G. Ozdemir,
A. Caner, E. Atalay, B. Pektas, S. Gulce Iz,
A. Degirmenci Doskaya, C. Un, Y. Guruz
P0672
Leishmaniasis in Turkey: emerging Leishmania
major infections in Anatolia
A. Ozbilgin* (Istanbul, Turkey), G. Culha, S. Uzun,
M. Harman, S. Gunasti Topal, F. Okudan, C. Gunduz,
F. Bastien, F. Pratlong, O. Kurt
P0673
Determination of the species of the sand
flies – the vector of cutaneous leishmaniasis
that is endemic in Mersin
M.E. Limoncu* (Manisa, Turkey), I.C. Balcioglu,
Y. Ozbel, S. Ozensoy Toz, S. Demir, H. Kavur, O. Ermis
P0674
Leishmanicidal activity of novel biurets against
L. tropica promastigotes: in silico and in vitro
comparative study
S. Khademvatan* (Ahvaz, Iran), A. Eskandari,
N. Adibpour, F. Rahim
P0675
Activity of antiretroviral drugs on Leishmania
infantum: synergistic effects with essential oils
S. Costa* (Coimbra, Portugal), R. Varandas,
M. Machado, C. Cavadas, L. Salgueiro, C. Cavaleiro,
M. Sousa
POSTER SESSION II:
Leishmania and Trypanosoma
P0665
P0666
168
The evolution of the Leishmania donovani
complex illustrated from an integrative and
genomic perspective assessed with 845 strains
O. Stark* (Berlin, Germany), B. Moser, H. Imamura,
J. Cotton, T. Downing, T. Wirth, G. Schönian
Toll-like receptor 9 polymorphism in Cretan
patients with Leishmania infantum infection
I. Messaritakis, G. Samonis, M. Antoniou,
A. Andrianaki, J. Papadakis, M. Zacharioudaki,
E. Pediaditis, M. Plataki, E. Galanakis, D. Kofteridis*
(Heraklion, Greece)
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Sunday, 11 May 2014
P0678
P0679
P0680
P0681
P0682
P0683
P0684
Early detection of L. siamensis DNA in saliva of
HIV-infected patients
A. Phumee* (Bangkok, Thailand), U. Thavara,
A. Tawatsin, S. Chusri, T. Hortiwakul, K. Silpapojakul,
P. Siriyasatien
12:30 – 13:30
Poster Area
POSTER SESSION II:
Toxoplasmosis
P0686
Changing epidemiology of toxoplasmosis in
pregnant women from the highland region of
Scotland
R. Evans* (Inverness, United Kingdom),
J. Chatterton, R. Milner, E. Watson
P0687
Acute primary toxoplasmosis in travellers
returning from Gabon
N. Katanic* (Belgrade, Serbia), L. Lavadinovic,
M. Pavlovic, K. Bojovic, I. Milosevic, J. Aritonovic
Pribakovic, E. Gvozdenovic, O. Dulovic, A. Odalovic,
Z. Dakic
P0688
Risk factors for Toxoplasma gondii infection in
women of childbearing age in the territory of
northern Kosovska Mitrovica
J. Aritonovic Pribakovic* (Kosovska Mitrovica, Serbia),
N. Katanic, R. Katanic, A. Ilic, V. Minic, A. Mladenovic
P0689
Detection of antibodies to Trypanosoma cruzi
(T. cruzi) in human serum/plasma with a new
fully automated assay, Liaison® XL Murex Chagas
M. De Luca, M. Calleri, D. Santelia* (Saluggia, Italy),
L. Pallavicini
A 5-year study of Toxoplasma gondii infection
in adults, children and pregnant women in northwestern Greece
E. Nita, C. Boboyianni, C. Gartzonika, P. Karagianni,
M. Papassava, S. Giannopoulos, S. Levidiotou*
(Ioannina, Greece)
P0690
Screening for Trypanosoma cruzi antibodies by
using three immunological assays in migrants to
Italy coming from endemic areas
R. Grande* (Milan, Italy), D. Mileto, L. Galimberti,
S. Antinori, S. Garelli, M.R. Gismondo, M. Galli
Comparison of serological and molecular
diagnosis of cerebral toxoplasmosis in blood and
cerebrospinal fluid in HIV-infected patients
H. Berredjem* (Annaba, Algeria), M. BenLaifa,
I. Becheker, R. Bardi, K. Ayed
P0691
Preliminary analysis of monosaccharides in
virulent T. gondii Ankara and Ege-1 strains by CAP
LC-ESI-MS/MS
U. Sahar* (Izmir, Turkey), M. Doskaya, A. Caner, H. Can,
E. Atalay, A. Degirmenci Doskaya, R. Deveci, Y. Guruz
Evaluation of the new BIO-FLASH® Chagas assay
on Biokit’s BIO-FLASH® analyser
L. Taberner* (Lliçà d’Amunt, Spain), N. López,
B. Canela, M. López, C. Hervás, L. Heredia
Evaluation in Brazil of the new BIO-FLASH®
Chagas assay on Biokit’s BIO-FLASH® analyser
S. Faraudo* (Lliçà d’Amunt, Spain), N. Lopez,
B. Canela, A. Guimaraes, A. Saez-Alquezar
Sensitivity and specificity of Liaison® XL Murex
Chagas assay for diagnosis of the Trypanosoma
cruzi infection in non-endemic area (Spain)
M. Flores-Chavez* (Madrid, Spain),
I. Vasquez-Dominguez, M. Hernandez, T. Garate,
J. Nieto
Effects of Lavandula luisieri and Cymbopogon
citratus on Trypanosoma brucei brucei:
antiproliferative activity through cell cycle arrest
at the G0/G1 phase
S. Costa* (Coimbra, Portugal), C. Cavadas,
C. Cavaleiro, L. Salgueiro, M.C. Sousa
24th ECCMID / Barcelona
Final Programme
169
Posters
First report of autochthonous leishmaniasis
caused by Leishmania siamensis in Myanmar:
case series
N. Noppakun, A. Phumee, U. Thavara, A. Tawatsin,
P. Siriyasatien* (Bangkok, Thailand)
Discovery of new therapeutics to combat
Trypanosoma cruzi infection and prevent Chagas
disease
L.M. Podust* (San Francisco, United States),
D.F. Vieira, J.Y. Choi, C.M. Calvet, D. Kellar,
J.L. Siqueira-Neto, J. Gut, J.H. McKerrow, W.R. Roush
Chairs, Speakers & Authors
P0677
P0685
Exhibition
Galactofuranose synthesis: an innovative
therapeutic target present in several species and
stages of Leishmania
S. Belaz* (Rennes, France), J.P. Gangneux, P. Lafite,
R. Daniellou, F. Robert-Gangneux
General Information
P0676
Poster Sessions
Sunday, 11 May 2014
Poster Area
P0700
Assessment of travel health services; situation in
Turkey between the years 2011-2013
G. Okay* (Istanbul, Turkey), T. Ozcan, S. Güler,
H. Hatipoglu
Stable populations of sandflies (Phlebotominae)
in eastern Austria: a comparison of the trapping
seasons 2012/2013
W. Poeppl, A.G. Obwaller, T.J. Naucke, G. Mooseder,
H. Aspöck, J. Walochnik, H. Burgmann* (Vienna,
Austria)
P0701
Neuropathic pain in old leprosy patients
J.M. Ramos* (Alicante, Spain),
B. Alonso Castañeda, D. Eshetu, D. Lemma,
F. Reyes, R. Belinchón, M. Gorgolas
P0702
Brucellosis complications; 15 years’ experience
H. Gul, C. Artuk, A. Karakas, G. Mert, O. Coskun*
(Ankara, Turkey), C. Eyigün
P0703
Clinical and epidemiological findings of tetanus in
Georgia
T. Tkhilaishvili, M. Javakhadze* (Tbilisi, Georgia),
D. Kikabidze
12:30 – 13:30
POSTER SESSION II:
Travel, tropical and parasitic diseases
P0692
P0693
P0694
Birds as vectors of various human pathogenic
parasites
S. Petersdorf* (Düsseldorf, Germany), F. Gestmann,
C. MacKenzie, K. Pfeffer, H. Mehlhorn
Transfusion transmissable infections in
South Sudan: cross-sectional study of human
immunodeficiency virus (HIV), hepatitis B and C
and syphilis prevalence among potential blood
donors at Juba teaching hospital
R. Wake* (London, United Kingdom), S. Williams,
K. De Polnay, P. Gillet
P0695
Clostridium difficile-associated diarrhoea in
travellers: experience from a tropical medical unit
in Spain
A. Sarria* (Madrid, Spain), P. Trevisi, A. Arroyo,
A. Enriquez, S. Puente, G. Ramirez, C. Toro
P0696
Knowledge, attitudes and practices of Romanian
international travellers
I. Niculescu* (Bucharest, Romania), A. Hristea,
R. Jipa, R. Petre, R. Moroti, C. Popescu, V. Arama,
A. Streinu-Cercel
P0697
P0698
P0699
170
Antibiotic susceptibility of diarrhoeagenic
Escherichia coli strains in patients with traveller’s
diarrhoea
N. Iglesias Nunez* (Madrid, Spain),
A. Arroyo Fajardo, P. Trevisi, B. López Quintana,
A. Sarría Visa, C. Ladrón de Guevara, C. Toro Rueda
Primary amoebic meningoencephalitis vs acute
bacterial meningitis: a comparison of clinical
presentations
S.F. Mahmood* (Karachi, Pakistan), M.F. Zahid,
M.H.S. Shaukat, B. Ahmed
Cutaneous anthrax in southeast Anatolia, Turkey
R. Tekin* (Diyarbakir, Turkey), B. Sula, O. Deveci,
A. Tekin, F. Bozkurt, S. Kaya, M. Bekcibasi, S. Hosoglu
24th ECCMID / Barcelona
Final Programme
12:30 – 13:30
Poster Area
POSTER SESSION II:
Molecular diagnostics of parasites
P0704
Evaluation of a novel RIDA®GENE Entamoeba
histolytica PCR for the detection of Entamoeba
histolytica in stool specimen and liver abscess
material
L. Kastl* (Darmstadt, Germany), H. Von Thien,
E. Tannich
P0705
Detection and epidemiology of Dientamoeba
fragilis – data from the Cologne metropolitan area
2012/2013
T. Hoppe, M. Steinmetz, U. Aurbach, C. Döffinger,
U. Schallenberg, H. Wisplinghoff* (Cologne, Germany)
P0706
Clinical performance of the BD MAX™ enteric
parasite panel for detection of Cryptosporidium,
Giardia lamblia, and Entamoeba histolytica DNA
from unpreserved and fixed stool specimens*
S.L. Knapp* (Durham, NC, United States), K.L. Lenz,
M.D. Adams, R.J. Swan, J.J. Marley
P0707
Contribution of multiplex real-time PCR for
detection and differentiation of Enterocytozoon
bieneusi and Encephalitozoon intestinalis in
faecal samples of immunocompromised patients
S.M. Alzagawy* (Ismailia, Egypt),
E.E. El-Hamshary, H.Z. Rayan, G.H. Ibrahim
Poster Sessions
Sunday, 11 May 2014
P0710
Evaluation of the enteric parasite panel for the BD
MAX™ system
P. Mölling* (Växjö, Sweden), P. Nilsson, T. Ennefors,
M. Neander, J. Ogren, S. Thulin Hedberg,
M. Sundqvist
P0711
Molecular characterisation of human isolates of
Giardia lamblia from the south-west of the Islamic
Republic of Iran using PCR – RFLP method
K. Manouchehri Naeini* (Shahr-Ekord, Iran),
M. Rezaeian, S.H. Hosseini
P0712
Detection and genotypic characterisation of
Giardia lamblia in a tertiary care centre in north
India
S. Malik* (Lucknow, India), U. Ghoshal, P. Pant,
R. Shukla, U.C. Ghoshal
P0713
Prospective cohort study to demonstrate rapid
clearance of Giardia lamblia DNA from the gut
after successful treatment
W. Van den Bijllaardt* (Tilburg, The Netherlands),
I.T. Overdevest, A.G. Buiting, J.J. Verweij
P0714
P0715
P0716
Evaluation of rapid diagnostic tests for the
detection of Cryptosporidium and Giardia
T. Derks* (Hengelo, The Netherlands),
K. Tasche-Borgreve, D. Vastert-Koop,
M. Biezen v d-Brinkman, B. Mulder
Contribution of Cryptosporidium real-time PCR to
the diagnosis of intestinal cryptosporidiosis
Y. Le Govic* (Lille, France), K. Guyot,
G. Certad, C. Mary, B. Sendid, E. Viscogliosi,
L. Favennec, E. Dei-Cas, E. Fréalle, E. Dutoit,
ANOFEL Cryptosporidium National Network
Advances in molecular detection of Toxoplasma
gondii oocysts for application in environmental
samples
B. Prewein* (Vienna, Austria), R. Kunert,
F. Allerberger, W. Ruppitsch
P0718
18S PCR – detection of parasite DNA in otherwise
sterile human clinical samples using a broadspecificity PCR-based approach
H. Nielsen* (Copenhagen, Denmark), A. Al-Jubury,
C. Stensvold, L. Andersen
13:30 – 14:30
Poster Area
POSTER SESSION III:
Diagnostic microbiology
P0719
Do semi-automated methods improve EQA
performance for identification of bacterial
pathogens?
E. Fagan* (London, United Kingdom), S. Seaton,
C. Walton
P0720
Forensic medicine: what is the contribution of
microbiological laboratory to the establishment
of cause of death? A retrospective study of 155
deaths
M.e. Reverdy, A. Tristan, O. Dauwalder* (Bron,
France), T. Guinet, G. Maujean, L. Fanton, D. Malicier,
F. Vandenesch
P0721
Proficiency of Romanian laboratories to perform
microbial identification and susceptibility
testing: results of participation in the external
quality assessment schemes provided by
CALILAB in 2013
M.C. Chifiriuc* (Bucharest, Romania), G. Sorescu,
R. Popa, E. Borcan, L. Vasile, L. Marutescu, C. Popa
P0722
The balanced scorecard as a management tool in
a microbiology laboratory
A. Anesi* (Lodi, Italy), D. Baroni, S. Asticcioli,
S. Pittalis
P0723
Exposure to hazard group 3 organisms in a
district general hospital: pitfalls and lessons
M. Strickland, F. Awad-El-Kariem* (Stevenage,
United Kingdom)
24th ECCMID / Barcelona
Final Programme
Posters
Evaluation of the automated real-time BD MAX™
enteric parasite panel assay
M.D. Perry* (Cardiff, United Kingdom)
A 4-year retrospective comparison of two
target genes, REP 529 and B1, for Toxoplasma
gondii detection by PCR, or why B1 should be
abandoned
S. Belaz* (Rennes, France), J.P. Gangneux,
C. Guiguen, F. Robert-Gangneux
Chairs, Speakers & Authors
P0709
P0717
Exhibition
Evaluation of a real-time PCR test for the
diagnosis of intestinal infection caused by
Giardia lamblia (duodenalis), Entamoeba
histolytica, Dientamoeba fragilis and
Cryptosporidium spp.
A. Raglio* (Bergamo, Italy), M. Cosentino,
M. Pegoraro, M.L. D’Annibale, A. Bruno, R. Maserati,
R. Grande, G. Mazzei, V. Besutti, C. Farina
171
General Information
P0708
Poster Sessions
Sunday, 11 May 2014
P0724
European-wide external quality assurance
exercises for the diagnoses of high threat
bacteria – QUANDHIP
R. Grunow* (Berlin, Germany), U. Sauer,
A.M. Rohleder, D. Jacob
P0732
Evaluation of two commercial GDH tests in a
diagnostic algorithm for Clostridium difficile
infection
C. Verfaillie, W. Mistiaen, M. Herpol, I. Leroux-Roels,
G. Claeys, J. Boelens* (Ghent, Belgium)
P0725
Real-time PCR diagnosis of bacterial meningitis
using the fast-track diagnostics’-bacterial
meningitis kit
M. Hofmann* (Junglinster, Luxembourg),
U. Greffrath, M. Steimer, W. Carman, J. Sheikh,
M. Antonio
P0733
Colonisation of patients with non-toxigenic
isolates of C. difficile: implications for infection
control
J. Smullen* (Harrogate, United Kingdom),
L. Jenkinson, N. Weightman, K. Kerr
P0734
C. diff Quik Chek Complete® for confirmation of
toxin production by Clostridium difficile isolates
M. Scholing* (Amsterdam, The Netherlands),
L. Thiel, G.B. Linde
P0735
Comparison of two matrix-assisted laser
desorption ionization time-of-flight mass
spectrometry systems, VITEK® MS and Bruker
Biotyper for the identification of Clostridium
difficile
B. Shin* (Seoul, Korea), S. Hong, E.-C. Kim, E. Lee
P0736
Comparison of two two-step algorithms for the
diagnosis of Clostridium difficile infections: novel
DiaSorin Liaison® algorithm compared to Meridian
ImmunoCard® GDH and illumigene® assay
J. Goret* (Bordeaux, France), J. Blanchi, S. Lacome,
A. Petit, F. Barbut, C. Eckert, C. Bébéar, F. Mégraud
P0737
Performance of VITEK®2 ANC system for
Clostridium difficile identification compared with
conventional methods (spore stain, odour) and
multiplex PCR assay
B. Shin* (Seoul, Korea), E. Lee
P0738
Optimised diagnosis of Clostridium difficile
infection; is there still room for improvement?
Results of a European point prevalence study of
C. difficile infection (EUCLID)
H.M. Ashwin* (Leeds, United Kingdom), K.A. Davies,
G.L. Davis, F. Lee, C.M. Longshaw, M.H. Wilcox
P0739
Novel chemiluminescent immunoassays for the
detection of Clostridium difficile infection
A. Makristathis* (Vienna, Austria), S. Riss, A. Hirschl
P0740
Clinical outcome and biological features of
patients with Clostridium difficile infection
according to testing methods
L. Rame, N. Khanafer, C. Eckert, V. Lalande,
F. Barbut* (Paris, France)
13:30 – 14:30
Poster Area
POSTER SESSION III:
Diagnosis of Clostridium difficile and other gastrointestinal
infections
P0726
Gastroenteritis and diarrhoea: a syndromic
approach to laboratory diagnosis of disease
A. Lual* (London, United Kingdom),
J. UK Standards for Microbiology Investigations
P0727
Antigen detection from faeces by separation-free
fluorescence TPX assay technique
J.M. Koskinen, J.M. Koskinen, H. Toivola* (Turku,
Finland), M. Vesala, J. Soukka, J.O. Koskinen
P0728
Evaluation of DiaSorin Liaison® test for diagnosis
of C. difficile infection
T. Lazzarotto* (Bologna, Italy), C. Vocale, F. Bellini,
M.P. Landini
P0729
Implementation of a nationally mandated
microbiological testing protocol for C. difficile
infection underestimates the true burden of
disease
L. Jenkinson* (Harrogate, United Kingdom),
J. Smullen, N. Weightman, K. Kerr
P0730
P0731
172
Evaluation of the impact of freezing on positive
Clostridium difficile stools using VIDAS®GDH,
VIDAS®CDA/B, Liaison® GDH, Liaison® A&B and C.
dif Quik Chek Complete®
J. Van Broeck* (Brussels, Belgium),
E. Ngyuvula Mantu, K. Soumillion, M. Delmée
Evaluation of a new 24-hour culture medium for
the isolation of Clostridium difficile from stool
samples
J. Van Broeck* (Brussels, Belgium),
E. Ngyuvula Mantu, K. Soumillion, M. Delmée
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Sunday, 11 May 2014
P0743
C. difficile diagnosis in a UK teaching hospital:
a tale of two toxin tests
N. Dawood, G.L. Vanstone, E. Yewnetu, D.J.F. Mack*
(London, United Kingdom)
P0744
Prevalence and pathogenicity of binary toxinpositive Clostridium difficile strains that do not
produce toxins A and B
C. Eckert* (Paris, France), L. Cathala,
H. Marchandin, H. Jean Pierre, French network
on C. difficile, F. Barbut
P0745
Earlier detection of Salmonella strains using a
selective chromogenic medium ChromID® ASAP
J.M. Roche* (Craponne, France)
P0746
Evaluation of the shiga toxin Quik Chek
(TECHLAB®) test for the detection of shiga
toxin-producing Escherichia coli (STEC) in human
faecal samples
K. De Rauw* (Brussels, Belgium), D. Piérard
P0747
Rapid-test ImmunoCard STAT!® CGE for detection
of intestinal parasites directly on faecal samples
A.L. Engsbro* (Hvidovre, Denmark), H.B. Eriksen,
A. Friis-Møller
P0748
CASA chromogenic agar: an optimal medium
for the isolation of clinically important
Campylobacter spp. from stool samples
L. Dalziel, M. Payne* (Newcastle-upon-Tyne,
United Kingdom), J. Perry P0749
Comparison of the clinical and microbiological
characteristics of Campylobacter and
Helicobacter bacteraemia: the importance of time
to blood culture positivity
K. Yamamoto* (Tokyo, Japan), K. Hayakawa,
S. Kutsuna, N. Takeshita, Y. Kato, S. Kanagawa,
K. Yamada, K. Mezaki, T. Kirikae, N. Ohmagari
13:30 – 14:30
Poster Area
POSTER SESSION III:
Clostridium difficile: epidemiology and outcomes
P0751
Alternative causes of diarrhoea and clinical
manifestations of Clostridium difficile infection
(CDI) among patients with a positive PCR and a
negative toxin-detecting assay
Y. Golan* (Boston, MA, United States), K. Johnson,
P. Gjini, S. Husain, F. Magro, S. Doron, S. Bollinger,
D. Snydman P0752
Population-based cohort study of Clostridium
difficile infection (CDI) in the United States
E. Dubberke* (St. Louis, MO, United States),
D. Stwalley, C. Mahe, M. Olsen
P0753
Second report from the European, multi-centre,
prospective bi-annual point prevalence study
of Clostridium difficile infection in hospitalised
patients with diarrhoea (EUCLID)
K.A. Davies* (Leeds, United Kingdom), G.L. Davis,
H.M. Ashwin, F. Lee, C.M. Longshaw, M.H. Wilcox
P0754
Towards a Europe-wide C. difficile infection
surveillance
S.M. Van Dorp* (Leiden, The Netherlands),
A. Kola, M. Behnke, P. Gastmeier, D. Schmid,
A. Hajdu, G.A. Kampinga, C. Suetens,
E.J. Kuijper, European Clostridium difficile infection surveillance network
P0755
C. difficile infections in acute care hospitals
– results of the pilot study of a European
surveillance initiative
S.M. Van Dorp* (Leiden, The Netherlands),
A. Kola, M. Behnke, P. Gastmeier, D. Schmid,
A. Hajdu, G. Kampinga, C. Suetens, E.J. Kuijper,
European Clostridium difficile infection
surveillance network
P0756
Cross-sectional study of community-acquired
Clostridium difficile infection in north-east
Scotland
C. Smith, C. Sinclair, T. Lawes, I. Gould, D. O’Brien*
(Aberdeen, United Kingdom)
24th ECCMID / Barcelona
Final Programme
Posters
Can a human gut model of Clostridium difficile
infection (CDI) be used to explain GDH-positive/
toxin-negative faecal samples seen in clinical
practice?
K. Davies* (Leeds, United Kingdom), C. Chilton,
G. Crowther, S. Todhunter, J. Heritage, M. Wilcox
BACTEC™ FX system as a tool for culturing gastric
biopsies and Helicobacter pylori diagnosis
(diagnosis of H. pylori by BACTEC™ FX)
A. Peretz* (Tiberias, Israel), A. On, A. Koiefman,
D. Brodsky, N. Isakovich, T. Glyatman, M. Paritsky Chairs, Speakers & Authors
P0742
P0750
Exhibition
Multicentre study of Clostridium difficile
infection in Spain (studies II and III): updating
the evolution of underdiagnosis of Clostridium
difficile infection in a whole nation
L. Alcala* (Madrid, Spain), E. Reigadas, M. Marín,
A. Martín, P. Catalán, E. Bouza,
Spanish Clostridium difficile Study Group
173
General Information
P0741
Poster Sessions
Sunday, 11 May 2014
P0757
Point-prevalence of Clostridium difficile
infections (CDI) in Greek hospitals:
a cross-sectional study
A. Pefanis, E. Vogiatzakis, G. Petrikkos, L. Zerva,
P. Gargalianos, M. Orfanidou, N. Sipsas, S. Smilakou,
I. Spiliopoulou, C. Gogos* (Patras, Greece)
P0758
Italian preliminary data obtained from the
European, multi-centre, prospective bi-annual
point prevalence study of Clostridium difficile
infection in hospitalised patients with diarrhoea
(EUCLID)
P. Spigaglia, F. Barbanti, P. Mastrantonio* (Rome,
Italy), K. Davies, C.M. Longshaw, M. Wilcox
P0759
Polish surveillance programme of Clostridium
difficile infections reveals persistently high
prevalence of Clostridium difficile type 027
H. Pituch* (Warsaw, Poland), D. Lachowicz,
P. Obuch-Woszczatynski, G. Mlynarczyk,
C. Harmanus, E. Kuijper
P0760
Clostridium difficile infection in a French
university hospital: molecular characteristics of
isolates and factors associated with severity
N. Khanafer* (Lyon, France), F. Barbut, C. Eckert,
M. Perraud, F. Vandenesh, C. El Guerche Seblain,
P. Vanhems
P0761
P0762
P0763
P0764
174
Assessment of severity of Clostridium difficile
infection using ATLAS score by the National
Institute for Infectious Diseases Prof Dr Matei
Bals, Bucharest
S. Benea* (Bucharest, Romania), G.A. Popescu,
D. Florea, I.R. Crismaru
Outbreak of Clostridium difficile PCR ribotype
027 – the recent experience of a regional hospital
M. Oleastro* (Lisbon, Portugal), M. Coelho, M. Gião,
S. Coutinho, S. Mota, A. Santos, J. Rodrigues,
D. Faria
Surveillance of Clostridium difficile binary
toxin and ribotype 027 using laboratory data in
Germany
J. Becker* (Frankfurt, Germany), T. Braeu,
M. Schellberger
The clinical utility of diagnostic tests for
Clostridium difficile infection: the prediction of
recurrence of infection
T. Planche* (London, United Kingdom), K.A. Davies,
D. Crook, N. Shetty, M. Wren, P.G. Coen, I. Monahan,
M.H. Wilcox
24th ECCMID / Barcelona
Final Programme
P0765
Recurrence and/or death after a first Clostridium
difficile symptomatic infection: influence of prior
therapy by proton pump inhibitor
O. Dos Santos, S. Boisset, O. Epaulard* (Grenoble,
France)
P0766
Recurrent Clostridium difficile infection: clinical
relevance, risk factors and prognosis
T. L.-Larrainzar Coghen, D. Rodriguez-Pardo*
(Barcelona, Spain), B. Almirante, V. Rodríguez,
C. Ferrer, C. Pigrau, N. Fernández-Hidalgo,
M. Puig-Asensio, T. Pumarola, A. Pahissa
P0767
Outcomes related to recurrent Clostridium
difficile infections – inpatient and outpatient
comparison from a large secondary database
analysis
G.J. Escobar, J.M. Baker, S.X. Li, Y. Xie*
(Whitehouse Station, NJ, United States),
S.W. Marcella, R.N. Kumar, P. Kipnis
P0768
Attributed costs of hospital-acquired Clostridium
difficile associated diarrhoea in Germany
C. Huebner* (Greifswald, Germany)
P0769
Advances in diagnostic technology suggest
limitations in the current case definition
and understanding of healthcare-associated
Clostridium difficile
E. Herding, D. Williams, G. Hansen* (Minneapolis,
United States)
P0770
Clinical implications of Clostridium difficile
infection (CDI) in kidney transplant recipients
(KTR): a retrospective case-control study
J. Origuen, C. Lumbreras, M.A. Orellana,
M.A. Pérez-Jacoiste, A. García-Reyne, T. Ruiz-Merlo,
N. Carrasco, R. San Juan, M. Fernández-Ruiz,
J.M. Aguado* (Madrid, Spain)
P0771
Detecting Clostridium difficile spores from
hospital surfaces. Which method is best?
T. Claro* (Dublin, Ireland), S. Daniels, H. Humphreys
P0772
C. difficile reservoirs and potential risk
of transmission in three patient groups:
asymptomatically colonised, C. difficile excretors
and infected patients
K. Bisnauthsing, A. Patel, C. Ward, J. Biswas*
(London, United Kingdom), D. Wyncoll, E. Van Kleef,
S. Goldenberg
Poster Sessions
Sunday, 11 May 2014
Low colonisation rate of Clostridium difficile
among patients and healthcare workers in
Sweden
O. Säll* (Örebro, Sweden), T. Norén
Immediate automated detection of nosocomial
transmission clusters (hotspots)
D. Flury* (St. Gallen, Switzerland), M. Hoffmann,
T. Meier, P. Kohler, M. Schreiner, M. Schlegel
P0782
Prevalence, molecular epidemiology and risk
factors for carriage of Clostridium difficile amongst
children <2 years of age in Oxfordshire, UK
N. Stoesser* (Oxford, United Kingdom), D.W. Eyre,
A. Vaughan, G. Pill, D.W. Crook, T.E. Peto, A.S. Walker P0783
A longitudinal study of Clostridium difficile
carriage at a Western Australian tertiary hospital
N.F. Foster* (Nedlands, Australia), S.L. Ditchburn,
C.N. Duncan, T.L. Scheller, H.E. Hong, D.L. Patterson,
T.V. Riley, A.C. Clements
P0784
Clostridium difficile infection in patients with
acute myelogenous leukemia and patients
undergoing allogeneic stem cell transplantation
– epidemiology and risk factor analysis
M.J.G.T. Vehreschild* (Cologne, Germany),
D. Weitershagen, L. Biehl, D. Tacke, D. Waldschmidt,
U. Töx, M.V. Bergwelt-Bailldon, O.A. Cornely,
J.J. Vehreschild
P0785
Storage duration of red blood cell transfusion and
Clostridium difficile infection: a within-person
comparison
M.A.M. Rogers* (Ann Arbor, United States), D. Micic,
N. Blumberg, V.B. Young, D.M. Aronoff
Implementation of contemporary molecular
methods for improving the diagnosis and
surveillance of Clostridium difficile infections in
Bulgaria
E. Dobreva* (Sofia, Bulgaria), I.N. Ivanov,
K. Ivanova, G. Asseva, P. Petrov, T. Velinov,
T. Kantardjiev
P0777
Evaluation of a rapid molecular test to genotype
C. difficile strains
C. Eckert* (Paris, France), N. Poccardi, G. Sika,
A. Petit, F. Barbut
P0778
The use of MVLA and whole genome sequencing
to study the relatedness of Clostridium difficile
isolates of ribotypes 106 and 174 within the
Midlands
S. Manzoor, C.B. Thomson, G. Kapatai, N. Loman,
K. Hardy, P.M. Hawkey* (Birmingham,
United Kingdom)
P0786
Comparative efficacy of peracetic acid and
hypochlorite on Clostridium difficile spores
L. Suzon, F. Barbut* (Paris, France)
P0787
Is our current cleaning method effective at
eradicating C. difficile?
L. Steriopoulos* (Kilmarnock, United Kingdom)
P0779
Emergence of Clostridium difficile type 176 in
Czech Republic
V. Beran* (Ostrava, Czech Republic), E. Kuijper,
C. Harmanus, I. Sanders, S. Van Dorp, J. Janeckova,
O. Kopecky, L. Barekova, D. Chmelar, I. Ciznar
P0788
Improved documentation of inpatient Clostridium
difficile infection (CDI) in electronic discharge
summaries following an intervention
R. Connolly, K. Burns* (Dublin, Ireland)
P0789
P0780
Polymerase chain reaction ribotyping revealed
outbreak caused by Clostridium difficile PCRribotype 027 in dialysis patients in Poland
D. Lachowicz, G. Szulencka,
P. Obuch-Woszczatynski, H. Pituch* (Warsaw,
Poland)
Clostridium difficile associated diarrhoea:
a comprehensive cost-of-illness analysis of
inpatient cases
S.M. Heimann* (Cologne, Germany), O.A. Cornely,
H. Wisplinghoff, M.J.G.T. Vehreschild, B. Franke,
I. Dohle, F. Müller, J.J. Vehreschild
24th ECCMID / Barcelona
Final Programme
Posters
P0776
175
Chairs, Speakers & Authors
P0775
Non-toxigenic Clostridium difficile colonisation
and risk of subsequent C. difficile infection
M. Natarajan, M.A.M. Rogers* (Ann Arbor, United
States), J. Bundy, D. Micic, K. Rao, S.T. Walk,
K. Santhosh, V.B. Young, D.M. Aronoff
P0781
Exhibition
P0774
Clostridium difficile: impact of colonisation
versus transmission on the development
of infection – results from a prospective
observational study
S. Tschudin Sutter* (Baltimore, MD, United States),
K.C. Carroll, P.D. Tamma, M.L. Sudekum, B.C. Ellis,
J. Bartlett, T.M. Perl
General Information
P0773
Poster Sessions
Sunday, 11 May 2014
P0798
Antimicrobial susceptibility and molecular
characterisation of moxifloxacin resistance from
Korean Clostridium difficile PCR ribotype 078
H.Y. Kim* (An-Yang, Korea), J.W. Byun, A. Cho,
M.H. Lee, B. Kim SMT 19969 for Clostridium difficile infection
(CDI): comparative efficacy compared to
fidaxomicin and vancomycin in the hamster
model of CDI
R. Vickers* (Abingdon, United Kingdom), J. Teague,
P. Thomas, P.A. Warn
P0799
Antimicrobial susceptibilities of Clostridium
difficile isolated in London, UK
K. Williams, D. Ready, N. HarrisBrown, N. Murphy,
C. Ryan, M. Cairns, R. Manuel* (London,
United Kingdom)
Persistence and removal of fidaxomicin from
C. difficile spores, and impact on spore recovery
C.H. Chilton* (Leeds, United Kingdom),
H.M. Ashwin, G.S. Crowther, C.M. Longshaw,
M.H. Wilcox
P0800
Low propensity of Clostridium difficile strains
from humans to develop resistance against the
novel combination nisin-miconazole
J. Dallow, E. Siegwart* (Fordham, United Kingdom),
S. Self, K. Knights
P0801
SMT 19969: a novel agent for Clostridium difficile
infection – summary results from in vitro
microbiology and a randomised double blind
phase 1 clinical trial
R.J. Vickers* (Abingdon, United Kingdom),
D.M. Citron, E.J.C. Goldstein, E.L. Best, M.H. Wilcox
P0802
In vitro activity of MCB3681 against Clostridium
difficile strains
M.U. Rashid, A. Dalhoff, A. Weintraub, C.E. Nord*
(Stockholm, Sweden)
P0803
Snare™ antibacterials: novel nanoparticulate
nucleic-acid based therapeutics for the treatment
of Clostridium difficile infections and prevention
of recurrence
T. Diaz Calvo* (Norwich, United Kingdom),
K. Hatzixanthis, P. Warn, A. Narbad, M. McArthur
P0804
DAV131, an oral adsorbent-based product, exerts
a dose-dependent protection of hamsters against
moxifloxacin-induced Clostridium difficile lethal
infection
C. Miossec, S. Sayah-Jeanne, V. Augustin,
E. Chachaty, W. Weiss, T. Murphy, M. Pulse,
A. Andremont, J. De Gunzburg* (Paris, France)
P0805
In vitro activity of surotomycin (formerly
CB-183,315) against 126 clinical isolates of
Clostridium difficile
O. Valentin, C. Eckert, L. Chesnel, F. Barbut* (Paris,
France)
P0806
In vitro demonstration of inhibition of
Clostridium difficile by commercial probiotics:
a real time study
M. Fredua-Agyeman* (London, United Kingdom),
A. Basit, P. Stapleton, A. Beezer, S. Gaisford
13:30 – 14:30
Poster Area
POSTER SESSION III:
C. difficile: antimicrobial susceptibility and treatment
P0790
P0791
P0792
P0793
Antibiotic susceptibility of surotomycin and five
other antibiotics against Clostridium difficile
isolates, collected at a pan-European survey in
2008 (n=119)
I.M. Sanders, C. Harmanus, S. Debast* (Leiden, The
Netherlands), E.J. Kuijper
Characterisation and antimicrobial susceptibility
of Clostridium difficile isolates from humans, food
producing and companion animals, 2007-2013, Italy
F. Agnoletti* (Treviso, Italy), E. Mazzolini, R. Rigoli,
G. Muffato, G. Merialdi, C. Magistrali, L. Bano,
C. Bacchin, E. Tonon, I. Drigo
P0794
Evaluation of antimicrobial susceptibility of
Clostridium difficile isolates from Bulgaria
K. Ivanova* (Sofia, Bulgaria), E. Dobreva, I. Ivanov,
G. Asseva, P. Petrov, T.Z. Velinov, T. Kantardjiev
P0795
In vitro susceptibility of Clostridium difficile
isolates to fidaxomicin, Austria 2012
V. Zeinzinger* (Vienna, Austria), S. Huhulescu,
A. Fiedler, F. Allerberger, A. Indra
P0796
P0797
176
Experience of using fidaxomicin for selected C.
difficile cases at County Durham and Darlington
Foundation Trust in the north east of England:
early findings!
D. Nayar* (Durham, United Kingdom), S. Brown,
D. Allison, C. Aldridge, L. Lim, J. Sloss, D. Kejariwal,
A. Dhar
Efficacy of tapered fidaxomicin dosing regimens
to treat simulated Clostridium difficile infection
(CDI) in an in vitro gut model
C.H. Chilton* (Leeds, United Kingdom),
G.S. Crowther, S.L. Todhunter, H.M. Ashwin, F. Lee,
C.M. Longshaw, M.H. Wilcox
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Comparison of practical issues associated with
introduction of different molecular assays as a
first-line test for Clostridium difficile screening
B.J. Parcell, J. Shone, G.V. Orange, J.E. Coia*
(Glasgow, United Kingdom), A. Whyte, D.L. Yirrell
P0808
Use of allelic exchange to characterise the
impact of three separate mutations in rpoB on the
fitness of Clostridium difficile and sensitivity to
fidaxomicin
A.W. Dempster* (Nottingham, United Kingdom),
M.M. Collery, S.A. Kuehne, C.M. Longshaw,
N.P. Minton
P0816
An evaluation of three different molecular assays
for detecting toxigenic Clostridium difficile in
human faecal samples
A. Ingebretsen* (Oslo, Norway), M.D. Borras,
F. Müller, E. Lingaas
P0817
Three years of loop-mediated isothermal
amplification (LAMP) and toxigenic culture (TC)
for Clostridium difficile diagnosis
T. Noren* (Örebro, Sweden), K. Johansson,
M. Unemo
P0818
Diagnosis of Clostridium difficile infections (CDI):
prospective clinical evaluation comparing two
molecular tests
D. Ali, B. Sémin, A. Guillouzouic, C. Bourigault,
D. Boutoille, J. Caillon, D. Lepelletier, P. Bémer*
(Nantes, France)
P0819
Performance characteristics the cobas® Cdiff
Test, a fully-automated assay on the cobas®
4800 system to detect Clostridium difficile in
clinical stool specimens
D. Fairley* (Belfast, Ireland), J. McKenna, J. Weaver,
P. Coyle
P0820
Toxigenic Clostridium difficile detection with the
cobas® Cdiff Test on the cobas® 4800 system
from stool specimens of patients from Hvidovre,
Denmark and Regensburg, Germany
A. Hiergeist* (Regensburg, Germany), S. Foerester,
S. Lowe, Y. Ohhashi, D. Kosarikov, J. Osiecki, A. Line,
O. Engsbro, H. Westh, U. Resichl
P0821
Evaluation of the EasyScreen™ C. difficile
detection kit for tcdA and tcdB
K. Carson* (Nedlands, WA, Australia), S. Siah,
D. Millar, B. MacKenzie, J. Melki, T. Riley
P0822
Evaluation of a molecular test based on
isothermal helicase-dependent amplification to
detect Clostridium difficile toxin A gene
C. Eckert* (Paris, France), A. Petit, E. Holscher,
V. Lalande, F. Barbut
P0823
Impact of Clostridium difficile associated disease
(CDAD) due to isolates carrying binary toxin
genes on recurrence of C. difficile associated
colitis and patient clinical outcome
M. Deffontaine, F. Hamdad, M. Belmekki, M. Biendo*
(Maurens Scopont, France), C. Casado
13:30 – 14:30
Poster Area
POSTER SESSION III:
New developments in molecular diagnosis of C. difficile
P0809
A three-stage algorithm for C. difficile testing
E. Trautt* (Oldham, United Kingdom), C. Chadwick,
D. Dean, S. Norris, J. Fielding, P. Taafe
P0810
3-step algorithm to improve CDI diagnosis
and ensure optimal patient management and
infection control
P. Marone* (Pavia, Italy), E. Travaglino,
M. Brandolini, M. Corbella, E. Giacobone, A. Piralla,
P. Cambieri
P0811
Diagnosis of Clostridium difficile infection:
comparison of different methods on specimens
collected for a cohort study in a large tertiarycare Italian hospital
N. Della Malva, R. Dei, E. Mantengoli, P. Pecile,
A. Bartoloni* (Florence, Italy), G.M. Rossolini
P0812
Comparison between different diagnostic
laboratory assays in the diagnosis of C. difficile
infection
D. Mileto* (Milan, Italy), S.G. Rimoldi, C. Pagani,
A. Mancon, M.R. Gismondo
P0813
Comparison of commercially available real-time
PCR test systems for the diagnosis of Clostridium
difficile infections
A. Boesl* (Feldkirch, Austria), K. Baruschke,
R. Stockinger, G. Hartmann, H. Dirschmid,
U. Gruber-Mösenbacher, F. Offner
P0814
Diagnosis of Clostridium difficile in a routine
laboratory: comparison between two isothermal
amplification methods, real-time PCR, cell
cytotoxicity test and culture
M. Becker* (Düsseldorf, Germany),
R. Guadarrama-Gonzalez, C. MacKenzie
24th ECCMID / Barcelona
Final Programme
177
Chairs, Speakers & Authors
P0815
Exhibition
Starving the superbug: novel antimicrobial
therapies that target selenium metabolism to
treat C. difficile infection
C. Roder* (Geelong, Australia), E. Athan,
M.J. Thomson
General Information
P0807
Posters
Sunday, 11 May 2014
Poster Sessions
Sunday, 11 May 2014
P0824
Inclusive and specific detection of toxinogenic
Clostridium difficile by the novel isothermal
amplification technology, SIBA®
P. Matero* (Espoo, Finland), R. Kärkkäinen,
J. Flinck, T. Siljander, T. Tomperi, S. Kukkamaa,
P. Rikkinen-Holm, K. Pousi, S. Filén, M. Mäki
P0825
Rapid random access diagnosis of Clostridium
difficile in the laboratory using DiaSorin®
LIAISON® antigen and toxin testing and isothermal
amplification methods in a two-step algorithm
M. Becker, I. Widera, D. Kara, R. GuadarramaGonzalez, C. MacKenzie* (Düsseldorf, Germany)
P0826
P0827
Development and performance of the QIAGEN
artus C. difficile QS-RGQ kit for detection of
toxigenic C. difficile using the QIAsymphony RGQ
MDx system
R. Hawwa* (Cambridge, United States), A. Zuniga,
H. Reiske, T. Glavan, K. Cerow, T. Pelletier, W. O’Brien,
M. Exner, A. Nesselrodt
Evaluation of the presence of binary toxin in
hospitalised patient with suspected Clostridium
difficile infection
P. Pedroni* (Pero, Italy), A. Bonamini, A. Indelicato,
P. Spigaglia, F. Barbanti, P. Mastrantonio
13:30 – 14:30
P0829
P0830
178
Food-poisoning aetiology in Catalonia:
2003-2013
T. Cornejo Sánchez* (Barcelona, Spain),
N. Piedra-Carrasco, J.J. González-López, S. Guix,
A. Martínez, N. Torner, Working group for the study
of outbreaks of acute gastroenteritis in Catalonia,
T. Pumarola, A. Domínguez, R. Bartolomé
P0832
Epidemiology of Campylobacter gastrointestinal
tract infections in humans in the Czech Republic
J. Bardon, V. Husickova* (Olomouc,
Czech Republic), M. Roderova, I. Kolackova,
R. Karpiskova, T. Stosova, M. Kolar
P0833
Campylobacter jejuni infection in Portugal: high
rates in hospital settings
M. Oleastro* (Lisbon, Portugal), A. Santos,
S. Ferreira, A. Rodrigues, C. Júlio
P0834
Combined ciprofloxacine and tetracycline
resistance among C. jejuni human faecal isolates
in the largest Croatian county: a cross-sectional
study
M. Carev* (Split, Croatia), A. Novak, A. Jeroncic,
M. Tonkic
P0835
Detection of Campylobacter in stool specimens
within the African setting: molecular
methodologies are essential and indispensable
tools
A.M. Smith* (Sandringham, South Africa), H. Ismail,
N.A. Page, S.A. Madhi, K.H. Keddy
Poster Area
POSTER SESSION III:
Gastrointestinal infections and pathogens
P0828
P0831
P0836
Disease burden of selected gastrointestinal
pathogens in Australia, 2010: comparing number
of gastroenteritis cases and deaths, disability
adjusted life years (DALYS) and DALYS/case
K. Gibney* (Melbourne, Australia), J. O’Toole,
M. Sinclair, K. Leder
Investigation of non-travel associated Shigella
flexneri serotype 3a infections in adult males in
England
S. Horridge* (London, United Kingdom), M. Day,
T. Peters, C.R. Lane, C. Jenkins
P0837
Viral and bacterial enteropathogens in a local
hospital in Spain for 8 years: prevalence and
sensitivity (2004-2011)
A. Sánchez-Maroto* (Madrid, Spain),
J.A. Pérez García, S. Illescas Fernández-Bermejo
Application of a novel method for demonstrating
frequent contamination of groundwater with
verotoxigenic E. coli (VTEC)
S. Kavanagh, M. Cormican, K. Carney,
B. MacDomhnaill, D. Morris* (Galway, Ireland)
P0838
Comparison of two methods for the detection of
verotoxins in human faecal samples during an
outbreak of HUS in Apulia, southern Italy
R. Monno, A. Parisi, E. Baglivo, C. Capolongo, C. Calia,
V. Cinquepalmi, G. Miragliotta* (Bari, Italy)
Food safety in school canteens: food handlers,
utensils and food as a potential source of
pathogenic microorganisms
S. Quinteira* (Vila Nova Famalicao, Portugal),
A. Gomes, S. Alves, C. Diniz, N. Ferreiro, J. Proença,
M.J. Neuparth
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Sunday, 11 May 2014
P0839
Gnd-typing as a tool for rapid epidemiology of
enteroaggregative Escherichia coli
S.I. Hauswaldt, C. Dracoloulos, E. Adomakoh,
M. Kalitzky, W. Solbach, J.K. Knobloch* (Lübeck,
Germany)
P0849
Outbreak of astrovirus type 5 gastroenteritis in a
residential care home for older people
A. Jarchow-MacDonald* (Dundee,
United Kingdom), S. Halley, D. Chandler, R. Gunson,
S. Shepherd, B. Parcell
P0840
Epidemiology and pathological significance of
enteroaggregative Escherichia coli in Danish
patients
B. Jensen* (Copenhagen, Denmark), A. Friis-Møller,
K.E.P. Olsen, A.M. Petersen, J. Engberg, K.A. Krogfelt
P0850
P0841
Results from a ten-year PCR screening for
enterohaemorrhagic Escherichia coli in children
in a Swedish county
A. Matussek* (Jönköping, Sweden), I.M. Einemo,
S. Löfdahl, S. Löfgren
Emerging trend of Vibrio in urban Bangladesh, a
retrospective study of serotype distribution and
antibiotic resistance
A.I.M.S. Ud-Din, S.U.H. Wahid, N. Akter, H.A. Latif,
K. Nahar, M.A. Hossain, D. Ahmed* (Dhaka,
Bangladesh)
Evaluation of luminex xTAG®-GPP
(gastrointestinal pathogen panel) in the
diagnostic of acute diarrhoeal diseases
C. Casañ* (Paterna, Spain), F. Grosson, M.D. Ocete,
J.L. Ramos, N. Tormo, R. Guna, R. Medina, C. Gimeno
P0852
A comparison of masscode vs luminex xTAG®
gastrointestinal panel for the simultaneous
diagnosis of multiple gastrointestinal pathogens
L.J. Pankhurst* (Oxford, United Kingdom),
L. Macfarlane-Smith, L.W. Anson, K. Davies,
H. Ashwin, T.E.A. Peto, A.S. Walker, M.H. Wilcox,
D.W. Crook
P0853
Evaluation of a commercial system (R-Biopharm
RIDA®GENE) for molecular detection of
gastrointestinal infections
T.M. Leegaard* (Lørenskog, Norway),
B. Follin-Arbelet, T.H. Nguyen, H. Esnaashari,
T.E. Ranheim, H.S. Tunsjø, A.K. Kvissel
P0844
Detection of Salmonella arizonae in an enteric
fever outbreak by the ID 32 GN automated
system
E. Gunal* (Diyarbakir, Turkey), H. Erdem
P0845
Extended-spectrum-beta-lactamase-producing
Salmonella enterica serovar Typhi of Central
American origin isolated in Spain
N. Piedra Carrasco* (Barcelona, Spain),
T. Cornejo-Sánchez, M.N. Larrosa, R.M. Bartolomé,
C. Gulin, A. Sánchez-Montalva, F. Salvador,
A.M. Planes, J.J. González-López
P0846
Unusual non-typhoidal Salmonella serotypes
dispersed in animals and environmental sources
in Angola
P. Antunes, J. Campos* (Porto, Portugal), J. Mourão,
L. Margalho, T. Ribeiro G, C. Novais, L. Peixe
P0854
Validation of a diagnostic tool for multiplex
screening of gastrointestinal pathogens on
multiplex QCMD panels: GastroFinder™ SMART 17
J. Van der Velden* (Maastricht, The Netherlands),
Y. Ozog, G. Simons
P0847
Salmonella Mbandaka – 15 years of successful
spread of ST413 clone in Poland
D. Wasyl* (Pulawy, Poland), A. Hoszowski, M. Zajac
P0855
P0848
Changes in genotypic distributions of human
group A rotavirus after vaccine introduction in
Korea
H.S. Kim* (Hwaseong, Korea), D.H. Whang,
S.H. Lee, H.S. Kim, J.S. Kim, W. Song
Increased recovery using the BD MAX™ enteric
bacterial panel* for rapid detection of DNA from
Salmonella spp., Shigella spp., Campylobacter,
and shiga-toxin producing E. coli
M. Porter* (Sparks, MD, United States), A. Lainesse,
C. Whiteford
24th ECCMID / Barcelona
Final Programme
179
Posters
P0851
Chairs, Speakers & Authors
Ciprofloxacin and azithromycin resistant
S. paratyphi A presenting as relapse
R.A. Corrigan* (Buckinghamshire, United Kingdom),
M.M. Raza POSTER SESSION III:
Molecular diagnosis of gastrointestinal bacterial infections
Exhibition
P0843
A rapid method for monitoring large water volumes
for verotoxigenic Escherichia coli (VTEC)
S. Kavanagh, M. Cormican, K. Carney,
B. Macdomhnaill, D. Morris* (Galway, Ireland)
Poster Area
General Information
P0842
13:30 – 14:30
Poster Sessions
Sunday, 11 May 2014
P0856
Time motion analysis of the BD MAX™ enteric
bacterial panel (EBP) compared to conventional
methodologies for the detection of stool
pathogens
J. Mortensen* (Cincinnati, United States), S. Hanna,
C. Ventrola
P0865
Distribution of six virulence factors in Aeromonas
species isolated from patients suffering from
diarrhorea in Spain
F. Galan-Sanchez, I. Guerrero-Lozano,
P. Marin-Casanova, A. Garcia-Tapia,
M.A. Rodriguez-Iglesias* (Cadiz, Spain)
P0857
Evaluation of the BD MAX™ enteric bacterial panel
assay for the detection of bacterial pathogens in
diarrhoeal stool specimens
K. McAulay* (Reading, United Kingdom), V. Lock,
A. Stacey, N. Virgincar, S. Iyer
P0866
P0858
A multicentre evaluation of the BD MAX™ enteric
bacterial panel for the detection of Salmonella
spp., Shigella spp., Campylobacter spp., and
shiga-toxin-producing Escherichia coli
J. Mortensen* (Cincinnati, United States),
S. Harrington, B. Buchan, C. Doern, R. Fader,
M. Ferraro, D. Pillai, J. Rychert
Comparison of the performance of several one
step rt-qPCR enzymes with fast-track diagnostics
FTD mix
M. Heckmann* (Junglinster, Luxembourg),
S. Balbier, C. Gruhn, H. Nummer, M. Hofmann,
M. Steimer, W. Carman
P0867
Comparison of two multiplex PCR for
diarrhoeagenic Escherichia coli diagnosis
N. Iglesias Nunez* (Madrid, Spain),
A. Arroyo Fajardo, P. Trevisi, A. Sarría Visa,
B. López Quintana, C. Ladrón de Guevara,
C. Toro Rueda
P0868
Evaluation of a new PCR-based platform for the
detection and identification of viruses or bacteria
from swab transport devices
K. Khan* (Slough, United Kingdom)
P0869
Evaluation of MSwab direct nucleic acid
extraction for detection of viruses, bacteria and
parasites in faecal samples using fast-track
diagnostics real-time multiplex kits
M. Hofmann* (Junglinster, Luxembourg), A. Hagen,
S. Castriciano, M. Heckmann, M. Steimer, W. Carman
P0859
Evaluation of the first microarray-based
molecular screening test for eight
gastrointestinal pathogens using the automated
NanoChip® platform
M.D. Perry* (Cardiff, United Kingdom)
P0860
Evaluation of the Verigene® EP IUO test for the
rapid detection of bacterial and toxin causes of
gastrointestinal infection
S. Novak-Weekley* (North Hollywood, United
States), E.M. Marlowe
P0861
A novel, fast and specific isothermal nucleic acid
amplification test for Salmonella enterica subsp.
enterica
J. Flinck, A. Wester, M. Mäki, J. Saharinen* (Espoo,
Finland)
P0862
Detection of bacterial pathogens associated with
acute diarrhoea using multiplex-PCR system
E. Raukas* (Pärnu, Estonia), A. Looväli, R. Pulk
P0863
Differentiation of epidemic and endemic strains
of Salmonella enterica serovar Newport by PCR
detection of a truncated bapA chromosomal gene
R.A. Horton* (Addlestone, United Kingdom), R. Card,
L.P. Randall, C. Teale
P0864
Screening with vanA/B PCR to detect vancomycinresistant enterococci using the Siemens
VERSANT® KPCR system
M. Bongaerts* (Sittard-Geleen, The Netherlands),
E.J. Van Hannen, K.C.J. Frijns, M.E.L.M. Manders,
E.R. Heddema
180 24th ECCMID / Barcelona
Final Programme
13:30 – 14:30
Poster Area
POSTER SESSION III:
Helicobacter pylori
P0870
Polymorphisms in interleukin-1beta gene
associated with peptic ulcer and gastric cancer
risk in Helicobacter pylori-positive patients
I.B. Ramis* (Rio Grande, Brazil), J.S. Vianna,
P.C.B. Halicki, T.B. Gautério, A. Von Groll, P.E.A. Silva
P0871
Prevalence of Helicobacter pylori gene alleles
among patients with different gastric lesions
Z. Said* (Cairo, Egypt), S. El-Shazly, S. Mustafa,
N. Abd El Rahman, K. El bassel, N. Abd El Haliem,
M. Metawea
P0872
Detection of prophage and CRISPR loci in
Helicobacter pylori
E. Aznar, T. Alarcón* (Madrid, Spain), M. López-Brea
Poster Sessions
P0876
Sensitivity evolution of Helicobacter pylori during
the years 2006 to 2013 in the south of Spain.
Treatment alternatives
F. Franco Álvarez de Luna* (Minas de Riotinto,
Spain), C. Santos Rosa, R. Sáenz Solís,
J.H. García Vela, A. Duque Calero
P0877
Evaluation of Helicobacter pylori vacA, cagA
genotypes and correlation with clinical outcome
in Iranian patients with dyspepsia
M. Alikhani* (Hamadan, Iran), A. Majlesi, M. Jaefari,
M. Arebestani
13:30 – 14:30
Poster Area
Identification of M. tuberculosis using MALDI-TOF MS
A. Mazzarelli, C. Venditti, S. D’Arezzo, E. Bordi,
A. Piscini, G. Delogu, C. Nisii, A. Di Caro* (Rome,
Italy)
P0883
Outbreak of tuberculosis in a Norwegian dance
academy delineated by mass spectrometry
I. Szpinda* (Oslo, Norway), A. Ingebretsen,
W. Egge-Jacobsen, P. Gaustad, T. Tonjum
P0884
A 3-year experience with a multiplex highthroughput molecular assay for characterisation
of genetic markers in the Mycobacterium
tuberculosis genome
S. Sengstake* (Amsterdam, The Netherlands),
I. Bergval, A. Schuitema, J. De Beer, E. Abadia,
P. Klatser, C. Sola, D. Van Soolingen, R. Anthony
P0885
Whole genome sequencing and epidemiological
analysis does not provide evidence for crosstransmission of M. abscessus in a cohort of
paediatric cystic fibrosis patients in a tertiary
referral centre
K.A. Harris* (London, United Kingdom),
A. Underwood, D.T.D. Kenna, P. Aurora, G.L.J. Dixon
P0886
Evaluation of Copan Myco-TB system for a rapid
and efficient decontamination of mycobacterial
specimens
L. Mancinelli* (Rome, Italy), L. Coltella,
G. Pizzichemi, E. Galeno, S. Gobbi, S. Landi,
D. Menichella, C. Russo
P0887
Application of an interferon-gamma release assay
in healthcare workers
M. De Paschale, C. Morazzoni, R.A. Bonazzina,
L. Gorla, C. Agrappi, P. Mirri, M.T. Manco, L. Belvisi,
A. Gatti, P. Clerici* (Legnano, Italy)
P0888
Demonstration of diagnostic utility of a new TB
serology rapid test in case-control studies of
clinically proven tuberculosis cases
A. Tam* (San Mateo, United States), I. Kwok,
V. Chan, G. Wang, V. Choi,
J. Wong-Lee
P0889
The microbiological diagnosis of tuberculosis
meningitis: results of Haydarpasa-1 study
H. Erdem, D. Ozturk-Engin, N. Elaldi, S. Gulsun,
G. Sengoz, A. Crisan, I. Somuncu Johansen,
A. Inan* (Istanbul, Turkey), M. Nechifor,
T. Tuberculosis Meningitis Study Group
POSTER SESSION III:
Diagnosis of mycobacterial infections: from genetics to
MALDI-TOF
P0878
Comparison of two interferon-gamma release
assays for the screening of healthcare workers in
a Swiss university hospital
P. Bittel* (Berne, Switzerland), D. Mayor, P. Iseli,
S. Pfister, F. Suter-Riniker
P0879
A false-positive immunochromatographic assay
associated with Elizabethkingia meningoseptica
for rapid identification of Mycobacterium
tuberculosis complex in liquid culture media
J. Lin* (Changhua City, Taiwan), L. Shih, C. Lin
P0880
Evaluation of the newly developed
Mycobacterium library of Bruker MALDI
Bbiotyper® for mycobacteria MALDI-TOF MS
identification in practical routine
P. Nguyen, S. Lali, B. Marchetti* (Montigny le Tilleul,
Belgium), D. Fameree, D. Govaerts
P0881
MALDI-TOF MS for direct identification of
nontuberculous mycobacteria (NTM) from
positive MGIT™ cultures of patient specimens
A.B. Pranada* (Dortmund, Germany), M. Timke,
E. Witt, M. Kostrzewa
24th ECCMID / Barcelona
Final Programme
Chairs, Speakers & Authors
Helicobacter pylori antibodies in patients with
idiopathic thrombocytopenic purpura
N. Hanafi* (Alexandria, Egypt), I. Mikhael,
D. Younan
P0882
Exhibition
P0874
Distribution of vacAi alleles in characterised
vacAs/m Helicobacter pylori isolated in Moroccan
population
M. El Khadir* (Fès, Morocco), S.A. Boukhris,
D.A. Benajah, K. El Rhazi, S.A. Ibrahimi, C. Nejjari,
A. Amarti, B. Bennani
181
General Information
P0873
Posters
Sunday, 11 May 2014
Poster Sessions
Sunday, 11 May 2014
13:30 – 14:30
Poster Area
P0898
POSTER SESSION III:
Epidemiological and clinical studies on non-tuberculous
mycobacteria
P0890
P0891
No impact of respiratory colonisation with
Mycobacterium avium-intracellulare in patients
with cystic fibrosis on the long-term course of the
forced expiratory volume in one second
C. Albrecht* (Hanover, Germany), F. Ringshausen,
S. Ott, D. Wagner, J. Rademacher, T. Welte,
M. Schneider, M.W. Pletz
Prevalence of non-tuberculous mycobacteria
(NTM) in a cystic fibrosis (CF) unit of Madrid
L. Llorca* (Madrid, Spain), D. Domingo,
J. Martiáñez, M.D. Guerrero, R. Girón, L. Cardeñoso
P0892
Nontuberculous mycobacteria colonisation and
disease in cystic fibrosis patients
R. Gilarranz* (Las Palmas de Gran Canaria, Spain),
F.J. Chamizo, M.I. Campos-Herrero, M.A. García,
G. Cabrera, J. Cuyas, J.A. Caminero
P0893
A follow up on two outbreaks of nontuberculous
mycobacterial skin and soft tissue infection in
Venezuela; identifying the infection source
J. Torres-Coy* (Caracas, Venezuela),
B.A. Rodriguez-Castillo, J.H. De Waard
P0894
Rapidly growing mycobacteria in Singapore:
infections and treatment outcome
D. Lye, S. Tang* (Singapore, Singapore), L. Sng,
R. Jureen, L. Hsu
P0895
Epidemiology of nontuberculous mycobacteria at
a medical centre in Taiwan, 2000-2012
P. Hsueh* (Taipei, Taiwan), J. Chien, C. Lai, W. Sheng
P0896
Outcome and prognostic factors of
nontuberculous mycobacteriosis in France:
a cohort study of 192 patients
C. Andrejak* (Amiens, France), O. Peuchant,
N. Veziris, O. Segonds, D. Terru, F. Hamdad,
A. Lagrange, V. Lalande, C. Laurain, P. Bemer
P0897
Descriptive analysis of nontuberculosis
mycobacteria isolated over a 5-year period at a
general university hospital
A. Vergara Gómez* (Barcelona, Spain), A. Lopez,
J.C. Hurtado, G. Tudo, E. Polverino, J.A. Martinez,
J. Gonzalez-Martin
182 24th ECCMID / Barcelona
Final Programme
Review of Tsukamurella spp. isolates in a
tertiary hospital
P. Falomir Salcedo* (Valencia, Spain), A. Gil-Brusola,
B. Montull, A. Hernández-Cabezas, J.M. Molina,
J.L. López-Hontangas
13:30 – 14:30
Poster Area
POSTER SESSION III:
Recent advances in molecular diagnosis of M. tuberculosis
P0899
Experience with the implementation of Xpert
MTB/RIF® assay in Rwanda, a low HIV/MDR-TB
burden setting
C. Muvunyi* (Huye, Rwanda), J.D. Birangwa,
I. Uwimana, E. Kamazni, J.B. Mazarati
P0900
Interest of the Xpert MTB/RIF® assay (CEPHEID)
for the diagnosis of spondylodiscitis caused by
Mycobacterium tuberculosis complex
A. Dubouix Bourandy* (St. Jean, France),
J. Duboureau, V. Pietri, J.L. Galinier, B. De Germay,
J.M. Gandois
P0901
Diagnostic accuracy of the Xpert MTB/RIF® assay
according to clinical purpose
H.J. Huh* (Seoul, Korea), K. Jeon, W.-J. Koh,
Y.-Y. Hwang, C.-S. Ki, N.Y. Lee
P0902
Evaluation of GeneXpert MTB/RIF® test
performance for respiratory and nonrespiratory
clinical samples
A. Ilki* (Istanbul, Turkey), B. Aksu, R. Ayas,
G. Soyletir
P0903
Evaluation of TrueNAT with GeneXpert MTB/RIF®
for rapid diagnosis of pulmonary tuberculosis
C. NIKAM* (Mumbai, India), M. Kazi, C. Nair,
A. Shetty, C. Rodrigues
P0904
Development and evaluation of the detection of
Mycobacterium tuberculosis complex on the BD
MAX™ system in a European multicentre study
I.O.M. Op den Buijs* (Veldhoven, The Netherlands),
A.L. Seagar, P. Baltar, R.T.J.M. Roymans,
K.E. Templeton, I.F. Laurenson, G. Barbeito,
J.H.B. Van de Bovenkamp
P0905
Large-scale evaluation of an integrated
rapid molecular test of multidrug-resistant
Mycobacterium tuberculosis in respiratory
specimens
T.C. Kwong, G.H.K. Siu* (Hong Kong, China),
W.C. Yam
Poster Sessions
Sunday, 11 May 2014
Multi-centre evaluation of Speed-oligo®
mycobacteria version 2 assay for identification
of Mycobacterium spp. in routine clinical
mycobacteriology
M.J. Martinez-Lirola* (Almería, Spain),
S. Hofmann-Thiel, J. Fernández Domínguez,
M.J. Muñoz-Dávia, V. Cepas, S. Campos Gutierrez,
M.J. Ruiz Serrano, M. Lecuona Fernández, F. Alcaide,
M. Marín-Arriaza
Evaluation of a new reverse hybridisationbased molecular method for detecting first- and
second-line drug resistance in Mycobacterium
tuberculosis in clinical samples
B. Molina* (Badalona, Spain), A. Lacoma, C. Prat,
E. Pimkina, J. Díaz, A. Dudnyk, J. Maldonado,
S. Samper, J. Ruiz-Manzano, J. Domínguez
P0916
Evaluation of the AID TB resistance line probe
assay for rapid detection of genetic alterations
associated with Mycobacterium tuberculosis drug
resistance
C. Ritter, K. Lucke, F.P. Maurer* (Zurich, Switzerland),
F.A. Sirgel, R.W. Warren, P.D. Van Helden, E.C. Böttger,
G.V. Bloemberg
Comparison between PCR and culture as
a diagnostic tool for pulmonary and extrapulmonary tuberculosis: seven years’ experience
of a Portuguese infectious disease centre
T. Azevedo* (Lisbon, Portugal), V. Moutinho,
C. Lopes, T. Pacheco, R. Santos, J. Fernandes,
S. Peres, F. Borges, K. Mansinho
P0917
Use of a new multiplex PCR for the detection of
Mycobacterium tuberculosis resistant to firstand second-line drugs in clinical strains and
samples
B. Molina* (Badalona, Spain), A. Lacoma, C. Prat,
E. Pimkina, J. Díaz, J. Maldonado, S. Samper,
J. Ruiz-Manzano, V. Ausina, J. Domínguez
P0910
Improvement of patient care and impact on
hospital finances by implementing a rapid PCR
test for Mycobacterium tuberculosis complex
R. Te Witt* (Rotterdam, The Netherlands),
A. Luijendijk
P0918
Low burden of rifampicin resistant TB lineages in
Nepal using rapid PCR technique
K. Moganeradj* (London, United Kingdom),
P. Sonnenberg, I. Abubakar, T.D. McHugh, S. Khadge,
D. Hagge, C. Arnold
P0911
Application of multiplex PCR to routine
diagnostics of tuberculosis and BCG-induced
events in children
M. Alvarez Figueroa* (Moscow, Russia), E. Dolgova,
D. Levi
P0919
P0912
Comparison of two nucleic acid amplification
assays in comparison to culture for detection
of Mycobacterium tuberculosis in respiratory
specimens
H. Al Helal, S. Al Johani* (Riyadh, Saudi Arabia)
Systemic infections by Mycobacterium
tuberculosis in HIV-positive patients as
determined by direct molecular testing:
influence of blood volume
F. Bwanga, W. Worodria, A. Luyombya,
I. Najjingo, L. Asege, T. Nalwoga, C. Disqué*
(Bremen, Germany), M. Lorenz, V. Allerheiligen,
M. Weizenegger
P0920
A simple method based on a reliable genetic
marker for identification of Mycobacterium
tuberculosis Beijing genotype
D. Fuentes, C. Villellas, M. Vitoria, S. Samper,
J.A. Aínsa, L. Rodrigues* (Zaragoza, Spain)
P0921
Application of the genotyping tool MIRU-VNTR
to the analysis of Mycobacterium tuberculosis
in the tuberculosis reference centre ‘University
Hospital Virgen del Rocío’ (Seville, 2009-2013)
V. Gonzalez Galan* (Seville, Spain), M.j. Torres,
J. Aznar
P0922
PCR separation of Mycobacterium intracellulare
and Mycobacterium chimaera
M.C. Muñoz Egea* (Madrid, Spain), J. Esteban,
J.O. Falkinham
P0913
P0914
Can we speed up TB diagnosis? Method
development for mycobacterial DNA extraction
and WGS from the first day positive liquid
cultures
A.A. Votintseva* (Oxford, United Kingdom),
L.J. Pankhurst, T.M. Walker, C. Del Ojo Elias,
D.H. Wyllie, A. Giess, T.E.A. Peto, D.W. Crook
Evaluation of an array-based test for the
detection of isoniazid and rifampicin resistance
in Mycobacterium tuberculosis clinical strains
and samples
B. Molina* (Badalona, Spain), G. Kazdaglis,
A. Lacoma, C. Prat, J. Díaz, J. Maldonado, S. Samper,
J. Ruiz-Manzano, V. Ausina, J. Domínguez
24th ECCMID / Barcelona
Final Programme
Posters
P0909
183
Chairs, Speakers & Authors
P0908
P0915
Exhibition
Performance comparison of two commercial tests
for rapid molecular diagnosis of exprapulmonary
tuberculosis in a low TB incidence country
E.M. Mokaddas* (Dasma, Kuwait), H. Saadaldeen,
S. Ahmad
General Information
P0906
Poster Sessions
Sunday, 11 May 2014
P0923
Tuberculous sepsis in HIV-infected patients:
modern possibilities of diagnostics
V. Zhuravlev* (St.Petersburg, Russia), N. Soloveva,
S. Mazokhina, E. Myakotina, T. Otten, M. Shulgina
13:30 – 14:30
P0925
P0926
P0927
P0928
P0929
P0930
Drug susceptibility pattern of Mycobacterium
tuberculosis isolated from patients with
pulmonary tuberculosis in Tripoli, Libya
A.S. Albarouni* (Tripoli, Libya), N.B. Aboguttaia,
W.M. Alamri, A.M. Fungi, M. Furjani, A. Zorgani
Efflux as mechanism involved in antimicrobial
resistance in clinical isolates of Mycobacterium
tuberculosis
T.S. Coelho, R.A. Maschmann, F.S. Spies, A. Von Groll,
M. Viveiros, M.L.R. Rossetti, P.E. Almeida da Silva*
(Rio Grande, Brazil)
Mycobacterium tuberculosis spoligotypes and
drug susceptibility pattern from tuberculosis
patients in region of Macedonia-Thrace, Greece
G. Kazdaglis* (Athens, Greece), B. Molina, G. Gioula,
K. Manika, M. Gomes, L. Haba, D. Papaventsis,
N. Malisiovas, J. Dominguez
Effect of ciprofloxacin in the ultrastructure
and development of biofilms formed by rapidly
growing mycobacteria
M.C. Muñoz Egea* (Madrid, Spain),
M. García-Pedrazuela, J. Esteban
Rapid detection of pyrazinamide-resistant
Mycobacterium tuberculosis and characterisation
of pncA gene mutations in Hong Kong
T.C. Kwong* (Hong Kong, China), W.C. Yam
An investigation of hydrophobicity and alphahelicity on the activities of synthetic cationic
antimicrobial peptides in mycobacteria
J.S. Khara* (Singapore, Singapore), F.K. Lim,
P.L.R. Ee
Combination of first-line anti-tuberculosis
drugs and coated magnetite nanopoarticles
against intrinsic resistance of Mycobacterium
smegmatis
P. Padwal* (Mumbai, India), R. Bandyopadhyaya,
S. Mehra
184 24th ECCMID / Barcelona
Polyclonality of non-pigmented rapidly
growing mycobacteria (NPRGM): phenotypic
and genotypic differences and their potential
implications
M. García-Pedrazuela, J.M. Frutos,
M.C. Muñoz-Egea* (Madrid, Spain), F. Alcaide,
T. Tórtola, A. Vitoria, P. Cortés, J. Esteban
P0932
Association of genetic ancestry with
Mycobacterium leprae genotypes in leprosy
patients from Colombia
N. Cardona-Castro* (Medellín, Colombia),
J.C. Beltrán-Alzate, M. Romero, E. Cortés, G. Bedoya
P0933
The predominance of subtype I among
Mycobacterium kansasii clinical isolates from
Poland, as evidenced by PCR restriction-enzyme
analysis of the hsp65 gene
Z. Bakula* (Warszawa, Poland), A. Safianowska,
M. Nowacka-Mazurek, J. Bielecki, T. Jagielski
P0934
Study of the effect of three drug combinations
against susceptible and resistant M. tuberculosis
using the time-killing curves method
A. López Gavín* (Benavent de Segrià, Spain),
G. Tudó Vilanova, J. González Martín, E. Rey Jurado
P0935
Subspecies distribution, antibiotic susceptibility
and genotypic resistance characteristics of
Mycobacterium abscessus group
J. Kim* (Seoul, Korea), H.S. Sung, J.S. Park,
T.S. Shim, M.N. Kim
P0936
Gene markers for predicting second-line antituberculosis drugs resistance
T. Jagielski* (Warszawa, Poland), Z. Bakula,
K. Roeske, M. Kaminski, A. Napiórkowska,
R. Stachowiak, E. Augustynowicz-Kopec, J. Bielecki
P0937
Polyclonal spread of antimicrobial resistant
Mycobacterium tuberculosis and characterisation
of resistance mutations in a university hospital,
central Greece
Z. Florou* (Larissa, Greece), A. Mavroidi, A. Vasdeki,
A. Liakopoulos, Z. Garyfalopoulou, E. Petinaki
P0938
Genetic diversity based on genomic deletion,
polymorphisms and species specific mutations
in first-line drug-resistant strains belonging to
Mycobacterium tuberculosis complex (MTC)
G. Fregni Serpini, A. Grottola, A. Fabio,
S. Tagliazucchi, W. Gennari, F. Rumpianesi,
M. Pecorari* (Modena, Italy)
Poster Area
POSTER SESSION III:
Mycobacterial susceptibility and molecular epidemiology
P0924
P0931
Final Programme
Poster Sessions
Comparison of clinical characteristics and
treatment outcome of tuberculosis with
diabetes mellitus, tuberculosis with human
immunodeficiency virus and tuberculosis alone
in tertiary care centre
G. Suwanpimolkul* (Bangkok, Thailand),
K. Kaewkittinarong, K. Ruxrungtham
P0949
A clinical 11-year experience in peripheral
tuberculous lymphadenitis
A. Velo-Garcia* (Pontevedra, Spain),
R. Brea Aparicio, A.E. Pena Graña,
A. Pallarés Sanmartin, L. Anibarro
P0950
Tuberculosis in patients treated with anti-TNF
J.F. García-Rodríguez* (Ferrol, Spain),
I. Gómez-Buela, C. Lijó-Carballeda, D. García-Alén,
H. Álvarez-Díaz, A. Mariño-Callejo,
M.V. Lorenzo-García
P0951
Genitourinary tuberculosis: a review of 48 cases
in Thailand
P. Uppathamnarakorn* (Bangkok, Thailand),
C. Suankratay
POSTER SESSION III:
Tuberculosis: clinical observations
P0939
P0940
Epidemiology of admissions for Mycobacterium
tuberculosis infection in Pavia, Lombardy,
northern Italy, 2006-2013
L. Scudeller* (Pavia, Italy), A. Bonoldi,
A. De Silvestri, T. Feletti, P. Marone, L. Pratico’,
A. Muzzi, E. Seminari
Tuberculosis in native residents and immigrants
in the last twelve years in an area of northern
Italy
P. Brugnaro* (Biancade, Italy), F. Cattelan,
E. Morelli, A. Petrucci, F. Cavinato, F. Eseme, V. Selle,
S. Grandesso, E. Raise
P0941
Changes in the epidemiology of mycobacterial
respiratory infections in Murcia, Spain
C. Candel Perez* (Murcia, Spain),
C. Guerrero Gomez, C. Casañ Lopez, J. Bravo Urbieta,
L. Lozano Garcia, R.m. Blazquez Garrido
P0942
A cross-sectional study of pulmonary
tuberculosis in a Libyan chest clinic in Misrata:
differences among native and immigrant
population
M. Daw* (Sirte, Libya), B. Babitsch, C. Legault
P0952
Osteoarticular tuberculosis: a case series of 118
patients from five French hospitals
A. Guillouzouic, C. Andrejak, O. Peuchant,
G. Héry-Arnaud, F. Hamdad, P. Lanotte, B. Olivero,
M. Dupe, M. Valette, P. Bémer* (Nantes, France)
P0943
Epidemiology of tuberculosis: investigation from
three geographical areas in Greece
F. Kontos, V. Mollaki, Z. Gitti, E. Petinaki, V. Liakou,
E. Trikka-Graphakos, K. Paraskevi, K. Tsiveriotis,
Z. Florou, L. Zerva* (Athens, Greece)
P0953
Changes in ultrasound findings during treatment
for HIV/TB co-infection
M.T. Giordani* (Vicenza, Italy), E. Brunetti, C. Stecca,
P. Benedetti, T. Heller
P0954
Isoniazid preventive therapy for tuberculosis
prevention in HIV patients: a retrospective study
of Dilla University Referral Hospital HIV cohort
H. Ayele* (Utrecht, The Netherlands), M. Bonten,
M. Mourik
P0955
Mycobacterium bovis in Burkina Faso,
epidemiologic and genetic links between humans
and cattle isolates
A. Sanou, Z. Tarnagda, E. Kanyala, D. Zingué,
M. Nouctara, H. Hien, A. Kabore, D. Neveu,
A.-L. Bañuls, S. Godreuil* (Montpellier, France)
Latent tuberculosis infection: what have we been
able to do so far?
F. Sanchez* (Barcelona, Spain), L. Moro, G. Orduna,
R. Oanea, N. Jové, J.P. Horcajada
P0956
Extrapulmonary tuberculosis during course of
fever of unknown origin
G. Stevanovic* (Belgrade, Serbia), L. Lavadinovic,
A. Spurnic-Radovanovic, M. Ilic, T. Kokotovic,
M. Pelemis
Sulfamethoxazole as a treatment option for drugresistant tuberculosis
L.M. Davies Forsman* (Stockholm, Sweden),
T. Schön, M. Larsson, P. Juréen, C.G. Giske,
J. Bruchfeld, U. Simonsson, K. Angeby
P0957
Fixed-dose combination drugs in tuberculosis
treatment and control
J.F. García-Rodríguez* (Ferrol, Spain),
I. Gómez-Buela, C. Lijó-Carballeda, H. Álvarez-Díaz,
A. Mariño-Callejo, P. Sesma-Sánchez
P0945
P0946
P0947
Epidemiology of Mycobacterium bovis disease in
humans, France, 2000-2010
M. Choisy, M.L. Boschiroli, J. Maugein, C. Segonds,
M.L. Abalain, V. Jacomo, M. Ponsada, G. Panteix,
A.L. Bañuls, S. Godreuil, N. Bouzinbi* (Montpellier,
France)
24th ECCMID / Barcelona
Final Programme
185
Chairs, Speakers & Authors
P0948
Exhibition
Poster Area
General Information
13:30 – 14:30
Posters
Sunday, 11 May 2014
Poster Sessions
Sunday, 11 May 2014
P0958
Out of pocket costs for patients with tuberculosis
in Colombia: evidence from three metropolitan
areas
J.M. Hernandez Sarmiento* (Medellin, Colombia),
L. Martinez, J. Cardona, E. Jimenez, L. Mejia,
Y. Sanchez, L. Ochoa, G. Gonzalez, C. Lazaro
P0959
Bilateral vitritis as a complication of intravesical
BCG immunotherapy
N. Elsakka, V. Bateman, G. Hepburn, L. Kuffova,
D. O’Brien* (Aberdeen, United Kingdom)
P0960
Prescriptions and dispensing of rifampicin
products for tuberculosis in Norway:
a retrospective study
T. Westergren* (Oslo, Norway), A. Falck,
G. Gadeholt, E. Lingaas
13:30 – 14:30
P0961
MGIT™ times to positivity in the REMoxTB study:
evidence for reducing the MGIT™ incubation time
M.E. Murphy* (London, United Kingdom),
A. Bateson, T.D. McHugh, S.H. Gillespie
P0962
Evaluation of a new generation of an acid-fast
bacilli aerospray automated slide stainer for
direct sputum smears
K. Mullen* (Logan, United States), E. Shipiki,
C. Helme
Comparison of the BD TB Fluorescent Stain Kit T
and RAL stainer system in staining smears from
pulmonary specimens: quality and time study
C. Cavusoglu* (Izmir, Turkey), A. Aslan
P0964
Validation of Copan Myco-TB and Myco-TB kit for
rapid digestion and decontamination of clinical
specimens for the detection of MTB with all
testing methods
E. Mazzola* (Brescia, Italy), A. Nava,
M. Delle Canne, S. Castriciano, G. Gesu
P0965
Molecular detection of Mycobacterium
tuberculosis from formalin-fixed, paraffinembedded tissues
H. Al Ghazal, S. Al Johani* (Riyadh, Saudi Arabia)
186 24th ECCMID / Barcelona
Can serum siderocalin levels predict active
tuberculosis in HIV-infected and non-HIV-infected
individuals?
G.M. Varghese* (Vellore, India), V.P. Turaka,
J. Janardhanan, T.S. Vijayakumar, B. Cherayil
P0967
Endobronchial ultrasonography-guided
transbronchial needle aspiration (EBUS-TBNA) for
the diagnosis of mediastinal tuberculosis
J.B. Stern* (Paris, France), R. Caliandro, P. Validire,
B. Wyplosz, L. Escaut, G. Lorillon, D. Gossot
P0968
Rational application of adenosine deaminase
activity in cerebrospinal fluid for the diagnosis of
tuberculous meningitis
V. Ramos, D. Vinuesa, V. Portillo-Tuñón,
N. Coronado-Álvarez, F. Anguita-Santos,
R. Cabo-Magadán, L. Muñoz-Medina, C. Dueñas,
J. Parra Ruiz* (Granada, Spain),
J. Hernández-Quero
P0969
QuantiFERON-Gold TB In-Tube assay – a critical
reassessment of results in a low prevalence
setting (Thuringia, Germany)
B. Hermann* (Jena, Germany), M. Baier
P0970
Interferon-gamma and tumoural necrosis
factor-alpha gene polymorphisms in pulmonary
tuberculosis: performance in TB-endemic
indigenous population
Z. Araujo García* (Caracas, Venezuela), A. Palacios,
R. Biomón, I. Rodríguez, J. Jiménez, A. Wide
P0971
A pilot study measuring the kinetic profile of IP-10
over the first 14 days of pulmonary tuberculosis
chemotherapy
R. Saunders* (Liverpool, United Kingdom),
M. Blakiston, L. Lawson, G. Harper, R. Anthony,
L.E. Cuevas
P0972
Distribution of killer cell immunoglobulin-like
receptors’ genes in patients with pulmonary
tuberculosis from northern Spain
J.G. Ocejo-Vinyals, C. González Rico, F. Ausín,
E. Puente de Mateo, J.L. Arroyo, R. Agüero,
M.C. Fariñas* (Santander, Spain)
Poster Area
POSTER SESSION III:
Tuberculosis:
non-molecular diagnosis and pathogenesis
P0963
P0966
Final Programme
Poster Sessions
Monday, 12 May 2014
P0982
Emergence of fluoroquinolone resistance
amongst three species of Haemophilus isolated
in a clinical laboratory
N. Liassine* (Geneva, Switzerland), K. Baroli,
O. Gaillot
P0983
Global prevalence, genetics and clonal
relatedness of macrolide resistance in Moraxella
catarrhalis (2010-2012)
D.J. Farrell* (North Liberty, IA, United States),
A.J. Costello, M. Castanheira, R.N. Jones
POSTER SESSION IV:
Molecular epidemiology of Haemophilus, Moraxella, and
Neisseria
P0975
Dynamics of Neisseria gonorrhoeae population
J. Serra Pladevall* (Barcelona, Spain), G. Roig,
R. Juve, J.J. Gonzalez, R. Bartolome, M.J. Barbera,
A. Andreu
P0976
P0977
P0978
Drug resistance in Neisseria gonorrhoeae due to
disorder in outer membrane proteins
E. Ilina* (Moscow, Russia), M. Malakhova, I. Bodoev,
O. Pobeguts, I. Altukhov, E. Khlebus, S. Kovalchuk,
V. Govorun
Beta-lactams plasmid-mediated resistance in
Neisseria gonorrhoeae in France
M. Michaelo, H. Jacquier, E. Cambau, A. Goubard,
P. Sednaoui, G. La Ruche, B. Bercot* (Paris, France)
Molecular epidemiology of quinolone resistance
in Neisseria gonorrhoeae in France
D. Gueret, T. Guillard, B. Bercot* (Paris, France),
G. La Ruche, A. Goubard, P. Sednaoui, E. Cambau
P0979
Phylogenetic diversity of ST4821 complex of
Neisseria meningitidis isolated from 1965 to
1985 and 2005 to 2013 in Shanghai, China
Q. Guo* (Shanghai, China), M. Chen, M. Chen,
M. Wang
P0980
Clinical and molecular epidemiology of
Haemophilus influenzae causing invasive
disease in adult patients
C. Puig Pitarch* (Hospitalet de Llobregat, Spain),
I. Grau, S. Marti, R. Pallares, C. Ardanuy, J. Liñares
P0981
Characterisation of ampicillin-resistant
Haemophilus influenzae isolates in middle ear
fluid from Japanese children with acute otitis
media
R. Kakuta* (Sendai, Japan), H. Yano, H. Hidaka,
M. Ogawa, A. Tanouchi, D. Ozawa, S. Endo,
H. Kanamori, M. Kaku, Y. Katori
12:30 – 13:30
Poster Area
POSTER SESSION IV:
Molecular epidemiology and surveillance of MDR
Pseudomonas and Acinetobacter
P0984
Carbapenem-resistant Pseudomonas aeruginosa
disseminated in Centro Hospitalar do Baixo
Vouga, Aveiro, Portugal
C. Santos* (Aveiro, Portugal), S. Ferreira,
E. Ramalheira, S. Mendo
P0985
Genetic diversity and antibiotic susceptibility of
Pseudomonas aeruginosa isolated from patients,
healthy volunteers and domestic animals in
Estonia
K. Telling* (Tartu, Estonia), V. Kisand, S. Kõljalg,
P. Kalmus, M. Maimets, I. Lutsar, T. Tenson
P0986
Epidemiological characterisation of class
1 integrons isolated in multidrug-resistant
Acinetobacter spp. in a tertiary hospital in
Daejeon, Korea for seven years
S. Koo* (Daejeon, Korea), G. Sung, G. Kwon, J. Kim,
J. Lim
P0987
Characterisation of intrinsic beta-lactam
resistance mechanisms among contemporary
ceftazidime non-susceptible Pseudomonas
aeruginosa from USA hospitals
M. Castanheira* (North Liberty, IA, United States),
J.C. Mills, R.E. Mendes, R.N. Jones
P0988
Analysis of metallo-beta-lactamase-encoding
class 1 integrons in Pseudomonas aeruginosa
isolates from the UK
L.L. Wright* (London, United Kingdom), J.F. Turton,
D.M. Livermore, K.L. Hopkins, N. Woodford
24th ECCMID / Barcelona
Final Programme
187
Posters
Molecular typing by NG-MAST of Neisseria
gonorrhoeae isolated from recurrent genital
infections
M. Gits-Muselli, B. Bercot* (Paris, France),
F. Lassau, M. Janier, E. Cambau
Chairs, Speakers & Authors
P0974
Exhibition
Poster Area
General Information
12:30 – 13:30
Poster Sessions
Monday, 12 May 2014
P0989
Carbapenem-resistant Acinetobacter baumannii
with OXA-72 carbapenemase and extendedspectrum beta-lactamase CTX-M-2
Y. Pfeifer* (Wernigerode, Germany), G. Werner,
K.P. Hunfeld, D. Maneg, S. Borgmann, W. Blobner,
P.G. Higgins
P0990
Prevalence of colistin-resistant Acinetobacter
spp. isolates in Centro Hospitalar entre Douro e
Vouga, Santa Maria da Feira, Portugal
C. Santos* (Aveiro, Portugal), A. Viana, A. Silva,
S. Mendo
P0991
Molecular characterisation of carbapenemresistant Acinetobacter baumannii isolates
from bloodstream infections from 15 university
hospitals in the republic of Korea
M.J. Kim* (Seoul, Korea), J.Y. Kim, J.Y. Kim,
J.W. Sohn, D.W. Park, Y.K. Yoon, C.S. Lee, S.Y. Ryu,
M.S. Lee, S.S. Lee
P0992
Molecular epidemiology of Acinetobacter spp.
causing bacteraemia in Japanese community
hospitals
S. Endo* (Sendai, Japan), H. Yano, H. Kanamori,
S. Inomata, T. Aoyagi, M. Hatta, Y. Gu, K. Tokuda,
M. Kitagawa, M. Kaku
P0993
Emergence and spread of blaNDM-1 along with
blaOXA-23 among Acinetobacter baumannii
clinical isolates from Egypt
M. Abdelgawad, M. Ali Amin, W. Tawakol, L. Loucif,
J.M. Rolain* (Marseille, France)
P0994
Identification of particular clonal complexes
and mobile elements associated with
the dissemination of blaOXA-23-carrying
Acinetobacter baumannii and blaVIM-2-carrying
Pseudomonas aeruginosa in Romania I. Gheorghe* (Bucharest, Romania), A. Novais,
F. Grosso, C. Rodrigues, C. Chifiriuc, V. Lazar, L. Peixe
P0995
Species distribution, clonal diversity and
antimicrobial susceptibility of Burkholderia
cepacia complex isolates from cystic fibrosis
patients in Barcelona
A. Mirambell Viñas* (Barcelona, Spain),
M. Lung, T. Cornejo-Sánchez, M.A. Cano, A. Ferrer,
R. Bartolomé, M.N. Larrosa, J.J. González-López
P0996
The critical role of molecular surveillance in
control of Acinetobacter baumannii infections
O. Ergonul* (Istanbul, Turkey), E. Donmez, C. Seref,
A. Komur, P. Ispir, D. Egeli, T. Kafadar, F. Can
188 24th ECCMID / Barcelona
Final Programme
P0997
Carbapenem-resistant Acinetobacter baumannii
harbouring OXA-type (OXA-24-, OXA-58- and OXA143-like) carbapenemases in Brazil
T.P.G. Chagas* (Rio de Janeiro, Brazil), I.C.O. Santos,
A.P.D.’A. Carvalho-Assef, M.D. Asensi
P0998
Molecular epidemiology, carbapenem and colistin
susceptibility of Acinetobacter baumannii
isolated as part of the MagicBullet clinical trial
P. Higgins* (Cologne, Germany), J. Nowak,
E. Zander, I. Roca, J. Vila, H. Seifert
P0999
Molecular epidemiology of carbapenem-resistant
Acinetobacter baumannii isolated in intensive
care units
D. Haciseyitoglu, Y. Cag* (Istanbul, Turkey), O. Ak,
S. Gencer, G. Akengin Ocal, F. Biteker, Z. Gurkan,
S. Ozer
P1000
Impact of carbapenem-resistant Acinetobacter
baumannii healthcare-associated infections in
patients admitted to Italian intensive care units:
results of the SPIN-UTI cohort study
A. Agodi* (Catania, Italy), F. Auxilia, M. Barchitta,
M.M. D’Errico, M.T. Montagna, C. Pasquarella,
S. Tardivo, I.I. Mura, G. S.I.t.I.
P1001
A case-control study to identify predictors of
14-day mortality following carbapenem-resistant
Acinetobacter baumannii bacteraemia
A. Nutman* (Tel Aviv, Israel), R. Glick, E. Temkin,
M. Hoshen, R. Edgar, T. Braun, Y. Carmeli
P1002
ICU-acquired pneumonia due to Pseudomonas
aeruginosa with and without multidrug
resistance: specific risks factors and associated
inflammatory response
L. Fernandez-Barat* (Barcelona, Spain), F. De Rosa,
M. Ferrer, A. Gabarrús, M. Esperatti, S. Terraneo,
M. Rinaudo, L.F. Difrancesco, G. Li Bassi, A. Torres
P1003
Risk factors and influence of carbapenem
exposure on the development of carbapenem
resistant Pseudomonas aeruginosa bloodstream
infections
M. Barron* (Aurora, United States), K. Richardson,
B. McCollister
P1004
Molecular characterisation of Pseudomonas
aeruginosa and Enterobacteriaceae isolates
harbouring the carbapenemase GIM-1
A. Hamprecht* (Cologne, Germany), S. Göttig,
L. Poirel, S. Gatermann, H. Seifert, M. Kaase
Poster Sessions
Carbapenem-resistant Acinetobacter baumannii
in adult intensive care unit: risk factors for
colonisation and infection
N. Aksu, I. Baran, M.A. Yetkin* (Ankara, Turkey),
D. Kanyilmaz, I. Mumcuoglu, A. Bastug, S. Alacam,
H. Yagmurdur, H. Bodur
12:30 – 13:30
Poster Area
Natural distribution of transmissible
beta-lactams resistance mechanisms in
Enterobacteriaceae
A. Xiaoman, A. Fajardo-Lubian* (Sydney, Australia),
A. Agyekum, A. Ginn, J. Iredell
P1013
Diverse Salmonella non-typhoid antibioticresistant clonal lineages are tolerant to copper
and silver metals
J. Mourão* (Porto, Portugal), J. Machado, C. Novais,
L. Peixe, P. Antunes
P1014
Replicon typing of Enterobacter cloacae complex
isolates producing extended-spectrum betalactamases (ESBL) from northern Spain
J. Calvo Montes* (Santander, Spain),
E. Román Paucar, M.P. Garcillán Barcia,
M.E. Cano García, A. Ocampo Sosa,
B. Ruiz del Castillo, L. Martínez Martínez
P1015
Detection of class 1, 2, and 3 integrons among
extended-spectrum beta-lactamase-producing
Klebsiella pneumoniae isolated from Baltic sea
region
K. Pärna, A. Balode A- Edquist P- Egorova
S- Kaftyreva L – Miciuleviciene J, M. Ivanova,
S. Kõljalg, K. Pai, A. Pavelkovich, T. Rööp, E. Sepp,
P. Naaber, J. Stsepetova* (Tartu, Estonia)
P1016
Relatively high prevalence of genetic and
phenotypic silver resistance among Enterobacter
cloacae isolates
S. Sütterlin* (Uppsala, Sweden), Y. Molin, A. Melhus
P1017
Characterisation of outer-membrane proteins
and carbapenemase in carbapenem-resistant
Enterobacter aerogenes and Enterobacter
cloacae
J.R. Ferraz, J. Calil, C. Rizek, C. Carrilho, S. Costa*
(Rio de Janeiro, Brazil)
P1018
Molecular characterisation of carbapenemases
amongst non-susceptible Enterobacteriaceae
isolated from South African hospitals: 1 October
2012 – 1 October 2013
J. Coetzee* (Pretoria, South Africa), A.J. Brink,
C. Corcoran, T. Marshall, C. Sriruttan, C. Clay
P1019
Characterisation of CTX-M-14-and CTX-M-15producing Escherichia coli and Klebsiella
pneumoniae isolates from urine specimens in a
tertiary hospital
S. Koo* (Daejeon, Korea), S. Kim, G. Kwon, J. Kim
POSTER SESSION IV:
Molecular epidemiology of MDR Enterobacteriaceae
P1007
Investigating antimicrobial resistance in
soil-culturable Gram-negative bacteria
D. Jones-Dias* (Lisbon, Portugal), E. Ferreira,
J. Almeida, M. Caniça
P1008
Resistance genes to aminoglycosides [aac(6?)Ib-cr, aac(3)-IIa, aadA], quinolones (qnrB) and
integrons in multirresistant KPC-producing
Klebsiella pneumoniae from Brazil
P. Silva Pereira* (Rio de Janeiro, Brazil), M. Borghi,
M. Dutra Asensi, A.P. D’Alincourt Carvalho Assef
P1009
Sensitivity and specificity of the MIC test strips
(MTS) mechanisms of detection against in-house
methods for 644 multi-drug resistant (MDR)
strains: a European multi-centre study
R. Canton, M. Gniadkowski, M. Morosini, M. Pirs,
G. Rossolini, M. Sukhorukova, A. Tsakris, G. Vrioni,
T. Walsh* (Cardiff, United Kingdom), D. Zabicka
P1010
P1011
Prevalence of 16S rRNA methylase genes in
enterobacterial isolates in two Greek hospitals in
a three-year period
I. Galani, H. Moraitou, K. Orlandou, K. Nafplioti,
M. Drogari-Apiranthitou, E. Vogiatzakis,
G. Petrikkos* (Athens, Greece), M. Souli
Recent dissemination of a GIM-1-producing
Serratia marcescens clone in North Rhine
Westphalia, Germany
A.F. Wendel* (Düsseldorf, Germany), H. Rieber,
C.R. MacKenzie
24th ECCMID / Barcelona
Final Programme 189
Chairs, Speakers & Authors
P1006
P1012
Exhibition
KPC-producing Pseudomonas aeruginosa from
the United States: what next?
L.M. Deshpande, K.M. Simpson, R.N. Jones,
M. Castanheira* (North Liberty, IA, United States)
General Information
P1005
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1020
Carbapenemase-producing Gram-negatives in
Colombia, between 2012 and 2013
S. Saavedra Rojas* (Bogota, Colombia), C. Duarte,
M. Gonzalez, M. Ovalle, A. Villalobos, S. Rivera,
M. Beltran, L. Barrero
P1021
ESBL-producing E. coli and K. pneumoniae: is the
community a reservoir of widespread clones or
clonal variants?
J. Pires* (Porto, Portugal), C. Rodrigues, R. Campainha,
S. Moniz, J. Amorim, L. Peixe, Â. Novais
P1043
P1022
P1023
P1024
P1025
P1021a
P1026
Correlation between antimicrobial consumption
in the intensive care unit and resistance of some
bacteria involved in pulmonary infections in
hospitalised patients
S. El Mais* (Craiova, Romania), L. Rosu, D. Calina,
A. Turculeanu, A. Rosu, O. Zlatian
P1027
The first detection of plasmid-mediated AmpC
beta-lactamase in multidrug-resistant Proteus
mirabilis isolates from University Hospital Centre
Split, Croatia
Z. Rubic* (Split, Croatia), S. Soprek, M. Jelic,
M. Radic, A. Novak, I. Goic-Barisic, M. Tonkic,
A. Tambic-Andrasevic
P1028
Association of plasmid-mediated AmpC and
extended-spectrum beta-lactamase in Klebsiella
pneumoniae isolated at Charles Nicolle Hospital
of Tunis, Tunisia
T. Chérif, M. Saidani, A. Kammoun, R. Ghozzi,
I. Boutiba* (Tunis, Tunisia), A. Slim
P1029
Investigation of virulence potential of the ESBLproducing Klebsiella pneumoniae strains isolated
from Bulgarian hospitals
D. Ivanova* (Sofia, Bulgaria), R. Markovska, I. Mitov
P1030
Detection of NDM-1- carbepenemase in
Providencia rettgeri isolates from 5 hospitals of
two cities in Colombia
S. Saavedra Rojas* (Bogota, Colombia), C. Duarte,
M. Gonzalez
P1031
Co-association of blaNDM-1 and blaKPC-2 in
Brazilian Enterobacteriaceae clinical isolates
M.G. Quiles* (São Paulo, Brazil), T.T. Rocchetti,
L.C. Fehlberg, E.J.U. Kusano, A. Chebabo,
R.M.G. Pereira, A.C. Gales, A.C.C. Pignatari
Emergence and spread of a novel carbapenem
resistance plasmid in a hospital cohort involving
multiple species of Enterobacteriaceae
A.E. Sheppard* (Oxford, United Kingdom), A. Giess,
N. Stoesser, A. Bashir, R. Sebra, A. Kasarkis,
D.W. Crook, C.D. Sifri, A.J. Mathers
P1032
Genetic determinants of antimicrobial resistance,
virulence factors and plasmid content in
multidrug-resistant Klebsiella pneumoniae from
four large hospitals in Brazil
L.N. Andrade* (São Paulo, Brazil), L.M.M. Stegani,
A.L.C. Darini
Carbapenemase and pathogenicity of
Enterobacteriaceae in north Lebanon between
2008 and 2012: towards an endemic diffusion of
OXA-48
R. Beyrouthy* (Clermont Ferrand, France), F. Robin,
F. Dabboussi, H. Mallat, M. Hamzé, R. Bonnet
P1033
Resistance plasmids in ESBL-producing
Klebsiella pneumoniae
J.B. Nielsen* (Hvidovre, Denmark), L.H. Hansen,
K. Schønning
P1034
Duration of hospitalisation in South African
healthcare facilities prior to the acquisition of
carbapenemase-producing Enterobacteriaceae
(CPE)
A. Brink* (Johannesburg, South Africa), J. Coetzee,
C. Corcoran, T. Marshall, C. Sriruttan, C. Clay
ESBL-producing Enterobacteriaceae other than
E. coli in Portuguese hospitals: the spread of
epidemic K. pneumoniae clones and plasmids
(IncR, IncFIIK, IncL/M)
C. Rodrigues* (Porto, Portugal), E. Machado,
L. Peixe, Â. Novais
Molecular survey of 2109 carbapenem-resistant
Enterobacteriaceae isolates from Portuguese
hospitals: co-production of carbapenemase KPC3 and the efflux pump OqxAB
V. Manageiro* (Lisbon, Portugal), E. Ferreira,
J. Almeida, S. Barbosa, C. Simões, Antimicrobial
Resistance Surveillance Program in Portugal,
M. Caniça
Outbreak of Salmonella enterica serovar Infantis
harbouring CTX-M-9-group extended-spectrum
beta-lactamase (ESBL) in children less than 6
years old with diarrhoea in Lima, Peru
M. Riveros Ramirez* (Lima, Peru), A. Granda Alacote,
K. Ocampo Cardenas, S. Martínez Puchol,
A. Corujo Fernandez, J. Ruiz, I. Reyes, T. Ochoa
Acquisition of ESBL- and carbapenemaseproducing Enterobacteriaceae in a large
prospective cohort of healthy travellers: the
Carriage Of Multiresistant Bacteria After Travel
(COMBAT) study
M.S. Arcilla, J.M. Van Hattem* (Rotterdam,
The Netherlands), P.J. Van Genderen, A. Goorhuis,
C. Schultsz, E.E. Stobberingh, H.A. Verbrugh,
M.D. De Jong, D.C. Melles, J. Penders
190 24th ECCMID / Barcelona
Final Programme
Poster Sessions
P1038
P1039
P1040
P1041
P1042
Increasing multidrug resistance in Gram-negative
bacteraemia: trends over 13 years in a teaching
hospital in London
C. Suarez Fernandez* (London, United Kingdom),
L. Whitney, A. Breathnach, T. Planche
P1045
Per-like extended-spectrum beta-lactamaseproducing Acinetobacter baumannii in Kuwait
A. Dashti* (Kuwait City, Kuwait), L. Vali, A. Opazo,
K. Al- Obaidi, S. Amyes
P1046
Prevalence of colonisation by ESBL-producing
enterobacteria in patients with Clostridium
difficile infection
M. Arvand* (Dillenburg, Germany)
P1047
Genetic characterisation of KPC-2 producing
Klebsiella pneumoniae and polymixin B
resistance from several hospitals in São Paulo
state, Brazil
G. Francisco* (São Paulo, Brazil), M.F. Bueno, Y. Doi,
D.O. Garcia
P1048
Molecular epidemiology and characteristics of
extended-spectrum beta-lactamase-producing
Escherichia coli in the Japanese clinical setting
H. Yano* (Sendai, Japan), A. Tanouchi, S. Endo,
H. Kanamori, T. Aoyagi, M. Hatta, Y. Gu, K. Tokuda,
M. Kitagawa, M. Kaku
Bacteraemia due to extended-spectrum
beta-lactamase (ESBL) / AmpC-positive
Enterobacteriaceae in hospitalised patients
at Basildon and Thurrock University Hospitals:
molecular, microbiological and clinical
characterisation
S.G. Udugama* (Essex, United Kingdom),
B.P. Cherian, D. Wareham, M. Parker
P1049
Distribution of extended-spectrum betalactamase (ESBL)-positive Enterobacteriaceae in
hospitals throughout Germany
R. Leistner* (Berlin, Germany), C. Schröder,
A.C. Breier, C. Geffers, P. Gastmeier, M. Behnke
Emergence of E. coli O25b-ST131 clone among
uropathogenic multidrug-resistant isolates and
associated clinical risk factors
F. Can, C. Seref* (Istanbul, Turkey), P. Ispir, I. Loclar,
O. Kurt-Azap, O. Ergonul
P1050
Bloodstream infections caused by ESBLproducing Escherichia coli: epidemiology and
clinical features
S. Cho* (Seoul, Korea), C.I. Kang, M. Cha, W.J. Lee,
D.R. Chung, N.Y. Lee, K.R. Peck, J.H. Song
Characterisation of Escherichia coli carrying
blaNDM-7 from the Sultanate of Oman
A. Sonnevend* (Al Ain, United Arab Emirates),
A. Ghazawi, D. Darwish, L. Villa, A. Carattoli, A. AlJardani, S. Al-Abri, T. Pál
P1051
Molecular characterisation of KPC-producing
Klebsiella pneumoniae from Belgium
C. Bauraing* (Yvoir, Belgium), P. Bogaerts,
A. Deplano, W. Boucharhouf, T.D. Huang, B. Jans,
O. Denis, Y. Glupczynski
Molecular characterisation of New Delhi
metallo-beta-lactamase-1 and it variants among
Enterobacteriaceae from India
K.N. Prasad* (Lucknow, India), M. Rahman,
S.K. Shukla, C.M. Ovejero, B. Pati, A. Tripathi,
A. Singh, B.G. Zorn
Report of the national reference laboratory for
multidrug-resistant Gram-negative bacteria on
carbapenemases in Germany in 2013
M. Kaase* (Bochum, Germany), A. Anders,
N. Pfennigwerth, S.G. Gatermann
The epidemiology of extended-spectrum betalactamase-producing Klebsiella pneumoniae that
contain qnr genes in Kuwait
A.A. Dashti* (Kuwait City, Kuwait), L. Vali,
M.M. Jadaon, S. El-Shazly
The mother provides an important risk factor for
colonisation of neonates with extended-spectrum
beta-lactamase-producing Enterobacteriaceae
(ESBL-E)
L.A. Denkel* (Berlin, Germany), F. Schwab,
B. Piening, A. Kola, C. Geffers, L. Garten,
K. Von Weizsäcker, P. Gastmeier
Chairs, Speakers & Authors
P1037
P1044
Exhibition
P1036
Prevalence and clinical characteristics of
hypermucoviscous Klebsiella pneumoniae
causing bacteraemia among adult patients in a
teaching hospital in Barcelona
M. Cubero* (L’Hospitalet de Llobregat, Spain),
I. Grau, F. Tubau, R. Pallarés, M.A. Domínguez,
J. Liñares, C. Ardanuy
24th ECCMID / Barcelona
Final Programme
191
General Information
P1035
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
Poster Area
P1060
Are urinary isolates more resistant than nonurinary isolates?
M.M. Soriano* (Chicago, United States),
A.T. Harrington, L.H. Danziger
P1052
Study to estimate the burden of ESBL E. coli and
Klebsiella species causing community-acquired
urinary tract infections in Tower Hamlets borough
of London
G. Jacob* (London, United Kingdom), S. Das
P1061
ESBL production is a common independent risk
factor for colonisation/infection by Escherichia
coli with phenotypic heterogeneous resistance to
carbapenems
L. Zhang* (Chongqing, China), J. Sun, S. Huang,
S. Pu, L. Zheng, C. Zhang
P1053
Low prevalence of extended-spectrum betalactamase (ESBL)-producing Escherichia coli in
community-acquired urinary tract infections in
Uppsala county, Sweden
M. Ericsson* (Uppsala, Sweden), A. Lindström,
G. Stridh Ekman, O. Andersson, S. Susanne
P1062
The effect of different quinolone groups on
selection of quinolone-resistant Escherichia coli
in faecal flora
Z. Bayindir* (Ankara, Turkey), G. Aydin, F. Yoruk
P1063
Use of pivmecillinam for treating urinary
tract infection caused by multidrug-resistant
Enterobacteriaceae
P. Hunter, F. Christison, J. McLaren, K. McCandless,
S. McCormick, D. Inverarity* (Airdrie,
United Kingdom), S.J. Dancer
P1064
Fosfomycin-resistant Escherichia coli causing
urinary tract infection (UTI)
A. Rando* (Barcelona, Spain), N. Larrosa,
L. Goterris, E. Garcia, Z. Moure, E. Dueñas, C. Gulín,
A. Andreu, D. Viu
P1065
Clinical and microbiological outcomes after
cefoxitin treatment for infections caused by
extended-spectrum-beta-lactamase-producing
Enterobacteriaceae: results of an observational
study
S. Kernéis* (Paris, France), S. Valade, G. Geri,
F. Compain, M. Lavollay, H. Rostane, E. Carbonnelle,
J. Mainardi
12:30 – 13:30
POSTER SESSION IV:
Resistance surveillance in Gram-negatives
P1054
Prevalence of ESBL-producing E. coli and K.
pneumoniae in Georgia 2011-2012
T. Davitashvili, N. Jashiashvili* (Tbilisi, Georgia)
P1055
Epidemiology and susceptibility of pathogens
from hospital- and community-associated urinary
tract infection in Turkey: SMART 2011-2012
S. Lob, G. Yilmaz, P. Zarakolu, L. Mulazimoglu,
B. Mete, Z. Gülay, R. Badal* (Sacramento,
CA, United States), S. Bouchillon, M. Hackel,
And the Turkish SMART Study Group
P1056
Risk factors for community-onset urinary tract
infection caused by extended-spectrum betalactamase-producing bacteria in adults
E. Koksal, N. Tulek* (Cankaya, Ankara, Turkey),
F. Temocin, C. Bulut, C. Ataman Hatipoglu,
F.S. Erdinc, G. Tuncer Ertem
P1057
Antibiotic susceptibility profiles of urinary
Escherichia coli isolates and community
antibiotic use in Tasmania, Australia
E. Meumann* (Hobart, Australia), L. Cooley,
A. McGregor, B. Mitchell
P1066
Survey of extended-spectrum beta-lactamase
(ESBL) producing Escherichia coli strains in the
French community (2008-2012)
S. Thibaut, A. Marquet, M. Lagneau,
J.F. Huon, G. Grandjean, J. Caillon*
(Nantes, France), F. Ballereau, & medical
analysis laboratories of MedQual network Isolation of extraintestinal pathogenic E. coli
from postcholecystectomic samples and their
antimicrobial resistance profile in Georgia
E. Vashakidze* (Tbilisi, Georgia), T. Megrelishvili,
E. Pachkoria, P. Imnadze, L. Tevzadze, G. Chanturia,
T. Tevdoradze, N. Khachidze
P1067
Presence of multiresistant Enterobacteriaceae in
university hospital wastewater
M. Htoutou Sedlakova* (Olomouc, Czech Republic),
V. Husickova, R. Silova, P. Imwensi, M. Roderova,
J. Bardon, M. Kolar
P1068
Five year analysis (2009-2013) of the
identification and antimicrobial susceptibility
trends for Enterobacter spp. collected from EU
countries in the test programme
D. Biedenbach* (Schaumburg, United States),
S. Bouchillon, M. Hackel, I. Morrissey
P1058
P1059
Extended-spectrum beta-lactamase and
quinolone-resistant Escherichia coli in acute
prostatitis: a study of 11345 cases of transrectal
ultrasound (TRUS)-guided prostate biopsy
H.G. Jeon, W. Song, H.W. Moon* (Seoul, Korea),
B.C. Jeong, S.I. Seo, S.S. Jeon, H.M. Lee, H.Y. Choi
192 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Tigecycline activity tested against carbapenemresistant Enterobacteriaceae from European
hospitals: results from the SENTRY program
(2010-2013)
H.S. Sader* (North Liberty, IA, United States),
M. Castanheira, D.J. Farrell, R.K. Flamm, R.N. Jones
P1072
P1073
Nationwide multicentric survey on multidrugresistant Pseudomonas aeruginosa isolates in
Belgian hospitals in 2012-2013
Y. Glupczynski* (Yvoir, Belgium), C. Berhin,
A. Deplano, C. Bauraing, T.-D. Huang, B. Jans,
O. Denis, P. Bogaerts
P1080
Prevalence of metallo-beta-lactamases in
carbapenem non-susceptible Pseudomonas
aeruginosa isolates in south east Austria
E. Leitner* (Graz, Austria), A. Badura, M. Hoenigl,
M. Gehrer, J. Luxner, L. Masoud-Landgraf, U. WagnerEibel, G. Feierl, A. Grisold
P1081
Stability of ertapenem MICs of Escherichia coli in
Europe: SMART 2008-2012
S. Lob, R. Badal* (Sacramento, CA, United States),
S. Bouchillon, M. Hackel, D. Hoban
High level of antimicrobial resistance of
Pseudomonas spp. isolates in a haematology unit
compared with the intensive care unit and other
hospital units in Saragossa, Spain
A.I. López-Calleja, I. Ferrer, L. Alcalá, P. Delgado,
M.C. Villuendas, P. Palacián, G. Martin, M.J. Revillo,
A. Rezusta* (Zaragoza, Spain)
P1082
Prevalence and antibiotic susceptibility of ESBLpositive pathogens: an evaluation of SMART data
2011-2012 from Lebanon compared to regional
Middle East
A. Hajj* (Beirut, Lebanon), L. Kazan,
D. Karam Sarkis
Epidemiology and susceptibility of pathogens
from intra-abdominal infections in different
patient settings in Turkey: SMART 2011-2012
S. Lob, I. Koksal, S. Unal, V. Korten, F. Tabak, E. Alp,
V. Oguz, R. Badal* (Sacramento, CA, United States),
M. Hackel, And the Turkish SMART Study Group
P1083
Resistance of bacteria isolated from clinical
samples in hospitalised patients in the burns
unit and plastic surgery ward in a Greek hospital
during five years
M. Orfanidou* (Athens, Greece), M. Kamperogianni,
A. Karonidis, G. Ganteris, L. Drosopoulou,
D. Tsoutsos, E. Vagiakou, H. Malamou-Lada
P1084
Comparison of CLSI and EUCAST clinical
breakpoints for surveillance of antimicrobial
resistance of Salmonella enterica in Bulgaria,
2011-2012
G. Asseva* (Sofia, Bulgaria), I. Tomova, K. Ivanova,
I. Ivanov, E. Dobreva, B. Panova, P. Petrov,
T. Kantardjiev
P1085
Differences in bacterial resistance observed
among pathogens collected from the TEST
programme (2004-2012) for individual countries
and regions in eastern and western Europe
M. Renteria* (Schaumburg, United States),
S. Bouchillon, D. Biedenbach, D. Hoban, M. Hackel,
H. Leister-Tebbe
Monitoring of ertapenem resistance in
Escherichia coli and Klebsiella pneumoniae
following introduction of ertapenem into hospital
formulary
T.Y. Tan* (Singapore, Singapore), L.S.Y. Ng,
N. Syahidah P1074
Fluoroquinolone resistance trends among
Enterobacteriaceae from European medical
centers 2011-2013
D. Biedenbach* (Schaumburg, United States),
J. Johnson, S. Bouchillon, M. Hackel, S. Hawser,
H. Leister-Tebbe
P1076
Distribution of multi-resistant organisms among
patients in outpatient renal dialysis units in
Germany, 2003-2012
A. Schrauder* (Darmstadt, Germany), C. Wendt
P1077
Antibiotic resistance in a collection of
Pseudomonas aeruginosa isolated from cystic
fibrosis patients through Europe (Belgium,
France, Germany and United Kingdom)
M.H. Mustafa* (Brussels, Belgium), H. Chalhoub,
M. Tunney, S. Elborn, A. Vergison, O. Denis, P. Plésiat,
B.C. Kahl, H. Traore, F. Vanderbist, J.M. Buyck,
P.M. Tulkens, F. Van Bambeke
P1078
Stability of Pseudomonas aeruginosa
antimicrobial susceptibility: SMART 2008-2012
R. Badal* (Sacramento, CA, United States), S. Lob,
S. Bouchillon, M. Hackel, I. Morrissey, S. Hawser
24th ECCMID / Barcelona
Final Programme
193
Chairs, Speakers & Authors
P1070
P1071
P1079
Exhibition
Tigecycline resistance among clinical isolates in
a tertiary care hospital
S. Basireddy* (Mahbubnagar, India), V. Kabra,
M. Singh, H. Reddy, S. Ali
General Information
P1069
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1086
Antimicrobial susceptibility of 29932 pathogens
isolated from patients in Canadian hospitals:
CANWARD study 2007-2012
G.G. Zhanel, H. Adam, P. Lagacé-Wiens* (Winnipeg,
Canada), J. Karlowsky, M. Baxter, K. Nichol,
M. Mulvey, G. Golding, D. Hoban
12:30 – 13:30
P1088
Are carbapenemases really pre-requisite for
carbapenem-resistance in Enterobacteriaceae?
Analysis of isolates submitted to a national
reference laboratory in 2012
R. Hill* (London, United Kingdom), D. Meunier,
R. Pike, K. Hopkins, K. Patabendige, T. Noorie,
N. Woodford Multiclonal spread of OXA-48-producers
involving CG258 (ST11) Klebsiella pneumoniae
and other Enterobacteriaceae in a VIM and
KPC carbapenemase-endemic hospital and
emergence in non-hospitalised patients
D. Gijon Cordero* (Madrid, Spain), M.I. Morosini,
S. García-Fernández, T.M. Coque, P. Ruíz-Garbajosa
P1089
OXA-48 carbapenem-producing E. coli isolates
from Tchad – another African country
M. Naas, S. Bernusset, P. Dabi, N. Fortineau,
L. Dortet, P. Nordmann, T. Naas* (Le Kremlin Bicêtre,
France)
P1090
Influence of bicarbonates on sensitivity
of diagnostic tests for OXA-48-producing
Enterobacteriaceae
V. Studentova, C.C. Papagiannitsis, E. Chudackova,
T. Bergerova, J. Hrabak* (Pilsen, Czech Republic)
P1091
Great diversity of blaOXA-48-like genes in
aquatic systems: have we been neglecting the
environment?
M. Tacao* (Aveiro, Portugal), C. Maia, I. Silva,
A. Correia, I. Henriques
P1092
Environmental enterobacteria carrying blaOXA48-like genes
M. Tacao* (Aveiro, Portugal), S. Araújo, A. Correia,
A. Alves, I. Henriques
P1093
Characterisation of OXA-370 producing isolates in
Brazil
V.B. Ribeiro* (Porto Alegre, Brazil), C.M. Magagnin,
F.P. Rozales, M. Pagano, D. Falci, J. Sampaio,
A.L. Barth, A.P. Zavascki
194 24th ECCMID / Barcelona
Identification of a novel variant of the
carbapenemase IMI in Enterobacter spp.
B. Aasnaes* (Tromsø, Norway), D. Skaare,
B. Haldorsen, A. Sundsfjord, O. Samuelsen
P1095
New amino acid modifications in porins of
Gram-negative isolates contributing to
carbapenem resistance
C. Simões, V. Manageiro, D. Jones-Dias, E. Ferreira,
M. Marin Canica* (Lisbon, Portugal)
P1096
NDM-1, novel TEM-205, novel TEM-213 and other
beta-lactamases co-expressed in isolates from
cystic fibrosis patients
N. Mhlongo, U. Govinden, S. Essack* (Durban,
South Africa)
P1097
Molecular characterisation of NDM-5 in an
Escherichia coli isolate from a non-traveller
patient in Spain
M. Sole Guiu* (Barcelona, Spain), C. Pitart,
A. Román, A. Moreno, I. Roca, J. Vila, F. Marco
P1098
Genomic analysis of NDM-1 producing Morganella
morganii through whole-genome sequencing
A. Olaitan, S.M. Diene, S.K. Gupta, A. Adler,
M.V. Assous, J.M. Rolain* (Marseille, France)
P1099
Novel tigecycline resistance mechanisms: the
alteration of the 30S ribosomal protein S10 in the
drug target site in KPC-2-producing Klebsiella
pneumoniae clinical isolates
C. Feudi, R. Galetti, D. Fortini, L. Villa, A. Carattoli*
(Rome, Italy)
P1100
Differentiation of K. variicola from K. pneumoniae
using PCR-multiplex, and its prevalence among
clinical isolates
U. Garza-Ramos* (Cuernavaca, Mexico), P. Tinoco,
J. Silva-Sanchez, M. Pina-Gonzales,
J. Martinez-Barnetche, E. Martinez-Romero,
D. Laureano-Gonzalez, P. Garcia-Moguel
P1101
Beta-lactamase-producing Gram-negative
isolates and molecular mechanisms involved in
the expression of tigecycline resistance
S. Barbosa, E. Ferreira, V. Manageiro,
D. Jones-Dias, Antimicrobial Resistance Surveillance
Program in Portugal, M. Marin Canica* (Lisbon,
Portugal)
P1102
Overexpression of ramA from Citrobacter freundii
mediates MDR phenotype in various Citrobacter
species and also in Escherichia coli
A. Reinhardt* (Hamburg, Germany), F. Kühn,
A. Heisig, P. Heisig
Poster Area
POSTER SESSION IV:
Enterobacteriaceae: resistance and fitness
P1087
P1094
Final Programme
Poster Sessions
Impact of a soxR mutation on fitness and
antibiotic resistance of an Escherichia coli isolate
and identification and characterisation of fitness
compensating mutations
J. Wenk* (Hamburg, Germany), A. Heisig, P. Heisig
P1105
Fitness cost and virulence associated with the
development of colistin resistance in Klebsiella
pneumoniae
S. Christ, L. Sedlaczek, A. Hamprecht, T. Wichelhaus,
V.A.J. Kempf, C. Ewers, S. Göttig* (Frankfurt,
Germany)
P1106
P1107
The discordant relationship between CTX-M-15
mRNA and protein production does not interfere
with beta-lactam/beta-lactamase inhibitor
combination susceptibilities in Escherichia coli
C. Geyer, R. Fowler, N. Hanson* (Nebraska, United
States)
Multiple drug resistance regions linked to
blaCTX-M-15 and atypical class 1 integrons
N. Echeverría Chagas* (Montevideo, Uruguay),
G. Khalil, A. Ingold, M. Castro, G. Borthagaray,
C. Márquez
P1108
Analysis of the resistance mechanisms to
nitrofurans in Salmonella spp. meat isolates
S. Martinez Puchol* (Barcelona, Spain), M.J. Pons,
C. Gomes, L. Ruiz, A. Corujo, T.J. Ochoa, J. Ruiz
P1109
Common transcriptomic changes in the
adaptation of Salmonella enterica Typhimurium to
biocides and antibiotics
T. Garcao Curiao* (Madrid, Spain), E. Marchi,
D. Grandgirard, C. Viti, S. Leib, F. Baquero,
M.R. Oggioni, J.L. Martínez, T.M. Coque
P1110
OXA-48 and VEB-8 producing Salmonella
Kentucky of ST198 in a patient transferred from
Libya to Switzerland
S.N. Seiffert, V. Perreten, S. Johannes, S. Droz,
T. Bodmer, A. Endimiani* (Berne, Switzerland)
Shigella sonnei CTX-M-55: first report from South
America
J. Zurita* (Quito, Ecuador), A.C. Vargas, E. Sierra,
I. Alcocer, D. Ortega-Paredes
P1112
Characterisation of nalidixic acid-resistant
Shigella strains isolated from paediatric patients
in Tehran, Iran
R. Ranjbar* (Tehran, Iran), V. Behnood, F. Pourali,
A. Najafi, N. Sadeghifard, N. Jonaidi, I. Morteza,
C. Mammina
P1113
Rise in ciprofloxacin-resistant Shigella isolates in
Ireland
N. De Lappe, J. O Connor, M. Cormican, D. Morris*
(Galway, Ireland)
P1114
Acquisition of ESBLs in Salmonella spp. and
Shigella spp. under systemic cephalosporin
therapy
B. Spellerberg* (Ulm, Germany), Y. Pfeifer,
C. Denzer, C. Posovszky, A. Essig, W. Rabsch
P1115
Changes in chlorhexidine sensitivity in Klebsiella
pneumoniae as a model Gram-negative pathogen
causing healthcare-associated infections
L.J. Bock, M.E. Wand* (Salisbury, United Kingdom),
J.M. Sutton
P1116
Membranotropic effects of 1-adamantane phenol
derivative
D. Dudikova* (Kiev, Ukraine)
P1117
Emergence of 16S rRNA methylase-producing
Enterobacteriaceae and P. aeruginosa human
clinical isolates and Aeromonas hydrophila
isolated from a fish in Serbia
B. Gutierrez* (Madrid, Spain), L. Hidalgo,
C.M. Ovejero, A. Hoefer, L. Carrilero, A. Santos-Lopez,
D. Thomas-Lopez, N. Montero, D. Misic,
B. Gonzalez-Zorn
P1118
High level fluoroquinolone resistance in
Escherichia coli isolated from animals in Turkey is
due to multiple mechanisms
M. Cengiz* (Bursa, Turkey), P. Sahinturk,
L.J.V. Piddock
Chairs, Speakers & Authors
P1104
P1111
Exhibition
Implications for efflux inhibitor design:
homologous RND efflux pumps respond to level of
AcrB expression
J. Blair* (Birmingham, United Kingdom),
H.E. Smith, V. Ricci, A.M. Bailey, A.J. Lawler,
H. Brown, L.J. Thompson, L.J.V. Piddock
24th ECCMID / Barcelona
Final Programme 195
General Information
P1103
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
12:30 – 13:30
Poster Area
POSTER SESSION IV:
Pseudomonas sp. and Burkholderia sp.: knowing the
mechanics of resistance
P1119
Molecular typing and carbapenem resistance in
non-clinical Pseudomonas aeruginosa strains
Y. Saenz Dominguez* (Logroño, Spain), V. Estepa,
C. Casado, B. Rojo-Bezares, C. Torres
P1120
Description of KHM-2, a novel metallo-betalactamase, found in a clinical Pseudomonas
aeruginosa isolate from Germany
N. Pfennigwerth* (Bochum, Germany),
A. Hoffmann, C. Belmar Campos, S.G. Gatermann,
M. Kaase
P1121
Dissemination of GES-1 and GES-5 producing
strains of Pseudomonas aeruginosa in France
D. Fournier, K. Jeannot, E. Müller, P. Plésiat*
(Besançon, France)
P1122
Can efflux confer high-level resistance to
meropenem (MEM) in Pseudomonas aeruginosa
(PA) clinical isolates?
H. Chalhoub* (Brussels, Belgium),
H. Rodriguez-Villalobos, A. Vergison, O. Denis,
B. Kahl, P.M. Tulkens, F. Van Bambeke
P1123
Rapid emergence of colistin resistant
Pseudomonas aeruginosa mutants
A. Nogues, A. Bolard, P. Plésiat, K. Jeannot*
(Besançon, France)
P1124
Class 3 integron containing metallo-betalactamase in Pseudomonas fulva detected in 3
patients
M. Yamamoto* (Kyoto, Japan), Y. Matsumura,
M. Nagao, Y. Ito, M. Tanaka, S. Takakura, S. Ichiyama
P1125
A subclass B3 metallo-beta-lactamase found in
Pseudomonas alcaligenes
M. Suzuki* (Tokyo, Japan), M. Matsui, S. Suzuki,
Y. Hiraki, F. Kawano, K. Shibayama
P1126
Membrane bound beta-lactamase of Burkholderia
pseudomallei
L.B. Randall, H.P. Schweizer* (Fort Collins, CO,
United States)
P1127
Molecular characterisation of blaOXA-10-like and
dfr23 genes among Burkholderia cepacia complex
(BCC) clinical isolates recovered from non-cystic
fibrosis patients
L.C. Fehlberg* (São Paulo, Brazil), D. Cassu-Corsi,
R. Cayô, J.R. Cordeiro-Moura, R. Girardello, A.C. Gales
196 24th ECCMID / Barcelona
Final Programme
12:30 – 13:30
Poster Area
POSTER SESSION IV:
Plasmids and other genetic elements
P1128
Natural instability of staphylococcal cassette
chromosome mec (SCCmec) in methicillinresistant Staphylococcus aureus strains:
a longitudinal study
C.R. Scharn* (Omaha, United States), R.V. Goering
P1129
Transposons carrying macrolide and/or
lincosamide and/or tetracycline resistance genes
in Streptococcus agalactiae
B. Rojo-Bezares* (Logroño, Spain),
J.M. Azcona-Gutiérrez, C. Torres, Y. Sáenz
P1131
Characterisation of new genetic elements in
Streptococcus mitis
F. Santoro* (Siena, Italy), F. Iannelli, G. Pozzi
P1132
Uncharted small plasmid carrying blaKPC-2 gene
in virulent and multidrug-resistant Pseudomonas
aeruginosa from Brazil
R. Galetti* (Ribeirao Preto, Brazil), L.N. Andrade,
J.C. Ferreira, A. Caratolli, A.L. Darini
P1133
Combination of plasmid-encoded qnrA1 and a
mutation blocking a central biosynthetic pathway
as basis for high-level fluoroquinolone resistance
in gyrA single mutants of Escherichia coli
H.-P. Sfeir* (Hamburg, Germany), P. Hebel, A. Heisig,
P. Heisig
P1134
Universal method for detecting and capturing
ColE1 plasmids reveals high prevalence of
small plasmids in multiresistant clinical
Enterobacteriaceae and Pasteurellaceae
A. Santos-López* (Madrid, Spain), R. Ortega Huedo,
A. San Millan, C. Bernabé, B. Gutierrez, L. Hidalgo,
L. Carrilero, C. Martinez-Ovejero, K.N. Prasad,
B. Gonzalez-Zorn
P1135
New members of the IncL/M resistance plasmid
family – comparative genomics of replicons
isolated from clinical and environmental samples
M. Adamczuk* (Minsk Mazowiecki, Poland),
P. Zaleski, L. Dziewit, R. Wolinowska, M. Nieckarz,
P. Wawrzyniak, A. Plucienniczak, D. Bartosik
P1136
The mRNA half-life of CTX-M-15 transcripts is
controlled by a factor encoded on the blaCTX-M15-containing plasmid
C. Geyer, N. Hanson* (Nebraska, United States)
Poster Sessions
P1144
Susceptibility analysis of Gram-negative
pathogens collected from ICU and non-ICU patient
infections in European countries collected from
the TEST programme over ten years (2004-2013)
D. Biedenbach* (Schaumburg, United States),
S. Bouchillon, M. Hackel, B. Jphnson, I. Morrissey,
H. Leister-Tebbe
P1138
In vivo transfer of ColE type plasmid encoded
OXA-232 in colonised patients
J. Yang* (Chungcheongbuk-Do, Korea), J. Park,
H. Kim, J. Ryu, Y. Lee, J. Yoo
P1145
P1139
New integron encompassing blaVIM-2, qnrVC1
and genes encoding bacterial group II intron from
clonal strains of Pseudomonas aeruginosa
P.T. Bedlotti, L. Thabet, L. Coulange-Mayonnve,
C. Andre, F. M’zali, C. Quentin, V. Dubois* (Bordeaux,
France)
IMP-5-producing multidrug-resistant
Acinetobacter bereziniae: environmental or
pathogen?
F. Grosso Ledo* (Porto, Portugal), S. Quinteira,
C. Sousa, L. Silva, H. Ramos, L. Peixe
P1146
First descriptions of plasmid-encoded NDM-1
in carbapenem-resistant Enterobacter cloacae,
Escherichia coli and Citrobacter freundii in Brazil
J. Campos* (São Paulo, Brazil), M. Silva, E. Barros,
M. Pereira, J. Sampaio
P1147
Introduction of an accurate screening method
to detect carriage of carbapenemase-producing
bacteria in patients within 24 hours
R.H.T. Nijhuis* (Velp, The Netherlands),
N.M. Hanemaaijer, B.J. Slotboom, E.M. Mascini,
A.A. Van Zwet
P1148
A novel IncN2 plasmid conferring carbapenem
resistance by the blaVIM-4 gene identified in
Enterobacter cloacae from the Sultanate of Oman
D. Fortini* (Rome, Italy), R. Galetti, A. Sonnevend,
A. Ghazawi, T. Pal, C. Feudi, A. Al-Jardani, S. Al-Abri,
L. Villa, A. Carattoli
P1149
Loss of extended-spectrum beta-lactamase
resistance genes during storage of bacterial
strains
C. Verhulst, M. Kluytmans - van den Bergh* (Breda,
The Netherlands), I. Willemsen, R. Roosendaal,
P. Savelkoul, C. Vandenbroucke-Grauls, C. Verduin,
J. Kluytmans
P1150
Diverse non-clinical reservoirs of CTX-M-15encoding plasmids and clones in a developing
country with close relations with Europe
T. Gonçalves Ribeiro* (Porto, Portugal), Â. Novais,
L. Peixe, E. Machado
Multiresistance plasmid pMOK1 – acquisition
of numerous resistance genes by formation of a
fusion of broad-host-range replicons
M. Adamczuk* (Minsk Mazowiecki, Poland),
O. Krysiak, D. Bartosik
P1141
The role of HigBA and SplTA toxin-antitoxin
systems from Acinetobacter baumannii in
plasmid maintenance
J. Armalyte* (Vilnius, Lithuania), M. Jurenaite,
E. Suziedeliene
12:30 – 13:30
Poster Area
POSTER SESSION IV:
MDR Gram-negatives – molecular biology of resistance genes
P1142
P1143
Dissemination of the cmy-2 cephalosporinase
gene in a clinical strain of Klebsiella pneumoniae
due to the insertion sequence IS 1294
H. Yassine, L. Bientz, J. Cros, J. Goret, C. Bébéar,
C. Quentin, C. Arpin* (Bordeaux, France)
Further dissemination of armA methylase gene
among nosocomial Enterobacteriaceae isolates
at the cancer centre in Bulgaria: emergence of
rtmB in Escherichia coli uropathogenic strain
S. Sabtcheva* (Sofia, Bulgaria), I.N. Ivanov,
E. Dobreva, T. Velinov, I. Petrova, V. Borissova,
B. Todorova, K. Ivancheva, T. Kantardjiev
24th ECCMID / Barcelona
Final Programme
197
General Information
P1140
Chairs, Speakers & Authors
Dissemination of plasmids belonging to different
incompatibility groups in clinical isolates of
E. coli and K. pneumoniae producing extendedspectrum beta-lactamases in Spain
B. Ruiz del Castillo* (Santander, Spain),
M. Fernandez-Martínez, J. Rodríguez-Baño,
A. Pascual, L. Martínez-Martínez
Exhibition
P1137
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
12:30 – 13:30
Poster Area
P1158
Wide intrahost-diversity in bacterial genomes,
antimicrobial resistance and virulence genes in
faecally-carried Escherichia coli identified using
whole-genome sequencing
N. Stoesser* (Oxford, United Kingdom), C.E. Moore,
T. Golubchik, C.M. Parry, N.P. Day, A. Sheppard,
A. Giess, T.E. Peto, A.S. Walker, D.W. Crook
P1159
Resistance pattern of Escherichia coli and
presence of Enterobacteriaceae harbouring
extended spectrum beta-lactamase isolated
from faecal samples of healthy humans in Styria,
Austria
H. Galler, G. Zarfel, J. Luxner, V. Breitler, C. Petternel,
D. Haas, B. Springer, A.J. Grisold, F.F. Reinthaler*
(Graz, Austria), G. Feierl
P1160
Classification of non-ESBL E. coli isolates from
urinary tract infections (UTI), from general
practices
F.B. Hertz* (Frederiksberg, Denmark), J.B. Nielsen,
P. Littauer, K. Schønning, J.D. Knudsen,
A. Løbner-Olesen, N. Frimodt-Møller
P1161
Intestinal colonisation with multidrug-resistant
Enterobacteriaceae in travellers, immigrants and
‘visiting friends and relatives’: dominance of
E. coli-non ST131 producing CTX-M-15
A. Valverde, M.C. Turrientes, E. San Martín,
F. Norman, L.M. Moreno, J.A. Pérez-Molina,
R. López-Vélez, R. Cantón* (Madrid, Spain)
P1162
Emergence of ST224 Escherichia coli harbouring
blaCTX-M-15-carrying IncF-type plasmids in
swine
K. Silva* (São Paulo, Brazil), M. Moreno,
N. Lincopan, B. Spira, A.M. Moreno
P1163
Prevalence and characteristics of ST131
Escherichia coli isolates: a multicentre study
from Korea
S. Kim* (Suwon, Korea), Y. Park, J. Yu
P1164
Phylogenetic diversity and antibiotic resistance
of Escherichia coli from water and faecal pollution
sources on an uninhabited island in Portugal
M. Alves, A. Pereira, S. Araújo, B. Castro, A. Correia,
I. Henriques* (Aveiro, Portugal)
P1165
Nitrofurantoin remains active against most
uropathogenic E. coli in primary care in Ireland,
including ciprofloxacin-resistant 025b-ST131 E.
coli – the SIMPle study
S. Galvin* (Galway, Ireland), S. Duane, A. Callan,
T. White, A.W. Murphy, M. Cormican, A. Vellinga
POSTER SESSION IV:
Resistance in Enterobacteriaceae
P1151
P1152
Strains belonging to clonal group O25b-ST131
are widely disseminated among CTX-M-15
producing Escherichia coli recovered from in- and
outpatients in Germany, 2010
B. Körber-Irrgang* (Rheinbach, Germany), Y. Pfeifer,
R. Wresch, M. Kresken
Prevalence and resistance profile of betalactamases in Escherichia coli isolates from pig
holdings in northwestern Germany
S. García* (Groningen, The Netherlands), R. Köck,
J. Frenzel, A.W. Friedrich, J.W.A. Rossen
P1153
Emergence of Escherichia coli sequence type
(ST) 131 carrying KPC-3 carbapenemase in Italy
M. Accogli, M. Monaco, M. Giufrè, T. Giani,
A. García-Fernández, V. Conte, G.M. Rossolini,
A. Pantosti, M. Cerquetti* (Rome, Italy)
P1154
Detection and molecular characterisation of
extended-spectrum beta-lactamase-producing
Escherichia coli sequence type ST131 from the
Baltic region
K. Pai* (Tartu, Estonia), K. Huik, M. Ivanova,
S. Kõljalg, A. Pavelkovich, K. Parv, T. Rööp, E. Sepp,
P. Naaber, B.S.G. Baltic Antibiotic Resistance
collaborative Network
P1155
Intraclonal diversity of ST131 Escherichia coli
causing bacteraemia in a Spanish hospital over
15 years (1996-2012)
I. Rodriguez Fernandez* (Madrid, Spain),
C.M. Rodríguez, R. Cantón, E. Loza, J. Zamora,
V. Fernández, F. De la Cruz, F. Baquero, T.M. Coque
P1156
P1157
Antimicrobial susceptibility profiles of
uropathogenic Escherichia coli are associated
with specific virulence markers and phylogenetic
background
V. Tavares Vinhas Calhau* (Coimbra, Portugal),
G. Ribeiro, N. Mendonça, G. Da Silva
Different recombination frequencies and
antibiotic resistance patterns among Escherichia
coli phylogenetic groups
M.C. Turrientes, J.M. González-Alba, M.I. Morosini,
A. Valverde, R. Cantón, F. Baquero, J.C. Galán*
(Madrid, Spain)
198 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Monday, 12 May 2014
P1168
Prevalence of broad-spectrum cephalosporin
resistance in commensal Escherichia coli strains
collected from healthy children in Tunisia
S. Ferjani, M. Saidani, Z. Hamzaoui, A. Slim,
I. Boutiba* (Tunis, Tunisia)
P1169
Characterisation of human uropathogenic ESBLproducing Escherichia coli: spread of CTX-M-27producing B2-025b-ST131 strains in Brno, Czech
Republic
L. Micenkova* (Brno, Czech Republic), P. Sisková,
D. Smajs
P1170
First Romanian report on the Escherichia coli
ST131 clone
C.R. Usein* (Bucharest, Romania),
R. Papagheorghe, M. Oprea, M. Condei, M. Straut
P1171
Comparison of Escherichia coli ST131 H30
subclone with other ST131 variants and B2-nonST131 isolates
A. Novais* (Porto, Portugal), C. Rodrigues, J. Pires,
L. Peixe
P1172
A multicentre study of the clonal structure and
resistance mechanism of KPC-producing E. coli
isolates in Israel
A. Adler* (Tel Aviv, Israel), T. Miller-Roll, M.V. Assous,
Y. Gefen, S. Paikin, D. Schwartz, Y. Wiener-Well,
K. Hussein, R. Cohen, Y. Carmeli
P1173
P1174
Emergence of E. coli ST405, ST648 and
STt101 producing NDM-1 and variants in the
Bangladesh environment modulated by specific
environmental bacteriophages
J. Bugert, A. Nizam, M. Toleman* (Cardiff,
United Kingdom)
First detection of ESBL and mutations in the
regulatory region of ampC gene in Escherichia
coli isolated from turtles
G. Cortés Cortés* (Puebla, Mexico), G. Moreno,
P. Lozano, M.G. Gutiérrez, C. Torres,
R.C. Rocha-Gracia
12:30 – 13:30
Poster Area
POSTER SESSION IV:
Molecular detection of bacterial resistance
P1176
Validation of a rapid molecular assay
(eazyplex® SuperBug) for frequently occurring
carbapenemase genes in Enterobacteriaceae
M. Kaase* (Bochum, Germany), A. Kaminski,
N. Pfennigwerth, A. Anders, L. Wassill,
S.G. Gatermann
P1177
Rapid detection of antibiotic resistance genes
using recombinase polymerase amplification
(RPA) on a microfluidic device
R.J. Watson* (Salisbury, United Kingdom),
J.M. Sutton, M.N. Tsaloglou, X. Niu, H. Morgan
P1178
A rapid two-step algorithm detects and identifies
macrolide and beta-lactam antibiotics resistance
genes
X. Lu* (Shenzhen, China), S.P. Nie, Q. Wang,
L.I. Zhang
P1179
An Xpert screen to identify carbapenemases
producers
M. Kazi* (Mumbai, India), V. Menon, C. Nikam,
A. Shetty, C. Rodrigues
P1180
Detection of carbapenemases by real-time PCR
and melt-curve analysis on the BD MAX™ system
A. Mischnik* (Heidelberg, Germany), M. Hofko,
M. Kaase, S. Zimmermann, A.H. Dalpke
P1181
Detection of resistance mechanisms and
molecular typing of carbapenem-resistant
Acinetobacter baumannii isolated from blood
cultures in a Greek tertiary hospital
E. Kraniotaki* (Athens, Greece), E. Perivolioti,
M. Nepka, V. Papastamopoulos, E. Belesiotou,
A. Skoutelis, K. Fountoulis
P1182
Screening of rectal swabs for carbapenemresistant microorganisms: evaluation of different
screening methods
G. Altinkanat Gelmez* (Istanbul, Turkey),
A. Karaaslan, S. Ozsoy, M. Kaya, E. Kepenekli,
A. Soysal, M. Bakir, G. Soyletir
24th ECCMID / Barcelona
Final Programme 199
Posters
Prevalence and independent risk factors
of phenotypic heterogeneous carbapenem
resistance among clinical Escherichia coli
isolates causing invasive infections
L. Zhang* (Chongqing, China), S. Huang, J. Sun,
S. Pu, C. Zhang, L. Zheng
Early development of the human gut resistome
explored in a birth cohort study
C.J.H. Von Wintersdorff* (Maastricht,
The Netherlands), J. Penders, P.H.M. Savelkoul,
R. Nijsen, E. Hamelmann, S. Lau, K. Gerhold,
P.F.G. Wolffs
Chairs, Speakers & Authors
P1167
P1175
Exhibition
Dominance of CTX-M-type extended-spectrum
beta-lactamase (ESBL)-producing Escherichia
coli originated from community-onset and
hospital-onset infection in patients in China
S. Xia* (Guangzhou, China), X. Fan, Y. Xu, R.C. Chen,
C. Zhuo
General Information
P1166
Poster Sessions
Monday, 12 May 2014
P1183
Evaluation of the AID ESBL line probe assay for
rapid detection of extended-spectrum betalactamase (ESBL) and KPC carbapenemase
genes in Enterobacteriaceae
G.V. Bloemberg, S. Polsfuss, F.P. Maurer* (Zurich,
Switzerland), V. Meyer, E.C. Böttger, M. Hombach
P1184
Evaluation of a commercial real-time PCR to
detect carbapenem-resistant Enterobacteriaceae
in rectal swabs
E. Carretto* (Reggio Emilia, Italy), D. Barbarini,
F. Brovarone, G. Russello, C. Capatti
P1185
Development of a real-time PCR (RT-PCR) assay
for carbapenemase-producing bacteria, including
Enterobacteriaceae
B. Mather, P.L. White, M. Wootton* (Cardiff,
United Kingdom), R.A. Howe
P1186
Carbapenemase-producing multidrug-resistant
Klebsiella pneumoniae isolates from blood
cultures and prevalence of class 1 integrons
E. Kraniotaki* (Athens, Greece), E. Perivolioti,
M. Nepka, Z. Psaroudaki, A. Argyropoulou,
K. Fountoulis
P1187
P1188
P1189
P1190
Molecular characterisation of carbapenemresistant Acinetobacter baumannii and
investigation of genetic diversity between local
and international clones
A. Ulu-Kilic* (Kayseri, Turkey), E. Alp Mese,
S. Shaeer Ahmed, G. Dinc
Validation of a new DNA extraction method from
agar or liquid swabs for molecular detection
of MRSA, VRE and KPC utilising the NanoChip®
microarray technology
Z. Greenberg* (Ashdod, Israel), V. Hurgin,
R. Sabban-Amin
Next generation sequencing for strain typing and
detection of resistance genes: performance of a
new commercial method during an outbreak of
ESBL-producing ST131 Escherichia coli
J. Veenemans* (Tilburg, The Netherlands),
I.T. Overdevest, E. Snelders, I. Willemsen,
Y. Hendriks, A. Adesokan, G. Doran, A. Rolfe,
A. Pettersson, J.A.J.W. Kluytmans
VIM-carbapenemases-producing Gram-negatives
from river and sea waters in Porto, Portugal
P. Cecílio* (Porto, Portugal), D. Gonçalves,
H. Ferreira
200 24th ECCMID / Barcelona
Final Programme
P1191
Characterisation of SCCmec insertion site in 108
isolates lacking the mecA gene and identified as
methicillin-resistant Staphylococcus aureus by
the rapid PCR GeneXpert test
M. Stojanov* (Lausanne, Switzerland), D.S. Blanc
P1192
Molecular characterisation of blaNDM-1 in an
Acinetobacter pittii strain isolated from Turkey in
2006
N. Mosqueda* (Barcelona, Spain), I. Roca, B. Altun,
P. Espinal, M. Akova, J. Vila
P1193
Identification of resistance genes in three multiresistant Bacteroides fragilis isolates by whole
genome sequencing
T. Vognbjerg Sydenham* (Odense, Denmark),
H. Hasman, M. Wang, J. Sóki, E. Nagy,
U. Stenz Justesen
13:30 – 14:30
Poster Area
POSTER SESSION V:
Worldwide spread of carbapenem resistance
P1194
Molecular epidemiology of carbapenem-resistant
Klebsiella pneumoniae and E. coli in Taiwan
L. Ma* (Miaoli County, Taiwan), L.K. Siu, J.C. Lin,
T.L. Wu, C.P. Fung, J.T. Wang, P.L. Lu, Y.C. Chuang
P1195
Carbapenem-resistant Klebsiella pneumoniae
clinical isolate harbouring a blaIMP-4- and
qnrS-carrying plasmid, as well as a conjugative
blaKPC-2 plasmid
R.E. Mendes* (North Liberty, United States),
S.E. Farrell, W. Wu, Y. Xu, Y. Wang, M. Castanheira,
R.N. Jones
P1196
First description of NDM-1-producing Klebsiella
pneumoniae in Brazil
P. Silva Pereira* (Rio de Janeiro, Brazil),
M. Borghi, R. Mattos Albano, G. Casemiro Berião,
J. Christian Oliveira Lopes, M. Dutra Asensi,
A.P. D’Alincourt Carvalho Assef P1197
Dissemination of NDM-1 and OXA-48 in Romania
is mainly associated with K. pneumoniae ST101
clone and infrequent carbapenemase-harbouring
plasmids (NDM-IncFII and OXA-48-non-typeable)
I. Czobor* (Bucharest, Romania), Â. Novais,
C. Rodrigues, M.C. Chifiriuc, G. Mihaescu, L. Peixe
P1198
Not only OXA-48 but VIM positivity also
considered in Klebsiella pneumoniae in Turkey
A. Tezer Tekce* (Ankara, Turkey), B. Mert Dinç,
O. Unaldi, R.I.Z.A. Durmaz
Poster Sessions
Emergence in Taiwan of novel imipenem-resistant
Acinetobacter baumannii ST455 causing
bloodstream infection in critically ill patients
L. Hao-Yuan* (Taoyuan, Taiwan), H. Chih-Wei,
W.A.N.G. Yi-Hsin, C.H.E.N. Chyi-Liang, C.H.I.U. ChengHsun P1200
Risk factors for carbapenem-resistant Klebsiella
pneumoniae colonisation in paediatric units
A. Ulu Kilic* (Ankara, Turkey), E. Alp, D. Percin,
F. Cevahir, C. Kurkcu, A. Ozturk, A. Ozturk
P1209
P1201
A treatment algorithm for carbapenem-resistant
Klebsiella pneumoniae infections based on the
resistance mechanisms of infecting strains
C.J. Clancy* (Pittsburgh, United States),
R.K. Shields, L. Chen, B. Kreiswirth, Y. Doi, B. Hao,
M.H. Nguyen
Microbiological surveillance data of
carbapenemase-producing Enterobacteriaceae in
Belgium in 2013
T.D. Huang* (Yvoir, Belgium), P. Bogaerts, C. Berhin,
B. Jans, O. Denis, Y. Glupczynski
P1210
Evidence of coproduction of VIM-1 and NDM-1
beta-lactamase and persistent predominance
of metallo-beta-lactamases among
Enterobacteriaceae from Croatia
B. Bedenic* (Zagreb, Croatia), N. Beader,
S. Sardelic, V. Plecko, Z. Bosnjak, D. Varda-Brkic
P1211
Spread of an OXA-23-producing trimethoprim/
sulfamethoxazole-susceptible ST2 Acinetobacter
baumannii clone in Greek hospitals
A. Poulou* (Athens, Greece), V. Pitiriga, M. Nepka,
O. Zarkotou, F. Markou, L. Politi, S. Pournaras,
A. Tsakris
P1212
Carbapenemase-producing Klebsiella pneumoniae
from invasive infections, Italy 2011-2013
V. Conte, M. Monaco, T. Giani* (Siena, Italy),
F. D’Ancona, M.L. Moro, G.M. Rossolini, A. Pantosti
P1213
Characterisation of blaOXA-48 positive members
of the Enterobacteriaceae family in Palestine
R. Kattan* (Bethlehem, Palestinian Authority),
H. Marzouqa, M. Hindiyeh
P1214
Community carriage and nosocomial acquisition
of blaNDM in hospitals in Karachi: a cohort study
M.J. Carvalho* (Cardiff, United Kingdom),
A. Mushtaq, S. Aguiar, T. Sequeira, S. Khatoon,
N. Chishti, F. Jehan, M. Farooqi, S.U. Kazmi, T.R. Walsh
P1215
Association of 16S rRNA methyltransferases and
NDM carbapenamase in India
C. Martinez Ovejero* (Madrid, Spain), L. Hidalgo,
D. Goilo, M. Rahman, B. Gutierrez, L. Carrilero,
A. Santos-Lopez, D. Thomas-Lopez, K.N. Prasad,
B. Gonzalez-Zorn
P1216
Acquisition of strains producing ESBLs or
carbapenemases, or resistant to quinolones,
during travel to a foreign country; a cohort study
E.A. Reuland* (Amsterdam, The Netherlands),
G. Sonder, N. Al Naiemi, A. Koek, G.B. Linde,
T.J.W. Van der Laar, C.M.J.E. Vandenbroucke-Grauls,
A.P. Van Dam
P1202
P1203
P1204
P1205
P1206
P1207
Prevalence of carbapenem-resistant Gramnegative bacterial pathogens in European
countries, including susceptibility of tigecycline
and comparator agents – TEST 2013
S. Bouchillon* (Schaumburg, United States),
M. Hackel, R. Badal, S. Hawser, D. Biedenbach,
H. Leister-Tebbe
Increasing prevalence of carbapenem-resistant
Enterobacteriaceae in critically ill patients and
use of carbapenems in four intensive care units
of Rio de Janeiro, Brazil 2005/2013
J. Delgado Correal* (Rio De Janeiro,
Brazil), P. Damasco Vieira, S. Da Cunha,
E. De Andrade Marques, A. Proença, M. Amaral,
D. Ribeiro, C. Cabral Dias, E.a. Ribeiro Castro
Carbapenemase-producing Gram-negative bacilli
in Afghanistan
D. Delaune* (Saint Mandé, France), H. Elannaz,
H. Delacour, M. Collot, S. Bugier, C. Gros, A. Merens
Parallel multiregional dissemination of KPCproducing Klebsiella pneumoniae in Poland in
2010-2012
A. BARANIAK* (Warsaw, Poland), R. Izdebski,
J. Fiett, K. Bojarska, M. Herda, D. Zabicka,
W. Hryniewicz, M. Gniadkowski
Epidemiological surveillance of OXA-48-type
carbapenemase-producing Enterobacteriaceae in
Belgium
B. Jans* (Brussels, Belgium), B. Catry
First report of pandrug-resistant metallo-betalactamase-producing Pseudomonas aeruginosa
isolates in Belarus
M. Salavei* (Minsk, Belarus), E. Skleenova,
M. Edelstein, O. Krechikova, I. Karpov
24th ECCMID / Barcelona
Final Programme 201
Chairs, Speakers & Authors
P1208
Exhibition
Detection of aminoglycoside-modifying enzymes
(AMES) identifies patterns of aminoglycoside
resistance among carbapenem-resistant
Klebsiella pneumoniae
R. Almaghrabi, C.J. Clancy, R.K. Shields, Y. Doi,
B. Hao, M.H. Nguyen* (Pittsburgh, United States)
General Information
P1199
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1217
P1218
Introduction of highly-resistant bacteria (HRB)
to a hospital from patients repatriated or recently
hospitalised in a foreign country
G. Birgand* (Paris, France), M. Lepainteur,
I. Lolom, C. Neulier, F. Reibel, L. Armand-Lefevre,
A. Andremont, J. Lucet
The characteristics of mecA-positive
Staphylococcus aureus from sterile sites with
low resistance to oxacillin and cefoxitin and their
association with genetic community background
(TIST, 2006-2010)
W. Wang* (Taichung, Taiwan), S. Tsao, T. Chiueh,
J. Lu, P. Hsueh
P1227
Molecular epidemiolgy and clinical features of
methecillin-susceptible Staphylococcus aureus
blood isolates, 2002-2011
P.Y. Chen* (New Taipei City, Taiwan), Y.C. Chuang,
J.T. Wang, S.C. Chang
P1228
Multi-locus sequence typing of Escherichia
coli isolates from a phase 2 complicated
intra-abdominal trial for eravacycline
C. Fyfe, T. Grossman, P. Tavares, J. Sutcliffe*
(Watertown, United States)
P1229
Staphylococcal toxic shock syndrome: successful
treatment without immunoglobulin therapy in
three cases
M. Kozma* (Letavertes, Hungary), I. Várkonyi,
J. Szabó, Z.R. Dombrádi, K. Rázsó, E. Rakoczi
P1230
Epidemiology of carbapenem-resistant bacterial
infections in a solid organ transplantation
department
T. Karampatakis* (Kalamaria-Nea Krini,
Greece), A. Geladari, O. Tsiatsiou, E. Iosifidis,
C. Antachopoulos, A. Orfanou, A. Karyoti, A. Tsakris,
E. Roilides
P1231
Targeted gene sequencing for the detection and
tracking of VRE in the ICU. What can it tell us?
H. McDermott* (Dublin, Ireland), A. Adesokan,
H. Humphreys, D. Fitzgerald-Hughes
P1232
Reduced responsiveness of blood leukocytes
to lipopolysaccharide does not relate to the
subsequent development of ICU-acquired
infections in critically ill patients
L.A. Van Vught* (Amsterdam, The Netherlands),
M.A. Wiewel, B.P. Scicluna, H. Belkasim-Bohoudi,
M.J. Schutlz, J. Horn, A.J. Hoogendijk, T. Van der Poll
P1233
Prevalence of methicillin-resistent
Staphylococcus aureus in end stage renal failure
patients in Saarland and Hessen
A. Dawson* (Saarbrücken, Germany), D. Mischler,
C. Petit, B. Gärtner, S. Gräber, R. Klein, U. Heudorf,
M. Herrmann
Poster Area
POSTER SESSION V:
Global epidemiology and molecular typing
Antibiotic resistance, SCCmec, ability of biofilm
formation of methicillin-resistant Staphylococcus
aureus isolates in a local hospital in southern
China, 2007-2010
Z. Xu* (Guangzhou, China), L. Li, B. Li, G. Yu,
M. Shirtliff
P1220
Molecular typing of MRSA from Iași, Romania
S. Monecke* (Dresden, Germany), E. Müller,
O.S. Dorneanu, T. Vremera, R. Ehricht
P1221
Genotyping of methicillin-resistant
Staphylococcus aureus in the Sultan Qaboos
University Hospital, Oman reveals the dominance
of PVL-negative ST6-IV/t304 clone
E. Udo* (Safat, Kuwait), B. Al-Lawati, B. Mathew,
B. Noronha, Z. Al-Muharrmi, S. Thukral
P1222
Characterisation of methicillin-resistant
Staphylococcus aureus in Kuwait hospitals:
1992-2010
S. Boswihi* (Kuwait City, Kuwait), E. Udo,
N. Al-Sweih
P1223
Lack of the human host adaptive factor SCN in
methicillin-resistant Staphylococcus aureus
(MRSA) of human origin
A. Larsen* (Copenhagen, Denmark), A. Petersen,
J. Larsen, M. Stegger, R. Skov
P1224
Molecular characterisation of staphylococcal
protein A (spa) deletions in clinical isolates of
methicillin-susceptible Staphylococcus aureus
C.R. Scharn* (Omaha, United States), F.C. Tenover,
R.V. Goering
P1225
P1226
Untangling plasmid micro-evolution across
an NDM-1-producing Klebsiella pneumoniae
outbreak
A. Giess* (Oxford, United Kingdom), N. Stoesser,
A.E. Sheppard, A. Bashir, R. Sebra, A. Kasarskis,
P. Amatya, S. Joshi, S. Thorson, D.W. Crook
13:30 – 14:30
P1219
Staphylococcus aureus, and identification of 3
novel function-impairing mutations
N.C. Gordon* (London, United Kingdom), T.E.A. Peto,
D. Crook, A.S. Walker, T. Golubchik
Prevalence of blaZ in UK clinical isolates of
202 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Monday, 12 May 2014
P1234
Detection and genotyping of human
papillomavirus in abnormal cervical samples.
Comparison between two different methods
R. Salvador * (Madrid, Spain), B. Saavedra,
A. Suarez, J.J. Picazo
P1235
Susceptibility of clinical methicillin-resistant
Staphylococcus aureus isolates to glycopeptides
and comparators and their spa types from a
Japanese multicentre study, the Kyoto Shiga
Microbiology Study Group
M. Nagao* (Kyoto, Japan), M. Yamamoto,
Y. Matsumura, S. Takakura, S. Ichiyama
P1244
Identification of a major worldwide disseminated
epidemic genetic lineage among nosocomial
Staphylococcus haemolyticus
O. Bouchami* (Oeirs, Portugal), H. De Lencastre,
M. Miragaia
Effect of influenza vaccination on the immune
cells in patients with allergy
V. Bulgakova* (Moscow, Russia), I. Balabolkin,
A. Baranov, I. Smirnov, I. Zubkova, E. Korolkova,
I. Larkova, L. Ksenzova, E. Antonova, K. Efendieva
P1245
Clinical efficacy of peroral autologous microbial
vaccines in the treatment of chronic and
recurrent vulvovaginitis
M. Czirfuszová* (Bratislava, Slovakia), G. Bertaová,
J. Hanzen
P1246
Immunomodulative properties of Vibrio cholerae
polysaccharide-protein conjugate vaccines
J. Korcova* (Bratislava, Slovakia), P. Farka,
E. Machova, S. Bystricky
P1247
Persistence of yellow fever vaccine-induced
antibodies after solid organ transplantation
B. Wyplosz* (Le Kremlin Bicêtre, France), C. Burdet,
H. François, A. Durrbach, J.C. Duclos-Vallée,
M.F. Mamzer-Bruneel, P. Poujol, O. Launay, D. Vittecoq,
P.H. Consigny
P1248
Prophylaxis with poly(i:c) protects
neutropenic mice against Escherichia coli
meningoencephalitis
S. Ribes* (Göttingen, Germany), C. Arcilla, M. Ott,
S. Redlich, S. Schütze, U.K. Hanisch, S. Nessler,
R. Nau
P1249
IgG2 antibody response to a prime-boost vaccine
strategy combining PCV13 followed by PPV23
versus PPV23 alone in HIV-infected adults
C. Sadlier* (Dublin, Ireland), N. Conlon, C. Rock,
A. Brown, S. O’Dea, J. Dunne, C. Bergin
P1250
Seroprevalence of varicella-zoster virus among
healthcare workers in Incheon, Korea
S.M. Moon* (Incheon, Korea), Y.S. Park, Y.K. Cho
P1251
Evaluation of long-term immunity from tetanus
and measles in school age children
S. Lito* (Geneva, Switzerland), G. Kuli-Lito, E. Kallfa,
Z. Ylli, G. Sulcebe
P1242
Sequencing, assembly and comparative
genomics analysis of six Enterococcus faecium
(EFM) ST117, emergent multiresistant clone
responsible for an increase of EFM bacteraemia
and faecal carriage in Spain
R. Tobes* (Granada, Spain), M. Manrique,
P. Pareja-Tobes, E. Pareja-Tobes, E. Pareja, A.P. Tedim,
P. Ruiz-Garbajosa, R. Canton, F. Baquero, T. Coque
Identification of ST8 clonal type as predominant
community-associated methicilin-resistant
Staphylococcus aureus isolate in Quito, Ecuador
applying a multiple locus variable number of
tandem-repeat analysis (MLVA)
J. Zurita* (Quito, Ecuador), D. Ortega-Paredes,
C. González, A.C. Vargas, A. Carrera, E. Sierra,
P. Barba
POSTER SESSION V:
Immunology, vaccination and host defences
24th ECCMID / Barcelona
Final Programme 203
Posters
P1241
Deciphering evolutionary events and presence
of resistance genes by full de novo genome
sequencing of clonally related multidrugresistant OXA-48 Klebsiella pneumoniae ST11
isolates
R. Tobes* (Granada, Spain), M. Manrique,
P. Pareja-Tobes, E. Pareja-Tobes, E. Pareja, D. Gijon,
P. Ruiz-Garbajosa, F. Baquero, T. Coque, R. Canton
Poster Area
Chairs, Speakers & Authors
P1240
Evolution of healthcare bacteraemic episodes
of Enterococcus faecium (1995-2012) reflects
changes in phylogenomic groups with internal
clonal epidemic waves
A.P. Tedim, P. Ruiz-Garbajosa* (Madrid, Spain),
C.M. Rodriguez, L. Derdoy, G. Cardenas, E. Loza,
R. Canton, F. Baquero, T.M. Coque
13:30 – 14:30
Exhibition
P1239
Community-sequence type ST72 methicillinresistant Staphylococcus aureus (MRSA) isolated
from patients in Spain
C. Potel* (Vigo, Spain), A. Moreno, S. Otero, S. Rey,
J. Rubio, M. Alvarez
General Information
P1236
P1243
Poster Sessions
Monday, 12 May 2014
P1252
Streptococcus pneumoniae antibody titres for
the serotypes circulating in Cuba evaluated on
clinical trial subjects
N. González García* (Havana, Cuba),
V. Echemendía, L. Rodriguez, Y. Soroa, A. Garcés,
D. García, Y. Valdés, D. Santana, S. Rosell, B. Paredes
P1253
Cholera toxin B subunit genetically fused
to N-terminal domains of flagellin induces
potent humoral immune responses against
Pseudomonas aeruginosa in BALB/c mice
F. Dakterzada* (lleida, Iran), A. Mohabati Mobarez,
M. Habibi Roudkenar
P1254
Development of hybrid polypeptides as possible
vaccine candidates against Streptococcus
agalactiae
I.V. Koroleva* (St. Petersburg, Russia),
A.S. Lanskova, E.V. Iurlova, T.V. Gupalova,
K.B. Grabovskaya, T.A. Kramskaya, A.N. Suvorov
P1255
Immunogenicity of conjugate based on detoxified
LPS antigen of Vibrio cholerae O139
A. Fleischhackerová* (Bratislava, Slovakia),
P. Farkas, S. Bystricks
P1256
Transcriptional response of chronic Q fever
patients’ mononuclear cells upon C. burnetii
stimulation reveals intact interferon-gamma
response pathway
T. Schoffelen* (Nijmegen, The Netherlands),
J. Textoris, A. Ben Amara, C.P. Bleeker-Rovers,
M.G. Netea, J.L. Mege, M. Van Deuren
P1257
P1258
P1259
P1260
The efficacy of toll-like receptor 4/MD-2
complex agonistic antibody UT12 for chronic
lower respiratory tract infection caused by
Pseudomonas aeruginosa in mice
S. Nakamura* (Nagasaki, Japan), N. Iwanaga,
K. Oshima, T. Kajihara, T. Takazono, Y. Imamura,
K. Izumikawa, K. Yanagihara, S. Kohno
Descriptive study of the cohort of patients
diagnosed with BCGitis and analysis of risk
factors in a tertiary hospital of northern Spain,
from 2003 to 2013
Z.S. Albines Fiestas* (Santander, Spain),
A. Arnaiz Garcia, M. Lisa Gracia, J. Fuentes Pastor,
J.A. Portillo Martín, F. Campos Juanatey,
J.L. Gutierrez Baños, M.C. Fariñas Alvarez
Q fever skin test: more than a diagnostic test
T. Schoffelen* (Nijmegen, The Netherlands),
T. Herremans, T. Sprong, M. Nabuurs-Franssen,
J.W.M. Van der Meer, L.A.B. Joosten, M.G. Netea,
H.A. Bijlmer, M. Van Deuren
The evaluation of cytokine concentration
204 24th ECCMID / Barcelona
Final Programme
(IL-4,IL-17,IL-23,IL-21) representing cellular and
humoral immunity in patients with herpes zoster
J.M. Zajkowska* (Bialystok, Poland), A. Moniuszko,
A. Zajkowska, A. Garkowski, S. Grygorczuk,
R. Swierzbinska, S. Pancewicz
P1261
Association of maternal HIV and malaria with
reduced placental transfer of antimalarial
antibodies
L. Moro* (Barcelona, Spain), A. Bardají, C. Dobaño,
E. Serra-Casas, B. Sigaúque, P. Cisteró, C.E. Chitnis,
P.L. Alonso, C. Menéndez, A. Mayor
P1262
Varicella zoster virus-specific cellular immunity
in immunocompetent and immunocompromised
patients with acute herpes zoster shows distinct
alterations of phenotype and functionality
D. Schub* (Homburg / Saar, Germany), E. Janssen,
T. Vogt, U. Sester, M. Sester, T. Schmidt
P1263
The synthetic Streptococcus pneumoniae
oligosaccharide conjugate protected mice from
severe pneumonia
K. Reppe* (Berlin, Germany), C. Anish, R. Bell,
C.L. Pereira et al., K. Dietert, L. Sander, A.D. Gruber,
N. Suttorp, P.H. Seeberger, M. Witzenrath
P1264
Human memory T-cells more avidly respond to
Staphylococcus aureus in patients recovering
from bloodstream infection
A. Brown* (Dublin, Ireland), T.R. Rogers,
R. McLoughlin 13:30 – 14:30
Poster Area
POSTER SESSION V:
Infections in immunocompromised patients
P1265
Prospective, cross-sectional analysis of excess
mortality associated with documented bacterial
and fungal infections in 797 adult patients with
haematological malignancies
R. Lewis* (Bologna, Italy), M. Stanzani, G. Tolomelli,
A. Conficoni, S. Ambretti, P. Viale, M. Cavo, N. Vianelli
P1266
Epidemiology of febrile events in acute
lymphoblastic leukemia: preliminary results from
the “SEIFEM 2012-B” prospective study
R. Di Blasi* (Rome, Italy), M. Caira, M. Cesarini,
G. Dragonetti, A. Busca, A. Candoni, S. Cesaro,
F. Farina, B. Martino, L. Pagano
P1267
A nightmare for haematology clinics: extensively
drug-resistant (XDR) Acinetobacter baumannii
G. Metan* (Kayseri, Turkey), C. Pala, L. Kaynar,
F. Cevahir, E. Alp
Poster Sessions
P1271
P1272
P1273
P1274
P1275
Breakthrough viridans streptococcal bacteraemia
in patients with haematological malignancies
receiving levofloxacin prophylaxis during the
neutropenic phase
M. Kimura* (Tokyo, Japan), H. Araoka, A. Yoshida,
M. Abe, Y. Okamoto, A. Hishinuma, K. Izutsu,
A. Wake, S. Taniguchi, A. Yoneyama
Viral respiratory infections in a cohort of adult
haematologic patients in a university hospital
C. López Sánchez* (Barcelona, Spain),
I. Ruiz-Camps, P. Martínez de Salazar, P. Barba,
D. Valcárcel, A. Antón, G. Codina, M. Campins,
M. Pérez, A. Pahissa
Coagulase-negative staphylococci in surveillance
cultures and blood cultures from patients with
haematological malignancies
B. Armannsdottir* (Gothenburg, Sweden),
S. Skovbjerg, C. Wennerås
Aetiology of bacteraemia as a risk factor for
septic shock at the onset of febrile neutropenia
in adult cancer patients
R.G. Rosa* (Porto Alegre, Brazil), L.Z. Goldani
Good outcomes for Gram-negative bacterial
necrotising fasciitis in haematology patients
R.M. Foo* (Singapore, Singapore), M.L. Tung,
M. Poon, N. Smitasin, L.Y. Hsu, P. Tambyah, L.P. Koh,
W.J. Chng, L. Chai
Descriptive study of pneumococcal bacteraemia
in haematology patients: report of 167 cases
R. Santiago Alonso* (Terrassa, Spain),
I. Ruiz-Camps, M. Rovira, M. Batlle,
J.M. Martí-Tutusaus, R. Martino, M. Salavert,
J. López, J.M. Moraleda, L. Gómez
Risk factors associated with mortality in patients
with febrile neutropenia
Y. Kartal, N. Erben* (Eskisehir, Turkey), O.M. Akay,
S. Nayman Alpat, I. Ozgunes, G. Usluer
P1277
Vessel occlusion detected by contrast agent flow
interruption in pulmonary computed tomography
scan is a characteristic radiomorphological sign
in immunocompromised patients with invasive
pulmonary aspergillosis
M. Reinwald* (Mannheim, Germany), D. Buchheidt,
C.A. Weis, S.A. Klein, D. Heidenreich, R. Vogelmann,
U. Benck, W.K. Hofmann, T. Henzler, C. Hagelstein
P1278
Factors associated with low posaconazole plasma
concentrations and impact of structured patient
education: a cohort study
M. Hoenigl* (Graz, Austria), W. Duettmann,
G. Theiler, J. Wagner, J. Prattes, T. Valentin,
K. Seeber, F. Prueller, R.B. Raggam, R. Krause
P1279
Role of cytomegalovirus DNA measurement in
diagnosis and monitoring of active infection in
patients receiving immunosuppressive therapy
N. Zotos, C. Gartzonika, E. Priavali, C. Boboyianni,
S. Levidiotou* (Ioannina, Greece)
P1280
CMV infection in patients with haematological
malignancies
G. Terhes, K. Piukovics, K.P. Sárvári* (Szeged,
Hungary), Z. Borbényi, J. Deák
P1281
Incidence and clinical outcome of mucormycosis
in paediatric cancer patients
R. Khedr, Y. Madney* (Cairo, Egypt), H. Hafiz,
A. Youssef, H. Taha, H. Al-Mahallawy, O. Hasannain,
L. Shalaby
P1282
Impact of time to antibiotic on survival in cancer
patients with febrile neutropenia: a cohort study
R. Rosa* (Porto Alegre, Brazil), L.Z. Goldani
P1283
Infections after colorectal cancer surgery and
patient survival
B. Beovic, M. Kerin Povsic* (Ljubljana, Slovenia)
P1284
Infections in hospitalised lung cancer patients
D. Kofteridis* (Heraklion, Greece), A. Andrianaki,
A. Valachis, K. Spetsotaki, S. Maragou,
M. Zacharioudaki, E. Pediaditis, S. Maraki,
A. Christidou, G. Samonis
P1285
Incidence of Pneumocystis jirovecii pneumonia
among groups at risk in HIV-negative patients
P. Fillâtre, O. Decaux, M. Revest, S. Jouneau,
A. Gacouin, F. Robert-Gangneux, A. Fresnel,
C. Guiguen, Y. Le Tulzo, P. Tattevin* (Rennes, France)
24th ECCMID / Barcelona
Final Programme 205
Chairs, Speakers & Authors
P1270
Epidemiological studies about invasive fungal
infection in leukemia patients receiving induction
chemotherapy in Taiwan – higher incidences and
adverse survival impact were noted
B.S. Ko* (Taipei, Taiwan), H.C. Kung, W.C. Li,
H.F. Tien, Y.C. Chen
P1276
Exhibition
P1269
First episode of febrile neutropenia under
levofloxacin prophylaxis in recipients of
allogeneic haematopoietic stem cell transplants:
microbiological characteristics and the role of
empiric vancomycin administration
M. Kimura* (Tokyo, Japan), H. Araoka, M. Abe,
Y. Asano-Mori, N. Uchida, K. Izutsu, S. Taniguchi,
A. Yoneyama
General Information
P1268
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1286
P1287
P1288
P1289
P1290
P1291
P1292
P1293
Clinical and microbiological features of
Campylobacter-related bacteraemia (CRB) at a
tertiary care hospital in Madrid (1996-2013)
J. Caballero Pérez* (Madrid, Spain), D. López,
E. Loza, P. Ruiz-Garbajosa, S. Del Campo, S. García,
R. Del Campo, S. Moreno, R. Cantón, A. Moreno
The risk of chronic Q fever in rheumatoid arthritis
patients with and without anti-TNF-beta therapy
T. Schoffelen* (Nijmegen, The Netherlands),
L.M. Kampschreur, S.E. Van Roeden, P.C. Wever,
A.A. Den Broeder, M.H. Nabuurs-Franssen,
P.L.C.M. Van Riel, J.J. Oosterheert, M. Van Deuren,
M.C.W. Creemers
Risk of bacteraemia in persons on chronic
haemodialysis – an observational cohort study
L. Skov Dalgaard* (Aarhus, Denmark),
M. Nørgaard, B. Jespersen, S. Jensen-Fangel,
O. Schmeltz Søgaard
Bloodstream infections (BSI) in patients with
liver diseases
M. Brandolini, M. Corbella, A. De Silvestri, C. Tinelli,
G. Albonico, R. Albertini, S. Ludovisi, R. Bruno,
P. Marone, E. Seminari* (Pavia, Italy)
Asymptomatic bacteriuria in female patients with
autoimmune rheumatic diseases: a prospective,
observational, case-controlled study
S. Georgiadou, M. Gamaletsou, I. Mpanaka,
A. Vlachou, V. Syriou, G. Kaltsas, M. Tektonidou,
M. Manoussakis, N. Sipsas* (Athens, Greece)
Effect of a TNF-alpha antagonist-based therapy
on the VZV-specific T-cell immunity in a cohort of
psoriatic patients
A. Saldan* (Padua, Italy), E. Sandini, D. Tinto,
G. Forner, F. Franceschi, S. Piaserico, A. Peserico,
G. Palù, D. Abate
Cellular immune response to polyomavirus JCV
in patients with multiple sclerosis treated with
natalizumab
A. Di Nauta* (Turin, Italy), F. Sidoti, S. Mantovani,
A. Piceghello, M. Rittà, P. Cavalla, S. Masera, C. Costa,
R. Cavallo
JC virus replication in multiple sclerosis and
natalizumab-treated and untreated patients
S. Delbue, F. Elia, D. Franciotta, M. Gastaldi,
E. Colombo, S. Carluccio, L. Signorini, S. Tadeo,
R. Bergamaschi, P. Ferrante* (Milan, Italy)
206 24th ECCMID / Barcelona
Final Programme
13:30 – 14:30
Poster Area
POSTER SESSION V:
Infections in transplant recipients
P1294
Epidemiology and risk factors for bloodstream
infections in solid organ transplants over a tenyear period
B. Berenger* (Edmonton, Canada), K. Doucette,
S.W. Smith
P1295
Bloodstream infections in allogeneic stem cell
transplantation patients: a single-centre, two
years experience
M. Simon, L. Lebras, G. Lina, M. Michallet, F. Ader,
O. Dumitrescu* (Lyon, France)
P1296
Infections in patients undergoing liver
transplantation for hilar cholangiocarcinoma
P. Ramanan* (Rochester, United States),
N. Cummins, M.P. Wilhelm, J.K. Heimbach,
R. Dierkhising, W. Kremers, C.B. Rosen, G.J. Gores,
R.R. Razonable
P1297
Treatment of carbapenemase-producing K.
pneumoniae in kidney transplant patients
M. Freire, F. Spadao, T. Guimaraes, F. Paula,
A. Miranda, F. Rossi, H. Caiaffa Filho, E. David-Neto,
L. Pierrotti* (São Paulo, Brazil)
P1298
Carbapenem-resistant Gram-negative infections
in Italian transplant recipients: a nationwide
prospective surveillance study
S. Lanini* (Rome, Italy), A. Nanni Costa, V. Puro,
P. Francesco, P.A. Grossi, F. Vespasiano, A. Ricci,
M.G. Ison, Y. Carmeli, G. Ippolito
P1299
Risk factors associated with bloodstream
infection due to P. aeruginosa harbouring
carbapenemases in haematopoietic and stem cell
transplant (HSCT) patients
L. Chaves* (São Paulo, Brazil), L. Tomich,
M. Salomao, J. Ramos, C. Rizek, T. Guimaraes,
A. Levin, S. Costa
P1300
Clinical and molecular epidemiologic
characterisation of methicillin-resistant
Staphylococcus aureus (MRSA) infections
occurring early after lung transplant
C.J. Clancy* (Pittsburgh, United States), M. Shelton,
R. Shields, J. Marsh, L. Harrison, C. Bermudez,
J. Pilewski, M. Crespo, M.H. Nguyen
Poster Sessions
Risk factors for recurrent urinary tract infections
in kidney transplant recipients
M. Bodro Marimont* (Barcelona, Spain),
G. Sanclemente, A. Moreno, I. Lipperheide, M. Allali,
F. Cofan, N. Esforzado, F. Oppenheimer, J. Bosch,
C. Cervera
P1303
Clonality and virulence of isolates of VRE in stem
cell transplanted patients
A.P. Marchi, I.M. Van der Heijden, E.T. Mendes,
C.F. Rizek, A. Doi, A.S.S. Levin, S.F. Costa*
(Rio de Janeiro, Brazil)
P1304
Effect of chlorhexidine bathing on VRE infections
in haematopoietic and stem cell transplant
(HSCT) patients and impact on emergence of
antiseptic resistance
E.T. Mendes* (São Paulo, Brazil), A.P. Marchi,
I. Van der Heijden, F. Dulley, T.A. De Lima, A.S. Levin,
S.F. Costa
P1305
P1306
P1307
Incidence of cytomegalovirus drug-resistant
mutations in solid organ transplant recipients
R. Lopez Aladid* (Barcelona, Spain),
M.M. Mosquera, A. Cervilla, F. Sanclemente, F. Cofán,
J. Niubó, E. Cordero, P. Muñoz
CMV specific humoral immune response kinetics,
relationship with cellular immune response and
influence in clinical progression of solid organ
transplant recipients (R-/D+)
P. Blanco Lobo* (Seville, Spain), E. Cordero,
E. Cordero, C. Martín-Gandul, M.A. Gentil,
J.M. Álamo-Martínez, J. Aznar, A. Porras-González,
P. Pérez-Romero
Evaluation of specific CMV cellular immunity in
kidney transplant patients
M. Mauro* (Quattromiglia, Italy), F. Greco, R. Tenuta,
F. Leone, R. Bonofiglio, C. Giraldi
P1308
Analysis of ganciclovir-resistant CMV (HHV5) using real-time PCR and pyrosequencing
technology in clinical samples
S. Retzlaff* (Hamburg, Germany), K. Hamprecht
P1309
Lack of influence of human cytomegalovirus’
(HCMV) susceptibility to current antiviral drugs
on HCMV-encoded US28 chemokine receptor
polymorphism
S. Burrel, H. Fenaux, L. Kalkias, H. Agut,
D. Boutolleau* (Paris, France)
Epstein-Barr viral load in whole blood or plasma:
what are we measuring?
C. Van Leer Buter* (Groningen, The Netherlands),
A. Riezebos-Brilman, H.G.M. Niesters
P1311
Epidemiology of respiratory viruses (RV) and
relationship with chronic lung allograft dysfunction
(CLAD) in lung transplant recipients (LTR)
J. Gavaldá* (Barcelona, Spain), M. Peghin,
H.H. Hirsch, G. Codina, A. Dumoulin, O. Len,
J. Solé, J. Rello, A. Roman, A. Pahissa
P1312
Characteristics and outcome of 75 HHV-6
reactivations after allogeneic haematopoietic
stem cell transplantation
A. Quintela, V. Escuret, S. Morisset, L. Gilis,
G. Monneret, M. Michallet, F. Ader* (Lyon, France)
P1313
Primary HHV-6 infections in paediatric liver and
kidney transplant recipients
T. Karlsson, R. Loginov, L. Mannonen,
T. Jahnukainen, H. Jalanko, I. Lautenschlager*
(Helsinki, Finland)
P1314
Post-exposure prophylaxis of varicella: VZIG
administration within 96 hours vs after 96 hours
of exposure to varicella zoster virus
S.J. Kim* (Seoul, Korea), Y.H. Kim, S.J. Kim,
B.K. Lee, Y.J. Kim
P1315
Evaluation of West Nile virus (WNV) in the
explanted kidney allograft of a recipient with
donor-derived WNV encephalitis
H.R. Vikram* (Phoenix, United States), D.M. Blau,
J. Bhatnagar, W.-J. Shieh, H.A. Khamash,
M.L. Smith, J.E. Staples
P1316
Breakthrough candidaemia with Candida
parapsilosis during prophylaxis with micafungin
after allogeneic haematopoietic stem cell
transplantation – cumulative case report
C. Langebrake, C. Wolschke, J. Schreiter, H. Rohde*
(Hamburg, Germany), N.M. Kröger
P1317
Outcome of mucormycosis in haematopoietic
stem cell transplant recipients has improved:
single centre experience
M. Popova, A. Volkova, S. Bondarenko, N. Stancheva,
S. Shirayev, Y. Borzova, T. Bogomolova,
L. Zubarovskaya, B. Afanasyev, N. Klimko*
(St. Petersburg, Russia)
24th ECCMID / Barcelona
Final Programme 207
Chairs, Speakers & Authors
P1302
P1310
Exhibition
ESBL-Enterobacteriaceae-related urinary tract
infections in kidney transplant recipients:
incidence and risk factors of relapse
B. Pilmis, A. Scemla, O. Join-Lambert, O. Lortholary,
C. Legendre, J.R. Zahar* (Paris , France)
General Information
P1301
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1318
Exserohilum rostratum invasive nasal infection in
a renal transplant recipient: the first case report
S. Medhajirapath* (Bangkok, Thailand),
C. Suankratay, S. Wannalerdsakun, A. Chindamporn
P1319
Nocardia infection in the solid organ transplant
recipient: a case-control study
J. Coussement* (Brussels, Belgium),
M.L. Vander Zwalmen, J. Anstey, J. Racapé,
S. Roisin, A. Le Moine, M. Antoine, T. Gustot,
C. Knoop, F. Jacobs
P1320
Is solid-organ transplantation a risk factor for
severe malaria?
M.C. Nguyen* (Lausanne, Switzerland), P. Gervais,
M. Pascual, O. Manuel
P1321
Is miltefosine an option as second-line treatment
for relapsing visceral leishmaniasis in solid organ
transplant recipients? A case series report
N. Carrasco Antón, A. Pérez-Jacoiste,
F. López Medrano, A. Pérez de Ayala, F. Gamarro,
J. Origuen, C. Lumbreras, R. San Juan, M. Lizasoain,
J.M. Aguado* (Madrid, Spain)
P1322
Poster Area
POSTER SESSION V:
Diagnostic microbiology: from lower respiratory tract
infections to gynaecological infections
P1324
P1325
CHROMagar™, StrepB agar and Granada media for
detection of group B Streptococcus in vaginal/
rectal prenatal screening
E. Grenzner* (l’Hospitalet de Llobregat, Spain),
E. Dopico, M. Aguilar, S. Herrero, M.A. Sánchez,
R. Manchado
P1327
An evaluation of Brilliance™ GBS Agar for the
detection of GBS from vaginal swabs
C. Hopper, E. Scopes, J. Heckendorn, M. Oleksiuk*
(Basingstoke, United Kingdom)
P1328
Enhanced detection of group B streptococci from
vaginal-rectal swabs by bedside inoculation of
the specimen in a Lim broth (Lim®, Copan)
S. Mulliez, R. Goemaes, G. Claeys, I. Leroux-Roels,
J. Boelens* (Ghent, Belgium)
P1329
An audit of compliance with NHS GGC primary
care guidelines for the investigation of vaginal
discharge in women of reproductive age
L. Cottom, G. Lochead, P. Wright* (Glasgow, United Kingdom)
P1330
Faecal gas analysis by electronic nose of
paediatric IBD patients and healthy controls:
a pilot study
E.F.J. De Groot* (Amsterdam, The Netherlands),
T.G.J. De Meij, Y.E. Lentferink, M.P.C. Van der Schee,
T. Paff, C.M.F. Kneepkens, K.H.N. De Boer
P1331
Peripheral DNA damage in osteomyelitis
S. Tekin Koruk* (Sanliufra, Turkey), S. Selek,
S. Sipahioglu, A. Taskin, I. Koruk, A. Kocyigit
P1332
Performance of Copan faecal swab and ESwab™
for culturing vancomycin-resistant Enterococcus
(VRE) from clinical specimens
L. Conter* (Brescia, Italy), B. Massetti, C. Comparini,
R. Paroni, S. Castriciano
P1333
Fluorescence anisotropy changes induced
by aminoglycosides in artificial and natural
membranes treated with Pseudomonas
aeruginosa
C. Istrate* (Bucharest, Romania), T. Savopol,
M. Iordache, M. Moisescu, F. Iordache, A. Holban,
E. Kovacs
P1334
The most appropriate sample type to detect
Salmonella in a cohort of Salmonella-positive
duck flocks
B. Gosling* (Addlestone, United Kingdom),
D. Mueller-Doblies, I. Mawhinney, F. Martelli
BacT/Alert FAN plus bottles for microbial testing
of haematopoietic progenitor cells
K. Varettas* (Sydney, Australia)
13:30 – 14:30
P1323
P1326
Evaluation of VITEK® MS identification of
Streptococcus pneumoniae and Streptococcus
pseudopneumoniae from respiratory samples
D. Lazzara* (Porto, Portugal), M. Ribeiro,
C. Pina-vaz, S. Conde, M. Espinar
The impact of performing bacterial identification
(BI) and antimicrobial susceptibility testing
(AST) for bronchoalveolar fluid (BAL) cultures
24h a day in a clinical microbiology laboratory
H. Pailhoriès* (Angers, France), A. Kouatchet,
S. Lasocki, C. Sargentini, C. Lemarié, M. Kempf,
C. Mahaza, M.-L. Joly-Guillou, M. Eveillard
Prospective study of prevalence and detection
methods for Mycoplasma pneumoniae infection
among upper respiratory infections in Japan
N. Matsuda* (Tokyo, Japan), T. Takahara, M. Tanei,
M. Matsuda, A. Nakamura, Y. Uehara, Y. Tabe, T. Naito
208 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Retrospective case-control study of Legionella
pneumonia and pneumococcal pneumonia at a
university hospital in Japan
A. Ueda* (Kanagawa, Japan), M. OKi, A. Tsuda,
H. Yanagi, H. Ozawa, A. Takagi
Poster Area
P1344
Increasing use of 3rd-generation cephalosporins
for pneumonia in the emergency department:
may some prescriptions be avoided?
E. Montassier, N. Lecadet, M. Cousin, N. Goffinet,
C. Peron, G. Potel, E. Batard* (Nantes, France)
Respiratory system involvement in brucellosis:
the results of the Kardelen study
H. Erdem, A. Inan* (Istanbul, Turkey),
N. Elaldi, L. Gorenek, R. Tekin, S. Gulsun,
C. Ataman-Hatipoglu, N. Beeching, O. Deveci,
P. Pulmonary brucellosis study group
P1345
Corynebacterium pseudodiphtheriticum, a
neglected pathogen in lower respiratory tract
infections?
L. Lozano García* (Murcia, Spain),
R. Cesteros Fernández, A.B. Pérez Jiménez,
C. Candel Pérez, A. Guarín Montes,
R. Blázquez Garrido P1346
Characteristics, serotypes, genotypes and
outcome of pneumococcal pneumonia in patients
with chronic obstructive pulmonary disease
S. Grillo* (L’Hospitalet de Llobregat, Spain),
C. Ardanuy, C. Garcia-Vidal, D. Viasus, A. Domenech,
A. Simonetti, S. Santos, J. Dorca, J. Liñares,
J. Carratalá
The scrutiny of detecting community-acquired
pneumonia in emergency departments
F.P. Paling* (Utrecht, The Netherlands),
C.H. Van Werkhoven, S.M. Huijts, M.J.M. Bonten
P1347
Comparison of clinical presentations between
nursing-home-acquired and community-acquired
pneumonia in a Korean teaching hospital: a
retrospective cohort study
J.H. Lee* (Jeju, Korea), S.J. Koh, S.T. Heo
Predicting cardiac complications in patients
hospitalised with community-acquired
pneumonia: a competing risk analysis
D.F. Postma* (Utrecht, The Netherlands),
C.H. Van Werkhoven, L.A. Michielsen, K. Verbon,
J.J. Oosterheert, M.J.M. Bonten
P1348
Procalcitonin as a survival marker in patients
with severe CAP
K. Bielosludtseva* (Dniepropetrovsk, Ukraine),
T. Pertseva, T. Kireeva
P1349
Serum phosphorus levels predict adverse
outcome in adult patients with communityacquired pneumonia: a cohort study
M. Naffaa, M. Mustafa, M. Azzam, T. Machiah,
Z.S. Azzam, E. Braun* (Haifa, Israel)
13:30 – 14:30
POSTER SESSION V:
Lower respiratory tract infections
P1336
P1337
P1338
P1339
P1340
Prevalence of respiratory viruses in patients
with upper and lower respiratory tract infection:
2002-2013
C. Cicek* (Izmir, Turkey), A. Arslan, H. Karakus,
M. Yalaz, E.U. Saz, H. Pullukcu, G. Cok
Clinical and laboratory features of pneumonia
in adults with positive pneumococcal urinary
antigen test
M. Trojanek* (Prague, Czech Republic),
K. Herrmannova, O. Dzupova, Z. Blechova,
S. Arientova, A. Gabrielova, B. Horova, V. Maresova
P1341
Evaluation of causative pathogens of pneumonia
that increased as a result of the 2011 tsunami
disaster in Japan
S. Fujimura* (Sendai, Japan), H. Takahashi,
M. Shoji, S. Ubukata, M. Utagawa, T. Kikuchi,
Y. Nakano, A. Watanabe
P1350
Additional value of the neutrophil/lymphocyte
ratio in predicting outcome for hospitalised
community-acquired pneumonia: a cohort study
D.F. Postma* (Utrecht, The Netherlands),
J.C. Schuurman, C.H. Van Werkhoven,
J.J. Oosterheert, M.J.M. Bonten
P1342
Update on Mycoplasma pneumoniae
epidemiology in Jerusalem – a cohort analysis
C. Hidalgo -Grass, A. Gayego, A. Abutbul,
D. Averbuch, A. Moses, R. Nir-Paz* (Jerusalem, Israel)
P1351
Use of meropenem 3g once a day for outpatient
treatment of acute infective exacerbations of
bronchiectasis
S. Sharma* (Kings Lynn, United Kingdom)
24th ECCMID / Barcelona
Final Programme 209
Chairs, Speakers & Authors
P1343
Exhibition
Misidentification of Escherichia albertii strains by
ENTEROtest 24 and Biolog GN2 MicroPlate
I. Sedlacek* (Brno, Czech Republic), L. Grillova,
J. Cernohlavkova, E. Kroupova, P. Svec
General Information
P1335
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
P1352
Bronchiectasis non-cystic fibrosis: clinical and
microbiological features
G. Barbeito Castiñeiras* (La Coruña, Spain),
A. Lama López, A. Palacios Bartolomé,
M.L. Pérez del Molino Bernal
P1360
Detection of viable but nonculturable
Legionella in hospital water network following
monochloramine disinfection
M. Totaro, B. Casini, F. Aquino* (Pisa, Italy), B. Bruni,
A. Porretta, S. Memmini, P. Valentini, G. Privitera
P1354
Five-year trend in ventilator-associated
pneumonia: a cross-sectional study to
evaluate correlation between microbiology and
antimicrobial consumption
V. Fihman* (Creteil, France), J. Messika, D. Hajage,
V. Tournier, S. Gaudry, F. Magdoud, G. Barnaud,
C. Branger, D. Dreyfuss, J.D. Ricard
P1361
Distribution of clinical Legionella pneumophila
isolates in Catalonia (Spain) by monoclonal
subgroups and sequence-based typing (SBT)
M. Garcia-Nuñez* (Barcelona, Spain),
M.L. Pedro-Botet, S. Quero, J.M. Alvarez,
I. Barrabeig, M.R. Sala, N. Parraga, J.M. Modol,
M. Sabria, O.B.O. Legionella Outbreaks
Study Group in Catalonia
P1362
Hospital water systems as sources of Legionella
– a 7-year follow-up study
P. Norton, J. Amaro* (Porto, Portugal), N. Martins,
M. Carneiro, M. Ribeiro, J.T. Guimarães
P1363
Association between ST1 clone of Legionella
pneumophila and hospital exposure: what’s the
trigger?
P. Cassier* (Lyon, France), C. Campese, Y. Le Strat,
D. Che, S. Jarraud
P1364
Aspiration as a mode of transmission of
Legionnaires’ disease
V. Isernia* (Barcelona, Spain), M.L. Pedro-Botet,
L. Llobera, L. Mateu, J.M. Mòdol, N. Sopena,
M. Sabrià
P1365
Colonisation of Legionella species in Turkish
baths
H. Erdogan* (Antalya, Turkey), H. Arslan
P1366
Domestically acquired Legionnaires’ disease:
two case reports
H. Erdogan* (Antalya, Turkey), H. Arslan
13:30 – 14:30
Poster Area
POSTER SESSION V:
Legionella: news in clinical and molecular epidemiology
P1355
P1356
Specific real-time PCR for detection and
identification of Legionella pneumophila
serogroup 1 ST47 in clinical and environmental
samples
P. Cassier* (Lyon, France), C. Ginevra,
L. Gomez-Valero, N. Jacotin, C. Buchrieser,
S. Jarraud, J. Etienne
New high-throughput typing methods
for genotyping Legionella pneumophila,
Pseudomonas aeruginosa and Staphylococcus
aureus strains
F. Loisy-Hamon* (La Chapelle Sur Erdre, France),
G. Leturnier, B. Lebeau, C. Pourcel, J. Gardes
P1357
Microarray-based strain assignment of Legionella
pneumophila isolates
C. Lück, S. Jarraud, R. Ehricht, N. Jacotin, T. Meyer,
M. Petzold, P. Slickers, A. Ziegler, S. Monecke*
(Dresden, Germany)
P1358
Whole genome sequencing investigation
of household water filters and cold water
humidifiers as emerging vehicles for paediatric
Legionnaires’ disease
J. Moran-Gilad* (Beit Kama, Israel), K. Prior,
E. Yakunin, T.G. Harrison, L. Valinsky, F. Krux,
T. Lazarovitch, M. Mentasti, I. Grotto, D. Harmsen
P1359
210
Demonstration of persistence for six years of a
single Legionella pneumophila genotype in the
freshwater system on a ship experiencing three
separate outbreaks of legionellosis
C. Ahlen* (Trondheim, Norway), M. Aas, J. Krusnell,
O.J. Iversen
24th ECCMID / Barcelona
Final Programme
13:30 – 14:30
Poster Area
POSTER SESSION V:
Molecular diagnostics of respiratory viruses
P1367
Point-of-care isothermal nucleic acid
amplification is superior to lateral flow
immunochromatographic assays for the
detection of influenza viruses
T.J. Gray* (Westmead, Australia), B. Hazelton, J. Ho,
D.E. Dwyer, J. Kok
Poster Sessions
Monday, 12 May 2014
P1368
Evaluation of the clinical performance of the
Xpert® flu next generation assay and BioFire™
FilmArray test for the rapid detection and
identification of influenza virus
A. Dixon, N. Gleadall, J. Heaney, S. Parmar*
(Cambridge, United Kingdom), S. Weller, E. Hutley,
M.D. Curran
P1369
Evaluation of a new RT-PCR for the detection of
influenza A/B and RSV (IMDx flu A/B and RSV for
Abbott m2000)
S. Gomez* (Madrid, Spain), C. Prieto, C. Vera,
L. Folgueira
P1378
Comparison PLEX-ID to Prodesse ProFluPlus and
Cepheid GeneXpert for the detection of influenza
and other respiratory viruses at a tertiary care
medical centre in 2012-2013
C.A. Gaydos* (Baltimore, MD, United States),
H. Hardick, A. Valsamakis, R. Rothman, A. Dugas
Detection of Bordetella pertussis infection by
culture, real-time polymerase chain reaction and
serologic tests in Valencian community
J. Gil-Tomás, J. Colomina-Rodríguez,
M. Borrás -Máñez* (Alzira, Spain), V. Pérez-Doñate,
S. Górriz-Pintado
P1379
Comparison of two multiplex RT-PCR assays for
respiratory virus detection: Anyplex RV 16 and
Seeplex RV 12
Y. Seo* (Incheon, Korea), P. Park, J. Ahn, K. Kim
Pertussis vaccination coverage among adults in
Lyon area: a cross-sectional study
D. Baratin, C. Del-Signore* (Lyon, France), J. Thierry,
E. Caulin, A.C. Jacquard, P. Vanhems
P1380
Evaluation of the FilmArray® respiratory panel
for the detection of influenza virus A/B and
respiratory syncytial virus in respiratory
specimens of children
T. Bodmer* (Liebefeld, Switzerland), C. Guler,
M. Ritzler, W. Baer, M. Risch
Antibody levels to pertussis toxin in neonates
and prevalence of recent pertussis infection in
pregnant women of Catalonia (Spain)
P. Plans* (Barcelona, Spain), F. De Ory, M. Campins,
E. Alvarez, T. Payà, P. Balfagón, K. Vallvé, P. Godoy,
L. Cabero, A. Domínguez
P1381
The importance of IgA anti-Bordetella pertussis
serologic testing for the diagnosis of acute
pertussis
O. Dakovic Rode* (Zagreb, Croatia),
M.L. Kosanovic Licina, M. Kujundzic Tiljak,
J. Iscic Bes, S. Zidovec Lepej, A. Tambic Andrasevic
Poster Area
P1373
Evaluation of the new RespiFinder® for the
detection of respiratory pathogens
K. Loens* (Antwerp, Belgium), C. Lammens,
H. Goossens, F. Coenjaerts, E. Claas, A. Van Loon,
M. Ieven
P1382
P1374
Investigation of aetiology by multiplex PCR
method in autopsy cases considered for lower
respiratory tract infection
N. Ziyade* (Istanbul, Turkey), N. Elgormus,
G. Yagmur, S. Celik, F. Karayel, Y. Buyuk
Surveillance and molecular characterisation of
measles in high density populated region of Italy
A. Piralla* (Pavia, Italy), M. Premoli, A. Girello,
A. Sarasini, F. Baldanti
P1383
Characteristics of adult patients who received
multiplex respiratory virus polymerase chain
reaction (MRV-PCR) tests and risk factors for
positive MRV-PCR at a tertiary care centre
S. Choi* (Seoul, Korea), M.H. Jeon, J.W. Chung,
M.Y. Ahn
Insufficient herd immunity against measles in
individuals aged <35 years could be one of the
factors explaining re-emergence of measles in
Catalonia (Spain)
P. Plans* (Barcelona, Spain), A. Martínez,
G. Carmona, J. Espuñes, N. Torner, M. Jané
P1384
Investigation of a rubella outbreak in Chandigarh,
north India
V. Bansal* (Haryana, India), M. Gupta, J. Khurana,
B. Buddhathoki, M. P Singh
P1375
P1376
Evaluation of multiple RealStar® RT-PCR kits for
the detection of viral respiratory tract infections
A. Boesl* (Feldkirch, Austria), K. Baruschke,
G. Hartmann, H. Dirschmid, U. Gruber-Mösenbacher,
F. Offner
24th ECCMID / Barcelona
Final Programme
211
Posters
POSTER SESSION V:
Bordetella, measles, rubella and mumps
Chairs, Speakers & Authors
P1372
13:30 – 14:30
Exhibition
P1371
Evaluation of throat-swab type and molecular
diagnostics for viral aetiologies of acute
pharyngitis
M. Ali* (Cambridge, United Kingdom), J. Han,
C.J. Gunst, S. Lim, K. Luinstra, M. Smieja
General Information
P1370
P1377
Poster Sessions
Monday, 12 May 2014
P1385
Virological and clinical differences between
mumps G5 strains
S. Gouma* (Bilthoven, The Netherlands),
D. Gijselaar, J. Cremer, H. Boot, S. Hahné,
M. Koopmans, R. Van Binnendijk
13:30 – 14:30
P1393
Evaluation of the Sofia fluorescent immunoassay
for the detection of influenza and respiratory
syncytial virus
B. Hazelton* (Westmead, Australia), J. Ho,
G. Nedeljkovic, D.E. Dwyer, J. Kok
P1394
Validation of the Alpha-Tec systems’ ETM™ (enteric
transport media) for the detection of rotaviruses
and adenoviruses from stool specimens using
four rapid immunochromatographic tests
J.F. Carod* (Avignon Les St Claude, France),
E. Puget, P. Pothier, K. Ambert-Balay
P1395
H1N1 testing: rapid detection test vs PCR
A. Alhetheel* (Riyadh, Saudi Arabia), A. Albarrag,
A. Somily, S. Eifan, Z. Hussain
P1396
Evaluation of BIO-FLASH® HSV-1 IgG and HSV-2
IgG assays on Biokit’s BIO-FLASH® analyser
M. Cedó, S. Hernanz* (Lliçà d’Amunt, Spain),
J. Juliá, B. Ballester, M. Tarragó
P1397
The advantages of EIA with improved sensitivity
for the detection of low concentrations of HBsAg
in samples with markers of HCV, HBV or HIV
infections
N. Egorova* (Nizhny Novgorod, Russia), S. Igolkina,
I. Pyrenkova, I. Sharipova, V. Puzyrev, A. Burkov,
T. Ulanova
P1398
Evaluation of the new assay Liaison® XL murex
HBsAg Quant for the quantification of hepatitis B
surface antigen in patients with chronic hepatitis B
V. Ghisetti* (Turin, Italy), E. Burdino, T. Ruggiero,
A. Olivero, G.P. Caviglia, M. Marietti, A. Smedile
P1399
Preliminary assessment of the performance of
“Architect® anti-HCV” plus “Liaison® XL murex
HCV-AB” to confirm doubtful HCV antibodies’
screening results
M. Oggioni, L. Saponaro, S. Giannotta, D. Campisi*
(Milan, Italy)
P1400
Performance of VIDAS® anti-HCV as a second-line
test for the detection of anti-HCV antibodies
G. Furlini* (Bologna, Italy), C. Foschi, P. Nardini,
S. Galli, M.G. Meliconi, M.P. Landini
P1401
Influence of heterogeneity of amino
acid sequence varying considerably on
immunoreactivity antigen region of HCV NS5
protein from position 2212 to 2313
G. Bochkova* (Nizhniy Novgorod, Russia),
T. Ulanova, V. Puzyrev, A. Burkov
Poster Area
POSTER SESSION V:
Molecular and non-molecular diagnostics of viruses
P1386
P1387
Evaluation of a rapid test for diagnosis of dengue
virus infection in travellers
I. Alejo Cancho* (Barcelona, Spain), D. Vilavella,
I. Campos, R. Ferre, R. Monte, A. Cañas, D. Martinez,
J. Gascon, M.J. Martinez
An evaluation of nine rubella IgG assays
highlights many discrepancies in the
interpretation of the results
E. Bouthry, D. Huzly, M.G. Revello, M. Furione,
L. Grangeot-Keros, C. Vauloup-Fellous* (Villejuif,
France)
P1388
Evaluation of new chemiluminescent
immunoassays for the determination of HSV-1 IgG
and HSV-2 IgG
F. De Ory* (Madrid, Spain), M.E. Guisasola,
P. Balfagón
P1389
Urea-modified protein antigens and their
potential to simultaneously induce CMV-specific
CD4 and CD8 T-cell responses comparing a new
CMV-EliSpot assay and flow-cytometric analysis
D. Schub* (Homburg / Saar, Germany), T. Schmidt,
C. Guckelmus, S. Kirsch, H. Bendfeldt, L. Deml,
U. Sester, M. Sester
P1390
P1391
P1392
212
Comparison of three automated immunoassay
methods for the determination of Epstein-Barr
virus immunoglobulins
R. Mouro Pinto* (Porto, Portugal), L. Ribeiro,
A. Castro, J.P. Carneiro, M.J. Cardoso
Performance of two new fully automated
immunoassay panels (Architect and BioPlex™
new EVB IgG) for the determination of serological
status of Epstein-Barr virus
T.d. Ly* (Ivry Sur Seine, France), C. Coignard,
C. Marcenaro
Development of human bocavirus antigen test for
mariPOC® platform
H. Toivola* (Turku, Finland), K. Hedman, V. Peltola,
M. Waris, T. Heikkinen, H. Aatola, R. Ruonamo,
J.O. Koskinen
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Evaluation of the novel Geenius™ HIV 1/2 HIV
confirmatory system
A. Blaich* (Basel, Switzerland), A. Geschke,
T. Klimkait, K. Rentsch, H. Freidank, A. Buser, R. Frei
P1404
Performance evaluation of the Beckman Coulter
Veris cytomegalovirus assay on the Veris MDx
system
Q. Li* (South Bend, United States), J. Williams,
K. Maggert, A. Lehr, A. LeMonte, A. Pantone,
J. Strefling, S. Kye, D. Broyles, K. Fife
Molecular identification of enteroviruses by
nested PCR and 5´UTR sequencing
N. Piskunova* (Ceske Budejovice, Czech Republic),
P. Trubac, O. Scheinost
P1412
Validation of human enterovirus (HEV)/
parechovirus (HPEV) multiplex one-step realtime RT-PCR and study of co-infection in positive
rotavirus group A (RV-A) children’s stools
L. Bubba* (Milan, Italy), E. Pariani, L. Pellegrinelli,
A. Ranghiero, V. Primache, A. Amendola, S. Binda
P1413
Evaluation of molecular assays for norovirus
detection
A. Hardie* (Edinburgh, United Kingdom), L. Lin,
L. Mackenzie, J. White, J. Kenicer, K. Templeton
P1414
Automated molecular detection of viral
gastroenteritis with the Roche FLOW System
R. Van Rhee-Luderer* (Leeuwarden,
The Netherlands), N. Storm, E. Poelstra,
A.-J. Stellingwerff, S.J. Mulder, A.H. Brandenburg,
J.F.L. Weel, T.A. Schuurs
P1405
Cytomegalovirus (CMV) viral load assay for the
Veris platform
A. Silvestro, H. Duan, S. Lim, J. Richards, J. O’Neil,
C. Howell* (Danvers, MA, United States),
N. Tusneem, E. Gustafson, T. Scholl
P1406
Veris molecular diagnostic system sample-tosample crossover contamination study
T. Arnold, M. Rundell* (Chaska, MN, United States),
K. Frey, B. Hanson, B. Wilson, H. Qureshi
P1415
Molecular detection of enteric viruses: faecal
samples versus rectal swabs
G. Eltringham* (Newcastle upon Tyne, United
Kingdom)
P1407
Evaluation of the BK Virus R-gene® quantification
kit for determination of BK viral load in renal
transplant patients
C. Sueur, R. Freitag, E. Soulier, P. Domingo-Calap,
S. Caillard, S. Bahram, F. Stoll-Keller,
S. Fafi-Kremer* (Strasbourg, France)
P1416
Standardised kits for rapid screening of norovirus
and enteric viruses in clinical samples
F. Loisy-Hamon* (La Chapelle Sur Erdre, France),
G. Leturnier, A. Delage, B. Lebeau, K. Balay, P. Pothier
P1417
Adaptation of Cepheid’s Smart Norovirus® kit to
the automated BD MAX™ open mode platform
N. Wohlwend* (Liebefeld-Berne, Switzerland),
A. Péclat, M. Ritzler, L. Risch, T. Bodmer
P1418
Clinical value of a norovirus (NV) rapid test in
patients (PTS) with gastroenteritis (GE)
S. Schwartz* (Berlin, Germany), E. Weise,
A. Stein, K. Lenz, J. Hofmann, M. Vergoulidou,
R. Somasundaram
P1419
Development of an external quality assessment
panel for the detection of norovirus
T. Wijamunige, B. Senechal* (London,
United Kingdom), V.L.A. James
P1420
Genotyping and double-controlled quantification
of parvovirus B19 by multiplex PCR assay
M. Nesic* (Belgrade, Serbia), D. Kuzmanovic,
I. Joksic, V. Libek, D. Ciric, M. Stanojevic, A. Knezevic,
G. Stamenkovic
P1408
P1409
P1410
Role of molecular detection of human herpesvirus
7 in central nervous system infections
M. Rodriguez Dominguez* (Madrid, Spain),
S. Sainz de la Maza, I. Corral, E. Otheo,
J.M. González-Alba, R. Cantón, J.C. Galán
CSF sample-to-answer validation studies using
Focus Diagnostics’ Simplexa™ HSV 1 & 2 direct
assay
J. Chen* (Cypress, CA, United States), Y. Xie,
Y. Parocua, L. Geller, J. Borgeson, N. Wilcox, B. Yu,
D. Jaiswal, M. Tabb
Performance characteristics of an automated
assay on the cobas® 4800 system to detect
herpes simplex virus with the cobas® HSV 1 & 2
test
D. Fairley* (Pleasanton, Ireland), J. McKenna,
C. Cox, P. Coyle
24th ECCMID / Barcelona
Final Programme
213
Chairs, Speakers & Authors
P1403
P1411
Exhibition
Performances of a new rapid confirmatory assay
for HIV1/2 serodiagnosis
I. Abbate* (Rome, Italy), C. Pergola, M. Pisciotta,
R. Sciamanna, C. Sias, N. Orchi, R. Libertone,
M.R. Capobianchi
General Information
P1402
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
Transient viraemia in HIV-infected patients: blip,
bust or laboratory artifact?
D. Bassetti* (Trento, Italy), L. Collini, C. Bezzi,
L. Tomasi, C. Nuzzo, P. Lanzafame
13:30 – 14:30
P1422
Quantitative detection of hepatitis B virus (HBV)
on the Veris platform
J. Arter Williams* (Danvers, MA, United States),
J. Rodriguez, Z. Wang, K. Lykstad, G. Donvito,
J. Fung, C. Howell, V. Colinayo, E. Gustafson,
T. Scholl
P1429
Lineage diversification and recombination in
human astroviruses
M.C. Medici, F. Tummolo, S. De Grazia,
G.M. Giammanco, C. Chezzi, F. De Conto,
M.C. Arcangeletti, A. Calderaro* (Parma, Italy),
V. Martella
P1423
Evaluation of performances of versant HCV RNA
1.0 assay (KPCR) and Roche cobas® AmpliPrep/
cobas® TaqMan HCV test v2.0 at low level
viraemia
L. Mazzuti, M. Lozzi, E. Riva, M. Gentile, O. Turriziani,
G. Antonelli* (Rome, Italy)
P1430
Norovirus GII.4 Sydney 2012 and new interpandemic recombinant GII.4 strains in Italy
M.C. Medici, F. Tummolo, R. Vasile Simone,
A. Fazzi, F. De Conto, M.C. Arcangeletti, C. Chezzi,
A. Calderaro* (Parma, Italy)
P1424
Quantitative detection of hepatitis C virus (HCV)
on the Veris platform
E. Joseph, R. Gilfillan, Z. Wang, Y. Xu, P. Brannen,
J. Wood, C. Howell, E. Gustafson, T. Scholl*
(Danvers, MA, United States)
P1431
Spatiotemporal transmission and phylodynamics
of coxsackievirus B1
P.Y. Chu* (Kaohsiung, Taiwan), Y.Y. Shi, Y.H. Chen
P1432
Seven day PCR testing for measles virus – a rapid
screening tool to aid public health actions
A. Hardie* (Edinburgh, United Kingdom),
F. Hamilton, J. White, P. McCulloch, J. Bremner,
S. Ramalingam, I. Johannessen, K. Templeton
Molecular epidemiology of coxsackievirus A24
variant in Taiwan: VP1 sequence-based analysis
of 1985-2010 isolates
J.Y. Zeng* (Kaohsiung, Taiwan), C.C. Lin, P.Y. Chu
P1433
Comparing detection and quantification
of Epstein Barr virus DNA using novel and
commercial real-time PCR methods
M. Skourtopoulos* (Tornesch, Germany),
K. Rutkowski, N. Mueller-Lantzsch, B. Gärtner
Sequence and phylogenetic analysis of group A
rotavirus strains circulating in Greece; purposes
and initial results of ongoing THALES project
D. Chatzopoulos* (Karditsa, Greece),
L.V. Athanasiou, G. Valiakos, M. Kantere, C. Billinis
P1434
Genetic analysis of post-pandemic influenza
A(H1N1)PDM09 haemagglutinin virus variants
that caused mild, severe and fatal infections in
northern Greece
A. Melidou, M. Exindari, G. Gioula, N. Malisiovas*
(Malisiovas, Greece)
P1435
Analysis of mutations associated with severity
and antiviral resistance in influenza virus in
Catalonia and Valencian community: season
2012-13
M.M. Mosquera* (Madrid, Spain), A. Vilella,
N. Torner, M. Miralles, R. Isanta, R. Vendrell, J. Vila,
M.A. Marcos, PIDIRAC Sentinel Surveillance Network
Physicians of Catalonia, Health Surveillance
Network of Valencian Community
P1436
Molecular epidemiology of human norovirus
strains isolated in south Korea during 2013
H.S. Kim* (Hwaseong, Korea), D.H. Whang,
H.S. Kim, J.S. Kim, W. Song
P1421
P1425
P1426
P1427
P1428
214
A PCR/ESI-MS assay designed to detect diverse
viral agents of disseminated infection in plasma
D. Baynes* (Carlsbad, United States), H. Carolan,
D. Toleno, D. Metzgar, L. Blyn, R. Sampath
POSTER SESSION V:
Molecular epidemiology of viruses
Performance of LAMP technology versus realtime PCR for BK virus detection in the follow-up of
paediatric transplant recipients
V. Spuri Vennarucci, L. Gentile* (Rome, Italy),
L. Mancinelli, L. Coltella, G. Pizzichemi, M.D. Caione,
C. Russo, D. Menichella
24th ECCMID / Barcelona
Final Programme
Poster Area
Poster Sessions
Pherotype polymorphism does not explain the
population genetic structure of Streptococcus
pneumoniae
B.A. Evans* (Cambridge, United Kingdom),
O.E. Cornejo, D.E. Rozen
P1445
Polymorphism of the PcrV protein from
Pseudomonas aeruginosa: epidemiological and
therapeutic implications
C. Bréchet, C. Muller, D. Fournier, P. Plesiat*
(Besançon, France)
P1446
Prevalence of PI-1 and PI-2 among Streptococcus
pneumoniae isolated from healthy
nasopharyngeal carriers and children with acute
otitis media
S. Belanov, I. Tsvetkova, S. Sidorenko* (St. Petersburg, Russia)
P1447
Effects of bacterial infection in exacerbations of
chronic obstructive pulmonary disease
T. Curran* (Belfast, United Kingdom), W.A. Coulter,
T.E. McManus, J. Kidney, P.V. Coyle
P1448
Streptococcus pneumoniae and Streptococcus
pseudopneumoniae: correct identification by
a multiplex-PCR based on species specific 16S
rRNA BP differences
R. Dargis* (Slagelse, Denmark), M. Kemp,
J.J. Christensen P1449
Routine real-time PCR for Legionella spp. as
part of a front-line syndromic molecular testing
algorithm for pneumonia patients in the UK
N.J. Gadsby, K.O. Helgason, E.M. Dickson,
J.M. Mills, D.S. Lindsay, G.F. Edwards, M.F. Hanson,
K.E. Templeton* (Edinburgh, United Kingdom)
Poster Area
POSTER SESSION V:
Molecular diagnosis of respiratory tract bacterial infections
P1438
Development and validation of a real-time
multiplex PCR method for detection of common
atypical respiratory tract bacterial pathogens
P. Jayaratne* (Hamilton, Canada)
P1439
Application of the BioFire FilmArray® pneumonia
panel for rapid identification of the causative
agents of ventilator-associated pneumonia
M.R. Pulido* (Seville, Spain), P. Moreno-Martínez,
F. Fernández-Cuenca, P. Egea, A. Pascual,
M.J. McConnell, J.M. Cisneros
P1440
Application of molecular biology (FilmArray®)
in the early diagnosis of ventilator-associated
respiratory infection in critically ill patients
M. Gordon Sahuquillo* (Valencia,
Spain), A. Quinza Real, E. Villarreal Tello,
E.M. Gonzalez Barbera, J.S. Frasquet Artés,
I. Calleja Serrano, M.T. Sanchez Aguilar,
I. Natividad Furio, J. Bonastre Mora,
P. Ramirez Galleymore
P1441
Rapid molecular detection and identification of
bacteria commonly associated with pneumonia in
critically ill patients using a PCR/ESI-MS assay
G. Richmond* (Carlsbad, United States),
D. Metzgar, M. Frinder, H. Carolan, D. Toleno,
L. Blyn, R. Sampath
P1442
The development of a multiplex PCR assay for
the detection of antibiotic resistance markers in
respiratory pathogens
A. Penninger* (Maastricht, The Netherlands),
Y. Ozog, R. Waber, G. Simons
P1443
Comparison of clinical molecular diagnostic tools
to discriminate among Burkholderia complex
species
C.C. Orelio* (Leiden, The Netherlands), M.C. Morsink,
S. Beiboer, S. Tektas, H.E. Dekter, W.B. Van Leeuwen
Chairs, Speakers & Authors
13:30 – 14:30
P1444
Exhibition
Genotype D8 reintroductions of measles in 2013
in Catalonia: replacement of genotype D4?
M.M. Mosquera* (Madrid, Spain), N. Torner,
M.A. Marcos, M. Jané, R. Isanta, R. Vendrell, J. Vila,
J. Costa, And the Measles Control Working Group of
Catalonia
24th ECCMID / Barcelona
Final Programme
215
General Information
P1437
Posters
Monday, 12 May 2014
Poster Sessions
Monday, 12 May 2014
13:30 – 14:30
Poster Area
P1458
Unusual complication by an unusual pathogen:
meningitis and bacteraemia due to Neisseria
cinerea following a percutaneous rhizotomy of
the trigeminal ganglion – a case report
M. Von Kietzell* (St. Gallen, Switzerland),
K. Huscher, T. Bruderer, D. Goldenberger, S. Emonet,
C. Strahm
P1459
Retrospective cohort study on the
epidemiological patterns of central nervous
system herpes simplex virus infection: 10 years
of experience of a general hospital
M. Casal Moura* (Porto, Portugal),
J. Sobrinho Simões, F. Friões, V. Braz, P. Dias,
G. Rocha, J. Almeida
P1460
A pilot study of the change in temporal lobe
volumes in herpes simplex virus (HSV)
encephalitis using stereological techniques
S. Defres* (Liverpool, United Kingdom), S. Keller,
L. Parkes, K. Das, N. Roberts, T. Solomon
P1461
Multi-centre validation of an electronic
surveillance model for drain-related meningitis
M.S.M. Van Mourik* (Utrecht, The Netherlands),
K.G.M. Moons, M.J.M. Bonten, On behalf of the drain-related meningitis study group
P1462
Time to culture positivity of CSF from ICU patients
with external drains
E. Kolwijck* (Nijmegen, The Netherlands),
A. Hoedemaekers, P. Sturm
POSTER SESSION V:
Central nervous system infections
P1450
Assessment of the management of bacterial
meningitis in the adult emergency room
C. Delaire* (Poitiers, France), G. Béraud,
H. Delelis-Fanien, F. Roblot, J.Y. Lardeur
P1451
Acute bacterial meningitis in adults admitted to
an infectious diseases department at Lisbon
M. Costa Pires* (Lisbon, Portugal), A. Zagalo,
J. Neves
P1452
Interest of laboratory database analysis
for assessing the total number of bacterial
meningitis cases managed in a French hospital
Y. Vandamme* (Angers, France), P. Holecska,
N. Crochette, V. Rabier, P. Abgueguen, M. Kempf,
N. Asseray
P1453
Group A streptococcal meningitis in adults:
a prospective cohort study
M.J. Lucas* (Amsterdam, The Netherlands),
M.C. Brouwer, D. Van de Beek
P1454
Neurological causes of death in adults with
Listeria monocytogenes meningoencephalitis:
hydrocephalus and seizures
I. Pelegrín Senent* (Barcelona, Spain), P.F. Viladrich,
J. Ariza, C. Cabellos
P1455
Distinctive characteristics of clinical and
laboratory presentation between Listeria and
pneumococcal meningitis in elderly
P. Pagliano* (Naples, Italy), M. Rossi, V. Attanasio,
T. Ascione, M. Conte, A. Bernardo, F.S. Faella
P1463
Central nervous system (CNS) melioidosis as an
emerging mimicker of CNS infection: a first case
series in the Philippines
A. Masbang* (Quezon City, Philippines), G.M. Zabat,
J. Cano, J.H. Gorriceta, C. Dumo, G.S. Mariano
P1456
Hyperglycaemia at admission and adjunctival
dexamethasone therapy in bacterial meningitis:
does it matter?
J. Bodilsen* (Aalborg, Denmark), M. Dalager-Pedersen,
H.C. Schønheyder, H. Nielsen
P1464
Impact of round-the-clock cerebrospinal fluid
Gram stain for suspected central nervous system
infections on medical therapeutic decisions: does
it make a difference?
F. Tissot* (Lausanne, Switzerland), G. Prod’hom,
G. Greub
P1457
Risk factors for mortality in systemic
meningococcal disease
M. Cabellos Minguez* (Barcelona, Spain),
I. Pelegrín, E. Benavent, M.D. Garcia Somoza,
F. Gudiol, J. Ariza, P.F. Viladrich
P1465
Exploring transmission of Escherichia coli
plasmids encoding CMY-2 beta-lactamase
between animals and humans in Denmark
K.H. Hansen* (Frederiksberg, Denmark),
C.A. Nielsen, V. Bortolaia, K. Schønning, Y. Agersø,
L. Guardabassi
216
24th ECCMID / Barcelona
Final Programme
Poster Sessions
Tuesday, 13 May 2014
P1467
P1468
P1469
P1470
P1471
P1472
Comparison of culture for MRSA and
Staphylococcus aureus with Copan MSwab and
ESwab™ specimen collection systems
J. Lu, H. Phan, C. Fillmore, C. Honisch* (Pleasanton,
United States), M. Lewinski, J. Osiecki
Improved detection of difficult-to-detect
methicillin-resistant Staphylococcus aureus
isolates on ChromID® MRSA SMART agar from
surveillance specimens
R. Kofol* (Ljubljana, Slovenia), M. Pirs,
N. Svent Kucina
Evaluation of a new chromogenic medium
for isolation of MRSA for use with or without
enrichment culture
J. Perry* (Newcastle-upon-Tyne, United Kingdom),
K. Day, A. Perry, J.M. Roche, S. Orenga
P1474
Rapid identification of Staphylococcus
epidermidis by colony PCR with S. epidermidis
surface protein SesC as a marker
L. Khodaparast* (Leuven, Belgium), M. Shahrooei,
J. Van Eldere
P1475
A novel selective and differential agar medium for
Staphylococcus lugdunensis
M.H. Leung* (Hong Kong, China), K.H. Chow, P. Law,
E.L. Lai, P.L. Ho
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Epidemiology and clinical impact of S. aureus resistance
P1476
Usability and performance of Copan eMRSA
broth for the preliminary detection of methicillinresistant Staphylococcus aureus in clinical
specimens
J. Hirvonen* (Tampere, Finland), S.-S. Kaukoranta
Trends in phenotypic and genotypic
characteristics of methicillin-resistant
Staphylococcus aureus over an eight-year period
in a university hospital
I. Cirkovic* (Belgrade, Serbia), S. Stepanovic,
S. Djukic, J. Trajkovic, A.R. Larsen
P1477
Comparison of Copan eMRSA and Oxoid™ contrast
MRSA broths for detection of methicillin-resistant
Staphylococcus aureus
J.J. Hirvonen* (Tampere, Finland), O. Liimatainen,
R. Vuento
Differences in antibiotic resistance between
MRSA genetic linages ST8-SCCmec IV and ST239SCCmec III
V. Gostev* (St. Petersburg, Russia), O. Dmitrenko,
S. Sidorenko
P1478
Resurgence of penicillin-sensitive
Staphylococcus aureus in a US tertiary care
hospital, a prevalence study
M. Chabot* (Springfield, United States), J. Larioza,
J. Friderici, M. Stefan, J. Schimmel
P1479
Contemporary staphylococcal resistance rates
observed in European countries using data
derived from TEST programme (2010-2013)
B. Johnson* (Schaumburg, United States),
M. Hackel, I. Morrissey, D. Biedenbach,
S. Bouchillon, J. Johnson
P1480
High genetic diversity of S. aureus isolates in
cystic fibrosis patients in Austria
A.J. Grisold* (Graz, Austria), G. Zarfel, A. Badura,
E. Eber, G. Feierl, J. Luxner, U. Wagner-Eibel,
S. Johler, L. Masoud- Landgraf
Rapid diagnostic testing with GeneXpert improves
enrolment in a randomised clinical trial for
detection of methicillin-resistant S. aureus in
acute bacterial skin and skin structure infections
K. Claeys* (Detroit, United States), A. Casapao,
J. Pogue, S. Saely, C. Giuliano, W. Hafeez, K. Kaye,
D. Levine, S. Davis, M. Rybak
Substantial effect of 2% NaCL on minimal
inhibitory concentration of communityassociated methicillin-resistant Staphylococcus
aureus against oxacillin (TIST study, 2006-2010)
W. Wang* (Taichung, Taiwan), T. Chiueh, J. Lu,
P. Hsueh
24th ECCMID / Barcelona
Final Programme
Exhibition
P1466
A modified agar screening method for detection
of heterogeneous vancomycin-intermediate
Staphylococcus aureus
L. Cui* (Kanagawa, Japan), H. Matsui, H. Hanaki
Posters
POSTER SESSION VI:
Detection of MRSA and identification of staphylococci at
species level
P1473
Chairs, Speakers & Authors
Poster Area
217
General Information
12:30 – 13:30
Poster Sessions
Tuesday, 13 May 2014
P1481
Quantifying the impact of frequent mupirocin
usage on the development of low-level mupirocin
resistance and the control of healthcareassociated, methicillin-resistant Staphylococcus
aureus
S.R. Deeny* (London, United Kingdom), C. Worby,
J. Edgeworth, B. Cooper, O. Tosas, J.V. Robotham
P1482
Beta-lactams versus vancomycin for treatment
of methicillin-susceptible Staphylococcus aureus
bacteraemia: a retrospective cohort study of data
from the U.S. Veterans’ Health Administration
J.S. McDanel, E.N. Perencevich, D.J. Diekema,
L.A. Herwaldt, T.C. Smith, E.A. Chrischilles,
J.D. Dawson, M.L. Schweizer* (Iowa City, IA, United
States)
P1483
P1484
P1485
P1486
P1487
218
Methicillin-resistant Staphylococcus aureus
bacteraemia: elevated MIC and 30-day mortality
D. Lye, M.K. Win* (Singapore, Singapore), B.S. Ang,
S. Choudhury, P. Krishnan, A. Chow
Validation of vancomycin minimum inhibitory
concentration and clinical outcomes in
methicillin-resistant Staphylococcus aureus
isolated from blood culture
H. Shoji* (Tokyo, Japan, M. Maeda, K. Fukuchi,
T. Shirakura, T. Takuma, K. Tanaka, K. Ishino, Y. Niki)
Impact of vancomycin minimum inhibitory
concentration on treatment outcome in invasive
Staphylococcus aureus infections: Korea
INfectious Diseases (KIND) study group
K.H. Song* (Seongnam, Korea), K.H. Park, S.I. Jung,
N. Yoon, D.M. Kim, H.C. Jang, Y. Park, K.S. Lee,
Y.G. Kwak, H.B. Kim
Impact of elevated vancomycin minimum
inhibitory concentrations on the outcome of
catheter-related bloodstream infection due to
methicillin-resistant Staphylococcus aureus
M. Fernández-Ruiz* (Madrid, Spain), R. San Juan,
J.M. Aguado, O. Gasch, M. Camoez,
F. López-Medrano, M.A. Domínguez, B. Almirante,
B. Padilla, M. Pujol
Community staphylococcal pyogenic skin
infections in England: PVL, MRSA & clonal
diversity
A. Kearns* (London, United Kingdom), A. Vickers,
B. Pichon, M. Ganner, A. Johnson, A. Charlett, R. Hill
24th ECCMID / Barcelona
Final Programme
P1488
Molecular epidemiology of methicillin-resistant
S. aureus strains from skin and soft tissue
infections in Israel
A. Rokney* (Jerusalem, Israel), E. Anuka,
M. Davidovich-Cohen, O. Barzilay, J. Moran-Gilad,
V. Agmon, L. Valinsky
P1489
The oral cavity acts as reservoir for
Staphylococcus aureus: implications for systemic
infections from prosthetic dental appliances
L. O’Donnell* (Glasgow, United Kingdom), G. Joyner,
K. Smith, D. Robertson, V. Hannah, G. Ramage
P1490
Molecular characterisation of methicillinresistant coagulase-negative staphylococci
isolated from environment
Z. Xu* (London, United Kingdom), H. Mkrtchyan,
R.R. Cutler
P1491
Distribution of the antiseptic resistance genes
qacA/B in 1004 whole genome sequenced
methicillin-resistant Staphylococcus aureus
isolated in the Danish healthcare setting
S. Skovgaard* (Hvidovre, Denmark), P. Worning,
H. Westh
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Epidemiology with molecular typing
P1492
Optimising genome assembly and genome
finishing of microbial pathogens using whole
genome mapping
B. Xavier* (Antwerp, Belgium), J. Sabirova,
H. Goossens, S. Malhotra-Kumar
P1493
Microarray-based genoserotyping and
antimicrobial resistance gene determination of
Salmonella enterica
S. Braun* (Jena, Germany), R. Ehricht
P1494
MG7: a scalable fast tool based on cloud
computing and graph databases for microbial
community profiling
M. Manrique, P. Pareja-Tobes, E. Kovach, A. Alekhin,
E. Pareja, E. Pareja-Tobes, R. Tobes* (Granada,
Spain)
P1496
Inter- and intra-cluster mechanisms of Neisseria
meningitidis molecular evolution
K.V. Siniuk* (Minsk, Belarus), L.P. Titov,
K.K. Wollenberg, S. Xirasagar, D. Hurt, Y. Huyen
Poster Sessions
Isolation of OXA beta-lactamases mRNA and DNA
by sequence-specific probes immobilised on
magnetic beads
C. Brandt* (Jena, Germany), O. Makarewicz,
M.W. Pletz
P1500
Fast epidemiological typing of the ESKAPE
pathogens using ligation-mediated real-time PCR
and high resolution melt analysis
H. Woksepp* (Kalmar, Sweden), A. Ryberg,
H. Billström, L.E. Nilsson, B. Olsson-Liljequist,
A. Hällgren, T. Schön
P1501
Genotyping of Campylobacter upsaliensis –
evidence of transmission from dog to human
J. Luxner* (Graz, Austria), G. Zarfel, A.J. Grisold,
S. Jelovcan, O. Ableitner, A. Badura, E. Leitner,
L. Masoud-Landgraf, G. Feierl
P1502
Serotype distribution of S. pneumoniae in
children with invasive disease and in healthy
nasopharyngeal carriers: usefulness of direct
capsular typing by molecular methods
E. Del Amo Moran* (Barcelona, Spain), L. Selva,
M. F de Sevilla, P. Ciruela, N. Peris, S. Hernandez,
L. Salleras, J. J Garcia-Garcia, A. Dominguez,
C. Muñoz-Almagro
P1503
P1504
A new assay for respiratory tract infections using
a lab-on-a-disk platform
G. Dingemans* (Maastricht, The Netherlands),
R. Waber, F. Schwemmer, M. Keller, W. Kaman,
O. Strohmeier, D. De Jongh, G. Simons,
W. Van Leeuwen, D. Mark
Direct identification of Streptococcus
pneumoniae capsular types in pleural fluid by
using multiplex PCR combined with automated
fluorescence-based capillary electrophoresis
L. Selva* (Barcelona, Spain), C. Berger,
J.J. Garcia-Garcia, H. De Paz, D. Nadal,
C. Munoz-Almagro
Comparative analysis of Streptococcus
agalactiae isolates causing infections in cattle
and humans in Iceland
E.S. Björnsdóttir* (Reykjavik, Iceland),
E.R. Ferreira Martins, H. Erlendsdóttir,
G. Haraldsson, J. Melo-Cristino, M. Ramirez,
K.G. Kristinsson
P1506
Sequencing-based molecular typing of
Treponema pallidum strains in the Czech Republic
during years 2012-2013
L. Grillová* (Brno, Czech Republic), H. Petrosová,
D. Smajs
P1507
DiversiLab® bacterial kit versus species-specific
Diversilab® kits for rep-polymerase chain typing
of nosocomial pathogens
S. Desmet* (Kortrijk, Belgium), A.M. Van den Abeele
P1508
Pneumococcal populations assessed by MLST
and MLVA
K. Elberse* (Bilthoven, The Netherlands), L. Selva,
G. Pluister, N. Peris, A. Van der Ende,
C. Muñoz-Almagro
P1509
Technical evaluation of SpectraCell RA®as
a bacterial typing tool for Pseudomonas
aeruginosa
H. Willemse-Erix* (Rotterdam, The Netherlands),
T. Bakker-Schut, G. Puppels, J. Hays, W. Goessens
P1510
Strain typing of hospital outbreaks with
multi-resistant Gram-negatives using mass
spectrometry
S. Zimmermann* (Heidelberg, Germany), J. Panitz,
I. Burckhardt
P1511
Genetic diversity and susceptibility profile of P.
aeruginosa isolated from cystic fibrosis patients
in São Paulo, Brazil
S.T.R. Nora, G.R. Francisco, M.F.C. Bueno,
L.V.R.F. Da Silva Filho, D. Garcia* (São Paulo, Brazil)
P1512
Phylo-typing of Escherichia coli by use of matrixassisted laser desorption ionization-time of flight
mass spectrometry (MALDI-TOF MS)
M. Sauget, X. Bertrand, D. Hocquet* (Besançon, France)
P1513
Multi single-nucleotide polymorphism typing of
Escherichia coli with real-time PCR detection:
a rapid and reliable tool
M. Kristiansson* (Jönköping, Sweden),
J. Söderman 24th ECCMID / Barcelona
Final Programme
219
Chairs, Speakers & Authors
P1499
P1505
Exhibition
Interspace microbiome profiling (IS-pro) enables
differentiation of IBD subclasses and disease
activity by specific loss of bacterial diversity
E.F.J. De Groot* (Amsterdam, The Netherlands),
T. Grasman, A.A. Van Bodegraven, A.E. Budding,
P.H.M. Savelkoul
General Information
P1498
Posters
Tuesday, 13 May 2014
Poster Sessions
Tuesday, 13 May 2014
P1514
MLST and PFGE typing of E. coli and K.
pneumoniae strains isolated from bloodstream
infections from very low birth weight infants in
Poland
A. Chmielarczyk* (Crakow, Poland), M. Pobiega,
D. Romaniszyn, J. Wojkowska-Mach
P1515
Development of a multilocus sequence typing
scheme for ‘Candidatus Neoehrlichia mikurensis’,
a new tick-borne bacterium
A. Granqvist* (Gothenburg, Sweden), E. Moore,
C. Welinder-Olsson, C. Wennerås
P1516
Genetic relatedness of clinical and environmental
Acinetobacter baumannii isolates from an
outbreak in an intensive care unit: first report
from Saudi Arabia using DiversiLab® analysis
A. Senok* (Riyadh, Saudi Arabia), G. Garaween,
H. Khubnani, A. Raji, A. Shibl
12:30 – 13:30
P1518
P1519
P1520
Genetic diversity among invasive pneumococci:
a multicentre study in adult patients in Spain
(2010-2013)
C. Ardanuy Tisaire* (Barcelona, Spain),
E. Cercenado, F. Marco, A. Fleites, M.C. Zúñiga,
B. Palop, A. Gil-Brusola, A.I. Aller, A. Fenoll, J. Liñares
Serotype distribution and antimicrobial
susceptibility of Streptococcus pneumoniae
isolated from patients with invasive
pneumococcal disease
M.A. Vásquez, E. Lain, J. Pereira, M.C. Villuendas,
I. Ferrer, A. Rezusta* (Zaragoza, Spain), F.J. Castillo,
M.J. Revillo
Emerging pneumococcal serotypes and its
association with mortality in southern Brazil
D.R. Falci* (Porto Alegre, Brazil), M. Garcia,
R.M. El Kadri, G.R. Da Cunha, J. Caierão, R. Matusiak,
C.A.G. Dias
Current snapshot of the Streptococcus
pneumoniae PspA clades causing invasive
disease in adults
A. Tercero* (Barcelona, Spain), M.D. Quesada,
D. Fontanals, J. Cámara, A. Fenoll, J. Linares,
C. Ardanuy Tisaire
220 24th ECCMID / Barcelona
Serotype epidemiology of invasive and colonising
Streptococcus pneumoniae, Switzerland, 20102012
L.J. Hathaway, M. Küffer, M. Hilty* (Berne,
Switzerland)
P1522
Serotype distribution and antimicrobial
susceptibility of Streptococcus pneumoniae
recovered principally from lower respiratory tract
specimens in patients aged >=50 years in select
European countries (2009-2011)
R.E. Mendes* (Collegeville, PA, United States),
A. Costello, R.C. Hollingsworth, R.E. Isturiz,
D. Hewlett Jr, D.J. Farrell, R.N. Jones
P1523
Increase in serotype 19A and estimated coverage
of the pneumococcal conjugate vaccine before
and after the approval of the PCV-7 vaccine in
northeast Mexico
R.M. Hinojosa-Robles* (Monterrey, Mexico),
M.J. De la Cruz Valdez, P.A. Hernández-Rodríguez,
L. Vera-Cabrera
P1524
Two-year surveillance of emm-types and
macrolide resistance of paediatric group A
streptococcal pharyngitis isolates in the central
part of Italy
D. Petrelli* (Camerino, Italy), M. Di Luca, G. Gherardi,
F. Pimentel de Araujo, P. Bernaschi, A. Repetto,
J. Bellesi, M. Prenna, L. Vitali
P1525
Epidemiological markers of Streptococcus
pyogenes blood strains in Bilbao (Spain) and
its relationship with 26 and 30-valent M protein
vaccines in development
M.J. Sada* (Bilbao, Spain), B. Caceda, M.J. Unzaga,
C. Aspichueta, G. Lopez, J.L. Diaz, R. Cisterna
P1526
In vitro activity of josamycin against
Streptococcus pyogenes isolated from upper
respiratory tract infections in France
M. Auzou, J. Caillon, C. Poyart, P. Weber, M.C. Ploy,
R. Leclercq, V. Cattoir* (Caen, France)
P1527
Diversity of resistance and virulence genes
among group B streptococcal serotypes in Spain
Y. Lopez* (Barcelona, Spain), J. Sala, V. Cepas,
E. Sáez López, J. Bosch, J. Vila, S. Soto
P1528
Serotype, genotype and antimicrobial resistance
of Streptococcus agalactiae isolates from
bacteraemic patients in a Korean hospital
H.J. Ryu* (Seoul, Korea), Y.J. Park, J.Y. Chang,
Y.K. Kim, J.K. Yu
Poster Area
POSTER SESSION VI:
Molecular epidemiology of pneumococcal serotypes and betahaemolytic strepococci
P1517
P1521
Final Programme
Poster Sessions
Tuesday, 13 May 2014
P1538
Improved laboratory reporting times and clinical
impact for Panton-Valentine leukocidin testing
using the Progenie RealCycler® SAPV real-time
PCR assay
N. Reading* (Birmingham, United Kingdom),
N. Ratnaraja P1539
DNA microarray-based genotyping of 1200
Staphylococcus aureus isolates of the AfricanGerman StaphNet multicentre study
U. Ruffing* (Homburg / Saar, Germany),
R. Akulenko, L. Wende, S. Schubert, T. Kazimoto,
V. Delfino, A. Alabi, M. Herrmann, F. Schaumburg,
W. Kern
P1540
Clinical relevance and diagnostics of
Staphylococcus petrasii, a recently described
coagulase-negative species
J. Cernohlavkova* (Brno, Czech Republic), P. Petras,
P. Svec, R. Pantucek, I. Sedlacek
P1541
Characterisation of MRSA isolates non-typeable
by the standard spa protocol
I. Doel Perez, A. Stoeger, F. Allerberger, W. Ruppitsch*
(Vienna, Austria)
P1542
Differentiation of Staphylococcus sciuri
subspecies
P. Svec* (Brno, Czech Republic), P. Petras,
R. Pantucek, I. Sedlacek
Poster Area
POSTER SESSION VI:
Molecular diagnosis and epidemiology of staphylococcal
infections
P1530
Pre-operative screening for Staphylococcus
aureus: strategy using PCR on patient admission
G. Richalet* (Echirolles, France)
P1531
Evaluation of Xpert MRSA SSTI and conventional
microbiological procedures for diagnosis of
acute osteoarticular infections in patients with
implanted orthopaedic devices
E. Celeste, B. Brunschweiler, B. Canarelli, M. Biendo*
(Maurens Scopont, France), C. Casado
P1532
Xpert MRSA: 4 years of experience in a
multicentre surveillance protocol; are negatives
really negative?
M. Depypere* (Aalst, Belgium), P. Vandecandelaere,
R. Cartuyvels, G. Coppens, E. Oris, J. Frans,
A.M. Van den Abeele, H. De Beenhouwer,
K. Van Vaerenbergh
P1533
Rapid turn-around time of diagnostic test results
for methicillin-resistant Staphylococcus aureus
(MRSA) improves quality of patient care and
hospital financials
H. Probst* (Schwabmünchen, Germany)
P1534
Fast screening for MRSA by quadruplex
real-time PCR
K. Boye* (Hvidovre, Denmark), K. Schønning,
H. Westh, G. Lisby
P1535
Detection of Staphylococcus aureus and
methicillin-resistant S. aureus from nasal
specimens of patients from Hvidovre, Denmark
and Regensburg, Germany with the cobas®
MRSA/SA test
A. Line* (Hvidovre, Denmark), O. Engsbro,
H. Westh, J. Osiecki, K. Lu, A. Hiergeist, S. Foerster,
V. Griefenberg, U. Reischl
12:30 – 13:30
Posters
Staphylococcus aureus and Panton-Valentine
leukocidin (PVL): an additional threat for a
third-level paediatric hospital?
P. Cocchi* (Florence, Italy), C. Montagnani,
S. Campana, C. Braggion, G. Taccetti, M. De Martino,
L. Galli
Poster Area
POSTER SESSION VI:
VRE: epidemiology and control
P1543
Report of a VRE outbreak in a neonatal unit at a
tertiary teaching hospital in Cape Town, South
Africa
R. Hoffmann* (Bellville, South Africa), M. Aucamp,
C. Moodley, K. Hoek, A. Bekker, A. Dramowski
P1544
Use of whole-genome sequencing to investigate
the epidemiology of vancomycin-resistant
enterococci on an intensive care unit
D. Tacke* (Cologne, Germany), M. Gillis, P.G. Higgins,
A.D. Millard, J.Z.M. Chan, M.J. Pallen, G. Fätkenheuer,
O.A. Cornely, H. Seifert, M.J.G.T. Vehreschild
24th ECCMID / Barcelona
Final Programme
221
Chairs, Speakers & Authors
12:30 – 13:30
P1537
Exhibition
Epidemiological survey and characterisation
of Streptococcus agalactiae isolates from the
Semmelweis University Clinics, Budapest,
Hungary
S. Kardos* (Budapest, Hungary), K. Laub,
A. Tóthpál, K. Kristóf, E. Ostorházi, K. Nagy,
O. Dobay
General Information
P1529
Poster Sessions
Tuesday, 13 May 2014
P1545
Outbreak of vancomycin-resistant enterococci
in a Norwegian hospital: the experience of the
Cepheid Xpert® vanA/vanB for VRE screening
A. Kanestrom* (Fredrikstad, Norway), A.L. Larsen,
J. Ringstad
P1546
GeneXpert EV technology allows rapid, noninvasive detection of human enteroviruses in
stool and plasma from children with multipleorgan dysfunction syndrome
L. Gentile* (Rome, Italy), V. Spuri Vennarucci,
M.D. Caione, L. Coltella, G. Pizzichemi, G. Buttinelli,
C. Russo, D. Menichella
P1547
P1548
P1549
P1550
P1551
P1552
First case of plasmid-mediated linezolidresistance in human faecal isolate of
Enterococcus faecium in Norway was associated
with import and high-level glycopeptide and
aminoglycoside resistance
T. Pedersen, T.M. Lunde, L. Thoresen, A. Onken,
B. Aasnæs, A. Sundsfjord, K. Hegstad* (Tromsö,
Norway)
Epidemiology of vancomycin-resistant
enterococci from France in 2012
M. Fines-Guyon* (Caen, France), G. Delente,
M. Auzou, F. Guérin, V. Cattoir
An ST203 vancomycin-resistant Enterococcus
faecium outbreak in intensive care units and
haematology service: epidemiological and
molecular analysis
R.K. Arican, O. ONcül, G. Karaahmetoglu, A. ULçay,
V. Turhan* (Istanbul, Turkey), A. Acar, H. Erdem,
L. Görenek
Sequence-type based clinical and
epidemiological characteristics of vancomycinresistant enterococci
W. Kwang-Sook* (Busan, Korea), C. Jae-Lim,
K. Bo-Ram, K. Ji-Eun, K. Kyeong-Hee, K. Jeong-Man,
H. Jin-Yeong
Vancomycin-resistant Enterococcus faecium
colonisation in paediatrics
A. Ulu-Kilic* (Kayseri, Turkey), E. Ozhan, D. Altun,
D. Percin, T. Günes, E. Alp Mese
Nosocomial ST117-E. faecium isolate is more
efficient in finger-to-finger transmission than
food-borne ST178: intra-individual and gender
differences
A.M. Sánchez-Díaz* (Madrid, Spain),
B. Romero-Hernández, J.D. Caballero,
M. Díez-Aguilar, M. Hernández-García, R. Cantón,
F. Baquero, R. Del Campo
222 24th ECCMID / Barcelona
Final Programme
P1553
Epidemiology and control of the first vancomycinresistant Enterococcus outbreak in a tertiarycare hospital in Bangkok, Thailand
D. Chotiprasitsakul* (Bangkok, Thailand),
P. Santanirand, P. Siriarayapon, P. Thitichai,
P. Rotjanapan, S. Sirichot, S. Watcharananun,
K. Malathum
P1554
Reduction of nosocomial vancomycin-resistant
Enterococcus faecium (VRE) colonisation on
an intensive care unit after the introduction
of antiseptic (octenidine-based) bathing: an
interrupted time series analysis
S. Messler* (Cologne, Germany), I. Klare, F. Wappler,
G. Werner, S.G. Sakka, F. Mattner
P1555
Longitudinal whole genome sequencing study of
evolution of linezolid resistance during treatment
for Enterococcus faecium infections
M. David* (Birmingham, United Kingdom), J. Quick,
M. Niebel, R. Marudanayagam, B. Oppenheim,
N. Loman
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Mechanism of resistance in Gram-positives: induction and
selection
P1556
Detection of methicillin-resistant Staphylococcus
aureus (MRSA) carrying the mecC gene in wild
small mammals in southern Spain
P. Gómez* (Logroño, Spain), D. González-Barrio,
D. Benito, J.T. García, J. Viñuela, M. Zarazaga,
F. Ruiz-Fons, C. Torres
P1557
Community-acquired methicillin-resistant
Staphylococcus aureus USA300 resists protein
A modulation by antibiotics and antimicrobial
peptides
E. Martin, A. Michel, C. Badiou, M. Bes, F. Laurent,
F. Vandenesch, G. Lina, O. Dumitrescu* (Lyon,
France)
P1558
Linezolid resistance mediated by the cfr gene in
staphylococci, first report in France
M. Desroches, N. Bourgeois-Nicolaos* (Clamart,
France), M. Archambaud, H. Jean-Pierre,
F. Jehl, C. Loiez-Durocher, M. Biendo, I. Patry,
J.W. Decousser, F. Doucet-Populaire
P1559
Impact of active efflux in the development of MDR
phenotypes in Staphylococcus aureus
S. Santos Costa* (Lisbon, Portugal), M. Viveiros,
J. Melo-Cristino, I. Couto
Poster Sessions
Methicillin resistance in Staphylococcus aureus
in Germany 2012 – first regional results
I. Noll* (Berlin, Germany), B. Schweickert, M. Feig,
T. Eckmanns
P1561
Beta-lactam antibiotics can induce vancomycinintermediate resistance in Staphylococcus
aureus
M. Roch* (Maxilly sur Léman, France), P. Clair,
A. Renzoni, M. Bes, A. Martra, A.M. Freydiere,
F. Laurent, P. Reix, O. Dumitrescu, F. Vandenesch
P1569
Vancomycin MIC creep in MRSA bloodstream
isolates in Israel
Y. Maor* (Tel Hashomer, Israel), N. Belausov,
G. Smollan, G. Rahav, N. Keller
P1570
The importance of vancomycin MIC for treatment
outcome in MRSA bacteraemia in Slovenia
Z. Martincic* (Ljubljana, Slovenia), B. Petek,
M. Mueller Premru, B. Beovic
P1571
Global transcriptomic analysis by RNA-Seq
of Enterococcus faecium in response to
ciprofloxacin
C. Sinel* (Caen, France), V. Cattoir
Evaluation of the prevalence of heterogeneous
vancomycin-intermediate Staphylococcus aureus
(HVISA) and clinical outcomes in patients with
bacteraemia
E. Wenzler* (Hilliard, United States), P. Pancholi,
D.A. Goff, K.A. Bauer
P1572
Binding of avibactam to penicillin-binding
proteins (PBPs) of Staphylococcus aureus,
Streptococcus pneumoniae and Haemophilus
influenzae
A. Asli* (Sherbrooke, Canada), E. Brouillette,
F. Malouin
Molecular epidemiology and susceptibility to
new antibiotics among methicillin-resistant
Staphylococcus aureus with high vancomycin
minimum inhibitory concentration: a multicentre
study in Taiwan
S.C. Pan* (Taipei, Taiwan), Y.C. Chen, J.T. Wang
P1573
Phenotypic and genotypic characterisation
of MLS resistance in Propionibacterium acnes
isolated from orthopaedic implant infections
C. Tournus* (Caen, France), F. Guérin, M. Auzou,
V. Cattoir
Linezolid susceptibility surveillance in Europe for
2013: ZAAPS program (5,076 strains)
R.N. Jones* (North Liberty, IA, United States),
J.E. Ross, R.K. Flamm, H.S. Sader, D.J. Farrell,
R.E. Mendes
P1574
In vivo selection of rifampicin-resistant Listeria
monocytogenes during orthopaedic implant
infection therapy
F.X. Toublet, M. Vergnaud, S. Galopin, M. Auzou,
V. Cattoir* (Caen, France)
Report of CFR-mediated linezolid resistance in
coagulase-negative staphylococci in a university
hospital in Ireland
T. Wanigasekera* (Wexford, Ireland), S. Fitzgibbon,
F. O’Riordan, J. Clair
P1575
The first report of CFR-mediated linezolid
resistance in Staphylococcus epidermidis in
Ireland
C. O’Connor* (Limerick, Ireland), N. O’Connell,
L. Power, J. Powell, C. Finnegan, A. O’Gorman,
C. Dunne, A. Kearns, K.L. Hopkins, R. Hill
P1576
Antimicrobial activity of daptomycin and
comparator agents tested against methicillinresistant S. aureus and vancomycin-resistant
enterococci: analysis of five-year trends in
Europe and USA hospitals (2009-2013)
H.S. Sader* (North Liberty, IA, United States),
D.J. Farrell, R.K. Flamm, R.N. Jones
P1562
P1563
P1564
P1565
P1566
In vitro selection of linezolid resistance in
coagulase-negative staphylococci isolated from
diabetic foot osteitis
C. Rouard* (Clamart, France), E. Aslanghul,
A. Riviere, M.j. Butel, F. Doucet-Populaire,
N. Bourgeois-Nicolaos
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Resistance surveillance: Gram-positives and others
P1567
Comparison of staphylococcal sensitivity data
using EUCAST vs CLSI
A. Marek* (Glasgow, United Kingdom),
D. Henderson, J. Wilson, G. Edwards, T. Inkster
24th ECCMID / Barcelona
Final Programme 223
Chairs, Speakers & Authors
P1568
Exhibition
Potential SNPs relevance to vancomycin-resistant
property in clinical isolates of vancomycinintermediate Staphylococcus aureus
L. Lin* (Taoyuan, Taiwan), B. Lin, Y. Chou, J. Lu
General Information
P1560
Posters
Tuesday, 13 May 2014
Poster Sessions
Tuesday, 13 May 2014
P1577
Tigecycline and daptomycin resistant MRSA
among colonisation sites isolates from a period of
surveillance when these drugs were not in use in
the hospital
A.N.G. Dabul, S.C. Bogni, I.L.B.C. Camargo*
(Sao Carlos, Brazil)
P1578
Emergence of daptomycin nonsusceptibility in
Staphylococcus aureus: epidemiological and
molecular characterisation of clinical isolates
D. García-Martínez de Artola, Á. SampereMartínez, E. Pérez-Roth, J. Alcoba-Flórez*
(Santa Cruz de Tenerife, Spain)
P1579
Telavancin activity tested against Gram-positive
clinical isolates from European hospitals (20112013) using a revised broth microdilution testing
method: redefining the baseline activity for
telavancin
R.E. Mendes* (North Liberty, United States),
D.J. Farrell, J.M. Streit, R.N. Jones
P1580
Activity of oritavancin tested against Grampositive clinical isolates responsible for
documented skin and soft tissue infections in
European hospitals (2011-2013)
R.E. Mendes* (North Liberty, United States),
R.K. Flamm, H.S. Sader, R.N. Jones
P1581
High prevalence of mupirocin resistance
associated with resistance to other
antimicrobials in Staphylococcus aureus isolated
from patients in private health care, Western
Cape, South Africa
E. Wasserman* (Goodwood, South Africa), H. Orth,
M. Senekal, J. Harvey
P1582
P1583
P1584
Fusidic acid resistance in commensal
Staphylococcus aureus in nine European
countries: a cross-sectional study
C. Den Heijer* (Maastricht, The Netherlands),
E. Van Bijnen, J. Paget, E. Stobberingh
Prevalence of SCCmec types and solithromycin
susceptibility of methicillin-resistant
Staphylococcus aureus (MRSA) from respiratory
samples collected in 2012-13
I. Morrissey* (Epalinges, Switzerland),
P. Fernandes, C. Tacchini, S. Hawser
Activity of solithromycin and comparators
against streptococci isolated from respiratory
samples collected in 2012-2013
I. Morrissey* (Epalinges, Switzerland),
P. Fernandes, B. Lemos, S. Hawser
224 24th ECCMID / Barcelona
Final Programme
P1585
Activity of solithromycin against azithromycinresistant Streptococcus pneumoniae with
characterised resistance mechanisms
I. Morrissey* (Epalinges, Switzerland),
P. Fernandes, B. Lemos, S. Hawser
P1586
Prevalence and resistance of commensal
Streptococcus pneumoniae in nine European
countries
R.Y. Yahiaoui* (Maastricht, The Netherlands),
C.D.J. Den Heijer, E.M.E. Van Bijnen,
W.J. Paget, M. Pringle, H. Goossens,
C.A. Bruggeman, F.G. Schellevis,
E.E. Stobberingh, And the APRES Study Team
P1587
Antibacterial resistance among Streptococcus
pneumoniae and Haemophilus influenzae from
11 centres in Vietnam: results from the survey of
antibiotic resistance (SOAR) 2009-2011
P.H. Van, P.T. Binh, N.H.L. Minh, I. Morrissey,
D. Torumkuney* (Brentford, United Kingdom)
P1588
Activity of ceftaroline and comparators against
Streptococcus pneumoniae from multiple
specimen sources in the European region 2012:
assessing worldwide antimicrobial resistance
evaluation (AWARE) programme
D. Hoban* (Schaumburg, United States), R. Badal,
D. Biedenbach, M. Hackel, S. Bouchillon, J. Ambler
P1589
Antibacterial resistance among Streptococcus
pneumoniae and Haemophilus influenzae from
Ukraine. Results from the survey of antibiotic
resistance (SOAR) 2011-2013
Y. Feshchenko, A. Dzyublik, T. Pertseva, E. Bratus,
Y. Dzyublik, G. Gladka, I. Morrissey, D. Torumkuney*
(Brentford, United Kingdom)
P1590
History of antibiotic exposure and antibiotic
resistance in non-bacteraemic pneumococcal
pneumonia
A. Shigayeva, W. Rudnick, K. Green,
A. Mcgeer* (Toronto, Canada),
T. Toronto Invasive Bacterial Diseases Network
P1591
Streptococci other than S. pneumoniae – 12-year
resistance trends in bacteraemia in the UK and
Ireland
R. Reynolds* (Bristol, United Kingdom), S. Mushtaq,
D.M. Livermore
P1592
Haemolytic multidrug-resistant enterococci from
diabetic foot ulcers
T. Semedo-Lemsaddek, C. Barroco, C. Mottola,
J.J. Mendes, J. Melo-Cristino, P. Cavaco-Silva,
L. Tavares, M. Oliveira* (Lisbon, Portugal)
Poster Sessions
Tuesday, 13 May 2014
P1596
In vitro activity of antimicrobial agents tested
against anaerobic pathogens from the European
TEST programme during 2012-2013
D. Biedenbach* (Schaumburg, United States),
M. Hackel, I. Morrissey, S. Bouchillon, H. LeisterTebbe
P1597
A 10-year surveillance of the trends of
antimicrobial resistance among anaerobes
isolated from clinical specimens in Kuwait
hospitals
W. Jamal* (Safat, Kuwait), M. Shahin, S. Al Najdi,
V. Rotimi
P1598
Proportions of community-associated and
healthcare-associated isolates in the EARSNet data vary depending on pathogen and
antimicrobial combination – analysis of EARS-Net
data 2011-2012
O.E. Heuer* (Stockholm, Sweden), L. Diaz Högberg,
C. Suetens, EARS-Net participants
P1599
Svebar – a Swedish early warning and
surveillance system for antimicrobial resistance
O. Aspevall* (Solna, Sweden),
T. Söderblom, L.G. Jacobsson, O. Wilander,
G. Kahlmeter, The Svebar AMR surveillance group
P1600
Results from the 2013 antimicrobial
susceptibility testing external quality
assessment (EQA) exercise organised for EARSNet participants
A. Laja* (London, United Kingdom), E. Fagan,
S. Seaton, A. Couchman, L. Quartermain, A. Thomas,
D. Brown, L. Diaz Hogberg, O. Heuer, C. Walton P1602
Lower respiratory tract bacterial infections in
cats and dogs: aetiology, antibiotic resistance
and current clinical practice
J. Fonseca* (London, United Kingdom), T. McHugh
P1603
National methicillin-resistant Staphylococcus
aureus (MRSA) surveillance in the The
Netherlands 1999-2012; changing riskcategories
D. Frentz* (Bilthoven, The Netherlands), A. Haenen,
L.M. Schouls, T. Bosch, T. Leenstra
P1604
Asymptomatic carriage of HA-MRSA in community
settings in northern Israel
A. Rokney* (Jerusalem, Israel), I. Nissan,
L. Valinsky, A. Peretz
P1605
The epidemiology and risk factors of
Staphylococcus aureus nasal carriage in children
attending day-care centres in Hungary
K. Laub* (Budapest, Hungary), S. Kardos,
A. Tóthpál, K. Nagy, O. Dobay
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Controling infections in long-term care facilities
P1606
Hospital-acquired infections in the elderly in
intensive care
A. Batirel* (Istanbul, Turkey), N. Benzonana, O. Ak,
M. Kavak, D. Akay, Y. Cag, S. Ozer
P1607
Urinary tract infections in nursing homes – the
need for antibiotic stewardship directed towards
the elderly in Denmark
C.S. Jensen* (Copenhagen, Denmark)
P1608
Effectiveness of a chlorine dioxide-based coating
on environmental contamination in care homes
for the elderly
S. Luk* (Hong Kong, China), T.K. Ng, S.H.H. Leung,
I.H.L. Tsang, E.H.Y. Chan, K.W. Choi, K.L. Yeung,
J.K.C. Kwan, A.T.Y. Wong
P1609
Carriage of extended-spectrum beta-lactamaseproducing Enterobacteriaceae on admission to
rehabilitation centres
E. Bilavsky* (Petah Tikva, Israel), E. Temkin,
Y. Lerman, A. Rabinovich, J. Salomon, C. Lawrence,
A. Rossini, A. Salvia, J. Samso, J. Fierro
24th ECCMID / Barcelona
Final Programme 225
Posters
Isolation of anaerobic bacteria and susceptibility
to antimicrobials from burn wounds in plastic
surgery and burns unit in a Greek hospital during
a two year period
M. Orfanidou* E. Vagiakou (Athens, Greece),
M. Kamperogianni, L. Drosopoulou, E. Kyriopoulou,
G. Ganteris, D. Tsoutsos,
Automated surveillance of multidrug-resistant
bacteria in the hospital setting
J. Elias* (Würzburg, Germany), U. Vogel
Chairs, Speakers & Authors
P1595
Antimicrobial susceptibility of periodontal
pathogens isolated from Slovenian patients
M. Furlan* (Ljubljana, Slovenia), P.J. Maver,
M. Kocjan Anzic, R. Gazpersic, A.J. Van Winkelhoff,
K. Seme
P1601
Exhibition
P1594
Activity of ceftaroline and comparators against
pathogens isolated from skin and soft tissue
infections in the European region – AWARE
surveillance 2012
R. Badal* (Schaumburg, United States), D. Hoban,
M. Hackel, S. Bouchillon, D. Biedenbach, S. Hawser,
J. Iaconis
General Information
P1593
Poster Sessions
Tuesday, 13 May 2014
P1610
P1611
P1612
P1613
P1614
P1615
P1616
Nursing homes and long-term care facilities:
a reservoir of Escherichia coli producing CTX-M
group 1 extended spectrum beta-lactamase, in
the north of Portugal
D. Gonçalves* (Porto, Portugal), P. Cecílio,
H. Ferreira
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Increasing hand hygiene: new and old perspectives
P1617
Compliance with the WHO hand hygiene
technique: a prospective observational study
S. Tschudin Sutter* (Basel, Switzerland),
D. Sepulcri, M. Dangel, H. Schuhmacher, A.F. Widmer
P1618
Nursing homes as reservoir of carbapenemresistant Acinetobacter baumannii
B. Bedenic* (Zagreb, Croatia), K. Godic-Torkar,
N. Beader, N. Barisic, M. Vranic-Ladavac,
A. Nikic-Hecer
A project to improve hand hygiene compliance
A. Pan* (Cremona, Italy), L. Galli, R. Canino,
G. Maghini, A. Grandi, A. Grandi, A. Zoncada,
S. Lorenzotti, N. Poli, C. Rossi
P1619
Influenza in an acute geriatric care ward during
the 2012/2013 outbreak: mortality and secondary
complications
G. Gavazzi* (Grenoble, France), M. Sylvie, Z. Nabil,
S. Drevet
Low-cost intervention for increasing hand
hygiene compliance using RFID in resourceconstrained settings
K. Radhakrishna* (Bangalore, India), A. Waghmare,
S. Sampath, T. Raj, M. Ekstrand
P1621
Extended-spectrum beta-lactamase-producing
Enterobacteriacae (ESBLE): significant increase
of the prevalence of carriage in elderly residents
between 2010 and 2013
D. Roux, H. Cochard, S. Borges Dos Santos,
R. Quentin, - Infection Control Study Group,
N. Van der Mee-Marquet* (Tours, France)
Impact of a hand hygiene campaign involving
active patient involvement in a resource-poor
country
S.F. Mahmood* (Karachi, Pakistan), R. Roshan,
S. Dadani, D. Hirani, S. Musani, A. Zafar, M. Salim,
E. Hussain
P1622
Trends in resistance rates in Enterobacteriaceae
collected globally from extended care facilities
(TEST 2004-2012)
S. Hawser* (Epalinges, Switzerland), R. Badal,
D. Biedenbach, I. Morrissey, H. Leister-Tebbe
Evaluation of the effectiveness of an infection
control programme in paediatric and neonatal
intensive care units: a report from a middleincome country
E. Alp Mese* (Kayseri, Turkey), T. Orhan,
C. Atalay Kurkcu, S. Ersoy, M.L. McLaws
P1623
Hand hygiene: from patient’s perspective
C. Buke* (Izmir, Turkey), G. Kitapcioglu, G. Guliyeva,
U. Onal, H. Akdeniz, E. Aydin, I. Karaca, B. Kilicaslan,
E. Koc
P1624
Burden of hand soap contamination by
Pseudomonas aeruginosa in a tertiary care
hospital: a large molecular epidemiological
investigation
L. Senn* (Lausanne, Switzerland), D.S. Blanc,
J. Wasserfallen, P. Genoud, G. Prod’hom, G. Greub,
G. Zanetti
Implementation of screening for methicillinresistant and methicillin-sensible
Staphylococcus aureus and targeted infection
control measures in residential homes
J. Becker* (Frankfurt, Germany), A. Martin
Methicillin-resistant Staphylococcus aureus from
residents in one nursing home are more closely
related than environmental isolates
C. Ludden, G. Brennan, D. Morris, B. Austin,
B. O’Connell, M. Cormican* (Galway, Ireland)
226 24th ECCMID / Barcelona
Final Programme
Poster Sessions
Tuesday, 13 May 2014
Risk of occupational HIV, HBV and HCV
transmission based on source patient
infectiousness and exposure intensity – data
from three Swiss hospitals
B. Bertisch* (St. Gallen, Switzerland), A. Martin,
B. Rusch, P. Vernazza
P1626
Genotyping of Pneumocystis in inpatients
and hospital healthcare workers support the
nosocomial transmission of this infective agent
R. Morilla, V. Friaza, M. Martínez-Risquez,
M.L. Calero, E. Campano, C. De la Horra, J. Varela,
M. Conde, E. Calderón, F. Medrano Gonzalez*
(Seville, Spain)
P1627
Fatal RSV outbreak in a haematology ward
T.O. Jensen, R. Lindeman, J. Gallard, K. Clezy*
(Randwick, Australia)
P1628
A meta-analysis comparing preemptive
and prophylactic strategies to prevent
cytomegalovirus disease in renal transplant
recipients
L. Chen* (Beijing, China), A.P. Ni, J.T. Cui, W.J. Yan,
L.J. Kong
P1629
P1630
P1631
P1632
Nosocomial Crimean-Congo haemorrhagic fever
outbreak in southern Kazakhstan
A. Dmitrovskiy* (Almaty, Kazakhstan),
M. Shermetova, R. Yegemberdiyeva, L. Yeraliyeva,
K. Abdiyeva, Z.H. Shapiyeva, G. Utepbergenova,
A. Kuzmina, E. Pak
An outbreak of candidaemia due to Candida
parapsilosis in an adult intensive care unit
Y. Cag, D. Haciseyitoglu, S. Gencer* (Istanbul,
Turkey), S. Ozer
The features of infectious diseases departments
in France and Turkey
H. Erdem, J.P. Stahl, A. Inan* (Istanbul,
Turkey), M. Akova, C. Rioux, I. Pierre,
A. Canestri, E. Haustraete, D. Ozturk-Engin,
A. And the study group
Carriage of hospital-associated Staphylococcus
epidermidis genotypes among staff in an
intensive care unit, a single-centre prospective
cohort study
M. Widerstrom* (Umeå, Sweden), J. Wiström,
H. Edebro, T. Monsen
POSTER SESSION VI:
MDR Enterobacteriaceae from animal sources
P1633
Extended-spectrum beta-lactamase, AmpCproducing and fluoroquinolone-resistant
Escherichia coli in broilers (poultry) in Italy
A. Ghodousi* (Palermo, Italy), C. Bonura, A. Aleo,
C. Mammina
P1634
Multidrug-resistant Escherichia coli among
poultry for human consumption: the relationship
between resistance genes and virulence factors
N. Mendonca* (Coimbra, Portugal), R. Figueiredo,
R. Card, M. Anjum, A. Henriques, R. Sereno,
G.J. Da Silva
P1635
Prevalence and characterisation of extendedspectrum beta-lactamase-producing Escherichia
coli in faecal samples of healthy chickens
A. Maamar, S. Hammami, M.S. Abassi, S. Ferjani,
N. Dakhli, M. Saidani, A. Slim, I. Boutiba* (Tunis,
Tunisia)
P1636
Investigation of IncN plasmids encoding CTX-M-1
extended-spectrum beta-lactamase among
bovine and swine Escherichia coli isolates
collected from diseased animals
G.B. Michael* (Neustadt-Mariensee, Germany),
K. Kadlec, H. Kaspar, S. Schwarz
P1637
Comparative analysis of CTX-M-1 producing E. coli
and associated plasmids originating from German
livestock farms
J. Fischer* (Berlin, Germany), N. Alonso, S. Schmoger,
B. Baumann, L. Kreienbrock, B. Appel, A. Kaesbohrer,
U. Roesler, R. Helmuth, B. Guerra Roman
P1638
Detection of CTX-M-15, SHV-2 and CMY-2 betalactamases in faecal Escherichia coli isolates of
dogs in Mexico
G. Cortés Cortés* (Puebla, Mexico), F. Bello,
P. Lozano, Y. Martínez, C. Torres, R.C. Rocha-Gracia
P1639
High prevalence of CTX-M-, CMY-, and OXA-48-like
bla genes in food for pets
S.N. Seiffert* (Berne, Switzerland), R. Tinguely,
A. Lupo, M. Hilty, V. Perreten, A. Endimiani
P1640
Cross-sectional prevalence study of CTX-Mtype extended-spectrum beta-lactamases in
Escherichia coli strains isolated from healthy
poultry
B. Castro, R. Abreu, E. Espigares-Rodríguez,
A. Madueño* (La Laguna, Spain), E. Moreno-Roldán,
M. Espigares, M. Lecuona, A. Arias
24th ECCMID / Barcelona
Final Programme 227
Posters
P1625
Poster Area
Chairs, Speakers & Authors
POSTER SESSION VI:
Infection control – not only for MDR bacteria
12:30 – 13:30
Exhibition
Poster Area
General Information
12:30 – 13:30
Poster Sessions
Tuesday, 13 May 2014
P1641
Characterisation of extended-spectrum
beta-lactamase (ESBL) Escherichia coli
isolated between 2011 and 2012 from farm
animals in the UK
L. Randall* (New Haw, United Kingdom), F. Lemma,
R. Card, J. Rogers, C. Teale
P1642
Presence of cephalosporin-resistant Salmonella
from pig farms using different medication
regimes
K. Cameron-Veas, M. Sola Guines, L. Fraile,
L. Migura* (Barcelona, Spain)
P1643
P1644
P1645
P1646
P1647
P1648
Microarray analysis of antimicrobial resistance
and virulence genes of Salmonella enterica
from food-producing animals: a non-invasive
S. infantis associated with uncommon island 1
pathogenicity
R. Figueiredo* (Coimbra, Portugal), R. Card,
C. Nunes, M. Anjum, N. Mendonça, G. Jorge da Silva
Drug sensitivity profiles and genomic rep-PCR
fingerprints of Pseudomonas aeruginosa strains
from animals against the background of P.
aeruginosa’s global population structure
D. De Vos* (Schellebelle, Belgium), J. Santos,
F. Bilocq, P. Soentjens, S. Jennes, W. Heuninckx,
A. Leitao, R. Seixas, M. Oliveira, J. Pirnay
Antimicrobial resistance and rep-PCR genomic
fingerprinting of Pseudomonas sp. isolated from
wild free-living sea turtles in the Gulf of Guinea
D. De Vos* (Schellebelle, Belgium), J. Santos,
F. Bilocq, P. Soentjens, S. Jennes, W. Heuninckx,
A. Leitao, R. Seixas, M. Oliveira, J. Pirnay
Trends of antimicrobial drug susceptibility of
clinical Stenotrophomonas maltophilia isolates in
veterinary medicine
A.R. Attili* (Matelica, Macerata, Italy), V. Ngu Ngwa,
M. Moriconi, S. Preziuso, A.M. Tambella, V. Cuteri
Bias in antimicrobial surveillance data as a result
of patient treatment history: an example from the
veterinary world
P. Damborg* (Frederiksberg, Denmark), L. Boysen,
J. Berg, R.F. Larsen, L. Guardabassi
Characterisation of ESBL and AmpC
cephalosporinase-producing Enterobacteriaceae
recovered from diseased European companion
animals
P. Bogaerts* (Yvoir, Belgium), T.-D. Huang,
W. Bouchahrouf, C. Berhin, C. Bauraing, F. El Garch,
Y. Glupczynski, Compath Study Group
228 24th ECCMID / Barcelona
Final Programme
P1650
Decrease of antimicrobial resistance in E. coli
from animal husbandry reflects the reduction
of antibiotic usage in animals in the The
Netherlands
K. Veldman* (Lelystad, The Netherlands),
C. Dierikx, J. Testerink, M. Japing, A. Van Essen,
D. Mevius
P1651
Aquaculture as an impact factor for antimicrobial
resistance results of the German national
antibiotic resistance monitoring (GermVet)
H. Kaspar* (Berlin, Germany), K. Heidemanns,
U. Steinacker, A. Römer, J. Wallmann
12:30 – 13:30
Poster Area
POSTER SESSION VI:
Zoonotic antimicrobial resistance
P1652
Plasmid diversity among Enterococcus faecalis of
different origins, including migratory birds, farm
animals and humans
R. Leon* (Madrid, Spain), A.P. Tedim, R. Del Campo,
C. Novais, A.R. Freitas, L. Peixe, F. Baquero,
T.M. Coque
P1652a
Extended virulence profile of Enterococcus
faecium from swine (Europe/USA, 1995-2008)
A.R. Freitas, E. Martins, C. Novais* (Sra. da Hora-Matosinhos, Portugal), T.M. Coque, L. Peixe
P1653
Molecular characterisation and differences
between MRSA ST398 and MSSA ST398 from a pig
farmer, his family and the pigs of the farm
D. Benito-Pascual* (Logroňo, Spain), C. Aspiroz,
E. Gómez-Sanz, P. Gómez, M. González-Dominguez,
C. Lozano, M. Zarazaga, C. Torres
P1654
Cfr-mediated transferable antibiotic resistance
in coagulase-negative staphylococci from
nasal colonisation of humans with occupational
exposure to livestock
C. Cuny* (Wernigerode, Germany), A.T. Feßler,
S. Schwarz, W. Witte
P1655
Staphylococcus aureus isolated from farm
animals and humans in close contact in Greece
E. Drougka* (Patras, Greece), A. Foka,
A. Liakopoulos, D. Komodromos, D. Sergkelidis,
E.D. Anastasiou, E. Peteinaki, I. Spiliopoulou
P1656
Dynamic epidemiology of MRSA among horses
and staff at a veterinary teaching hospital, and
successful intervention to suppress spread
M.J. Schwaber* (Tel Aviv, Israel), S. Masarwa,
A. Adler, Y. Carmeli, G. Kelmer, A. Steinman
Poster Sessions
Tuesday, 13 May 2014
P1661
Detection of PVL-positive ST152 and of ST398
MRSA isolates in dairy products in a region of
southern Italy
M. Monaco* (Rome, Italy), G. La Salandra,
F. Mancini, M.G. Basanisi, A. Pantosti
Genetic characteristics of 3rd generation
cephalosporin-resistant Klebsiella pneumoniae
from humans and animals in Switzerland
N. Wohlwend, A. Endimiani, V. Perreten* (Berne,
Switzerland)
P1662
Prevalence and antibiotic susceptibilities of
pathogenic Yersinia enterocolitica strains in pigs
slaughtered in northern Italy
M.C. Ossiprandi* (Parma, Italy), L. Zerbini
P1663
Temporal and spatial dissemination of two main
genotypes of Streptococcus dysgalactiae subsp.
equisimilis isolates in Brazil and evidence for
zoonotic transmission
L.G. Silva, G.L. Genteluci, T.S. Glatthardt,
M.C. De Mattos, A.M.S. Figueiredo, B.T.F. Carvalho*
(Rio de Janeiro, Brazil)
P1664
P1665
Microbiological and molecular analysis of human
invasive Streptococcus suis isolates
A. Bojarska* (Warsaw, Poland), E. Molska,
E. Stefaniuk, W. Hryniewicz, E. Sadowy
The effects of zinc on methicillin-resistant
Staphylococcus aureus in swine production:
a randomised-controlled trial
M. Slifierz* (Guelph, Canada), R. Friendship,
J.S. Weese
POSTER SESSION VI:
New quinolones, oxazolidones, and a chimera of both
P1666
In vitro activity of topoisomerase inhibitor
GSK2140944 against Legionella pneumophila
J. Dubois* (Sherbrooke, Canada), M. Dubois,
J.-F. Martel, D.L. Butler
P1667
AZD0914: establishment of preliminary quality
control ranges against bacterial reference
strains
S. Patey* (Waltham, United States), L. Otterson,
M. Huband
P1668
Zabofloxacin for the treatment of mild to
moderate community-acquired bacterial
pneumonia compared to moxifloxacin; a phase 2
study
G. Tillotson* (Downingtown, United States),
Y.S. Kim, M.J. Kim, K.R. Baek, C.H. Lim, J. Rock,
D.R. Choi
P1669
Efficacy of the investigational fluoroquinolone
finafloxacin against resistant staphylococci as
compared to ciprofloxacin, levofloxacin, and
moxifloxacin
I. Morrissey, S. Hawser, A. Vente* (Berlin, Germany),
A. Dalhoff
P1670
Ecological and pharmacodynamic effects of
MCB3681 on skin, nasal, oropharyngeal and
intestinal microbiota
M.U. Rashid, A. Dalhoff, T. Kapsner, T. Bäckström,
L. Björkhem Bergman, G. Panagiotidis, A. Weintraub,
C.E. Nord* (Stockholm, Sweden)
P1671
Mode of action of MCB3681 – analysis of
MCB3681 proteome signature
A. Dalhoff* (Kiel, Germany), B. Voigt, T. Kapsner
P1672
Linezolid use in bone and joint infection in a
tertiary care centre
R. Buzelé* (Tours,